data_2kms_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kms _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 35.9 m -72.87 -67.83 0.53 Allowed 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.33 0.586 . . . . 0.0 109.485 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 130.11 -161.46 23.08 Favored Glycine 1 N--CA 1.367 -5.938 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -41.14 116.19 0.7 Allowed 'General case' 0 C--N 1.274 -2.696 0 C-N-CA 127.196 2.198 . . . . 0.0 112.09 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.506 HG22 HG23 ' A' ' 715' ' ' VAL . 1.7 pp -59.94 149.56 72.99 Favored Pre-proline 0 N--CA 1.435 -1.205 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.017 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.411 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 71.2 Cg_endo -74.11 -160.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.611 2.207 . . . . 0.0 110.42 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . 0.597 ' HA ' ' HE2' ' A' ' 717' ' ' PHE . 13.1 pt-20 -149.85 170.3 19.11 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.735 HD11 ' SG ' ' A' ' 744' ' ' CYS . 17.7 mt -97.48 128.71 44.47 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 123.914 0.759 . . . . 0.0 111.376 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -46.17 -33.88 3.9 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.078 -1.874 . . . . 0.0 112.723 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.417 ' HB3' ' CE1' ' A' ' 723' ' ' PHE . 96.4 m-70 -145.89 26.7 1.23 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -137.94 -148.36 5.36 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.472 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -150.9 176.2 11.31 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -104.69 157.34 17.25 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.421 ' HA ' ' NE2' ' A' ' 703' ' ' GLN . 22.0 mm-40 -94.6 -68.75 0.78 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.092 0.472 . . . . 0.0 111.297 175.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . 0.463 ' O ' HG11 ' A' ' 715' ' ' VAL . 58.9 tp -146.14 123.39 11.56 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.472 ' HB3' ' CG1' ' A' ' 715' ' ' VAL . 2.8 p -144.86 105.0 4.06 Favored 'General case' 0 N--CA 1.396 -3.131 0 CA-C-O 122.024 0.916 . . . . 0.0 109.347 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 10.2 m -116.34 132.03 23.52 Favored Pre-proline 0 C--N 1.246 -3.914 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.621 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.462 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 57.5 Cg_endo -64.65 172.87 6.22 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.592 2.194 . . . . 0.0 110.183 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.69 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.0 Cg_exo -76.61 -7.03 28.4 Favored 'Cis proline' 0 N--CA 1.487 1.124 0 N-CA-C 114.839 1.053 . . . . 0.0 114.839 6.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 57.4 m-85 72.95 79.28 0.14 Allowed 'General case' 0 C--N 1.314 -0.975 0 O-C-N 124.242 0.964 . . . . 0.0 109.217 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.69 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 38.1 m-85 -87.0 172.52 9.94 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.235 -175.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -69.32 131.7 45.26 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.994 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.65 -15.16 60.07 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 0.5 OUTLIER -65.42 145.98 55.47 Favored 'General case' 0 CA--C 1.477 -1.861 0 CA-C-O 121.42 0.628 . . . . 0.0 110.262 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 17.8 m -133.97 148.83 51.2 Favored 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.506 HG23 HG22 ' A' ' 694' ' ' ILE . 61.8 t -134.58 130.61 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.845 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 44.0 mt-10 -82.16 139.28 34.42 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 121.609 0.719 . . . . 0.0 110.813 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.597 ' HE2' ' HA ' ' A' ' 696' ' ' GLU . 28.5 m-85 -137.35 120.55 16.79 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 125.867 1.667 . . . . 0.0 107.478 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -128.78 -163.44 1.29 Allowed 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 22.3 m -118.87 134.03 55.44 Favored 'General case' 0 C--N 1.267 -3.018 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 21.1 t -73.15 -84.5 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 O-C-N 123.923 0.764 . . . . 0.0 112.019 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -133.77 132.59 40.7 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.459 0.303 . . . . 0.0 110.632 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 4.4 t 71.9 26.29 2.97 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 124.598 1.186 . . . . 0.0 110.055 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.3 m-85 -140.72 145.98 37.17 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.51 HG21 ' O ' ' A' ' 745' ' ' VAL . 6.4 t -75.23 -118.38 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.605 -174.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.514 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 7.9 ttp 162.82 104.83 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 128.898 2.879 . . . . 0.0 105.29 174.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.9 mm -119.96 139.25 47.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 102.17 -75.79 0.33 Allowed Glycine 0 N--CA 1.429 -1.797 0 O-C-N 123.559 0.537 . . . . 0.0 112.729 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.555 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 2.1 t60 -146.98 -172.97 4.12 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.514 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -141.89 22.94 2.09 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.28 170.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.434 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 16.4 p -157.44 162.71 38.97 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.034 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 714' ' ' SER . 32.4 pt -122.6 164.6 19.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 732' ' ' THR . . . . . 0.415 ' O ' HG21 ' A' ' 739' ' ' THR . 7.3 m -135.77 135.01 39.58 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.977 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 6.0 t -84.68 106.83 16.52 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.473 0.654 . . . . 0.0 110.437 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -142.97 143.58 24.98 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 125.221 1.408 . . . . 0.0 109.988 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 64.39 4.2 2.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.06 13.5 52.46 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 738' ' ' TRP . 80.7 t -140.66 154.23 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.464 ' O ' HG13 ' A' ' 737' ' ' VAL . 94.2 m95 -79.95 177.64 8.78 Favored 'General case' 0 C--N 1.273 -2.748 0 O-C-N 121.89 -0.506 . . . . 0.0 109.786 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.415 HG21 ' O ' ' A' ' 732' ' ' THR . 27.1 p -84.89 -163.95 0.91 Allowed 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.856 0.836 . . . . 0.0 112.506 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.467 ' H ' ' NE2' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -74.81 -17.05 60.68 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -168.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 1.5 mt 68.73 151.33 0.13 Allowed Pre-proline 0 N--CA 1.479 1.019 0 O-C-N 123.889 0.743 . . . . 0.0 112.231 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.555 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 42.9 Cg_endo -73.56 177.52 7.89 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.796 1.664 . . . . 0.0 111.249 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -120.17 103.09 8.97 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.234 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.735 ' SG ' HD11 ' A' ' 697' ' ' LEU . 84.1 m -79.07 110.26 14.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.971 173.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.51 ' O ' HG21 ' A' ' 724' ' ' THR . 46.6 t -104.72 147.03 11.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.96 -0.85 1.71 Allowed 'General case' 0 C--N 1.284 -2.253 0 C-N-CA 125.204 1.402 . . . . 0.0 114.089 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.547 ' HB ' ' O ' ' A' ' 746' ' ' ALA . 48.6 mt 74.54 -14.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 125.589 1.555 . . . . 0.0 110.93 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 746' ' ' ALA . 1.0 OUTLIER -75.3 -27.89 59.5 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 126.149 1.78 . . . . 0.0 108.755 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -106.92 16.96 23.71 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.063 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.769 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 1.3 mp -83.15 -178.67 7.18 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.766 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . 0.571 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 55.0 mtpt -125.59 150.66 47.32 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.58 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -90.14 111.22 22.29 Favored 'General case' 0 C--N 1.251 -3.689 0 CA-C-N 112.421 -2.172 . . . . 0.0 108.726 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 61.2 m -70.78 138.29 50.29 Favored 'General case' 0 C--N 1.269 -2.898 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.14 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -107.86 138.28 44.38 Favored 'General case' 0 C--N 1.271 -2.806 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.13 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 755' ' ' SER . . . . . 0.405 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.4 p -67.83 123.65 21.13 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.465 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.63 ' HB3' HG13 ' A' ' 759' ' ' ILE . 25.9 t -70.89 146.18 49.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.9 3.28 49.09 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -92.46 -29.52 16.21 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.63 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -98.53 158.51 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.294 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.057 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.1 131.87 59.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.403 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 85.8 mt -105.56 179.82 4.16 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.143 0.497 . . . . 0.0 110.124 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . 0.638 ' HB2' HD22 ' A' ' 765' ' ' LEU . 37.8 mt-10 -69.4 170.53 10.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.731 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.02 -20.09 66.32 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.16 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . 0.486 ' HB2' HD23 ' A' ' 765' ' ' LEU . 15.6 m-70 -90.1 -30.09 17.9 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.638 HD22 ' HB2' ' A' ' 762' ' ' GLU . 2.7 mm? -93.9 -14.18 26.33 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.371 -165.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 28.5 mtmm -71.77 -8.8 56.44 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.762 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -94.57 -1.7 52.85 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -105.28 126.34 51.98 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . 0.83 ' HG3' ' HG2' ' A' ' 770' ' ' GLU . 18.8 ptpt -98.49 -29.37 13.14 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.612 0.72 . . . . 0.0 109.107 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . 0.83 ' HG2' ' HG3' ' A' ' 769' ' ' LYS . 4.7 pt-20 -140.06 136.38 33.58 Favored 'General case' 0 N--CA 1.39 -3.456 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.462 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.415 ' CE2' HG22 ' A' ' 777' ' ' ILE . 86.3 m-85 -110.66 148.66 31.78 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.623 -175.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -90.91 166.04 13.26 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.525 ' HB3' HD23 ' A' ' 750' ' ' LEU . 26.6 t60 -62.67 157.35 21.07 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 122.328 0.251 . . . . 0.0 111.076 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 77.69 9.8 2.36 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.209 1.004 . . . . 0.0 109.654 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 47.4 t -86.36 104.5 15.93 Favored 'General case' 0 N--CA 1.385 -3.687 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.454 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -90.13 101.37 14.08 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 177.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.415 HG22 ' CE2' ' A' ' 771' ' ' PHE . 7.9 pt -112.32 -174.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 CA-C-O 121.591 0.71 . . . . 0.0 109.797 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.572 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 27.6 ptt180 -141.08 122.5 14.97 Favored 'General case' 0 N--CA 1.391 -3.424 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.555 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.497 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 9.6 p90 -113.66 172.9 6.7 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -155.47 169.26 24.68 Favored 'General case' 0 N--CA 1.411 -2.379 0 O-C-N 123.934 0.771 . . . . 0.0 109.356 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.562 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 16.4 t -102.26 162.22 13.09 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . 0.413 ' O ' ' HG3' ' A' ' 782' ' ' ARG . 12.0 ptm180 -74.8 80.14 2.09 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.601 1.191 . . . . 0.0 108.293 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 147.28 -27.72 1.54 Allowed Glycine 0 N--CA 1.417 -2.596 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.269 -172.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.562 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 14.3 mptt -84.02 103.32 13.16 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -87.34 81.27 7.93 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 162.62 -170.02 38.05 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 106.261 -2.736 . . . . 0.0 106.261 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 64.7 m95 -130.76 158.51 39.93 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 118.962 1.381 . . . . 0.0 109.364 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.497 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -99.94 -41.94 9.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.132 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 11.3 m170 80.7 133.25 0.06 Allowed 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.052 1.341 . . . . 0.0 110.259 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 799' ' ' PRO . 4.5 t -157.17 158.98 37.27 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.107 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 45.0 t -120.91 133.24 68.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.273 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 37.9 t -68.33 115.11 7.39 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.152 0.501 . . . . 0.0 109.995 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 45.3 mm -117.3 83.09 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 C-N-CA 123.726 0.81 . . . . 0.0 109.332 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.769 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 0.6 OUTLIER 49.78 66.01 1.25 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.811 0.845 . . . . 0.0 111.259 176.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 77.44 14.36 82.58 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.887 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -139.02 166.11 25.37 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.1 m95 -116.88 156.3 27.58 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -147.62 104.28 3.7 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 43.1 Cg_endo -70.51 142.76 73.04 Favored 'Cis proline' 0 C--O 1.239 0.575 0 C-N-CA 124.0 -1.25 . . . . 0.0 113.248 0.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 47.3 mt-10 -53.86 125.42 18.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.445 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 1 N--CA 1.371 -4.404 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.719 -175.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.421 -1.892 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 51.8 m -79.06 -66.99 0.8 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 93.17 142.22 11.51 Favored Glycine 0 N--CA 1.405 -3.38 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.666 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 35.6 t70 53.69 97.32 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 125.815 1.646 . . . . 0.0 112.441 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.439 HG23 HG22 ' A' ' 715' ' ' VAL . 1.8 pp -63.68 147.3 95.94 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.399 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.42 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.9 Cg_endo -69.63 -171.61 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.729 2.286 . . . . 0.0 112.134 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -121.79 179.05 4.61 Favored 'General case' 0 N--CA 1.393 -3.297 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.554 HD21 ' HB3' ' A' ' 717' ' ' PHE . 25.0 tp -124.33 129.43 50.71 Favored 'General case' 0 C--N 1.251 -3.675 0 CA-C-O 120.915 0.388 . . . . 0.0 110.953 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 5.5 pt-20 -38.66 -51.34 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.479 1.912 . . . . 0.0 114.756 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.651 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.8 m-70 -141.12 26.26 2.03 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -139.16 -146.39 4.92 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.552 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -152.05 178.31 9.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -174.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -113.05 143.88 43.56 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -73.56 -62.71 1.39 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.6 tt -166.56 135.52 2.95 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.459 ' HB3' HG12 ' A' ' 715' ' ' VAL . 13.1 p -129.95 119.86 23.89 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-O 121.351 0.596 . . . . 0.0 110.074 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 13.2 p -108.47 113.17 60.42 Favored Pre-proline 0 C--N 1.276 -2.609 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.239 -174.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.467 ' HA ' ' N ' ' A' ' 709' ' ' TYR . 57.6 Cg_endo -69.7 171.5 14.28 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.856 2.37 . . . . 0.0 110.527 176.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 709' ' ' TYR . 18.1 Cg_endo -64.84 -4.89 3.07 Favored 'Cis proline' 0 N--CA 1.496 1.676 0 N-CA-C 117.077 1.914 . . . . 0.0 117.077 2.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 35.6 m-85 68.68 65.57 0.31 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.509 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 16.7 m-85 -69.75 172.77 7.05 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.877 -1.511 . . . . 0.0 112.103 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -72.21 132.05 43.58 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.901 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.34 -6.41 65.81 Favored Glycine 0 N--CA 1.413 -2.867 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.82 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 1.4 t70 -68.79 155.89 39.35 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 19.4 m -146.81 145.08 29.78 Favored 'General case' 0 C--N 1.274 -2.697 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 730' ' ' SER . 46.1 t -132.04 134.69 59.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.887 -176.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -79.85 133.85 36.29 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 123.78 0.675 . . . . 0.0 111.676 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.554 ' HB3' HD21 ' A' ' 697' ' ' LEU . 26.7 m-85 -138.28 129.88 27.88 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 125.38 1.472 . . . . 0.0 107.28 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -137.71 -161.5 1.18 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 725' ' ' MET . 11.7 m -118.71 131.77 56.15 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 18.9 t -67.02 -75.61 0.09 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 124.239 0.962 . . . . 0.0 110.721 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 722' ' ' SER . 44.7 mt-10 -149.18 152.9 36.86 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 69.3 m 72.92 2.69 4.46 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 124.285 0.991 . . . . 0.0 112.766 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.65 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.7 m-85 -138.56 144.74 40.0 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.498 HG22 HD22 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -107.09 136.43 46.95 Favored 'General case' 0 C--N 1.255 -3.505 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.265 -177.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.756 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 7.6 ttp -84.29 118.6 24.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 124.196 0.998 . . . . 0.0 109.636 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 48.3 mm -127.33 141.68 45.65 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.998 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 106.5 -66.9 0.25 Allowed Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.392 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 20.7 t60 -165.83 -177.6 4.37 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 -175.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.756 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -143.31 25.43 1.71 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 119.027 0.831 . . . . 0.0 110.699 176.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 16.0 m -152.47 163.66 39.1 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.884 -0.51 . . . . 0.0 109.782 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.475 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 32.2 pt -125.3 163.45 26.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.745 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 732' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 739' ' ' THR . 17.5 m -137.03 134.1 36.2 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.252 0.345 . . . . 0.0 111.08 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 3.4 t -86.84 105.85 17.32 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -141.28 140.43 31.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.984 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 60.44 14.19 4.61 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 89.11 25.22 29.59 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.81 144.89 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.089 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.489 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 97.3 m95 -72.63 -179.34 3.01 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.5 0.667 . . . . 0.0 110.138 170.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 732' ' ' THR . 27.9 p -90.95 -152.9 0.29 Allowed 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.458 ' NE2' ' HB ' ' A' ' 739' ' ' THR . 0.0 OUTLIER -81.52 -14.87 56.4 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -169.029 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.2 mm? 71.12 151.59 0.14 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 123.967 0.792 . . . . 0.0 110.824 -175.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.546 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 36.2 Cg_endo -71.13 177.64 6.29 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.028 1.819 . . . . 0.0 110.736 172.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -125.07 132.92 53.09 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.651 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 84.6 m -116.38 107.06 14.33 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-O 121.458 0.646 . . . . 0.0 109.834 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 747' ' ' ILE . 21.6 t -97.58 142.82 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.682 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.657 ' O ' ' HB ' ' A' ' 747' ' ' ILE . . . -65.97 1.91 1.27 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 125.247 1.419 . . . . 0.0 113.414 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.657 ' HB ' ' O ' ' A' ' 746' ' ' ALA . 40.0 mt 79.35 -19.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 125.41 1.484 . . . . 0.0 111.031 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.0 t70 -72.01 -34.26 68.71 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.118 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -98.74 17.76 18.57 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.274 -1.785 . . . . 0.0 109.498 -172.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.83 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 1.7 mp -82.37 -174.06 4.93 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.539 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . 0.6 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 1.2 mmpt? -136.43 -177.1 4.57 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -130.97 144.4 51.45 Favored 'General case' 0 C--N 1.268 -2.963 0 C-N-CA 125.297 1.439 . . . . 0.0 107.202 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 770' ' ' GLU . 69.1 m -92.78 167.08 12.1 Favored 'General case' 0 C--N 1.246 -3.899 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.24 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -125.88 136.0 52.56 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.895 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 755' ' ' SER . . . . . 0.417 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.0 p -67.18 118.44 10.6 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.582 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.556 ' HB3' HG13 ' A' ' 759' ' ' ILE . 28.3 t -66.15 143.15 57.46 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -77.85 -6.97 55.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 89.2 mt -105.16 -11.69 16.45 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.813 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.556 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -96.43 162.32 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.806 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . 0.453 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.4 mp -118.98 117.4 54.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.777 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 63.7 mt -93.51 -177.25 4.35 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . 0.507 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 31.5 mt-10 -62.85 176.84 0.63 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.354 0.597 . . . . 0.0 110.093 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -86.02 -6.06 59.11 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 123.431 1.586 . . . . 0.0 107.406 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . 0.274 63.8 t60 -88.98 -43.04 11.43 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 110.712 -2.949 . . . . 0.0 108.194 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.513 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 54.8 mt -96.2 -13.43 23.49 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.861 -171.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 54.1 mtmt -65.66 -15.9 63.22 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.806 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -89.84 1.64 55.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.506 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . 0.446 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 11.3 tppt? -103.52 109.91 21.74 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -83.02 -36.49 24.94 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 753' ' ' CYS . 3.8 pt-20 -130.29 134.02 46.9 Favored 'General case' 0 N--CA 1.403 -2.789 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.635 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.777 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 81.0 m-85 -112.09 143.19 43.53 Favored 'General case' 0 C--N 1.267 -3.012 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.009 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.89 154.78 19.61 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.488 ' CB ' HD23 ' A' ' 750' ' ' LEU . 18.5 p-80 -43.21 143.56 0.81 Allowed 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.974 1.31 . . . . 0.0 111.55 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 14.0 m120 68.19 12.28 8.7 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.23 1.012 . . . . 0.0 113.435 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 775' ' ' SER . . . . . 0.522 ' HG ' HG22 ' A' ' 777' ' ' ILE . 43.4 t -77.84 110.48 12.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.425 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.8 OUTLIER -86.82 101.3 13.22 Favored 'General case' 0 CA--C 1.494 -1.203 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.596 HG21 ' CE2' ' A' ' 771' ' ' PHE . 5.6 pt -114.0 -173.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.269 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.534 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 26.9 ptt180 -142.28 124.81 15.76 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.478 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 4.4 p90 -114.79 172.54 6.98 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . 0.453 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 27.0 ptt180 -150.19 178.57 8.86 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 48.1 t -114.94 162.94 16.27 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -74.51 -21.49 59.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.286 0.565 . . . . 0.0 110.129 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -99.93 -8.79 50.56 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.072 175.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.572 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 13.3 mptt -128.14 104.53 7.81 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 122.686 -0.302 . . . . 0.0 110.735 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.31 169.92 17.39 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 97.58 -168.02 23.69 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 75.6 m95 -138.69 142.9 38.96 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 118.613 1.206 . . . . 0.0 109.714 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.478 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.5 mp -93.6 -40.51 11.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.056 -177.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . 0.481 ' HA ' ' O ' ' A' ' 777' ' ' ILE . 15.3 m170 75.0 129.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.677 1.191 . . . . 0.0 109.633 -174.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 3.4 t -151.42 154.61 36.96 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 120.755 0.312 . . . . 0.0 110.334 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.3 t -115.99 133.42 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.395 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 54.0 t -69.38 112.48 5.95 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.788 0.804 . . . . 0.0 110.173 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 47.4 mm -112.45 81.35 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 C-N-CA 124.534 1.133 . . . . 0.0 108.84 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.83 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 0.4 OUTLIER 51.62 66.13 1.29 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.374 176.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.49 20.25 79.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.348 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -147.29 163.99 34.65 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.6 m95 -108.92 162.09 14.53 Favored 'General case' 0 C--N 1.258 -3.388 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.684 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -150.24 102.14 3.15 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.81 140.56 64.45 Favored 'Cis proline' 0 N--CA 1.48 0.705 0 C-N-CA 123.917 -1.284 . . . . 0.0 113.704 -0.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 44.6 mt-10 -50.48 123.85 9.51 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.585 175.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 1 N--CA 1.374 -4.264 0 CA-C-O 121.458 0.647 . . . . 0.0 111.078 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.431 -1.424 0 CA-C-O 120.864 0.364 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 64.2 m -73.5 -70.89 0.35 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 94.23 135.78 7.92 Favored Glycine 0 N--CA 1.413 -2.876 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.616 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 25.3 t70 62.25 112.94 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 O-C-N 125.324 1.249 . . . . 0.0 111.829 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.62 HG22 HG22 ' A' ' 715' ' ' VAL . 1.6 pp -80.0 147.03 64.86 Favored Pre-proline 0 C--N 1.283 -2.305 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.05 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.419 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 71.1 Cg_endo -71.64 -166.9 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 123.499 2.799 . . . . 0.0 112.994 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -129.91 164.64 23.76 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 717' ' ' PHE . 23.7 tp -109.32 132.9 53.69 Favored 'General case' 0 C--N 1.256 -3.498 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.742 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 7.0 pt-20 -43.49 -53.43 5.5 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 125.925 1.69 . . . . 0.0 113.713 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.469 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 89.9 m-70 -137.49 28.15 2.75 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -136.2 -151.63 6.14 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.541 -176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -150.21 174.55 12.68 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -108.66 142.27 39.4 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -78.3 -67.87 0.69 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 120.72 0.295 . . . . 0.0 111.524 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.3 tt -161.68 137.21 7.61 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.468 ' HA ' HG12 ' A' ' 715' ' ' VAL . 35.5 p -111.8 -49.2 3.0 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -169.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 706' ' ' SER . . . . . 0.403 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 66.0 m 58.84 100.26 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 706' ' ' SER . 40.9 Cg_endo -66.69 171.72 10.46 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.416 2.077 . . . . 0.0 109.733 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.601 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.8 Cg_endo -73.67 -2.22 14.73 Favored 'Cis proline' 0 N--CA 1.484 0.962 0 N-CA-C 116.662 1.755 . . . . 0.0 116.662 7.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.483 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 33.5 m-85 68.55 72.94 0.28 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 123.691 0.62 . . . . 0.0 109.413 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.601 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 22.5 m-85 -81.2 172.67 13.36 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.459 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -72.58 127.43 32.53 Favored 'General case' 0 CA--C 1.481 -1.691 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.143 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.1 -17.86 53.18 Favored Glycine 0 N--CA 1.406 -3.303 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.656 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.67 144.83 56.67 Favored 'General case' 0 CA--C 1.481 -1.692 0 CA-C-O 121.285 0.564 . . . . 0.0 110.089 177.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 10.2 m -128.11 153.69 46.56 Favored 'General case' 0 N--CA 1.404 -2.739 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.898 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.62 HG22 HG22 ' A' ' 694' ' ' ILE . 46.4 t -135.83 127.4 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.559 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 37.0 mt-10 -84.86 138.01 32.8 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.889 0.852 . . . . 0.0 111.702 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.551 ' HB3' HD21 ' A' ' 697' ' ' LEU . 30.1 m-85 -138.08 128.83 26.8 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 125.487 1.515 . . . . 0.0 107.028 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -124.69 -163.12 1.14 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 22.4 m -107.39 136.55 47.0 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 23.3 t -66.14 -62.56 1.42 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 123.924 0.765 . . . . 0.0 111.416 -169.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.47 153.13 15.04 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 55.7 m 64.43 13.08 7.85 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 94.4 m-85 -141.27 146.15 36.45 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-O 122.028 0.918 . . . . 0.0 110.169 -175.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.44 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -110.19 134.95 51.7 Favored 'General case' 0 C--N 1.253 -3.617 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.932 -179.201 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.778 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.4 ttp -82.21 121.77 27.05 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.602 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.51 128.31 74.55 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.27 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.12 -90.51 0.53 Allowed Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.154 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.65 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 15.6 t60 -144.74 164.39 31.16 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.778 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -118.72 23.75 11.28 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.504 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.559 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 6.3 p -153.11 159.67 42.81 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.97 0.414 . . . . 0.0 111.389 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 741' ' ' LEU . 27.8 pt -110.43 166.86 5.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.545 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 732' ' ' THR . . . . . 0.452 ' O ' HG22 ' A' ' 739' ' ' THR . 19.4 m -138.41 133.49 32.92 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.724 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 2.1 t -81.13 105.21 12.16 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.306 0.574 . . . . 0.0 109.708 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 736' ' ' GLY . 1.6 pp -143.97 144.75 22.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.022 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 71.02 -15.49 0.4 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.982 0.913 . . . . 0.0 113.322 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 734' ' ' ILE . . . 118.94 17.99 4.84 Favored Glycine 1 CA--C 1.445 -4.328 0 CA-C-O 121.364 0.424 . . . . 0.0 112.878 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -154.24 177.79 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.39 -3.456 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.483 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 89.8 m95 -90.38 -173.89 3.95 Favored 'General case' 0 C--N 1.266 -3.065 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 732' ' ' THR . 38.8 p -85.06 -155.76 0.23 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.225 0.536 . . . . 0.0 110.257 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.5 OUTLIER -93.83 3.48 55.35 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -168.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.0 mm? 71.6 159.93 0.16 Allowed Pre-proline 0 N--CA 1.481 1.123 0 O-C-N 123.82 0.7 . . . . 0.0 110.404 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.65 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 18.5 Cg_endo -72.94 -177.71 3.07 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 121.673 1.582 . . . . 0.0 111.356 171.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -122.1 125.94 47.29 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.472 ' SG ' HD22 ' A' ' 697' ' ' LEU . 64.7 m -116.7 94.87 4.78 Favored 'General case' 0 CA--C 1.481 -1.689 0 CA-C-O 121.659 0.742 . . . . 0.0 110.554 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.476 ' C ' ' H ' ' A' ' 747' ' ' ILE . 30.7 t -89.16 143.02 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.881 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.616 -177.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -62.51 4.31 0.16 Allowed 'General case' 0 C--N 1.283 -2.305 0 C-N-CA 125.733 1.613 . . . . 0.0 114.89 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.825 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 65.7 mt 77.37 -17.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 126.156 1.782 . . . . 0.0 111.34 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.7 t70 -79.85 -31.77 40.47 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-N 113.177 -1.829 . . . . 0.0 109.293 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -107.35 19.82 19.77 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.193 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.825 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 85.0 mt -81.46 -177.69 6.62 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 114.547 -1.206 . . . . 0.0 107.898 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . 0.52 ' HE3' ' HA3' ' A' ' 795' ' ' GLY . 27.1 mtpp -98.63 156.4 16.83 Favored 'General case' 0 N--CA 1.386 -3.638 0 CA-C-O 121.954 0.883 . . . . 0.0 108.977 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . 0.598 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 43.5 mtpt -105.65 116.82 32.59 Favored 'General case' 1 C--N 1.238 -4.242 0 CA-C-N 112.524 -2.126 . . . . 0.0 108.171 -172.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 65.2 m -76.52 132.77 39.75 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.051 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.45 135.0 41.51 Favored 'General case' 0 C--N 1.278 -2.538 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.699 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 47.3 t -60.94 129.34 40.95 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.703 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.543 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 41.0 t -73.27 151.04 41.52 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -82.97 -0.38 48.42 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 98.8 mt -112.82 -8.87 13.71 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.543 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.2 pp -102.28 150.93 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 122.163 0.982 . . . . 0.0 113.385 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.4 mp -105.04 130.86 55.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.487 0 CA-C-N 113.595 -1.639 . . . . 0.0 107.387 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.28 -176.6 2.93 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . 0.448 ' HB2' HD22 ' A' ' 765' ' ' LEU . 48.1 mt-10 -65.29 165.72 11.18 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.885 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.33 -7.7 44.7 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.501 0.667 . . . . 0.0 111.795 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -4.45 17.35 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.797 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.448 HD22 ' HB2' ' A' ' 762' ' ' GLU . 3.0 mm? -117.04 -11.71 10.73 Favored 'General case' 0 C--O 1.207 -1.136 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.438 ' HZ1' ' HB2' ' A' ' 766' ' ' LYS . 10.4 mtmp? -70.85 -16.49 62.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.454 0.645 . . . . 0.0 110.228 176.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -78.72 -13.53 59.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.917 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 7.9 tppt? -98.32 126.81 43.98 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . 0.435 ' HE2' ' HB3' ' A' ' 769' ' ' LYS . 15.3 ptpt -110.37 -19.65 12.89 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . 0.598 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 36.4 mt-10 -134.25 107.79 7.87 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.543 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 768' ' ' LYS . 79.4 m-85 -93.2 162.71 13.91 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.84 -175.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -101.86 154.78 18.61 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.483 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 28.5 t60 -60.19 144.38 50.21 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.902 0.126 . . . . 0.0 111.038 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 63.7 t30 88.12 3.1 0.31 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 125.445 1.716 . . . . 0.0 111.27 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 86.8 p -73.61 105.75 5.08 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 119.803 -0.759 . . . . 0.0 108.988 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.446 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -87.03 90.2 8.27 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 789' ' ' HIS . 7.6 pt -104.55 -170.91 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.562 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.581 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 16.6 ptt180 -142.83 125.61 16.02 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.066 174.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.626 ' CD2' HG11 ' A' ' 801' ' ' VAL . 13.1 p90 -106.87 167.46 9.86 Favored 'General case' 0 C--O 1.257 1.496 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -155.67 161.82 40.7 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 3.1 m -98.95 173.88 6.63 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -101.91 36.25 2.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.479 1.133 . . . . 0.0 109.674 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -176.72 -33.72 0.05 OUTLIER Glycine 0 CA--C 1.473 -2.564 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 0.4 OUTLIER -96.82 139.72 32.44 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 176.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.31 154.41 19.4 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.572 0.701 . . . . 0.0 112.891 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 91.2 154.51 30.67 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.349 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 52.0 m95 -95.85 141.04 29.77 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.476 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -95.42 -31.21 4.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.568 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . 0.499 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 12.0 m170 72.44 118.37 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 124.062 0.945 . . . . 0.0 111.114 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.521 HG21 ' CG2' ' A' ' 801' ' ' VAL . 3.4 t -141.51 153.28 44.8 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.556 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 38.9 t -114.45 132.91 62.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.712 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.15 115.06 8.92 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.483 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 46.5 mm -114.5 84.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.406 ' C ' ' HB2' ' A' ' 751' ' ' LYS . 7.7 t-20 46.92 68.11 0.68 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.845 0.858 . . . . 0.0 111.992 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . 0.52 ' HA3' ' HE3' ' A' ' 751' ' ' LYS . . . 72.28 24.09 76.92 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 114.958 -1.019 . . . . 0.0 114.293 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -146.88 168.5 21.3 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.574 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 91.3 m95 -117.24 161.99 18.6 Favored 'General case' 0 C--N 1.266 -3.038 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -150.58 104.56 3.08 Favored Pre-proline 0 C--N 1.296 -1.727 0 O-C-N 123.344 0.402 . . . . 0.0 110.063 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 36.7 Cg_endo -68.57 140.98 59.77 Favored 'Cis proline' 0 C--O 1.239 0.565 0 C-N-CA 123.993 -1.253 . . . . 0.0 112.306 -1.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 52.2 mt-10 -49.33 120.71 4.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.876 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.626 HG11 ' CD2' ' A' ' 779' ' ' TYR . 67.7 t . . . . . 0 N--CA 1.439 -1.004 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.104 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.599 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.2 m -82.25 -61.97 1.75 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.004 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 134.08 174.56 13.55 Favored Glycine 1 N--CA 1.374 -5.466 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.698 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 29.9 t70 -52.0 135.34 31.04 Favored 'General case' 0 C--N 1.276 -2.589 0 O-C-N 124.803 0.943 . . . . 0.0 111.38 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.572 HG21 HG22 ' A' ' 715' ' ' VAL . 1.3 pp -55.6 150.34 25.95 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.145 -1.389 . . . . 0.0 114.076 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.483 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 65.1 Cg_endo -72.67 -161.62 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.468 2.778 . . . . 0.0 111.321 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -135.82 151.86 50.49 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 717' ' ' PHE . 26.4 tp -92.66 123.22 35.79 Favored 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.893 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.524 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 5.4 pt-20 -34.63 -50.78 0.46 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.334 2.253 . . . . 0.0 114.417 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.524 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 83.5 m-70 -136.28 28.83 3.07 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -142.17 -156.15 6.7 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.389 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . 0.43 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -140.25 -178.31 5.42 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -115.72 146.09 42.19 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -74.16 -68.57 0.51 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.337 0.589 . . . . 0.0 110.806 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.4 tt -159.8 138.97 10.99 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.447 ' HB3' HG13 ' A' ' 715' ' ' VAL . 4.1 p -153.44 123.54 6.96 Favored 'General case' 0 N--CA 1.395 -3.197 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 20.6 m -128.08 130.44 23.6 Favored Pre-proline 0 C--N 1.278 -2.539 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.284 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.45 168.59 14.25 Favored 'Trans proline' 0 C--O 1.248 0.976 0 C-N-CA 122.715 2.277 . . . . 0.0 109.716 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.594 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 2.6 Cg_endo -71.64 -11.71 15.77 Favored 'Cis proline' 0 N--CA 1.483 0.892 0 N-CA-C 116.097 1.537 . . . . 0.0 116.097 6.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.698 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 66.7 m-85 68.92 77.77 0.22 Allowed 'General case' 0 C--O 1.248 0.995 0 O-C-N 123.857 0.723 . . . . 0.0 109.643 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.594 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 47.5 m-85 -82.99 171.53 13.73 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.843 0.83 . . . . 0.0 113.204 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 0.651 ' HH ' ' HA2' ' A' ' 736' ' ' GLY . 91.1 m-85 -71.41 132.41 44.77 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.271 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.57 -15.63 55.7 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.1 147.67 46.48 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-O 121.088 0.47 . . . . 0.0 111.547 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 15.8 m -135.57 144.37 46.17 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.999 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.572 HG22 HG21 ' A' ' 694' ' ' ILE . 38.3 t -127.24 138.2 55.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.58 125.27 33.68 Favored 'General case' 0 N--CA 1.425 -1.723 0 O-C-N 124.338 1.024 . . . . 0.0 111.073 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.497 ' HB3' HD23 ' A' ' 697' ' ' LEU . 21.9 m-85 -128.21 118.12 22.76 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 125.785 1.634 . . . . 0.0 107.655 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.43 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 17.7 m-80 -120.41 -162.1 0.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 5.5 m -112.33 134.37 53.91 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 720' ' ' SER . . . . . 0.415 ' HA ' ' CE2' ' A' ' 701' ' ' TRP . 22.4 t -61.56 -58.54 7.72 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.216 0.532 . . . . 0.0 110.568 -172.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 722' ' ' SER . 12.6 pt-20 -174.18 166.2 4.14 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 68.4 m 68.33 0.63 2.58 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.239 0.962 . . . . 0.0 112.051 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.559 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.8 m-85 -137.22 144.83 43.01 Favored 'General case' 0 N--CA 1.395 -3.196 0 C-N-CA 124.243 1.017 . . . . 0.0 109.133 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.432 HG21 HD22 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -110.36 134.66 52.08 Favored 'General case' 0 C--N 1.254 -3.58 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.219 -177.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.5 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.0 ttp -84.62 122.81 29.58 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 124.236 1.015 . . . . 0.0 109.237 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.402 ' HA ' HD11 ' A' ' 726' ' ' ILE . 34.5 mm -111.28 122.81 66.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.822 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.728 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 99.44 -87.62 0.77 Allowed Glycine 0 N--CA 1.42 -2.422 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.634 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.453 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 48.9 p-80 -135.8 179.13 6.53 Favored 'General case' 0 N--CA 1.393 -3.286 0 C-N-CA 124.113 0.965 . . . . 0.0 108.478 -173.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.5 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.0 ppt_? -135.7 8.99 3.34 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 32.5 m -130.82 155.1 47.27 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.49 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 714' ' ' SER . 36.5 pt -110.4 160.66 9.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.24 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 732' ' ' THR . . . . . 0.418 ' O ' HG22 ' A' ' 739' ' ' THR . 26.9 m -135.75 133.71 38.26 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.192 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 7.1 t -84.87 103.88 14.33 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.86 145.87 23.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.776 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 72.69 -49.93 0.7 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.63 1.172 . . . . 0.0 111.919 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.651 ' HA2' ' HH ' ' A' ' 711' ' ' TYR . . . 158.4 24.26 0.03 OUTLIER Glycine 0 C--N 1.29 -1.991 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.367 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.4 p -160.01 157.88 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.483 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 93.5 m95 -78.39 170.68 16.24 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 24.8 p -74.91 -163.5 0.23 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.389 1.09 . . . . 0.0 113.528 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.587 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.0 OUTLIER -68.88 -23.9 64.27 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -170.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.3 mm? 81.95 148.22 0.11 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 124.786 1.304 . . . . 0.0 109.22 -173.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 19.6 Cg_endo -72.85 -175.56 1.95 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.928 1.752 . . . . 0.0 112.885 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -119.78 126.37 50.86 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 78.5 m -118.46 111.8 19.13 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.275 0.559 . . . . 0.0 109.799 177.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.471 ' C ' ' H ' ' A' ' 747' ' ' ILE . 41.7 t -100.91 145.14 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.583 ' O ' ' HB ' ' A' ' 747' ' ' ILE . . . -65.99 4.25 0.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.184 1.393 . . . . 0.0 113.672 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' A' ' 746' ' ' ALA . 32.0 mt 80.11 -26.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 126.302 1.841 . . . . 0.0 111.801 173.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 746' ' ' ALA . 38.7 t70 -82.95 -25.31 32.45 Favored 'General case' 0 C--N 1.248 -3.841 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.375 -172.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . 0.465 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 9.4 ptmt -112.65 34.91 4.09 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.72 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.841 ' HG ' ' HB2' ' A' ' 794' ' ' ASN . 0.8 OUTLIER -78.71 -166.36 0.87 Allowed 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.092 176.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -121.34 -178.66 3.84 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 121.542 0.687 . . . . 0.0 109.625 -174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -114.43 132.94 56.08 Favored 'General case' 0 C--N 1.262 -3.23 0 CA-C-N 112.991 -1.913 . . . . 0.0 107.804 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 58.3 m -90.49 174.29 7.62 Favored 'General case' 0 C--N 1.244 -4.0 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.391 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 754' ' ' LYS . 15.7 ptmt -144.15 152.39 40.84 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.173 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 20.4 p -62.52 126.06 26.04 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.69 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.532 ' HB2' HG13 ' A' ' 759' ' ' ILE . 11.3 m -72.85 136.37 45.32 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -72.09 -4.4 28.72 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 88.6 mt -105.6 -21.0 13.29 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.032 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.8 pp -98.48 171.31 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.077 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . 0.416 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.3 mp -117.31 136.44 54.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.429 HD13 ' CZ ' ' A' ' 771' ' ' PHE . 80.4 mt -107.11 177.0 4.98 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . 0.423 ' HB2' HD21 ' A' ' 765' ' ' LEU . 43.7 mt-10 -62.06 162.04 9.95 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.986 0.422 . . . . 0.0 110.736 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -70.18 -9.62 56.28 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.464 0.649 . . . . 0.0 111.02 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -109.86 -0.5 18.29 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.029 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 762' ' ' GLU . 3.1 mm? -123.67 -14.62 7.23 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.413 ' HG2' ' HB2' ' A' ' 761' ' ' LEU . 29.3 mtmm -68.37 -19.55 64.64 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.123 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -78.95 -17.27 55.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.139 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -85.99 107.98 18.01 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . 0.473 ' HG3' ' HG2' ' A' ' 770' ' ' GLU . 8.5 ptpp? -74.23 -32.65 63.07 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.688 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . 0.473 ' HG2' ' HG3' ' A' ' 769' ' ' LYS . 22.7 mm-40 -131.96 139.52 48.7 Favored 'General case' 0 CA--C 1.478 -1.799 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.429 ' CZ ' HD13 ' A' ' 761' ' ' LEU . 90.8 m-85 -112.45 134.0 54.22 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.724 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -86.21 155.71 20.6 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.526 ' HB2' HD23 ' A' ' 750' ' ' LEU . 18.8 p-80 -49.7 143.98 6.65 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.117 0.967 . . . . 0.0 112.052 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 19.1 m120 67.76 25.75 7.94 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 124.211 1.004 . . . . 0.0 112.781 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 69.0 m -93.86 109.12 20.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.542 ' HA ' HG12 ' A' ' 791' ' ' VAL . 0.7 OUTLIER -83.46 114.32 21.39 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.419 HD11 HD23 ' A' ' 761' ' ' LEU . 5.8 pt -127.38 -174.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.486 0.66 . . . . 0.0 111.006 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.528 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 98.1 mtt180 -134.29 124.52 25.99 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.541 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 13.2 p90 -111.98 166.77 10.93 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 171.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . 0.416 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 36.8 ptt180 -152.57 160.13 43.23 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 3.4 m -95.18 163.39 13.3 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.144 0.497 . . . . 0.0 112.271 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -68.33 -27.9 66.68 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.825 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -110.23 9.09 31.13 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.961 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 1.8 mptm? -121.2 113.2 19.64 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.904 0.383 . . . . 0.0 110.469 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -90.87 87.51 6.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.571 0.7 . . . . 0.0 109.242 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 166.14 145.4 4.44 Favored Glycine 0 C--N 1.291 -1.941 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 54.4 m95 -96.1 142.86 27.79 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.541 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -96.7 -29.69 3.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.517 -176.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . 0.443 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 21.5 m170 76.77 128.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.565 1.146 . . . . 0.0 109.739 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.568 HG22 ' CG2' ' A' ' 801' ' ' VAL . 2.7 t -153.75 159.9 42.1 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 798' ' ' ASP . 5.9 m -124.36 153.13 30.65 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.505 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 43.2 t -80.95 116.21 20.81 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.407 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 51.0 mm -121.05 86.2 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.841 ' HB2' ' HG ' ' A' ' 750' ' ' LEU . 23.7 t-20 54.01 69.06 0.76 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.13 0.967 . . . . 0.0 111.508 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.12 66.29 Favored Glycine 0 C--N 1.297 -1.635 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.49 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -140.54 168.43 19.83 Favored 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.607 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 82.7 m95 -116.26 155.51 28.23 Favored 'General case' 0 C--N 1.26 -3.31 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . 0.621 ' HB3' HG23 ' A' ' 791' ' ' VAL . 26.0 t70 -133.3 100.47 13.98 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 119.567 -0.254 . . . . 0.0 110.973 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . 0.443 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 44.3 Cg_endo -73.07 145.0 82.82 Favored 'Cis proline' 0 C--O 1.24 0.59 0 C-N-CA 124.377 -1.093 . . . . 0.0 112.153 -1.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.607 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 27.0 tt0 -48.59 122.15 5.25 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.014 0.821 . . . . 0.0 111.249 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.568 ' CG2' HG22 ' A' ' 790' ' ' THR . 64.4 t . . . . . 0 N--CA 1.427 -1.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.42 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 18.9 m -67.54 -80.69 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 123.326 0.391 . . . . 0.0 111.729 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 156.94 164.15 13.23 Favored Glycine 0 N--CA 1.399 -3.807 0 N-CA-C 106.845 -2.502 . . . . 0.0 106.845 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.792 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 36.5 t70 -45.68 128.91 8.85 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 124.069 0.948 . . . . 0.0 112.24 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.785 HG22 HG23 ' A' ' 715' ' ' VAL . 1.4 pp -50.06 148.18 6.2 Favored Pre-proline 0 N--CA 1.429 -1.491 0 O-C-N 125.042 1.464 . . . . 0.0 114.294 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.46 -164.33 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.123 2.549 . . . . 0.0 112.308 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -137.17 141.15 42.18 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.605 HD22 ' SG ' ' A' ' 744' ' ' CYS . 25.0 tp -89.01 123.35 33.25 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.729 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -42.38 -48.53 5.12 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 126.723 2.009 . . . . 0.0 115.079 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -134.54 24.99 3.75 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.446 0.641 . . . . 0.0 110.174 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -134.02 -145.69 5.33 Favored Glycine 0 C--N 1.288 -2.11 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.272 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -154.23 172.16 18.06 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -104.23 150.37 24.47 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -81.44 -77.9 0.2 Allowed 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.674 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 67.0 tp -172.2 129.84 0.6 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.268 0.227 . . . . 0.0 110.412 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.452 ' HB2' HG11 ' A' ' 715' ' ' VAL . 48.2 t -141.2 -50.65 0.43 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.856 175.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 35.9 p 58.03 155.45 0.09 OUTLIER Pre-proline 0 CA--C 1.57 1.747 0 C-N-CA 125.392 1.477 . . . . 0.0 113.018 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.543 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 60.9 Cg_endo -66.51 174.91 5.69 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.027 1.818 . . . . 0.0 111.256 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.0 Cg_endo -79.07 -9.25 37.86 Favored 'Cis proline' 0 N--CA 1.485 1.013 0 N-CA-C 115.176 1.183 . . . . 0.0 115.176 5.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.792 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 77.8 m-85 72.59 76.17 0.15 Allowed 'General case' 0 C--N 1.316 -0.872 0 O-C-N 124.173 0.921 . . . . 0.0 110.242 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.445 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 25.0 m-85 -79.99 167.6 20.26 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.868 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 0.478 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 64.9 m-85 -72.77 134.81 45.12 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.042 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.61 -4.95 66.78 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.21 149.43 35.51 Favored 'General case' 0 CA--C 1.477 -1.832 0 CA-C-O 121.361 0.6 . . . . 0.0 110.853 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 12.7 m -129.58 153.38 48.11 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.785 HG23 HG22 ' A' ' 694' ' ' ILE . 24.8 t -136.48 142.35 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.656 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.49 136.67 37.58 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-O 121.532 0.682 . . . . 0.0 110.483 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.535 ' HB3' HD21 ' A' ' 697' ' ' LEU . 32.1 m-85 -135.4 118.89 16.88 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -121.91 -163.8 1.1 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 21.6 m -116.02 141.39 48.18 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 38.8 t -64.24 -92.14 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 123.841 0.713 . . . . 0.0 111.22 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 722' ' ' SER . 35.1 mm-40 -139.09 153.6 48.05 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 74.8 m 71.62 1.51 3.9 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.491 1.119 . . . . 0.0 113.164 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.7 m-85 -132.17 143.55 50.05 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-O 121.73 0.776 . . . . 0.0 109.585 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 0.9 OUTLIER -111.71 141.95 44.67 Favored 'General case' 0 C--N 1.253 -3.619 0 CA-C-N 113.097 -1.865 . . . . 0.0 111.869 -178.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.709 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 2.8 ttp -85.64 122.91 30.41 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.476 1.51 . . . . 0.0 108.977 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 50.8 mm -115.77 129.43 72.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.378 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 93.85 -85.17 1.06 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.329 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.567 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -125.36 172.41 9.63 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.709 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -135.37 18.52 3.38 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 170.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 34.7 p -144.92 158.91 43.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.285 0.564 . . . . 0.0 110.919 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.415 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 34.5 pt -123.31 162.82 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.345 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 732' ' ' THR . . . . . 0.434 ' O ' HG21 ' A' ' 739' ' ' THR . 24.0 m -136.15 133.75 37.53 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.204 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.4 t -85.31 101.21 12.36 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 734' ' ' ILE . 1.6 pp -136.9 140.08 43.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.903 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 64.38 6.39 3.04 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.94 18.43 31.99 Favored Glycine 0 CA--C 1.494 -1.279 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.044 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.18 148.62 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.413 ' HA ' ' O ' ' A' ' 732' ' ' THR . 93.5 m95 -78.95 169.71 17.8 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.037 173.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.434 HG21 ' O ' ' A' ' 732' ' ' THR . 38.9 p -81.16 -166.9 1.25 Allowed 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 121.857 0.836 . . . . 0.0 112.825 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.25 -4.82 23.67 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -168.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 68.16 158.6 0.15 Allowed Pre-proline 0 N--CA 1.493 1.722 0 CA-C-O 120.998 0.428 . . . . 0.0 111.256 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.567 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 44.9 Cg_endo -81.92 178.04 6.82 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.854 1.703 . . . . 0.0 111.188 170.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . 0.521 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.6 tt0 -120.41 115.15 22.95 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.605 ' SG ' HD22 ' A' ' 697' ' ' LEU . 94.2 m -97.94 108.09 20.72 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.609 0.719 . . . . 0.0 110.71 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.496 ' C ' ' H ' ' A' ' 747' ' ' ILE . 26.8 t -100.93 141.95 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.596 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.525 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.582 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.39 4.11 0.58 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 125.913 1.685 . . . . 0.0 113.455 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.567 ' HA ' HD23 ' A' ' 750' ' ' LEU . 60.3 mt 74.76 -14.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 126.238 1.815 . . . . 0.0 111.028 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 746' ' ' ALA . 19.2 t70 -80.42 -30.55 37.67 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.648 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . 0.638 ' HZ2' ' HB3' ' A' ' 749' ' ' LYS . 0.2 OUTLIER -95.38 11.89 31.17 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.711 -1.586 . . . . 0.0 108.706 -176.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 1.033 ' HG ' HD21 ' A' ' 794' ' ' ASN . 0.4 OUTLIER -82.41 -168.94 2.19 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.737 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . 0.525 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 31.7 mmmt -126.13 146.81 49.79 Favored 'General case' 0 N--CA 1.392 -3.348 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -103.72 122.39 44.95 Favored 'General case' 1 C--N 1.242 -4.068 0 CA-C-N 112.92 -1.945 . . . . 0.0 107.781 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 55.6 m -71.91 157.48 37.78 Favored 'General case' 0 C--N 1.253 -3.61 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.314 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -127.77 145.4 50.93 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 48.2 t -56.63 127.67 32.54 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.286 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.565 ' HB3' HG12 ' A' ' 759' ' ' ILE . 26.3 t -76.52 160.53 29.39 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.401 0.619 . . . . 0.0 110.358 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -86.92 -4.1 59.14 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.322 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -110.52 -2.71 16.35 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.966 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.565 HG12 ' HB3' ' A' ' 756' ' ' SER . 28.6 pt -109.94 156.79 10.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.852 -173.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . 0.564 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.6 mp -121.27 127.46 75.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 2.0 mm? -105.37 -178.71 3.73 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . 0.448 ' HB2' HD22 ' A' ' 765' ' ' LEU . 38.1 mt-10 -68.6 173.97 4.62 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.79 -17.81 64.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.964 -0.46 . . . . 0.0 111.57 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . 0.472 ' HB2' HD23 ' A' ' 765' ' ' LEU . 6.3 m-70 -87.26 -35.0 18.73 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 761' ' ' LEU . 2.6 mm? -90.97 -19.47 23.21 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.288 -171.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -71.04 -16.5 62.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.689 0.757 . . . . 0.0 109.25 170.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.87 16.83 22.5 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.367 1.08 . . . . 0.0 108.464 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -111.71 111.76 22.97 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 769' ' ' LYS . 26.8 ttpp -73.33 -42.59 62.14 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.389 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -139.53 143.4 37.41 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.105 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 753' ' ' CYS . 83.4 m-85 -113.48 135.96 53.31 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.45 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -86.52 160.73 18.88 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.47 ' HB3' HD22 ' A' ' 750' ' ' LEU . 65.7 t60 -61.84 151.27 34.87 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.382 0.134 . . . . 0.0 110.667 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 4.3 m120 78.44 14.19 1.4 Allowed 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 123.987 0.915 . . . . 0.0 112.453 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 44.3 m -91.78 113.26 25.49 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -90.65 111.4 22.71 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.409 HD13 HD13 ' A' ' 761' ' ' LEU . 10.2 pt -122.81 179.3 2.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 121.586 0.708 . . . . 0.0 109.165 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.625 ' HA ' ' HA ' ' A' ' 789' ' ' HIS . 20.7 ptt180 -133.25 120.7 21.44 Favored 'General case' 0 N--CA 1.399 -3.023 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.632 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 2.7 p90 -108.21 167.61 9.89 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . 0.489 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 32.9 ptt180 -146.34 156.05 43.06 Favored 'General case' 0 C--N 1.262 -3.204 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 73.7 m -100.47 134.42 43.45 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.53 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . 0.564 ' HB3' HD11 ' A' ' 760' ' ' ILE . 36.7 ptt180 -59.57 -48.95 79.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -85.92 6.0 82.3 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.319 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.7 mptt -110.02 -47.75 3.28 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 70.19 129.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.238 1.415 . . . . 0.0 111.771 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 111.95 144.96 9.67 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -175.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.518 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 25.9 m95 -93.93 144.23 25.63 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.632 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -100.94 -32.23 3.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.628 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 11.5 m170 73.95 129.93 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 124.555 1.142 . . . . 0.0 110.091 -175.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 3.2 t -151.8 159.18 44.0 Favored 'General case' 0 C--N 1.274 -2.675 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.771 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.17 134.77 62.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.985 -176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.09 114.09 7.91 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.453 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 50.8 mm -116.94 87.92 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 124.745 1.218 . . . . 0.0 109.21 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 1.033 HD21 ' HG ' ' A' ' 750' ' ' LEU . 0.6 OUTLIER 46.74 66.01 1.08 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.762 0.825 . . . . 0.0 112.353 175.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 69.99 27.88 72.48 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.341 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -151.03 166.44 30.7 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.554 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 98.1 m95 -110.81 160.74 16.47 Favored 'General case' 0 C--N 1.256 -3.493 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -147.68 103.3 3.68 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.05 138.22 46.1 Favored 'Cis proline' 0 C--O 1.246 0.916 0 C-N-CA 123.956 -1.268 . . . . 0.0 112.325 1.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.554 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 4.2 tp10 -59.58 126.6 28.24 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.304 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 1 N--CA 1.358 -5.054 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.584 -172.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 12.6 m -72.83 -59.4 2.73 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.908 0.385 . . . . 0.0 110.768 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 130.51 179.79 16.33 Favored Glycine 1 N--CA 1.367 -5.923 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -40.51 130.12 2.39 Favored 'General case' 0 C--N 1.278 -2.507 0 C-N-CA 126.348 1.859 . . . . 0.0 111.747 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.573 HG22 HG23 ' A' ' 715' ' ' VAL . 1.5 pp -61.94 149.05 86.86 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.64 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.464 ' HG3' HD21 ' A' ' 741' ' ' LEU . 59.7 Cg_endo -71.98 -161.62 0.1 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.475 2.784 . . . . 0.0 111.276 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -136.31 149.74 48.57 Favored 'General case' 0 N--CA 1.408 -2.555 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.557 HD21 ' SG ' ' A' ' 744' ' ' CYS . 23.3 tp -93.82 123.37 37.12 Favored 'General case' 0 C--N 1.255 -3.522 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.073 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 5.0 pt-20 -34.24 -53.43 0.49 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.215 1.806 . . . . 0.0 115.545 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.456 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 82.4 m-70 -135.98 27.83 3.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -128.7 -149.96 7.07 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 119.605 -1.284 . . . . 0.0 112.096 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.23 175.04 10.8 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.12 133.55 49.71 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 14.0 mm100 -74.42 -61.76 1.76 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.054 0.454 . . . . 0.0 111.4 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.7 tt -169.65 138.29 1.86 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 103.486 -2.783 . . . . 0.0 103.486 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.551 ' HA ' HG12 ' A' ' 715' ' ' VAL . 59.2 p -115.59 -41.76 3.21 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -169.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 33.5 m 62.3 95.58 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 125.094 1.358 . . . . 0.0 113.887 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.15 172.55 13.75 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.297 1.998 . . . . 0.0 108.745 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.484 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 16.5 Cg_exo -71.16 -5.15 10.96 Favored 'Cis proline' 0 N--CA 1.506 2.226 0 CA-C-N 120.825 1.33 . . . . 0.0 115.27 4.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 56.9 m-85 78.98 69.99 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 O-C-N 124.876 1.36 . . . . 0.0 109.154 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.484 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 58.3 m-85 -77.46 170.4 16.63 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.941 -1.482 . . . . 0.0 112.589 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -73.39 129.63 38.41 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.053 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.48 -4.87 51.26 Favored Glycine 0 N--CA 1.421 -2.363 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.352 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.86 151.19 26.12 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 120.878 0.371 . . . . 0.0 110.924 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 3.8 m -131.29 156.07 46.08 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.573 HG23 HG22 ' A' ' 694' ' ' ILE . 52.7 t -137.64 129.74 40.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 47.0 mt-10 -77.35 134.46 38.47 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 123.988 0.805 . . . . 0.0 111.038 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.546 ' HB3' HD23 ' A' ' 697' ' ' LEU . 35.8 m-85 -139.94 112.94 8.16 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 125.026 1.33 . . . . 0.0 107.584 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -121.07 -164.51 1.13 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 7.1 m -109.7 133.84 52.66 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 2.4 m -53.07 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.751 0.82 . . . . 0.0 111.137 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 722' ' ' SER . 12.7 pt-20 -169.31 158.73 8.34 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 176.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 66.0 m 69.73 13.36 8.12 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.203 0.939 . . . . 0.0 111.563 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.717 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.4 m-85 -143.74 145.14 32.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 C-N-CA 124.733 1.213 . . . . 0.0 107.752 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.478 ' HB ' HD13 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -113.74 136.41 52.88 Favored 'General case' 0 C--N 1.257 -3.44 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.988 -177.016 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.472 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.2 ttp -81.76 120.22 24.86 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.848 1.259 . . . . 0.0 109.516 -175.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.549 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 45.4 mm -113.1 121.25 64.96 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.222 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 87.49 -82.13 1.61 Allowed Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 114.856 -1.065 . . . . 0.0 114.121 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.7 m80 -114.3 173.9 6.22 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 123.797 0.839 . . . . 0.0 110.569 -173.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.472 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -146.14 15.95 1.35 Allowed 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 121.276 0.56 . . . . 0.0 109.647 172.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 37.5 m -152.59 162.1 41.68 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 121.554 -0.716 . . . . 0.0 110.291 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.5 pt -123.84 162.23 25.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.299 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.7 m -133.31 134.18 43.52 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 123.522 0.514 . . . . 0.0 110.841 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 5.0 t -85.24 106.42 16.65 Favored 'General case' 0 C--O 1.256 1.429 0 CA-C-O 121.694 0.759 . . . . 0.0 109.389 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.402 ' O ' HD12 ' A' ' 734' ' ' ILE . 1.3 pp -138.32 142.17 35.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.618 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 72.87 -53.47 0.7 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.726 1.21 . . . . 0.0 111.367 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 160.39 26.29 0.02 OUTLIER Glycine 0 C--N 1.288 -2.117 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 24.2 t -151.25 154.4 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 -173.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -78.98 -178.85 6.31 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 18.3 p -84.69 -158.5 0.35 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.347 0.594 . . . . 0.0 112.253 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.3 pp0? -81.56 -11.45 59.15 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.4 mm? 72.17 137.69 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 30.8 Cg_endo -66.07 -179.44 1.41 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.773 2.315 . . . . 0.0 112.729 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . 0.549 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 53.3 tt0 -124.45 137.75 54.41 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.557 ' SG ' HD21 ' A' ' 697' ' ' LEU . 58.6 m -123.92 98.75 5.94 Favored 'General case' 0 CA--C 1.466 -2.273 0 CA-C-O 121.586 0.708 . . . . 0.0 109.642 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.537 ' C ' ' H ' ' A' ' 747' ' ' ILE . 32.1 t -86.85 140.73 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.059 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.717 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.14 4.83 0.61 Allowed 'General case' 0 C--N 1.274 -2.704 0 C-N-CA 125.188 1.395 . . . . 0.0 114.112 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.889 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 32.3 mt 75.62 -17.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 125.626 1.57 . . . . 0.0 111.428 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 746' ' ' ALA . 8.4 t70 -76.64 -32.35 57.96 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 125.671 1.588 . . . . 0.0 109.124 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -103.63 12.51 34.79 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.216 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.889 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 67.5 mt -76.77 148.82 36.43 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.39 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -90.04 -170.25 2.72 Favored 'General case' 0 C--N 1.261 -3.269 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.011 -172.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -120.26 126.8 51.5 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 113.352 -1.749 . . . . 0.0 106.477 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 35.9 m -87.77 150.59 23.48 Favored 'General case' 0 C--N 1.249 -3.763 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.061 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -116.81 139.84 50.12 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 755' ' ' SER . . . . . 0.44 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 14.7 p -61.54 139.58 58.23 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.237 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.613 ' HB2' HG13 ' A' ' 759' ' ' ILE . 20.3 m -78.02 149.21 34.06 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -91.95 7.95 39.76 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 112.223 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.98 -9.72 16.17 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.873 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.613 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.7 pp -109.0 152.11 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.74 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . 0.445 ' HB ' ' CG ' ' A' ' 780' ' ' ARG . 3.5 mp -109.18 131.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.752 HD12 ' HZ ' ' A' ' 771' ' ' PHE . 44.9 mt -103.63 178.82 4.45 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.51 168.7 8.68 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.26 -22.29 64.69 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.752 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -79.98 -42.3 24.19 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.594 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 35.0 mt -83.03 -19.78 36.29 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.003 -1.908 . . . . 0.0 113.102 -167.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -70.81 -6.38 37.42 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.352 0.596 . . . . 0.0 111.121 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.48 15.38 27.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 6.2 tppt? -122.61 105.87 10.48 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -75.78 -45.6 35.35 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -125.14 131.31 53.27 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.048 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.752 ' HZ ' HD12 ' A' ' 761' ' ' LEU . 40.2 m-85 -103.0 164.89 11.34 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.448 -175.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -104.74 142.14 35.23 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.336 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.423 ' HA ' ' SG ' ' A' ' 792' ' ' CYS . 32.6 p-80 -41.37 140.1 0.93 Allowed 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.825 1.25 . . . . 0.0 113.716 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 25.1 m120 70.4 23.25 4.99 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 125.171 1.389 . . . . 0.0 112.965 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 22.0 t -96.11 121.75 38.22 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.458 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -92.7 104.11 16.41 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.594 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.5 pt -114.15 -173.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.972 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 1.6 ptt180 -143.77 127.93 17.63 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.0 174.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.478 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 6.8 p90 -117.22 174.94 5.84 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 177.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . 0.445 ' CG ' ' HB ' ' A' ' 760' ' ' ILE . 10.6 ptm180 -153.87 170.58 20.66 Favored 'General case' 0 N--CA 1.407 -2.62 0 O-C-N 124.374 1.047 . . . . 0.0 108.447 177.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 49.7 t -100.47 161.46 13.59 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -73.74 -21.51 60.18 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.938 0.399 . . . . 0.0 109.942 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -93.03 -4.99 64.45 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.214 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 13.7 mptt -120.8 107.9 13.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . 0.409 ' HA ' ' NH2' ' A' ' 780' ' ' ARG . 12.2 tp10 -81.93 99.9 9.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 160.09 -165.91 34.94 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 107.665 -2.174 . . . . 0.0 107.665 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 61.4 m95 -139.72 146.62 39.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.64 1.22 . . . . 0.0 109.665 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.478 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -100.29 -34.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.456 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 12.8 m170 77.24 135.15 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.622 1.169 . . . . 0.0 110.452 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.44 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.8 t -158.57 157.58 32.27 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.091 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.5 136.84 55.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 45.8 t -71.23 107.53 4.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.631 0.729 . . . . 0.0 109.482 177.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.3 mm -113.89 83.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.165 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.42 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.589 HD21 ' HA ' ' A' ' 750' ' ' LEU . 25.3 t-20 58.76 66.34 1.08 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 122.403 1.097 . . . . 0.0 111.175 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 62.03 24.31 64.81 Favored Glycine 0 C--N 1.299 -1.478 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.488 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -145.02 166.27 25.79 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -111.67 158.08 19.7 Favored 'General case' 0 C--N 1.255 -3.54 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -148.32 107.02 3.59 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.36 142.54 66.8 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.971 -1.262 . . . . 0.0 113.074 0.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -55.54 117.03 3.23 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.406 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.44 ' CG1' HG21 ' A' ' 790' ' ' THR . 7.2 m . . . . . 1 N--CA 1.376 -4.171 0 C-N-CA 124.667 1.187 . . . . 0.0 112.519 -173.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 13.7 m -93.81 -167.39 1.68 Allowed 'General case' 0 C--N 1.25 -3.735 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . -118.12 -156.23 10.22 Favored Glycine 1 N--CA 1.39 -4.386 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.19 142.36 57.7 Favored 'General case' 0 C--N 1.278 -2.507 0 O-C-N 124.717 0.892 . . . . 0.0 108.753 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.587 HG21 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -63.68 151.7 87.96 Favored Pre-proline 0 C--N 1.284 -2.25 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.928 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.454 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 55.8 Cg_endo -71.14 -162.15 0.1 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.074 2.516 . . . . 0.0 112.925 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.17 158.84 43.45 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.534 HD11 ' HA3' ' A' ' 700' ' ' GLY . 0.8 OUTLIER -98.28 134.61 41.07 Favored 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.583 177.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -56.24 -37.97 70.47 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -144.65 29.54 1.24 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.534 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -140.0 -138.92 3.68 Favored Glycine 0 C--N 1.305 -1.141 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.074 -176.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.09 179.83 8.68 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.394 0.678 . . . . 0.0 109.403 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -114.22 144.58 42.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -71.41 -68.31 0.46 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.353 0.597 . . . . 0.0 110.861 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.9 tt -162.87 133.4 4.65 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.467 ' OG ' HG12 ' A' ' 694' ' ' ILE . 0.4 OUTLIER -137.1 114.0 10.51 Favored 'General case' 0 N--CA 1.401 -2.88 0 CA-C-O 121.747 0.784 . . . . 0.0 109.924 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -103.41 124.07 39.42 Favored Pre-proline 0 C--N 1.273 -2.749 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.447 -174.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.429 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 56.8 Cg_endo -66.45 172.49 9.03 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.495 2.13 . . . . 0.0 109.628 175.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.506 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.1 Cg_exo -75.21 -4.36 21.2 Favored 'Cis proline' 0 CA--C 1.497 -1.343 0 CA-C-N 119.801 0.965 . . . . 0.0 114.487 5.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 57.7 m-85 74.74 78.73 0.11 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 124.936 1.398 . . . . 0.0 108.488 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.506 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 22.4 m-85 -82.41 172.13 13.4 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -73.75 125.85 29.04 Favored 'General case' 0 CA--C 1.485 -1.523 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.29 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.75 -5.91 51.48 Favored Glycine 0 N--CA 1.411 -3.001 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.086 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.84 154.06 42.48 Favored 'General case' 0 C--O 1.251 1.179 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 19.8 m -140.21 143.64 36.15 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.846 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.587 HG21 HG21 ' A' ' 694' ' ' ILE . 47.0 t -131.54 137.08 56.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -85.84 135.21 33.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.966 0.889 . . . . 0.0 109.52 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -134.76 114.95 13.17 Favored 'General case' 0 C--N 1.268 -2.96 0 C-N-CA 126.395 1.878 . . . . 0.0 108.069 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -120.84 -165.71 1.25 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 4.6 m -115.62 134.73 54.77 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.3 m -56.95 -80.5 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 O-C-N 124.166 0.916 . . . . 0.0 111.256 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 722' ' ' SER . 48.0 mt-10 -154.16 161.35 41.92 Favored 'General case' 0 CA--C 1.472 -2.047 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 58.0 m 70.63 7.24 6.14 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 124.723 1.264 . . . . 0.0 111.948 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.625 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.1 m-85 -139.72 144.56 37.56 Favored 'General case' 0 N--CA 1.4 -2.956 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.1 m -113.07 140.7 47.64 Favored 'General case' 0 C--N 1.246 -3.908 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.637 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.2 ttp -85.86 115.88 23.77 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.533 1.133 . . . . 0.0 108.853 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.0 mm -113.15 130.17 67.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.419 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 87.84 -74.65 2.17 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.914 -1.039 . . . . 0.0 114.164 173.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.03 174.35 9.28 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -174.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.557 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -140.44 10.51 2.29 Favored 'General case' 0 C--O 1.201 -1.47 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 1.6 m -141.59 168.35 19.99 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.2 pt -129.32 161.09 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 732' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 739' ' ' THR . 5.8 m -135.85 139.17 43.19 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 44.0 t -94.22 116.24 28.62 Favored 'General case' 0 N--CA 1.407 -2.611 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.336 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.3 pp -144.26 147.43 19.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 C-N-CA 125.403 1.481 . . . . 0.0 108.168 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 64.18 15.04 9.07 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 86.59 17.59 59.95 Favored Glycine 0 CA--C 1.505 -0.546 0 C-N-CA 121.628 -0.32 . . . . 0.0 112.84 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.2 p -153.06 156.97 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.454 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 88.7 m95 -78.98 169.11 18.71 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 120.988 0.423 . . . . 0.0 110.16 175.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 732' ' ' THR . 21.8 p -73.48 -163.35 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.995 0.902 . . . . 0.0 112.845 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.46 ' H ' ' NE2' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -73.03 -12.95 61.11 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 124.772 1.229 . . . . 0.0 113.831 -170.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.4 mm? 73.28 149.96 0.13 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 123.921 0.763 . . . . 0.0 111.025 -175.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.57 175.87 10.09 Favored 'Trans proline' 0 C--O 1.253 1.231 0 C-N-CA 121.761 1.64 . . . . 0.0 110.96 173.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -126.47 107.58 10.39 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 724' ' ' THR . 86.9 m -91.0 113.27 25.49 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.078 175.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.499 ' C ' ' H ' ' A' ' 747' ' ' ILE . 49.6 t -100.58 144.08 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.34 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.625 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.02 6.8 0.34 Allowed 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 125.973 1.709 . . . . 0.0 114.313 -175.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.85 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 55.4 mt 75.15 -19.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 125.663 1.585 . . . . 0.0 112.03 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.5 t70 -73.39 -34.09 65.35 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.671 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . 0.44 ' HB3' ' HE3' ' A' ' 749' ' ' LYS . 0.0 OUTLIER -114.11 29.93 7.65 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.859 -175.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.85 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 91.1 mt -83.32 -175.72 5.97 Favored 'General case' 0 N--CA 1.407 -2.609 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -105.92 147.09 29.17 Favored 'General case' 0 N--CA 1.384 -3.768 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 770' ' ' GLU . 22.4 mtpp -103.25 122.56 45.02 Favored 'General case' 1 C--N 1.237 -4.32 0 CA-C-N 113.041 -1.891 . . . . 0.0 108.65 -174.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 60.9 m -70.96 150.12 46.0 Favored 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.44 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -112.37 143.89 42.72 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.314 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 4.4 p -67.23 118.06 10.1 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.644 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.417 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 43.2 t -79.37 153.82 29.47 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -100.82 0.45 38.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.084 0.469 . . . . 0.0 111.595 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 6.4 mp -91.43 -8.49 47.69 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.049 0.928 . . . . 0.0 108.573 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.496 HG12 ' CG1' ' A' ' 801' ' ' VAL . 2.8 pp -118.45 169.73 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.649 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . 0.546 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.5 mp -119.44 124.88 73.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.799 HD11 ' HZ ' ' A' ' 771' ' ' PHE . 96.2 mt -97.47 179.24 4.93 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.15 167.73 13.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.385 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -12.38 61.6 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -100.64 -10.99 20.38 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.531 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.535 HD13 ' HB ' ' A' ' 777' ' ' ILE . 74.7 mt -110.4 -19.44 12.96 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -69.86 -12.74 61.85 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.755 0.788 . . . . 0.0 110.274 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -101.96 11.23 38.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.734 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . 0.432 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 14.4 tppt? -104.5 108.44 19.88 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -36.7 68.6 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.185 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 752' ' ' LYS . 43.3 mt-10 -144.41 133.4 22.69 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.898 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.799 ' HZ ' HD11 ' A' ' 761' ' ' LEU . 71.7 m-85 -103.56 149.04 25.26 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -92.39 159.08 15.73 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.14 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.626 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 31.8 t60 -62.21 140.78 58.45 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.037 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 89.17 3.26 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.957 1.703 . . . . 0.0 109.972 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 74.9 m -83.35 114.08 21.18 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.505 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.428 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -88.25 113.47 23.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.848 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.535 ' HB ' HD13 ' A' ' 765' ' ' LEU . 4.8 pt -126.98 -173.83 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.521 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 30.4 ptt180 -143.17 127.38 17.59 Favored 'General case' 0 N--CA 1.413 -2.278 0 O-C-N 122.165 -0.334 . . . . 0.0 110.173 173.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.681 ' CD2' HG13 ' A' ' 801' ' ' VAL . 11.0 p90 -108.74 170.92 7.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 174.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . 0.546 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 9.3 ptt180 -146.66 155.44 42.43 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 173.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . . . . . . . . . 14.0 t -83.81 155.36 23.03 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -76.03 -5.74 47.81 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.624 0.726 . . . . 0.0 110.568 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -102.34 -10.13 39.7 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.074 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -122.07 125.04 45.36 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.084 -0.656 . . . . 0.0 111.697 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.65 79.9 4.8 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 122.073 0.939 . . . . 0.0 108.625 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 173.08 153.2 9.31 Favored Glycine 0 C--N 1.299 -1.494 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 40.4 m95 -101.58 164.86 11.54 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 117.085 0.443 . . . . 0.0 110.192 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.403 HD11 ' N ' ' A' ' 788' ' ' ILE . 3.6 mp -115.25 -34.03 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.343 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 31.6 m170 76.18 121.35 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 124.493 1.117 . . . . 0.0 109.45 -173.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.469 HG22 ' CG2' ' A' ' 801' ' ' VAL . 3.5 t -141.92 155.89 45.49 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.13 134.07 61.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 46.9 t -68.96 119.66 13.63 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.626 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 49.5 mm -119.54 86.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 C-N-CA 124.774 1.23 . . . . 0.0 108.694 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 45.69 72.17 0.24 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.567 1.147 . . . . 0.0 112.233 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 68.16 19.66 72.32 Favored Glycine 0 C--N 1.3 -1.424 0 CA-C-N 115.05 -0.977 . . . . 0.0 114.178 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -144.52 165.13 28.84 Favored 'General case' 0 C--O 1.19 -2.043 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.6 m95 -111.6 160.41 17.23 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 121.735 -0.603 . . . . 0.0 110.225 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -149.29 105.77 3.33 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.76 139.91 50.96 Favored 'Cis proline' 0 C--O 1.245 0.835 0 C-N-CA 123.842 -1.316 . . . . 0.0 110.508 -0.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.556 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.3 tt0 -56.27 125.27 21.07 Favored 'General case' 0 N--CA 1.432 -1.334 0 O-C-N 123.684 0.615 . . . . 0.0 111.153 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.681 HG13 ' CD2' ' A' ' 779' ' ' TYR . 93.9 t . . . . . 0 N--CA 1.428 -1.551 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.249 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.414 -2.266 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 40.4 m -84.59 -76.36 0.31 Allowed 'General case' 0 C--N 1.254 -3.582 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.321 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 149.09 -177.29 27.41 Favored Glycine 1 N--CA 1.358 -6.558 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -51.61 130.12 27.37 Favored 'General case' 0 C--N 1.278 -2.525 0 O-C-N 125.588 1.405 . . . . 0.0 109.946 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.612 HG21 HG23 ' A' ' 715' ' ' VAL . 1.6 pp -60.01 150.25 70.71 Favored Pre-proline 0 N--CA 1.432 -1.352 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.915 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.514 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.0 Cg_endo -71.84 -163.51 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 122.86 2.374 . . . . 0.0 111.471 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -135.74 156.51 48.7 Favored 'General case' 0 N--CA 1.402 -2.871 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.501 HD11 ' HA3' ' A' ' 700' ' ' GLY . 1.1 mt -88.56 144.65 26.19 Favored 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.358 177.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.42 -41.09 93.24 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 744' ' ' CYS . 93.6 m-70 -146.84 32.2 0.94 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.501 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -141.72 -149.65 5.24 Favored Glycine 0 C--N 1.3 -1.434 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.775 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.38 -179.35 6.89 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -112.58 144.63 41.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.464 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 39.3 mm-40 -73.98 -67.71 0.58 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.33 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 68.5 tp -158.2 125.45 5.02 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.49 ' CB ' HG12 ' A' ' 694' ' ' ILE . 5.5 p -118.52 132.29 56.22 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 22.9 t -121.72 112.97 32.01 Favored Pre-proline 0 C--N 1.288 -2.098 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.999 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.33 165.62 26.27 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.143 1.896 . . . . 0.0 108.642 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.521 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 16.9 Cg_exo -67.81 -10.63 8.59 Favored 'Cis proline' 0 N--CA 1.498 1.759 0 N-CA-C 115.194 1.19 . . . . 0.0 115.194 5.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.487 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 61.9 m-85 74.07 87.04 0.1 Allowed 'General case' 0 C--N 1.309 -1.17 0 O-C-N 124.65 1.219 . . . . 0.0 108.044 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.556 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 50.3 m-85 -90.98 172.54 8.51 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.686 -176.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -71.45 138.51 49.1 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.255 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.77 77.78 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 2.5 t70 -77.34 165.79 23.99 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 20.2 m -151.86 142.41 22.67 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.612 HG23 HG21 ' A' ' 694' ' ' ILE . 44.8 t -133.56 134.37 56.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 39.1 mt-10 -80.51 135.67 36.15 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 123.896 0.748 . . . . 0.0 111.426 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -136.61 114.3 11.13 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 125.837 1.655 . . . . 0.0 107.471 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -124.06 -163.0 1.11 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 10.0 m -108.16 144.23 35.86 Favored 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 720' ' ' SER . . . . . 0.598 ' O ' ' HG3' ' A' ' 721' ' ' GLU . 5.1 m -55.81 -70.43 0.11 Allowed 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.769 0.668 . . . . 0.0 109.872 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . 0.598 ' HG3' ' O ' ' A' ' 720' ' ' SER . 30.7 mt-10 -175.22 164.39 3.25 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 129.279 3.031 . . . . 0.0 102.822 173.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 62.6 m 68.51 12.56 8.75 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.993 0.808 . . . . 0.0 111.509 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.728 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.8 m-85 -143.74 147.96 34.96 Favored 'General case' 0 N--CA 1.407 -2.615 0 C-N-CA 124.83 1.252 . . . . 0.0 108.11 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.46 HG22 HD21 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -112.93 135.27 53.89 Favored 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.996 -177.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.707 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.8 ttp -85.06 113.26 21.34 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 124.93 1.292 . . . . 0.0 109.758 -177.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 793' ' ' ILE . 45.3 mm -115.27 131.3 67.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.336 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 94.57 -91.34 1.4 Allowed Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.772 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.531 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.1 m80 -114.34 178.42 4.29 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 114.508 -0.846 . . . . 0.0 110.357 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.707 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -144.92 14.21 1.5 Allowed 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 168.2 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 33.9 m -149.18 162.41 40.05 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 714' ' ' SER . 28.8 pt -121.1 166.73 15.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 732' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 739' ' ' THR . 3.8 m -135.75 139.94 43.96 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 43.3 t -99.82 116.91 32.99 Favored 'General case' 0 N--CA 1.406 -2.634 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.47 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.426 ' C ' ' H ' ' A' ' 736' ' ' GLY . 1.2 pp -142.82 149.29 18.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-N 114.004 -1.453 . . . . 0.0 107.444 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 734' ' ' ILE . 52.3 m-70 73.74 -21.83 0.26 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.662 0.785 . . . . 0.0 112.087 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 734' ' ' ILE . . . 120.24 14.27 5.53 Favored Glycine 0 CA--C 1.505 -0.542 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.3 p -148.53 150.53 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.514 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.8 m95 -77.2 169.25 18.66 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.467 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 732' ' ' THR . 24.9 p -77.23 -160.8 0.18 Allowed 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.67 0.748 . . . . 0.0 112.396 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.0 OUTLIER -84.69 -12.86 53.0 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.991 -168.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 0.9 OUTLIER 70.81 159.32 0.16 Allowed Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 124.009 0.818 . . . . 0.0 112.237 -177.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.531 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 37.6 Cg_endo -75.13 178.9 6.68 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.241 1.961 . . . . 0.0 112.155 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -122.91 101.33 7.37 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.023 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.423 ' SG ' HD11 ' A' ' 697' ' ' LEU . 73.1 m -84.59 112.4 20.4 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-O 121.094 0.474 . . . . 0.0 110.58 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.467 ' C ' ' H ' ' A' ' 747' ' ' ILE . 22.5 t -99.72 144.04 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.728 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.33 1.16 0.81 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 125.08 1.352 . . . . 0.0 114.254 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.631 ' HB ' ' O ' ' A' ' 746' ' ' ALA . 34.5 mt 76.54 -18.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 124.991 1.317 . . . . 0.0 110.971 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.0 t70 -77.84 -23.82 48.81 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 125.884 1.673 . . . . 0.0 109.203 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -110.89 18.95 19.02 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.586 -1.643 . . . . 0.0 108.842 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.85 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 3.1 mp -85.7 -176.8 6.19 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.859 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . 0.454 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 53.1 mtpt -140.48 164.92 28.84 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -109.02 140.39 42.61 Favored 'General case' 0 C--N 1.257 -3.423 0 C-N-CA 126.021 1.728 . . . . 0.0 108.256 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 59.8 m -88.01 165.06 15.45 Favored 'General case' 1 C--N 1.239 -4.238 0 CA-C-N 114.106 -1.407 . . . . 0.0 109.147 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 754' ' ' LYS . 17.4 ptpt -132.77 147.62 52.32 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.988 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.18 114.04 3.53 Favored 'General case' 0 C--N 1.27 -2.875 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.916 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.626 ' HB2' ' CG1' ' A' ' 759' ' ' ILE . 55.9 m -72.98 149.78 43.03 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -80.08 -9.24 59.69 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.887 0.851 . . . . 0.0 110.458 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.83 -11.92 40.63 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.402 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.626 ' CG1' ' HB2' ' A' ' 756' ' ' SER . 2.4 pp -118.06 140.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.401 -173.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.1 mp -104.39 131.21 53.83 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.53 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 2.1 mm? -108.56 -177.79 3.41 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 120.845 0.355 . . . . 0.0 110.114 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -71.48 167.61 19.28 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -57.86 -17.54 16.98 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.054 0.941 . . . . 0.0 112.639 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -85.62 -42.1 14.63 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.645 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 66.7 mt -85.65 -15.42 42.45 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 113.452 -1.704 . . . . 0.0 112.652 -169.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -73.96 -13.81 60.94 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.472 0.653 . . . . 0.0 110.508 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -96.51 0.33 50.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.335 1.064 . . . . 0.0 108.459 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . 0.412 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 8.7 tppt? -103.08 118.48 36.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -96.76 -19.85 18.64 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -136.25 122.7 20.73 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.283 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.48 ' HZ ' ' HG ' ' A' ' 761' ' ' LEU . 76.1 m-85 -98.96 142.56 30.31 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -87.71 148.2 24.87 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.954 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.51 ' CB ' HD22 ' A' ' 750' ' ' LEU . 47.1 p-80 -42.47 141.7 0.95 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.359 1.463 . . . . 0.0 111.259 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 63.6 t30 75.57 2.42 3.78 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.026 1.33 . . . . 0.0 111.825 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 18.2 t -82.24 118.49 23.15 Favored 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 121.292 -0.88 . . . . 0.0 108.666 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.449 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -87.81 106.22 17.93 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.159 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.645 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.6 pt -115.97 -170.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 7.1 ptp180 -150.82 134.99 16.86 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.532 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 8.1 p90 -119.15 173.52 6.87 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' A' ' 785' ' ' GLU . 10.5 ptt180 -155.4 169.82 23.36 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 59.3 m -97.79 164.31 12.44 Favored 'General case' 0 C--N 1.282 -2.341 0 O-C-N 123.876 0.735 . . . . 0.0 109.093 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . 0.413 ' HD2' ' H ' ' A' ' 782' ' ' ARG . 0.0 OUTLIER -66.72 -36.95 83.69 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.854 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -98.35 5.18 60.64 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.404 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.0 mptt -127.65 105.15 8.28 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 780' ' ' ARG . 35.9 tt0 -90.58 78.88 6.21 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.879 0.847 . . . . 0.0 109.952 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -164.1 144.58 9.56 Favored Glycine 0 CA--C 1.472 -2.636 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.556 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 38.5 m95 -101.66 131.61 47.81 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 117.405 0.602 . . . . 0.0 109.992 -174.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.532 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -87.87 -30.5 5.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.757 -174.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 15.3 m170 71.53 125.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.549 1.14 . . . . 0.0 109.119 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 3.4 t -147.9 155.6 41.77 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 122.196 -0.315 . . . . 0.0 110.438 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.58 135.69 57.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 53.6 t -72.92 114.08 10.66 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.845 0.831 . . . . 0.0 110.342 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.507 HG21 HD12 ' A' ' 726' ' ' ILE . 50.9 mm -115.29 80.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 C-N-CA 124.501 1.121 . . . . 0.0 108.713 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.85 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 1.0 OUTLIER 52.08 64.64 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.464 176.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.61 22.53 78.31 Favored Glycine 0 C--N 1.308 -0.996 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.576 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -147.28 164.18 34.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.0 m95 -111.75 159.56 18.15 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-O 120.581 0.229 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -149.19 103.79 3.33 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.13 141.57 71.08 Favored 'Cis proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.876 -1.302 . . . . 0.0 113.602 -0.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 2.9 mm-40 -53.32 127.73 25.76 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.138 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 759' ' ' ILE . 3.2 m . . . . . 1 N--CA 1.372 -4.362 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.997 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.42 -1.937 0 CA-C-O 120.971 0.415 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 39.0 m -80.62 -66.23 0.91 Allowed 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.54 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 128.37 -177.54 17.66 Favored Glycine 1 N--CA 1.367 -5.917 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -34.14 128.36 0.4 Allowed 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 127.023 2.129 . . . . 0.0 112.727 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.665 HG22 HG22 ' A' ' 715' ' ' VAL . 1.5 pp -61.82 150.29 82.82 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.163 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.419 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 57.0 Cg_endo -72.17 -159.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.684 2.256 . . . . 0.0 111.74 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . 0.449 ' HA ' ' HE2' ' A' ' 717' ' ' PHE . 10.8 pt-20 -134.15 -173.29 3.22 Favored 'General case' 0 N--CA 1.401 -2.884 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 175.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.529 HD23 ' HB3' ' A' ' 717' ' ' PHE . 22.0 tp -128.6 126.0 39.36 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-O 120.872 0.368 . . . . 0.0 110.384 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -49.44 -37.9 27.47 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.4 m-70 -137.09 24.68 3.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -141.79 -146.76 4.74 Favored Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.21 -0.995 . . . . 0.0 110.846 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . 0.408 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.01 179.21 8.25 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.704 0.288 . . . . 0.0 110.324 -177.234 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -112.49 143.41 43.68 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.2 -75.54 0.17 Allowed 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.241 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.7 tt -176.46 132.17 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.441 ' HB2' HG13 ' A' ' 715' ' ' VAL . 9.9 t -154.23 146.96 24.25 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 10.1 t -117.07 149.14 43.73 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.532 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 59.4 Cg_endo -65.97 174.54 5.64 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.61 2.207 . . . . 0.0 110.454 177.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.532 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.8 Cg_endo -79.95 -4.18 40.5 Favored 'Cis proline' 0 C--O 1.215 -0.633 0 CA-C-N 119.799 0.964 . . . . 0.0 114.541 4.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.44 ' CD2' ' HA ' ' A' ' 707' ' ' PRO . 77.1 m-85 68.92 79.32 0.21 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.326 0.584 . . . . 0.0 110.262 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.487 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 30.1 m-85 -83.56 170.81 13.97 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 0.455 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 44.0 m-85 -68.46 137.11 54.19 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.322 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.9 -5.38 68.99 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.3 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 2.9 t70 -71.14 157.59 37.9 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 20.2 m -149.22 139.36 22.17 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.665 HG22 HG22 ' A' ' 694' ' ' ILE . 41.0 t -130.48 140.93 47.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.033 -174.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 729' ' ' ARG . 1.6 mp0 -80.2 131.79 35.76 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 122.168 0.985 . . . . 0.0 112.872 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.529 ' HB3' HD23 ' A' ' 697' ' ' LEU . 32.1 m-85 -135.89 107.96 7.19 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 113.608 -1.633 . . . . 0.0 107.297 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.408 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 9.0 m-80 -115.51 -163.46 0.89 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 8.3 m -116.06 134.91 54.45 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 3.2 m -58.04 -70.87 0.12 Allowed 'General case' 0 C--N 1.288 -2.094 0 O-C-N 124.163 0.914 . . . . 0.0 111.87 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 722' ' ' SER . 14.4 pt-20 -164.33 161.37 21.72 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 74.9 m 69.84 2.75 3.99 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.995 0.81 . . . . 0.0 112.847 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.619 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.5 m-85 -137.5 148.75 46.26 Favored 'General case' 0 N--CA 1.401 -2.892 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.481 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -115.08 141.91 47.36 Favored 'General case' 0 C--N 1.259 -3.336 0 C-N-CA 124.991 1.316 . . . . 0.0 109.996 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.553 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.8 ttp -85.84 120.71 27.56 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 124.071 0.948 . . . . 0.0 109.826 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 43.2 mm -111.82 122.18 65.68 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.763 174.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 114.15 -94.86 0.71 Allowed Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.966 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 53.0 t60 -156.97 139.1 14.55 Favored 'General case' 0 CA--C 1.472 -2.054 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.553 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -85.71 25.76 1.04 Allowed 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 15.4 m -143.87 156.24 44.39 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.776 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 714' ' ' SER . 41.2 pt -118.65 160.58 18.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.419 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 732' ' ' THR . . . . . 0.462 ' O ' HG22 ' A' ' 739' ' ' THR . 20.1 m -134.02 135.87 43.68 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.973 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.3 t -85.65 104.07 15.05 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.8 pp -146.65 144.18 20.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 124.034 0.934 . . . . 0.0 110.246 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 67.85 8.16 6.25 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 94.51 20.28 29.96 Favored Glycine 0 CA--C 1.5 -0.844 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.376 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.7 p -157.46 158.93 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.419 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 94.5 m95 -78.04 172.71 13.1 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 171.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 25.5 p -76.38 -169.56 1.23 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.976 0.893 . . . . 0.0 112.999 -174.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.56 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.2 pp0? -65.55 -20.64 66.41 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 -173.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 5.6 mt 70.68 138.55 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 124.547 1.154 . . . . 0.0 112.882 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 56.7 Cg_endo -67.04 167.12 20.75 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.363 2.042 . . . . 0.0 112.428 -177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . 0.414 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.2 tt0 -112.47 102.42 10.53 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.493 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 724' ' ' THR . 89.4 m -82.55 111.19 18.31 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.614 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.507 ' C ' ' H ' ' A' ' 747' ' ' ILE . 48.2 t -99.45 145.35 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.497 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.619 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.67 4.16 0.63 Allowed 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 125.411 1.484 . . . . 0.0 113.716 -175.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.923 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 57.6 mt 76.47 -22.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 126.183 1.793 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 746' ' ' ALA . 12.1 t70 -67.41 -34.86 78.12 Favored 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 126.029 1.732 . . . . 0.0 109.841 -174.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.75 24.12 13.35 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 113.578 -1.647 . . . . 0.0 111.658 -175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.923 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 85.9 mt -78.65 166.01 23.0 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-O 121.644 0.735 . . . . 0.0 109.899 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -91.19 -167.62 1.85 Allowed 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 126.701 2.0 . . . . 0.0 112.408 -171.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . 0.526 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 28.4 mmmt -123.72 134.03 53.77 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 126.357 1.863 . . . . 0.0 106.793 -176.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 0.0 OUTLIER -87.39 -179.47 6.39 Favored 'General case' 0 C--N 1.257 -3.454 0 C-N-CA 125.44 1.496 . . . . 0.0 109.433 -177.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -141.14 137.99 33.14 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.93 -0.481 . . . . 0.0 110.433 -176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 38.9 t -71.79 120.56 17.56 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 172.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.534 ' HB3' HG12 ' A' ' 759' ' ' ILE . 42.9 t -70.33 163.18 27.14 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -96.41 -1.09 48.27 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.95 18.26 19.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.983 0.42 . . . . 0.0 110.71 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.534 HG12 ' HB3' ' A' ' 756' ' ' SER . 23.8 pt -126.41 157.71 36.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.538 0.685 . . . . 0.0 112.07 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . 0.407 HD12 ' HB3' ' A' ' 782' ' ' ARG . 3.2 mp -117.74 132.54 67.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.573 ' HG ' ' HZ ' ' A' ' 771' ' ' PHE . 2.7 mm? -106.94 178.17 4.64 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . 0.521 ' HB2' HD22 ' A' ' 765' ' ' LEU . 47.4 mt-10 -62.01 162.22 9.56 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.97 176.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.7 -11.99 56.58 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.538 0.685 . . . . 0.0 111.264 -176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.31 -0.61 26.1 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.573 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.521 HD22 ' HB2' ' A' ' 762' ' ' GLU . 3.3 mm? -122.97 -12.12 8.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 8.7 mtmp? -62.65 -27.02 68.93 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -88.1 5.71 39.86 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . 0.691 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 19.0 ttmm -101.94 109.92 21.77 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . 0.505 ' HE3' ' HG3' ' A' ' 770' ' ' GLU . 34.6 ttpt -79.46 -37.29 37.24 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.251 1.024 . . . . 0.0 108.444 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . 0.505 ' HG3' ' HE3' ' A' ' 769' ' ' LYS . 41.4 mt-10 -127.92 114.61 17.39 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.438 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.691 ' CD2' ' HD2' ' A' ' 768' ' ' LYS . 82.3 m-85 -88.76 -178.68 5.83 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.972 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -118.68 138.54 52.55 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.59 -175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.744 ' CD2' ' HB2' ' A' ' 750' ' ' LEU . 9.8 p-80 -45.91 146.86 1.1 Allowed 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.642 1.177 . . . . 0.0 112.738 174.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 72.22 10.95 5.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.27 1.028 . . . . 0.0 110.702 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 46.8 t -94.25 127.99 40.45 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.467 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.6 OUTLIER -97.6 111.25 23.6 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.46 HD11 HD13 ' A' ' 761' ' ' LEU . 7.8 pt -118.91 176.46 3.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 121.662 0.744 . . . . 0.0 109.596 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 79.5 mtt180 -122.28 133.29 54.69 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 173.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -128.59 168.33 15.88 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -160.08 163.9 33.51 Favored 'General case' 0 N--CA 1.412 -2.372 0 O-C-N 124.521 1.138 . . . . 0.0 109.281 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 90.7 m -82.48 175.34 10.28 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 123.53 0.519 . . . . 0.0 109.797 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . 0.407 ' HB3' HD12 ' A' ' 760' ' ' ILE . 12.5 ptm180 -91.4 -29.19 17.21 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.936 0.398 . . . . 0.0 110.504 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -92.24 -3.11 67.71 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.791 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 2.2 mptp? -130.74 107.62 9.29 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.62 149.38 27.44 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 111.45 141.11 8.43 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -174.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 47.4 m95 -98.61 149.8 22.4 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 117.047 0.424 . . . . 0.0 110.746 -171.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.16 -31.7 3.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.06 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 36.7 m170 73.19 118.92 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 124.843 1.257 . . . . 0.0 110.206 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.534 HG22 ' CG1' ' A' ' 801' ' ' VAL . 4.1 t -140.32 158.52 43.9 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.836 -0.54 . . . . 0.0 110.232 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.94 134.48 63.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 54.0 t -72.19 117.27 13.62 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.533 0.682 . . . . 0.0 110.327 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.07 79.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.48 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 750' ' ' LEU . 24.8 t-20 55.09 71.94 0.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.845 0.831 . . . . 0.0 112.171 171.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 75.26 3.58 70.74 Favored Glycine 0 C--N 1.292 -1.902 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.988 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -136.19 174.58 10.46 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.564 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 97.5 m95 -121.12 159.48 25.71 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -148.3 106.52 3.58 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.92 142.45 73.76 Favored 'Cis proline' 0 C--O 1.244 0.814 0 C-N-CA 123.588 -1.422 . . . . 0.0 112.956 -0.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 1.9 mm-40 -50.51 126.1 14.48 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 115.096 -0.956 . . . . 0.0 113.118 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.534 ' CG1' HG22 ' A' ' 790' ' ' THR . 3.6 m . . . . . 1 N--CA 1.35 -5.462 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.589 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 690' ' ' THR . . . . . 0.574 HG22 ' HB2' ' A' ' 708' ' ' PRO . 12.4 p . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 23.7 m -72.31 -63.08 1.22 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.059 0.457 . . . . 0.0 110.169 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 131.3 -164.23 23.44 Favored Glycine 1 N--CA 1.356 -6.675 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -45.61 136.8 5.61 Favored 'General case' 0 C--N 1.26 -3.315 0 C-N-CA 126.182 1.793 . . . . 0.0 111.828 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.493 HG23 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -68.7 148.22 98.02 Favored Pre-proline 0 N--CA 1.427 -1.61 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.066 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.508 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 70.9 Cg_endo -72.76 -168.98 0.44 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 123.327 2.685 . . . . 0.0 111.838 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -135.52 143.28 45.69 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 717' ' ' PHE . 24.5 tp -92.56 123.79 36.11 Favored 'General case' 0 C--N 1.254 -3.552 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.187 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.496 ' HG2' HD13 ' A' ' 697' ' ' LEU . 7.4 pt-20 -30.42 -51.74 0.15 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.319 2.248 . . . . 0.0 115.556 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 78.8 m-70 -136.15 23.39 3.26 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -134.04 -159.11 8.8 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.998 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . 0.431 ' CE2' ' HA ' ' A' ' 720' ' ' SER . 0.4 OUTLIER -141.07 176.34 8.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.692 0.282 . . . . 0.0 111.382 -173.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -111.52 133.66 53.64 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.474 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 53.7 mm-40 -74.42 -73.26 0.24 Allowed 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 705' ' ' SER . 7.0 tt -161.3 139.63 9.58 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.474 -177.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.696 ' HB2' HG23 ' A' ' 715' ' ' VAL . 35.8 t -164.36 -175.7 4.05 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 26.7 p -152.11 140.74 13.71 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.89 167.29 23.68 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 121.798 1.666 . . . . 0.0 109.39 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.585 ' HG2' ' CE1' ' A' ' 710' ' ' TYR . 1.3 Cg_endo -73.74 -1.83 14.62 Favored 'Cis proline' 0 C--O 1.243 0.73 0 N-CA-C 115.201 1.193 . . . . 0.0 115.201 6.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 72.5 m-85 72.55 75.58 0.15 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.39 1.056 . . . . 0.0 109.318 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.585 ' CE1' ' HG2' ' A' ' 708' ' ' PRO . 18.3 m-85 -79.49 169.95 17.3 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.158 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 0.52 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 54.3 m-85 -68.81 133.95 49.02 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.905 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.74 -11.23 60.98 Favored Glycine 0 N--CA 1.426 -1.973 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.463 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 2.4 t70 -68.29 150.82 47.78 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 15.6 m -140.01 142.77 36.24 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 121.196 0.522 . . . . 0.0 109.904 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 705' ' ' SER . 20.5 t -131.88 127.09 58.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 40.0 mt-10 -71.66 138.22 48.46 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.919 0.39 . . . . 0.0 111.266 174.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.526 ' HB3' HD22 ' A' ' 697' ' ' LEU . 19.7 m-85 -138.19 123.76 19.66 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -136.22 -165.21 1.68 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 9.4 m -115.53 130.23 56.8 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 720' ' ' SER . . . . . 0.431 ' HA ' ' CE2' ' A' ' 701' ' ' TRP . 4.0 m -47.0 -71.98 0.06 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 124.984 1.427 . . . . 0.0 112.09 -172.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 722' ' ' SER . 12.2 pt-20 -169.46 164.61 10.54 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 175.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 66.9 m 66.31 8.23 5.48 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.087 0.867 . . . . 0.0 112.288 -178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.676 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.5 m-85 -141.35 142.69 33.78 Favored 'General case' 0 N--CA 1.412 -2.363 0 C-N-CA 124.141 0.976 . . . . 0.0 108.771 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.499 ' HB ' HD13 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -107.37 133.97 51.12 Favored 'General case' 0 C--N 1.251 -3.713 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.784 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.748 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.3 ttp -87.97 121.17 30.06 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.259 1.024 . . . . 0.0 109.923 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.609 HD11 HG23 ' A' ' 793' ' ' ILE . 49.9 mm -120.16 131.18 73.19 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.714 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.084 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 111.49 -81.46 0.29 Allowed Glycine 0 C--N 1.306 -1.124 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.679 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.579 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 5.9 t60 -150.92 171.45 17.23 Favored 'General case' 0 C--O 1.202 -1.414 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.748 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -131.3 25.75 4.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 73.3 m -157.51 166.84 31.87 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.521 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 39.5 pt -129.91 161.35 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 O-C-N 124.654 1.221 . . . . 0.0 108.216 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 18.6 m -136.55 135.27 38.32 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.76 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.6 t -80.71 107.77 13.8 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.247 0.546 . . . . 0.0 110.499 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 736' ' ' GLY . 1.4 pp -145.89 146.72 19.05 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.229 0 C-N-CA 125.125 1.37 . . . . 0.0 110.051 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . 0.405 ' HD2' ' HB ' ' A' ' 734' ' ' ILE . 19.1 m-70 70.75 -12.93 0.51 Allowed 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 123.603 0.761 . . . . 0.0 111.685 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.47 ' CA ' ' HH ' ' A' ' 711' ' ' TYR . . . 105.0 19.26 10.97 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 33.2 t -143.1 159.12 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.508 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.6 m95 -86.19 179.0 7.01 Favored 'General case' 0 C--N 1.256 -3.462 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.521 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 25.1 p -76.64 -158.76 0.11 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.558 0.694 . . . . 0.0 112.053 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.502 ' H ' ' NE2' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -83.28 -9.38 59.14 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -165.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.2 mm? 71.82 150.59 0.13 Allowed Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 123.11 0.564 . . . . 0.0 111.11 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.579 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 10.9 Cg_exo -68.82 -161.36 0.07 OUTLIER 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.555 2.17 . . . . 0.0 112.292 173.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -142.1 137.65 31.14 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 87.3 m -130.09 107.62 9.46 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.147 0.498 . . . . 0.0 110.78 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.484 ' C ' ' H ' ' A' ' 747' ' ' ILE . 41.1 t -99.52 143.15 13.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.676 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -63.3 2.5 0.38 Allowed 'General case' 0 C--N 1.287 -2.148 0 C-N-CA 126.213 1.805 . . . . 0.0 114.79 -175.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.84 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 59.6 mt 75.48 -16.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 125.302 1.441 . . . . 0.0 111.309 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.7 t70 -72.54 -35.84 68.14 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.166 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 29.86 7.49 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.336 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.84 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 73.3 mt -86.72 -160.63 0.59 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.432 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . 0.44 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 54.9 mtpt -145.86 168.48 20.71 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -116.77 139.83 50.13 Favored 'General case' 0 C--N 1.271 -2.823 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . 0.472 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 46.4 m -92.01 172.86 8.16 Favored 'General case' 0 C--N 1.249 -3.792 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.681 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -138.0 147.69 44.45 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 9.3 p -64.83 139.66 58.79 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.188 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.591 ' HB2' HG12 ' A' ' 759' ' ' ILE . 50.7 m -77.92 173.04 12.58 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -97.13 -15.52 20.9 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 121.543 -0.723 . . . . 0.0 111.608 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.27 16.47 24.23 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.774 -0.579 . . . . 0.0 110.542 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.591 HG12 ' HB2' ' A' ' 756' ' ' SER . 11.8 pt -124.27 153.94 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.701 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.57 131.91 65.27 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.4 HD12 HD11 ' A' ' 759' ' ' ILE . 1.9 mm? -108.12 178.01 4.64 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 45.8 mt-10 -65.33 156.68 31.36 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 171.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 766' ' ' LYS 0.256 0.0 OUTLIER -68.51 -11.16 59.48 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 119.214 0.915 . . . . 0.0 112.802 -174.59 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -74.65 -31.73 62.04 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.704 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 64.3 mt -98.21 -25.37 14.9 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.708 -172.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.428 ' HG3' ' HA ' ' A' ' 763' ' ' GLU . 7.0 mtmp? -62.58 -32.17 73.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.338 0.59 . . . . 0.0 110.586 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -91.85 5.36 50.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.993 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . 0.542 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 22.1 ttmm -87.31 -48.97 7.57 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.03 -54.41 0.57 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.038 1.335 . . . . 0.0 111.201 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 768' ' ' LYS . 47.1 mt-10 -113.69 123.75 50.65 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.542 ' CD2' ' HD2' ' A' ' 768' ' ' LYS . 11.4 m-85 -110.96 149.07 31.19 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -173.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.05 156.16 17.06 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.406 ' HD2' ' OG1' ' A' ' 724' ' ' THR . 9.4 p-80 -46.55 149.74 0.76 Allowed 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.57 1.148 . . . . 0.0 112.876 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 1.9 t30 67.9 12.12 8.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.379 1.472 . . . . 0.0 111.823 174.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 775' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 791' ' ' VAL . 20.1 p -77.33 110.89 12.45 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.453 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -84.92 93.7 8.6 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.704 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.6 pt -106.01 -177.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.809 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.556 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 76.8 mtt85 -132.47 135.37 45.98 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.495 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 4.7 p90 -131.37 168.63 17.25 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -159.05 164.5 35.38 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 93.8 m -83.56 161.35 21.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.93 -30.24 58.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -172.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -99.49 8.34 60.21 Favored Glycine 0 CA--C 1.499 -0.921 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 4.4 mptp? -119.62 162.53 18.81 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -131.14 162.47 29.84 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 96.92 145.03 18.45 Favored Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -172.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.556 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 54.2 m95 -110.25 139.69 45.17 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 117.339 0.57 . . . . 0.0 110.307 -174.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.495 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.0 mp -87.67 -27.41 5.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.276 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . 0.52 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 24.4 m170 72.45 127.43 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 124.406 1.082 . . . . 0.0 109.673 -176.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.486 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.0 t -149.05 151.77 35.05 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.122 176.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 775' ' ' SER . 39.3 t -113.4 132.83 61.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 C-N-CA 123.611 0.764 . . . . 0.0 110.025 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 35.8 t -70.06 113.93 7.73 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.993 0.901 . . . . 0.0 110.417 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.609 HG23 HD11 ' A' ' 726' ' ' ILE . 47.5 mm -114.64 80.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.268 -2.965 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.544 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.671 ' ND2' HD23 ' A' ' 750' ' ' LEU . 1.1 m120 50.26 68.48 0.75 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.817 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 76.68 11.98 84.84 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.975 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -142.12 170.62 15.37 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -176.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 95.0 m95 -116.77 161.79 18.71 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -148.45 102.21 3.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 41.8 Cg_endo -71.26 142.23 72.35 Favored 'Cis proline' 0 C--O 1.244 0.777 0 C-N-CA 123.932 -1.278 . . . . 0.0 112.881 -1.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 24.7 mt-10 -51.13 121.09 5.61 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.989 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.486 ' CG1' HG21 ' A' ' 790' ' ' THR . 5.9 m . . . . . 1 N--CA 1.365 -4.709 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.196 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.422 -1.839 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 24.4 m -78.01 -54.1 6.66 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.286 0.565 . . . . 0.0 110.294 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 118.68 -171.81 14.27 Favored Glycine 1 N--CA 1.356 -6.641 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -34.48 122.54 0.51 Allowed 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 126.645 1.978 . . . . 0.0 111.884 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.605 HG22 HG23 ' A' ' 715' ' ' VAL . 1.6 pp -62.93 147.68 93.61 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.247 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.401 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 43.0 Cg_endo -68.15 -167.02 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.777 2.318 . . . . 0.0 112.396 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -133.75 152.24 51.82 Favored 'General case' 0 N--CA 1.384 -3.773 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.492 HD21 ' SG ' ' A' ' 744' ' ' CYS . 22.0 tp -99.74 114.19 27.17 Favored 'General case' 0 C--N 1.258 -3.371 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -43.32 -43.03 4.78 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 114.382 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -130.22 27.31 5.1 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.037 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -142.58 -150.9 5.4 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.645 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . 0.42 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -145.05 174.54 10.96 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -177.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.81 147.99 28.03 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -84.65 -71.54 0.51 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.947 0.403 . . . . 0.0 110.487 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.0 tt -165.88 138.8 4.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.414 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 70.8 p -123.56 -63.95 1.19 Allowed 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 120.766 0.317 . . . . 0.0 110.854 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 32.7 t 71.41 105.96 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 125.301 1.44 . . . . 0.0 111.483 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.635 ' HB3' ' CE2' ' A' ' 709' ' ' TYR . 91.4 Cg_endo -74.43 162.88 37.37 Favored 'Trans proline' 0 CA--C 1.556 1.579 0 C-N-CA 122.407 2.072 . . . . 0.0 112.119 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 51.3 Cg_exo -65.27 171.01 34.24 Favored 'Cis proline' 0 CA--C 1.478 -2.302 0 CA-C-O 123.136 1.223 . . . . 0.0 113.599 0.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.635 ' CE2' ' HB3' ' A' ' 707' ' ' PRO . 70.2 m-85 -115.14 74.83 0.9 Allowed 'General case' 1 C--N 1.23 -4.614 0 CA-C-N 112.184 -2.28 . . . . 0.0 109.871 -174.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -76.07 170.53 16.1 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.898 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 0.527 ' HH ' ' HA2' ' A' ' 736' ' ' GLY . 68.3 m-85 -73.08 131.58 42.26 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.579 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.78 -8.72 63.77 Favored Glycine 0 N--CA 1.419 -2.439 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.37 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.83 154.92 38.06 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 120.783 0.325 . . . . 0.0 110.227 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 13.3 m -140.15 149.14 42.63 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.605 HG23 HG22 ' A' ' 694' ' ' ILE . 44.5 t -132.61 134.02 59.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 45.0 mt-10 -89.67 141.59 28.46 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.436 0.636 . . . . 0.0 112.253 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.482 ' HB3' HD23 ' A' ' 697' ' ' LEU . 58.6 m-85 -141.16 129.85 22.83 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.875 1.67 . . . . 0.0 107.501 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.42 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 13.2 m-80 -132.63 -161.61 1.15 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 12.5 m -110.07 143.32 40.27 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 2.8 m -73.17 -84.94 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 123.373 0.421 . . . . 0.0 110.708 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -138.15 152.57 48.83 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 53.7 m 66.82 11.6 8.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.656 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.9 m-85 -137.55 148.31 45.82 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.474 ' HB ' HD12 ' A' ' 750' ' ' LEU . 1.1 m -116.65 135.11 54.06 Favored 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.54 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.596 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.8 ttp -92.81 124.26 36.67 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 123.93 0.892 . . . . 0.0 109.221 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 45.8 mm -126.13 144.0 37.74 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.593 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.441 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 100.45 -79.39 0.45 Allowed Glycine 0 N--CA 1.433 -1.505 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.456 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.472 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 2.8 t60 -146.0 179.84 7.2 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.596 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.2 OUTLIER -136.3 22.22 3.21 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.147 177.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.413 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.2 p -157.2 170.1 23.25 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.087 -175.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.45 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 35.7 pt -125.42 161.57 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.69 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 732' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 738' ' ' TRP . 23.7 m -133.74 138.04 45.56 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 123.674 0.609 . . . . 0.0 110.104 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.2 103.19 15.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.49 145.21 24.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.431 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 69.42 -13.62 0.37 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.527 ' HA2' ' HH ' ' A' ' 711' ' ' TYR . . . 117.33 14.9 6.76 Favored Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.7 p -152.24 150.89 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.426 ' HA ' ' O ' ' A' ' 732' ' ' THR . 94.0 m95 -73.5 163.83 27.5 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.656 171.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 34.3 p -74.2 -161.34 0.12 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.083 0.944 . . . . 0.0 113.268 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.4 -3.06 54.92 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -165.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 68.81 155.38 0.14 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 123.665 0.603 . . . . 0.0 111.136 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.472 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 46.0 Cg_endo -74.77 177.75 8.09 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.854 1.703 . . . . 0.0 109.916 170.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -122.91 120.09 32.42 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.818 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.492 ' SG ' HD21 ' A' ' 697' ' ' LEU . 61.4 m -102.25 108.82 20.32 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.778 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 747' ' ' ILE . 22.8 t -97.05 141.3 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.384 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.656 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.54 6.87 0.4 Allowed 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 125.63 1.572 . . . . 0.0 113.99 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.853 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 35.1 mt 75.82 -15.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 125.095 1.358 . . . . 0.0 111.675 177.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.501 ' H ' ' C ' ' A' ' 746' ' ' ALA . 3.3 t70 -81.39 -31.11 33.42 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 126.109 1.763 . . . . 0.0 108.427 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . 0.45 ' HB2' ' CG1' ' A' ' 745' ' ' VAL . 13.6 mttm -106.64 22.86 15.19 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 113.233 -1.803 . . . . 0.0 108.221 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.853 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 73.9 mt -87.94 -169.9 2.77 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.586 174.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . 0.558 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 58.9 mtpt -118.16 168.29 10.71 Favored 'General case' 0 N--CA 1.397 -3.091 0 CA-C-O 122.103 0.954 . . . . 0.0 111.097 -173.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . 0.413 ' HB2' ' HE3' ' A' ' 752' ' ' LYS . 37.0 mtmt -107.17 121.05 43.74 Favored 'General case' 0 C--N 1.253 -3.602 0 CA-C-N 112.79 -2.004 . . . . 0.0 107.141 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . 0.533 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 0.0 OUTLIER -77.89 158.76 29.28 Favored 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 113.824 -1.534 . . . . 0.0 107.979 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -131.75 139.93 49.1 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.14 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 3.9 m -71.26 107.81 4.43 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.445 ' HB2' HG13 ' A' ' 759' ' ' ILE . 70.1 m -58.19 143.74 43.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.821 0.343 . . . . 0.0 110.383 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -78.77 -3.3 43.7 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.336 0.589 . . . . 0.0 111.78 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.73 -15.78 15.64 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.673 -0.642 . . . . 0.0 110.689 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.445 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.7 pp -100.44 161.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.893 -174.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . 0.538 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.5 mp -114.2 129.87 69.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.508 HD11 ' HZ ' ' A' ' 771' ' ' PHE . 86.5 mt -105.32 176.99 4.98 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 120.997 0.427 . . . . 0.0 110.095 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.62 168.8 7.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.988 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -71.22 -7.22 45.34 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.478 0.656 . . . . 0.0 111.42 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.65 -2.96 16.1 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.9 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.24 -10.47 8.95 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.488 ' HZ1' ' HB2' ' A' ' 766' ' ' LYS . 10.4 mtmp? -71.28 -10.09 59.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.841 0.829 . . . . 0.0 110.15 174.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -88.62 -0.83 57.66 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.949 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -114.44 129.99 56.69 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . 0.659 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 9.6 ptpp? -107.1 -24.55 11.91 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . 0.659 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 46.3 mt-10 -132.65 128.44 37.07 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.673 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 753' ' ' CYS . 83.4 m-85 -108.72 176.11 5.22 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.367 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -115.77 158.83 22.28 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.404 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -47.81 151.91 0.82 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.111 1.364 . . . . 0.0 112.622 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 15.3 m120 59.15 13.42 2.97 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 10.4 t -76.94 108.61 10.11 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.404 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.8 OUTLIER -83.94 105.68 15.01 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.493 HG21 ' CE2' ' A' ' 771' ' ' PHE . 7.2 pt -119.77 -177.96 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.504 ' HG2' ' CD2' ' A' ' 789' ' ' HIS . 98.6 mtt180 -125.8 135.28 51.82 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 6.8 p90 -125.82 165.71 18.17 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 170.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . 0.538 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 14.5 ptt180 -145.16 163.48 34.24 Favored 'General case' 0 C--N 1.251 -3.697 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 19.9 t -109.27 162.27 14.47 Favored 'General case' 0 N--CA 1.395 -3.213 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -73.5 -39.05 65.13 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.838 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -84.08 -17.97 63.95 Favored Glycine 0 C--O 1.24 0.5 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.345 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.1 mptt -124.84 84.71 2.31 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -85.5 89.28 7.66 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 122.297 1.046 . . . . 0.0 110.836 -172.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 175.66 152.91 9.82 Favored Glycine 0 C--N 1.287 -2.19 0 N-CA-C 106.145 -2.782 . . . . 0.0 106.145 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.426 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 45.3 m95 -84.46 142.37 30.13 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 118.126 0.963 . . . . 0.0 109.797 -173.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.483 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -99.92 -31.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.041 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . 0.504 ' CD2' ' HG2' ' A' ' 778' ' ' ARG . 28.1 m170 74.75 116.89 0.06 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 124.836 1.254 . . . . 0.0 109.156 -174.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 4.3 t -137.53 152.83 49.89 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.906 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 58.1 t -116.06 133.86 61.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 53.2 t -70.27 129.07 38.36 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.36 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.39 79.76 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.631 ' OD1' HD21 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 54.03 70.43 0.61 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.193 178.398 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 76.82 -4.75 51.47 Favored Glycine 0 C--N 1.301 -1.384 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.778 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -115.89 172.55 7.07 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.534 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.0 m95 -121.76 154.89 36.35 Favored 'General case' 0 C--N 1.266 -3.032 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -144.67 105.61 4.6 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.91 143.08 74.88 Favored 'Cis proline' 0 C--O 1.248 0.993 0 C-N-CA 123.8 -1.333 . . . . 0.0 112.292 -0.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.534 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 38.6 mt-10 -53.19 125.96 19.28 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.659 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.454 ' HA ' ' CE2' ' A' ' 779' ' ' TYR . 4.6 m . . . . . 1 N--CA 1.365 -4.678 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 35.6 m -72.17 -79.47 0.07 Allowed 'General case' 0 C--N 1.268 -2.954 0 C-N-CA 123.872 0.869 . . . . 0.0 111.389 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 148.03 173.19 18.76 Favored Glycine 1 N--CA 1.362 -6.255 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -38.33 130.44 1.27 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 125.926 1.69 . . . . 0.0 111.048 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.684 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -63.23 151.72 86.23 Favored Pre-proline 0 C--N 1.296 -1.741 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.449 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.477 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.1 Cg_endo -72.18 -157.84 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 122.822 2.348 . . . . 0.0 112.941 177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -133.21 146.19 51.26 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' ' 717' ' ' PHE . 30.1 tp -90.25 126.04 35.7 Favored 'General case' 0 C--N 1.263 -3.166 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.09 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.536 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 6.8 pt-20 -32.84 -55.3 0.37 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.24 2.216 . . . . 0.0 114.527 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.536 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 92.3 m-70 -135.53 25.47 3.44 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -131.0 -150.72 6.84 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.05 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . 0.405 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.02 179.13 8.31 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -109.69 146.28 35.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -81.32 -66.48 0.88 Allowed 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.301 0.572 . . . . 0.0 110.536 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.0 tt -161.33 139.61 9.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.403 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 58.6 p -130.73 119.48 22.41 Favored 'General case' 0 N--CA 1.395 -3.206 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 7.4 p -97.46 112.7 61.9 Favored Pre-proline 0 C--N 1.253 -3.598 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.681 -174.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.06 172.52 14.56 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.755 2.303 . . . . 0.0 109.397 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.631 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 4.0 Cg_exo -74.24 -0.21 14.82 Favored 'Cis proline' 0 N--CA 1.489 1.213 0 CA-C-N 120.295 1.141 . . . . 0.0 114.544 5.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 54.2 m-85 74.53 73.1 0.11 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 124.86 1.35 . . . . 0.0 107.79 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.631 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 23.3 m-85 -78.35 172.24 13.9 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.072 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -72.25 138.44 47.47 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.927 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 89.2 -3.83 84.33 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 0.2 OUTLIER -76.1 151.22 37.1 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 17.1 m -130.32 149.9 51.8 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.929 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.684 HG21 HG21 ' A' ' 694' ' ' ILE . 31.7 t -133.92 140.25 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.862 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.43 130.98 43.46 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-O 122.063 0.935 . . . . 0.0 112.209 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.491 ' HB3' HD22 ' A' ' 697' ' ' LEU . 20.3 m-85 -131.96 122.95 26.4 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 126.305 1.842 . . . . 0.0 106.677 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.405 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 26.8 m-80 -119.47 -162.53 0.92 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 6.8 m -111.31 129.42 56.0 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 3.1 m -51.36 -76.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.783 1.233 . . . . 0.0 112.672 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 722' ' ' SER . 45.7 mt-10 -159.3 154.84 25.85 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 101.851 -3.388 . . . . 0.0 101.851 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 67.3 m 68.46 15.37 9.19 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.248 0.967 . . . . 0.0 112.852 176.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.716 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.0 m-85 -143.17 146.96 34.18 Favored 'General case' 0 N--CA 1.417 -2.1 0 C-N-CA 123.898 0.879 . . . . 0.0 108.981 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 2.4 t -103.24 148.37 25.89 Favored 'General case' 0 C--N 1.267 -3.0 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -177.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.6 ttp -104.59 118.06 35.64 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.426 HG12 HG23 ' A' ' 724' ' ' THR . 39.5 mm -116.12 127.75 73.62 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.545 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 108.19 -93.93 0.84 Allowed Glycine 0 CA--C 1.488 -1.652 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.841 174.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 7.2 p-80 -136.16 -175.84 4.12 Favored 'General case' 0 N--CA 1.397 -3.075 0 C-N-CA 125.618 1.567 . . . . 0.0 107.631 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.427 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -132.59 12.73 4.48 Favored 'General case' 0 C--O 1.208 -1.119 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.748 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 87.7 p -128.81 166.48 18.97 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.399 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.55 HG23 ' HA ' ' A' ' 741' ' ' LEU . 32.5 pt -119.07 160.14 19.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.74 174.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 732' ' ' THR . . . . . 0.465 ' O ' HG21 ' A' ' 739' ' ' THR . 3.7 m -134.18 134.92 42.67 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.664 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 40.3 t -94.0 119.93 33.56 Favored 'General case' 0 N--CA 1.405 -2.705 0 C-N-CA 118.821 -1.151 . . . . 0.0 110.259 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.406 ' O ' HD13 ' A' ' 734' ' ' ILE . 1.2 pp -143.8 140.5 25.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 113.836 -1.529 . . . . 0.0 107.676 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 66.45 7.07 4.74 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.76 8.98 61.62 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 738' ' ' TRP . 48.4 t -130.87 139.03 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -175.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.477 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.3 m95 -72.77 166.98 21.81 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.935 172.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 732' ' ' THR . 19.5 p -75.71 -163.09 0.24 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 122.084 0.945 . . . . 0.0 112.021 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.64 2.45 54.72 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.946 -171.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.603 ' HB3' ' HD2' ' A' ' 742' ' ' PRO . 2.0 mp 70.5 169.88 0.11 Allowed Pre-proline 0 C--O 1.237 0.41 0 O-C-N 124.094 0.872 . . . . 0.0 112.338 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 741' ' ' LEU . 39.2 Cg_endo -76.42 -177.06 3.44 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.416 2.077 . . . . 0.0 111.561 171.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -119.79 124.78 46.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 724' ' ' THR . 87.1 m -115.42 107.51 15.3 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 120.9 0.381 . . . . 0.0 110.207 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.502 ' HB ' HG21 ' A' ' 724' ' ' THR . 44.0 t -96.96 145.68 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.716 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.82 1.96 1.19 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 125.039 1.336 . . . . 0.0 114.125 -174.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.791 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 15.8 mt 74.53 -19.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 125.068 1.347 . . . . 0.0 111.697 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.5 t70 -69.82 -33.72 72.71 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 126.72 2.008 . . . . 0.0 109.502 -175.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.18 31.28 6.8 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.585 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.791 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 55.1 mt -85.83 -179.28 6.79 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 121.566 0.698 . . . . 0.0 109.877 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . 0.483 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 56.2 mtpt -116.33 -178.16 3.35 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.109 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -130.19 126.28 37.02 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 113.253 -1.794 . . . . 0.0 107.835 -175.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . 0.429 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 57.5 m -75.41 155.53 36.27 Favored 'General case' 0 C--N 1.264 -3.124 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.047 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -120.09 135.87 54.79 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 45.2 t -58.42 127.1 30.42 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.118 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.583 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 41.0 t -72.17 165.41 24.42 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -84.2 -19.21 34.41 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 91.6 mt -111.53 10.97 21.29 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.021 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.583 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -112.22 149.31 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-O 121.677 0.751 . . . . 0.0 112.642 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . 0.544 HD12 ' HB3' ' A' ' 782' ' ' ARG . 3.3 mp -113.44 133.57 58.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.437 HD12 HD12 ' A' ' 777' ' ' ILE . 1.4 mm? -110.58 -177.95 3.36 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.13 152.83 19.41 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.85 -17.12 34.04 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.84 -6.3 32.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.497 0.665 . . . . 0.0 111.012 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -117.63 -4.78 11.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.677 0.751 . . . . 0.0 110.295 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.462 ' HB3' ' HE3' ' A' ' 766' ' ' LYS . 17.8 mmmt -65.57 -17.35 64.51 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.336 1.055 . . . . 0.0 111.96 176.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -105.64 16.48 25.3 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.099 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . 0.489 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 12.2 tppt? -110.21 113.07 25.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . 0.441 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 8.2 ptpp? -85.8 -32.03 22.0 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.472 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 45.5 mt-10 -132.11 119.67 21.27 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.232 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.489 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 70.4 m-85 -97.58 157.34 16.08 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.804 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -93.28 148.68 21.83 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.627 ' CD2' HD13 ' A' ' 750' ' ' LEU . 15.1 p-80 -48.0 142.82 4.74 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.052 0.941 . . . . 0.0 111.669 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 22.1 m120 68.78 21.7 7.62 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 51.9 m -93.05 120.43 33.34 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.5 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -90.18 111.37 22.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.195 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.437 HD12 HD12 ' A' ' 761' ' ' LEU . 7.8 pt -120.28 -179.7 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.906 0.86 . . . . 0.0 110.459 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.461 ' HG2' ' CD2' ' A' ' 789' ' ' HIS . 88.9 mtm180 -124.75 137.72 54.32 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.587 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 8.4 p90 -130.44 166.2 21.01 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . 0.507 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 24.3 ptt180 -154.25 157.17 38.32 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 27.6 m -87.73 166.14 14.85 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . 0.544 ' HB3' HD12 ' A' ' 760' ' ' ILE . 39.4 ptt85 -84.49 -27.99 27.07 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.169 -0.613 . . . . 0.0 112.089 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -91.88 -5.8 65.97 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.018 -1.087 . . . . 0.0 112.227 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 2.8 mptp? -128.36 104.85 7.95 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -86.24 115.93 24.1 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.603 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 151.57 146.96 4.45 Favored Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 31.3 m95 -94.68 143.22 26.62 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.587 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.1 mp -97.95 -27.93 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.084 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . 0.475 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 28.8 m170 75.95 128.88 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 124.623 1.169 . . . . 0.0 109.923 -174.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.505 HG23 ' CG1' ' A' ' 801' ' ' VAL . 4.7 t -151.38 157.86 42.99 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.241 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.82 135.52 59.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 50.9 t -70.76 112.15 6.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.574 0.702 . . . . 0.0 110.093 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.6 mm -112.89 83.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.034 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.561 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 53.85 56.45 7.13 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.901 172.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . 0.478 ' HA3' ' HE2' ' A' ' 751' ' ' LYS . . . 81.95 16.49 72.31 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.495 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . 0.401 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 35.5 ttt180 -147.42 166.08 28.3 Favored 'General case' 0 C--O 1.19 -2.05 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.566 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 99.0 m95 -111.45 162.7 14.81 Favored 'General case' 0 C--N 1.256 -3.466 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -146.47 105.76 4.05 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 29.2 Cg_endo -67.21 140.61 52.68 Favored 'Cis proline' 0 C--O 1.247 0.95 0 C-N-CA 124.061 -1.225 . . . . 0.0 111.679 -1.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.566 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.7 tt0 -57.51 118.63 5.39 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-O 121.32 0.581 . . . . 0.0 110.431 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.505 ' CG1' HG23 ' A' ' 790' ' ' THR . 1.9 m . . . . . 1 N--CA 1.363 -4.816 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.91 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 690' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 708' ' ' PRO . 15.9 p . . . . . 0 N--CA 1.422 -1.838 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 67.0 m -74.23 -58.51 3.25 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 171.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 81.76 132.29 1.45 Allowed Glycine 0 N--CA 1.417 -2.612 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.137 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 21.1 t70 62.24 106.17 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.729 0.899 . . . . 0.0 111.19 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.61 HG22 HG23 ' A' ' 715' ' ' VAL . 1.7 pp -70.12 147.13 95.47 Favored Pre-proline 0 C--N 1.291 -1.952 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.828 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.439 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 58.9 Cg_endo -69.64 -162.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 123.023 2.482 . . . . 0.0 112.823 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.93 144.92 49.12 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.625 HD11 ' HA3' ' A' ' 700' ' ' GLY . 0.5 OUTLIER -85.8 132.57 34.09 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -49.26 -47.02 46.98 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.818 1.247 . . . . 0.0 113.793 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -141.63 29.58 1.74 Allowed 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.625 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -141.89 -141.01 3.86 Favored Glycine 0 C--N 1.301 -1.395 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.186 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -157.62 179.97 8.73 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -176.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.74 158.21 16.89 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 13.5 mm100 -86.02 -61.5 1.74 Allowed 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.341 0.591 . . . . 0.0 110.618 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.3 tt -167.0 133.24 2.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.491 ' HB2' ' CE1' ' A' ' 709' ' ' TYR . 15.8 p -126.16 137.21 53.56 Favored 'General case' 0 N--CA 1.392 -3.329 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 15.0 t -124.87 109.43 27.88 Favored Pre-proline 0 C--N 1.279 -2.469 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.248 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.43 170.97 12.48 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 123.058 2.506 . . . . 0.0 110.316 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.509 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 15.4 Cg_exo -68.92 -7.35 8.5 Favored 'Cis proline' 0 N--CA 1.499 1.801 0 CA-C-N 119.968 1.024 . . . . 0.0 114.686 3.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 705' ' ' SER . 51.5 m-85 76.15 73.96 0.08 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.73 1.269 . . . . 0.0 108.531 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.509 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 37.0 m-85 -82.26 174.17 11.41 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.5 -176.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -72.63 125.17 26.82 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.746 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 103.52 2.18 47.06 Favored Glycine 0 N--CA 1.411 -3.014 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.313 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.09 151.0 23.61 Favored 'General case' 0 CA--C 1.5 -0.969 0 O-C-N 122.445 -0.444 . . . . 0.0 111.153 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 21.7 m -132.69 156.89 46.18 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.61 HG23 HG22 ' A' ' 694' ' ' ILE . 39.8 t -138.24 136.43 44.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 48.6 mt-10 -91.07 141.71 28.54 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 123.434 0.459 . . . . 0.0 110.249 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.454 ' HB3' ' CD1' ' A' ' 697' ' ' LEU . 42.8 m-85 -138.98 121.65 16.35 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 124.655 1.182 . . . . 0.0 108.693 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -124.46 -165.76 1.42 Allowed 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 8.0 m -117.91 140.97 48.96 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.9 m -60.73 -68.1 0.34 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-O 120.83 0.348 . . . . 0.0 110.551 -175.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 722' ' ' SER . 8.3 pt-20 -172.8 160.51 4.45 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 40.4 m 71.43 7.59 6.07 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.682 1.239 . . . . 0.0 110.493 -174.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.599 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 93.2 m-85 -140.03 144.73 37.05 Favored 'General case' 0 N--CA 1.382 -3.849 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.658 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.482 HG23 HD21 ' A' ' 750' ' ' LEU . 1.1 m -120.38 144.74 47.74 Favored 'General case' 0 C--N 1.264 -3.138 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.786 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.703 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.7 ttp -81.95 116.72 21.71 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 124.91 1.284 . . . . 0.0 109.564 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 46.6 mm -115.25 137.13 49.77 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.954 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.518 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 96.3 -80.05 0.75 Allowed Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.123 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.549 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 4.2 t60 -147.09 177.48 9.13 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -173.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.703 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -133.3 22.44 4.06 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.542 176.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 32.4 p -156.25 162.43 40.15 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.784 -0.572 . . . . 0.0 110.42 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . . . . . . . . . 36.2 pt -121.67 161.09 22.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 124.217 0.948 . . . . 0.0 108.579 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.5 m -133.37 135.8 44.93 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 123.595 0.56 . . . . 0.0 110.424 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.71 104.17 16.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.416 ' C ' ' H ' ' A' ' 736' ' ' GLY . 1.7 pp -146.34 161.68 10.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.912 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 71.7 -43.62 0.57 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.406 1.082 . . . . 0.0 111.565 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 734' ' ' ILE . . . 138.15 37.14 0.14 Allowed Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 125.162 1.363 . . . . 0.0 109.769 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.8 p -174.41 161.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.474 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 95.8 m95 -77.36 172.87 12.63 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.645 173.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 29.5 p -80.4 -159.19 0.22 Allowed 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.699 0.762 . . . . 0.0 112.259 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.9 -4.57 58.79 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -165.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 68.73 156.13 0.15 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 123.432 0.458 . . . . 0.0 111.504 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.549 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 59.0 Cg_endo -80.25 173.66 12.27 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.826 1.684 . . . . 0.0 111.041 172.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -116.36 114.96 25.02 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 724' ' ' THR . 59.1 m -98.08 100.29 11.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-O 122.156 0.979 . . . . 0.0 109.483 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 723' ' ' PHE . 10.6 p -77.87 155.03 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.292 0 CA-C-N 113.82 -1.537 . . . . 0.0 108.737 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.599 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -79.17 1.33 24.87 Favored 'General case' 0 C--N 1.251 -3.7 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.948 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 746' ' ' ALA . 18.8 mt 77.08 -24.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 126.48 1.912 . . . . 0.0 112.24 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.501 ' H ' ' C ' ' A' ' 746' ' ' ALA . 22.9 t70 -72.23 -34.3 68.22 Favored 'General case' 0 C--N 1.264 -3.128 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.103 -175.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -102.42 27.8 6.5 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 112.687 -2.051 . . . . 0.0 111.541 -174.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.547 ' CD1' HG12 ' A' ' 745' ' ' VAL . 1.9 tp -84.31 -179.46 7.2 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -107.37 -172.82 2.15 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.586 -173.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . 0.528 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 25.0 mtpp -123.03 156.04 35.65 Favored 'General case' 0 C--N 1.265 -3.07 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 79.2 m -112.18 168.6 9.49 Favored 'General case' 1 C--N 1.241 -4.136 0 C-N-CA 123.354 0.662 . . . . 0.0 109.532 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -129.2 141.36 51.17 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 48.1 t -61.86 131.37 49.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.562 ' HB2' HG12 ' A' ' 759' ' ' ILE . 17.7 m -76.17 175.01 9.39 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 123.079 0.551 . . . . 0.0 111.539 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -85.73 -35.02 21.06 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -172.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.18 12.55 26.57 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.525 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.562 HG12 ' HB2' ' A' ' 756' ' ' SER . 23.2 pt -105.59 156.21 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.183 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . 0.45 HD13 ' HB3' ' A' ' 782' ' ' ARG . 3.1 mp -122.6 129.44 75.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.64 HD11 ' HZ ' ' A' ' 771' ' ' PHE . 81.9 mt -97.52 -173.54 2.67 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.629 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 35.0 mt-10 -68.77 162.3 26.56 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . 0.523 ' HA ' ' HE2' ' A' ' 766' ' ' LYS . 38.9 mm-40 -61.74 -21.81 64.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.432 0.634 . . . . 0.0 110.738 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.27 2.02 45.18 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.471 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -126.94 -12.44 5.88 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 763' ' ' GLU . 57.0 mtmt -68.37 -7.53 32.2 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -102.61 0.67 33.67 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -95.02 102.43 14.24 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -78.55 -31.81 47.59 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.368 0.604 . . . . 0.0 109.656 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -131.17 128.25 39.64 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.936 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.64 ' HZ ' HD11 ' A' ' 761' ' ' LEU . 92.6 m-85 -107.15 162.62 13.71 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 752' ' ' LYS . 2.6 p30 -113.55 168.72 9.52 Favored 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 118.1 -1.44 . . . . 0.0 109.126 175.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.424 ' CD2' HG22 ' A' ' 747' ' ' ILE . 2.1 p-80 -47.42 150.09 0.98 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.984 0.914 . . . . 0.0 112.835 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 70.93 3.62 4.71 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.934 1.293 . . . . 0.0 111.324 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 12.8 t -78.85 114.39 17.75 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.434 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.8 OUTLIER -89.05 113.23 24.32 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.173 178.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.45 HG22 ' CE2' ' A' ' 771' ' ' PHE . 8.2 pt -125.89 178.05 4.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-O 121.337 0.589 . . . . 0.0 109.688 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.572 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 31.4 ptt180 -133.45 127.84 34.18 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.515 ' CE1' HG12 ' A' ' 801' ' ' VAL . 6.6 p90 -119.38 168.04 11.33 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . 0.402 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 35.0 ptt180 -144.53 161.01 40.16 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 85.2 m -90.27 143.12 27.05 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.884 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . 0.45 ' HB3' HD13 ' A' ' 760' ' ' ILE . 27.4 ptt180 -67.75 130.49 43.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 95.94 -10.59 68.11 Favored Glycine 0 C--N 1.294 -1.765 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.4 mptt -114.02 140.38 48.49 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -116.87 87.66 2.74 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.395 0.617 . . . . 0.0 110.066 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 172.61 158.54 17.11 Favored Glycine 0 N--CA 1.425 -2.036 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 60.4 m95 -114.32 145.39 41.84 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 117.368 0.584 . . . . 0.0 109.71 -175.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.428 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -95.84 -35.33 5.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.388 -177.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 7.1 m170 70.92 114.41 0.05 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 124.31 1.044 . . . . 0.0 109.785 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 3.6 t -139.46 163.08 33.47 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.97 138.96 52.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 C-N-CA 123.388 0.675 . . . . 0.0 109.459 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.7 t -73.41 110.69 7.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.559 0.695 . . . . 0.0 110.258 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.4 mm -111.81 81.57 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.639 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.7 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.452 ' HB2' ' HG ' ' A' ' 750' ' ' LEU . 26.5 t-20 53.52 68.67 0.81 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.947 0.88 . . . . 0.0 112.22 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 70.55 17.4 74.66 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.824 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -143.52 166.2 25.46 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.517 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 95.1 m95 -112.61 158.92 19.4 Favored 'General case' 0 C--N 1.252 -3.638 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -148.05 106.67 3.65 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.82 138.53 46.98 Favored 'Cis proline' 0 C--O 1.241 0.633 0 C-N-CA 123.62 -1.408 . . . . 0.0 111.541 -0.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.1 tp10 -57.36 128.27 36.17 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.669 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.515 HG12 ' CE1' ' A' ' 779' ' ' TYR . 15.8 m . . . . . 1 N--CA 1.363 -4.786 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.706 -173.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 690' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 708' ' ' PRO . 19.6 p . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.4 m -74.82 -59.38 2.76 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 135.35 166.88 11.18 Favored Glycine 1 N--CA 1.383 -4.857 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -177.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.645 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 34.1 t70 -53.54 135.78 39.53 Favored 'General case' 0 C--N 1.281 -2.397 0 O-C-N 124.658 0.858 . . . . 0.0 111.062 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.766 HG22 HG22 ' A' ' 715' ' ' VAL . 1.2 pp -52.76 150.27 9.98 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 113.15 -1.841 . . . . 0.0 115.654 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.82 -162.87 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.61 2.873 . . . . 0.0 111.866 175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -135.5 154.64 51.34 Favored 'General case' 0 N--CA 1.395 -3.214 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.636 HD22 ' SG ' ' A' ' 744' ' ' CYS . 21.9 tp -104.25 111.5 24.14 Favored 'General case' 0 C--N 1.252 -3.656 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.593 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -43.9 -37.11 2.68 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.806 1.642 . . . . 0.0 115.22 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -134.73 26.61 3.67 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 121.942 -0.474 . . . . 0.0 110.429 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -139.71 -147.78 5.1 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.207 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -149.61 173.3 13.8 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 122.617 0.367 . . . . 0.0 110.208 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.61 139.38 40.3 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -82.27 -75.22 0.31 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.962 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 705' ' ' SER . 1.0 OUTLIER -170.66 162.38 7.83 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.217 0.532 . . . . 0.0 111.343 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.608 ' CB ' HG21 ' A' ' 715' ' ' VAL . 33.8 t 174.92 179.38 0.13 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 128.527 2.731 . . . . 0.0 105.007 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 23.4 p -148.63 140.82 14.74 Favored Pre-proline 0 C--N 1.305 -1.344 0 CA-C-N 118.619 0.645 . . . . 0.0 110.833 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.506 ' HA ' ' N ' ' A' ' 709' ' ' TYR . 50.4 Cg_endo -68.52 163.9 34.95 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.019 1.813 . . . . 0.0 109.064 175.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.504 ' HB2' ' CG2' ' A' ' 690' ' ' THR . 29.7 Cg_endo -64.68 -5.14 3.05 Favored 'Cis proline' 0 N--CA 1.502 1.973 0 N-CA-C 117.353 2.02 . . . . 0.0 117.353 4.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.645 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 74.7 m-85 66.33 66.55 0.47 Allowed 'General case' 0 C--O 1.255 1.362 0 CA-C-O 122.288 1.042 . . . . 0.0 108.566 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -67.11 169.85 7.85 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.336 -1.756 . . . . 0.0 112.111 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 0.493 ' HH ' ' HA2' ' A' ' 736' ' ' GLY . 58.3 m-85 -67.63 137.33 55.53 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.928 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 87.52 8.17 74.46 Favored Glycine 0 N--CA 1.41 -3.048 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.09 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.68 156.77 24.9 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 13.8 m -141.27 139.43 33.69 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 694' ' ' ILE . 20.2 t -126.78 136.65 60.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.507 ' HG3' ' HG2' ' A' ' 729' ' ' ARG . 26.5 tt0 -96.89 140.59 31.22 Favored 'General case' 0 N--CA 1.381 -3.918 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.519 ' HB3' HD21 ' A' ' 697' ' ' LEU . 50.4 m-85 -138.67 120.39 15.24 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 125.833 1.653 . . . . 0.0 107.396 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -122.28 -165.36 1.27 Allowed 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 7.1 m -112.97 135.89 53.25 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 11.9 t -57.94 -68.93 0.2 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 722' ' ' SER . 11.4 pt-20 -172.26 163.81 5.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 75.4 m 72.13 5.95 5.44 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.193 0.933 . . . . 0.0 110.872 -177.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.663 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.6 m-85 -141.52 145.53 35.28 Favored 'General case' 0 N--CA 1.401 -2.895 0 C-N-CA 125.192 1.397 . . . . 0.0 107.95 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.2 m -114.21 138.24 50.72 Favored 'General case' 0 C--N 1.251 -3.716 0 C-N-CA 125.709 1.604 . . . . 0.0 111.998 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.599 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.1 ttp -91.01 122.36 33.6 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.893 1.277 . . . . 0.0 109.486 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 39.8 mm -124.21 135.89 62.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.949 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 101.35 -74.99 0.37 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.206 173.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.518 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.1 OUTLIER -141.16 177.18 8.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -176.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.599 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -135.46 8.92 3.4 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.0 0.905 . . . . 0.0 109.359 170.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 54.4 p -145.72 163.0 36.29 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.699 -0.625 . . . . 0.0 110.235 -176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.506 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 35.7 pt -122.76 163.4 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 732' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 739' ' ' THR . 21.2 m -139.17 137.25 35.89 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.937 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 5.7 t -86.48 99.9 11.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.7 pp -140.75 146.27 24.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.284 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 67.87 -4.78 0.93 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.493 ' HA2' ' HH ' ' A' ' 711' ' ' TYR . . . 112.47 13.38 11.77 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 121.581 -0.342 . . . . 0.0 112.613 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.2 p -155.09 157.22 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.423 ' HA ' ' O ' ' A' ' 732' ' ' THR . 96.9 m95 -73.33 167.58 20.93 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 121.056 0.455 . . . . 0.0 109.816 171.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 42.8 p -77.61 -163.12 0.36 Allowed 'General case' 0 N--CA 1.426 -1.638 0 CA-C-O 122.021 0.915 . . . . 0.0 112.616 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -1.89 32.93 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -167.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 67.61 161.44 0.14 Allowed Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 122.735 0.414 . . . . 0.0 110.386 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.518 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 49.8 Cg_endo -83.64 174.35 8.79 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.443 1.429 . . . . 0.0 110.241 168.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -117.39 117.09 28.53 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.636 ' SG ' HD22 ' A' ' 697' ' ' LEU . 95.4 m -102.67 107.77 18.8 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.188 0.518 . . . . 0.0 110.154 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.463 ' C ' ' H ' ' A' ' 747' ' ' ILE . 39.6 t -96.31 145.05 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.663 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -67.89 6.89 0.61 Allowed 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 125.048 1.339 . . . . 0.0 114.438 -175.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.841 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 36.9 mt 76.34 -16.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 C-N-CA 125.561 1.544 . . . . 0.0 112.025 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 746' ' ' ALA . 14.9 t70 -81.82 -31.96 31.48 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.616 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -107.33 23.23 14.76 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.946 -1.934 . . . . 0.0 108.442 -172.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.841 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 72.5 mt -82.58 -165.21 0.98 Allowed 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.361 175.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . 0.479 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 61.3 mtpt -124.51 152.7 43.1 Favored 'General case' 0 N--CA 1.393 -3.314 0 CA-C-O 121.834 0.826 . . . . 0.0 110.19 -173.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . 0.41 ' HE3' ' OE1' ' A' ' 770' ' ' GLU . 43.8 mtmt -101.87 115.56 30.8 Favored 'General case' 0 C--N 1.251 -3.674 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.034 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . 0.493 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 0.0 OUTLIER -75.71 166.65 23.23 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-N 112.991 -1.913 . . . . 0.0 109.143 -178.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -145.68 161.84 38.93 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.004 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 31.4 t -65.53 121.74 15.61 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.357 172.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.619 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 30.6 t -63.91 153.48 36.82 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -58.76 -26.96 64.52 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 124.24 1.016 . . . . 0.0 113.459 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.59 -13.84 14.16 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.831 -170.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.619 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -87.7 155.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.09 134.41 55.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 113.78 -1.555 . . . . 0.0 107.17 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 1.8 mm? -114.12 178.7 4.19 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . 0.538 ' HB2' HD22 ' A' ' 765' ' ' LEU . 34.6 mt-10 -73.15 163.12 28.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -52.93 -27.61 19.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . 0.444 ' HB2' HD23 ' A' ' 765' ' ' LEU . 31.2 m-70 -76.6 -35.97 57.78 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 762' ' ' GLU . 2.0 mm? -91.11 -15.55 29.26 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.192 -1.822 . . . . 0.0 112.551 -168.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -77.48 -6.78 54.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.202 0.525 . . . . 0.0 110.951 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -114.46 13.18 17.59 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . 0.442 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 13.5 tppt? -105.85 112.61 25.73 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -87.31 -29.53 21.53 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.189 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . 0.41 ' OE1' ' HE3' ' A' ' 752' ' ' LYS . 45.2 mt-10 -139.66 138.29 35.95 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.653 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.442 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 39.5 m-85 -117.02 177.0 4.87 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -121.48 166.2 14.5 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 792' ' ' CYS . 34.9 t60 -65.54 149.73 49.58 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 83.03 0.41 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.789 1.236 . . . . 0.0 108.668 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 54.0 m -83.41 106.57 15.27 Favored 'General case' 0 N--CA 1.41 -2.467 0 C-N-CA 119.001 -1.079 . . . . 0.0 108.885 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.442 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -88.41 101.94 14.4 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.401 HG12 ' CZ3' ' A' ' 797' ' ' TRP . 4.3 pt -112.87 178.36 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 121.773 0.797 . . . . 0.0 109.868 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 79.2 mtt180 -130.06 127.76 40.54 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.594 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 7.6 p90 -121.73 168.48 11.76 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -152.93 171.35 18.46 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.688 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 52.7 t -113.06 162.03 16.39 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -77.98 104.24 8.42 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 120.65 -44.21 1.41 Allowed Glycine 0 C--N 1.276 -2.765 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.037 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.688 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.7 mptt -97.89 91.04 5.15 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.75 148.28 31.55 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.245 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 100.62 154.34 27.08 Favored Glycine 0 C--N 1.294 -1.763 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -172.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.582 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 45.4 m95 -99.9 139.79 35.05 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 117.622 0.711 . . . . 0.0 110.994 -173.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.594 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -90.35 -33.01 5.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.674 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 18.6 m170 78.45 125.46 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 C-N-CA 124.784 1.234 . . . . 0.0 110.206 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.2 t -151.55 152.98 33.65 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 52.7 t -117.59 134.85 59.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 773' ' ' HIS . 52.4 t -67.46 132.78 48.28 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.972 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.61 83.21 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 C-N-CA 124.418 1.087 . . . . 0.0 108.074 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.682 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.8 OUTLIER 45.93 72.74 0.2 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.097 0.959 . . . . 0.0 112.809 177.468 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 78.4 0.55 78.93 Favored Glycine 0 C--N 1.296 -1.666 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.012 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 36.1 ttm180 -130.38 173.48 10.78 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 98.5 m95 -116.78 162.18 18.11 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 122.351 0.26 . . . . 0.0 111.179 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -144.68 108.08 4.73 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.17 140.05 56.5 Favored 'Cis proline' 0 C--O 1.248 0.992 0 C-N-CA 123.637 -1.401 . . . . 0.0 111.129 -1.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.9 tt0 -57.11 125.58 23.33 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.006 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 9.5 m . . . . . 1 N--CA 1.363 -4.788 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.808 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.422 -1.832 0 CA-C-O 121.721 0.772 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.7 m -76.41 -74.18 0.24 Allowed 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.161 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 143.72 179.09 20.03 Favored Glycine 1 N--CA 1.356 -6.663 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -39.66 126.52 1.92 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 126.313 1.845 . . . . 0.0 111.484 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.54 HG21 HG23 ' A' ' 715' ' ' VAL . 1.7 pp -63.16 147.78 94.07 Favored Pre-proline 0 N--CA 1.425 -1.707 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.406 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.467 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 72.9 Cg_endo -72.69 -166.22 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.818 2.345 . . . . 0.0 112.828 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -126.6 165.19 19.65 Favored 'General case' 0 N--CA 1.399 -2.977 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.598 HD22 ' SG ' ' A' ' 744' ' ' CYS . 37.6 tp -119.67 110.64 17.07 Favored 'General case' 0 C--N 1.251 -3.705 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.901 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.05 -40.24 6.5 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -173.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 88.2 m-70 -128.24 20.7 6.27 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 121.473 -0.767 . . . . 0.0 110.16 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -125.29 -139.61 5.24 Favored Glycine 0 C--N 1.304 -1.2 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.93 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . 0.564 ' HE1' ' CG ' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -160.85 177.92 9.93 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -109.96 154.65 22.83 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -91.27 -74.32 0.51 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 120.933 0.397 . . . . 0.0 110.369 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 705' ' ' SER . 6.3 tt -157.22 133.56 9.77 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 177.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.454 ' HB2' ' CE1' ' A' ' 709' ' ' TYR . 4.2 p -133.96 110.73 9.88 Favored 'General case' 0 N--CA 1.393 -3.297 0 CA-C-O 121.724 0.773 . . . . 0.0 110.145 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 39.8 t -90.26 111.45 47.1 Favored Pre-proline 0 C--N 1.277 -2.557 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.993 -174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.26 171.81 15.31 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.774 2.316 . . . . 0.0 109.363 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.521 ' HG2' ' CE1' ' A' ' 710' ' ' TYR . 2.8 Cg_exo -70.75 -7.24 11.57 Favored 'Cis proline' 0 CA--C 1.498 -1.316 0 N-CA-C 115.505 1.31 . . . . 0.0 115.505 5.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 43.3 m-85 78.55 86.1 0.07 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.521 ' CE1' ' HG2' ' A' ' 708' ' ' PRO . 26.9 m-85 -91.2 174.65 7.28 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.815 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 0.434 ' CE2' ' HA2' ' A' ' 736' ' ' GLY . 64.1 m-85 -74.71 136.64 41.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.231 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 91.26 -4.91 81.01 Favored Glycine 0 N--CA 1.416 -2.657 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.356 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -73.59 147.79 43.52 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 6.8 m -129.02 152.53 48.53 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.54 HG23 HG21 ' A' ' 694' ' ' ILE . 41.1 t -136.29 133.01 49.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.544 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 36.7 mt-10 -95.17 140.32 30.25 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.962 0.886 . . . . 0.0 111.638 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.508 ' HB3' HD21 ' A' ' 697' ' ' LEU . 37.3 m-85 -138.76 129.96 26.95 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.564 ' CG ' ' HE1' ' A' ' 701' ' ' TRP . 9.1 p30 -128.44 -167.77 1.82 Allowed 'General case' 1 N--CA 1.377 -4.089 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 44.4 m -108.65 124.06 49.94 Favored 'General case' 0 C--N 1.247 -3.864 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 24.2 t -44.9 -80.75 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 O-C-N 125.689 1.868 . . . . 0.0 112.834 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 722' ' ' SER . 48.2 mt-10 -153.83 150.74 28.75 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 176.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 43.3 m 69.19 9.65 7.46 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.262 0.976 . . . . 0.0 113.611 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 719' ' ' CYS . 96.5 m-85 -134.3 145.53 49.16 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.526 HG21 ' O ' ' A' ' 745' ' ' VAL . 6.4 t -75.86 -115.53 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.898 -175.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.629 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.2 ttp 165.09 107.86 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.732 2.813 . . . . 0.0 105.227 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.681 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 42.1 mm -119.03 143.96 28.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 92.48 -68.87 1.81 Allowed Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.731 173.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.538 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.5 t60 -154.58 -178.71 7.37 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -174.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.629 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -139.35 20.31 2.57 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.379 0.609 . . . . 0.0 110.012 173.278 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.544 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 59.9 p -156.08 162.3 40.29 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.879 -177.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 714' ' ' SER . 35.8 pt -120.34 157.75 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 732' ' ' THR . . . . . 0.506 ' O ' HG22 ' A' ' 739' ' ' THR . 6.1 m -131.26 135.6 47.48 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.0 t -95.77 111.57 23.5 Favored 'General case' 0 N--CA 1.392 -3.346 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.763 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 736' ' ' GLY . 1.4 pp -138.09 154.23 28.05 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.128 0 CA-C-N 113.649 -1.614 . . . . 0.0 107.089 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 76.76 -44.74 0.48 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.311 1.044 . . . . 0.0 110.26 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.434 ' HA2' ' CE2' ' A' ' 711' ' ' TYR . . . 144.86 25.78 0.11 Allowed Glycine 0 C--N 1.298 -1.559 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 8.5 p -163.64 167.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.467 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 86.8 m95 -84.33 173.02 11.28 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 121.156 0.503 . . . . 0.0 111.634 177.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 732' ' ' THR . 21.3 p -86.92 -157.25 0.36 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.481 ' NE2' ' HB ' ' A' ' 739' ' ' THR . 0.0 OUTLIER -69.49 -24.28 63.75 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 126.065 1.746 . . . . 0.0 113.468 -171.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 1.6 mt 70.08 155.27 0.15 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 124.452 1.095 . . . . 0.0 111.206 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.538 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 37.6 Cg_endo -71.61 175.28 9.75 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.792 1.661 . . . . 0.0 111.812 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . 0.681 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.4 tt0 -123.11 119.2 29.59 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.598 ' SG ' HD22 ' A' ' 697' ' ' LEU . 90.7 m -105.0 104.4 14.13 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.18 0.514 . . . . 0.0 110.965 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.526 ' O ' HG21 ' A' ' 724' ' ' THR . 42.2 t -101.83 147.2 8.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 748' ' ' ASP . . . -65.76 3.73 0.73 Allowed 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 124.867 1.267 . . . . 0.0 113.788 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.534 ' HA ' HD23 ' A' ' 750' ' ' LEU . 61.4 mt 73.8 -17.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.821 1.648 . . . . 0.0 110.938 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 746' ' ' ALA . 7.2 t70 -72.51 -33.03 66.63 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 126.402 1.881 . . . . 0.0 109.267 -177.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -105.05 18.91 21.53 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.566 -172.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 1.013 ' HG ' HD21 ' A' ' 794' ' ' ASN . 0.2 OUTLIER -82.06 -172.9 4.2 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.06 179.179 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' A' ' 751' ' ' LYS . 28.1 mmmt -115.04 148.7 38.55 Favored 'General case' 0 N--CA 1.381 -3.906 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.706 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -109.82 119.26 38.79 Favored 'General case' 1 C--N 1.23 -4.613 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.378 -173.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 770' ' ' GLU . 27.2 m -67.27 162.73 22.06 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.762 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 769' ' ' LYS . 16.9 ptpt -126.44 144.15 50.94 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.181 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 48.0 p -68.06 114.13 6.33 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.754 171.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.578 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 45.2 t -69.76 156.9 38.31 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -84.32 -13.39 52.54 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.278 0.561 . . . . 0.0 112.385 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 5.6 mp -95.53 -4.28 45.08 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.059 -173.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.578 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.1 pp -118.96 152.24 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 CA-C-O 121.985 0.897 . . . . 0.0 112.138 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.58 127.77 64.76 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.795 0 CA-C-N 113.814 -1.539 . . . . 0.0 107.365 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -107.6 -175.18 2.72 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . 0.555 ' HB2' HD21 ' A' ' 765' ' ' LEU . 25.6 mt-10 -76.87 171.86 14.07 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.263 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.33 -31.34 67.47 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.282 0.633 . . . . 0.0 110.544 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.32 2.09 54.6 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.731 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' A' ' 762' ' ' GLU . 2.9 mm? -122.28 -24.45 5.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 53.8 mtmt -66.38 -23.78 66.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -86.77 -2.83 58.86 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.939 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . 0.46 ' HE3' ' CD2' ' A' ' 771' ' ' PHE . 23.4 ttpt -99.4 110.22 22.74 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . 0.59 ' HG2' ' HG3' ' A' ' 770' ' ' GLU . 0.0 OUTLIER -93.03 -23.98 18.48 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . 0.59 ' HG3' ' HG2' ' A' ' 769' ' ' LYS . 37.6 mt-10 -127.77 106.41 9.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.46 ' CD2' ' HE3' ' A' ' 768' ' ' LYS . 67.5 m-85 -89.59 147.95 23.64 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.916 -174.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -89.49 144.59 25.92 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.158 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.572 ' CB ' HD22 ' A' ' 750' ' ' LEU . 49.9 t60 -57.95 146.77 31.18 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.319 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 83.44 3.75 0.9 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.37 1.468 . . . . 0.0 110.232 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 67.8 m -86.41 113.6 22.5 Favored 'General case' 0 N--CA 1.398 -3.047 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.407 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -85.89 90.6 8.11 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.497 179.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . . . . . . . . . 7.4 pt -95.23 -175.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 0.2 OUTLIER -141.55 121.06 13.26 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.007 175.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.546 ' CD2' HG12 ' A' ' 801' ' ' VAL . 10.6 p90 -106.71 168.71 8.99 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 174.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -149.82 146.91 27.4 Favored 'General case' 0 C--N 1.257 -3.45 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.581 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 5.0 t -79.36 168.43 19.52 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -74.21 -1.38 20.25 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.113 0.482 . . . . 0.0 111.901 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -113.15 -6.6 22.2 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.581 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 3.8 mptp? -112.58 137.53 50.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -106.59 4.89 28.52 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.43 1.11 . . . . 0.0 110.805 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -113.04 157.84 14.67 Favored Glycine 0 C--N 1.268 -3.225 0 CA-C-N 113.446 -1.706 . . . . 0.0 108.943 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 46.0 m95 -100.35 141.45 33.18 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 117.231 0.516 . . . . 0.0 110.298 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.521 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -91.93 -31.31 4.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 15.4 m170 73.25 123.62 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 124.455 1.102 . . . . 0.0 110.13 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.483 HG23 ' CG2' ' A' ' 801' ' ' VAL . 2.3 t -146.33 155.36 42.57 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 24.9 t -114.21 133.26 60.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 41.6 t -70.46 117.2 11.7 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.527 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 47.8 mm -119.29 89.15 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 C-N-CA 123.861 0.865 . . . . 0.0 109.382 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 1.013 HD21 ' HG ' ' A' ' 750' ' ' LEU . 0.9 OUTLIER 43.59 62.35 1.93 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.083 0.953 . . . . 0.0 112.754 175.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.15 36.47 56.29 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.968 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -158.79 165.53 34.05 Favored 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.562 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.4 m95 -114.23 160.36 19.11 Favored 'General case' 0 C--N 1.258 -3.385 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -148.1 102.13 3.6 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.77 142.59 72.9 Favored 'Cis proline' 0 C--O 1.244 0.824 0 C-N-CA 123.886 -1.298 . . . . 0.0 112.96 0.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 45.5 mt-10 -48.55 125.34 9.66 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.287 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 779' ' ' TYR . 75.5 t . . . . . 0 C--N 1.305 -1.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.24 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 54.1 m -78.62 -75.1 0.24 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.304 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 143.13 -167.9 26.26 Favored Glycine 1 N--CA 1.378 -5.226 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -48.89 130.34 18.01 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 125.462 1.505 . . . . 0.0 110.417 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.662 HG21 HG21 ' A' ' 715' ' ' VAL . 1.3 pp -58.52 150.61 55.12 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.324 -177.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.563 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 74.3 Cg_endo -72.15 -159.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 123.276 2.65 . . . . 0.0 114.147 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -125.31 158.86 33.13 Favored 'General case' 0 N--CA 1.397 -3.115 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.568 HD12 ' HA3' ' A' ' 700' ' ' GLY . 0.5 OUTLIER -107.4 129.36 54.93 Favored 'General case' 0 C--N 1.26 -3.312 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -45.87 -45.68 15.32 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -141.22 27.18 1.95 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.417 0.627 . . . . 0.0 109.536 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.568 ' HA3' HD12 ' A' ' 697' ' ' LEU . . . -134.0 -146.32 5.44 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.807 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -153.41 178.11 10.15 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 122.94 0.496 . . . . 0.0 110.257 -175.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -108.55 147.5 31.68 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -71.34 -77.78 0.09 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.146 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.6 tt 179.66 135.98 0.1 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.475 ' HB2' HG13 ' A' ' 715' ' ' VAL . 22.9 t -144.81 -168.89 3.04 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 9.7 t -152.46 139.56 12.64 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.45 169.11 10.18 Favored 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 122.963 2.442 . . . . 0.0 110.072 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 710' ' ' TYR . 2.8 Cg_exo -72.44 -9.95 16.99 Favored 'Cis proline' 0 N--CA 1.49 1.279 0 N-CA-C 115.184 1.186 . . . . 0.0 115.184 7.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 62.3 m-85 73.28 79.85 0.13 Allowed 'General case' 0 C--N 1.312 -1.064 0 O-C-N 124.575 1.172 . . . . 0.0 108.993 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.516 ' CZ ' ' HG2' ' A' ' 708' ' ' PRO . 21.4 m-85 -84.05 168.67 15.69 Favored 'General case' 0 CA--C 1.477 -1.84 0 CA-C-N 113.943 -1.481 . . . . 0.0 112.717 -174.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -69.66 128.3 35.97 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.07 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.57 -15.53 55.79 Favored Glycine 0 N--CA 1.414 -2.791 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.611 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.47 145.25 52.89 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 10.8 m -131.32 150.28 52.21 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.662 HG21 HG21 ' A' ' 694' ' ' ILE . 42.7 t -138.15 124.65 26.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.656 ' HG3' ' HG2' ' A' ' 729' ' ' ARG . 2.3 mp0 -65.68 134.55 53.46 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.722 0.772 . . . . 0.0 112.623 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.418 ' HB3' ' CD1' ' A' ' 697' ' ' LEU . 19.9 m-85 -137.61 114.91 10.99 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 126.374 1.87 . . . . 0.0 107.063 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -124.15 -168.56 1.81 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -175.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 23.3 m -116.17 138.62 51.11 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 5.0 m -57.55 -78.13 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 123.973 0.796 . . . . 0.0 112.152 -174.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -157.79 159.36 36.67 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 58.4 m 65.95 9.56 6.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.614 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 94.6 m-85 -142.14 146.04 34.89 Favored 'General case' 0 N--CA 1.407 -2.586 0 C-N-CA 124.12 0.968 . . . . 0.0 108.771 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.0 OUTLIER -113.09 137.31 51.62 Favored 'General case' 0 C--N 1.256 -3.478 0 C-N-CA 125.432 1.493 . . . . 0.0 111.129 -178.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 725' ' ' MET . . . . . . . . . . . . . 9.2 tmm? -87.54 125.36 34.29 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.9 mm -124.91 133.32 69.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.009 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 121.33 -89.37 0.43 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.095 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.497 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 28.0 t60 -157.03 145.55 19.69 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.656 ' HG2' ' HG3' ' A' ' 716' ' ' GLU . 0.0 OUTLIER -86.84 13.77 8.35 Favored 'General case' 0 C--N 1.274 -2.691 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.879 -171.552 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 716' ' ' GLU . 6.0 p -156.66 168.56 27.03 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.951 -0.468 . . . . 0.0 111.987 -176.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 714' ' ' SER . 35.1 pt -117.0 164.61 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.587 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.3 m -136.08 134.24 38.19 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.698 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 8.5 t -84.14 107.57 16.54 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.092 0.472 . . . . 0.0 110.037 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -144.95 145.64 20.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 C-N-CA 125.085 1.354 . . . . 0.0 109.896 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 66.62 -0.31 1.61 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.39 24.45 24.05 Favored Glycine 0 CA--C 1.498 -0.973 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.09 153.26 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.563 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.4 m95 -79.11 177.83 8.51 Favored 'General case' 0 C--N 1.277 -2.545 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.468 168.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.412 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 17.1 p -80.84 -169.81 2.37 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.686 0.755 . . . . 0.0 112.873 -176.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.3 pp0? -71.46 -14.98 62.31 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -171.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 2.1 mt 69.54 146.53 0.11 Allowed Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 124.394 1.059 . . . . 0.0 113.853 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.497 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 48.1 Cg_endo -69.23 169.11 19.0 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 121.968 1.778 . . . . 0.0 112.346 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -115.22 104.69 12.08 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.821 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 724' ' ' THR . 87.3 m -84.8 99.74 11.09 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.653 0.739 . . . . 0.0 110.112 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.632 ' CG1' ' HG3' ' A' ' 749' ' ' LYS . 41.7 t -92.8 142.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.537 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.614 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.32 2.29 0.62 Allowed 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 125.857 1.663 . . . . 0.0 114.624 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.784 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 49.0 mt 78.33 -14.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 126.063 1.745 . . . . 0.0 111.699 176.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 746' ' ' ALA . 24.9 t70 -83.88 -30.14 26.65 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.729 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . 0.632 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 7.8 ptmt -110.58 29.78 7.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.002 -1.453 . . . . 0.0 111.838 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.784 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 96.2 mt -84.33 176.1 8.94 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.827 177.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -99.81 145.31 27.87 Favored 'General case' 0 N--CA 1.388 -3.564 0 CA-C-O 122.727 1.251 . . . . 0.0 110.293 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -98.17 111.84 24.02 Favored 'General case' 1 C--N 1.236 -4.366 0 CA-C-N 111.248 -2.705 . . . . 0.0 109.21 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 42.5 m -66.99 138.54 57.32 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.867 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -107.95 136.39 47.73 Favored 'General case' 0 C--N 1.27 -2.867 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.407 -174.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 15.5 p -52.75 132.82 36.92 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.842 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.566 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 29.8 t -80.46 166.75 20.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -93.36 -17.28 23.72 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 74.5 mt -113.23 14.37 19.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.299 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.566 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.1 pp -115.05 149.18 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.961 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . 0.542 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.2 mp -107.95 129.95 61.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.862 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -177.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.535 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 1.9 mm? -108.17 178.76 4.41 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -77.96 172.21 13.84 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -66.47 -8.77 28.42 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 122.952 0.501 . . . . 0.0 112.035 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -93.13 -17.09 24.18 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.725 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 81.8 mt -117.03 -18.13 10.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -170.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -62.48 -26.17 68.39 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -101.42 8.35 42.21 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.714 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . 0.692 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 19.2 ttmm -98.42 94.93 6.99 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.23 -30.3 66.17 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.952 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.83 123.24 20.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.558 0.694 . . . . 0.0 110.915 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.692 ' CD2' ' HD2' ' A' ' 768' ' ' LYS . 14.2 m-85 -101.51 156.51 17.43 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.709 -174.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -98.7 156.12 16.99 Favored 'General case' 0 C--N 1.281 -2.393 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.011 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.572 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 47.5 t60 -59.16 137.47 57.95 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.238 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 84.93 12.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 O-C-N 125.633 1.833 . . . . 0.0 109.746 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 58.7 m -87.32 117.78 26.32 Favored 'General case' 0 N--CA 1.41 -2.473 0 C-N-CA 119.208 -0.997 . . . . 0.0 108.783 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.486 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -91.96 107.37 19.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.725 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 5.6 pt -118.9 -175.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.414 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 17.3 ptp180 -147.13 128.5 14.88 Favored 'General case' 0 N--CA 1.399 -2.979 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 173.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.526 ' CD2' HG11 ' A' ' 801' ' ' VAL . 10.3 p90 -108.36 169.54 8.57 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . 0.542 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 15.3 ptt180 -144.81 154.18 42.41 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 173.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.519 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 5.5 t -96.76 158.61 15.35 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -65.69 -22.94 66.67 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -103.42 -1.35 47.2 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.606 175.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.519 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 5.0 mptp? -108.56 103.09 12.14 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 122.616 -0.344 . . . . 0.0 110.879 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.84 86.43 6.92 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.512 1.148 . . . . 0.0 108.528 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 157.31 145.27 4.16 Favored Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 52.6 m95 -92.34 145.23 24.64 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.522 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -97.79 -27.56 3.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.948 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 15.1 m170 72.53 123.61 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.842 1.257 . . . . 0.0 109.135 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.539 ' HA ' ' HD2' ' A' ' 799' ' ' PRO . 3.1 t -145.28 156.75 44.01 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.887 0.375 . . . . 0.0 111.142 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 34.7 t -118.95 135.04 60.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 C-N-CA 122.639 0.376 . . . . 0.0 110.132 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.3 t -69.97 118.79 13.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.572 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 47.2 mm -117.84 87.17 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 124.338 1.055 . . . . 0.0 108.526 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 42.9 67.69 0.59 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.373 1.069 . . . . 0.0 113.272 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 74.69 23.35 75.32 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 115.06 -0.973 . . . . 0.0 114.127 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -150.02 166.24 30.3 Favored 'General case' 0 C--O 1.197 -1.681 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.508 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 91.2 m95 -114.82 157.13 23.7 Favored 'General case' 0 C--N 1.264 -3.142 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -148.75 106.24 3.46 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . 0.539 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 38.0 Cg_endo -66.32 138.73 40.27 Favored 'Cis proline' 0 C--O 1.237 0.443 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.014 -0.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.9 tt0 -53.56 134.77 40.99 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.863 0.865 . . . . 0.0 110.888 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 779' ' ' TYR . 57.9 t . . . . . 0 N--CA 1.434 -1.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.534 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.4 m -73.44 -66.57 0.68 Allowed 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.17 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 124.57 -156.0 18.48 Favored Glycine 1 N--CA 1.363 -6.213 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -36.87 123.93 0.86 Allowed 'General case' 0 C--N 1.278 -2.534 0 O-C-N 126.52 1.953 . . . . 0.0 112.239 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.654 HG23 HG22 ' A' ' 715' ' ' VAL . 1.5 pp -69.3 146.54 96.73 Favored Pre-proline 0 N--CA 1.415 -2.198 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.271 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.427 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 72.4 Cg_endo -72.08 -165.31 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.767 2.312 . . . . 0.0 112.444 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.68 161.42 35.18 Favored 'General case' 0 N--CA 1.394 -3.265 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' A' ' 717' ' ' PHE . 21.7 tp -106.07 117.97 35.41 Favored 'General case' 1 C--N 1.244 -4.017 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.186 -177.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -33.55 -44.91 0.15 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.403 2.281 . . . . 0.0 115.288 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 91.5 m-70 -137.57 25.09 2.89 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -136.76 -142.19 4.39 Favored Glycine 0 CA--C 1.497 -1.044 0 C-N-CA 120.094 -1.051 . . . . 0.0 112.252 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -158.59 174.53 14.92 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.37 145.78 32.46 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 57.3 mm-40 -89.03 -80.76 0.29 Allowed 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.052 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 53.5 tp -160.6 151.46 18.7 Favored 'General case' 0 C--O 1.243 0.749 0 O-C-N 122.458 -0.151 . . . . 0.0 110.683 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.637 ' CB ' HG21 ' A' ' 715' ' ' VAL . 23.5 t -166.19 -54.29 0.03 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.434 0.693 . . . . 0.0 110.38 172.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 37.4 m 70.66 142.82 0.09 OUTLIER Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.916 1.686 . . . . 0.0 113.085 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.52 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 58.1 Cg_endo -63.63 176.53 2.21 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 123.809 3.006 . . . . 0.0 113.089 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.52 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.9 Cg_exo -77.15 -7.21 30.43 Favored 'Cis proline' 0 N--CA 1.498 1.737 0 N-CA-C 114.67 0.989 . . . . 0.0 114.67 3.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.428 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 58.9 m-85 74.41 82.21 0.11 Allowed 'General case' 0 C--N 1.309 -1.167 0 O-C-N 124.515 1.134 . . . . 0.0 110.333 177.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -86.24 173.51 9.72 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.35 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -69.37 135.2 50.0 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.85 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.21 -18.69 57.02 Favored Glycine 0 N--CA 1.422 -2.278 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.207 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.22 155.15 40.28 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.228 0.537 . . . . 0.0 111.588 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 11.8 m -135.86 157.15 47.54 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.663 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.654 HG22 HG23 ' A' ' 694' ' ' ILE . 23.5 t -137.64 129.3 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 41.6 mt-10 -77.16 138.05 39.25 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 123.675 0.609 . . . . 0.0 111.733 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.542 ' HB3' HD22 ' A' ' 697' ' ' LEU . 32.7 m-85 -140.53 129.97 23.95 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 124.483 1.113 . . . . 0.0 108.698 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.433 ' O ' HD21 ' A' ' 697' ' ' LEU . 10.9 m-80 -138.05 -164.81 1.68 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 10.8 m -118.99 139.74 51.18 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 6.1 m -62.49 -79.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 O-C-N 123.65 0.594 . . . . 0.0 111.613 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 722' ' ' SER . 42.6 mt-10 -148.11 161.93 40.43 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 66.6 m 71.03 -6.36 1.32 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.516 1.135 . . . . 0.0 112.859 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.552 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 93.8 m-85 -131.74 146.57 52.23 Favored 'General case' 0 N--CA 1.392 -3.361 0 CA-C-O 121.88 0.848 . . . . 0.0 108.959 -175.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 0.9 OUTLIER -116.68 143.82 45.18 Favored 'General case' 1 C--N 1.241 -4.129 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.204 179.873 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.536 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.7 ttp -86.22 123.92 32.04 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.557 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 45.0 mm -121.44 137.45 55.06 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 113.17 -90.76 0.55 Allowed Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.573 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 27.6 t60 -159.95 143.35 14.07 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.536 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.8 ppt_? -81.67 17.18 1.52 Allowed 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -174.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 22.0 p -161.21 153.28 19.82 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.791 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . . . . . . . . . 27.3 pt -104.85 168.61 2.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.407 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 11.3 m -138.32 135.56 35.53 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.447 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 9.5 t -83.67 105.11 14.32 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.44 0.638 . . . . 0.0 109.94 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -140.31 144.62 27.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 124.695 1.198 . . . . 0.0 110.344 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 69.75 -11.26 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.55 0.74 . . . . 0.0 112.673 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 113.37 10.77 14.52 Favored Glycine 0 C--O 1.242 0.617 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . 0.484 HG11 ' O ' ' A' ' 738' ' ' TRP . 58.8 t -142.23 154.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.484 ' O ' HG11 ' A' ' 737' ' ' VAL . 95.5 m95 -78.76 172.53 13.6 Favored 'General case' 0 C--N 1.273 -2.727 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.211 170.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.9 p -74.09 -165.69 0.33 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.846 0.831 . . . . 0.0 111.211 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.5 OUTLIER -83.38 -3.03 57.14 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -166.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 3.9 mm? 72.79 157.25 0.16 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 124.15 0.906 . . . . 0.0 109.639 -174.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.573 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 26.2 Cg_endo -71.64 179.72 4.45 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.232 1.288 . . . . 0.0 110.825 171.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . 0.452 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 52.0 tt0 -117.36 105.4 12.12 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 724' ' ' THR . 95.4 m -89.43 103.51 16.14 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 121.397 0.617 . . . . 0.0 110.236 177.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.523 ' C ' ' H ' ' A' ' 747' ' ' ILE . 34.7 t -97.92 144.32 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.022 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.582 ' O ' ' HB ' ' A' ' 747' ' ' ILE . . . -64.93 5.2 0.35 Allowed 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 125.73 1.612 . . . . 0.0 113.531 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 746' ' ' ALA . 59.0 mt 77.15 -17.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 125.932 1.693 . . . . 0.0 111.239 176.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 746' ' ' ALA . 3.2 t70 -75.86 -31.76 59.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.517 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -103.29 21.65 15.53 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.243 -173.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.83 ' HG ' HD21 ' A' ' 794' ' ' ASN . 0.4 OUTLIER -85.36 -177.88 6.59 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 113.83 -1.532 . . . . 0.0 107.778 175.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . 0.596 ' HB3' ' N ' ' A' ' 795' ' ' GLY . 39.0 tptt -98.19 161.33 13.76 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 14.5 mmmm -101.96 112.7 25.42 Favored 'General case' 1 C--N 1.233 -4.493 0 CA-C-N 112.237 -2.256 . . . . 0.0 107.452 -177.423 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 150.07 41.15 Favored 'General case' 0 C--N 1.257 -3.419 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.184 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 769' ' ' LYS . 88.4 tttt -126.94 136.77 52.73 Favored 'General case' 0 C--N 1.258 -3.391 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.69 -174.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 46.6 p -63.78 112.89 3.08 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.622 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.603 ' HB2' HG12 ' A' ' 759' ' ' ILE . 49.1 m -61.94 133.5 55.47 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 173.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.13 4.31 8.81 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.026 0.917 . . . . 0.0 111.134 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.19 -21.88 16.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.978 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.603 HG12 ' HB2' ' A' ' 756' ' ' SER . 31.3 pt -103.27 167.97 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.401 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.837 -174.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.39 130.73 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.248 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.459 HD11 HD13 ' A' ' 777' ' ' ILE . 1.9 mm? -108.95 -177.12 3.22 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . 0.786 ' HB2' HD22 ' A' ' 765' ' ' LEU . 40.3 mt-10 -72.04 175.15 6.17 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.49 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . 0.416 ' HA ' ' HE2' ' A' ' 766' ' ' LYS . 40.9 mt-10 -77.84 4.59 11.47 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -171.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . 0.472 ' HB2' HD23 ' A' ' 765' ' ' LEU . 16.5 m-70 -108.13 -22.26 12.45 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 171.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.786 HD22 ' HB2' ' A' ' 762' ' ' GLU . 2.6 mm? -101.37 -13.18 18.11 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.681 -168.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 763' ' ' GLU . 50.6 mtmt -75.59 -19.92 58.93 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -85.25 -3.76 58.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.243 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . 0.465 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 9.9 tppt? -106.12 107.5 18.53 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 754' ' ' LYS . 38.0 ttpt -85.82 -37.63 19.02 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . 0.419 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 47.2 mt-10 -117.48 118.02 31.05 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.511 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.465 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 66.6 m-85 -102.56 174.44 5.9 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.46 167.68 10.52 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.545 ' CB ' HD21 ' A' ' 750' ' ' LEU . 19.2 t60 -70.48 151.33 45.23 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 8.0 t30 83.36 3.17 0.95 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.998 1.436 . . . . 0.0 109.225 177.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 66.7 m -82.14 112.64 19.37 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.567 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -88.89 109.89 20.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.459 HD13 HD11 ' A' ' 761' ' ' LEU . 9.5 pt -126.15 178.19 4.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.589 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 25.6 ptt180 -131.55 128.96 40.34 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -118.03 169.16 9.89 Favored 'General case' 0 C--O 1.259 1.576 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -150.72 157.11 42.56 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 35.6 t -81.98 159.48 23.54 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -69.53 -23.3 63.57 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.762 0.315 . . . . 0.0 111.137 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -102.97 -9.03 40.79 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.813 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.3 mptt -115.89 122.89 46.69 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.915 0.358 . . . . 0.0 110.158 -177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -95.87 99.61 11.39 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.53 0.681 . . . . 0.0 109.886 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 159.78 143.22 3.6 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.589 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 34.6 m95 -98.79 144.78 27.64 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 117.402 0.601 . . . . 0.0 109.838 -174.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.419 HD11 ' N ' ' A' ' 788' ' ' ILE . 3.6 mp -99.17 -31.32 3.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.009 -177.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 12.4 m170 72.23 120.1 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 124.414 1.086 . . . . 0.0 110.152 -174.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.419 HG21 ' CG1' ' A' ' 801' ' ' VAL . 3.5 t -139.19 156.58 47.01 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.094 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 71.0 t -118.08 130.31 73.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 773' ' ' HIS . 49.0 t -66.55 134.63 52.76 Favored 'General case' 0 CA--C 1.479 -1.769 0 C-N-CA 118.841 -1.144 . . . . 0.0 109.299 176.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . 0.54 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 49.4 mm -124.68 90.3 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.83 HD21 ' HG ' ' A' ' 750' ' ' LEU . 18.7 t-20 44.22 73.5 0.15 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.001 0.92 . . . . 0.0 112.471 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . 0.596 ' N ' ' HB3' ' A' ' 751' ' ' LYS . . . 77.8 -11.23 21.38 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.615 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -117.33 178.11 4.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.537 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 99.0 m95 -122.08 162.02 21.99 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 117.761 0.255 . . . . 0.0 110.779 178.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -148.23 105.0 3.56 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.446 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -67.42 138.5 42.54 Favored 'Cis proline' 0 C--O 1.247 0.972 0 C-N-CA 123.791 -1.337 . . . . 0.0 111.344 -1.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 13.6 tt0 -55.02 119.1 4.93 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.068 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.419 ' CG1' HG21 ' A' ' 790' ' ' THR . 16.6 m . . . . . 0 N--CA 1.38 -3.945 0 C-N-CA 123.73 0.812 . . . . 0.0 112.487 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.443 -0.779 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 65.1 m -72.28 -75.97 0.12 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.026 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 141.37 -145.24 15.63 Favored Glycine 1 N--CA 1.379 -5.163 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -53.02 133.65 38.38 Favored 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 125.369 1.468 . . . . 0.0 111.814 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.66 HG23 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -76.05 148.1 81.04 Favored Pre-proline 0 N--CA 1.41 -2.474 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.885 176.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.416 ' HG2' HD22 ' A' ' 741' ' ' LEU . 53.5 Cg_endo -71.04 -163.72 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.347 2.698 . . . . 0.0 112.625 176.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 717' ' ' PHE . 15.5 pt-20 -148.76 169.58 20.13 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.632 HD11 ' SG ' ' A' ' 744' ' ' CYS . 17.0 mt -102.77 146.44 28.25 Favored 'General case' 0 C--N 1.27 -2.851 0 O-C-N 123.792 0.682 . . . . 0.0 111.197 175.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.62 -37.69 87.3 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.168 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 744' ' ' CYS . 96.0 m-70 -140.06 27.8 2.15 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.04 0.448 . . . . 0.0 110.688 -177.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -140.65 -146.02 4.72 Favored Glycine 0 C--N 1.297 -1.615 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -156.58 171.84 19.62 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 117.216 0.508 . . . . 0.0 111.305 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.23 144.86 33.41 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 703' ' ' GLN . 13.7 mt-30 -73.36 -79.75 0.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.21 0.318 . . . . 0.0 111.197 177.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 8.3 tt 172.67 130.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.63 ' CB ' HG23 ' A' ' 715' ' ' VAL . 22.7 t -131.18 -32.67 1.57 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.653 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 32.9 t 74.3 124.07 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.04 1.336 . . . . 0.0 112.41 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.465 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 37.3 Cg_endo -61.24 176.7 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.891 3.061 . . . . 0.0 111.564 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.515 ' O ' ' HB2' ' A' ' 709' ' ' TYR . 13.3 Cg_exo -71.72 -18.86 14.12 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 N-CA-C 114.626 0.972 . . . . 0.0 114.626 4.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 45.6 m-85 83.29 90.6 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.119 0 O-C-N 124.771 1.294 . . . . 0.0 110.885 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -91.93 176.03 6.66 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.205 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -72.71 136.86 45.65 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.028 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 93.02 -10.82 73.24 Favored Glycine 0 N--CA 1.417 -2.63 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.428 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.61 150.87 44.25 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 14.2 m -138.69 148.96 44.6 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.66 HG21 HG23 ' A' ' 694' ' ' ILE . 21.2 t -130.27 130.38 65.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.5 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 41.3 mt-10 -89.58 135.91 33.33 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 123.658 0.599 . . . . 0.0 111.269 -177.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.597 ' HD2' ' HG ' ' A' ' 697' ' ' LEU . 25.7 m-85 -132.23 132.34 42.99 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 124.521 1.128 . . . . 0.0 109.053 -177.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -137.97 -162.68 1.33 Allowed 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 7.6 m -120.0 140.41 51.0 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 43.1 t -50.6 -72.44 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 O-C-N 124.216 0.948 . . . . 0.0 110.909 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 722' ' ' SER . 0.5 OUTLIER -173.28 163.2 4.54 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 173.62 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 73.9 m 67.41 16.99 10.1 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 124.189 0.93 . . . . 0.0 111.271 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.715 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 87.4 m-85 -147.38 149.13 32.16 Favored 'General case' 0 N--CA 1.405 -2.703 0 C-N-CA 125.976 1.71 . . . . 0.0 107.685 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.532 ' HB ' HD12 ' A' ' 750' ' ' LEU . 1.1 m -117.5 144.93 44.57 Favored 'General case' 0 C--N 1.278 -2.522 0 O-C-N 123.805 0.69 . . . . 0.0 110.58 -176.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.48 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.5 ttp -99.1 123.32 43.31 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 123.564 0.745 . . . . 0.0 109.685 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.451 HD13 ' ND2' ' A' ' 794' ' ' ASN . 48.8 mm -121.14 143.68 32.64 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 114.4 -89.42 0.51 Allowed Glycine 0 C--N 1.3 -1.429 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.491 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 53.0 t60 -169.03 141.4 2.64 Favored 'General case' 0 CA--C 1.475 -1.921 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.48 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.7 OUTLIER -82.64 20.26 1.16 Allowed 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -172.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.5 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 2.8 p -162.53 159.34 24.71 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.812 -0.555 . . . . 0.0 112.14 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.49 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 39.4 pt -120.09 163.56 17.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.003 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 20.9 m -136.0 137.7 41.49 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 2.4 t -85.76 108.38 18.05 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.105 0.478 . . . . 0.0 110.003 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.24 143.09 21.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 124.811 1.245 . . . . 0.0 109.624 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 68.46 -1.09 2.0 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.212 0.605 . . . . 0.0 112.599 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.21 19.33 30.88 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 738' ' ' TRP . 24.9 t -141.62 150.99 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.462 ' O ' HG13 ' A' ' 737' ' ' VAL . 96.8 m95 -80.65 170.3 16.51 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 121.712 -0.618 . . . . 0.0 109.66 168.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.49 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 40.6 p -77.14 -166.49 0.72 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.521 0.677 . . . . 0.0 112.001 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.6 OUTLIER -73.96 -15.71 61.1 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -167.241 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.416 HD22 ' HG2' ' A' ' 695' ' ' PRO . 2.3 mt 68.85 151.53 0.13 Allowed Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 56.4 Cg_endo -75.74 179.26 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.332 2.021 . . . . 0.0 111.347 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -126.08 114.61 18.63 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.632 ' SG ' HD11 ' A' ' 697' ' ' LEU . 77.7 m -93.64 114.77 27.17 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 122.073 0.939 . . . . 0.0 110.278 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.638 ' CG1' HD21 ' A' ' 750' ' ' LEU . 11.8 p -97.4 159.77 3.08 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.279 0 CA-C-N 113.071 -1.877 . . . . 0.0 108.91 -178.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.715 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -80.5 -1.83 43.42 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.869 -177.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.634 ' HB ' ' O ' ' A' ' 746' ' ' ALA . 18.2 mt 77.41 -20.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 125.526 1.53 . . . . 0.0 111.701 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 746' ' ' ALA . 32.8 t70 -84.56 -19.25 33.42 Favored 'General case' 0 C--N 1.253 -3.614 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.19 -171.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 749' ' ' LYS . 10.5 ptpt -113.03 30.14 7.42 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.142 176.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.638 HD21 ' CG1' ' A' ' 745' ' ' VAL . 57.0 mt -89.05 -170.26 2.83 Favored 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.355 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . 0.434 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 58.9 mtpt -128.16 154.08 46.17 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . 0.446 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 93.3 mttt -100.97 145.97 27.99 Favored 'General case' 0 C--N 1.248 -3.828 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.301 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 89.3 m -89.15 160.15 17.14 Favored 'General case' 1 C--N 1.235 -4.376 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.419 179.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -118.7 133.19 56.03 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.77 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 42.3 t -59.17 116.21 3.71 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.659 ' HB2' ' CG1' ' A' ' 759' ' ' ILE . 18.4 m -79.36 135.14 36.63 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -76.14 4.36 8.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.745 0.783 . . . . 0.0 112.126 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.4 -14.63 14.82 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.279 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.659 ' CG1' ' HB2' ' A' ' 756' ' ' SER . 2.3 pp -114.06 151.39 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 121.262 0.553 . . . . 0.0 111.319 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.32 134.15 52.26 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.454 HD13 HD12 ' A' ' 777' ' ' ILE . 1.9 mm? -110.24 171.83 7.22 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -55.18 153.27 7.0 Favored 'General case' 0 C--O 1.208 -1.088 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.99 -2.97 14.14 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 118.245 0.475 . . . . 0.0 112.045 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -83.22 -37.5 23.51 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.687 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 96.8 mt -93.31 -16.46 24.69 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.599 -172.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -75.9 2.21 13.07 Favored 'General case' 1 N--CA 1.369 -4.49 0 CA-C-O 122.127 0.965 . . . . 0.0 110.188 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -120.1 9.34 11.13 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.175 173.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -102.89 130.05 49.8 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -95.71 -38.35 10.39 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-O 122.441 1.115 . . . . 0.0 108.119 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -129.55 129.43 44.46 Favored 'General case' 0 N--CA 1.409 -2.517 0 CA-C-N 113.283 -1.78 . . . . 0.0 109.749 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.528 ' HB2' ' HB2' ' A' ' 753' ' ' CYS . 73.3 m-85 -105.94 142.47 35.6 Favored 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.955 -177.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.7 155.59 18.18 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -49.23 152.01 1.29 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.065 0.946 . . . . 0.0 111.607 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 67.71 4.93 4.14 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.715 0.806 . . . . 0.0 111.376 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 8.2 t -81.23 111.76 17.93 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.422 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.8 OUTLIER -81.85 112.69 19.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.687 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.5 pt -123.71 174.2 8.3 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.712 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.523 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 95.4 mtt180 -125.93 128.93 48.3 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 174.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.615 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 6.3 p90 -120.0 167.35 12.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -147.76 157.14 43.4 Favored 'General case' 0 C--N 1.267 -2.991 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 17.3 t -93.58 147.18 23.23 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -73.78 -12.35 60.67 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.084 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -112.93 0.68 25.73 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.894 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 1.2 mptm? -118.16 -50.71 2.46 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 72.78 140.18 0.06 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.25 1.02 . . . . 0.0 110.768 -174.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 103.17 140.75 11.01 Favored Glycine 0 CA--C 1.493 -1.316 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 29.3 m95 -89.6 143.27 26.95 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.052 0.453 . . . . 0.0 111.373 -171.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.615 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -102.95 -26.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.013 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 17.6 m170 71.9 119.16 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.948 0 C-N-CA 124.033 0.933 . . . . 0.0 110.733 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 4.1 t -143.13 157.42 44.53 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.64 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 47.5 t -119.67 135.24 60.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.57 114.18 10.41 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.668 0.747 . . . . 0.0 110.168 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.6 mm -112.66 82.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 C-N-CA 124.04 0.936 . . . . 0.0 108.494 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.589 ' OD1' HD23 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 51.32 67.74 0.9 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.76 176.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 78.95 3.05 87.75 Favored Glycine 0 C--N 1.299 -1.514 0 C-N-CA 120.299 -0.953 . . . . 0.0 114.334 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -134.03 167.89 19.8 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 87.3 m95 -113.92 158.79 20.64 Favored 'General case' 0 C--N 1.26 -3.298 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -149.0 107.61 3.43 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -71.18 142.12 71.89 Favored 'Cis proline' 0 C--O 1.246 0.889 0 C-N-CA 123.552 -1.436 . . . . 0.0 112.687 -0.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 43.9 mt-10 -53.58 126.89 23.3 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.637 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 7.7 m . . . . . 1 N--CA 1.363 -4.825 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 45.0 m -64.69 -71.91 0.17 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.75 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 134.84 -164.5 24.71 Favored Glycine 1 N--CA 1.367 -5.952 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -43.17 119.68 1.62 Allowed 'General case' 0 C--N 1.276 -2.613 0 C-N-CA 126.173 1.789 . . . . 0.0 111.552 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.62 HG23 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -58.28 149.32 59.23 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.482 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.489 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 70.6 Cg_endo -71.01 -163.89 0.14 Allowed 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 123.001 2.467 . . . . 0.0 111.818 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.63 154.91 51.17 Favored 'General case' 0 N--CA 1.393 -3.322 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 717' ' ' PHE . 18.7 tp -98.61 127.35 44.51 Favored 'General case' 0 C--N 1.25 -3.74 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.433 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 6.8 pt-20 -38.41 -61.01 0.73 Allowed 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 127.094 2.158 . . . . 0.0 114.349 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.751 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.2 m-70 -128.02 26.82 5.76 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -131.82 -155.06 7.92 Favored Glycine 0 N--CA 1.424 -2.115 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.405 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -145.48 174.28 11.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.639 0.257 . . . . 0.0 110.641 -175.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.83 137.17 46.31 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.422 ' HA ' ' NE2' ' A' ' 703' ' ' GLN . 24.5 mm-40 -86.11 -77.65 0.3 Allowed 'General case' 0 N--CA 1.427 -1.577 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.524 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 705' ' ' SER . 1.9 tm? -167.72 163.1 14.25 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.607 ' N ' HD13 ' A' ' 704' ' ' LEU . 46.7 t -178.36 -62.71 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.402 1.481 . . . . 0.0 109.191 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 50.6 m 67.85 153.52 0.13 Allowed Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 125.155 1.382 . . . . 0.0 112.238 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.438 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 56.4 Cg_endo -62.95 171.94 5.45 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 123.015 2.477 . . . . 0.0 112.69 -175.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.608 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 1.9 Cg_endo -75.46 -8.18 25.04 Favored 'Cis proline' 0 N--CA 1.488 1.156 0 N-CA-C 115.235 1.206 . . . . 0.0 115.235 5.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 69.14 60.29 0.33 Allowed 'General case' 0 C--N 1.313 -0.983 0 O-C-N 124.297 0.998 . . . . 0.0 109.062 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.608 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 37.0 m-85 -68.04 173.33 4.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.429 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 0.739 ' HH ' ' HA2' ' A' ' 736' ' ' GLY . 47.3 m-85 -72.33 136.64 46.25 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.178 175.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.64 -18.88 56.58 Favored Glycine 0 C--N 1.286 -2.217 0 C-N-CA 120.422 -0.894 . . . . 0.0 110.876 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 143.14 55.21 Favored 'General case' 0 CA--C 1.478 -1.79 0 CA-C-O 121.348 0.594 . . . . 0.0 110.017 178.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 16.0 m -124.58 157.27 35.83 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.054 178.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.62 HG21 HG23 ' A' ' 694' ' ' ILE . 33.1 t -137.03 133.69 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -80.85 130.72 35.2 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 123.835 0.709 . . . . 0.0 110.901 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.541 ' HB3' HD23 ' A' ' 697' ' ' LEU . 27.6 m-85 -137.09 116.93 13.12 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 125.018 1.327 . . . . 0.0 108.232 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.405 ' O ' HD22 ' A' ' 697' ' ' LEU . 4.5 m-80 -127.23 -167.75 1.78 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 24.3 m -112.43 135.44 53.12 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 24.8 t -52.57 -67.63 0.24 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 124.187 0.929 . . . . 0.0 111.724 -170.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -171.32 156.88 4.77 Favored 'General case' 0 CA--C 1.476 -1.889 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 75.0 m 66.64 14.3 9.7 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 124.404 1.065 . . . . 0.0 111.242 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 85.0 m-85 -140.12 145.47 37.62 Favored 'General case' 0 N--CA 1.404 -2.755 0 C-N-CA 124.823 1.249 . . . . 0.0 108.596 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 5.5 t -97.59 151.71 19.79 Favored 'General case' 0 C--N 1.252 -3.631 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.756 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.4 ttp -108.72 118.39 36.66 Favored 'General case' 0 C--N 1.263 -3.155 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 41.9 mm -121.86 135.38 62.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 118.7 -81.85 0.33 Allowed Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 121.422 -0.418 . . . . 0.0 112.323 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . 0.474 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 43.3 t60 -171.05 138.33 1.26 Allowed 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.756 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.3 ppt_? -84.94 19.65 2.06 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 2.7 p -156.51 159.76 38.89 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.32 0.581 . . . . 0.0 112.119 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.506 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 36.1 pt -116.89 164.71 12.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.754 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 21.5 m -139.61 136.1 34.01 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.223 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 9.1 t -83.08 107.25 15.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.316 0.579 . . . . 0.0 109.765 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 735' ' ' HIS . 1.5 pp -145.46 151.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 124.721 1.208 . . . . 0.0 109.839 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 734' ' ' ILE . 82.6 m-70 73.61 -51.01 0.7 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.346 1.059 . . . . 0.0 110.625 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.739 ' HA2' ' HH ' ' A' ' 711' ' ' TYR . . . 148.45 34.28 0.05 OUTLIER Glycine 0 C--N 1.299 -1.489 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.0 p -165.85 159.49 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.489 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.9 m95 -77.63 175.6 9.74 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 172.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 18.3 p -80.12 -171.1 2.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.047 0.927 . . . . 0.0 112.658 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.7 OUTLIER -63.55 -15.77 58.94 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -172.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.6 mm? 69.59 141.65 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 32.8 Cg_endo -67.05 177.22 3.8 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.115 1.876 . . . . 0.0 112.035 174.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -121.84 129.73 52.84 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.751 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 73.8 m -113.84 103.8 11.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.11 0.481 . . . . 0.0 110.726 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.495 ' HB ' HG22 ' A' ' 724' ' ' THR . 46.6 t -97.27 143.7 12.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.55 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -60.49 2.33 0.1 Allowed 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 126.236 1.814 . . . . 0.0 115.293 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.823 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 19.4 mt 75.75 -13.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 C-N-CA 125.625 1.57 . . . . 0.0 111.956 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 746' ' ' ALA . 17.2 t70 -87.25 -25.88 23.75 Favored 'General case' 0 C--N 1.272 -2.772 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.533 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -103.09 20.53 17.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.358 -176.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.823 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 49.5 mt -84.53 -167.13 1.67 Allowed 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.773 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . 0.479 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 10.2 mtpm? -130.0 154.41 47.42 Favored 'General case' 0 N--CA 1.381 -3.915 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.505 -177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . 0.67 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 55.2 mtpt -105.71 120.71 42.39 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 113.269 -1.787 . . . . 0.0 109.317 -175.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 56.0 m -74.34 159.05 32.91 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.403 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . 0.422 ' HB3' ' HE2' ' A' ' 754' ' ' LYS . 18.3 ptpt -132.32 151.49 51.82 Favored 'General case' 0 N--CA 1.401 -2.885 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.699 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 30.6 t -63.35 121.54 14.0 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.54 -1.663 . . . . 0.0 109.956 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.791 ' HB3' HG13 ' A' ' 759' ' ' ILE . 28.2 t -74.63 155.02 38.26 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.99 -1.4 57.27 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.09 -20.13 21.6 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.794 0.807 . . . . 0.0 109.08 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.791 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.5 pp -111.66 159.68 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.435 -177.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 19.9 mt -118.67 129.04 75.47 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.924 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.661 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . 0.461 HD13 HD11 ' A' ' 777' ' ' ILE . 1.8 mm? -105.6 -176.94 3.22 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . 0.837 ' HB2' HD23 ' A' ' 765' ' ' LEU . 41.1 mt-10 -59.66 151.78 24.06 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . 0.405 ' HG2' ' HE2' ' A' ' 766' ' ' LYS . 40.6 mt-10 -72.25 1.19 8.09 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -171.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . 0.512 ' HB2' HD21 ' A' ' 765' ' ' LEU . 8.8 m-70 -90.51 -43.47 10.21 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 168.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . 0.837 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.3 mm? -78.5 -11.57 59.96 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.001 -168.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.405 ' HE2' ' HG2' ' A' ' 763' ' ' GLU . 47.4 mtmt -67.82 -18.69 64.92 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.79 13.38 24.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.563 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -113.16 110.96 21.29 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 19.5 ptpt -83.55 -34.82 25.14 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.072 -1.051 . . . . 0.0 109.372 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . 0.67 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 45.3 mt-10 -128.83 135.56 49.29 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.757 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -115.49 142.65 46.43 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.387 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.19 163.67 18.56 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -62.4 150.5 39.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.438 0.161 . . . . 0.0 110.758 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 81.24 6.6 1.26 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.027 1.331 . . . . 0.0 110.345 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 38.9 m -80.68 105.72 12.14 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.406 HD21 ' N ' ' A' ' 776' ' ' ASN . 0.8 OUTLIER -86.42 101.87 13.53 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . 0.461 HD11 HD13 ' A' ' 761' ' ' LEU . 11.9 pt -113.25 -174.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 121.832 0.825 . . . . 0.0 109.376 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.584 ' HA ' ' HA ' ' A' ' 789' ' ' HIS . 19.9 ptt180 -139.24 134.79 33.16 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.544 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 11.0 p90 -123.44 166.33 15.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -147.4 154.85 41.37 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.476 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 0.8 OUTLIER -82.58 146.9 28.91 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-O 121.047 0.451 . . . . 0.0 111.943 178.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -64.26 103.78 0.67 Allowed 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 110.73 -7.9 29.83 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.476 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.476 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 0.8 OUTLIER -119.41 113.59 21.02 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -89.3 90.06 8.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.618 0.723 . . . . 0.0 110.975 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 172.02 141.78 3.51 Favored Glycine 0 CA--C 1.487 -1.674 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.561 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 44.5 m95 -101.53 145.44 29.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.992 0.396 . . . . 0.0 110.127 -174.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.544 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -100.04 -28.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.013 -178.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 25.6 m170 74.43 133.66 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.602 1.161 . . . . 0.0 108.911 -176.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.6 t -156.44 155.21 31.69 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 120.703 0.287 . . . . 0.0 111.154 178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.96 137.6 53.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.3 t -70.59 113.97 8.23 Favored 'General case' 0 C--O 1.255 1.377 0 CA-C-O 121.658 0.742 . . . . 0.0 110.359 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 47.4 mm -114.25 80.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 124.32 1.048 . . . . 0.0 109.317 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.559 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 52.2 65.57 1.47 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.77 175.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . 0.468 ' HA3' ' HZ3' ' A' ' 751' ' ' LYS . . . 73.87 21.2 79.52 Favored Glycine 0 C--N 1.303 -1.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.97 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -146.64 164.33 33.01 Favored 'General case' 0 C--O 1.202 -1.408 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.589 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.7 m95 -111.58 157.68 20.1 Favored 'General case' 0 C--N 1.246 -3.926 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -144.12 105.89 4.83 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 38.2 Cg_endo -70.14 139.03 53.31 Favored 'Cis proline' 0 C--O 1.248 1.006 0 C-N-CA 123.725 -1.365 . . . . 0.0 110.919 -0.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.589 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 26.5 tt0 -56.42 124.05 16.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 779' ' ' TYR . 14.0 m . . . . . 1 N--CA 1.371 -4.381 0 C-N-CA 124.391 1.077 . . . . 0.0 110.585 -175.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 59.7 m -68.02 -65.12 0.73 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 94.21 134.67 7.44 Favored Glycine 0 N--CA 1.42 -2.394 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.262 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 37.8 t70 46.28 101.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.134 1.774 . . . . 0.0 113.508 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.656 HG23 HG22 ' A' ' 715' ' ' VAL . 1.8 pp -59.34 151.33 59.72 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.289 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.404 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 37.7 Cg_endo -68.28 -157.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 123.039 2.492 . . . . 0.0 112.517 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.12 160.52 37.54 Favored 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.524 HD11 ' HA3' ' A' ' 700' ' ' GLY . 0.3 OUTLIER -99.16 133.05 43.99 Favored 'General case' 0 C--N 1.259 -3.356 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.563 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -49.06 -39.47 27.7 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 124.406 1.082 . . . . 0.0 113.689 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -143.21 28.05 1.54 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.129 0.49 . . . . 0.0 110.264 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -141.59 -146.05 4.64 Favored Glycine 0 C--N 1.299 -1.511 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.066 -177.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -151.08 -175.56 5.2 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -176.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -117.5 142.83 46.7 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -74.13 -78.2 0.1 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.204 0.526 . . . . 0.0 110.785 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.3 tt -149.87 130.41 13.95 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.419 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 67.9 p -117.65 -70.83 0.77 Allowed 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -176.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 23.3 t 64.16 123.99 0.02 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 125.696 1.598 . . . . 0.0 112.559 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.534 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 41.2 Cg_endo -63.66 176.0 2.54 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.456 2.771 . . . . 0.0 111.682 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.534 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 6.0 Cg_exo -77.6 -10.28 32.26 Favored 'Cis proline' 0 CA--C 1.504 -1.002 0 N-CA-C 115.017 1.122 . . . . 0.0 115.017 5.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 56.7 m-85 72.56 78.74 0.15 Allowed 'General case' 0 C--O 1.245 0.868 0 O-C-N 124.248 0.967 . . . . 0.0 110.005 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 29.9 m-85 -85.48 171.51 11.71 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.492 0.663 . . . . 0.0 112.469 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -67.33 133.31 49.41 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.697 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.11 68.09 Favored Glycine 0 N--CA 1.418 -2.522 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.19 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.17 145.36 44.29 Favored 'General case' 0 CA--C 1.493 -1.214 0 O-C-N 122.085 -0.656 . . . . 0.0 110.706 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 14.2 m -131.07 151.04 51.85 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.656 HG22 HG23 ' A' ' 694' ' ' ILE . 34.4 t -134.99 140.1 45.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -85.64 123.44 31.05 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 124.128 0.893 . . . . 0.0 111.6 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -124.36 105.55 9.53 Favored 'General case' 0 C--N 1.273 -2.759 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -113.37 -162.68 0.81 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 5.0 m -113.47 134.44 54.66 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -178.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 39.5 t -65.64 -64.02 0.96 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 123.689 0.618 . . . . 0.0 110.87 -172.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -164.68 156.31 15.57 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 73.9 m 69.78 1.94 3.63 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.303 1.002 . . . . 0.0 113.171 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.574 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.1 m-85 -134.14 147.43 50.81 Favored 'General case' 0 N--CA 1.403 -2.795 0 C-N-CA 123.75 0.82 . . . . 0.0 109.078 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.541 ' HB ' HD12 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -113.5 138.13 50.57 Favored 'General case' 0 C--N 1.264 -3.122 0 C-N-CA 125.546 1.539 . . . . 0.0 110.445 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.487 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.7 ttp -86.64 121.93 29.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.65 1.18 . . . . 0.0 109.348 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.428 HD11 ' HA ' ' A' ' 726' ' ' ILE . 31.7 mm -111.87 127.4 69.08 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.973 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.132 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 99.2 -82.97 0.58 Allowed Glycine 0 CA--C 1.481 -2.051 0 CA-C-N 114.645 -1.162 . . . . 0.0 112.253 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -147.04 178.02 8.7 Favored 'General case' 0 N--CA 1.388 -3.55 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -174.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.487 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.2 OUTLIER -128.15 6.4 5.91 Favored 'General case' 0 C--O 1.2 -1.546 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.637 -177.41 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 3.1 p -126.54 160.1 31.58 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 119.07 -1.052 . . . . 0.0 113.732 -172.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 714' ' ' SER . 36.6 pt -119.66 159.51 20.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.106 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 14.6 m -134.77 135.28 41.74 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.791 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 7.6 t -86.01 104.13 15.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.156 0.503 . . . . 0.0 109.953 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.7 pp -144.69 147.45 19.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 124.655 1.182 . . . . 0.0 110.037 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 64.9 4.07 2.31 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 96.81 24.87 12.41 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.14 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.04 162.22 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.404 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.3 m95 -80.29 173.08 12.96 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.485 ' HB ' ' NE2' ' A' ' 740' ' ' GLN . 23.6 p -78.8 -162.44 0.38 Allowed 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.837 0.827 . . . . 0.0 112.42 -177.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.553 ' H ' ' NE2' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -84.89 2.01 44.58 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 124.453 1.101 . . . . 0.0 113.575 -167.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.421 HD13 HG23 ' A' ' 731' ' ' ILE . 4.1 mm? 71.21 155.87 0.16 Allowed Pre-proline 0 N--CA 1.483 1.215 0 O-C-N 123.667 0.605 . . . . 0.0 111.557 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -80.24 -173.58 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.219 1.946 . . . . 0.0 111.963 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -123.15 104.62 9.29 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 122.359 -0.213 . . . . 0.0 110.533 -176.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.429 ' SG ' HD11 ' A' ' 697' ' ' LEU . 86.8 m -96.99 114.35 25.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.106 0.479 . . . . 0.0 110.776 172.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.455 ' CG1' ' HG3' ' A' ' 749' ' ' LYS . 58.8 t -108.29 146.79 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . 0.639 ' O ' ' HB ' ' A' ' 747' ' ' ILE . . . -64.74 2.52 0.67 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 125.726 1.611 . . . . 0.0 114.201 -175.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.803 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 37.1 mt 78.14 -24.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 125.482 1.513 . . . . 0.0 111.544 175.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 748' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 746' ' ' ALA . 28.7 t70 -81.4 -24.32 37.04 Favored 'General case' 0 C--N 1.258 -3.389 0 CA-C-N 112.893 -1.958 . . . . 0.0 109.248 -172.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 749' ' ' LYS . . . . . 0.455 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 1.7 ptmm? -115.46 23.6 12.26 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.919 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.803 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 55.1 mt -81.41 -168.88 2.03 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.442 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 751' ' ' LYS . . . . . 0.544 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 30.0 mtpp -122.63 158.43 30.02 Favored 'General case' 0 N--CA 1.396 -3.167 0 CA-C-O 121.836 0.827 . . . . 0.0 109.085 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -110.25 138.23 46.91 Favored 'General case' 0 C--N 1.245 -3.939 0 CA-C-N 113.184 -1.825 . . . . 0.0 107.943 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 753' ' ' CYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 78.2 m -85.39 178.99 7.26 Favored 'General case' 0 C--N 1.252 -3.649 0 CA-C-N 113.416 -1.72 . . . . 0.0 110.517 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -140.87 141.54 34.61 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 755' ' ' SER . . . . . 0.407 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 5.4 p -62.78 128.35 35.52 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 123.622 0.576 . . . . 0.0 110.467 173.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 756' ' ' SER . . . . . 0.603 ' HB2' ' CG1' ' A' ' 759' ' ' ILE . 9.5 m -75.35 162.99 27.91 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -89.76 -15.36 32.59 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 758' ' ' LEU . . . . . 0.405 HD22 ' NH2' ' A' ' 782' ' ' ARG . 40.2 mt -93.71 -18.43 22.12 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.66 0.743 . . . . 0.0 110.159 -174.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 759' ' ' ILE . . . . . 0.603 ' CG1' ' HB2' ' A' ' 756' ' ' SER . 2.4 pp -100.24 160.16 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.61 135.79 56.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 761' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.29 -179.28 3.73 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 762' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 42.0 mt-10 -63.55 157.22 24.23 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.73 -18.43 64.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.209 0.528 . . . . 0.0 111.045 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -95.63 -0.12 52.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.922 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 765' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -124.72 -11.78 7.2 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 57.1 mtmt -69.5 -21.05 63.71 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.546 0.689 . . . . 0.0 110.598 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -88.15 14.02 10.1 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.097 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 768' ' ' LYS . . . . . 0.517 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 12.0 tppt? -110.52 117.33 33.26 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.89 -43.1 20.4 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.72 117.59 23.78 Favored 'General case' 0 CA--C 1.483 -1.599 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.003 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 771' ' ' PHE . . . . . 0.517 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 88.3 m-85 -91.13 136.01 33.38 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -78.73 143.21 36.4 Favored 'General case' 0 C--N 1.276 -2.593 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.537 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 773' ' ' HIS . . . . . 0.662 ' CD2' HD11 ' A' ' 750' ' ' LEU . 47.9 p-80 -40.05 138.55 0.81 Allowed 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 124.948 1.299 . . . . 0.0 111.696 171.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 74.14 6.38 4.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.796 1.638 . . . . 0.0 113.279 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 70.5 m -75.38 116.69 16.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.442 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -86.01 102.16 13.56 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 777' ' ' ILE . . . . . . . . . . . . . 7.8 pt -113.93 179.56 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.676 0.751 . . . . 0.0 109.76 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.548 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 98.8 mtt180 -127.35 119.98 27.49 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 779' ' ' TYR . . . . . 0.668 ' CD2' HG12 ' A' ' 801' ' ' VAL . 13.5 p90 -105.58 164.14 12.13 Favored 'General case' 0 C--O 1.26 1.611 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 171.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -147.76 157.25 43.45 Favored 'General case' 0 C--N 1.263 -3.157 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 781' ' ' CYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 42.8 t -96.23 163.54 13.05 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -176.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 782' ' ' ARG . . . . . 0.405 ' NH2' HD22 ' A' ' 758' ' ' LEU . 21.3 ptt180 -82.57 -23.0 34.67 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 120.992 0.425 . . . . 0.0 110.356 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -94.15 -13.27 54.9 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.078 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 784' ' ' LYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 0.1 OUTLIER -131.19 98.46 4.57 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -88.52 87.92 7.44 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.237 1.018 . . . . 0.0 111.339 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -173.63 152.55 15.56 Favored Glycine 0 CA--C 1.479 -2.157 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 787' ' ' TRP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 26.2 m95 -93.18 134.81 34.98 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 117.571 0.685 . . . . 0.0 110.345 -172.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 788' ' ' ILE . . . . . 0.524 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.1 mp -94.61 -28.0 4.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.117 -177.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 18.7 m170 74.62 119.54 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 124.375 1.07 . . . . 0.0 109.835 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 790' ' ' THR . . . . . 0.434 HG22 ' CG2' ' A' ' 801' ' ' VAL . 3.8 t -143.65 160.77 40.09 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.169 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.32 135.78 60.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 123.897 0.879 . . . . 0.0 109.427 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 52.8 t -72.52 103.07 3.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.05 0.928 . . . . 0.0 110.854 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.6 mm -99.28 79.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.499 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 794' ' ' ASN . . . . . 0.655 ' OD1' HD21 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 50.39 68.81 0.7 Allowed 'General case' 0 C--O 1.238 0.447 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.771 176.145 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 80.2 6.28 89.28 Favored Glycine 0 C--N 1.306 -1.092 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.043 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -139.53 169.09 18.38 Favored 'General case' 0 C--O 1.198 -1.657 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 797' ' ' TRP . . . . . 0.537 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.6 m95 -111.43 161.09 16.47 Favored 'General case' 0 C--N 1.264 -3.112 0 O-C-N 122.293 -0.254 . . . . 0.0 110.429 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -150.33 106.23 3.14 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 799' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 34.8 Cg_endo -67.63 138.52 43.29 Favored 'Cis proline' 0 C--O 1.243 0.774 0 C-N-CA 123.651 -1.396 . . . . 0.0 111.103 -1.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 800' ' ' GLU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 30.1 tt0 -55.16 121.59 9.14 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.058 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 801' ' ' VAL . . . . . 0.668 HG12 ' CD2' ' A' ' 779' ' ' TYR . 91.8 t . . . . . 0 C--N 1.311 -1.076 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.233 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 35.9 m -72.87 -67.83 0.53 Allowed 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.33 0.586 . . . . 0.0 109.485 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 130.11 -161.46 23.08 Favored Glycine 1 N--CA 1.367 -5.938 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -41.14 116.19 0.7 Allowed 'General case' 0 C--N 1.274 -2.696 0 C-N-CA 127.196 2.198 . . . . 0.0 112.09 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.506 HG22 HG23 ' A' ' 715' ' ' VAL . 1.7 pp -59.94 149.56 72.99 Favored Pre-proline 0 N--CA 1.435 -1.205 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.017 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.411 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 71.2 Cg_endo -74.11 -160.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.611 2.207 . . . . 0.0 110.42 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . 0.597 ' HA ' ' HE2' ' A' ' 717' ' ' PHE . 13.1 pt-20 -149.85 170.3 19.11 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.735 HD11 ' SG ' ' A' ' 744' ' ' CYS . 17.7 mt -97.48 128.71 44.47 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 123.914 0.759 . . . . 0.0 111.376 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -46.17 -33.88 3.9 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.078 -1.874 . . . . 0.0 112.723 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.417 ' HB3' ' CE1' ' A' ' 723' ' ' PHE . 96.4 m-70 -145.89 26.7 1.23 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -137.94 -148.36 5.36 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.472 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -150.9 176.2 11.31 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -104.69 157.34 17.25 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.421 ' HA ' ' NE2' ' A' ' 703' ' ' GLN . 22.0 mm-40 -94.6 -68.75 0.78 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.092 0.472 . . . . 0.0 111.297 175.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . 0.463 ' O ' HG11 ' A' ' 715' ' ' VAL . 58.9 tp -146.14 123.39 11.56 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.472 ' HB3' ' CG1' ' A' ' 715' ' ' VAL . 2.8 p -144.86 105.0 4.06 Favored 'General case' 0 N--CA 1.396 -3.131 0 CA-C-O 122.024 0.916 . . . . 0.0 109.347 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 10.2 m -116.34 132.03 23.52 Favored Pre-proline 0 C--N 1.246 -3.914 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.621 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.462 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 57.5 Cg_endo -64.65 172.87 6.22 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.592 2.194 . . . . 0.0 110.183 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.69 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.0 Cg_exo -76.61 -7.03 28.4 Favored 'Cis proline' 0 N--CA 1.487 1.124 0 N-CA-C 114.839 1.053 . . . . 0.0 114.839 6.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 57.4 m-85 72.95 79.28 0.14 Allowed 'General case' 0 C--N 1.314 -0.975 0 O-C-N 124.242 0.964 . . . . 0.0 109.217 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.69 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 38.1 m-85 -87.0 172.52 9.94 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.235 -175.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -69.32 131.7 45.26 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.994 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.65 -15.16 60.07 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 0.5 OUTLIER -65.42 145.98 55.47 Favored 'General case' 0 CA--C 1.477 -1.861 0 CA-C-O 121.42 0.628 . . . . 0.0 110.262 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 17.8 m -133.97 148.83 51.2 Favored 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.506 HG23 HG22 ' A' ' 694' ' ' ILE . 61.8 t -134.58 130.61 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.845 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.434 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 44.0 mt-10 -82.16 139.28 34.42 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 121.609 0.719 . . . . 0.0 110.813 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.597 ' HE2' ' HA ' ' A' ' 696' ' ' GLU . 28.5 m-85 -137.35 120.55 16.79 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 125.867 1.667 . . . . 0.0 107.478 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -128.78 -163.44 1.29 Allowed 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 22.3 m -118.87 134.03 55.44 Favored 'General case' 0 C--N 1.267 -3.018 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 21.1 t -73.15 -84.5 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 O-C-N 123.923 0.764 . . . . 0.0 112.019 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -133.77 132.59 40.7 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.459 0.303 . . . . 0.0 110.632 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 4.4 t 71.9 26.29 2.97 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 124.598 1.186 . . . . 0.0 110.055 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.585 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.3 m-85 -140.72 145.98 37.17 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.51 HG21 ' O ' ' A' ' 745' ' ' VAL . 6.4 t -75.23 -118.38 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.605 -174.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.514 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 7.9 ttp 162.82 104.83 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 128.898 2.879 . . . . 0.0 105.29 174.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.9 mm -119.96 139.25 47.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 102.17 -75.79 0.33 Allowed Glycine 0 N--CA 1.429 -1.797 0 O-C-N 123.559 0.537 . . . . 0.0 112.729 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.555 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 2.1 t60 -146.98 -172.97 4.12 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.514 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -141.89 22.94 2.09 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.28 170.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.434 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 16.4 p -157.44 162.71 38.97 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.034 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 714' ' ' SER . 32.4 pt -122.6 164.6 19.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 732' ' ' THR . . . . . 0.415 ' O ' HG21 ' A' ' 739' ' ' THR . 7.3 m -135.77 135.01 39.58 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.977 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 6.0 t -84.68 106.83 16.52 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.473 0.654 . . . . 0.0 110.437 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -142.97 143.58 24.98 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 125.221 1.408 . . . . 0.0 109.988 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 64.39 4.2 2.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.06 13.5 52.46 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 738' ' ' TRP . 80.7 t -140.66 154.23 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.464 ' O ' HG13 ' A' ' 737' ' ' VAL . 94.2 m95 -79.95 177.64 8.78 Favored 'General case' 0 C--N 1.273 -2.748 0 O-C-N 121.89 -0.506 . . . . 0.0 109.786 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.415 HG21 ' O ' ' A' ' 732' ' ' THR . 27.1 p -84.89 -163.95 0.91 Allowed 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.856 0.836 . . . . 0.0 112.506 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.467 ' H ' ' NE2' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -74.81 -17.05 60.68 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -168.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 1.5 mt 68.73 151.33 0.13 Allowed Pre-proline 0 N--CA 1.479 1.019 0 O-C-N 123.889 0.743 . . . . 0.0 112.231 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.555 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 42.9 Cg_endo -73.56 177.52 7.89 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.796 1.664 . . . . 0.0 111.249 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -120.17 103.09 8.97 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.234 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.735 ' SG ' HD11 ' A' ' 697' ' ' LEU . 84.1 m -79.07 110.26 14.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.971 173.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.51 ' O ' HG21 ' A' ' 724' ' ' THR . 46.6 t -104.72 147.03 11.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.96 -0.85 1.71 Allowed 'General case' 0 C--N 1.284 -2.253 0 C-N-CA 125.204 1.402 . . . . 0.0 114.089 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.547 ' HB ' ' O ' ' A' ' 746' ' ' ALA . 48.6 mt 74.54 -14.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 125.589 1.555 . . . . 0.0 110.93 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 746' ' ' ALA . 1.0 OUTLIER -75.3 -27.89 59.5 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 126.149 1.78 . . . . 0.0 108.755 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -106.92 16.96 23.71 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.063 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.769 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 1.3 mp -83.15 -178.67 7.18 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.766 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . 0.571 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 55.0 mtpt -125.59 150.66 47.32 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.58 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -90.14 111.22 22.29 Favored 'General case' 0 C--N 1.251 -3.689 0 CA-C-N 112.421 -2.172 . . . . 0.0 108.726 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 61.2 m -70.78 138.29 50.29 Favored 'General case' 0 C--N 1.269 -2.898 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.14 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -107.86 138.28 44.38 Favored 'General case' 0 C--N 1.271 -2.806 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.13 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 755' ' ' SER . . . . . 0.405 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.4 p -67.83 123.65 21.13 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.465 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.63 ' HB3' HG13 ' A' ' 759' ' ' ILE . 25.9 t -70.89 146.18 49.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.9 3.28 49.09 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 803' ' ' CYS . 4.1 mm? -92.46 -29.52 16.21 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.63 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -98.53 158.51 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.294 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.057 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.1 131.87 59.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.403 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 85.8 mt -105.56 179.82 4.16 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.143 0.497 . . . . 0.0 110.124 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.638 ' HB2' HD22 ' A' ' 765' ' ' LEU . 37.8 mt-10 -69.4 170.53 10.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.731 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.02 -20.09 66.32 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.16 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . 0.486 ' HB2' HD23 ' A' ' 765' ' ' LEU . 15.6 m-70 -90.1 -30.09 17.9 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.638 HD22 ' HB2' ' A' ' 762' ' ' GLU . 2.7 mm? -93.9 -14.18 26.33 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.371 -165.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.531 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 28.5 mtmm -71.77 -8.8 56.44 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.762 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -94.57 -1.7 52.85 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -105.28 126.34 51.98 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . 0.83 ' HG3' ' HG2' ' A' ' 770' ' ' GLU . 18.8 ptpt -98.49 -29.37 13.14 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.612 0.72 . . . . 0.0 109.107 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . 0.83 ' HG2' ' HG3' ' A' ' 769' ' ' LYS . 4.7 pt-20 -140.06 136.38 33.58 Favored 'General case' 0 N--CA 1.39 -3.456 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.462 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.415 ' CE2' HG22 ' A' ' 777' ' ' ILE . 86.3 m-85 -110.66 148.66 31.78 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.623 -175.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -90.91 166.04 13.26 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.525 ' HB3' HD23 ' A' ' 750' ' ' LEU . 26.6 t60 -62.67 157.35 21.07 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 122.328 0.251 . . . . 0.0 111.076 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 77.69 9.8 2.36 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.209 1.004 . . . . 0.0 109.654 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 47.4 t -86.36 104.5 15.93 Favored 'General case' 0 N--CA 1.385 -3.687 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.454 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -90.13 101.37 14.08 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 177.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.415 HG22 ' CE2' ' A' ' 771' ' ' PHE . 7.9 pt -112.32 -174.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 CA-C-O 121.591 0.71 . . . . 0.0 109.797 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.572 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 27.6 ptt180 -141.08 122.5 14.97 Favored 'General case' 0 N--CA 1.391 -3.424 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.555 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.497 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 9.6 p90 -113.66 172.9 6.7 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -155.47 169.26 24.68 Favored 'General case' 0 N--CA 1.411 -2.379 0 O-C-N 123.934 0.771 . . . . 0.0 109.356 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.562 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 16.4 t -102.26 162.22 13.09 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . 0.597 ' HG2' ' SG ' ' A' ' 803' ' ' CYS . 12.0 ptm180 -74.8 80.14 2.09 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.601 1.191 . . . . 0.0 108.293 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 147.28 -27.72 1.54 Allowed Glycine 0 N--CA 1.417 -2.596 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.269 -172.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.562 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 14.3 mptt -84.02 103.32 13.16 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -87.34 81.27 7.93 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 162.62 -170.02 38.05 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 106.261 -2.736 . . . . 0.0 106.261 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 64.7 m95 -130.76 158.51 39.93 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 118.962 1.381 . . . . 0.0 109.364 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.497 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -99.94 -41.94 9.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.132 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 11.3 m170 80.7 133.25 0.06 Allowed 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.052 1.341 . . . . 0.0 110.259 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.412 ' HA ' ' HD2' ' A' ' 799' ' ' PRO . 4.5 t -157.17 158.98 37.27 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.107 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 45.0 t -120.91 133.24 68.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.273 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 37.9 t -68.33 115.11 7.39 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.152 0.501 . . . . 0.0 109.995 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 45.3 mm -117.3 83.09 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 C-N-CA 123.726 0.81 . . . . 0.0 109.332 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.769 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 0.6 OUTLIER 49.78 66.01 1.25 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.811 0.845 . . . . 0.0 111.259 176.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 77.44 14.36 82.58 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.887 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -139.02 166.11 25.37 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.471 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.1 m95 -116.88 156.3 27.58 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -147.62 104.28 3.7 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 43.1 Cg_endo -70.51 142.76 73.04 Favored 'Cis proline' 0 C--O 1.239 0.575 0 C-N-CA 124.0 -1.25 . . . . 0.0 113.248 0.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 47.3 mt-10 -53.86 125.42 18.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.445 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 5.0 m -75.48 140.2 17.78 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.404 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.719 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -155.98 131.4 9.52 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.769 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . 0.597 ' SG ' ' HG2' ' A' ' 782' ' ' ARG . 42.3 t -128.65 -5.6 5.21 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.044 0.926 . . . . 0.0 109.054 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.42 -1.97 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.267 178.371 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.421 -1.892 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 51.8 m -79.06 -66.99 0.8 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 93.17 142.22 11.51 Favored Glycine 0 N--CA 1.405 -3.38 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.666 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 35.6 t70 53.69 97.32 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 125.815 1.646 . . . . 0.0 112.441 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.439 HG23 HG22 ' A' ' 715' ' ' VAL . 1.8 pp -63.68 147.3 95.94 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.399 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.42 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.9 Cg_endo -69.63 -171.61 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.729 2.286 . . . . 0.0 112.134 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -121.79 179.05 4.61 Favored 'General case' 0 N--CA 1.393 -3.297 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.554 HD21 ' HB3' ' A' ' 717' ' ' PHE . 25.0 tp -124.33 129.43 50.71 Favored 'General case' 0 C--N 1.251 -3.675 0 CA-C-O 120.915 0.388 . . . . 0.0 110.953 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 5.5 pt-20 -38.66 -51.34 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.479 1.912 . . . . 0.0 114.756 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.651 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.8 m-70 -141.12 26.26 2.03 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -139.16 -146.39 4.92 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.552 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -152.05 178.31 9.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -174.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -113.05 143.88 43.56 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -73.56 -62.71 1.39 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.6 tt -166.56 135.52 2.95 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.459 ' HB3' HG12 ' A' ' 715' ' ' VAL . 13.1 p -129.95 119.86 23.89 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-O 121.351 0.596 . . . . 0.0 110.074 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 13.2 p -108.47 113.17 60.42 Favored Pre-proline 0 C--N 1.276 -2.609 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.239 -174.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.467 ' HA ' ' N ' ' A' ' 709' ' ' TYR . 57.6 Cg_endo -69.7 171.5 14.28 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.856 2.37 . . . . 0.0 110.527 176.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 709' ' ' TYR . 18.1 Cg_endo -64.84 -4.89 3.07 Favored 'Cis proline' 0 N--CA 1.496 1.676 0 N-CA-C 117.077 1.914 . . . . 0.0 117.077 2.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 35.6 m-85 68.68 65.57 0.31 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.509 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 16.7 m-85 -69.75 172.77 7.05 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.877 -1.511 . . . . 0.0 112.103 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -72.21 132.05 43.58 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.901 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.34 -6.41 65.81 Favored Glycine 0 N--CA 1.413 -2.867 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.82 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 1.4 t70 -68.79 155.89 39.35 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 19.4 m -146.81 145.08 29.78 Favored 'General case' 0 C--N 1.274 -2.697 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 730' ' ' SER . 46.1 t -132.04 134.69 59.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.887 -176.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -79.85 133.85 36.29 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 123.78 0.675 . . . . 0.0 111.676 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.554 ' HB3' HD21 ' A' ' 697' ' ' LEU . 26.7 m-85 -138.28 129.88 27.88 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 125.38 1.472 . . . . 0.0 107.28 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -137.71 -161.5 1.18 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 725' ' ' MET . 11.7 m -118.71 131.77 56.15 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 18.9 t -67.02 -75.61 0.09 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 124.239 0.962 . . . . 0.0 110.721 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 722' ' ' SER . 44.7 mt-10 -149.18 152.9 36.86 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 69.3 m 72.92 2.69 4.46 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 124.285 0.991 . . . . 0.0 112.766 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.65 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.7 m-85 -138.56 144.74 40.0 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.498 HG22 HD22 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -107.09 136.43 46.95 Favored 'General case' 0 C--N 1.255 -3.505 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.265 -177.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.756 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 7.6 ttp -84.29 118.6 24.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 124.196 0.998 . . . . 0.0 109.636 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 48.3 mm -127.33 141.68 45.65 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.998 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 106.5 -66.9 0.25 Allowed Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.392 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.546 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 20.7 t60 -165.83 -177.6 4.37 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 -175.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.756 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -143.31 25.43 1.71 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 119.027 0.831 . . . . 0.0 110.699 176.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 16.0 m -152.47 163.66 39.1 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.884 -0.51 . . . . 0.0 109.782 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.475 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 32.2 pt -125.3 163.45 26.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.745 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 732' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 739' ' ' THR . 17.5 m -137.03 134.1 36.2 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.252 0.345 . . . . 0.0 111.08 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 3.4 t -86.84 105.85 17.32 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -141.28 140.43 31.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.984 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 60.44 14.19 4.61 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 89.11 25.22 29.59 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.81 144.89 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.089 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.489 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 97.3 m95 -72.63 -179.34 3.01 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.5 0.667 . . . . 0.0 110.138 170.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 732' ' ' THR . 27.9 p -90.95 -152.9 0.29 Allowed 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.458 ' NE2' ' HB ' ' A' ' 739' ' ' THR . 0.0 OUTLIER -81.52 -14.87 56.4 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -169.029 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.2 mm? 71.12 151.59 0.14 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 123.967 0.792 . . . . 0.0 110.824 -175.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.546 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 36.2 Cg_endo -71.13 177.64 6.29 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.028 1.819 . . . . 0.0 110.736 172.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -125.07 132.92 53.09 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.651 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 84.6 m -116.38 107.06 14.33 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-O 121.458 0.646 . . . . 0.0 109.834 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.474 ' C ' ' H ' ' A' ' 747' ' ' ILE . 21.6 t -97.58 142.82 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.682 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.657 ' O ' ' HB ' ' A' ' 747' ' ' ILE . . . -65.97 1.91 1.27 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 125.247 1.419 . . . . 0.0 113.414 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.657 ' HB ' ' O ' ' A' ' 746' ' ' ALA . 40.0 mt 79.35 -19.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 125.41 1.484 . . . . 0.0 111.031 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.0 t70 -72.01 -34.26 68.71 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.118 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -98.74 17.76 18.57 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.274 -1.785 . . . . 0.0 109.498 -172.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.83 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 1.7 mp -82.37 -174.06 4.93 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.539 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . 0.6 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 1.2 mmpt? -136.43 -177.1 4.57 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -130.97 144.4 51.45 Favored 'General case' 0 C--N 1.268 -2.963 0 C-N-CA 125.297 1.439 . . . . 0.0 107.202 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 770' ' ' GLU . 69.1 m -92.78 167.08 12.1 Favored 'General case' 0 C--N 1.246 -3.899 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.24 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -125.88 136.0 52.56 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.895 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 755' ' ' SER . . . . . 0.417 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.0 p -67.18 118.44 10.6 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.582 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.556 ' HB3' HG13 ' A' ' 759' ' ' ILE . 28.3 t -66.15 143.15 57.46 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -77.85 -6.97 55.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 804' ' ' SER . 89.2 mt -105.16 -11.69 16.45 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.813 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.556 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -96.43 162.32 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.806 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . 0.453 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.4 mp -118.98 117.4 54.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.777 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 63.7 mt -93.51 -177.25 4.35 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.507 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 31.5 mt-10 -62.85 176.84 0.63 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.354 0.597 . . . . 0.0 110.093 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -86.02 -6.06 59.11 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 123.431 1.586 . . . . 0.0 107.406 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . 0.274 63.8 t60 -88.98 -43.04 11.43 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 110.712 -2.949 . . . . 0.0 108.194 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.513 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 54.8 mt -96.2 -13.43 23.49 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.861 -171.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 54.1 mtmt -65.66 -15.9 63.22 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.806 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -89.84 1.64 55.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.506 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . 0.446 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 11.3 tppt? -103.52 109.91 21.74 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -83.02 -36.49 24.94 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 753' ' ' CYS . 3.8 pt-20 -130.29 134.02 46.9 Favored 'General case' 0 N--CA 1.403 -2.789 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.635 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.777 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 81.0 m-85 -112.09 143.19 43.53 Favored 'General case' 0 C--N 1.267 -3.012 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.009 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.89 154.78 19.61 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.488 ' CB ' HD23 ' A' ' 750' ' ' LEU . 18.5 p-80 -43.21 143.56 0.81 Allowed 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.974 1.31 . . . . 0.0 111.55 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 14.0 m120 68.19 12.28 8.7 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.23 1.012 . . . . 0.0 113.435 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 775' ' ' SER . . . . . 0.522 ' HG ' HG22 ' A' ' 777' ' ' ILE . 43.4 t -77.84 110.48 12.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.425 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.8 OUTLIER -86.82 101.3 13.22 Favored 'General case' 0 CA--C 1.494 -1.203 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.596 HG21 ' CE2' ' A' ' 771' ' ' PHE . 5.6 pt -114.0 -173.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.269 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.534 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 26.9 ptt180 -142.28 124.81 15.76 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.478 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 4.4 p90 -114.79 172.54 6.98 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . 0.453 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 27.0 ptt180 -150.19 178.57 8.86 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.572 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 48.1 t -114.94 162.94 16.27 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . 0.421 ' HG2' ' SG ' ' A' ' 803' ' ' CYS . 38.1 ptt180 -74.51 -21.49 59.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.286 0.565 . . . . 0.0 110.129 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -99.93 -8.79 50.56 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.072 175.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.572 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 13.3 mptt -128.14 104.53 7.81 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 122.686 -0.302 . . . . 0.0 110.735 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.31 169.92 17.39 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 97.58 -168.02 23.69 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 75.6 m95 -138.69 142.9 38.96 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 118.613 1.206 . . . . 0.0 109.714 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.478 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.5 mp -93.6 -40.51 11.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.056 -177.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.481 ' HA ' ' O ' ' A' ' 777' ' ' ILE . 15.3 m170 75.0 129.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.677 1.191 . . . . 0.0 109.633 -174.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 3.4 t -151.42 154.61 36.96 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 120.755 0.312 . . . . 0.0 110.334 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.3 t -115.99 133.42 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.395 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 54.0 t -69.38 112.48 5.95 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.788 0.804 . . . . 0.0 110.173 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 47.4 mm -112.45 81.35 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 C-N-CA 124.534 1.133 . . . . 0.0 108.84 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.83 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 0.4 OUTLIER 51.62 66.13 1.29 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.374 176.659 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.49 20.25 79.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.348 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -147.29 163.99 34.65 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.557 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.6 m95 -108.92 162.09 14.53 Favored 'General case' 0 C--N 1.258 -3.388 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.684 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -150.24 102.14 3.15 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.81 140.56 64.45 Favored 'Cis proline' 0 N--CA 1.48 0.705 0 C-N-CA 123.917 -1.284 . . . . 0.0 113.704 -0.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 44.6 mt-10 -50.48 123.85 9.51 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.585 175.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 3.9 m -76.67 131.64 34.46 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.264 0 CA-C-O 121.458 0.647 . . . . 0.0 111.078 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -156.59 108.17 2.45 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . 0.491 ' HB2' HG23 ' A' ' 759' ' ' ILE . 42.6 t -94.86 -30.73 14.04 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 804' ' ' SER . . . . . 0.509 ' HB2' HD13 ' A' ' 758' ' ' LEU . 60.7 m . . . . . 0 N--CA 1.437 -1.111 0 C-N-CA 128.87 2.868 . . . . 0.0 103.984 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.431 -1.424 0 CA-C-O 120.864 0.364 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 64.2 m -73.5 -70.89 0.35 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 94.23 135.78 7.92 Favored Glycine 0 N--CA 1.413 -2.876 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.616 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 25.3 t70 62.25 112.94 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 O-C-N 125.324 1.249 . . . . 0.0 111.829 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.62 HG22 HG22 ' A' ' 715' ' ' VAL . 1.6 pp -80.0 147.03 64.86 Favored Pre-proline 0 C--N 1.283 -2.305 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.05 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.419 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 71.1 Cg_endo -71.64 -166.9 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 123.499 2.799 . . . . 0.0 112.994 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -129.91 164.64 23.76 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 717' ' ' PHE . 23.7 tp -109.32 132.9 53.69 Favored 'General case' 0 C--N 1.256 -3.498 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.742 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 7.0 pt-20 -43.49 -53.43 5.5 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 125.925 1.69 . . . . 0.0 113.713 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.469 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 89.9 m-70 -137.49 28.15 2.75 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -136.2 -151.63 6.14 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.541 -176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -150.21 174.55 12.68 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -108.66 142.27 39.4 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -78.3 -67.87 0.69 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 120.72 0.295 . . . . 0.0 111.524 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.3 tt -161.68 137.21 7.61 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.468 ' HA ' HG12 ' A' ' 715' ' ' VAL . 35.5 p -111.8 -49.2 3.0 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -169.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' SER . . . . . 0.403 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 66.0 m 58.84 100.26 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 706' ' ' SER . 40.9 Cg_endo -66.69 171.72 10.46 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.416 2.077 . . . . 0.0 109.733 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.601 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.8 Cg_endo -73.67 -2.22 14.73 Favored 'Cis proline' 0 N--CA 1.484 0.962 0 N-CA-C 116.662 1.755 . . . . 0.0 116.662 7.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.483 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 33.5 m-85 68.55 72.94 0.28 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 123.691 0.62 . . . . 0.0 109.413 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.601 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 22.5 m-85 -81.2 172.67 13.36 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.459 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -72.58 127.43 32.53 Favored 'General case' 0 CA--C 1.481 -1.691 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.143 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.1 -17.86 53.18 Favored Glycine 0 N--CA 1.406 -3.303 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.656 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.67 144.83 56.67 Favored 'General case' 0 CA--C 1.481 -1.692 0 CA-C-O 121.285 0.564 . . . . 0.0 110.089 177.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 10.2 m -128.11 153.69 46.56 Favored 'General case' 0 N--CA 1.404 -2.739 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.898 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.62 HG22 HG22 ' A' ' 694' ' ' ILE . 46.4 t -135.83 127.4 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.559 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 37.0 mt-10 -84.86 138.01 32.8 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.889 0.852 . . . . 0.0 111.702 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.551 ' HB3' HD21 ' A' ' 697' ' ' LEU . 30.1 m-85 -138.08 128.83 26.8 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 125.487 1.515 . . . . 0.0 107.028 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -124.69 -163.12 1.14 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 22.4 m -107.39 136.55 47.0 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 23.3 t -66.14 -62.56 1.42 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 123.924 0.765 . . . . 0.0 111.416 -169.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.47 153.13 15.04 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 55.7 m 64.43 13.08 7.85 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.606 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 94.4 m-85 -141.27 146.15 36.45 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-O 122.028 0.918 . . . . 0.0 110.169 -175.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.44 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -110.19 134.95 51.7 Favored 'General case' 0 C--N 1.253 -3.617 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.932 -179.201 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.778 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.4 ttp -82.21 121.77 27.05 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.602 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.51 128.31 74.55 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.27 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.12 -90.51 0.53 Allowed Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.154 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.65 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 15.6 t60 -144.74 164.39 31.16 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.778 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -118.72 23.75 11.28 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.504 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.559 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 6.3 p -153.11 159.67 42.81 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.97 0.414 . . . . 0.0 111.389 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.421 HG23 HD11 ' A' ' 741' ' ' LEU . 27.8 pt -110.43 166.86 5.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.545 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 732' ' ' THR . . . . . 0.452 ' O ' HG22 ' A' ' 739' ' ' THR . 19.4 m -138.41 133.49 32.92 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.724 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 2.1 t -81.13 105.21 12.16 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.306 0.574 . . . . 0.0 109.708 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.413 ' C ' ' H ' ' A' ' 736' ' ' GLY . 1.6 pp -143.97 144.75 22.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.022 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 71.02 -15.49 0.4 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.982 0.913 . . . . 0.0 113.322 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 734' ' ' ILE . . . 118.94 17.99 4.84 Favored Glycine 1 CA--C 1.445 -4.328 0 CA-C-O 121.364 0.424 . . . . 0.0 112.878 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -154.24 177.79 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.39 -3.456 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.483 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 89.8 m95 -90.38 -173.89 3.95 Favored 'General case' 0 C--N 1.266 -3.065 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 732' ' ' THR . 38.8 p -85.06 -155.76 0.23 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.225 0.536 . . . . 0.0 110.257 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.452 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.5 OUTLIER -93.83 3.48 55.35 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -168.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.0 mm? 71.6 159.93 0.16 Allowed Pre-proline 0 N--CA 1.481 1.123 0 O-C-N 123.82 0.7 . . . . 0.0 110.404 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.65 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 18.5 Cg_endo -72.94 -177.71 3.07 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 121.673 1.582 . . . . 0.0 111.356 171.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -122.1 125.94 47.29 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.472 ' SG ' HD22 ' A' ' 697' ' ' LEU . 64.7 m -116.7 94.87 4.78 Favored 'General case' 0 CA--C 1.481 -1.689 0 CA-C-O 121.659 0.742 . . . . 0.0 110.554 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.476 ' C ' ' H ' ' A' ' 747' ' ' ILE . 30.7 t -89.16 143.02 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.881 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.616 -177.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.606 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -62.51 4.31 0.16 Allowed 'General case' 0 C--N 1.283 -2.305 0 C-N-CA 125.733 1.613 . . . . 0.0 114.89 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.825 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 65.7 mt 77.37 -17.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 126.156 1.782 . . . . 0.0 111.34 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.516 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.7 t70 -79.85 -31.77 40.47 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-N 113.177 -1.829 . . . . 0.0 109.293 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -107.35 19.82 19.77 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.193 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.825 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 85.0 mt -81.46 -177.69 6.62 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 114.547 -1.206 . . . . 0.0 107.898 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . 0.52 ' HE3' ' HA3' ' A' ' 795' ' ' GLY . 27.1 mtpp -98.63 156.4 16.83 Favored 'General case' 0 N--CA 1.386 -3.638 0 CA-C-O 121.954 0.883 . . . . 0.0 108.977 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . 0.598 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 43.5 mtpt -105.65 116.82 32.59 Favored 'General case' 1 C--N 1.238 -4.242 0 CA-C-N 112.524 -2.126 . . . . 0.0 108.171 -172.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 65.2 m -76.52 132.77 39.75 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.051 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.45 135.0 41.51 Favored 'General case' 0 C--N 1.278 -2.538 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.699 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 47.3 t -60.94 129.34 40.95 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.703 171.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.543 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 41.0 t -73.27 151.04 41.52 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -82.97 -0.38 48.42 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 98.8 mt -112.82 -8.87 13.71 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.543 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.2 pp -102.28 150.93 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 122.163 0.982 . . . . 0.0 113.385 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.4 mp -105.04 130.86 55.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.487 0 CA-C-N 113.595 -1.639 . . . . 0.0 107.387 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.28 -176.6 2.93 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.448 ' HB2' HD22 ' A' ' 765' ' ' LEU . 48.1 mt-10 -65.29 165.72 11.18 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.885 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.33 -7.7 44.7 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.501 0.667 . . . . 0.0 111.795 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -4.45 17.35 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.797 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.448 HD22 ' HB2' ' A' ' 762' ' ' GLU . 3.0 mm? -117.04 -11.71 10.73 Favored 'General case' 0 C--O 1.207 -1.136 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.438 ' HZ1' ' HB2' ' A' ' 766' ' ' LYS . 10.4 mtmp? -70.85 -16.49 62.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.454 0.645 . . . . 0.0 110.228 176.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -78.72 -13.53 59.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.917 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 7.9 tppt? -98.32 126.81 43.98 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . 0.435 ' HE2' ' HB3' ' A' ' 769' ' ' LYS . 15.3 ptpt -110.37 -19.65 12.89 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . 0.598 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 36.4 mt-10 -134.25 107.79 7.87 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.543 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 768' ' ' LYS . 79.4 m-85 -93.2 162.71 13.91 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.84 -175.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -101.86 154.78 18.61 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.483 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 28.5 t60 -60.19 144.38 50.21 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.902 0.126 . . . . 0.0 111.038 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 63.7 t30 88.12 3.1 0.31 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 125.445 1.716 . . . . 0.0 111.27 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 86.8 p -73.61 105.75 5.08 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 119.803 -0.759 . . . . 0.0 108.988 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.446 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -87.03 90.2 8.27 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 789' ' ' HIS . 7.6 pt -104.55 -170.91 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.562 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.581 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 16.6 ptt180 -142.83 125.61 16.02 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.066 174.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.626 ' CD2' HG11 ' A' ' 801' ' ' VAL . 13.1 p90 -106.87 167.46 9.86 Favored 'General case' 0 C--O 1.257 1.496 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 13.3 ptt180 -155.67 161.82 40.7 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 175.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 3.1 m -98.95 173.88 6.63 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -101.91 36.25 2.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.479 1.133 . . . . 0.0 109.674 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -176.72 -33.72 0.05 OUTLIER Glycine 0 CA--C 1.473 -2.564 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.58 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 0.4 OUTLIER -96.82 139.72 32.44 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 176.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.31 154.41 19.4 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.572 0.701 . . . . 0.0 112.891 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 91.2 154.51 30.67 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.349 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 52.0 m95 -95.85 141.04 29.77 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.476 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -95.42 -31.21 4.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.568 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.499 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 12.0 m170 72.44 118.37 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 124.062 0.945 . . . . 0.0 111.114 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.521 HG21 ' CG2' ' A' ' 801' ' ' VAL . 3.4 t -141.51 153.28 44.8 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.556 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 38.9 t -114.45 132.91 62.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.712 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.15 115.06 8.92 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.483 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 46.5 mm -114.5 84.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.406 ' C ' ' HB2' ' A' ' 751' ' ' LYS . 7.7 t-20 46.92 68.11 0.68 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.845 0.858 . . . . 0.0 111.992 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . 0.52 ' HA3' ' HE3' ' A' ' 751' ' ' LYS . . . 72.28 24.09 76.92 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 114.958 -1.019 . . . . 0.0 114.293 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -146.88 168.5 21.3 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.574 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 91.3 m95 -117.24 161.99 18.6 Favored 'General case' 0 C--N 1.266 -3.038 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -150.58 104.56 3.08 Favored Pre-proline 0 C--N 1.296 -1.727 0 O-C-N 123.344 0.402 . . . . 0.0 110.063 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 36.7 Cg_endo -68.57 140.98 59.77 Favored 'Cis proline' 0 C--O 1.239 0.565 0 C-N-CA 123.993 -1.253 . . . . 0.0 112.306 -1.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.574 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 52.2 mt-10 -49.33 120.71 4.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.876 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.626 HG11 ' CD2' ' A' ' 779' ' ' TYR . 67.7 t -69.6 119.2 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.104 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . 0.537 HD22 ' HB2' ' A' ' 804' ' ' SER . 7.6 t30 -141.2 141.19 34.09 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . 0.508 ' HB2' HG21 ' A' ' 759' ' ' ILE . 5.0 t -123.47 14.12 9.52 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.391 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 804' ' ' SER . . . . . 0.537 ' HB2' HD22 ' A' ' 802' ' ' ASN . 13.9 m . . . . . 0 C--N 1.288 -2.099 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.6 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.599 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.2 m -82.25 -61.97 1.75 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.004 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 134.08 174.56 13.55 Favored Glycine 1 N--CA 1.374 -5.466 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.698 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 29.9 t70 -52.0 135.34 31.04 Favored 'General case' 0 C--N 1.276 -2.589 0 O-C-N 124.803 0.943 . . . . 0.0 111.38 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.572 HG21 HG22 ' A' ' 715' ' ' VAL . 1.3 pp -55.6 150.34 25.95 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.145 -1.389 . . . . 0.0 114.076 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.483 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 65.1 Cg_endo -72.67 -161.62 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.468 2.778 . . . . 0.0 111.321 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -135.82 151.86 50.49 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.497 HD23 ' HB3' ' A' ' 717' ' ' PHE . 26.4 tp -92.66 123.22 35.79 Favored 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.893 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.524 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 5.4 pt-20 -34.63 -50.78 0.46 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.334 2.253 . . . . 0.0 114.417 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.524 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 83.5 m-70 -136.28 28.83 3.07 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -142.17 -156.15 6.7 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.389 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . 0.43 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -140.25 -178.31 5.42 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -115.72 146.09 42.19 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -74.16 -68.57 0.51 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.337 0.589 . . . . 0.0 110.806 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.4 tt -159.8 138.97 10.99 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.447 ' HB3' HG13 ' A' ' 715' ' ' VAL . 4.1 p -153.44 123.54 6.96 Favored 'General case' 0 N--CA 1.395 -3.197 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 20.6 m -128.08 130.44 23.6 Favored Pre-proline 0 C--N 1.278 -2.539 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.284 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.45 168.59 14.25 Favored 'Trans proline' 0 C--O 1.248 0.976 0 C-N-CA 122.715 2.277 . . . . 0.0 109.716 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.594 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 2.6 Cg_endo -71.64 -11.71 15.77 Favored 'Cis proline' 0 N--CA 1.483 0.892 0 N-CA-C 116.097 1.537 . . . . 0.0 116.097 6.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.698 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 66.7 m-85 68.92 77.77 0.22 Allowed 'General case' 0 C--O 1.248 0.995 0 O-C-N 123.857 0.723 . . . . 0.0 109.643 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.594 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 47.5 m-85 -82.99 171.53 13.73 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.843 0.83 . . . . 0.0 113.204 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 0.651 ' HH ' ' HA2' ' A' ' 736' ' ' GLY . 91.1 m-85 -71.41 132.41 44.77 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.271 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.57 -15.63 55.7 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.1 147.67 46.48 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-O 121.088 0.47 . . . . 0.0 111.547 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 15.8 m -135.57 144.37 46.17 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.999 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.572 HG22 HG21 ' A' ' 694' ' ' ILE . 38.3 t -127.24 138.2 55.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.58 125.27 33.68 Favored 'General case' 0 N--CA 1.425 -1.723 0 O-C-N 124.338 1.024 . . . . 0.0 111.073 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.497 ' HB3' HD23 ' A' ' 697' ' ' LEU . 21.9 m-85 -128.21 118.12 22.76 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 125.785 1.634 . . . . 0.0 107.655 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.43 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 17.7 m-80 -120.41 -162.1 0.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 5.5 m -112.33 134.37 53.91 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' SER . . . . . 0.415 ' HA ' ' CE2' ' A' ' 701' ' ' TRP . 22.4 t -61.56 -58.54 7.72 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.216 0.532 . . . . 0.0 110.568 -172.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 722' ' ' SER . 12.6 pt-20 -174.18 166.2 4.14 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 68.4 m 68.33 0.63 2.58 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.239 0.962 . . . . 0.0 112.051 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.559 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.8 m-85 -137.22 144.83 43.01 Favored 'General case' 0 N--CA 1.395 -3.196 0 C-N-CA 124.243 1.017 . . . . 0.0 109.133 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.432 HG21 HD22 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -110.36 134.66 52.08 Favored 'General case' 0 C--N 1.254 -3.58 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.219 -177.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.5 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.0 ttp -84.62 122.81 29.58 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 124.236 1.015 . . . . 0.0 109.237 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.402 ' HA ' HD11 ' A' ' 726' ' ' ILE . 34.5 mm -111.28 122.81 66.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.822 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.728 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 99.44 -87.62 0.77 Allowed Glycine 0 N--CA 1.42 -2.422 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.634 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.453 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 48.9 p-80 -135.8 179.13 6.53 Favored 'General case' 0 N--CA 1.393 -3.286 0 C-N-CA 124.113 0.965 . . . . 0.0 108.478 -173.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.5 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.0 ppt_? -135.7 8.99 3.34 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 32.5 m -130.82 155.1 47.27 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.49 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 714' ' ' SER . 36.5 pt -110.4 160.66 9.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.24 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 732' ' ' THR . . . . . 0.418 ' O ' HG22 ' A' ' 739' ' ' THR . 26.9 m -135.75 133.71 38.26 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.192 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 7.1 t -84.87 103.88 14.33 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.86 145.87 23.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.776 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 72.69 -49.93 0.7 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.63 1.172 . . . . 0.0 111.919 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.651 ' HA2' ' HH ' ' A' ' 711' ' ' TYR . . . 158.4 24.26 0.03 OUTLIER Glycine 0 C--N 1.29 -1.991 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.367 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.4 p -160.01 157.88 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.483 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 93.5 m95 -78.39 170.68 16.24 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 24.8 p -74.91 -163.5 0.23 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.389 1.09 . . . . 0.0 113.528 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.587 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.0 OUTLIER -68.88 -23.9 64.27 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -170.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.587 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.3 mm? 81.95 148.22 0.11 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 124.786 1.304 . . . . 0.0 109.22 -173.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 19.6 Cg_endo -72.85 -175.56 1.95 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.928 1.752 . . . . 0.0 112.885 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -119.78 126.37 50.86 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.483 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 78.5 m -118.46 111.8 19.13 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.275 0.559 . . . . 0.0 109.799 177.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.471 ' C ' ' H ' ' A' ' 747' ' ' ILE . 41.7 t -100.91 145.14 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.583 ' O ' ' HB ' ' A' ' 747' ' ' ILE . . . -65.99 4.25 0.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.184 1.393 . . . . 0.0 113.672 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' A' ' 746' ' ' ALA . 32.0 mt 80.11 -26.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 126.302 1.841 . . . . 0.0 111.801 173.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 746' ' ' ALA . 38.7 t70 -82.95 -25.31 32.45 Favored 'General case' 0 C--N 1.248 -3.841 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.375 -172.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.465 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 9.4 ptmt -112.65 34.91 4.09 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.72 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.841 ' HG ' ' HB2' ' A' ' 794' ' ' ASN . 0.8 OUTLIER -78.71 -166.36 0.87 Allowed 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.092 176.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -121.34 -178.66 3.84 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 121.542 0.687 . . . . 0.0 109.625 -174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -114.43 132.94 56.08 Favored 'General case' 0 C--N 1.262 -3.23 0 CA-C-N 112.991 -1.913 . . . . 0.0 107.804 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 58.3 m -90.49 174.29 7.62 Favored 'General case' 0 C--N 1.244 -4.0 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.391 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 754' ' ' LYS . 15.7 ptmt -144.15 152.39 40.84 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.173 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 20.4 p -62.52 126.06 26.04 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.69 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.532 ' HB2' HG13 ' A' ' 759' ' ' ILE . 11.3 m -72.85 136.37 45.32 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -72.09 -4.4 28.72 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 88.6 mt -105.6 -21.0 13.29 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.032 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.8 pp -98.48 171.31 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.077 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . 0.416 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.3 mp -117.31 136.44 54.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.429 HD13 ' CZ ' ' A' ' 771' ' ' PHE . 80.4 mt -107.11 177.0 4.98 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.423 ' HB2' HD21 ' A' ' 765' ' ' LEU . 43.7 mt-10 -62.06 162.04 9.95 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.986 0.422 . . . . 0.0 110.736 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -70.18 -9.62 56.28 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.464 0.649 . . . . 0.0 111.02 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -109.86 -0.5 18.29 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.029 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 762' ' ' GLU . 3.1 mm? -123.67 -14.62 7.23 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.413 ' HG2' ' HB2' ' A' ' 761' ' ' LEU . 29.3 mtmm -68.37 -19.55 64.64 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.123 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -78.95 -17.27 55.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.139 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -85.99 107.98 18.01 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . 0.473 ' HG3' ' HG2' ' A' ' 770' ' ' GLU . 8.5 ptpp? -74.23 -32.65 63.07 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.688 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . 0.473 ' HG2' ' HG3' ' A' ' 769' ' ' LYS . 22.7 mm-40 -131.96 139.52 48.7 Favored 'General case' 0 CA--C 1.478 -1.799 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.429 ' CZ ' HD13 ' A' ' 761' ' ' LEU . 90.8 m-85 -112.45 134.0 54.22 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.724 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -86.21 155.71 20.6 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.526 ' HB2' HD23 ' A' ' 750' ' ' LEU . 18.8 p-80 -49.7 143.98 6.65 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.117 0.967 . . . . 0.0 112.052 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 19.1 m120 67.76 25.75 7.94 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 124.211 1.004 . . . . 0.0 112.781 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 69.0 m -93.86 109.12 20.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.542 ' HA ' HG12 ' A' ' 791' ' ' VAL . 0.7 OUTLIER -83.46 114.32 21.39 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.419 HD11 HD23 ' A' ' 761' ' ' LEU . 5.8 pt -127.38 -174.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.486 0.66 . . . . 0.0 111.006 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.528 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 98.1 mtt180 -134.29 124.52 25.99 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.541 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 13.2 p90 -111.98 166.77 10.93 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 171.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . 0.416 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 36.8 ptt180 -152.57 160.13 43.23 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 3.4 m -95.18 163.39 13.3 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.144 0.497 . . . . 0.0 112.271 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -68.33 -27.9 66.68 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.825 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -110.23 9.09 31.13 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.961 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 1.8 mptm? -121.2 113.2 19.64 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.904 0.383 . . . . 0.0 110.469 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -90.87 87.51 6.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.571 0.7 . . . . 0.0 109.242 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 166.14 145.4 4.44 Favored Glycine 0 C--N 1.291 -1.941 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 54.4 m95 -96.1 142.86 27.79 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.541 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -96.7 -29.69 3.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.517 -176.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.443 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 21.5 m170 76.77 128.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.565 1.146 . . . . 0.0 109.739 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.568 HG22 ' CG2' ' A' ' 801' ' ' VAL . 2.7 t -153.75 159.9 42.1 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.621 HG23 ' HB3' ' A' ' 798' ' ' ASP . 5.9 m -124.36 153.13 30.65 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.505 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 43.2 t -80.95 116.21 20.81 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.407 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 51.0 mm -121.05 86.2 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.841 ' HB2' ' HG ' ' A' ' 750' ' ' LEU . 23.7 t-20 54.01 69.06 0.76 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.13 0.967 . . . . 0.0 111.508 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.12 66.29 Favored Glycine 0 C--N 1.297 -1.635 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.49 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -140.54 168.43 19.83 Favored 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.607 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 82.7 m95 -116.26 155.51 28.23 Favored 'General case' 0 C--N 1.26 -3.31 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . 0.621 ' HB3' HG23 ' A' ' 791' ' ' VAL . 26.0 t70 -133.3 100.47 13.98 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 119.567 -0.254 . . . . 0.0 110.973 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . 0.443 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 44.3 Cg_endo -73.07 145.0 82.82 Favored 'Cis proline' 0 C--O 1.24 0.59 0 C-N-CA 124.377 -1.093 . . . . 0.0 112.153 -1.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.607 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 27.0 tt0 -48.59 122.15 5.25 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.014 0.821 . . . . 0.0 111.249 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.568 ' CG2' HG22 ' A' ' 790' ' ' THR . 64.4 t -74.09 120.68 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.42 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -151.96 130.4 12.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 10.1 t -101.6 -25.2 13.97 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.244 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.414 -2.247 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.854 -178.458 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 18.9 m -67.54 -80.69 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 123.326 0.391 . . . . 0.0 111.729 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 156.94 164.15 13.23 Favored Glycine 0 N--CA 1.399 -3.807 0 N-CA-C 106.845 -2.502 . . . . 0.0 106.845 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.792 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 36.5 t70 -45.68 128.91 8.85 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 124.069 0.948 . . . . 0.0 112.24 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.785 HG22 HG23 ' A' ' 715' ' ' VAL . 1.4 pp -50.06 148.18 6.2 Favored Pre-proline 0 N--CA 1.429 -1.491 0 O-C-N 125.042 1.464 . . . . 0.0 114.294 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.46 -164.33 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.123 2.549 . . . . 0.0 112.308 177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -137.17 141.15 42.18 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.605 HD22 ' SG ' ' A' ' 744' ' ' CYS . 25.0 tp -89.01 123.35 33.25 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.729 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -42.38 -48.53 5.12 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 126.723 2.009 . . . . 0.0 115.079 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -134.54 24.99 3.75 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.446 0.641 . . . . 0.0 110.174 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -134.02 -145.69 5.33 Favored Glycine 0 C--N 1.288 -2.11 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.272 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -154.23 172.16 18.06 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -104.23 150.37 24.47 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -81.44 -77.9 0.2 Allowed 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.674 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 67.0 tp -172.2 129.84 0.6 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.268 0.227 . . . . 0.0 110.412 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.452 ' HB2' HG11 ' A' ' 715' ' ' VAL . 48.2 t -141.2 -50.65 0.43 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.856 175.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 35.9 p 58.03 155.45 0.09 OUTLIER Pre-proline 0 CA--C 1.57 1.747 0 C-N-CA 125.392 1.477 . . . . 0.0 113.018 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.543 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 60.9 Cg_endo -66.51 174.91 5.69 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.027 1.818 . . . . 0.0 111.256 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.0 Cg_endo -79.07 -9.25 37.86 Favored 'Cis proline' 0 N--CA 1.485 1.013 0 N-CA-C 115.176 1.183 . . . . 0.0 115.176 5.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.792 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 77.8 m-85 72.59 76.17 0.15 Allowed 'General case' 0 C--N 1.316 -0.872 0 O-C-N 124.173 0.921 . . . . 0.0 110.242 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.445 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 25.0 m-85 -79.99 167.6 20.26 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.868 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 0.478 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 64.9 m-85 -72.77 134.81 45.12 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.042 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.61 -4.95 66.78 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.21 149.43 35.51 Favored 'General case' 0 CA--C 1.477 -1.832 0 CA-C-O 121.361 0.6 . . . . 0.0 110.853 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 12.7 m -129.58 153.38 48.11 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.785 HG23 HG22 ' A' ' 694' ' ' ILE . 24.8 t -136.48 142.35 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.656 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.49 136.67 37.58 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-O 121.532 0.682 . . . . 0.0 110.483 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.535 ' HB3' HD21 ' A' ' 697' ' ' LEU . 32.1 m-85 -135.4 118.89 16.88 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -121.91 -163.8 1.1 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 21.6 m -116.02 141.39 48.18 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 38.8 t -64.24 -92.14 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 123.841 0.713 . . . . 0.0 111.22 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 722' ' ' SER . 35.1 mm-40 -139.09 153.6 48.05 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 74.8 m 71.62 1.51 3.9 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.491 1.119 . . . . 0.0 113.164 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.7 m-85 -132.17 143.55 50.05 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-O 121.73 0.776 . . . . 0.0 109.585 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 0.9 OUTLIER -111.71 141.95 44.67 Favored 'General case' 0 C--N 1.253 -3.619 0 CA-C-N 113.097 -1.865 . . . . 0.0 111.869 -178.159 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.709 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 2.8 ttp -85.64 122.91 30.41 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.476 1.51 . . . . 0.0 108.977 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 50.8 mm -115.77 129.43 72.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.378 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 93.85 -85.17 1.06 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.329 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.567 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -125.36 172.41 9.63 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.709 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -135.37 18.52 3.38 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 170.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 34.7 p -144.92 158.91 43.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.285 0.564 . . . . 0.0 110.919 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.415 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 34.5 pt -123.31 162.82 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.345 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 732' ' ' THR . . . . . 0.434 ' O ' HG21 ' A' ' 739' ' ' THR . 24.0 m -136.15 133.75 37.53 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.204 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . 0.478 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.4 t -85.31 101.21 12.36 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 734' ' ' ILE . 1.6 pp -136.9 140.08 43.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.903 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 64.38 6.39 3.04 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.94 18.43 31.99 Favored Glycine 0 CA--C 1.494 -1.279 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.044 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.18 148.62 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.413 ' HA ' ' O ' ' A' ' 732' ' ' THR . 93.5 m95 -78.95 169.71 17.8 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.037 173.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.434 HG21 ' O ' ' A' ' 732' ' ' THR . 38.9 p -81.16 -166.9 1.25 Allowed 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 121.857 0.836 . . . . 0.0 112.825 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.25 -4.82 23.67 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -168.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 68.16 158.6 0.15 Allowed Pre-proline 0 N--CA 1.493 1.722 0 CA-C-O 120.998 0.428 . . . . 0.0 111.256 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.567 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 44.9 Cg_endo -81.92 178.04 6.82 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.854 1.703 . . . . 0.0 111.188 170.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . 0.521 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.6 tt0 -120.41 115.15 22.95 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.605 ' SG ' HD22 ' A' ' 697' ' ' LEU . 94.2 m -97.94 108.09 20.72 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.609 0.719 . . . . 0.0 110.71 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.496 ' C ' ' H ' ' A' ' 747' ' ' ILE . 26.8 t -100.93 141.95 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.596 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.525 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.582 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.39 4.11 0.58 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 125.913 1.685 . . . . 0.0 113.455 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.567 ' HA ' HD23 ' A' ' 750' ' ' LEU . 60.3 mt 74.76 -14.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 126.238 1.815 . . . . 0.0 111.028 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 746' ' ' ALA . 19.2 t70 -80.42 -30.55 37.67 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.648 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.638 ' HZ2' ' HB3' ' A' ' 749' ' ' LYS . 0.2 OUTLIER -95.38 11.89 31.17 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.711 -1.586 . . . . 0.0 108.706 -176.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 1.033 ' HG ' HD21 ' A' ' 794' ' ' ASN . 0.4 OUTLIER -82.41 -168.94 2.19 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.737 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . 0.525 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 31.7 mmmt -126.13 146.81 49.79 Favored 'General case' 0 N--CA 1.392 -3.348 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -103.72 122.39 44.95 Favored 'General case' 1 C--N 1.242 -4.068 0 CA-C-N 112.92 -1.945 . . . . 0.0 107.781 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . 0.487 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 55.6 m -71.91 157.48 37.78 Favored 'General case' 0 C--N 1.253 -3.61 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.314 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -127.77 145.4 50.93 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 48.2 t -56.63 127.67 32.54 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.286 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.565 ' HB3' HG12 ' A' ' 759' ' ' ILE . 26.3 t -76.52 160.53 29.39 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.401 0.619 . . . . 0.0 110.358 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -86.92 -4.1 59.14 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.322 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . 0.488 ' HG ' ' HB2' ' A' ' 804' ' ' SER . 2.8 mm? -110.52 -2.71 16.35 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.966 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.664 HG23 ' SG ' ' A' ' 803' ' ' CYS . 28.6 pt -109.94 156.79 10.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.852 -173.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . 0.564 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.6 mp -121.27 127.46 75.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 2.0 mm? -105.37 -178.71 3.73 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.448 ' HB2' HD22 ' A' ' 765' ' ' LEU . 38.1 mt-10 -68.6 173.97 4.62 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.79 -17.81 64.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.964 -0.46 . . . . 0.0 111.57 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . 0.472 ' HB2' HD23 ' A' ' 765' ' ' LEU . 6.3 m-70 -87.26 -35.0 18.73 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 761' ' ' LEU . 2.6 mm? -90.97 -19.47 23.21 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.288 -171.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -71.04 -16.5 62.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.689 0.757 . . . . 0.0 109.25 170.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.87 16.83 22.5 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.367 1.08 . . . . 0.0 108.464 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -111.71 111.76 22.97 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 769' ' ' LYS . 26.8 ttpp -73.33 -42.59 62.14 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.389 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -139.53 143.4 37.41 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.105 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.487 ' HB2' ' HB2' ' A' ' 753' ' ' CYS . 83.4 m-85 -113.48 135.96 53.31 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.45 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -86.52 160.73 18.88 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.47 ' HB3' HD22 ' A' ' 750' ' ' LEU . 65.7 t60 -61.84 151.27 34.87 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.382 0.134 . . . . 0.0 110.667 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 4.3 m120 78.44 14.19 1.4 Allowed 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 123.987 0.915 . . . . 0.0 112.453 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 44.3 m -91.78 113.26 25.49 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -90.65 111.4 22.71 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.409 HD13 HD13 ' A' ' 761' ' ' LEU . 10.2 pt -122.81 179.3 2.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 121.586 0.708 . . . . 0.0 109.165 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.625 ' HA ' ' HA ' ' A' ' 789' ' ' HIS . 20.7 ptt180 -133.25 120.7 21.44 Favored 'General case' 0 N--CA 1.399 -3.023 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.632 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 2.7 p90 -108.21 167.61 9.89 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . 0.489 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 32.9 ptt180 -146.34 156.05 43.06 Favored 'General case' 0 C--N 1.262 -3.204 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 73.7 m -100.47 134.42 43.45 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.53 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . 0.564 ' HB3' HD11 ' A' ' 760' ' ' ILE . 36.7 ptt180 -59.57 -48.95 79.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -85.92 6.0 82.3 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.319 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.7 mptt -110.02 -47.75 3.28 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 70.19 129.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.238 1.415 . . . . 0.0 111.771 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 111.95 144.96 9.67 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -175.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.518 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 25.9 m95 -93.93 144.23 25.63 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.632 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -100.94 -32.23 3.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.628 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 11.5 m170 73.95 129.93 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 124.555 1.142 . . . . 0.0 110.091 -175.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 3.2 t -151.8 159.18 44.0 Favored 'General case' 0 C--N 1.274 -2.675 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.771 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.17 134.77 62.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.985 -176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.09 114.09 7.91 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.453 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 50.8 mm -116.94 87.92 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 124.745 1.218 . . . . 0.0 109.21 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 1.033 HD21 ' HG ' ' A' ' 750' ' ' LEU . 0.6 OUTLIER 46.74 66.01 1.08 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.762 0.825 . . . . 0.0 112.353 175.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 69.99 27.88 72.48 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.341 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -151.03 166.44 30.7 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.554 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 98.1 m95 -110.81 160.74 16.47 Favored 'General case' 0 C--N 1.256 -3.493 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -147.68 103.3 3.68 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.05 138.22 46.1 Favored 'Cis proline' 0 C--O 1.246 0.916 0 C-N-CA 123.956 -1.268 . . . . 0.0 112.325 1.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.554 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 4.2 tp10 -59.58 126.6 28.24 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.304 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.02 129.28 36.1 Favored 'Isoleucine or valine' 1 N--CA 1.358 -5.054 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.584 -172.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -153.69 106.51 2.9 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . 0.664 ' SG ' HG23 ' A' ' 759' ' ' ILE . 85.7 m -109.02 4.05 22.76 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.119 0.485 . . . . 0.0 111.73 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 804' ' ' SER . . . . . 0.488 ' HB2' ' HG ' ' A' ' 758' ' ' LEU . 24.0 t . . . . . 0 N--CA 1.423 -1.777 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 12.6 m -72.83 -59.4 2.73 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.908 0.385 . . . . 0.0 110.768 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 130.51 179.79 16.33 Favored Glycine 1 N--CA 1.367 -5.923 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -40.51 130.12 2.39 Favored 'General case' 0 C--N 1.278 -2.507 0 C-N-CA 126.348 1.859 . . . . 0.0 111.747 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.573 HG22 HG23 ' A' ' 715' ' ' VAL . 1.5 pp -61.94 149.05 86.86 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.64 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.464 ' HG3' HD21 ' A' ' 741' ' ' LEU . 59.7 Cg_endo -71.98 -161.62 0.1 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.475 2.784 . . . . 0.0 111.276 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -136.31 149.74 48.57 Favored 'General case' 0 N--CA 1.408 -2.555 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.557 HD21 ' SG ' ' A' ' 744' ' ' CYS . 23.3 tp -93.82 123.37 37.12 Favored 'General case' 0 C--N 1.255 -3.522 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.073 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 5.0 pt-20 -34.24 -53.43 0.49 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.215 1.806 . . . . 0.0 115.545 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.456 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 82.4 m-70 -135.98 27.83 3.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -128.7 -149.96 7.07 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 119.605 -1.284 . . . . 0.0 112.096 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -146.23 175.04 10.8 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.12 133.55 49.71 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 14.0 mm100 -74.42 -61.76 1.76 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.054 0.454 . . . . 0.0 111.4 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.7 tt -169.65 138.29 1.86 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 103.486 -2.783 . . . . 0.0 103.486 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.551 ' HA ' HG12 ' A' ' 715' ' ' VAL . 59.2 p -115.59 -41.76 3.21 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -169.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 33.5 m 62.3 95.58 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 125.094 1.358 . . . . 0.0 113.887 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.15 172.55 13.75 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.297 1.998 . . . . 0.0 108.745 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.484 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 16.5 Cg_exo -71.16 -5.15 10.96 Favored 'Cis proline' 0 N--CA 1.506 2.226 0 CA-C-N 120.825 1.33 . . . . 0.0 115.27 4.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 56.9 m-85 78.98 69.99 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 O-C-N 124.876 1.36 . . . . 0.0 109.154 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.484 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 58.3 m-85 -77.46 170.4 16.63 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.941 -1.482 . . . . 0.0 112.589 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -73.39 129.63 38.41 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.053 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.48 -4.87 51.26 Favored Glycine 0 N--CA 1.421 -2.363 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.352 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.86 151.19 26.12 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 120.878 0.371 . . . . 0.0 110.924 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 3.8 m -131.29 156.07 46.08 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.573 HG23 HG22 ' A' ' 694' ' ' ILE . 52.7 t -137.64 129.74 40.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 47.0 mt-10 -77.35 134.46 38.47 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 123.988 0.805 . . . . 0.0 111.038 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.546 ' HB3' HD23 ' A' ' 697' ' ' LEU . 35.8 m-85 -139.94 112.94 8.16 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 125.026 1.33 . . . . 0.0 107.584 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -121.07 -164.51 1.13 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 7.1 m -109.7 133.84 52.66 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 2.4 m -53.07 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.751 0.82 . . . . 0.0 111.137 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 722' ' ' SER . 12.7 pt-20 -169.31 158.73 8.34 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 176.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 66.0 m 69.73 13.36 8.12 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.203 0.939 . . . . 0.0 111.563 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.717 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.4 m-85 -143.74 145.14 32.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 C-N-CA 124.733 1.213 . . . . 0.0 107.752 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.478 ' HB ' HD13 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -113.74 136.41 52.88 Favored 'General case' 0 C--N 1.257 -3.44 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.988 -177.016 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.472 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.2 ttp -81.76 120.22 24.86 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.848 1.259 . . . . 0.0 109.516 -175.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.549 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 45.4 mm -113.1 121.25 64.96 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.222 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 87.49 -82.13 1.61 Allowed Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 114.856 -1.065 . . . . 0.0 114.121 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.7 m80 -114.3 173.9 6.22 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 123.797 0.839 . . . . 0.0 110.569 -173.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.472 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -146.14 15.95 1.35 Allowed 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 121.276 0.56 . . . . 0.0 109.647 172.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 37.5 m -152.59 162.1 41.68 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 121.554 -0.716 . . . . 0.0 110.291 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.5 pt -123.84 162.23 25.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.299 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.7 m -133.31 134.18 43.52 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 123.522 0.514 . . . . 0.0 110.841 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 5.0 t -85.24 106.42 16.65 Favored 'General case' 0 C--O 1.256 1.429 0 CA-C-O 121.694 0.759 . . . . 0.0 109.389 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.402 ' O ' HD12 ' A' ' 734' ' ' ILE . 1.3 pp -138.32 142.17 35.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.618 -177.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 72.87 -53.47 0.7 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.726 1.21 . . . . 0.0 111.367 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 160.39 26.29 0.02 OUTLIER Glycine 0 C--N 1.288 -2.117 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 24.2 t -151.25 154.4 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 -173.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -78.98 -178.85 6.31 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 18.3 p -84.69 -158.5 0.35 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.347 0.594 . . . . 0.0 112.253 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.532 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.3 pp0? -81.56 -11.45 59.15 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.4 mm? 72.17 137.69 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 30.8 Cg_endo -66.07 -179.44 1.41 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.773 2.315 . . . . 0.0 112.729 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . 0.549 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 53.3 tt0 -124.45 137.75 54.41 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.557 ' SG ' HD21 ' A' ' 697' ' ' LEU . 58.6 m -123.92 98.75 5.94 Favored 'General case' 0 CA--C 1.466 -2.273 0 CA-C-O 121.586 0.708 . . . . 0.0 109.642 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.537 ' C ' ' H ' ' A' ' 747' ' ' ILE . 32.1 t -86.85 140.73 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.059 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.717 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.14 4.83 0.61 Allowed 'General case' 0 C--N 1.274 -2.704 0 C-N-CA 125.188 1.395 . . . . 0.0 114.112 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.889 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 32.3 mt 75.62 -17.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 125.626 1.57 . . . . 0.0 111.428 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 746' ' ' ALA . 8.4 t70 -76.64 -32.35 57.96 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 125.671 1.588 . . . . 0.0 109.124 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -103.63 12.51 34.79 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.216 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.889 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 67.5 mt -76.77 148.82 36.43 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.39 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -90.04 -170.25 2.72 Favored 'General case' 0 C--N 1.261 -3.269 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.011 -172.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -120.26 126.8 51.5 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 113.352 -1.749 . . . . 0.0 106.477 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 35.9 m -87.77 150.59 23.48 Favored 'General case' 0 C--N 1.249 -3.763 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.061 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -116.81 139.84 50.12 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 755' ' ' SER . . . . . 0.44 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 14.7 p -61.54 139.58 58.23 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.237 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.613 ' HB2' HG13 ' A' ' 759' ' ' ILE . 20.3 m -78.02 149.21 34.06 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -91.95 7.95 39.76 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 112.223 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 803' ' ' CYS . 4.3 mm? -106.98 -9.72 16.17 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.873 174.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.613 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.7 pp -109.0 152.11 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.74 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . 0.445 ' HB ' ' CG ' ' A' ' 780' ' ' ARG . 3.5 mp -109.18 131.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.752 HD12 ' HZ ' ' A' ' 771' ' ' PHE . 44.9 mt -103.63 178.82 4.45 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.51 168.7 8.68 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.26 -22.29 64.69 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.752 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -79.98 -42.3 24.19 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.594 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 35.0 mt -83.03 -19.78 36.29 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.003 -1.908 . . . . 0.0 113.102 -167.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -70.81 -6.38 37.42 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.352 0.596 . . . . 0.0 111.121 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.48 15.38 27.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 6.2 tppt? -122.61 105.87 10.48 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -75.78 -45.6 35.35 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -125.14 131.31 53.27 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.048 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.752 ' HZ ' HD12 ' A' ' 761' ' ' LEU . 40.2 m-85 -103.0 164.89 11.34 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.448 -175.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -104.74 142.14 35.23 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.336 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.423 ' HA ' ' SG ' ' A' ' 792' ' ' CYS . 32.6 p-80 -41.37 140.1 0.93 Allowed 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.825 1.25 . . . . 0.0 113.716 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 25.1 m120 70.4 23.25 4.99 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 125.171 1.389 . . . . 0.0 112.965 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 22.0 t -96.11 121.75 38.22 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.458 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -92.7 104.11 16.41 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.594 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.5 pt -114.15 -173.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.972 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 1.6 ptt180 -143.77 127.93 17.63 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.0 174.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.478 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 6.8 p90 -117.22 174.94 5.84 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 177.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . 0.445 ' CG ' ' HB ' ' A' ' 760' ' ' ILE . 10.6 ptm180 -153.87 170.58 20.66 Favored 'General case' 0 N--CA 1.407 -2.62 0 O-C-N 124.374 1.047 . . . . 0.0 108.447 177.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 49.7 t -100.47 161.46 13.59 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -73.74 -21.51 60.18 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.938 0.399 . . . . 0.0 109.942 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -93.03 -4.99 64.45 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.214 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 13.7 mptt -120.8 107.9 13.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . 0.409 ' HA ' ' NH2' ' A' ' 780' ' ' ARG . 12.2 tp10 -81.93 99.9 9.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 160.09 -165.91 34.94 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 107.665 -2.174 . . . . 0.0 107.665 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 61.4 m95 -139.72 146.62 39.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.64 1.22 . . . . 0.0 109.665 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.478 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -100.29 -34.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.456 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 12.8 m170 77.24 135.15 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.622 1.169 . . . . 0.0 110.452 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.44 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.8 t -158.57 157.58 32.27 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.091 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.5 136.84 55.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . 0.423 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 45.8 t -71.23 107.53 4.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.631 0.729 . . . . 0.0 109.482 177.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.3 mm -113.89 83.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.165 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.42 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.589 HD21 ' HA ' ' A' ' 750' ' ' LEU . 25.3 t-20 58.76 66.34 1.08 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 122.403 1.097 . . . . 0.0 111.175 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 62.03 24.31 64.81 Favored Glycine 0 C--N 1.299 -1.478 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.488 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -145.02 166.27 25.79 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -111.67 158.08 19.7 Favored 'General case' 0 C--N 1.255 -3.54 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -148.32 107.02 3.59 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.36 142.54 66.8 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.971 -1.262 . . . . 0.0 113.074 0.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -55.54 117.03 3.23 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.406 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.44 ' CG1' HG21 ' A' ' 790' ' ' THR . 7.2 m -70.11 138.2 22.5 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.171 0 C-N-CA 124.667 1.187 . . . . 0.0 112.519 -173.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -153.66 138.76 17.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.566 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 758' ' ' LEU . 49.7 t -125.22 -22.92 4.28 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.975 0.893 . . . . 0.0 108.886 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.423 -1.808 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.482 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 13.7 m -93.81 -167.39 1.68 Allowed 'General case' 0 C--N 1.25 -3.735 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . -118.12 -156.23 10.22 Favored Glycine 1 N--CA 1.39 -4.386 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.19 142.36 57.7 Favored 'General case' 0 C--N 1.278 -2.507 0 O-C-N 124.717 0.892 . . . . 0.0 108.753 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.587 HG21 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -63.68 151.7 87.96 Favored Pre-proline 0 C--N 1.284 -2.25 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.928 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.454 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 55.8 Cg_endo -71.14 -162.15 0.1 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.074 2.516 . . . . 0.0 112.925 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.17 158.84 43.45 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.534 HD11 ' HA3' ' A' ' 700' ' ' GLY . 0.8 OUTLIER -98.28 134.61 41.07 Favored 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.583 177.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -56.24 -37.97 70.47 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -144.65 29.54 1.24 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.534 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -140.0 -138.92 3.68 Favored Glycine 0 C--N 1.305 -1.141 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.074 -176.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.09 179.83 8.68 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.394 0.678 . . . . 0.0 109.403 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -114.22 144.58 42.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -71.41 -68.31 0.46 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.353 0.597 . . . . 0.0 110.861 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.9 tt -162.87 133.4 4.65 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.467 ' OG ' HG12 ' A' ' 694' ' ' ILE . 0.4 OUTLIER -137.1 114.0 10.51 Favored 'General case' 0 N--CA 1.401 -2.88 0 CA-C-O 121.747 0.784 . . . . 0.0 109.924 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -103.41 124.07 39.42 Favored Pre-proline 0 C--N 1.273 -2.749 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.447 -174.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.429 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 56.8 Cg_endo -66.45 172.49 9.03 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.495 2.13 . . . . 0.0 109.628 175.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.506 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.1 Cg_exo -75.21 -4.36 21.2 Favored 'Cis proline' 0 CA--C 1.497 -1.343 0 CA-C-N 119.801 0.965 . . . . 0.0 114.487 5.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.438 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 57.7 m-85 74.74 78.73 0.11 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 124.936 1.398 . . . . 0.0 108.488 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.506 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 22.4 m-85 -82.41 172.13 13.4 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -73.75 125.85 29.04 Favored 'General case' 0 CA--C 1.485 -1.523 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.29 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.75 -5.91 51.48 Favored Glycine 0 N--CA 1.411 -3.001 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.086 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.84 154.06 42.48 Favored 'General case' 0 C--O 1.251 1.179 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 19.8 m -140.21 143.64 36.15 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.846 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.587 HG21 HG21 ' A' ' 694' ' ' ILE . 47.0 t -131.54 137.08 56.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -85.84 135.21 33.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.966 0.889 . . . . 0.0 109.52 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -134.76 114.95 13.17 Favored 'General case' 0 C--N 1.268 -2.96 0 C-N-CA 126.395 1.878 . . . . 0.0 108.069 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -120.84 -165.71 1.25 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 4.6 m -115.62 134.73 54.77 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.3 m -56.95 -80.5 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 O-C-N 124.166 0.916 . . . . 0.0 111.256 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 722' ' ' SER . 48.0 mt-10 -154.16 161.35 41.92 Favored 'General case' 0 CA--C 1.472 -2.047 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.484 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 58.0 m 70.63 7.24 6.14 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 124.723 1.264 . . . . 0.0 111.948 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.625 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.1 m-85 -139.72 144.56 37.56 Favored 'General case' 0 N--CA 1.4 -2.956 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.1 m -113.07 140.7 47.64 Favored 'General case' 0 C--N 1.246 -3.908 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.637 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.2 ttp -85.86 115.88 23.77 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.533 1.133 . . . . 0.0 108.853 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.0 mm -113.15 130.17 67.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.419 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 87.84 -74.65 2.17 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.914 -1.039 . . . . 0.0 114.164 173.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -128.03 174.35 9.28 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -174.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.557 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -140.44 10.51 2.29 Favored 'General case' 0 C--O 1.201 -1.47 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 1.6 m -141.59 168.35 19.99 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.2 pt -129.32 161.09 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 732' ' ' THR . . . . . 0.502 ' O ' HG22 ' A' ' 739' ' ' THR . 5.8 m -135.85 139.17 43.19 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 44.0 t -94.22 116.24 28.62 Favored 'General case' 0 N--CA 1.407 -2.611 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.336 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.3 pp -144.26 147.43 19.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 C-N-CA 125.403 1.481 . . . . 0.0 108.168 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 64.18 15.04 9.07 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 86.59 17.59 59.95 Favored Glycine 0 CA--C 1.505 -0.546 0 C-N-CA 121.628 -0.32 . . . . 0.0 112.84 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.2 p -153.06 156.97 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.454 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 88.7 m95 -78.98 169.11 18.71 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 120.988 0.423 . . . . 0.0 110.16 175.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 732' ' ' THR . 21.8 p -73.48 -163.35 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.995 0.902 . . . . 0.0 112.845 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.46 ' H ' ' NE2' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -73.03 -12.95 61.11 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 124.772 1.229 . . . . 0.0 113.831 -170.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.4 mm? 73.28 149.96 0.13 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 123.921 0.763 . . . . 0.0 111.025 -175.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.57 175.87 10.09 Favored 'Trans proline' 0 C--O 1.253 1.231 0 C-N-CA 121.761 1.64 . . . . 0.0 110.96 173.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -126.47 107.58 10.39 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 724' ' ' THR . 86.9 m -91.0 113.27 25.49 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.078 175.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.499 ' C ' ' H ' ' A' ' 747' ' ' ILE . 49.6 t -100.58 144.08 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.34 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.625 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.02 6.8 0.34 Allowed 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 125.973 1.709 . . . . 0.0 114.313 -175.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.85 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 55.4 mt 75.15 -19.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 125.663 1.585 . . . . 0.0 112.03 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.5 t70 -73.39 -34.09 65.35 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.671 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.44 ' HB3' ' HE3' ' A' ' 749' ' ' LYS . 0.0 OUTLIER -114.11 29.93 7.65 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.859 -175.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.85 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 91.1 mt -83.32 -175.72 5.97 Favored 'General case' 0 N--CA 1.407 -2.609 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -105.92 147.09 29.17 Favored 'General case' 0 N--CA 1.384 -3.768 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 770' ' ' GLU . 22.4 mtpp -103.25 122.56 45.02 Favored 'General case' 1 C--N 1.237 -4.32 0 CA-C-N 113.041 -1.891 . . . . 0.0 108.65 -174.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 60.9 m -70.96 150.12 46.0 Favored 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.44 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -112.37 143.89 42.72 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.314 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 4.4 p -67.23 118.06 10.1 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.644 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.417 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 43.2 t -79.37 153.82 29.47 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -100.82 0.45 38.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.084 0.469 . . . . 0.0 111.595 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 6.4 mp -91.43 -8.49 47.69 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.049 0.928 . . . . 0.0 108.573 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.496 HG12 ' CG1' ' A' ' 801' ' ' VAL . 2.8 pp -118.45 169.73 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.649 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . 0.546 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.5 mp -119.44 124.88 73.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.799 HD11 ' HZ ' ' A' ' 771' ' ' PHE . 96.2 mt -97.47 179.24 4.93 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.15 167.73 13.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.385 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -12.38 61.6 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 4.6 p-80 -100.64 -10.99 20.38 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.531 175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.535 HD13 ' HB ' ' A' ' 777' ' ' ILE . 74.7 mt -110.4 -19.44 12.96 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -69.86 -12.74 61.85 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.755 0.788 . . . . 0.0 110.274 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -101.96 11.23 38.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.734 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . 0.432 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 14.4 tppt? -104.5 108.44 19.88 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -36.7 68.6 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.185 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 752' ' ' LYS . 43.3 mt-10 -144.41 133.4 22.69 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.898 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.799 ' HZ ' HD11 ' A' ' 761' ' ' LEU . 71.7 m-85 -103.56 149.04 25.26 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -92.39 159.08 15.73 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.14 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.626 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 31.8 t60 -62.21 140.78 58.45 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.037 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 89.17 3.26 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.957 1.703 . . . . 0.0 109.972 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 74.9 m -83.35 114.08 21.18 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.505 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.428 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -88.25 113.47 23.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.848 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.535 ' HB ' HD13 ' A' ' 765' ' ' LEU . 4.8 pt -126.98 -173.83 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.521 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 30.4 ptt180 -143.17 127.38 17.59 Favored 'General case' 0 N--CA 1.413 -2.278 0 O-C-N 122.165 -0.334 . . . . 0.0 110.173 173.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.681 ' CD2' HG13 ' A' ' 801' ' ' VAL . 11.0 p90 -108.74 170.92 7.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 174.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . 0.546 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 9.3 ptt180 -146.66 155.44 42.43 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 173.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . . . . . . . . . 14.0 t -83.81 155.36 23.03 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -76.03 -5.74 47.81 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.624 0.726 . . . . 0.0 110.568 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -102.34 -10.13 39.7 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.074 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -122.07 125.04 45.36 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.084 -0.656 . . . . 0.0 111.697 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.65 79.9 4.8 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 122.073 0.939 . . . . 0.0 108.625 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 173.08 153.2 9.31 Favored Glycine 0 C--N 1.299 -1.494 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 40.4 m95 -101.58 164.86 11.54 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 117.085 0.443 . . . . 0.0 110.192 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.403 HD11 ' N ' ' A' ' 788' ' ' ILE . 3.6 mp -115.25 -34.03 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.343 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.433 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 31.6 m170 76.18 121.35 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 124.493 1.117 . . . . 0.0 109.45 -173.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.469 HG22 ' CG2' ' A' ' 801' ' ' VAL . 3.5 t -141.92 155.89 45.49 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.13 134.07 61.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 46.9 t -68.96 119.66 13.63 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.626 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 49.5 mm -119.54 86.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 C-N-CA 124.774 1.23 . . . . 0.0 108.694 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 45.69 72.17 0.24 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.567 1.147 . . . . 0.0 112.233 177.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 68.16 19.66 72.32 Favored Glycine 0 C--N 1.3 -1.424 0 CA-C-N 115.05 -0.977 . . . . 0.0 114.178 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -144.52 165.13 28.84 Favored 'General case' 0 C--O 1.19 -2.043 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.6 m95 -111.6 160.41 17.23 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 121.735 -0.603 . . . . 0.0 110.225 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -149.29 105.77 3.33 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.76 139.91 50.96 Favored 'Cis proline' 0 C--O 1.245 0.835 0 C-N-CA 123.842 -1.316 . . . . 0.0 110.508 -0.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.556 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.3 tt0 -56.27 125.27 21.07 Favored 'General case' 0 N--CA 1.432 -1.334 0 O-C-N 123.684 0.615 . . . . 0.0 111.153 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.681 HG13 ' CD2' ' A' ' 779' ' ' TYR . 93.9 t -65.89 108.77 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.249 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -144.62 127.1 15.96 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . 0.418 ' HB2' HG21 ' A' ' 759' ' ' ILE . 47.5 t -98.84 -33.48 10.87 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.439 -0.975 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.806 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.414 -2.266 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 40.4 m -84.59 -76.36 0.31 Allowed 'General case' 0 C--N 1.254 -3.582 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.321 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 149.09 -177.29 27.41 Favored Glycine 1 N--CA 1.358 -6.558 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -51.61 130.12 27.37 Favored 'General case' 0 C--N 1.278 -2.525 0 O-C-N 125.588 1.405 . . . . 0.0 109.946 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.612 HG21 HG23 ' A' ' 715' ' ' VAL . 1.6 pp -60.01 150.25 70.71 Favored Pre-proline 0 N--CA 1.432 -1.352 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.915 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.514 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.0 Cg_endo -71.84 -163.51 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 122.86 2.374 . . . . 0.0 111.471 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -135.74 156.51 48.7 Favored 'General case' 0 N--CA 1.402 -2.871 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.501 HD11 ' HA3' ' A' ' 700' ' ' GLY . 1.1 mt -88.56 144.65 26.19 Favored 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.358 177.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.42 -41.09 93.24 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.413 ' HB2' ' O ' ' A' ' 744' ' ' CYS . 93.6 m-70 -146.84 32.2 0.94 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.501 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -141.72 -149.65 5.24 Favored Glycine 0 C--N 1.3 -1.434 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.775 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -148.38 -179.35 6.89 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -112.58 144.63 41.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.464 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 39.3 mm-40 -73.98 -67.71 0.58 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.33 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 68.5 tp -158.2 125.45 5.02 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.49 ' CB ' HG12 ' A' ' 694' ' ' ILE . 5.5 p -118.52 132.29 56.22 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 22.9 t -121.72 112.97 32.01 Favored Pre-proline 0 C--N 1.288 -2.098 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.999 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.33 165.62 26.27 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.143 1.896 . . . . 0.0 108.642 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.521 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 16.9 Cg_exo -67.81 -10.63 8.59 Favored 'Cis proline' 0 N--CA 1.498 1.759 0 N-CA-C 115.194 1.19 . . . . 0.0 115.194 5.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.487 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 61.9 m-85 74.07 87.04 0.1 Allowed 'General case' 0 C--N 1.309 -1.17 0 O-C-N 124.65 1.219 . . . . 0.0 108.044 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.556 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 50.3 m-85 -90.98 172.54 8.51 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.686 -176.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -71.45 138.51 49.1 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.255 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.77 77.78 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . 0.556 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 2.5 t70 -77.34 165.79 23.99 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 20.2 m -151.86 142.41 22.67 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.612 HG23 HG21 ' A' ' 694' ' ' ILE . 44.8 t -133.56 134.37 56.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 39.1 mt-10 -80.51 135.67 36.15 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 123.896 0.748 . . . . 0.0 111.426 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -136.61 114.3 11.13 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 125.837 1.655 . . . . 0.0 107.471 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -124.06 -163.0 1.11 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 10.0 m -108.16 144.23 35.86 Favored 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' SER . . . . . 0.598 ' O ' ' HG3' ' A' ' 721' ' ' GLU . 5.1 m -55.81 -70.43 0.11 Allowed 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.769 0.668 . . . . 0.0 109.872 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . 0.598 ' HG3' ' O ' ' A' ' 720' ' ' SER . 30.7 mt-10 -175.22 164.39 3.25 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 129.279 3.031 . . . . 0.0 102.822 173.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 62.6 m 68.51 12.56 8.75 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.993 0.808 . . . . 0.0 111.509 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.728 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.8 m-85 -143.74 147.96 34.96 Favored 'General case' 0 N--CA 1.407 -2.615 0 C-N-CA 124.83 1.252 . . . . 0.0 108.11 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.46 HG22 HD21 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -112.93 135.27 53.89 Favored 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.996 -177.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.707 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.8 ttp -85.06 113.26 21.34 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 124.93 1.292 . . . . 0.0 109.758 -177.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 793' ' ' ILE . 45.3 mm -115.27 131.3 67.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.336 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 94.57 -91.34 1.4 Allowed Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.772 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.531 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.1 m80 -114.34 178.42 4.29 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 114.508 -0.846 . . . . 0.0 110.357 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.707 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -144.92 14.21 1.5 Allowed 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 168.2 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 33.9 m -149.18 162.41 40.05 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 714' ' ' SER . 28.8 pt -121.1 166.73 15.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 732' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 739' ' ' THR . 3.8 m -135.75 139.94 43.96 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 43.3 t -99.82 116.91 32.99 Favored 'General case' 0 N--CA 1.406 -2.634 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.47 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.426 ' C ' ' H ' ' A' ' 736' ' ' GLY . 1.2 pp -142.82 149.29 18.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-N 114.004 -1.453 . . . . 0.0 107.444 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 734' ' ' ILE . 52.3 m-70 73.74 -21.83 0.26 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.662 0.785 . . . . 0.0 112.087 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 734' ' ' ILE . . . 120.24 14.27 5.53 Favored Glycine 0 CA--C 1.505 -0.542 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.3 p -148.53 150.53 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.514 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.8 m95 -77.2 169.25 18.66 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.467 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 732' ' ' THR . 24.9 p -77.23 -160.8 0.18 Allowed 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.67 0.748 . . . . 0.0 112.396 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.0 OUTLIER -84.69 -12.86 53.0 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.991 -168.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 0.9 OUTLIER 70.81 159.32 0.16 Allowed Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 124.009 0.818 . . . . 0.0 112.237 -177.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.531 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 37.6 Cg_endo -75.13 178.9 6.68 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.241 1.961 . . . . 0.0 112.155 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -122.91 101.33 7.37 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.023 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.423 ' SG ' HD11 ' A' ' 697' ' ' LEU . 73.1 m -84.59 112.4 20.4 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-O 121.094 0.474 . . . . 0.0 110.58 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.467 ' C ' ' H ' ' A' ' 747' ' ' ILE . 22.5 t -99.72 144.04 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.728 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.33 1.16 0.81 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 125.08 1.352 . . . . 0.0 114.254 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.631 ' HB ' ' O ' ' A' ' 746' ' ' ALA . 34.5 mt 76.54 -18.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 124.991 1.317 . . . . 0.0 110.971 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.0 t70 -77.84 -23.82 48.81 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 125.884 1.673 . . . . 0.0 109.203 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -110.89 18.95 19.02 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.586 -1.643 . . . . 0.0 108.842 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.85 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 3.1 mp -85.7 -176.8 6.19 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.859 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . 0.454 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 53.1 mtpt -140.48 164.92 28.84 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -109.02 140.39 42.61 Favored 'General case' 0 C--N 1.257 -3.423 0 C-N-CA 126.021 1.728 . . . . 0.0 108.256 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 59.8 m -88.01 165.06 15.45 Favored 'General case' 1 C--N 1.239 -4.238 0 CA-C-N 114.106 -1.407 . . . . 0.0 109.147 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 754' ' ' LYS . 17.4 ptpt -132.77 147.62 52.32 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.988 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.18 114.04 3.53 Favored 'General case' 0 C--N 1.27 -2.875 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.916 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.626 ' HB2' ' CG1' ' A' ' 759' ' ' ILE . 55.9 m -72.98 149.78 43.03 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -80.08 -9.24 59.69 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.887 0.851 . . . . 0.0 110.458 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.83 -11.92 40.63 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.402 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.626 ' CG1' ' HB2' ' A' ' 756' ' ' SER . 2.4 pp -118.06 140.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.401 -173.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.1 mp -104.39 131.21 53.83 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.53 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 2.1 mm? -108.56 -177.79 3.41 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 120.845 0.355 . . . . 0.0 110.114 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -71.48 167.61 19.28 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -57.86 -17.54 16.98 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.054 0.941 . . . . 0.0 112.639 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -85.62 -42.1 14.63 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.645 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 66.7 mt -85.65 -15.42 42.45 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 113.452 -1.704 . . . . 0.0 112.652 -169.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -73.96 -13.81 60.94 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.472 0.653 . . . . 0.0 110.508 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -96.51 0.33 50.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.335 1.064 . . . . 0.0 108.459 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . 0.412 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 8.7 tppt? -103.08 118.48 36.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -96.76 -19.85 18.64 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -136.25 122.7 20.73 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.283 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.48 ' HZ ' ' HG ' ' A' ' 761' ' ' LEU . 76.1 m-85 -98.96 142.56 30.31 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -87.71 148.2 24.87 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.954 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.51 ' CB ' HD22 ' A' ' 750' ' ' LEU . 47.1 p-80 -42.47 141.7 0.95 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.359 1.463 . . . . 0.0 111.259 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 63.6 t30 75.57 2.42 3.78 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.026 1.33 . . . . 0.0 111.825 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 18.2 t -82.24 118.49 23.15 Favored 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 121.292 -0.88 . . . . 0.0 108.666 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.449 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -87.81 106.22 17.93 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.159 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.645 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.6 pt -115.97 -170.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.556 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 7.1 ptp180 -150.82 134.99 16.86 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.532 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 8.1 p90 -119.15 173.52 6.87 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' A' ' 785' ' ' GLU . 10.5 ptt180 -155.4 169.82 23.36 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 59.3 m -97.79 164.31 12.44 Favored 'General case' 0 C--N 1.282 -2.341 0 O-C-N 123.876 0.735 . . . . 0.0 109.093 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . 0.413 ' HD2' ' H ' ' A' ' 782' ' ' ARG . 0.0 OUTLIER -66.72 -36.95 83.69 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.854 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -98.35 5.18 60.64 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.404 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.606 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.0 mptt -127.65 105.15 8.28 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 780' ' ' ARG . 35.9 tt0 -90.58 78.88 6.21 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.879 0.847 . . . . 0.0 109.952 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -164.1 144.58 9.56 Favored Glycine 0 CA--C 1.472 -2.636 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.556 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 38.5 m95 -101.66 131.61 47.81 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 117.405 0.602 . . . . 0.0 109.992 -174.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.532 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -87.87 -30.5 5.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.757 -174.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 15.3 m170 71.53 125.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.549 1.14 . . . . 0.0 109.119 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 3.4 t -147.9 155.6 41.77 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 122.196 -0.315 . . . . 0.0 110.438 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.58 135.69 57.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 53.6 t -72.92 114.08 10.66 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.845 0.831 . . . . 0.0 110.342 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.507 HG21 HD12 ' A' ' 726' ' ' ILE . 50.9 mm -115.29 80.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 C-N-CA 124.501 1.121 . . . . 0.0 108.713 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.85 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 1.0 OUTLIER 52.08 64.64 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.464 176.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.61 22.53 78.31 Favored Glycine 0 C--N 1.308 -0.996 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.576 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -147.28 164.18 34.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.55 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.0 m95 -111.75 159.56 18.15 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-O 120.581 0.229 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -149.19 103.79 3.33 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.13 141.57 71.08 Favored 'Cis proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.876 -1.302 . . . . 0.0 113.602 -0.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 2.9 mm-40 -53.32 127.73 25.76 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.138 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 759' ' ' ILE . 3.2 m -84.17 138.75 18.64 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.362 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.997 -176.269 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -165.77 135.88 3.51 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 759' ' ' ILE . 58.1 m -142.64 34.33 1.43 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 17.8 p . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.285 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.42 -1.937 0 CA-C-O 120.971 0.415 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 39.0 m -80.62 -66.23 0.91 Allowed 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.54 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 128.37 -177.54 17.66 Favored Glycine 1 N--CA 1.367 -5.917 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -34.14 128.36 0.4 Allowed 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 127.023 2.129 . . . . 0.0 112.727 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.665 HG22 HG22 ' A' ' 715' ' ' VAL . 1.5 pp -61.82 150.29 82.82 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.163 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.419 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 57.0 Cg_endo -72.17 -159.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.684 2.256 . . . . 0.0 111.74 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . 0.449 ' HA ' ' HE2' ' A' ' 717' ' ' PHE . 10.8 pt-20 -134.15 -173.29 3.22 Favored 'General case' 0 N--CA 1.401 -2.884 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 175.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.529 HD23 ' HB3' ' A' ' 717' ' ' PHE . 22.0 tp -128.6 126.0 39.36 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-O 120.872 0.368 . . . . 0.0 110.384 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -49.44 -37.9 27.47 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.4 m-70 -137.09 24.68 3.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -141.79 -146.76 4.74 Favored Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.21 -0.995 . . . . 0.0 110.846 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . 0.408 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.01 179.21 8.25 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.704 0.288 . . . . 0.0 110.324 -177.234 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -112.49 143.41 43.68 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.2 -75.54 0.17 Allowed 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.241 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.7 tt -176.46 132.17 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.441 ' HB2' HG13 ' A' ' 715' ' ' VAL . 9.9 t -154.23 146.96 24.25 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 10.1 t -117.07 149.14 43.73 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.532 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 59.4 Cg_endo -65.97 174.54 5.64 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.61 2.207 . . . . 0.0 110.454 177.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.532 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.8 Cg_endo -79.95 -4.18 40.5 Favored 'Cis proline' 0 C--O 1.215 -0.633 0 CA-C-N 119.799 0.964 . . . . 0.0 114.541 4.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.44 ' CD2' ' HA ' ' A' ' 707' ' ' PRO . 77.1 m-85 68.92 79.32 0.21 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.326 0.584 . . . . 0.0 110.262 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.487 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 30.1 m-85 -83.56 170.81 13.97 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 0.455 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 44.0 m-85 -68.46 137.11 54.19 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.322 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.9 -5.38 68.99 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.3 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 2.9 t70 -71.14 157.59 37.9 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 20.2 m -149.22 139.36 22.17 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.665 HG22 HG22 ' A' ' 694' ' ' ILE . 41.0 t -130.48 140.93 47.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.033 -174.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 729' ' ' ARG . 1.6 mp0 -80.2 131.79 35.76 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 122.168 0.985 . . . . 0.0 112.872 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.529 ' HB3' HD23 ' A' ' 697' ' ' LEU . 32.1 m-85 -135.89 107.96 7.19 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 113.608 -1.633 . . . . 0.0 107.297 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.408 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 9.0 m-80 -115.51 -163.46 0.89 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 8.3 m -116.06 134.91 54.45 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 3.2 m -58.04 -70.87 0.12 Allowed 'General case' 0 C--N 1.288 -2.094 0 O-C-N 124.163 0.914 . . . . 0.0 111.87 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 722' ' ' SER . 14.4 pt-20 -164.33 161.37 21.72 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 74.9 m 69.84 2.75 3.99 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.995 0.81 . . . . 0.0 112.847 178.288 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.619 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.5 m-85 -137.5 148.75 46.26 Favored 'General case' 0 N--CA 1.401 -2.892 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.481 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -115.08 141.91 47.36 Favored 'General case' 0 C--N 1.259 -3.336 0 C-N-CA 124.991 1.316 . . . . 0.0 109.996 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.553 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.8 ttp -85.84 120.71 27.56 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 124.071 0.948 . . . . 0.0 109.826 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.414 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 43.2 mm -111.82 122.18 65.68 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.763 174.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 114.15 -94.86 0.71 Allowed Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.966 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 53.0 t60 -156.97 139.1 14.55 Favored 'General case' 0 CA--C 1.472 -2.054 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.553 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -85.71 25.76 1.04 Allowed 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 15.4 m -143.87 156.24 44.39 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.776 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 714' ' ' SER . 41.2 pt -118.65 160.58 18.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.419 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 732' ' ' THR . . . . . 0.462 ' O ' HG22 ' A' ' 739' ' ' THR . 20.1 m -134.02 135.87 43.68 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.973 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.3 t -85.65 104.07 15.05 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.8 pp -146.65 144.18 20.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 124.034 0.934 . . . . 0.0 110.246 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 67.85 8.16 6.25 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 94.51 20.28 29.96 Favored Glycine 0 CA--C 1.5 -0.844 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.376 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.7 p -157.46 158.93 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.419 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 94.5 m95 -78.04 172.71 13.1 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 171.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 25.5 p -76.38 -169.56 1.23 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.976 0.893 . . . . 0.0 112.999 -174.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.56 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.2 pp0? -65.55 -20.64 66.41 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 -173.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 5.6 mt 70.68 138.55 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 124.547 1.154 . . . . 0.0 112.882 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 56.7 Cg_endo -67.04 167.12 20.75 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.363 2.042 . . . . 0.0 112.428 -177.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . 0.414 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.2 tt0 -112.47 102.42 10.53 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.493 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 724' ' ' THR . 89.4 m -82.55 111.19 18.31 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.614 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.507 ' C ' ' H ' ' A' ' 747' ' ' ILE . 48.2 t -99.45 145.35 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.497 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.619 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.67 4.16 0.63 Allowed 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 125.411 1.484 . . . . 0.0 113.716 -175.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.923 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 57.6 mt 76.47 -22.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 126.183 1.793 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 746' ' ' ALA . 12.1 t70 -67.41 -34.86 78.12 Favored 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 126.029 1.732 . . . . 0.0 109.841 -174.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.75 24.12 13.35 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 113.578 -1.647 . . . . 0.0 111.658 -175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.923 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 85.9 mt -78.65 166.01 23.0 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-O 121.644 0.735 . . . . 0.0 109.899 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -91.19 -167.62 1.85 Allowed 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 126.701 2.0 . . . . 0.0 112.408 -171.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . 0.526 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 28.4 mmmt -123.72 134.03 53.77 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 126.357 1.863 . . . . 0.0 106.793 -176.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 0.0 OUTLIER -87.39 -179.47 6.39 Favored 'General case' 0 C--N 1.257 -3.454 0 C-N-CA 125.44 1.496 . . . . 0.0 109.433 -177.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -141.14 137.99 33.14 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.93 -0.481 . . . . 0.0 110.433 -176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 38.9 t -71.79 120.56 17.56 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 172.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.534 ' HB3' HG12 ' A' ' 759' ' ' ILE . 42.9 t -70.33 163.18 27.14 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -96.41 -1.09 48.27 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.95 18.26 19.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.983 0.42 . . . . 0.0 110.71 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.534 HG12 ' HB3' ' A' ' 756' ' ' SER . 23.8 pt -126.41 157.71 36.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.538 0.685 . . . . 0.0 112.07 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . 0.407 HD12 ' HB3' ' A' ' 782' ' ' ARG . 3.2 mp -117.74 132.54 67.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.573 ' HG ' ' HZ ' ' A' ' 771' ' ' PHE . 2.7 mm? -106.94 178.17 4.64 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.521 ' HB2' HD22 ' A' ' 765' ' ' LEU . 47.4 mt-10 -62.01 162.22 9.56 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.97 176.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.7 -11.99 56.58 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.538 0.685 . . . . 0.0 111.264 -176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.31 -0.61 26.1 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.573 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.521 HD22 ' HB2' ' A' ' 762' ' ' GLU . 3.3 mm? -122.97 -12.12 8.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 8.7 mtmp? -62.65 -27.02 68.93 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -88.1 5.71 39.86 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . 0.691 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 19.0 ttmm -101.94 109.92 21.77 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . 0.505 ' HE3' ' HG3' ' A' ' 770' ' ' GLU . 34.6 ttpt -79.46 -37.29 37.24 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.251 1.024 . . . . 0.0 108.444 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . 0.505 ' HG3' ' HE3' ' A' ' 769' ' ' LYS . 41.4 mt-10 -127.92 114.61 17.39 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.438 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.691 ' CD2' ' HD2' ' A' ' 768' ' ' LYS . 82.3 m-85 -88.76 -178.68 5.83 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.972 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -118.68 138.54 52.55 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.59 -175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.744 ' CD2' ' HB2' ' A' ' 750' ' ' LEU . 9.8 p-80 -45.91 146.86 1.1 Allowed 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.642 1.177 . . . . 0.0 112.738 174.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 72.22 10.95 5.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.27 1.028 . . . . 0.0 110.702 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 46.8 t -94.25 127.99 40.45 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.467 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.6 OUTLIER -97.6 111.25 23.6 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.46 HD11 HD13 ' A' ' 761' ' ' LEU . 7.8 pt -118.91 176.46 3.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 121.662 0.744 . . . . 0.0 109.596 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 79.5 mtt180 -122.28 133.29 54.69 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 173.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -128.59 168.33 15.88 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -160.08 163.9 33.51 Favored 'General case' 0 N--CA 1.412 -2.372 0 O-C-N 124.521 1.138 . . . . 0.0 109.281 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 90.7 m -82.48 175.34 10.28 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 123.53 0.519 . . . . 0.0 109.797 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . 0.407 ' HB3' HD12 ' A' ' 760' ' ' ILE . 12.5 ptm180 -91.4 -29.19 17.21 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.936 0.398 . . . . 0.0 110.504 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -92.24 -3.11 67.71 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.791 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.575 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 2.2 mptp? -130.74 107.62 9.29 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.62 149.38 27.44 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 111.45 141.11 8.43 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -174.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 47.4 m95 -98.61 149.8 22.4 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 117.047 0.424 . . . . 0.0 110.746 -171.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.16 -31.7 3.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.06 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 36.7 m170 73.19 118.92 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 124.843 1.257 . . . . 0.0 110.206 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.534 HG22 ' CG1' ' A' ' 801' ' ' VAL . 4.1 t -140.32 158.52 43.9 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.836 -0.54 . . . . 0.0 110.232 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.94 134.48 63.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . 0.525 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 54.0 t -72.19 117.27 13.62 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.533 0.682 . . . . 0.0 110.327 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.07 79.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.48 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.507 ' ND2' ' HA ' ' A' ' 750' ' ' LEU . 24.8 t-20 55.09 71.94 0.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.845 0.831 . . . . 0.0 112.171 171.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 75.26 3.58 70.74 Favored Glycine 0 C--N 1.292 -1.902 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.988 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -136.19 174.58 10.46 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.564 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 97.5 m95 -121.12 159.48 25.71 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -148.3 106.52 3.58 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.92 142.45 73.76 Favored 'Cis proline' 0 C--O 1.244 0.814 0 C-N-CA 123.588 -1.422 . . . . 0.0 112.956 -0.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.564 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 1.9 mm-40 -50.51 126.1 14.48 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 115.096 -0.956 . . . . 0.0 113.118 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.534 ' CG1' HG22 ' A' ' 790' ' ' THR . 3.6 m -84.31 123.55 39.09 Favored 'Isoleucine or valine' 1 N--CA 1.35 -5.462 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.589 -179.069 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 801' ' ' VAL . 2.5 t-20 174.03 132.37 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 5.8 t -98.1 21.12 11.23 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.49 1.138 . . . . 0.0 109.611 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.412 -2.36 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.52 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' THR . . . . . 0.574 HG22 ' HB2' ' A' ' 708' ' ' PRO . 12.4 p . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 23.7 m -72.31 -63.08 1.22 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.059 0.457 . . . . 0.0 110.169 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 131.3 -164.23 23.44 Favored Glycine 1 N--CA 1.356 -6.675 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -45.61 136.8 5.61 Favored 'General case' 0 C--N 1.26 -3.315 0 C-N-CA 126.182 1.793 . . . . 0.0 111.828 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.493 HG23 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -68.7 148.22 98.02 Favored Pre-proline 0 N--CA 1.427 -1.61 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.066 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.508 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 70.9 Cg_endo -72.76 -168.98 0.44 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 123.327 2.685 . . . . 0.0 111.838 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -135.52 143.28 45.69 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.526 HD22 ' HB3' ' A' ' 717' ' ' PHE . 24.5 tp -92.56 123.79 36.11 Favored 'General case' 0 C--N 1.254 -3.552 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.187 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.496 ' HG2' HD13 ' A' ' 697' ' ' LEU . 7.4 pt-20 -30.42 -51.74 0.15 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.319 2.248 . . . . 0.0 115.556 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 78.8 m-70 -136.15 23.39 3.26 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -134.04 -159.11 8.8 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.998 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . 0.431 ' CE2' ' HA ' ' A' ' 720' ' ' SER . 0.4 OUTLIER -141.07 176.34 8.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.692 0.282 . . . . 0.0 111.382 -173.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -111.52 133.66 53.64 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.474 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 53.7 mm-40 -74.42 -73.26 0.24 Allowed 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . 0.415 HD22 ' N ' ' A' ' 705' ' ' SER . 7.0 tt -161.3 139.63 9.58 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.474 -177.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.696 ' HB2' HG23 ' A' ' 715' ' ' VAL . 35.8 t -164.36 -175.7 4.05 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 26.7 p -152.11 140.74 13.71 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.89 167.29 23.68 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 121.798 1.666 . . . . 0.0 109.39 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.585 ' HG2' ' CE1' ' A' ' 710' ' ' TYR . 1.3 Cg_endo -73.74 -1.83 14.62 Favored 'Cis proline' 0 C--O 1.243 0.73 0 N-CA-C 115.201 1.193 . . . . 0.0 115.201 6.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 72.5 m-85 72.55 75.58 0.15 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.39 1.056 . . . . 0.0 109.318 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.585 ' CE1' ' HG2' ' A' ' 708' ' ' PRO . 18.3 m-85 -79.49 169.95 17.3 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.158 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 0.52 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 54.3 m-85 -68.81 133.95 49.02 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.905 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.74 -11.23 60.98 Favored Glycine 0 N--CA 1.426 -1.973 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.463 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 2.4 t70 -68.29 150.82 47.78 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 15.6 m -140.01 142.77 36.24 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 121.196 0.522 . . . . 0.0 109.904 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.696 HG23 ' HB2' ' A' ' 705' ' ' SER . 20.5 t -131.88 127.09 58.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 40.0 mt-10 -71.66 138.22 48.46 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.919 0.39 . . . . 0.0 111.266 174.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.526 ' HB3' HD22 ' A' ' 697' ' ' LEU . 19.7 m-85 -138.19 123.76 19.66 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -136.22 -165.21 1.68 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 9.4 m -115.53 130.23 56.8 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' SER . . . . . 0.431 ' HA ' ' CE2' ' A' ' 701' ' ' TRP . 4.0 m -47.0 -71.98 0.06 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 124.984 1.427 . . . . 0.0 112.09 -172.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 722' ' ' SER . 12.2 pt-20 -169.46 164.61 10.54 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 175.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 66.9 m 66.31 8.23 5.48 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.087 0.867 . . . . 0.0 112.288 -178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.676 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.5 m-85 -141.35 142.69 33.78 Favored 'General case' 0 N--CA 1.412 -2.363 0 C-N-CA 124.141 0.976 . . . . 0.0 108.771 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.499 ' HB ' HD13 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -107.37 133.97 51.12 Favored 'General case' 0 C--N 1.251 -3.713 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.784 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.748 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.3 ttp -87.97 121.17 30.06 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.259 1.024 . . . . 0.0 109.923 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.609 HD11 HG23 ' A' ' 793' ' ' ILE . 49.9 mm -120.16 131.18 73.19 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.714 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.084 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 111.49 -81.46 0.29 Allowed Glycine 0 C--N 1.306 -1.124 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.679 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.579 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 5.9 t60 -150.92 171.45 17.23 Favored 'General case' 0 C--O 1.202 -1.414 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.748 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -131.3 25.75 4.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 73.3 m -157.51 166.84 31.87 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.521 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 39.5 pt -129.91 161.35 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 O-C-N 124.654 1.221 . . . . 0.0 108.216 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 18.6 m -136.55 135.27 38.32 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.76 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.6 t -80.71 107.77 13.8 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.247 0.546 . . . . 0.0 110.499 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 736' ' ' GLY . 1.4 pp -145.89 146.72 19.05 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.229 0 C-N-CA 125.125 1.37 . . . . 0.0 110.051 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . 0.405 ' HD2' ' HB ' ' A' ' 734' ' ' ILE . 19.1 m-70 70.75 -12.93 0.51 Allowed 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 123.603 0.761 . . . . 0.0 111.685 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.47 ' CA ' ' HH ' ' A' ' 711' ' ' TYR . . . 105.0 19.26 10.97 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -175.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 33.2 t -143.1 159.12 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.508 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.6 m95 -86.19 179.0 7.01 Favored 'General case' 0 C--N 1.256 -3.462 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.521 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 25.1 p -76.64 -158.76 0.11 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.558 0.694 . . . . 0.0 112.053 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.502 ' H ' ' NE2' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -83.28 -9.38 59.14 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -165.521 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.2 mm? 71.82 150.59 0.13 Allowed Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 123.11 0.564 . . . . 0.0 111.11 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.579 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 10.9 Cg_exo -68.82 -161.36 0.07 OUTLIER 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.555 2.17 . . . . 0.0 112.292 173.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -142.1 137.65 31.14 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 87.3 m -130.09 107.62 9.46 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.147 0.498 . . . . 0.0 110.78 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.484 ' C ' ' H ' ' A' ' 747' ' ' ILE . 41.1 t -99.52 143.15 13.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.676 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -63.3 2.5 0.38 Allowed 'General case' 0 C--N 1.287 -2.148 0 C-N-CA 126.213 1.805 . . . . 0.0 114.79 -175.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.84 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 59.6 mt 75.48 -16.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 125.302 1.441 . . . . 0.0 111.309 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.535 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.7 t70 -72.54 -35.84 68.14 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.166 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 29.86 7.49 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.336 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.84 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 73.3 mt -86.72 -160.63 0.59 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.432 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . 0.44 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 54.9 mtpt -145.86 168.48 20.71 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -116.77 139.83 50.13 Favored 'General case' 0 C--N 1.271 -2.823 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . 0.472 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 46.4 m -92.01 172.86 8.16 Favored 'General case' 0 C--N 1.249 -3.792 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.681 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -138.0 147.69 44.45 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 9.3 p -64.83 139.66 58.79 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.188 172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.591 ' HB2' HG12 ' A' ' 759' ' ' ILE . 50.7 m -77.92 173.04 12.58 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -97.13 -15.52 20.9 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 121.543 -0.723 . . . . 0.0 111.608 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.27 16.47 24.23 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.774 -0.579 . . . . 0.0 110.542 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.591 HG12 ' HB2' ' A' ' 756' ' ' SER . 11.8 pt -124.27 153.94 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.701 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.57 131.91 65.27 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.4 HD12 HD11 ' A' ' 759' ' ' ILE . 1.9 mm? -108.12 178.01 4.64 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 45.8 mt-10 -65.33 156.68 31.36 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 171.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 766' ' ' LYS 0.256 0.0 OUTLIER -68.51 -11.16 59.48 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 119.214 0.915 . . . . 0.0 112.802 -174.59 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -74.65 -31.73 62.04 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.704 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 64.3 mt -98.21 -25.37 14.9 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.708 -172.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.428 ' HG3' ' HA ' ' A' ' 763' ' ' GLU . 7.0 mtmp? -62.58 -32.17 73.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.338 0.59 . . . . 0.0 110.586 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -91.85 5.36 50.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.993 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . 0.542 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 22.1 ttmm -87.31 -48.97 7.57 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.03 -54.41 0.57 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.038 1.335 . . . . 0.0 111.201 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 768' ' ' LYS . 47.1 mt-10 -113.69 123.75 50.65 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.542 ' CD2' ' HD2' ' A' ' 768' ' ' LYS . 11.4 m-85 -110.96 149.07 31.19 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -173.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.05 156.16 17.06 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.406 ' HD2' ' OG1' ' A' ' 724' ' ' THR . 9.4 p-80 -46.55 149.74 0.76 Allowed 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.57 1.148 . . . . 0.0 112.876 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 1.9 t30 67.9 12.12 8.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.379 1.472 . . . . 0.0 111.823 174.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 775' ' ' SER . . . . . 0.491 ' O ' ' HA ' ' A' ' 791' ' ' VAL . 20.1 p -77.33 110.89 12.45 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.453 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -84.92 93.7 8.6 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.704 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.6 pt -106.01 -177.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.809 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.556 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 76.8 mtt85 -132.47 135.37 45.98 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.495 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 4.7 p90 -131.37 168.63 17.25 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -159.05 164.5 35.38 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 93.8 m -83.56 161.35 21.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.93 -30.24 58.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -172.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -99.49 8.34 60.21 Favored Glycine 0 CA--C 1.499 -0.921 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 4.4 mptp? -119.62 162.53 18.81 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -131.14 162.47 29.84 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 96.92 145.03 18.45 Favored Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -172.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.556 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 54.2 m95 -110.25 139.69 45.17 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 117.339 0.57 . . . . 0.0 110.307 -174.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.495 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.0 mp -87.67 -27.41 5.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.276 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.52 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 24.4 m170 72.45 127.43 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 124.406 1.082 . . . . 0.0 109.673 -176.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.486 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.0 t -149.05 151.77 35.05 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.122 176.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 775' ' ' SER . 39.3 t -113.4 132.83 61.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 C-N-CA 123.611 0.764 . . . . 0.0 110.025 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 35.8 t -70.06 113.93 7.73 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.993 0.901 . . . . 0.0 110.417 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.609 HG23 HD11 ' A' ' 726' ' ' ILE . 47.5 mm -114.64 80.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.268 -2.965 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.544 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.671 ' ND2' HD23 ' A' ' 750' ' ' LEU . 1.1 m120 50.26 68.48 0.75 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.817 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 76.68 11.98 84.84 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.975 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -142.12 170.62 15.37 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -176.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.542 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 95.0 m95 -116.77 161.79 18.71 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -148.45 102.21 3.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 41.8 Cg_endo -71.26 142.23 72.35 Favored 'Cis proline' 0 C--O 1.244 0.777 0 C-N-CA 123.932 -1.278 . . . . 0.0 112.881 -1.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.542 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 24.7 mt-10 -51.13 121.09 5.61 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.989 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.486 ' CG1' HG21 ' A' ' 790' ' ' THR . 5.9 m -76.26 130.6 36.07 Favored 'Isoleucine or valine' 1 N--CA 1.365 -4.709 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.196 -176.249 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -156.96 122.43 4.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 84.5 m -131.12 15.99 5.11 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.422 -1.829 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.518 178.129 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.422 -1.839 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 24.4 m -78.01 -54.1 6.66 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.286 0.565 . . . . 0.0 110.294 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 118.68 -171.81 14.27 Favored Glycine 1 N--CA 1.356 -6.641 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -34.48 122.54 0.51 Allowed 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 126.645 1.978 . . . . 0.0 111.884 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.605 HG22 HG23 ' A' ' 715' ' ' VAL . 1.6 pp -62.93 147.68 93.61 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.247 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.401 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 43.0 Cg_endo -68.15 -167.02 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.777 2.318 . . . . 0.0 112.396 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -133.75 152.24 51.82 Favored 'General case' 0 N--CA 1.384 -3.773 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.492 HD21 ' SG ' ' A' ' 744' ' ' CYS . 22.0 tp -99.74 114.19 27.17 Favored 'General case' 0 C--N 1.258 -3.371 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -43.32 -43.03 4.78 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 114.382 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -130.22 27.31 5.1 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.037 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -142.58 -150.9 5.4 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.645 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . 0.42 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -145.05 174.54 10.96 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -177.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.81 147.99 28.03 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -84.65 -71.54 0.51 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.947 0.403 . . . . 0.0 110.487 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.0 tt -165.88 138.8 4.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.414 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 70.8 p -123.56 -63.95 1.19 Allowed 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 120.766 0.317 . . . . 0.0 110.854 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 32.7 t 71.41 105.96 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 125.301 1.44 . . . . 0.0 111.483 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.635 ' HB3' ' CE2' ' A' ' 709' ' ' TYR . 91.4 Cg_endo -74.43 162.88 37.37 Favored 'Trans proline' 0 CA--C 1.556 1.579 0 C-N-CA 122.407 2.072 . . . . 0.0 112.119 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 51.3 Cg_exo -65.27 171.01 34.24 Favored 'Cis proline' 0 CA--C 1.478 -2.302 0 CA-C-O 123.136 1.223 . . . . 0.0 113.599 0.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.635 ' CE2' ' HB3' ' A' ' 707' ' ' PRO . 70.2 m-85 -115.14 74.83 0.9 Allowed 'General case' 1 C--N 1.23 -4.614 0 CA-C-N 112.184 -2.28 . . . . 0.0 109.871 -174.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -76.07 170.53 16.1 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.898 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 0.527 ' HH ' ' HA2' ' A' ' 736' ' ' GLY . 68.3 m-85 -73.08 131.58 42.26 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.579 179.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.78 -8.72 63.77 Favored Glycine 0 N--CA 1.419 -2.439 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.37 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.83 154.92 38.06 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 120.783 0.325 . . . . 0.0 110.227 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 13.3 m -140.15 149.14 42.63 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.605 HG23 HG22 ' A' ' 694' ' ' ILE . 44.5 t -132.61 134.02 59.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.413 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 45.0 mt-10 -89.67 141.59 28.46 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.436 0.636 . . . . 0.0 112.253 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.482 ' HB3' HD23 ' A' ' 697' ' ' LEU . 58.6 m-85 -141.16 129.85 22.83 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.875 1.67 . . . . 0.0 107.501 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.42 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 13.2 m-80 -132.63 -161.61 1.15 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.516 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 12.5 m -110.07 143.32 40.27 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 2.8 m -73.17 -84.94 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 123.373 0.421 . . . . 0.0 110.708 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -138.15 152.57 48.83 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 53.7 m 66.82 11.6 8.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.656 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.9 m-85 -137.55 148.31 45.82 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.474 ' HB ' HD12 ' A' ' 750' ' ' LEU . 1.1 m -116.65 135.11 54.06 Favored 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.54 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.596 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.8 ttp -92.81 124.26 36.67 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 123.93 0.892 . . . . 0.0 109.221 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 45.8 mm -126.13 144.0 37.74 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.593 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.441 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 100.45 -79.39 0.45 Allowed Glycine 0 N--CA 1.433 -1.505 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.456 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.472 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 2.8 t60 -146.0 179.84 7.2 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.596 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.2 OUTLIER -136.3 22.22 3.21 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.147 177.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.413 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.2 p -157.2 170.1 23.25 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.087 -175.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.45 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 35.7 pt -125.42 161.57 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.69 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 732' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 738' ' ' TRP . 23.7 m -133.74 138.04 45.56 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 123.674 0.609 . . . . 0.0 110.104 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.2 103.19 15.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.49 145.21 24.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.431 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 69.42 -13.62 0.37 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.527 ' HA2' ' HH ' ' A' ' 711' ' ' TYR . . . 117.33 14.9 6.76 Favored Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.7 p -152.24 150.89 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.426 ' HA ' ' O ' ' A' ' 732' ' ' THR . 94.0 m95 -73.5 163.83 27.5 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.656 171.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 34.3 p -74.2 -161.34 0.12 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.083 0.944 . . . . 0.0 113.268 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -82.4 -3.06 54.92 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -165.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 68.81 155.38 0.14 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 123.665 0.603 . . . . 0.0 111.136 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.472 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 46.0 Cg_endo -74.77 177.75 8.09 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.854 1.703 . . . . 0.0 109.916 170.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -122.91 120.09 32.42 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.818 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.492 ' SG ' HD21 ' A' ' 697' ' ' LEU . 61.4 m -102.25 108.82 20.32 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.778 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.514 ' C ' ' H ' ' A' ' 747' ' ' ILE . 22.8 t -97.05 141.3 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.384 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.656 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.54 6.87 0.4 Allowed 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 125.63 1.572 . . . . 0.0 113.99 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.853 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 35.1 mt 75.82 -15.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 125.095 1.358 . . . . 0.0 111.675 177.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.501 ' H ' ' C ' ' A' ' 746' ' ' ALA . 3.3 t70 -81.39 -31.11 33.42 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 126.109 1.763 . . . . 0.0 108.427 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.45 ' HB2' ' CG1' ' A' ' 745' ' ' VAL . 13.6 mttm -106.64 22.86 15.19 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 113.233 -1.803 . . . . 0.0 108.221 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.853 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 73.9 mt -87.94 -169.9 2.77 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.586 174.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . 0.558 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 58.9 mtpt -118.16 168.29 10.71 Favored 'General case' 0 N--CA 1.397 -3.091 0 CA-C-O 122.103 0.954 . . . . 0.0 111.097 -173.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . 0.413 ' HB2' ' HE3' ' A' ' 752' ' ' LYS . 37.0 mtmt -107.17 121.05 43.74 Favored 'General case' 0 C--N 1.253 -3.602 0 CA-C-N 112.79 -2.004 . . . . 0.0 107.141 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . 0.533 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 0.0 OUTLIER -77.89 158.76 29.28 Favored 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 113.824 -1.534 . . . . 0.0 107.979 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -131.75 139.93 49.1 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.14 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 3.9 m -71.26 107.81 4.43 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.445 ' HB2' HG13 ' A' ' 759' ' ' ILE . 70.1 m -58.19 143.74 43.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.821 0.343 . . . . 0.0 110.383 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -78.77 -3.3 43.7 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.336 0.589 . . . . 0.0 111.78 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 803' ' ' CYS . 3.2 mm? -103.73 -15.78 15.64 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.673 -0.642 . . . . 0.0 110.689 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.445 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.7 pp -100.44 161.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.893 -174.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . 0.538 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.5 mp -114.2 129.87 69.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.508 HD11 ' HZ ' ' A' ' 771' ' ' PHE . 86.5 mt -105.32 176.99 4.98 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 120.997 0.427 . . . . 0.0 110.095 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.62 168.8 7.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.988 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -71.22 -7.22 45.34 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.478 0.656 . . . . 0.0 111.42 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.65 -2.96 16.1 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.9 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.24 -10.47 8.95 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.488 ' HZ1' ' HB2' ' A' ' 766' ' ' LYS . 10.4 mtmp? -71.28 -10.09 59.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.841 0.829 . . . . 0.0 110.15 174.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -88.62 -0.83 57.66 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.949 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -114.44 129.99 56.69 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . 0.659 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 9.6 ptpp? -107.1 -24.55 11.91 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . 0.659 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 46.3 mt-10 -132.65 128.44 37.07 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.673 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 753' ' ' CYS . 83.4 m-85 -108.72 176.11 5.22 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.367 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -115.77 158.83 22.28 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.404 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -47.81 151.91 0.82 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.111 1.364 . . . . 0.0 112.622 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 15.3 m120 59.15 13.42 2.97 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 10.4 t -76.94 108.61 10.11 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.404 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.8 OUTLIER -83.94 105.68 15.01 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.493 HG21 ' CE2' ' A' ' 771' ' ' PHE . 7.2 pt -119.77 -177.96 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.504 ' HG2' ' CD2' ' A' ' 789' ' ' HIS . 98.6 mtt180 -125.8 135.28 51.82 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 6.8 p90 -125.82 165.71 18.17 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 170.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . 0.538 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 14.5 ptt180 -145.16 163.48 34.24 Favored 'General case' 0 C--N 1.251 -3.697 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.589 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 19.9 t -109.27 162.27 14.47 Favored 'General case' 0 N--CA 1.395 -3.213 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -73.5 -39.05 65.13 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.838 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -84.08 -17.97 63.95 Favored Glycine 0 C--O 1.24 0.5 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.345 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.1 mptt -124.84 84.71 2.31 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -85.5 89.28 7.66 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 122.297 1.046 . . . . 0.0 110.836 -172.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 175.66 152.91 9.82 Favored Glycine 0 C--N 1.287 -2.19 0 N-CA-C 106.145 -2.782 . . . . 0.0 106.145 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.426 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 45.3 m95 -84.46 142.37 30.13 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 118.126 0.963 . . . . 0.0 109.797 -173.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.483 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -99.92 -31.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.041 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.504 ' CD2' ' HG2' ' A' ' 778' ' ' ARG . 28.1 m170 74.75 116.89 0.06 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 124.836 1.254 . . . . 0.0 109.156 -174.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 4.3 t -137.53 152.83 49.89 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.906 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 58.1 t -116.06 133.86 61.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 53.2 t -70.27 129.07 38.36 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.36 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.39 79.76 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.631 ' OD1' HD21 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 54.03 70.43 0.61 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.193 178.398 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 76.82 -4.75 51.47 Favored Glycine 0 C--N 1.301 -1.384 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.778 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -115.89 172.55 7.07 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.534 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.0 m95 -121.76 154.89 36.35 Favored 'General case' 0 C--N 1.266 -3.032 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -144.67 105.61 4.6 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.91 143.08 74.88 Favored 'Cis proline' 0 C--O 1.248 0.993 0 C-N-CA 123.8 -1.333 . . . . 0.0 112.292 -0.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.534 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 38.6 mt-10 -53.19 125.96 19.28 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.659 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.454 ' HA ' ' CE2' ' A' ' 779' ' ' TYR . 4.6 m -72.03 141.95 15.94 Favored 'Isoleucine or valine' 1 N--CA 1.365 -4.678 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -165.38 138.33 4.42 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.012 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 758' ' ' LEU . 56.8 m -137.91 -3.0 1.85 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.141 0.496 . . . . 0.0 110.849 172.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 62.9 m . . . . . 0 C--N 1.314 -0.944 0 N-CA-C 106.806 -1.554 . . . . 0.0 106.806 -179.244 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 35.6 m -72.17 -79.47 0.07 Allowed 'General case' 0 C--N 1.268 -2.954 0 C-N-CA 123.872 0.869 . . . . 0.0 111.389 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 148.03 173.19 18.76 Favored Glycine 1 N--CA 1.362 -6.255 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -38.33 130.44 1.27 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 125.926 1.69 . . . . 0.0 111.048 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.684 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -63.23 151.72 86.23 Favored Pre-proline 0 C--N 1.296 -1.741 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.449 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.477 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.1 Cg_endo -72.18 -157.84 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 122.822 2.348 . . . . 0.0 112.941 177.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -133.21 146.19 51.26 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.491 HD22 ' HB3' ' A' ' 717' ' ' PHE . 30.1 tp -90.25 126.04 35.7 Favored 'General case' 0 C--N 1.263 -3.166 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.09 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.536 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 6.8 pt-20 -32.84 -55.3 0.37 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.24 2.216 . . . . 0.0 114.527 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.536 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 92.3 m-70 -135.53 25.47 3.44 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -131.0 -150.72 6.84 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.05 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . 0.405 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.02 179.13 8.31 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -109.69 146.28 35.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -81.32 -66.48 0.88 Allowed 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.301 0.572 . . . . 0.0 110.536 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.0 tt -161.33 139.61 9.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.403 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 58.6 p -130.73 119.48 22.41 Favored 'General case' 0 N--CA 1.395 -3.206 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 7.4 p -97.46 112.7 61.9 Favored Pre-proline 0 C--N 1.253 -3.598 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.681 -174.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.06 172.52 14.56 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.755 2.303 . . . . 0.0 109.397 175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.631 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 4.0 Cg_exo -74.24 -0.21 14.82 Favored 'Cis proline' 0 N--CA 1.489 1.213 0 CA-C-N 120.295 1.141 . . . . 0.0 114.544 5.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 54.2 m-85 74.53 73.1 0.11 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 124.86 1.35 . . . . 0.0 107.79 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.631 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 23.3 m-85 -78.35 172.24 13.9 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.072 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -72.25 138.44 47.47 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.927 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 89.2 -3.83 84.33 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 0.2 OUTLIER -76.1 151.22 37.1 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 17.1 m -130.32 149.9 51.8 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.929 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.684 HG21 HG21 ' A' ' 694' ' ' ILE . 31.7 t -133.92 140.25 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.862 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.43 130.98 43.46 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-O 122.063 0.935 . . . . 0.0 112.209 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.491 ' HB3' HD22 ' A' ' 697' ' ' LEU . 20.3 m-85 -131.96 122.95 26.4 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 126.305 1.842 . . . . 0.0 106.677 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.405 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 26.8 m-80 -119.47 -162.53 0.92 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 6.8 m -111.31 129.42 56.0 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 3.1 m -51.36 -76.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.783 1.233 . . . . 0.0 112.672 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . 0.455 ' O ' ' HB2' ' A' ' 722' ' ' SER . 45.7 mt-10 -159.3 154.84 25.85 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 101.851 -3.388 . . . . 0.0 101.851 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 67.3 m 68.46 15.37 9.19 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.248 0.967 . . . . 0.0 112.852 176.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.716 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.0 m-85 -143.17 146.96 34.18 Favored 'General case' 0 N--CA 1.417 -2.1 0 C-N-CA 123.898 0.879 . . . . 0.0 108.981 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.587 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 2.4 t -103.24 148.37 25.89 Favored 'General case' 0 C--N 1.267 -3.0 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -177.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.6 ttp -104.59 118.06 35.64 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.426 HG12 HG23 ' A' ' 724' ' ' THR . 39.5 mm -116.12 127.75 73.62 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.545 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 108.19 -93.93 0.84 Allowed Glycine 0 CA--C 1.488 -1.652 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.841 174.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.415 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 7.2 p-80 -136.16 -175.84 4.12 Favored 'General case' 0 N--CA 1.397 -3.075 0 C-N-CA 125.618 1.567 . . . . 0.0 107.631 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.427 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -132.59 12.73 4.48 Favored 'General case' 0 C--O 1.208 -1.119 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.748 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 87.7 p -128.81 166.48 18.97 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.399 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.55 HG23 ' HA ' ' A' ' 741' ' ' LEU . 32.5 pt -119.07 160.14 19.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.74 174.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 732' ' ' THR . . . . . 0.465 ' O ' HG21 ' A' ' 739' ' ' THR . 3.7 m -134.18 134.92 42.67 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.664 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 40.3 t -94.0 119.93 33.56 Favored 'General case' 0 N--CA 1.405 -2.705 0 C-N-CA 118.821 -1.151 . . . . 0.0 110.259 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.406 ' O ' HD13 ' A' ' 734' ' ' ILE . 1.2 pp -143.8 140.5 25.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 113.836 -1.529 . . . . 0.0 107.676 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 66.45 7.07 4.74 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.76 8.98 61.62 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 738' ' ' TRP . 48.4 t -130.87 139.03 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -175.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.477 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.3 m95 -72.77 166.98 21.81 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.935 172.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 732' ' ' THR . 19.5 p -75.71 -163.09 0.24 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 122.084 0.945 . . . . 0.0 112.021 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.64 2.45 54.72 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.946 -171.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.603 ' HB3' ' HD2' ' A' ' 742' ' ' PRO . 2.0 mp 70.5 169.88 0.11 Allowed Pre-proline 0 C--O 1.237 0.41 0 O-C-N 124.094 0.872 . . . . 0.0 112.338 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' A' ' 741' ' ' LEU . 39.2 Cg_endo -76.42 -177.06 3.44 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.416 2.077 . . . . 0.0 111.561 171.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -119.79 124.78 46.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 724' ' ' THR . 87.1 m -115.42 107.51 15.3 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 120.9 0.381 . . . . 0.0 110.207 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.502 ' HB ' HG21 ' A' ' 724' ' ' THR . 44.0 t -96.96 145.68 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.716 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.82 1.96 1.19 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 125.039 1.336 . . . . 0.0 114.125 -174.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.791 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 15.8 mt 74.53 -19.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 125.068 1.347 . . . . 0.0 111.697 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.5 t70 -69.82 -33.72 72.71 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 126.72 2.008 . . . . 0.0 109.502 -175.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.18 31.28 6.8 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.585 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.791 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 55.1 mt -85.83 -179.28 6.79 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 121.566 0.698 . . . . 0.0 109.877 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . 0.483 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 56.2 mtpt -116.33 -178.16 3.35 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.109 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -130.19 126.28 37.02 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 113.253 -1.794 . . . . 0.0 107.835 -175.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . 0.429 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 57.5 m -75.41 155.53 36.27 Favored 'General case' 0 C--N 1.264 -3.124 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.047 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -120.09 135.87 54.79 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 45.2 t -58.42 127.1 30.42 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.118 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.583 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 41.0 t -72.17 165.41 24.42 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -84.2 -19.21 34.41 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . 0.464 ' HB2' ' HB3' ' A' ' 803' ' ' CYS . 91.6 mt -111.53 10.97 21.29 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.021 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.583 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -112.22 149.31 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-O 121.677 0.751 . . . . 0.0 112.642 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . 0.544 HD12 ' HB3' ' A' ' 782' ' ' ARG . 3.3 mp -113.44 133.57 58.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.437 HD12 HD12 ' A' ' 777' ' ' ILE . 1.4 mm? -110.58 -177.95 3.36 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.13 152.83 19.41 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.85 -17.12 34.04 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.84 -6.3 32.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.497 0.665 . . . . 0.0 111.012 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -117.63 -4.78 11.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.677 0.751 . . . . 0.0 110.295 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.462 ' HB3' ' HE3' ' A' ' 766' ' ' LYS . 17.8 mmmt -65.57 -17.35 64.51 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.336 1.055 . . . . 0.0 111.96 176.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -105.64 16.48 25.3 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.099 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . 0.489 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 12.2 tppt? -110.21 113.07 25.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . 0.441 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 8.2 ptpp? -85.8 -32.03 22.0 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.472 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . 0.441 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 45.5 mt-10 -132.11 119.67 21.27 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.232 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.489 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 70.4 m-85 -97.58 157.34 16.08 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.804 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -93.28 148.68 21.83 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.627 ' CD2' HD13 ' A' ' 750' ' ' LEU . 15.1 p-80 -48.0 142.82 4.74 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.052 0.941 . . . . 0.0 111.669 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 22.1 m120 68.78 21.7 7.62 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 51.9 m -93.05 120.43 33.34 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.5 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -90.18 111.37 22.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.195 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.437 HD12 HD12 ' A' ' 761' ' ' LEU . 7.8 pt -120.28 -179.7 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.906 0.86 . . . . 0.0 110.459 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.461 ' HG2' ' CD2' ' A' ' 789' ' ' HIS . 88.9 mtm180 -124.75 137.72 54.32 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.587 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 8.4 p90 -130.44 166.2 21.01 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . 0.507 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 24.3 ptt180 -154.25 157.17 38.32 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 27.6 m -87.73 166.14 14.85 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . 0.544 ' HB3' HD12 ' A' ' 760' ' ' ILE . 39.4 ptt85 -84.49 -27.99 27.07 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.169 -0.613 . . . . 0.0 112.089 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -91.88 -5.8 65.97 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.018 -1.087 . . . . 0.0 112.227 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 2.8 mptp? -128.36 104.85 7.95 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -86.24 115.93 24.1 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.603 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 151.57 146.96 4.45 Favored Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.46 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 31.3 m95 -94.68 143.22 26.62 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.587 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.1 mp -97.95 -27.93 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.084 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.475 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 28.8 m170 75.95 128.88 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 124.623 1.169 . . . . 0.0 109.923 -174.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.505 HG23 ' CG1' ' A' ' 801' ' ' VAL . 4.7 t -151.38 157.86 42.99 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.241 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.82 135.52 59.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 50.9 t -70.76 112.15 6.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.574 0.702 . . . . 0.0 110.093 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.6 mm -112.89 83.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.034 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.561 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 53.85 56.45 7.13 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.901 172.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . 0.478 ' HA3' ' HE2' ' A' ' 751' ' ' LYS . . . 81.95 16.49 72.31 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.495 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . 0.401 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 35.5 ttt180 -147.42 166.08 28.3 Favored 'General case' 0 C--O 1.19 -2.05 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.566 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 99.0 m95 -111.45 162.7 14.81 Favored 'General case' 0 C--N 1.256 -3.466 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -146.47 105.76 4.05 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 29.2 Cg_endo -67.21 140.61 52.68 Favored 'Cis proline' 0 C--O 1.247 0.95 0 C-N-CA 124.061 -1.225 . . . . 0.0 111.679 -1.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.566 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.7 tt0 -57.51 118.63 5.39 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-O 121.32 0.581 . . . . 0.0 110.431 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.505 ' CG1' HG23 ' A' ' 790' ' ' THR . 1.9 m -78.53 125.34 37.96 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.816 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.91 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -157.68 129.73 7.08 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 758' ' ' LEU . 8.5 t -128.9 5.45 5.43 Favored 'General case' 0 C--N 1.284 -2.239 0 C-N-CA 119.114 -1.034 . . . . 0.0 109.387 -178.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.412 -2.339 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.759 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 708' ' ' PRO . 15.9 p . . . . . 0 N--CA 1.422 -1.838 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 67.0 m -74.23 -58.51 3.25 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 171.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 81.76 132.29 1.45 Allowed Glycine 0 N--CA 1.417 -2.612 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.137 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 21.1 t70 62.24 106.17 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.729 0.899 . . . . 0.0 111.19 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.61 HG22 HG23 ' A' ' 715' ' ' VAL . 1.7 pp -70.12 147.13 95.47 Favored Pre-proline 0 C--N 1.291 -1.952 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.828 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.439 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 58.9 Cg_endo -69.64 -162.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 123.023 2.482 . . . . 0.0 112.823 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.93 144.92 49.12 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.625 HD11 ' HA3' ' A' ' 700' ' ' GLY . 0.5 OUTLIER -85.8 132.57 34.09 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -49.26 -47.02 46.98 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.818 1.247 . . . . 0.0 113.793 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -141.63 29.58 1.74 Allowed 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.625 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -141.89 -141.01 3.86 Favored Glycine 0 C--N 1.301 -1.395 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.186 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -157.62 179.97 8.73 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -176.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.74 158.21 16.89 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 13.5 mm100 -86.02 -61.5 1.74 Allowed 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.341 0.591 . . . . 0.0 110.618 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.3 tt -167.0 133.24 2.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.491 ' HB2' ' CE1' ' A' ' 709' ' ' TYR . 15.8 p -126.16 137.21 53.56 Favored 'General case' 0 N--CA 1.392 -3.329 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 15.0 t -124.87 109.43 27.88 Favored Pre-proline 0 C--N 1.279 -2.469 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.248 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.43 170.97 12.48 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 123.058 2.506 . . . . 0.0 110.316 177.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.509 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 15.4 Cg_exo -68.92 -7.35 8.5 Favored 'Cis proline' 0 N--CA 1.499 1.801 0 CA-C-N 119.968 1.024 . . . . 0.0 114.686 3.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.491 ' CE1' ' HB2' ' A' ' 705' ' ' SER . 51.5 m-85 76.15 73.96 0.08 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.73 1.269 . . . . 0.0 108.531 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.509 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 37.0 m-85 -82.26 174.17 11.41 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.5 -176.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -72.63 125.17 26.82 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.746 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 103.52 2.18 47.06 Favored Glycine 0 N--CA 1.411 -3.014 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.313 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.09 151.0 23.61 Favored 'General case' 0 CA--C 1.5 -0.969 0 O-C-N 122.445 -0.444 . . . . 0.0 111.153 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 21.7 m -132.69 156.89 46.18 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.61 HG23 HG22 ' A' ' 694' ' ' ILE . 39.8 t -138.24 136.43 44.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 48.6 mt-10 -91.07 141.71 28.54 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 123.434 0.459 . . . . 0.0 110.249 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.454 ' HB3' ' CD1' ' A' ' 697' ' ' LEU . 42.8 m-85 -138.98 121.65 16.35 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 124.655 1.182 . . . . 0.0 108.693 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 41.4 m-20 -124.46 -165.76 1.42 Allowed 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.45 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 8.0 m -117.91 140.97 48.96 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.9 m -60.73 -68.1 0.34 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-O 120.83 0.348 . . . . 0.0 110.551 -175.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 722' ' ' SER . 8.3 pt-20 -172.8 160.51 4.45 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 40.4 m 71.43 7.59 6.07 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.682 1.239 . . . . 0.0 110.493 -174.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.599 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 93.2 m-85 -140.03 144.73 37.05 Favored 'General case' 0 N--CA 1.382 -3.849 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.658 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.482 HG23 HD21 ' A' ' 750' ' ' LEU . 1.1 m -120.38 144.74 47.74 Favored 'General case' 0 C--N 1.264 -3.138 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.786 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.703 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.7 ttp -81.95 116.72 21.71 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 124.91 1.284 . . . . 0.0 109.564 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 46.6 mm -115.25 137.13 49.77 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.954 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.518 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 96.3 -80.05 0.75 Allowed Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.123 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.549 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 4.2 t60 -147.09 177.48 9.13 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -173.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.703 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -133.3 22.44 4.06 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.542 176.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 32.4 p -156.25 162.43 40.15 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.784 -0.572 . . . . 0.0 110.42 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . . . . . . . . . 36.2 pt -121.67 161.09 22.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 124.217 0.948 . . . . 0.0 108.579 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 10.5 m -133.37 135.8 44.93 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 123.595 0.56 . . . . 0.0 110.424 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.71 104.17 16.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.416 ' C ' ' H ' ' A' ' 736' ' ' GLY . 1.7 pp -146.34 161.68 10.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.912 -179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 71.7 -43.62 0.57 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.406 1.082 . . . . 0.0 111.565 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 734' ' ' ILE . . . 138.15 37.14 0.14 Allowed Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 125.162 1.363 . . . . 0.0 109.769 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.8 p -174.41 161.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.474 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 95.8 m95 -77.36 172.87 12.63 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.645 173.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 29.5 p -80.4 -159.19 0.22 Allowed 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.699 0.762 . . . . 0.0 112.259 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.9 -4.57 58.79 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -165.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 68.73 156.13 0.15 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 123.432 0.458 . . . . 0.0 111.504 -176.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.549 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 59.0 Cg_endo -80.25 173.66 12.27 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.826 1.684 . . . . 0.0 111.041 172.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -116.36 114.96 25.02 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 724' ' ' THR . 59.1 m -98.08 100.29 11.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-O 122.156 0.979 . . . . 0.0 109.483 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 723' ' ' PHE . 10.6 p -77.87 155.03 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.292 0 CA-C-N 113.82 -1.537 . . . . 0.0 108.737 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.599 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -79.17 1.33 24.87 Favored 'General case' 0 C--N 1.251 -3.7 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.948 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.542 ' HB ' ' O ' ' A' ' 746' ' ' ALA . 18.8 mt 77.08 -24.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 126.48 1.912 . . . . 0.0 112.24 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.501 ' H ' ' C ' ' A' ' 746' ' ' ALA . 22.9 t70 -72.23 -34.3 68.22 Favored 'General case' 0 C--N 1.264 -3.128 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.103 -175.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -102.42 27.8 6.5 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 112.687 -2.051 . . . . 0.0 111.541 -174.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.547 ' CD1' HG12 ' A' ' 745' ' ' VAL . 1.9 tp -84.31 -179.46 7.2 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -107.37 -172.82 2.15 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.586 -173.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . 0.528 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 25.0 mtpp -123.03 156.04 35.65 Favored 'General case' 0 C--N 1.265 -3.07 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 79.2 m -112.18 168.6 9.49 Favored 'General case' 1 C--N 1.241 -4.136 0 C-N-CA 123.354 0.662 . . . . 0.0 109.532 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -129.2 141.36 51.17 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 48.1 t -61.86 131.37 49.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.562 ' HB2' HG12 ' A' ' 759' ' ' ILE . 17.7 m -76.17 175.01 9.39 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 123.079 0.551 . . . . 0.0 111.539 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -85.73 -35.02 21.06 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -172.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . 0.511 HD13 ' HG ' ' A' ' 804' ' ' SER . 85.3 mt -108.18 12.55 26.57 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.525 -172.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.588 HG22 ' SG ' ' A' ' 803' ' ' CYS . 23.2 pt -105.59 156.21 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.183 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . 0.45 HD13 ' HB3' ' A' ' 782' ' ' ARG . 3.1 mp -122.6 129.44 75.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.64 HD11 ' HZ ' ' A' ' 771' ' ' PHE . 81.9 mt -97.52 -173.54 2.67 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.629 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 35.0 mt-10 -68.77 162.3 26.56 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . 0.523 ' HA ' ' HE2' ' A' ' 766' ' ' LYS . 38.9 mm-40 -61.74 -21.81 64.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.432 0.634 . . . . 0.0 110.738 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.27 2.02 45.18 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.471 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -126.94 -12.44 5.88 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.523 ' HE2' ' HA ' ' A' ' 763' ' ' GLU . 57.0 mtmt -68.37 -7.53 32.2 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -102.61 0.67 33.67 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 8.4 tppt? -95.02 102.43 14.24 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -78.55 -31.81 47.59 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.368 0.604 . . . . 0.0 109.656 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -131.17 128.25 39.64 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.936 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.64 ' HZ ' HD11 ' A' ' 761' ' ' LEU . 92.6 m-85 -107.15 162.62 13.71 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 752' ' ' LYS . 2.6 p30 -113.55 168.72 9.52 Favored 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 118.1 -1.44 . . . . 0.0 109.126 175.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.424 ' CD2' HG22 ' A' ' 747' ' ' ILE . 2.1 p-80 -47.42 150.09 0.98 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.984 0.914 . . . . 0.0 112.835 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 70.93 3.62 4.71 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.934 1.293 . . . . 0.0 111.324 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 12.8 t -78.85 114.39 17.75 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.434 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.8 OUTLIER -89.05 113.23 24.32 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.173 178.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.45 HG22 ' CE2' ' A' ' 771' ' ' PHE . 8.2 pt -125.89 178.05 4.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-O 121.337 0.589 . . . . 0.0 109.688 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.572 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 31.4 ptt180 -133.45 127.84 34.18 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.515 ' CE1' HG12 ' A' ' 801' ' ' VAL . 6.6 p90 -119.38 168.04 11.33 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . 0.402 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 35.0 ptt180 -144.53 161.01 40.16 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 85.2 m -90.27 143.12 27.05 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.884 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . 0.45 ' HB3' HD13 ' A' ' 760' ' ' ILE . 27.4 ptt180 -67.75 130.49 43.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 95.94 -10.59 68.11 Favored Glycine 0 C--N 1.294 -1.765 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.4 mptt -114.02 140.38 48.49 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -116.87 87.66 2.74 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.395 0.617 . . . . 0.0 110.066 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 172.61 158.54 17.11 Favored Glycine 0 N--CA 1.425 -2.036 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.572 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 60.4 m95 -114.32 145.39 41.84 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 117.368 0.584 . . . . 0.0 109.71 -175.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.428 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -95.84 -35.33 5.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.388 -177.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 7.1 m170 70.92 114.41 0.05 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 124.31 1.044 . . . . 0.0 109.785 -178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 3.6 t -139.46 163.08 33.47 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.97 138.96 52.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 C-N-CA 123.388 0.675 . . . . 0.0 109.459 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.7 t -73.41 110.69 7.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.559 0.695 . . . . 0.0 110.258 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.4 mm -111.81 81.57 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.639 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.7 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.452 ' HB2' ' HG ' ' A' ' 750' ' ' LEU . 26.5 t-20 53.52 68.67 0.81 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.947 0.88 . . . . 0.0 112.22 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 70.55 17.4 74.66 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.824 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -143.52 166.2 25.46 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.517 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 95.1 m95 -112.61 158.92 19.4 Favored 'General case' 0 C--N 1.252 -3.638 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -148.05 106.67 3.65 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.82 138.53 46.98 Favored 'Cis proline' 0 C--O 1.241 0.633 0 C-N-CA 123.62 -1.408 . . . . 0.0 111.541 -0.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.517 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.1 tp10 -57.36 128.27 36.17 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.669 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.515 HG12 ' CE1' ' A' ' 779' ' ' TYR . 15.8 m -72.52 136.12 26.3 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.786 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.706 -173.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -152.57 111.09 3.74 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.101 0.477 . . . . 0.0 110.551 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . 0.588 ' SG ' HG22 ' A' ' 759' ' ' ILE . 73.4 m -131.32 24.88 4.85 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 122.413 1.102 . . . . 0.0 108.598 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 804' ' ' SER . . . . . 0.511 ' HG ' HD13 ' A' ' 758' ' ' LEU . 19.3 m . . . . . 0 N--CA 1.417 -2.125 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' THR . . . . . 0.504 ' CG2' ' HB2' ' A' ' 708' ' ' PRO . 19.6 p . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.4 m -74.82 -59.38 2.76 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 135.35 166.88 11.18 Favored Glycine 1 N--CA 1.383 -4.857 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -177.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.645 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 34.1 t70 -53.54 135.78 39.53 Favored 'General case' 0 C--N 1.281 -2.397 0 O-C-N 124.658 0.858 . . . . 0.0 111.062 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.766 HG22 HG22 ' A' ' 715' ' ' VAL . 1.2 pp -52.76 150.27 9.98 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 113.15 -1.841 . . . . 0.0 115.654 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.82 -162.87 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.61 2.873 . . . . 0.0 111.866 175.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -135.5 154.64 51.34 Favored 'General case' 0 N--CA 1.395 -3.214 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.636 HD22 ' SG ' ' A' ' 744' ' ' CYS . 21.9 tp -104.25 111.5 24.14 Favored 'General case' 0 C--N 1.252 -3.656 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.593 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -43.9 -37.11 2.68 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.806 1.642 . . . . 0.0 115.22 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -134.73 26.61 3.67 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 121.942 -0.474 . . . . 0.0 110.429 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -139.71 -147.78 5.1 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.207 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -149.61 173.3 13.8 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 122.617 0.367 . . . . 0.0 110.208 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.61 139.38 40.3 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -82.27 -75.22 0.31 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.962 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . 0.522 HD11 ' N ' ' A' ' 705' ' ' SER . 1.0 OUTLIER -170.66 162.38 7.83 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.217 0.532 . . . . 0.0 111.343 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.608 ' CB ' HG21 ' A' ' 715' ' ' VAL . 33.8 t 174.92 179.38 0.13 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 128.527 2.731 . . . . 0.0 105.007 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 23.4 p -148.63 140.82 14.74 Favored Pre-proline 0 C--N 1.305 -1.344 0 CA-C-N 118.619 0.645 . . . . 0.0 110.833 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.506 ' HA ' ' N ' ' A' ' 709' ' ' TYR . 50.4 Cg_endo -68.52 163.9 34.95 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.019 1.813 . . . . 0.0 109.064 175.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.504 ' HB2' ' CG2' ' A' ' 690' ' ' THR . 29.7 Cg_endo -64.68 -5.14 3.05 Favored 'Cis proline' 0 N--CA 1.502 1.973 0 N-CA-C 117.353 2.02 . . . . 0.0 117.353 4.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.645 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 74.7 m-85 66.33 66.55 0.47 Allowed 'General case' 0 C--O 1.255 1.362 0 CA-C-O 122.288 1.042 . . . . 0.0 108.566 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -67.11 169.85 7.85 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.336 -1.756 . . . . 0.0 112.111 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 0.493 ' HH ' ' HA2' ' A' ' 736' ' ' GLY . 58.3 m-85 -67.63 137.33 55.53 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.928 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 87.52 8.17 74.46 Favored Glycine 0 N--CA 1.41 -3.048 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.09 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.68 156.77 24.9 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 13.8 m -141.27 139.43 33.69 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.766 HG22 HG22 ' A' ' 694' ' ' ILE . 20.2 t -126.78 136.65 60.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.507 ' HG3' ' HG2' ' A' ' 729' ' ' ARG . 26.5 tt0 -96.89 140.59 31.22 Favored 'General case' 0 N--CA 1.381 -3.918 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.519 ' HB3' HD21 ' A' ' 697' ' ' LEU . 50.4 m-85 -138.67 120.39 15.24 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 125.833 1.653 . . . . 0.0 107.396 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -122.28 -165.36 1.27 Allowed 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 7.1 m -112.97 135.89 53.25 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 11.9 t -57.94 -68.93 0.2 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 722' ' ' SER . 11.4 pt-20 -172.26 163.81 5.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.479 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 75.4 m 72.13 5.95 5.44 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.193 0.933 . . . . 0.0 110.872 -177.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.663 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.6 m-85 -141.52 145.53 35.28 Favored 'General case' 0 N--CA 1.401 -2.895 0 C-N-CA 125.192 1.397 . . . . 0.0 107.95 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.2 m -114.21 138.24 50.72 Favored 'General case' 0 C--N 1.251 -3.716 0 C-N-CA 125.709 1.604 . . . . 0.0 111.998 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.599 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.1 ttp -91.01 122.36 33.6 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.893 1.277 . . . . 0.0 109.486 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 39.8 mm -124.21 135.89 62.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.949 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 101.35 -74.99 0.37 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.206 173.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.518 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.1 OUTLIER -141.16 177.18 8.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -176.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.599 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -135.46 8.92 3.4 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.0 0.905 . . . . 0.0 109.359 170.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 54.4 p -145.72 163.0 36.29 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.699 -0.625 . . . . 0.0 110.235 -176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.506 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 35.7 pt -122.76 163.4 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 732' ' ' THR . . . . . 0.434 ' O ' HG22 ' A' ' 739' ' ' THR . 21.2 m -139.17 137.25 35.89 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.937 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 5.7 t -86.48 99.9 11.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.7 pp -140.75 146.27 24.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.284 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 67.87 -4.78 0.93 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.493 ' HA2' ' HH ' ' A' ' 711' ' ' TYR . . . 112.47 13.38 11.77 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 121.581 -0.342 . . . . 0.0 112.613 179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.2 p -155.09 157.22 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.423 ' HA ' ' O ' ' A' ' 732' ' ' THR . 96.9 m95 -73.33 167.58 20.93 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 121.056 0.455 . . . . 0.0 109.816 171.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 42.8 p -77.61 -163.12 0.36 Allowed 'General case' 0 N--CA 1.426 -1.638 0 CA-C-O 122.021 0.915 . . . . 0.0 112.616 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -1.89 32.93 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -167.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 67.61 161.44 0.14 Allowed Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 122.735 0.414 . . . . 0.0 110.386 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.518 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 49.8 Cg_endo -83.64 174.35 8.79 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.443 1.429 . . . . 0.0 110.241 168.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -117.39 117.09 28.53 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.636 ' SG ' HD22 ' A' ' 697' ' ' LEU . 95.4 m -102.67 107.77 18.8 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.188 0.518 . . . . 0.0 110.154 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.463 ' C ' ' H ' ' A' ' 747' ' ' ILE . 39.6 t -96.31 145.05 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.663 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -67.89 6.89 0.61 Allowed 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 125.048 1.339 . . . . 0.0 114.438 -175.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.841 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 36.9 mt 76.34 -16.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 C-N-CA 125.561 1.544 . . . . 0.0 112.025 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 746' ' ' ALA . 14.9 t70 -81.82 -31.96 31.48 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.616 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -107.33 23.23 14.76 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.946 -1.934 . . . . 0.0 108.442 -172.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.841 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 72.5 mt -82.58 -165.21 0.98 Allowed 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.361 175.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . 0.479 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 61.3 mtpt -124.51 152.7 43.1 Favored 'General case' 0 N--CA 1.393 -3.314 0 CA-C-O 121.834 0.826 . . . . 0.0 110.19 -173.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . 0.41 ' HE3' ' OE1' ' A' ' 770' ' ' GLU . 43.8 mtmt -101.87 115.56 30.8 Favored 'General case' 0 C--N 1.251 -3.674 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.034 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . 0.493 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 0.0 OUTLIER -75.71 166.65 23.23 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-N 112.991 -1.913 . . . . 0.0 109.143 -178.092 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -145.68 161.84 38.93 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.004 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 31.4 t -65.53 121.74 15.61 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.357 172.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.619 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 30.6 t -63.91 153.48 36.82 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -58.76 -26.96 64.52 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 124.24 1.016 . . . . 0.0 113.459 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 803' ' ' CYS . 1.5 mm? -110.59 -13.84 14.16 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.831 -170.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.619 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -87.7 155.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.09 134.41 55.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 113.78 -1.555 . . . . 0.0 107.17 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 1.8 mm? -114.12 178.7 4.19 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.538 ' HB2' HD22 ' A' ' 765' ' ' LEU . 34.6 mt-10 -73.15 163.12 28.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -52.93 -27.61 19.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . 0.444 ' HB2' HD23 ' A' ' 765' ' ' LEU . 31.2 m-70 -76.6 -35.97 57.78 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.538 HD22 ' HB2' ' A' ' 762' ' ' GLU . 2.0 mm? -91.11 -15.55 29.26 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.192 -1.822 . . . . 0.0 112.551 -168.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -77.48 -6.78 54.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.202 0.525 . . . . 0.0 110.951 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -114.46 13.18 17.59 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . 0.442 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 13.5 tppt? -105.85 112.61 25.73 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -87.31 -29.53 21.53 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.189 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . 0.41 ' OE1' ' HE3' ' A' ' 752' ' ' LYS . 45.2 mt-10 -139.66 138.29 35.95 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.653 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.442 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 39.5 m-85 -117.02 177.0 4.87 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -121.48 166.2 14.5 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.583 ' HA ' ' HB3' ' A' ' 792' ' ' CYS . 34.9 t60 -65.54 149.73 49.58 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 83.03 0.41 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.789 1.236 . . . . 0.0 108.668 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 54.0 m -83.41 106.57 15.27 Favored 'General case' 0 N--CA 1.41 -2.467 0 C-N-CA 119.001 -1.079 . . . . 0.0 108.885 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.442 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -88.41 101.94 14.4 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.401 HG12 ' CZ3' ' A' ' 797' ' ' TRP . 4.3 pt -112.87 178.36 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 121.773 0.797 . . . . 0.0 109.868 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.582 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 79.2 mtt180 -130.06 127.76 40.54 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.594 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 7.6 p90 -121.73 168.48 11.76 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -152.93 171.35 18.46 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.688 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 52.7 t -113.06 162.03 16.39 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . 0.444 ' HG2' ' SG ' ' A' ' 803' ' ' CYS . 32.4 ptt180 -77.98 104.24 8.42 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 120.65 -44.21 1.41 Allowed Glycine 0 C--N 1.276 -2.765 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.037 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.688 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.7 mptt -97.89 91.04 5.15 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.75 148.28 31.55 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.245 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 100.62 154.34 27.08 Favored Glycine 0 C--N 1.294 -1.763 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -172.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.582 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 45.4 m95 -99.9 139.79 35.05 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 117.622 0.711 . . . . 0.0 110.994 -173.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.594 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -90.35 -33.01 5.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.674 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 18.6 m170 78.45 125.46 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 C-N-CA 124.784 1.234 . . . . 0.0 110.206 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.2 t -151.55 152.98 33.65 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 52.7 t -117.59 134.85 59.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . 0.583 ' HB3' ' HA ' ' A' ' 773' ' ' HIS . 52.4 t -67.46 132.78 48.28 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.972 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.61 83.21 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 C-N-CA 124.418 1.087 . . . . 0.0 108.074 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.682 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.8 OUTLIER 45.93 72.74 0.2 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.097 0.959 . . . . 0.0 112.809 177.468 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 78.4 0.55 78.93 Favored Glycine 0 C--N 1.296 -1.666 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.012 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . 0.404 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 36.1 ttm180 -130.38 173.48 10.78 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 98.5 m95 -116.78 162.18 18.11 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 122.351 0.26 . . . . 0.0 111.179 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -144.68 108.08 4.73 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.17 140.05 56.5 Favored 'Cis proline' 0 C--O 1.248 0.992 0 C-N-CA 123.637 -1.401 . . . . 0.0 111.129 -1.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.543 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.9 tt0 -57.11 125.58 23.33 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.006 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 9.5 m -66.21 133.88 30.53 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.788 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.808 -175.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -147.99 127.03 12.82 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . 0.511 ' HB3' ' HB2' ' A' ' 758' ' ' LEU . 42.0 t -117.92 -18.39 9.51 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-O 121.548 0.69 . . . . 0.0 109.85 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 C--N 1.301 -1.502 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.361 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.422 -1.832 0 CA-C-O 121.721 0.772 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.7 m -76.41 -74.18 0.24 Allowed 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.161 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 143.72 179.09 20.03 Favored Glycine 1 N--CA 1.356 -6.663 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -39.66 126.52 1.92 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 126.313 1.845 . . . . 0.0 111.484 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.54 HG21 HG23 ' A' ' 715' ' ' VAL . 1.7 pp -63.16 147.78 94.07 Favored Pre-proline 0 N--CA 1.425 -1.707 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.406 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.467 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 72.9 Cg_endo -72.69 -166.22 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.818 2.345 . . . . 0.0 112.828 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -126.6 165.19 19.65 Favored 'General case' 0 N--CA 1.399 -2.977 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.598 HD22 ' SG ' ' A' ' 744' ' ' CYS . 37.6 tp -119.67 110.64 17.07 Favored 'General case' 0 C--N 1.251 -3.705 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.901 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.05 -40.24 6.5 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -173.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.451 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 88.2 m-70 -128.24 20.7 6.27 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 121.473 -0.767 . . . . 0.0 110.16 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -125.29 -139.61 5.24 Favored Glycine 0 C--N 1.304 -1.2 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.93 -177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . 0.564 ' HE1' ' CG ' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -160.85 177.92 9.93 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -109.96 154.65 22.83 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -91.27 -74.32 0.51 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 120.933 0.397 . . . . 0.0 110.369 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 705' ' ' SER . 6.3 tt -157.22 133.56 9.77 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 177.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.454 ' HB2' ' CE1' ' A' ' 709' ' ' TYR . 4.2 p -133.96 110.73 9.88 Favored 'General case' 0 N--CA 1.393 -3.297 0 CA-C-O 121.724 0.773 . . . . 0.0 110.145 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 39.8 t -90.26 111.45 47.1 Favored Pre-proline 0 C--N 1.277 -2.557 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.993 -174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.26 171.81 15.31 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.774 2.316 . . . . 0.0 109.363 175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.521 ' HG2' ' CE1' ' A' ' 710' ' ' TYR . 2.8 Cg_exo -70.75 -7.24 11.57 Favored 'Cis proline' 0 CA--C 1.498 -1.316 0 N-CA-C 115.505 1.31 . . . . 0.0 115.505 5.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 43.3 m-85 78.55 86.1 0.07 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.521 ' CE1' ' HG2' ' A' ' 708' ' ' PRO . 26.9 m-85 -91.2 174.65 7.28 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.815 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 0.434 ' CE2' ' HA2' ' A' ' 736' ' ' GLY . 64.1 m-85 -74.71 136.64 41.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.231 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 91.26 -4.91 81.01 Favored Glycine 0 N--CA 1.416 -2.657 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.356 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -73.59 147.79 43.52 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 6.8 m -129.02 152.53 48.53 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.54 HG23 HG21 ' A' ' 694' ' ' ILE . 41.1 t -136.29 133.01 49.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.544 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 36.7 mt-10 -95.17 140.32 30.25 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.962 0.886 . . . . 0.0 111.638 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.508 ' HB3' HD21 ' A' ' 697' ' ' LEU . 37.3 m-85 -138.76 129.96 26.95 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.564 ' CG ' ' HE1' ' A' ' 701' ' ' TRP . 9.1 p30 -128.44 -167.77 1.82 Allowed 'General case' 1 N--CA 1.377 -4.089 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 44.4 m -108.65 124.06 49.94 Favored 'General case' 0 C--N 1.247 -3.864 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 24.2 t -44.9 -80.75 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 O-C-N 125.689 1.868 . . . . 0.0 112.834 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 722' ' ' SER . 48.2 mt-10 -153.83 150.74 28.75 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 176.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 43.3 m 69.19 9.65 7.46 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.262 0.976 . . . . 0.0 113.611 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 719' ' ' CYS . 96.5 m-85 -134.3 145.53 49.16 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.526 HG21 ' O ' ' A' ' 745' ' ' VAL . 6.4 t -75.86 -115.53 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.898 -175.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.629 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.2 ttp 165.09 107.86 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.732 2.813 . . . . 0.0 105.227 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.681 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 42.1 mm -119.03 143.96 28.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 92.48 -68.87 1.81 Allowed Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.731 173.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.538 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.5 t60 -154.58 -178.71 7.37 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -174.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.629 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -139.35 20.31 2.57 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.379 0.609 . . . . 0.0 110.012 173.278 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.544 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 59.9 p -156.08 162.3 40.29 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.879 -177.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 714' ' ' SER . 35.8 pt -120.34 157.75 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 732' ' ' THR . . . . . 0.506 ' O ' HG22 ' A' ' 739' ' ' THR . 6.1 m -131.26 135.6 47.48 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.0 t -95.77 111.57 23.5 Favored 'General case' 0 N--CA 1.392 -3.346 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.763 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.422 ' C ' ' H ' ' A' ' 736' ' ' GLY . 1.4 pp -138.09 154.23 28.05 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.128 0 CA-C-N 113.649 -1.614 . . . . 0.0 107.089 178.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 76.76 -44.74 0.48 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.311 1.044 . . . . 0.0 110.26 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.434 ' HA2' ' CE2' ' A' ' 711' ' ' TYR . . . 144.86 25.78 0.11 Allowed Glycine 0 C--N 1.298 -1.559 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 8.5 p -163.64 167.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.467 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 86.8 m95 -84.33 173.02 11.28 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 121.156 0.503 . . . . 0.0 111.634 177.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.506 HG22 ' O ' ' A' ' 732' ' ' THR . 21.3 p -86.92 -157.25 0.36 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.481 ' NE2' ' HB ' ' A' ' 739' ' ' THR . 0.0 OUTLIER -69.49 -24.28 63.75 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 126.065 1.746 . . . . 0.0 113.468 -171.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 1.6 mt 70.08 155.27 0.15 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 124.452 1.095 . . . . 0.0 111.206 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.538 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 37.6 Cg_endo -71.61 175.28 9.75 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.792 1.661 . . . . 0.0 111.812 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . 0.681 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.4 tt0 -123.11 119.2 29.59 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.598 ' SG ' HD22 ' A' ' 697' ' ' LEU . 90.7 m -105.0 104.4 14.13 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.18 0.514 . . . . 0.0 110.965 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.526 ' O ' HG21 ' A' ' 724' ' ' THR . 42.2 t -101.83 147.2 8.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 748' ' ' ASP . . . -65.76 3.73 0.73 Allowed 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 124.867 1.267 . . . . 0.0 113.788 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.534 ' HA ' HD23 ' A' ' 750' ' ' LEU . 61.4 mt 73.8 -17.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.821 1.648 . . . . 0.0 110.938 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 746' ' ' ALA . 7.2 t70 -72.51 -33.03 66.63 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 126.402 1.881 . . . . 0.0 109.267 -177.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -105.05 18.91 21.53 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.566 -172.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 1.013 ' HG ' HD21 ' A' ' 794' ' ' ASN . 0.2 OUTLIER -82.06 -172.9 4.2 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.06 179.179 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . 0.421 ' HE3' ' HB3' ' A' ' 751' ' ' LYS . 28.1 mmmt -115.04 148.7 38.55 Favored 'General case' 0 N--CA 1.381 -3.906 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.706 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -109.82 119.26 38.79 Favored 'General case' 1 C--N 1.23 -4.613 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.378 -173.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 770' ' ' GLU . 27.2 m -67.27 162.73 22.06 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.762 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 769' ' ' LYS . 16.9 ptpt -126.44 144.15 50.94 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.181 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 48.0 p -68.06 114.13 6.33 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.754 171.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.578 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 45.2 t -69.76 156.9 38.31 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -84.32 -13.39 52.54 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.278 0.561 . . . . 0.0 112.385 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 5.6 mp -95.53 -4.28 45.08 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.059 -173.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.578 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.1 pp -118.96 152.24 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 CA-C-O 121.985 0.897 . . . . 0.0 112.138 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.58 127.77 64.76 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.795 0 CA-C-N 113.814 -1.539 . . . . 0.0 107.365 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -107.6 -175.18 2.72 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.555 ' HB2' HD21 ' A' ' 765' ' ' LEU . 25.6 mt-10 -76.87 171.86 14.07 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.263 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.33 -31.34 67.47 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.282 0.633 . . . . 0.0 110.544 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.32 2.09 54.6 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.731 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' A' ' 762' ' ' GLU . 2.9 mm? -122.28 -24.45 5.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 53.8 mtmt -66.38 -23.78 66.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -86.77 -2.83 58.86 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.939 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . 0.46 ' HE3' ' CD2' ' A' ' 771' ' ' PHE . 23.4 ttpt -99.4 110.22 22.74 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . 0.59 ' HG2' ' HG3' ' A' ' 770' ' ' GLU . 0.0 OUTLIER -93.03 -23.98 18.48 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . 0.59 ' HG3' ' HG2' ' A' ' 769' ' ' LYS . 37.6 mt-10 -127.77 106.41 9.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.46 ' CD2' ' HE3' ' A' ' 768' ' ' LYS . 67.5 m-85 -89.59 147.95 23.64 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.916 -174.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -89.49 144.59 25.92 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.158 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.572 ' CB ' HD22 ' A' ' 750' ' ' LEU . 49.9 t60 -57.95 146.77 31.18 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.319 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 83.44 3.75 0.9 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.37 1.468 . . . . 0.0 110.232 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 67.8 m -86.41 113.6 22.5 Favored 'General case' 0 N--CA 1.398 -3.047 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.407 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.437 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -85.89 90.6 8.11 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.497 179.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . . . . . . . . . 7.4 pt -95.23 -175.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 0.2 OUTLIER -141.55 121.06 13.26 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.007 175.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.546 ' CD2' HG12 ' A' ' 801' ' ' VAL . 10.6 p90 -106.71 168.71 8.99 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 174.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -149.82 146.91 27.4 Favored 'General case' 0 C--N 1.257 -3.45 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.581 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 5.0 t -79.36 168.43 19.52 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -74.21 -1.38 20.25 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.113 0.482 . . . . 0.0 111.901 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -113.15 -6.6 22.2 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.581 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 3.8 mptp? -112.58 137.53 50.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -106.59 4.89 28.52 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.43 1.11 . . . . 0.0 110.805 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -113.04 157.84 14.67 Favored Glycine 0 C--N 1.268 -3.225 0 CA-C-N 113.446 -1.706 . . . . 0.0 108.943 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 46.0 m95 -100.35 141.45 33.18 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 117.231 0.516 . . . . 0.0 110.298 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.521 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -91.93 -31.31 4.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 15.4 m170 73.25 123.62 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 124.455 1.102 . . . . 0.0 110.13 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.483 HG23 ' CG2' ' A' ' 801' ' ' VAL . 2.3 t -146.33 155.36 42.57 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 24.9 t -114.21 133.26 60.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 41.6 t -70.46 117.2 11.7 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.527 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 47.8 mm -119.29 89.15 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 C-N-CA 123.861 0.865 . . . . 0.0 109.382 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 1.013 HD21 ' HG ' ' A' ' 750' ' ' LEU . 0.9 OUTLIER 43.59 62.35 1.93 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.083 0.953 . . . . 0.0 112.754 175.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.15 36.47 56.29 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.968 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -158.79 165.53 34.05 Favored 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.562 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.4 m95 -114.23 160.36 19.11 Favored 'General case' 0 C--N 1.258 -3.385 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -148.1 102.13 3.6 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.77 142.59 72.9 Favored 'Cis proline' 0 C--O 1.244 0.824 0 C-N-CA 123.886 -1.298 . . . . 0.0 112.96 0.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 45.5 mt-10 -48.55 125.34 9.66 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.287 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.546 HG12 ' CD2' ' A' ' 779' ' ' TYR . 75.5 t -82.45 116.62 26.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.24 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -159.15 122.36 3.71 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.547 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 28.6 m -106.55 -18.15 14.05 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.643 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.307 -1.24 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.476 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 54.1 m -78.62 -75.1 0.24 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.304 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 143.13 -167.9 26.26 Favored Glycine 1 N--CA 1.378 -5.226 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -48.89 130.34 18.01 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 125.462 1.505 . . . . 0.0 110.417 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.662 HG21 HG21 ' A' ' 715' ' ' VAL . 1.3 pp -58.52 150.61 55.12 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.324 -177.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.563 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 74.3 Cg_endo -72.15 -159.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 123.276 2.65 . . . . 0.0 114.147 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -125.31 158.86 33.13 Favored 'General case' 0 N--CA 1.397 -3.115 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.568 HD12 ' HA3' ' A' ' 700' ' ' GLY . 0.5 OUTLIER -107.4 129.36 54.93 Favored 'General case' 0 C--N 1.26 -3.312 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.539 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -45.87 -45.68 15.32 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -141.22 27.18 1.95 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.417 0.627 . . . . 0.0 109.536 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.568 ' HA3' HD12 ' A' ' 697' ' ' LEU . . . -134.0 -146.32 5.44 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.807 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -153.41 178.11 10.15 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 122.94 0.496 . . . . 0.0 110.257 -175.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -108.55 147.5 31.68 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -71.34 -77.78 0.09 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.146 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.6 tt 179.66 135.98 0.1 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.475 ' HB2' HG13 ' A' ' 715' ' ' VAL . 22.9 t -144.81 -168.89 3.04 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 9.7 t -152.46 139.56 12.64 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.45 169.11 10.18 Favored 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 122.963 2.442 . . . . 0.0 110.072 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 710' ' ' TYR . 2.8 Cg_exo -72.44 -9.95 16.99 Favored 'Cis proline' 0 N--CA 1.49 1.279 0 N-CA-C 115.184 1.186 . . . . 0.0 115.184 7.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 62.3 m-85 73.28 79.85 0.13 Allowed 'General case' 0 C--N 1.312 -1.064 0 O-C-N 124.575 1.172 . . . . 0.0 108.993 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.516 ' CZ ' ' HG2' ' A' ' 708' ' ' PRO . 21.4 m-85 -84.05 168.67 15.69 Favored 'General case' 0 CA--C 1.477 -1.84 0 CA-C-N 113.943 -1.481 . . . . 0.0 112.717 -174.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -69.66 128.3 35.97 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.07 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.57 -15.53 55.79 Favored Glycine 0 N--CA 1.414 -2.791 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.611 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.47 145.25 52.89 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 10.8 m -131.32 150.28 52.21 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.662 HG21 HG21 ' A' ' 694' ' ' ILE . 42.7 t -138.15 124.65 26.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.656 ' HG3' ' HG2' ' A' ' 729' ' ' ARG . 2.3 mp0 -65.68 134.55 53.46 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.722 0.772 . . . . 0.0 112.623 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.418 ' HB3' ' CD1' ' A' ' 697' ' ' LEU . 19.9 m-85 -137.61 114.91 10.99 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 126.374 1.87 . . . . 0.0 107.063 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 -124.15 -168.56 1.81 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -175.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 23.3 m -116.17 138.62 51.11 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 5.0 m -57.55 -78.13 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 123.973 0.796 . . . . 0.0 112.152 -174.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -157.79 159.36 36.67 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 58.4 m 65.95 9.56 6.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.614 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 94.6 m-85 -142.14 146.04 34.89 Favored 'General case' 0 N--CA 1.407 -2.586 0 C-N-CA 124.12 0.968 . . . . 0.0 108.771 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.0 OUTLIER -113.09 137.31 51.62 Favored 'General case' 0 C--N 1.256 -3.478 0 C-N-CA 125.432 1.493 . . . . 0.0 111.129 -178.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' MET . . . . . . . . . . . . . 9.2 tmm? -87.54 125.36 34.29 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.9 mm -124.91 133.32 69.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.009 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 121.33 -89.37 0.43 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.095 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.497 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 28.0 t60 -157.03 145.55 19.69 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.656 ' HG2' ' HG3' ' A' ' 716' ' ' GLU . 0.0 OUTLIER -86.84 13.77 8.35 Favored 'General case' 0 C--N 1.274 -2.691 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.879 -171.552 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 716' ' ' GLU . 6.0 p -156.66 168.56 27.03 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.951 -0.468 . . . . 0.0 111.987 -176.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 714' ' ' SER . 35.1 pt -117.0 164.61 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.587 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.3 m -136.08 134.24 38.19 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.698 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 8.5 t -84.14 107.57 16.54 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.092 0.472 . . . . 0.0 110.037 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -144.95 145.64 20.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 C-N-CA 125.085 1.354 . . . . 0.0 109.896 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 66.62 -0.31 1.61 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.39 24.45 24.05 Favored Glycine 0 CA--C 1.498 -0.973 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.09 153.26 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.563 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.4 m95 -79.11 177.83 8.51 Favored 'General case' 0 C--N 1.277 -2.545 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.468 168.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.412 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 17.1 p -80.84 -169.81 2.37 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.686 0.755 . . . . 0.0 112.873 -176.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.3 pp0? -71.46 -14.98 62.31 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -171.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 2.1 mt 69.54 146.53 0.11 Allowed Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 124.394 1.059 . . . . 0.0 113.853 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.497 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 48.1 Cg_endo -69.23 169.11 19.0 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 121.968 1.778 . . . . 0.0 112.346 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -115.22 104.69 12.08 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.821 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 724' ' ' THR . 87.3 m -84.8 99.74 11.09 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.653 0.739 . . . . 0.0 110.112 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.632 ' CG1' ' HG3' ' A' ' 749' ' ' LYS . 41.7 t -92.8 142.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.537 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.614 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.32 2.29 0.62 Allowed 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 125.857 1.663 . . . . 0.0 114.624 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.784 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 49.0 mt 78.33 -14.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 126.063 1.745 . . . . 0.0 111.699 176.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 746' ' ' ALA . 24.9 t70 -83.88 -30.14 26.65 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.729 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.632 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 7.8 ptmt -110.58 29.78 7.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.002 -1.453 . . . . 0.0 111.838 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.784 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 96.2 mt -84.33 176.1 8.94 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.827 177.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -99.81 145.31 27.87 Favored 'General case' 0 N--CA 1.388 -3.564 0 CA-C-O 122.727 1.251 . . . . 0.0 110.293 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -98.17 111.84 24.02 Favored 'General case' 1 C--N 1.236 -4.366 0 CA-C-N 111.248 -2.705 . . . . 0.0 109.21 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 42.5 m -66.99 138.54 57.32 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.867 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -107.95 136.39 47.73 Favored 'General case' 0 C--N 1.27 -2.867 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.407 -174.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 15.5 p -52.75 132.82 36.92 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.842 173.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.566 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 29.8 t -80.46 166.75 20.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -93.36 -17.28 23.72 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 804' ' ' SER . 74.5 mt -113.23 14.37 19.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.299 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.566 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.1 pp -115.05 149.18 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.961 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . 0.542 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.2 mp -107.95 129.95 61.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.862 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -177.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.535 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 1.9 mm? -108.17 178.76 4.41 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -77.96 172.21 13.84 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -66.47 -8.77 28.42 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 122.952 0.501 . . . . 0.0 112.035 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -93.13 -17.09 24.18 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.725 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 81.8 mt -117.03 -18.13 10.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -170.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -62.48 -26.17 68.39 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -101.42 8.35 42.21 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.714 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . 0.692 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 19.2 ttmm -98.42 94.93 6.99 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.23 -30.3 66.17 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.952 -177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.83 123.24 20.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.558 0.694 . . . . 0.0 110.915 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.692 ' CD2' ' HD2' ' A' ' 768' ' ' LYS . 14.2 m-85 -101.51 156.51 17.43 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.709 -174.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -98.7 156.12 16.99 Favored 'General case' 0 C--N 1.281 -2.393 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.011 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.572 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 47.5 t60 -59.16 137.47 57.95 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.238 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 84.93 12.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 O-C-N 125.633 1.833 . . . . 0.0 109.746 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 58.7 m -87.32 117.78 26.32 Favored 'General case' 0 N--CA 1.41 -2.473 0 C-N-CA 119.208 -0.997 . . . . 0.0 108.783 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.486 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -91.96 107.37 19.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.725 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 5.6 pt -118.9 -175.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.414 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 17.3 ptp180 -147.13 128.5 14.88 Favored 'General case' 0 N--CA 1.399 -2.979 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 173.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.526 ' CD2' HG11 ' A' ' 801' ' ' VAL . 10.3 p90 -108.36 169.54 8.57 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . 0.542 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 15.3 ptt180 -144.81 154.18 42.41 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 173.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.519 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 5.5 t -96.76 158.61 15.35 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -65.69 -22.94 66.67 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -103.42 -1.35 47.2 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.606 175.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.519 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 5.0 mptp? -108.56 103.09 12.14 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 122.616 -0.344 . . . . 0.0 110.879 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.84 86.43 6.92 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.512 1.148 . . . . 0.0 108.528 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 157.31 145.27 4.16 Favored Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 52.6 m95 -92.34 145.23 24.64 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.522 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -97.79 -27.56 3.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.948 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 15.1 m170 72.53 123.61 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.842 1.257 . . . . 0.0 109.135 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.539 ' HA ' ' HD2' ' A' ' 799' ' ' PRO . 3.1 t -145.28 156.75 44.01 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.887 0.375 . . . . 0.0 111.142 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 34.7 t -118.95 135.04 60.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 C-N-CA 122.639 0.376 . . . . 0.0 110.132 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.3 t -69.97 118.79 13.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.572 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 47.2 mm -117.84 87.17 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 124.338 1.055 . . . . 0.0 108.526 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 42.9 67.69 0.59 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.373 1.069 . . . . 0.0 113.272 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 74.69 23.35 75.32 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 115.06 -0.973 . . . . 0.0 114.127 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -150.02 166.24 30.3 Favored 'General case' 0 C--O 1.197 -1.681 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.508 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 91.2 m95 -114.82 157.13 23.7 Favored 'General case' 0 C--N 1.264 -3.142 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -148.75 106.24 3.46 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . 0.539 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 38.0 Cg_endo -66.32 138.73 40.27 Favored 'Cis proline' 0 C--O 1.237 0.443 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.014 -0.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.9 tt0 -53.56 134.77 40.99 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.863 0.865 . . . . 0.0 110.888 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 779' ' ' TYR . 57.9 t -99.8 117.12 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.534 -176.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -159.89 116.53 2.52 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 65.2 m -124.53 13.6 8.76 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 804' ' ' SER . . . . . 0.737 ' HA ' HD12 ' A' ' 758' ' ' LEU . 7.4 m . . . . . 0 N--CA 1.416 -2.145 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.501 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.4 m -73.44 -66.57 0.68 Allowed 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.17 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 124.57 -156.0 18.48 Favored Glycine 1 N--CA 1.363 -6.213 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -36.87 123.93 0.86 Allowed 'General case' 0 C--N 1.278 -2.534 0 O-C-N 126.52 1.953 . . . . 0.0 112.239 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.654 HG23 HG22 ' A' ' 715' ' ' VAL . 1.5 pp -69.3 146.54 96.73 Favored Pre-proline 0 N--CA 1.415 -2.198 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.271 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.427 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 72.4 Cg_endo -72.08 -165.31 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.767 2.312 . . . . 0.0 112.444 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.68 161.42 35.18 Favored 'General case' 0 N--CA 1.394 -3.265 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.542 HD22 ' HB3' ' A' ' 717' ' ' PHE . 21.7 tp -106.07 117.97 35.41 Favored 'General case' 1 C--N 1.244 -4.017 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.186 -177.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -33.55 -44.91 0.15 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.403 2.281 . . . . 0.0 115.288 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 91.5 m-70 -137.57 25.09 2.89 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -136.76 -142.19 4.39 Favored Glycine 0 CA--C 1.497 -1.044 0 C-N-CA 120.094 -1.051 . . . . 0.0 112.252 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -158.59 174.53 14.92 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.37 145.78 32.46 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 57.3 mm-40 -89.03 -80.76 0.29 Allowed 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.052 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 53.5 tp -160.6 151.46 18.7 Favored 'General case' 0 C--O 1.243 0.749 0 O-C-N 122.458 -0.151 . . . . 0.0 110.683 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.637 ' CB ' HG21 ' A' ' 715' ' ' VAL . 23.5 t -166.19 -54.29 0.03 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.434 0.693 . . . . 0.0 110.38 172.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 37.4 m 70.66 142.82 0.09 OUTLIER Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.916 1.686 . . . . 0.0 113.085 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.52 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 58.1 Cg_endo -63.63 176.53 2.21 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 123.809 3.006 . . . . 0.0 113.089 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.52 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.9 Cg_exo -77.15 -7.21 30.43 Favored 'Cis proline' 0 N--CA 1.498 1.737 0 N-CA-C 114.67 0.989 . . . . 0.0 114.67 3.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.428 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 58.9 m-85 74.41 82.21 0.11 Allowed 'General case' 0 C--N 1.309 -1.167 0 O-C-N 124.515 1.134 . . . . 0.0 110.333 177.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -86.24 173.51 9.72 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.35 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -69.37 135.2 50.0 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.85 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.21 -18.69 57.02 Favored Glycine 0 N--CA 1.422 -2.278 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.207 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.22 155.15 40.28 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.228 0.537 . . . . 0.0 111.588 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 11.8 m -135.86 157.15 47.54 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.663 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.654 HG22 HG23 ' A' ' 694' ' ' ILE . 23.5 t -137.64 129.3 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 41.6 mt-10 -77.16 138.05 39.25 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 123.675 0.609 . . . . 0.0 111.733 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.542 ' HB3' HD22 ' A' ' 697' ' ' LEU . 32.7 m-85 -140.53 129.97 23.95 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 124.483 1.113 . . . . 0.0 108.698 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.433 ' O ' HD21 ' A' ' 697' ' ' LEU . 10.9 m-80 -138.05 -164.81 1.68 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 10.8 m -118.99 139.74 51.18 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 6.1 m -62.49 -79.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 O-C-N 123.65 0.594 . . . . 0.0 111.613 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 722' ' ' SER . 42.6 mt-10 -148.11 161.93 40.43 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 66.6 m 71.03 -6.36 1.32 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.516 1.135 . . . . 0.0 112.859 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.552 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 93.8 m-85 -131.74 146.57 52.23 Favored 'General case' 0 N--CA 1.392 -3.361 0 CA-C-O 121.88 0.848 . . . . 0.0 108.959 -175.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 0.9 OUTLIER -116.68 143.82 45.18 Favored 'General case' 1 C--N 1.241 -4.129 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.204 179.873 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.536 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.7 ttp -86.22 123.92 32.04 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.557 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 45.0 mm -121.44 137.45 55.06 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 113.17 -90.76 0.55 Allowed Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.573 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 27.6 t60 -159.95 143.35 14.07 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.536 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.8 ppt_? -81.67 17.18 1.52 Allowed 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -174.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 22.0 p -161.21 153.28 19.82 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.791 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . . . . . . . . . 27.3 pt -104.85 168.61 2.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.407 -179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 11.3 m -138.32 135.56 35.53 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.447 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 9.5 t -83.67 105.11 14.32 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.44 0.638 . . . . 0.0 109.94 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -140.31 144.62 27.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 124.695 1.198 . . . . 0.0 110.344 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 69.75 -11.26 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.55 0.74 . . . . 0.0 112.673 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 113.37 10.77 14.52 Favored Glycine 0 C--O 1.242 0.617 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . 0.484 HG11 ' O ' ' A' ' 738' ' ' TRP . 58.8 t -142.23 154.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.484 ' O ' HG11 ' A' ' 737' ' ' VAL . 95.5 m95 -78.76 172.53 13.6 Favored 'General case' 0 C--N 1.273 -2.727 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.211 170.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.9 p -74.09 -165.69 0.33 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.846 0.831 . . . . 0.0 111.211 178.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.5 OUTLIER -83.38 -3.03 57.14 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -166.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 3.9 mm? 72.79 157.25 0.16 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 124.15 0.906 . . . . 0.0 109.639 -174.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.573 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 26.2 Cg_endo -71.64 179.72 4.45 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.232 1.288 . . . . 0.0 110.825 171.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . 0.452 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 52.0 tt0 -117.36 105.4 12.12 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 724' ' ' THR . 95.4 m -89.43 103.51 16.14 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 121.397 0.617 . . . . 0.0 110.236 177.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.523 ' C ' ' H ' ' A' ' 747' ' ' ILE . 34.7 t -97.92 144.32 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.022 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.582 ' O ' ' HB ' ' A' ' 747' ' ' ILE . . . -64.93 5.2 0.35 Allowed 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 125.73 1.612 . . . . 0.0 113.531 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.582 ' HB ' ' O ' ' A' ' 746' ' ' ALA . 59.0 mt 77.15 -17.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 125.932 1.693 . . . . 0.0 111.239 176.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 746' ' ' ALA . 3.2 t70 -75.86 -31.76 59.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.517 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -103.29 21.65 15.53 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.243 -173.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.83 ' HG ' HD21 ' A' ' 794' ' ' ASN . 0.4 OUTLIER -85.36 -177.88 6.59 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 113.83 -1.532 . . . . 0.0 107.778 175.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . 0.596 ' HB3' ' N ' ' A' ' 795' ' ' GLY . 39.0 tptt -98.19 161.33 13.76 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 14.5 mmmm -101.96 112.7 25.42 Favored 'General case' 1 C--N 1.233 -4.493 0 CA-C-N 112.237 -2.256 . . . . 0.0 107.452 -177.423 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 150.07 41.15 Favored 'General case' 0 C--N 1.257 -3.419 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.184 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 769' ' ' LYS . 88.4 tttt -126.94 136.77 52.73 Favored 'General case' 0 C--N 1.258 -3.391 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.69 -174.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 46.6 p -63.78 112.89 3.08 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.622 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.603 ' HB2' HG12 ' A' ' 759' ' ' ILE . 49.1 m -61.94 133.5 55.47 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 173.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.13 4.31 8.81 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.026 0.917 . . . . 0.0 111.134 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.19 -21.88 16.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.978 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.603 HG12 ' HB2' ' A' ' 756' ' ' SER . 31.3 pt -103.27 167.97 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.401 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.837 -174.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.39 130.73 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.248 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.459 HD11 HD13 ' A' ' 777' ' ' ILE . 1.9 mm? -108.95 -177.12 3.22 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.786 ' HB2' HD22 ' A' ' 765' ' ' LEU . 40.3 mt-10 -72.04 175.15 6.17 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.49 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . 0.416 ' HA ' ' HE2' ' A' ' 766' ' ' LYS . 40.9 mt-10 -77.84 4.59 11.47 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -171.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . 0.472 ' HB2' HD23 ' A' ' 765' ' ' LEU . 16.5 m-70 -108.13 -22.26 12.45 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 171.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.786 HD22 ' HB2' ' A' ' 762' ' ' GLU . 2.6 mm? -101.37 -13.18 18.11 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.681 -168.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' A' ' 763' ' ' GLU . 50.6 mtmt -75.59 -19.92 58.93 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -85.25 -3.76 58.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.243 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . 0.465 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 9.9 tppt? -106.12 107.5 18.53 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 754' ' ' LYS . 38.0 ttpt -85.82 -37.63 19.02 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . 0.419 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 47.2 mt-10 -117.48 118.02 31.05 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.511 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.465 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 66.6 m-85 -102.56 174.44 5.9 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.46 167.68 10.52 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.545 ' CB ' HD21 ' A' ' 750' ' ' LEU . 19.2 t60 -70.48 151.33 45.23 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 8.0 t30 83.36 3.17 0.95 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.998 1.436 . . . . 0.0 109.225 177.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 66.7 m -82.14 112.64 19.37 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.567 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -88.89 109.89 20.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.459 HD13 HD11 ' A' ' 761' ' ' LEU . 9.5 pt -126.15 178.19 4.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.589 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 25.6 ptt180 -131.55 128.96 40.34 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -118.03 169.16 9.89 Favored 'General case' 0 C--O 1.259 1.576 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -150.72 157.11 42.56 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.553 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 35.6 t -81.98 159.48 23.54 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -69.53 -23.3 63.57 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.762 0.315 . . . . 0.0 111.137 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -102.97 -9.03 40.79 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.813 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.3 mptt -115.89 122.89 46.69 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.915 0.358 . . . . 0.0 110.158 -177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -95.87 99.61 11.39 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.53 0.681 . . . . 0.0 109.886 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 159.78 143.22 3.6 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.589 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 34.6 m95 -98.79 144.78 27.64 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 117.402 0.601 . . . . 0.0 109.838 -174.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.419 HD11 ' N ' ' A' ' 788' ' ' ILE . 3.6 mp -99.17 -31.32 3.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.009 -177.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.459 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 12.4 m170 72.23 120.1 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 124.414 1.086 . . . . 0.0 110.152 -174.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.419 HG21 ' CG1' ' A' ' 801' ' ' VAL . 3.5 t -139.19 156.58 47.01 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.094 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 71.0 t -118.08 130.31 73.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . 0.52 ' HB3' ' HA ' ' A' ' 773' ' ' HIS . 49.0 t -66.55 134.63 52.76 Favored 'General case' 0 CA--C 1.479 -1.769 0 C-N-CA 118.841 -1.144 . . . . 0.0 109.299 176.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . 0.54 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 49.4 mm -124.68 90.3 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.83 HD21 ' HG ' ' A' ' 750' ' ' LEU . 18.7 t-20 44.22 73.5 0.15 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.001 0.92 . . . . 0.0 112.471 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . 0.596 ' N ' ' HB3' ' A' ' 751' ' ' LYS . . . 77.8 -11.23 21.38 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.615 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -117.33 178.11 4.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -175.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.537 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 99.0 m95 -122.08 162.02 21.99 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 117.761 0.255 . . . . 0.0 110.779 178.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -148.23 105.0 3.56 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.446 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -67.42 138.5 42.54 Favored 'Cis proline' 0 C--O 1.247 0.972 0 C-N-CA 123.791 -1.337 . . . . 0.0 111.344 -1.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 13.6 tt0 -55.02 119.1 4.93 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.068 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.419 ' CG1' HG21 ' A' ' 790' ' ' THR . 16.6 m -61.63 137.37 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.945 0 C-N-CA 123.73 0.812 . . . . 0.0 112.487 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -145.64 149.42 34.47 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 32.7 t -142.49 27.59 1.7 Allowed 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.628 1.204 . . . . 0.0 108.644 178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.156 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.443 -0.779 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 65.1 m -72.28 -75.97 0.12 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.026 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 141.37 -145.24 15.63 Favored Glycine 1 N--CA 1.379 -5.163 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -53.02 133.65 38.38 Favored 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 125.369 1.468 . . . . 0.0 111.814 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.66 HG23 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -76.05 148.1 81.04 Favored Pre-proline 0 N--CA 1.41 -2.474 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.885 176.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.416 ' HG2' HD22 ' A' ' 741' ' ' LEU . 53.5 Cg_endo -71.04 -163.72 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.347 2.698 . . . . 0.0 112.625 176.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . 0.435 ' HA ' ' HE2' ' A' ' 717' ' ' PHE . 15.5 pt-20 -148.76 169.58 20.13 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.632 HD11 ' SG ' ' A' ' 744' ' ' CYS . 17.0 mt -102.77 146.44 28.25 Favored 'General case' 0 C--N 1.27 -2.851 0 O-C-N 123.792 0.682 . . . . 0.0 111.197 175.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.62 -37.69 87.3 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.168 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 744' ' ' CYS . 96.0 m-70 -140.06 27.8 2.15 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.04 0.448 . . . . 0.0 110.688 -177.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -140.65 -146.02 4.72 Favored Glycine 0 C--N 1.297 -1.615 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -156.58 171.84 19.62 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 117.216 0.508 . . . . 0.0 111.305 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.23 144.86 33.41 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 703' ' ' GLN . 13.7 mt-30 -73.36 -79.75 0.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.21 0.318 . . . . 0.0 111.197 177.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 8.3 tt 172.67 130.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.63 ' CB ' HG23 ' A' ' 715' ' ' VAL . 22.7 t -131.18 -32.67 1.57 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.653 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 32.9 t 74.3 124.07 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.04 1.336 . . . . 0.0 112.41 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.465 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 37.3 Cg_endo -61.24 176.7 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.891 3.061 . . . . 0.0 111.564 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.515 ' O ' ' HB2' ' A' ' 709' ' ' TYR . 13.3 Cg_exo -71.72 -18.86 14.12 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 N-CA-C 114.626 0.972 . . . . 0.0 114.626 4.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.515 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 45.6 m-85 83.29 90.6 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.119 0 O-C-N 124.771 1.294 . . . . 0.0 110.885 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -91.93 176.03 6.66 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.205 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -72.71 136.86 45.65 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.028 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 93.02 -10.82 73.24 Favored Glycine 0 N--CA 1.417 -2.63 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.428 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.61 150.87 44.25 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 14.2 m -138.69 148.96 44.6 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.66 HG21 HG23 ' A' ' 694' ' ' ILE . 21.2 t -130.27 130.38 65.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.5 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 41.3 mt-10 -89.58 135.91 33.33 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 123.658 0.599 . . . . 0.0 111.269 -177.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.597 ' HD2' ' HG ' ' A' ' 697' ' ' LEU . 25.7 m-85 -132.23 132.34 42.99 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 124.521 1.128 . . . . 0.0 109.053 -177.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -137.97 -162.68 1.33 Allowed 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 7.6 m -120.0 140.41 51.0 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 43.1 t -50.6 -72.44 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 O-C-N 124.216 0.948 . . . . 0.0 110.909 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 722' ' ' SER . 0.5 OUTLIER -173.28 163.2 4.54 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 173.62 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 73.9 m 67.41 16.99 10.1 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 124.189 0.93 . . . . 0.0 111.271 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.715 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 87.4 m-85 -147.38 149.13 32.16 Favored 'General case' 0 N--CA 1.405 -2.703 0 C-N-CA 125.976 1.71 . . . . 0.0 107.685 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.532 ' HB ' HD12 ' A' ' 750' ' ' LEU . 1.1 m -117.5 144.93 44.57 Favored 'General case' 0 C--N 1.278 -2.522 0 O-C-N 123.805 0.69 . . . . 0.0 110.58 -176.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.48 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.5 ttp -99.1 123.32 43.31 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 123.564 0.745 . . . . 0.0 109.685 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.451 HD13 ' ND2' ' A' ' 794' ' ' ASN . 48.8 mm -121.14 143.68 32.64 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 114.4 -89.42 0.51 Allowed Glycine 0 C--N 1.3 -1.429 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.491 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 53.0 t60 -169.03 141.4 2.64 Favored 'General case' 0 CA--C 1.475 -1.921 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.48 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.7 OUTLIER -82.64 20.26 1.16 Allowed 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -172.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.5 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 2.8 p -162.53 159.34 24.71 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.812 -0.555 . . . . 0.0 112.14 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.49 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 39.4 pt -120.09 163.56 17.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.003 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 20.9 m -136.0 137.7 41.49 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 2.4 t -85.76 108.38 18.05 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.105 0.478 . . . . 0.0 110.003 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.24 143.09 21.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 124.811 1.245 . . . . 0.0 109.624 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 68.46 -1.09 2.0 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.212 0.605 . . . . 0.0 112.599 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.21 19.33 30.88 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 738' ' ' TRP . 24.9 t -141.62 150.99 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.462 ' O ' HG13 ' A' ' 737' ' ' VAL . 96.8 m95 -80.65 170.3 16.51 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 121.712 -0.618 . . . . 0.0 109.66 168.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.49 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 40.6 p -77.14 -166.49 0.72 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.521 0.677 . . . . 0.0 112.001 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.6 OUTLIER -73.96 -15.71 61.1 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -167.241 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.416 HD22 ' HG2' ' A' ' 695' ' ' PRO . 2.3 mt 68.85 151.53 0.13 Allowed Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.491 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 56.4 Cg_endo -75.74 179.26 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.332 2.021 . . . . 0.0 111.347 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -126.08 114.61 18.63 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.632 ' SG ' HD11 ' A' ' 697' ' ' LEU . 77.7 m -93.64 114.77 27.17 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 122.073 0.939 . . . . 0.0 110.278 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.638 ' CG1' HD21 ' A' ' 750' ' ' LEU . 11.8 p -97.4 159.77 3.08 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.279 0 CA-C-N 113.071 -1.877 . . . . 0.0 108.91 -178.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.715 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -80.5 -1.83 43.42 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.869 -177.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.634 ' HB ' ' O ' ' A' ' 746' ' ' ALA . 18.2 mt 77.41 -20.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 125.526 1.53 . . . . 0.0 111.701 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 746' ' ' ALA . 32.8 t70 -84.56 -19.25 33.42 Favored 'General case' 0 C--N 1.253 -3.614 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.19 -171.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 749' ' ' LYS . 10.5 ptpt -113.03 30.14 7.42 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.142 176.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.638 HD21 ' CG1' ' A' ' 745' ' ' VAL . 57.0 mt -89.05 -170.26 2.83 Favored 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.355 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . 0.434 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 58.9 mtpt -128.16 154.08 46.17 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . 0.446 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 93.3 mttt -100.97 145.97 27.99 Favored 'General case' 0 C--N 1.248 -3.828 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.301 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 89.3 m -89.15 160.15 17.14 Favored 'General case' 1 C--N 1.235 -4.376 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.419 179.355 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -118.7 133.19 56.03 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.77 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 42.3 t -59.17 116.21 3.71 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.659 ' HB2' ' CG1' ' A' ' 759' ' ' ILE . 18.4 m -79.36 135.14 36.63 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -76.14 4.36 8.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.745 0.783 . . . . 0.0 112.126 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.4 -14.63 14.82 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.279 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.659 ' CG1' ' HB2' ' A' ' 756' ' ' SER . 2.3 pp -114.06 151.39 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 121.262 0.553 . . . . 0.0 111.319 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.32 134.15 52.26 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.454 HD13 HD12 ' A' ' 777' ' ' ILE . 1.9 mm? -110.24 171.83 7.22 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -55.18 153.27 7.0 Favored 'General case' 0 C--O 1.208 -1.088 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.99 -2.97 14.14 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 118.245 0.475 . . . . 0.0 112.045 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -83.22 -37.5 23.51 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.687 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 96.8 mt -93.31 -16.46 24.69 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.599 -172.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -75.9 2.21 13.07 Favored 'General case' 1 N--CA 1.369 -4.49 0 CA-C-O 122.127 0.965 . . . . 0.0 110.188 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -120.1 9.34 11.13 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.175 173.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -102.89 130.05 49.8 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -95.71 -38.35 10.39 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-O 122.441 1.115 . . . . 0.0 108.119 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -129.55 129.43 44.46 Favored 'General case' 0 N--CA 1.409 -2.517 0 CA-C-N 113.283 -1.78 . . . . 0.0 109.749 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.528 ' HB2' ' HB2' ' A' ' 753' ' ' CYS . 73.3 m-85 -105.94 142.47 35.6 Favored 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.955 -177.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.7 155.59 18.18 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -49.23 152.01 1.29 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.065 0.946 . . . . 0.0 111.607 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 67.71 4.93 4.14 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.715 0.806 . . . . 0.0 111.376 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 8.2 t -81.23 111.76 17.93 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.422 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.8 OUTLIER -81.85 112.69 19.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.687 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.5 pt -123.71 174.2 8.3 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.712 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.523 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 95.4 mtt180 -125.93 128.93 48.3 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 174.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.615 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 6.3 p90 -120.0 167.35 12.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -147.76 157.14 43.4 Favored 'General case' 0 C--N 1.267 -2.991 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.524 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 17.3 t -93.58 147.18 23.23 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -73.78 -12.35 60.67 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.084 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -112.93 0.68 25.73 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.894 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 1.2 mptm? -118.16 -50.71 2.46 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 72.78 140.18 0.06 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.25 1.02 . . . . 0.0 110.768 -174.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 103.17 140.75 11.01 Favored Glycine 0 CA--C 1.493 -1.316 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.523 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 29.3 m95 -89.6 143.27 26.95 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.052 0.453 . . . . 0.0 111.373 -171.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.615 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -102.95 -26.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.013 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 17.6 m170 71.9 119.16 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.948 0 C-N-CA 124.033 0.933 . . . . 0.0 110.733 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 4.1 t -143.13 157.42 44.53 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.64 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 47.5 t -119.67 135.24 60.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.57 114.18 10.41 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.668 0.747 . . . . 0.0 110.168 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.6 mm -112.66 82.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 C-N-CA 124.04 0.936 . . . . 0.0 108.494 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.589 ' OD1' HD23 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 51.32 67.74 0.9 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.76 176.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 78.95 3.05 87.75 Favored Glycine 0 C--N 1.299 -1.514 0 C-N-CA 120.299 -0.953 . . . . 0.0 114.334 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -134.03 167.89 19.8 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 87.3 m95 -113.92 158.79 20.64 Favored 'General case' 0 C--N 1.26 -3.298 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -149.0 107.61 3.43 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -71.18 142.12 71.89 Favored 'Cis proline' 0 C--O 1.246 0.889 0 C-N-CA 123.552 -1.436 . . . . 0.0 112.687 -0.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.527 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 43.9 mt-10 -53.58 126.89 23.3 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.637 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 7.7 m -70.45 141.66 16.72 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.825 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -162.44 132.01 4.44 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.937 -172.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 12.4 m -124.08 -5.84 7.85 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--N 1.308 -1.231 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 176.865 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 45.0 m -64.69 -71.91 0.17 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.75 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 134.84 -164.5 24.71 Favored Glycine 1 N--CA 1.367 -5.952 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -43.17 119.68 1.62 Allowed 'General case' 0 C--N 1.276 -2.613 0 C-N-CA 126.173 1.789 . . . . 0.0 111.552 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.62 HG23 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -58.28 149.32 59.23 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.482 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.489 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 70.6 Cg_endo -71.01 -163.89 0.14 Allowed 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 123.001 2.467 . . . . 0.0 111.818 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.63 154.91 51.17 Favored 'General case' 0 N--CA 1.393 -3.322 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 717' ' ' PHE . 18.7 tp -98.61 127.35 44.51 Favored 'General case' 0 C--N 1.25 -3.74 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.433 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 6.8 pt-20 -38.41 -61.01 0.73 Allowed 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 127.094 2.158 . . . . 0.0 114.349 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.751 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.2 m-70 -128.02 26.82 5.76 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -131.82 -155.06 7.92 Favored Glycine 0 N--CA 1.424 -2.115 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.405 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -145.48 174.28 11.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.639 0.257 . . . . 0.0 110.641 -175.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.83 137.17 46.31 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.422 ' HA ' ' NE2' ' A' ' 703' ' ' GLN . 24.5 mm-40 -86.11 -77.65 0.3 Allowed 'General case' 0 N--CA 1.427 -1.577 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.524 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . 0.607 HD13 ' N ' ' A' ' 705' ' ' SER . 1.9 tm? -167.72 163.1 14.25 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.607 ' N ' HD13 ' A' ' 704' ' ' LEU . 46.7 t -178.36 -62.71 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.402 1.481 . . . . 0.0 109.191 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 50.6 m 67.85 153.52 0.13 Allowed Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 125.155 1.382 . . . . 0.0 112.238 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.438 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 56.4 Cg_endo -62.95 171.94 5.45 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 123.015 2.477 . . . . 0.0 112.69 -175.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.608 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 1.9 Cg_endo -75.46 -8.18 25.04 Favored 'Cis proline' 0 N--CA 1.488 1.156 0 N-CA-C 115.235 1.206 . . . . 0.0 115.235 5.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 69.14 60.29 0.33 Allowed 'General case' 0 C--N 1.313 -0.983 0 O-C-N 124.297 0.998 . . . . 0.0 109.062 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.608 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 37.0 m-85 -68.04 173.33 4.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.429 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 0.739 ' HH ' ' HA2' ' A' ' 736' ' ' GLY . 47.3 m-85 -72.33 136.64 46.25 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.178 175.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.64 -18.88 56.58 Favored Glycine 0 C--N 1.286 -2.217 0 C-N-CA 120.422 -0.894 . . . . 0.0 110.876 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 143.14 55.21 Favored 'General case' 0 CA--C 1.478 -1.79 0 CA-C-O 121.348 0.594 . . . . 0.0 110.017 178.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 16.0 m -124.58 157.27 35.83 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.054 178.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.62 HG21 HG23 ' A' ' 694' ' ' ILE . 33.1 t -137.03 133.69 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -80.85 130.72 35.2 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 123.835 0.709 . . . . 0.0 110.901 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.541 ' HB3' HD23 ' A' ' 697' ' ' LEU . 27.6 m-85 -137.09 116.93 13.12 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 125.018 1.327 . . . . 0.0 108.232 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.405 ' O ' HD22 ' A' ' 697' ' ' LEU . 4.5 m-80 -127.23 -167.75 1.78 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 24.3 m -112.43 135.44 53.12 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 24.8 t -52.57 -67.63 0.24 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 124.187 0.929 . . . . 0.0 111.724 -170.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -171.32 156.88 4.77 Favored 'General case' 0 CA--C 1.476 -1.889 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 75.0 m 66.64 14.3 9.7 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 124.404 1.065 . . . . 0.0 111.242 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 85.0 m-85 -140.12 145.47 37.62 Favored 'General case' 0 N--CA 1.404 -2.755 0 C-N-CA 124.823 1.249 . . . . 0.0 108.596 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 5.5 t -97.59 151.71 19.79 Favored 'General case' 0 C--N 1.252 -3.631 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.756 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.4 ttp -108.72 118.39 36.66 Favored 'General case' 0 C--N 1.263 -3.155 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 41.9 mm -121.86 135.38 62.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 176.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 118.7 -81.85 0.33 Allowed Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 121.422 -0.418 . . . . 0.0 112.323 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . 0.474 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 43.3 t60 -171.05 138.33 1.26 Allowed 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.756 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.3 ppt_? -84.94 19.65 2.06 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 2.7 p -156.51 159.76 38.89 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.32 0.581 . . . . 0.0 112.119 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.506 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 36.1 pt -116.89 164.71 12.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.754 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 21.5 m -139.61 136.1 34.01 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.223 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 9.1 t -83.08 107.25 15.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.316 0.579 . . . . 0.0 109.765 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.422 ' O ' ' HB2' ' A' ' 735' ' ' HIS . 1.5 pp -145.46 151.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 124.721 1.208 . . . . 0.0 109.839 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 734' ' ' ILE . 82.6 m-70 73.61 -51.01 0.7 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.346 1.059 . . . . 0.0 110.625 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.739 ' HA2' ' HH ' ' A' ' 711' ' ' TYR . . . 148.45 34.28 0.05 OUTLIER Glycine 0 C--N 1.299 -1.489 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.0 p -165.85 159.49 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.489 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.9 m95 -77.63 175.6 9.74 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 172.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.506 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 18.3 p -80.12 -171.1 2.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.047 0.927 . . . . 0.0 112.658 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.7 OUTLIER -63.55 -15.77 58.94 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -172.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.6 mm? 69.59 141.65 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 32.8 Cg_endo -67.05 177.22 3.8 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.115 1.876 . . . . 0.0 112.035 174.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -121.84 129.73 52.84 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.751 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 73.8 m -113.84 103.8 11.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.11 0.481 . . . . 0.0 110.726 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.495 ' HB ' HG22 ' A' ' 724' ' ' THR . 46.6 t -97.27 143.7 12.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.55 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -60.49 2.33 0.1 Allowed 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 126.236 1.814 . . . . 0.0 115.293 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.823 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 19.4 mt 75.75 -13.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 C-N-CA 125.625 1.57 . . . . 0.0 111.956 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 746' ' ' ALA . 17.2 t70 -87.25 -25.88 23.75 Favored 'General case' 0 C--N 1.272 -2.772 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.533 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -103.09 20.53 17.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.358 -176.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.823 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 49.5 mt -84.53 -167.13 1.67 Allowed 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.773 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . 0.479 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 10.2 mtpm? -130.0 154.41 47.42 Favored 'General case' 0 N--CA 1.381 -3.915 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.505 -177.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . 0.67 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 55.2 mtpt -105.71 120.71 42.39 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 113.269 -1.787 . . . . 0.0 109.317 -175.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 56.0 m -74.34 159.05 32.91 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.403 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . 0.422 ' HB3' ' HE2' ' A' ' 754' ' ' LYS . 18.3 ptpt -132.32 151.49 51.82 Favored 'General case' 0 N--CA 1.401 -2.885 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.699 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 30.6 t -63.35 121.54 14.0 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.54 -1.663 . . . . 0.0 109.956 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.791 ' HB3' HG13 ' A' ' 759' ' ' ILE . 28.2 t -74.63 155.02 38.26 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.99 -1.4 57.27 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.09 -20.13 21.6 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.794 0.807 . . . . 0.0 109.08 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.791 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.5 pp -111.66 159.68 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.435 -177.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 19.9 mt -118.67 129.04 75.47 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.924 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.661 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . 0.461 HD13 HD11 ' A' ' 777' ' ' ILE . 1.8 mm? -105.6 -176.94 3.22 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.837 ' HB2' HD23 ' A' ' 765' ' ' LEU . 41.1 mt-10 -59.66 151.78 24.06 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . 0.405 ' HG2' ' HE2' ' A' ' 766' ' ' LYS . 40.6 mt-10 -72.25 1.19 8.09 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -171.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . 0.512 ' HB2' HD21 ' A' ' 765' ' ' LEU . 8.8 m-70 -90.51 -43.47 10.21 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 168.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . 0.837 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.3 mm? -78.5 -11.57 59.96 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.001 -168.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.405 ' HE2' ' HG2' ' A' ' 763' ' ' GLU . 47.4 mtmt -67.82 -18.69 64.92 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.79 13.38 24.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.563 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -113.16 110.96 21.29 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . 0.406 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 19.5 ptpt -83.55 -34.82 25.14 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.072 -1.051 . . . . 0.0 109.372 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . 0.67 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 45.3 mt-10 -128.83 135.56 49.29 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.757 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -115.49 142.65 46.43 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.387 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.19 163.67 18.56 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -62.4 150.5 39.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.438 0.161 . . . . 0.0 110.758 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 81.24 6.6 1.26 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.027 1.331 . . . . 0.0 110.345 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 38.9 m -80.68 105.72 12.14 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.406 HD21 ' N ' ' A' ' 776' ' ' ASN . 0.8 OUTLIER -86.42 101.87 13.53 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . 0.461 HD11 HD13 ' A' ' 761' ' ' LEU . 11.9 pt -113.25 -174.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 121.832 0.825 . . . . 0.0 109.376 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.584 ' HA ' ' HA ' ' A' ' 789' ' ' HIS . 19.9 ptt180 -139.24 134.79 33.16 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.544 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 11.0 p90 -123.44 166.33 15.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -147.4 154.85 41.37 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.476 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 0.8 OUTLIER -82.58 146.9 28.91 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-O 121.047 0.451 . . . . 0.0 111.943 178.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -64.26 103.78 0.67 Allowed 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 110.73 -7.9 29.83 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.476 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.476 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 0.8 OUTLIER -119.41 113.59 21.02 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -89.3 90.06 8.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.618 0.723 . . . . 0.0 110.975 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 172.02 141.78 3.51 Favored Glycine 0 CA--C 1.487 -1.674 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.561 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 44.5 m95 -101.53 145.44 29.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.992 0.396 . . . . 0.0 110.127 -174.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.544 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -100.04 -28.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.013 -178.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 25.6 m170 74.43 133.66 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.602 1.161 . . . . 0.0 108.911 -176.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.432 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.6 t -156.44 155.21 31.69 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 120.703 0.287 . . . . 0.0 111.154 178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.96 137.6 53.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.3 t -70.59 113.97 8.23 Favored 'General case' 0 C--O 1.255 1.377 0 CA-C-O 121.658 0.742 . . . . 0.0 110.359 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 47.4 mm -114.25 80.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 124.32 1.048 . . . . 0.0 109.317 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.559 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 52.2 65.57 1.47 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.77 175.506 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . 0.468 ' HA3' ' HZ3' ' A' ' 751' ' ' LYS . . . 73.87 21.2 79.52 Favored Glycine 0 C--N 1.303 -1.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.97 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -146.64 164.33 33.01 Favored 'General case' 0 C--O 1.202 -1.408 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.589 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.7 m95 -111.58 157.68 20.1 Favored 'General case' 0 C--N 1.246 -3.926 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -144.12 105.89 4.83 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 38.2 Cg_endo -70.14 139.03 53.31 Favored 'Cis proline' 0 C--O 1.248 1.006 0 C-N-CA 123.725 -1.365 . . . . 0.0 110.919 -0.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.589 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 26.5 tt0 -56.42 124.05 16.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 779' ' ' TYR . 14.0 m -57.58 124.76 12.29 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.381 0 C-N-CA 124.391 1.077 . . . . 0.0 110.585 -175.97 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -129.59 116.62 19.16 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.198 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 1.1 t -121.77 3.27 10.06 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.636 175.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 53.2 m . . . . . 0 N--CA 1.422 -1.859 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 176.532 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 59.7 m -68.02 -65.12 0.73 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 94.21 134.67 7.44 Favored Glycine 0 N--CA 1.42 -2.394 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.262 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 37.8 t70 46.28 101.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.134 1.774 . . . . 0.0 113.508 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.656 HG23 HG22 ' A' ' 715' ' ' VAL . 1.8 pp -59.34 151.33 59.72 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.289 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.404 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 37.7 Cg_endo -68.28 -157.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 123.039 2.492 . . . . 0.0 112.517 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.12 160.52 37.54 Favored 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.524 HD11 ' HA3' ' A' ' 700' ' ' GLY . 0.3 OUTLIER -99.16 133.05 43.99 Favored 'General case' 0 C--N 1.259 -3.356 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.563 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -49.06 -39.47 27.7 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 124.406 1.082 . . . . 0.0 113.689 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -143.21 28.05 1.54 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.129 0.49 . . . . 0.0 110.264 -177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -141.59 -146.05 4.64 Favored Glycine 0 C--N 1.299 -1.511 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.066 -177.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -151.08 -175.56 5.2 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -176.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -117.5 142.83 46.7 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -74.13 -78.2 0.1 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.204 0.526 . . . . 0.0 110.785 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.3 tt -149.87 130.41 13.95 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.419 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 67.9 p -117.65 -70.83 0.77 Allowed 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -176.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 23.3 t 64.16 123.99 0.02 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 125.696 1.598 . . . . 0.0 112.559 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.534 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 41.2 Cg_endo -63.66 176.0 2.54 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.456 2.771 . . . . 0.0 111.682 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.534 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 6.0 Cg_exo -77.6 -10.28 32.26 Favored 'Cis proline' 0 CA--C 1.504 -1.002 0 N-CA-C 115.017 1.122 . . . . 0.0 115.017 5.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 708' ' ' PRO . 56.7 m-85 72.56 78.74 0.15 Allowed 'General case' 0 C--O 1.245 0.868 0 O-C-N 124.248 0.967 . . . . 0.0 110.005 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 29.9 m-85 -85.48 171.51 11.71 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.492 0.663 . . . . 0.0 112.469 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -67.33 133.31 49.41 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.697 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.11 68.09 Favored Glycine 0 N--CA 1.418 -2.522 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.19 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.17 145.36 44.29 Favored 'General case' 0 CA--C 1.493 -1.214 0 O-C-N 122.085 -0.656 . . . . 0.0 110.706 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 14.2 m -131.07 151.04 51.85 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.656 HG22 HG23 ' A' ' 694' ' ' ILE . 34.4 t -134.99 140.1 45.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -85.64 123.44 31.05 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 124.128 0.893 . . . . 0.0 111.6 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -124.36 105.55 9.53 Favored 'General case' 0 C--N 1.273 -2.759 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -113.37 -162.68 0.81 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 5.0 m -113.47 134.44 54.66 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -178.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 39.5 t -65.64 -64.02 0.96 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 123.689 0.618 . . . . 0.0 110.87 -172.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -164.68 156.31 15.57 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 73.9 m 69.78 1.94 3.63 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.303 1.002 . . . . 0.0 113.171 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.574 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.1 m-85 -134.14 147.43 50.81 Favored 'General case' 0 N--CA 1.403 -2.795 0 C-N-CA 123.75 0.82 . . . . 0.0 109.078 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.541 ' HB ' HD12 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -113.5 138.13 50.57 Favored 'General case' 0 C--N 1.264 -3.122 0 C-N-CA 125.546 1.539 . . . . 0.0 110.445 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.487 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.7 ttp -86.64 121.93 29.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.65 1.18 . . . . 0.0 109.348 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.428 HD11 ' HA ' ' A' ' 726' ' ' ILE . 31.7 mm -111.87 127.4 69.08 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.973 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.132 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 99.2 -82.97 0.58 Allowed Glycine 0 CA--C 1.481 -2.051 0 CA-C-N 114.645 -1.162 . . . . 0.0 112.253 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -147.04 178.02 8.7 Favored 'General case' 0 N--CA 1.388 -3.55 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -174.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.487 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.2 OUTLIER -128.15 6.4 5.91 Favored 'General case' 0 C--O 1.2 -1.546 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.637 -177.41 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 3.1 p -126.54 160.1 31.58 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 119.07 -1.052 . . . . 0.0 113.732 -172.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 714' ' ' SER . 36.6 pt -119.66 159.51 20.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.106 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 14.6 m -134.77 135.28 41.74 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.791 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 7.6 t -86.01 104.13 15.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.156 0.503 . . . . 0.0 109.953 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.7 pp -144.69 147.45 19.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 124.655 1.182 . . . . 0.0 110.037 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 64.9 4.07 2.31 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 96.81 24.87 12.41 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.14 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.04 162.22 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.404 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.3 m95 -80.29 173.08 12.96 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.485 ' HB ' ' NE2' ' A' ' 740' ' ' GLN . 23.6 p -78.8 -162.44 0.38 Allowed 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.837 0.827 . . . . 0.0 112.42 -177.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.553 ' H ' ' NE2' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -84.89 2.01 44.58 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 124.453 1.101 . . . . 0.0 113.575 -167.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.421 HD13 HG23 ' A' ' 731' ' ' ILE . 4.1 mm? 71.21 155.87 0.16 Allowed Pre-proline 0 N--CA 1.483 1.215 0 O-C-N 123.667 0.605 . . . . 0.0 111.557 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -80.24 -173.58 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.219 1.946 . . . . 0.0 111.963 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -123.15 104.62 9.29 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 122.359 -0.213 . . . . 0.0 110.533 -176.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.429 ' SG ' HD11 ' A' ' 697' ' ' LEU . 86.8 m -96.99 114.35 25.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.106 0.479 . . . . 0.0 110.776 172.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.455 ' CG1' ' HG3' ' A' ' 749' ' ' LYS . 58.8 t -108.29 146.79 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . 0.639 ' O ' ' HB ' ' A' ' 747' ' ' ILE . . . -64.74 2.52 0.67 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 125.726 1.611 . . . . 0.0 114.201 -175.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.803 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 37.1 mt 78.14 -24.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 125.482 1.513 . . . . 0.0 111.544 175.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 748' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 746' ' ' ALA . 28.7 t70 -81.4 -24.32 37.04 Favored 'General case' 0 C--N 1.258 -3.389 0 CA-C-N 112.893 -1.958 . . . . 0.0 109.248 -172.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 749' ' ' LYS . . . . . 0.455 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 1.7 ptmm? -115.46 23.6 12.26 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.919 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.803 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 55.1 mt -81.41 -168.88 2.03 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.442 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 751' ' ' LYS . . . . . 0.544 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 30.0 mtpp -122.63 158.43 30.02 Favored 'General case' 0 N--CA 1.396 -3.167 0 CA-C-O 121.836 0.827 . . . . 0.0 109.085 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -110.25 138.23 46.91 Favored 'General case' 0 C--N 1.245 -3.939 0 CA-C-N 113.184 -1.825 . . . . 0.0 107.943 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 753' ' ' CYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 78.2 m -85.39 178.99 7.26 Favored 'General case' 0 C--N 1.252 -3.649 0 CA-C-N 113.416 -1.72 . . . . 0.0 110.517 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -140.87 141.54 34.61 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 755' ' ' SER . . . . . 0.407 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 5.4 p -62.78 128.35 35.52 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 123.622 0.576 . . . . 0.0 110.467 173.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 756' ' ' SER . . . . . 0.603 ' HB2' ' CG1' ' A' ' 759' ' ' ILE . 9.5 m -75.35 162.99 27.91 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -89.76 -15.36 32.59 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 758' ' ' LEU . . . . . 0.405 HD22 ' NH2' ' A' ' 782' ' ' ARG . 40.2 mt -93.71 -18.43 22.12 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.66 0.743 . . . . 0.0 110.159 -174.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 759' ' ' ILE . . . . . 0.603 ' CG1' ' HB2' ' A' ' 756' ' ' SER . 2.4 pp -100.24 160.16 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.61 135.79 56.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 761' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -110.29 -179.28 3.73 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 762' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 42.0 mt-10 -63.55 157.22 24.23 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.73 -18.43 64.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.209 0.528 . . . . 0.0 111.045 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -95.63 -0.12 52.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.922 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 765' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -124.72 -11.78 7.2 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 57.1 mtmt -69.5 -21.05 63.71 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.546 0.689 . . . . 0.0 110.598 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -88.15 14.02 10.1 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.097 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 768' ' ' LYS . . . . . 0.517 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 12.0 tppt? -110.52 117.33 33.26 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.89 -43.1 20.4 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.72 117.59 23.78 Favored 'General case' 0 CA--C 1.483 -1.599 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.003 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 771' ' ' PHE . . . . . 0.517 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 88.3 m-85 -91.13 136.01 33.38 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -78.73 143.21 36.4 Favored 'General case' 0 C--N 1.276 -2.593 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.537 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 773' ' ' HIS . . . . . 0.662 ' CD2' HD11 ' A' ' 750' ' ' LEU . 47.9 p-80 -40.05 138.55 0.81 Allowed 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 124.948 1.299 . . . . 0.0 111.696 171.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 74.14 6.38 4.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.796 1.638 . . . . 0.0 113.279 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 70.5 m -75.38 116.69 16.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.442 ' N ' HD21 ' A' ' 776' ' ' ASN . 0.7 OUTLIER -86.01 102.16 13.56 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 777' ' ' ILE . . . . . . . . . . . . . 7.8 pt -113.93 179.56 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.676 0.751 . . . . 0.0 109.76 -177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.548 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 98.8 mtt180 -127.35 119.98 27.49 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 779' ' ' TYR . . . . . 0.668 ' CD2' HG12 ' A' ' 801' ' ' VAL . 13.5 p90 -105.58 164.14 12.13 Favored 'General case' 0 C--O 1.26 1.611 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 171.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -147.76 157.25 43.45 Favored 'General case' 0 C--N 1.263 -3.157 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 781' ' ' CYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 42.8 t -96.23 163.54 13.05 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -176.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 782' ' ' ARG . . . . . 0.405 ' NH2' HD22 ' A' ' 758' ' ' LEU . 21.3 ptt180 -82.57 -23.0 34.67 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 120.992 0.425 . . . . 0.0 110.356 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -94.15 -13.27 54.9 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.078 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 784' ' ' LYS . . . . . 0.555 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 0.1 OUTLIER -131.19 98.46 4.57 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -88.52 87.92 7.44 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.237 1.018 . . . . 0.0 111.339 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -173.63 152.55 15.56 Favored Glycine 0 CA--C 1.479 -2.157 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 787' ' ' TRP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 26.2 m95 -93.18 134.81 34.98 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 117.571 0.685 . . . . 0.0 110.345 -172.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 788' ' ' ILE . . . . . 0.524 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.1 mp -94.61 -28.0 4.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.117 -177.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 18.7 m170 74.62 119.54 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 124.375 1.07 . . . . 0.0 109.835 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 790' ' ' THR . . . . . 0.434 HG22 ' CG2' ' A' ' 801' ' ' VAL . 3.8 t -143.65 160.77 40.09 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.169 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.32 135.78 60.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 123.897 0.879 . . . . 0.0 109.427 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 52.8 t -72.52 103.07 3.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.05 0.928 . . . . 0.0 110.854 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.6 mm -99.28 79.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.499 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 794' ' ' ASN . . . . . 0.655 ' OD1' HD21 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 50.39 68.81 0.7 Allowed 'General case' 0 C--O 1.238 0.447 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.771 176.145 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 80.2 6.28 89.28 Favored Glycine 0 C--N 1.306 -1.092 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.043 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -139.53 169.09 18.38 Favored 'General case' 0 C--O 1.198 -1.657 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 797' ' ' TRP . . . . . 0.537 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.6 m95 -111.43 161.09 16.47 Favored 'General case' 0 C--N 1.264 -3.112 0 O-C-N 122.293 -0.254 . . . . 0.0 110.429 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -150.33 106.23 3.14 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 799' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 34.8 Cg_endo -67.63 138.52 43.29 Favored 'Cis proline' 0 C--O 1.243 0.774 0 C-N-CA 123.651 -1.396 . . . . 0.0 111.103 -1.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 800' ' ' GLU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 30.1 tt0 -55.16 121.59 9.14 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.058 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 801' ' ' VAL . . . . . 0.668 HG12 ' CD2' ' A' ' 779' ' ' TYR . 91.8 t -63.07 123.21 15.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.233 -174.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -141.03 138.51 33.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 803' ' ' CYS . . . . . 0.421 ' HB2' HG22 ' A' ' 759' ' ' ILE . 21.7 t -131.38 23.89 4.8 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.594 1.188 . . . . 0.0 108.929 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 C--N 1.293 -1.885 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.018 176.293 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 35.9 m -72.87 -67.83 0.53 Allowed 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.33 0.586 . . . . 0.0 109.485 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 130.11 -161.46 23.08 Favored Glycine 1 N--CA 1.367 -5.938 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -41.14 116.19 0.7 Allowed 'General case' 0 C--N 1.274 -2.696 0 C-N-CA 127.196 2.198 . . . . 0.0 112.09 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.533 HG21 HG21 ' A' ' 715' ' ' VAL . 1.7 pp -59.94 149.56 72.99 Favored Pre-proline 0 N--CA 1.435 -1.205 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.017 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.441 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 71.2 Cg_endo -74.11 -160.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.611 2.207 . . . . 0.0 110.42 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 696' ' ' GLU . . . . . 0.595 ' HA ' ' HE2' ' A' ' 717' ' ' PHE . 13.1 pt-20 -149.85 170.3 19.11 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.752 HD13 ' SG ' ' A' ' 744' ' ' CYS . 17.7 mt -97.48 128.71 44.47 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 123.914 0.759 . . . . 0.0 111.376 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -46.17 -33.88 3.9 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.078 -1.874 . . . . 0.0 112.723 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.426 ' HB3' ' CE1' ' A' ' 723' ' ' PHE . 96.4 m-70 -145.89 26.7 1.23 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -137.94 -148.36 5.36 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.472 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.461 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.6 OUTLIER -150.9 176.2 11.31 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.051 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -104.69 157.34 17.25 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -94.6 -68.75 0.78 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.092 0.472 . . . . 0.0 111.297 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 704' ' ' LEU . . . . . 0.476 ' O ' HG13 ' A' ' 715' ' ' VAL . 58.9 tp -146.14 123.39 11.56 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.487 ' HB3' ' CG1' ' A' ' 715' ' ' VAL . 2.8 p -144.86 105.0 4.06 Favored 'General case' 0 N--CA 1.396 -3.131 0 CA-C-O 122.024 0.916 . . . . 0.0 109.347 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 10.2 m -116.34 132.03 23.52 Favored Pre-proline 0 C--N 1.246 -3.914 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.621 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.457 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 57.5 Cg_endo -64.65 172.87 6.22 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.592 2.194 . . . . 0.0 110.183 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.64 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.0 Cg_exo -76.61 -7.03 28.4 Favored 'Cis proline' 0 N--CA 1.487 1.124 0 N-CA-C 114.839 1.053 . . . . 0.0 114.839 6.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.464 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 57.4 m-85 72.95 79.28 0.14 Allowed 'General case' 0 C--N 1.314 -0.975 0 O-C-N 124.242 0.964 . . . . 0.0 109.217 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.64 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 38.1 m-85 -87.0 172.52 9.94 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.235 -175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -69.32 131.7 45.26 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.994 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.65 -15.16 60.07 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 713' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 0.5 OUTLIER -65.42 145.98 55.47 Favored 'General case' 0 CA--C 1.477 -1.861 0 CA-C-O 121.42 0.628 . . . . 0.0 110.262 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 17.8 m -133.97 148.83 51.2 Favored 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.533 HG21 HG21 ' A' ' 694' ' ' ILE . 61.8 t -134.58 130.61 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.845 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.465 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 44.0 mt-10 -82.16 139.28 34.42 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 121.609 0.719 . . . . 0.0 110.813 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.595 ' HE2' ' HA ' ' A' ' 696' ' ' GLU . 28.5 m-85 -137.35 120.55 16.79 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 125.867 1.667 . . . . 0.0 107.478 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.461 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 16.1 m-80 -128.78 -163.44 1.29 Allowed 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 22.3 m -118.87 134.03 55.44 Favored 'General case' 0 C--N 1.267 -3.018 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 21.1 t -73.15 -84.5 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 O-C-N 123.923 0.764 . . . . 0.0 112.019 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -133.77 132.59 40.7 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.459 0.303 . . . . 0.0 110.632 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 4.4 t 71.9 26.29 2.97 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 124.598 1.186 . . . . 0.0 110.055 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.3 m-85 -140.72 145.98 37.17 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.551 HG21 HD11 ' A' ' 750' ' ' LEU . 6.4 t -75.23 -118.38 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.605 -174.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.517 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 7.9 ttp 162.82 104.83 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 128.898 2.879 . . . . 0.0 105.29 174.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.9 mm -119.96 139.25 47.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 102.17 -75.79 0.33 Allowed Glycine 0 N--CA 1.429 -1.797 0 O-C-N 123.559 0.537 . . . . 0.0 112.729 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.579 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 2.1 t60 -146.98 -172.97 4.12 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.517 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -141.89 22.94 2.09 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.28 170.418 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 16.4 p -157.44 162.71 38.97 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.034 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 714' ' ' SER . 32.4 pt -122.6 164.6 19.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 739' ' ' THR . 7.3 m -135.77 135.01 39.58 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.977 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 6.0 t -84.68 106.83 16.52 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.473 0.654 . . . . 0.0 110.437 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -142.97 143.58 24.98 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 125.221 1.408 . . . . 0.0 109.988 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 64.39 4.2 2.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.06 13.5 52.46 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 737' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 738' ' ' TRP . 80.7 t -140.66 154.23 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.465 ' O ' HG12 ' A' ' 737' ' ' VAL . 94.2 m95 -79.95 177.64 8.78 Favored 'General case' 0 C--N 1.273 -2.748 0 O-C-N 121.89 -0.506 . . . . 0.0 109.786 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.458 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 27.1 p -84.89 -163.95 0.91 Allowed 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.856 0.836 . . . . 0.0 112.506 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.458 ' H ' ' HB ' ' A' ' 739' ' ' THR . 5.1 pm0 -74.81 -17.05 60.68 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -168.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 1.5 mt 68.73 151.33 0.13 Allowed Pre-proline 0 N--CA 1.479 1.019 0 O-C-N 123.889 0.743 . . . . 0.0 112.231 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.579 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 42.9 Cg_endo -73.56 177.52 7.89 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.796 1.664 . . . . 0.0 111.249 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -120.17 103.09 8.97 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.234 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.752 ' SG ' HD13 ' A' ' 697' ' ' LEU . 84.1 m -79.07 110.26 14.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.971 173.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.531 ' O ' HG22 ' A' ' 724' ' ' THR . 46.6 t -104.72 147.03 11.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.96 -0.85 1.71 Allowed 'General case' 0 C--N 1.284 -2.253 0 C-N-CA 125.204 1.402 . . . . 0.0 114.089 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.714 ' HA ' HD22 ' A' ' 750' ' ' LEU . 48.6 mt 74.54 -14.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 125.589 1.555 . . . . 0.0 110.93 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 746' ' ' ALA . 1.0 OUTLIER -75.3 -27.89 59.5 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 126.149 1.78 . . . . 0.0 108.755 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -106.92 16.96 23.71 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.063 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.714 HD22 ' HA ' ' A' ' 747' ' ' ILE . 1.3 mp -83.15 -178.67 7.18 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.766 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.592 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 55.0 mtpt -125.59 150.66 47.32 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.58 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 752' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 770' ' ' GLU . 14.1 mmmm -90.14 111.22 22.29 Favored 'General case' 0 C--N 1.251 -3.689 0 CA-C-N 112.421 -2.172 . . . . 0.0 108.726 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 61.2 m -70.78 138.29 50.29 Favored 'General case' 0 C--N 1.269 -2.898 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.14 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -107.86 138.28 44.38 Favored 'General case' 0 C--N 1.271 -2.806 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.13 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 755' ' ' SER . . . . . 0.421 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.4 p -67.83 123.65 21.13 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.465 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.673 ' HB3' HG13 ' A' ' 759' ' ' ILE . 25.9 t -70.89 146.18 49.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.9 3.28 49.09 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -92.46 -29.52 16.21 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.673 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -98.53 158.51 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.294 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.057 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.1 131.87 59.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.412 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 85.8 mt -105.56 179.82 4.16 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.143 0.497 . . . . 0.0 110.124 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 762' ' ' GLU . . . . . 0.714 ' HB2' HD23 ' A' ' 765' ' ' LEU . 37.8 mt-10 -69.4 170.53 10.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.731 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.02 -20.09 66.32 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.16 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 764' ' ' HIS . . . . . 0.572 ' HB2' HD22 ' A' ' 765' ' ' LEU . 15.6 m-70 -90.1 -30.09 17.9 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.714 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.7 mm? -93.9 -14.18 26.33 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.371 -165.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 28.5 mtmm -71.77 -8.8 56.44 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.762 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -94.57 -1.7 52.85 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -105.28 126.34 51.98 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 769' ' ' LYS . . . . . 0.846 ' HG3' ' HG2' ' A' ' 770' ' ' GLU . 18.8 ptpt -98.49 -29.37 13.14 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.612 0.72 . . . . 0.0 109.107 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 770' ' ' GLU . . . . . 0.846 ' HG2' ' HG3' ' A' ' 769' ' ' LYS . 4.7 pt-20 -140.06 136.38 33.58 Favored 'General case' 0 N--CA 1.39 -3.456 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.462 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.484 ' HE2' HD12 ' A' ' 765' ' ' LEU . 86.3 m-85 -110.66 148.66 31.78 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.623 -175.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -90.91 166.04 13.26 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.626 ' HB3' HD23 ' A' ' 750' ' ' LEU . 26.6 t60 -62.67 157.35 21.07 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 122.328 0.251 . . . . 0.0 111.076 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 77.69 9.8 2.36 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.209 1.004 . . . . 0.0 109.654 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 47.4 t -86.36 104.5 15.93 Favored 'General case' 0 N--CA 1.385 -3.687 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -90.13 101.37 14.08 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.424 HG21 ' CE2' ' A' ' 771' ' ' PHE . 7.9 pt -112.32 -174.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 CA-C-O 121.591 0.71 . . . . 0.0 109.797 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.624 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 27.6 ptt180 -141.08 122.5 14.97 Favored 'General case' 0 N--CA 1.391 -3.424 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.555 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.488 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 9.6 p90 -113.66 172.9 6.7 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -155.47 169.26 24.68 Favored 'General case' 0 N--CA 1.411 -2.379 0 O-C-N 123.934 0.771 . . . . 0.0 109.356 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.675 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 16.4 t -102.26 162.22 13.09 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -74.8 80.14 2.09 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.601 1.191 . . . . 0.0 108.293 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 147.28 -27.72 1.54 Allowed Glycine 0 N--CA 1.417 -2.596 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.269 -172.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.675 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 14.3 mptt -84.02 103.32 13.16 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -87.34 81.27 7.93 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 162.62 -170.02 38.05 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 106.261 -2.736 . . . . 0.0 106.261 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.624 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 64.7 m95 -130.76 158.51 39.93 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 118.962 1.381 . . . . 0.0 109.364 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.488 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -99.94 -41.94 9.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.132 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 789' ' ' HIS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 0.3 OUTLIER 80.7 133.25 0.06 Allowed 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.052 1.341 . . . . 0.0 110.259 -176.043 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.419 ' HA ' ' HD2' ' A' ' 799' ' ' PRO . 4.5 t -157.17 158.98 37.27 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.107 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 45.0 t -120.91 133.24 68.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.273 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 37.9 t -68.33 115.11 7.39 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.152 0.501 . . . . 0.0 109.995 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 45.3 mm -117.3 83.09 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 C-N-CA 123.726 0.81 . . . . 0.0 109.332 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.607 ' OD1' ' HG ' ' A' ' 750' ' ' LEU . 4.7 m-20 49.78 66.01 1.25 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.811 0.845 . . . . 0.0 111.259 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 77.44 14.36 82.58 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.887 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -139.02 166.11 25.37 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.1 m95 -116.88 156.3 27.58 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 798' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 18.9 t70 -147.62 104.28 3.7 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 799' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 43.1 Cg_endo -70.51 142.76 73.04 Favored 'Cis proline' 0 C--O 1.239 0.575 0 C-N-CA 124.0 -1.25 . . . . 0.0 113.248 0.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 47.3 mt-10 -53.86 125.42 18.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.445 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 1 N--CA 1.371 -4.404 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.719 -175.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.421 -1.892 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 51.8 m -79.06 -66.99 0.8 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 93.17 142.22 11.51 Favored Glycine 0 N--CA 1.405 -3.38 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.666 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 35.6 t70 53.69 97.32 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 125.815 1.646 . . . . 0.0 112.441 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.454 HG21 HG21 ' A' ' 715' ' ' VAL . 1.8 pp -63.68 147.3 95.94 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.399 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.449 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.9 Cg_endo -69.63 -171.61 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.729 2.286 . . . . 0.0 112.134 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -121.79 179.05 4.61 Favored 'General case' 0 N--CA 1.393 -3.297 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.587 HD22 ' HB3' ' A' ' 717' ' ' PHE . 25.0 tp -124.33 129.43 50.71 Favored 'General case' 0 C--N 1.251 -3.675 0 CA-C-O 120.915 0.388 . . . . 0.0 110.953 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -38.66 -51.34 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.479 1.912 . . . . 0.0 114.756 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.681 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.8 m-70 -141.12 26.26 2.03 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -139.16 -146.39 4.92 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.552 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.465 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -152.05 178.31 9.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -174.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -113.05 143.88 43.56 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -73.56 -62.71 1.39 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.6 tt -166.56 135.52 2.95 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.546 ' HB3' HG11 ' A' ' 715' ' ' VAL . 13.1 p -129.95 119.86 23.89 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-O 121.351 0.596 . . . . 0.0 110.074 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 706' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 13.2 p -108.47 113.17 60.42 Favored Pre-proline 0 C--N 1.276 -2.609 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.239 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.491 ' HA ' ' N ' ' A' ' 709' ' ' TYR . 57.6 Cg_endo -69.7 171.5 14.28 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.856 2.37 . . . . 0.0 110.527 176.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.84 -4.89 3.07 Favored 'Cis proline' 0 N--CA 1.496 1.676 0 N-CA-C 117.077 1.914 . . . . 0.0 117.077 2.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.521 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 35.6 m-85 68.68 65.57 0.31 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.493 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 16.7 m-85 -69.75 172.77 7.05 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.877 -1.511 . . . . 0.0 112.103 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -72.21 132.05 43.58 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.901 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.34 -6.41 65.81 Favored Glycine 0 N--CA 1.413 -2.867 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.82 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 713' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 1.4 t70 -68.79 155.89 39.35 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 19.4 m -146.81 145.08 29.78 Favored 'General case' 0 C--N 1.274 -2.697 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.546 HG11 ' HB3' ' A' ' 705' ' ' SER . 46.1 t -132.04 134.69 59.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.887 -176.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -79.85 133.85 36.29 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 123.78 0.675 . . . . 0.0 111.676 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.587 ' HB3' HD22 ' A' ' 697' ' ' LEU . 26.7 m-85 -138.28 129.88 27.88 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 125.38 1.472 . . . . 0.0 107.28 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.465 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 13.5 m120 -137.71 -161.5 1.18 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 725' ' ' MET . 11.7 m -118.71 131.77 56.15 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 18.9 t -67.02 -75.61 0.09 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 124.239 0.962 . . . . 0.0 110.721 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -149.18 152.9 36.86 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 69.3 m 72.92 2.69 4.46 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 124.285 0.991 . . . . 0.0 112.766 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.642 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.7 m-85 -138.56 144.74 40.0 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.674 HG21 HD21 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -107.09 136.43 46.95 Favored 'General case' 0 C--N 1.255 -3.505 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.265 -177.702 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.768 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 7.6 ttp -84.29 118.6 24.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 124.196 0.998 . . . . 0.0 109.636 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.481 HD11 HD21 ' A' ' 794' ' ' ASN . 48.3 mm -127.33 141.68 45.65 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.998 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 106.5 -66.9 0.25 Allowed Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.392 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.561 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 6.5 t-80 -165.83 -177.6 4.37 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 -175.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.768 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -143.31 25.43 1.71 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 119.027 0.831 . . . . 0.0 110.699 176.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 16.0 m -152.47 163.66 39.1 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.884 -0.51 . . . . 0.0 109.782 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 714' ' ' SER . 32.2 pt -125.3 163.45 26.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.745 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 739' ' ' THR . 17.5 m -137.03 134.1 36.2 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.252 0.345 . . . . 0.0 111.08 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 3.4 t -86.84 105.85 17.32 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -141.28 140.43 31.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.984 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 60.44 14.19 4.61 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 89.11 25.22 29.59 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.81 144.89 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.089 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.521 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 97.3 m95 -72.63 -179.34 3.01 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.5 0.667 . . . . 0.0 110.138 170.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 732' ' ' THR . 27.9 p -90.95 -152.9 0.29 Allowed 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.44 ' H ' ' HB ' ' A' ' 739' ' ' THR . 5.2 pm0 -81.52 -14.87 56.4 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -169.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.2 mm? 71.12 151.59 0.14 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 123.967 0.792 . . . . 0.0 110.824 -175.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.561 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 36.2 Cg_endo -71.13 177.64 6.29 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.028 1.819 . . . . 0.0 110.736 172.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -125.07 132.92 53.09 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.681 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 84.6 m -116.38 107.06 14.33 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-O 121.458 0.646 . . . . 0.0 109.834 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.58 142.82 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.682 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.642 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.97 1.91 1.27 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 125.247 1.419 . . . . 0.0 113.414 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.693 ' HA ' HD22 ' A' ' 750' ' ' LEU . 40.0 mt 79.35 -19.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 125.41 1.484 . . . . 0.0 111.031 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.0 t70 -72.01 -34.26 68.71 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.118 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -98.74 17.76 18.57 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.274 -1.785 . . . . 0.0 109.498 -172.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.803 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 1.7 mp -82.37 -174.06 4.93 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.539 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.627 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 1.2 mmpt? -136.43 -177.1 4.57 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -130.97 144.4 51.45 Favored 'General case' 0 C--N 1.268 -2.963 0 C-N-CA 125.297 1.439 . . . . 0.0 107.202 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 753' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 770' ' ' GLU . 69.1 m -92.78 167.08 12.1 Favored 'General case' 0 C--N 1.246 -3.899 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.24 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -125.88 136.0 52.56 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.895 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 755' ' ' SER . . . . . 0.441 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.0 p -67.18 118.44 10.6 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.582 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.577 ' HB3' HG13 ' A' ' 759' ' ' ILE . 28.3 t -66.15 143.15 57.46 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -77.85 -6.97 55.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 89.2 mt -105.16 -11.69 16.45 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.813 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.577 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -96.43 162.32 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.806 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 760' ' ' ILE . . . . . 0.444 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.4 mp -118.98 117.4 54.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.791 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 63.7 mt -93.51 -177.25 4.35 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 762' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 31.5 mt-10 -62.85 176.84 0.63 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.354 0.597 . . . . 0.0 110.093 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -86.02 -6.06 59.11 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 123.431 1.586 . . . . 0.0 107.406 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . 0.274 63.8 t60 -88.98 -43.04 11.43 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 110.712 -2.949 . . . . 0.0 108.194 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.691 HD22 ' HE2' ' A' ' 771' ' ' PHE . 54.8 mt -96.2 -13.43 23.49 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.861 -171.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 54.1 mtmt -65.66 -15.9 63.22 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.806 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -89.84 1.64 55.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.506 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.463 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 11.3 tppt? -103.52 109.91 21.74 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -83.02 -36.49 24.94 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 770' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 753' ' ' CYS . 3.8 pt-20 -130.29 134.02 46.9 Favored 'General case' 0 N--CA 1.403 -2.789 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.635 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.791 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 81.0 m-85 -112.09 143.19 43.53 Favored 'General case' 0 C--N 1.267 -3.012 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.009 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.89 154.78 19.61 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.634 ' CG ' HD23 ' A' ' 750' ' ' LEU . 18.5 p-80 -43.21 143.56 0.81 Allowed 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.974 1.31 . . . . 0.0 111.55 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 68.19 12.28 8.7 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.23 1.012 . . . . 0.0 113.435 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 43.4 t -77.84 110.48 12.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -86.82 101.3 13.22 Favored 'General case' 0 CA--C 1.494 -1.203 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.702 HG21 ' CE2' ' A' ' 771' ' ' PHE . 5.6 pt -114.0 -173.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.269 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 26.9 ptt180 -142.28 124.81 15.76 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.473 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 4.4 p90 -114.79 172.54 6.98 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 780' ' ' ARG . . . . . 0.444 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 27.0 ptt180 -150.19 178.57 8.86 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 48.1 t -114.94 162.94 16.27 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -74.51 -21.49 59.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.286 0.565 . . . . 0.0 110.129 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -99.93 -8.79 50.56 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.072 175.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 13.3 mptt -128.14 104.53 7.81 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 122.686 -0.302 . . . . 0.0 110.735 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.31 169.92 17.39 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 97.58 -168.02 23.69 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 75.6 m95 -138.69 142.9 38.96 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 118.613 1.206 . . . . 0.0 109.714 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.473 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.5 mp -93.6 -40.51 11.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.056 -177.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 789' ' ' HIS . . . . . 0.456 ' HA ' ' O ' ' A' ' 777' ' ' ILE . 0.3 OUTLIER 75.0 129.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.677 1.191 . . . . 0.0 109.633 -174.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 3.4 t -151.42 154.61 36.96 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 120.755 0.312 . . . . 0.0 110.334 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.3 t -115.99 133.42 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.395 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 54.0 t -69.38 112.48 5.95 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.788 0.804 . . . . 0.0 110.173 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 47.4 mm -112.45 81.35 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 C-N-CA 124.534 1.133 . . . . 0.0 108.84 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.803 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 0.4 OUTLIER 51.62 66.13 1.29 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.374 176.659 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.49 20.25 79.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.348 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -147.29 163.99 34.65 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.662 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.6 m95 -108.92 162.09 14.53 Favored 'General case' 0 C--N 1.258 -3.388 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.684 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -150.24 102.14 3.15 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.81 140.56 64.45 Favored 'Cis proline' 0 N--CA 1.48 0.705 0 C-N-CA 123.917 -1.284 . . . . 0.0 113.704 -0.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.662 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 44.6 mt-10 -50.48 123.85 9.51 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.585 175.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 1 N--CA 1.374 -4.264 0 CA-C-O 121.458 0.647 . . . . 0.0 111.078 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.431 -1.424 0 CA-C-O 120.864 0.364 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 64.2 m -73.5 -70.89 0.35 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 94.23 135.78 7.92 Favored Glycine 0 N--CA 1.413 -2.876 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.616 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 25.3 t70 62.25 112.94 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 O-C-N 125.324 1.249 . . . . 0.0 111.829 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.662 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -80.0 147.03 64.86 Favored Pre-proline 0 C--N 1.283 -2.305 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.05 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.451 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 71.1 Cg_endo -71.64 -166.9 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 123.499 2.799 . . . . 0.0 112.994 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -129.91 164.64 23.76 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 717' ' ' PHE . 23.7 tp -109.32 132.9 53.69 Favored 'General case' 0 C--N 1.256 -3.498 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.742 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 7.0 pt-20 -43.49 -53.43 5.5 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 125.925 1.69 . . . . 0.0 113.713 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.459 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 89.9 m-70 -137.49 28.15 2.75 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.447 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -136.2 -151.63 6.14 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.541 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.438 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.21 174.55 12.68 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.411 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -108.66 142.27 39.4 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -78.3 -67.87 0.69 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 120.72 0.295 . . . . 0.0 111.524 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.3 tt -161.68 137.21 7.61 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.444 ' HA ' HG13 ' A' ' 715' ' ' VAL . 35.5 p -111.8 -49.2 3.0 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -169.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 706' ' ' SER . . . . . 0.441 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 66.0 m 58.84 100.26 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 706' ' ' SER . 40.9 Cg_endo -66.69 171.72 10.46 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.416 2.077 . . . . 0.0 109.733 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.635 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.8 Cg_endo -73.67 -2.22 14.73 Favored 'Cis proline' 0 N--CA 1.484 0.962 0 N-CA-C 116.662 1.755 . . . . 0.0 116.662 7.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 33.5 m-85 68.55 72.94 0.28 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 123.691 0.62 . . . . 0.0 109.413 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.635 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 22.5 m-85 -81.2 172.67 13.36 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.459 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -72.58 127.43 32.53 Favored 'General case' 0 CA--C 1.481 -1.691 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.143 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.1 -17.86 53.18 Favored Glycine 0 N--CA 1.406 -3.303 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.656 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.67 144.83 56.67 Favored 'General case' 0 CA--C 1.481 -1.692 0 CA-C-O 121.285 0.564 . . . . 0.0 110.089 177.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 10.2 m -128.11 153.69 46.56 Favored 'General case' 0 N--CA 1.404 -2.739 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.898 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.662 HG21 HG21 ' A' ' 694' ' ' ILE . 46.4 t -135.83 127.4 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.608 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 37.0 mt-10 -84.86 138.01 32.8 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.889 0.852 . . . . 0.0 111.702 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.658 ' HB3' HD22 ' A' ' 697' ' ' LEU . 30.1 m-85 -138.08 128.83 26.8 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 125.487 1.515 . . . . 0.0 107.028 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.438 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 21.7 m-80 -124.69 -163.12 1.14 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 22.4 m -107.39 136.55 47.0 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 23.3 t -66.14 -62.56 1.42 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 123.924 0.765 . . . . 0.0 111.416 -169.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.47 153.13 15.04 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 55.7 m 64.43 13.08 7.85 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 94.4 m-85 -141.27 146.15 36.45 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-O 122.028 0.918 . . . . 0.0 110.169 -175.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.417 ' OG1' HG12 ' A' ' 747' ' ' ILE . 1.0 OUTLIER -110.19 134.95 51.7 Favored 'General case' 0 C--N 1.253 -3.617 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.932 -179.201 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.784 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.4 ttp -82.21 121.77 27.05 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.602 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.51 128.31 74.55 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.27 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.12 -90.51 0.53 Allowed Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.154 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.657 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 22.2 t-80 -144.74 164.39 31.16 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.784 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -118.72 23.75 11.28 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.504 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.608 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 6.3 p -153.11 159.67 42.81 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.97 0.414 . . . . 0.0 111.389 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.509 HG21 HD13 ' A' ' 741' ' ' LEU . 27.8 pt -110.43 166.86 5.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.545 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 739' ' ' THR . 19.4 m -138.41 133.49 32.92 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.724 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 2.1 t -81.13 105.21 12.16 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.306 0.574 . . . . 0.0 109.708 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.97 144.75 22.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.022 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 27.9 m80 71.02 -15.49 0.4 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.982 0.913 . . . . 0.0 113.322 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 118.94 17.99 4.84 Favored Glycine 1 CA--C 1.445 -4.328 0 CA-C-O 121.364 0.424 . . . . 0.0 112.878 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -154.24 177.79 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.39 -3.456 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.519 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 89.8 m95 -90.38 -173.89 3.95 Favored 'General case' 0 C--N 1.266 -3.065 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 732' ' ' THR . 38.8 p -85.06 -155.76 0.23 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.225 0.536 . . . . 0.0 110.257 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.5 OUTLIER -93.83 3.48 55.35 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -168.737 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.509 HD13 HG21 ' A' ' 731' ' ' ILE . 4.0 mm? 71.6 159.93 0.16 Allowed Pre-proline 0 N--CA 1.481 1.123 0 O-C-N 123.82 0.7 . . . . 0.0 110.404 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.657 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 18.5 Cg_endo -72.94 -177.71 3.07 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 121.673 1.582 . . . . 0.0 111.356 171.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -122.1 125.94 47.29 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.435 ' SG ' HD21 ' A' ' 697' ' ' LEU . 64.7 m -116.7 94.87 4.78 Favored 'General case' 0 CA--C 1.481 -1.689 0 CA-C-O 121.659 0.742 . . . . 0.0 110.554 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.474 ' HB ' HD21 ' A' ' 750' ' ' LEU . 30.7 t -89.16 143.02 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.881 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.616 -177.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.582 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -62.51 4.31 0.16 Allowed 'General case' 0 C--N 1.283 -2.305 0 C-N-CA 125.733 1.613 . . . . 0.0 114.89 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.757 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 65.7 mt 77.37 -17.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 126.156 1.782 . . . . 0.0 111.34 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.7 t70 -79.85 -31.77 40.47 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-N 113.177 -1.829 . . . . 0.0 109.293 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -107.35 19.82 19.77 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.193 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.757 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 85.0 mt -81.46 -177.69 6.62 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 114.547 -1.206 . . . . 0.0 107.898 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.544 ' HE3' ' HA3' ' A' ' 795' ' ' GLY . 27.1 mtpp -98.63 156.4 16.83 Favored 'General case' 0 N--CA 1.386 -3.638 0 CA-C-O 121.954 0.883 . . . . 0.0 108.977 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 752' ' ' LYS . . . . . 0.637 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 43.5 mtpt -105.65 116.82 32.59 Favored 'General case' 1 C--N 1.238 -4.242 0 CA-C-N 112.524 -2.126 . . . . 0.0 108.171 -172.032 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 65.2 m -76.52 132.77 39.75 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.051 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.45 135.0 41.51 Favored 'General case' 0 C--N 1.278 -2.538 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.699 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 755' ' ' SER . . . . . 0.419 ' HB2' ' HE1' ' A' ' 771' ' ' PHE . 47.3 t -60.94 129.34 40.95 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.703 171.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.547 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 41.0 t -73.27 151.04 41.52 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -82.97 -0.38 48.42 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 98.8 mt -112.82 -8.87 13.71 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.552 HG12 HG11 ' A' ' 801' ' ' VAL . 2.2 pp -102.28 150.93 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 122.163 0.982 . . . . 0.0 113.385 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.4 mp -105.04 130.86 55.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.487 0 CA-C-N 113.595 -1.639 . . . . 0.0 107.387 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 777' ' ' ILE . 1.8 mm? -113.28 -176.6 2.93 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 762' ' ' GLU . . . . . 0.46 ' HB2' HD23 ' A' ' 765' ' ' LEU . 48.1 mt-10 -65.29 165.72 11.18 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.885 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.33 -7.7 44.7 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.501 0.667 . . . . 0.0 111.795 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -4.45 17.35 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.797 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.0 mm? -117.04 -11.71 10.73 Favored 'General case' 0 C--O 1.207 -1.136 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 10.4 mtmp? -70.85 -16.49 62.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.454 0.645 . . . . 0.0 110.228 176.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -78.72 -13.53 59.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.917 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 7.9 tppt? -98.32 126.81 43.98 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 769' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 769' ' ' LYS . 15.3 ptpt -110.37 -19.65 12.89 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 770' ' ' GLU . . . . . 0.637 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 36.4 mt-10 -134.25 107.79 7.87 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.543 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.419 ' HE1' ' HB2' ' A' ' 755' ' ' SER . 79.4 m-85 -93.2 162.71 13.91 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.84 -175.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -101.86 154.78 18.61 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.566 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 28.5 t60 -60.19 144.38 50.21 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.902 0.126 . . . . 0.0 111.038 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 63.7 t30 88.12 3.1 0.31 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 125.445 1.716 . . . . 0.0 111.27 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 775' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 791' ' ' VAL . 86.8 p -73.61 105.75 5.08 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 119.803 -0.759 . . . . 0.0 108.988 177.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.03 90.2 8.27 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 789' ' ' HIS . 7.6 pt -104.55 -170.91 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.562 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.641 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 16.6 ptt180 -142.83 125.61 16.02 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.066 174.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.646 ' CD2' HG13 ' A' ' 801' ' ' VAL . 13.1 p90 -106.87 167.46 9.86 Favored 'General case' 0 C--O 1.257 1.496 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 780' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 780' ' ' ARG . 13.3 ptt180 -155.67 161.82 40.7 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 175.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.639 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 3.1 m -98.95 173.88 6.63 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -101.91 36.25 2.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.479 1.133 . . . . 0.0 109.674 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -176.72 -33.72 0.05 OUTLIER Glycine 0 CA--C 1.473 -2.564 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.639 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 0.4 OUTLIER -96.82 139.72 32.44 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 176.015 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.31 154.41 19.4 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.572 0.701 . . . . 0.0 112.891 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 91.2 154.51 30.67 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.349 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 52.0 m95 -95.85 141.04 29.77 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.471 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -95.42 -31.21 4.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.568 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 789' ' ' HIS . . . . . 0.495 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 12.0 m170 72.44 118.37 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 124.062 0.945 . . . . 0.0 111.114 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.527 HG21 ' CG2' ' A' ' 801' ' ' VAL . 3.4 t -141.51 153.28 44.8 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.556 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 775' ' ' SER . 38.9 t -114.45 132.91 62.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.712 -176.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.15 115.06 8.92 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.566 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 46.5 mm -114.5 84.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.427 ' C ' ' HB2' ' A' ' 751' ' ' LYS . 6.4 t30 46.92 68.11 0.68 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.845 0.858 . . . . 0.0 111.992 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 795' ' ' GLY . . . . . 0.544 ' HA3' ' HE3' ' A' ' 751' ' ' LYS . . . 72.28 24.09 76.92 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 114.958 -1.019 . . . . 0.0 114.293 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -146.88 168.5 21.3 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.664 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 91.3 m95 -117.24 161.99 18.6 Favored 'General case' 0 C--N 1.266 -3.038 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -150.58 104.56 3.08 Favored Pre-proline 0 C--N 1.296 -1.727 0 O-C-N 123.344 0.402 . . . . 0.0 110.063 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 799' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 36.7 Cg_endo -68.57 140.98 59.77 Favored 'Cis proline' 0 C--O 1.239 0.565 0 C-N-CA 123.993 -1.253 . . . . 0.0 112.306 -1.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.664 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 52.2 mt-10 -49.33 120.71 4.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.876 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.646 HG13 ' CD2' ' A' ' 779' ' ' TYR . 67.7 t . . . . . 0 N--CA 1.439 -1.004 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.104 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.599 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.2 m -82.25 -61.97 1.75 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.004 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 134.08 174.56 13.55 Favored Glycine 1 N--CA 1.374 -5.466 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.714 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 29.9 t70 -52.0 135.34 31.04 Favored 'General case' 0 C--N 1.276 -2.589 0 O-C-N 124.803 0.943 . . . . 0.0 111.38 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.589 HG21 HG21 ' A' ' 715' ' ' VAL . 1.3 pp -55.6 150.34 25.95 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.145 -1.389 . . . . 0.0 114.076 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.52 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 65.1 Cg_endo -72.67 -161.62 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.468 2.778 . . . . 0.0 111.321 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -135.82 151.86 50.49 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 717' ' ' PHE . 26.4 tp -92.66 123.22 35.79 Favored 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.893 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 5.4 pt-20 -34.63 -50.78 0.46 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.334 2.253 . . . . 0.0 114.417 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 83.5 m-70 -136.28 28.83 3.07 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -142.17 -156.15 6.7 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.389 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.5 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -140.25 -178.31 5.42 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.003 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -115.72 146.09 42.19 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -74.16 -68.57 0.51 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.337 0.589 . . . . 0.0 110.806 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.4 tt -159.8 138.97 10.99 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.521 ' HB3' HG11 ' A' ' 715' ' ' VAL . 4.1 p -153.44 123.54 6.96 Favored 'General case' 0 N--CA 1.395 -3.197 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 20.6 m -128.08 130.44 23.6 Favored Pre-proline 0 C--N 1.278 -2.539 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.284 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.45 168.59 14.25 Favored 'Trans proline' 0 C--O 1.248 0.976 0 C-N-CA 122.715 2.277 . . . . 0.0 109.716 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.59 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 2.6 Cg_endo -71.64 -11.71 15.77 Favored 'Cis proline' 0 N--CA 1.483 0.892 0 N-CA-C 116.097 1.537 . . . . 0.0 116.097 6.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.714 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 66.7 m-85 68.92 77.77 0.22 Allowed 'General case' 0 C--O 1.248 0.995 0 O-C-N 123.857 0.723 . . . . 0.0 109.643 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.59 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 47.5 m-85 -82.99 171.53 13.73 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.843 0.83 . . . . 0.0 113.204 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.426 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 91.1 m-85 -71.41 132.41 44.77 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.271 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.57 -15.63 55.7 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.1 147.67 46.48 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-O 121.088 0.47 . . . . 0.0 111.547 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 15.8 m -135.57 144.37 46.17 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.999 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.589 HG21 HG21 ' A' ' 694' ' ' ILE . 38.3 t -127.24 138.2 55.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.58 125.27 33.68 Favored 'General case' 0 N--CA 1.425 -1.723 0 O-C-N 124.338 1.024 . . . . 0.0 111.073 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.6 ' HB3' HD22 ' A' ' 697' ' ' LEU . 21.9 m-85 -128.21 118.12 22.76 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 125.785 1.634 . . . . 0.0 107.655 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.5 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 17.7 m-80 -120.41 -162.1 0.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 5.5 m -112.33 134.37 53.91 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 720' ' ' SER . . . . . 0.414 ' HA ' ' CE2' ' A' ' 701' ' ' TRP . 22.4 t -61.56 -58.54 7.72 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.216 0.532 . . . . 0.0 110.568 -172.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -174.18 166.2 4.14 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 68.4 m 68.33 0.63 2.58 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.239 0.962 . . . . 0.0 112.051 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' A' ' 719' ' ' CYS . 96.8 m-85 -137.22 144.83 43.01 Favored 'General case' 0 N--CA 1.395 -3.196 0 C-N-CA 124.243 1.017 . . . . 0.0 109.133 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.484 HG21 HD21 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -110.36 134.66 52.08 Favored 'General case' 0 C--N 1.254 -3.58 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.219 -177.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.497 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.0 ttp -84.62 122.81 29.58 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 124.236 1.015 . . . . 0.0 109.237 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 726' ' ' ILE . 34.5 mm -111.28 122.81 66.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.822 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.728 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 99.44 -87.62 0.77 Allowed Glycine 0 N--CA 1.42 -2.422 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.634 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.476 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 48.9 p-80 -135.8 179.13 6.53 Favored 'General case' 0 N--CA 1.393 -3.286 0 C-N-CA 124.113 0.965 . . . . 0.0 108.478 -173.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.497 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.0 ppt_? -135.7 8.99 3.34 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 32.5 m -130.82 155.1 47.27 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.49 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 714' ' ' SER . 36.5 pt -110.4 160.66 9.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.24 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 739' ' ' THR . 26.9 m -135.75 133.71 38.26 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.192 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 733' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 7.1 t -84.87 103.88 14.33 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.86 145.87 23.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.776 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 72.69 -49.93 0.7 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.63 1.172 . . . . 0.0 111.919 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 158.4 24.26 0.03 OUTLIER Glycine 0 C--N 1.29 -1.991 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.367 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.4 p -160.01 157.88 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.52 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 93.5 m95 -78.39 170.68 16.24 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 24.8 p -74.91 -163.5 0.23 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.389 1.09 . . . . 0.0 113.528 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.0 OUTLIER -68.88 -23.9 64.27 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -170.048 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.3 mm? 81.95 148.22 0.11 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 124.786 1.304 . . . . 0.0 109.22 -173.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 19.6 Cg_endo -72.85 -175.56 1.95 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.928 1.752 . . . . 0.0 112.885 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.411 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 54.0 tt0 -119.78 126.37 50.86 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 78.5 m -118.46 111.8 19.13 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.275 0.559 . . . . 0.0 109.799 177.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.47 ' CG1' ' HG3' ' A' ' 749' ' ' LYS . 41.7 t -100.91 145.14 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.548 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.99 4.25 0.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.184 1.393 . . . . 0.0 113.672 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.587 ' HA ' HD13 ' A' ' 750' ' ' LEU . 32.0 mt 80.11 -26.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 126.302 1.841 . . . . 0.0 111.801 173.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 746' ' ' ALA . 38.7 t70 -82.95 -25.31 32.45 Favored 'General case' 0 C--N 1.248 -3.841 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.375 -172.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 749' ' ' LYS . . . . . 0.47 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 9.4 ptmt -112.65 34.91 4.09 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.72 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.817 ' HG ' ' HB2' ' A' ' 794' ' ' ASN . 0.8 OUTLIER -78.71 -166.36 0.87 Allowed 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.092 176.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.442 ' H ' ' HA ' ' A' ' 794' ' ' ASN . 30.6 mtpp -121.34 -178.66 3.84 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 121.542 0.687 . . . . 0.0 109.625 -174.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -114.43 132.94 56.08 Favored 'General case' 0 C--N 1.262 -3.23 0 CA-C-N 112.991 -1.913 . . . . 0.0 107.804 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 753' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 58.3 m -90.49 174.29 7.62 Favored 'General case' 0 C--N 1.244 -4.0 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.391 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 754' ' ' LYS . . . . . 0.417 ' HB2' ' HE3' ' A' ' 754' ' ' LYS . 15.7 ptmt -144.15 152.39 40.84 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.173 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 20.4 p -62.52 126.06 26.04 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.69 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.574 ' HB2' HG13 ' A' ' 759' ' ' ILE . 11.3 m -72.85 136.37 45.32 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -72.09 -4.4 28.72 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 88.6 mt -105.6 -21.0 13.29 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.032 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.596 HG12 HG11 ' A' ' 801' ' ' VAL . 2.8 pp -98.48 171.31 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.077 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.31 136.44 54.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 777' ' ' ILE . 80.4 mt -107.11 177.0 4.98 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 762' ' ' GLU . . . . . 0.44 ' HB2' HD23 ' A' ' 765' ' ' LEU . 43.7 mt-10 -62.06 162.04 9.95 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.986 0.422 . . . . 0.0 110.736 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -70.18 -9.62 56.28 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.464 0.649 . . . . 0.0 111.02 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -109.86 -0.5 18.29 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.029 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.1 mm? -123.67 -14.62 7.23 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' A' ' 761' ' ' LEU . 29.3 mtmm -68.37 -19.55 64.64 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.123 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -78.95 -17.27 55.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.139 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 8.4 tppt? -85.99 107.98 18.01 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 769' ' ' LYS . . . . . 0.522 ' HG3' ' HG2' ' A' ' 770' ' ' GLU . 8.5 ptpp? -74.23 -32.65 63.07 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.688 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 770' ' ' GLU . . . . . 0.522 ' HG2' ' HG3' ' A' ' 769' ' ' LYS . 22.7 mm-40 -131.96 139.52 48.7 Favored 'General case' 0 CA--C 1.478 -1.799 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.439 ' CZ ' HD13 ' A' ' 761' ' ' LEU . 90.8 m-85 -112.45 134.0 54.22 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.724 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -86.21 155.71 20.6 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.675 ' HB2' HD23 ' A' ' 750' ' ' LEU . 18.8 p-80 -49.7 143.98 6.65 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.117 0.967 . . . . 0.0 112.052 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 19.1 m120 67.76 25.75 7.94 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 124.211 1.004 . . . . 0.0 112.781 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 69.0 m -93.86 109.12 20.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.596 ' HA ' HG12 ' A' ' 791' ' ' VAL . 2.5 m-20 -83.46 114.32 21.39 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.45 HD12 HD22 ' A' ' 761' ' ' LEU . 5.8 pt -127.38 -174.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.486 0.66 . . . . 0.0 111.006 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 98.1 mtt180 -134.29 124.52 25.99 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.535 ' CD2' HG13 ' A' ' 801' ' ' VAL . 13.2 p90 -111.98 166.77 10.93 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 171.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -152.57 160.13 43.23 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 3.4 m -95.18 163.39 13.3 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.144 0.497 . . . . 0.0 112.271 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -68.33 -27.9 66.68 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.825 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -110.23 9.09 31.13 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.961 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 1.8 mptm? -121.2 113.2 19.64 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.904 0.383 . . . . 0.0 110.469 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -90.87 87.51 6.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.571 0.7 . . . . 0.0 109.242 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 166.14 145.4 4.44 Favored Glycine 0 C--N 1.291 -1.941 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.553 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 54.4 m95 -96.1 142.86 27.79 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.533 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -96.7 -29.69 3.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.517 -176.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 789' ' ' HIS . . . . . 0.467 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 1.1 m-70 76.77 128.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.565 1.146 . . . . 0.0 109.739 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.577 HG21 ' CG2' ' A' ' 801' ' ' VAL . 2.7 t -153.75 159.9 42.1 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.822 HG22 ' HB3' ' A' ' 798' ' ' ASP . 5.9 m -124.36 153.13 30.65 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.505 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 43.2 t -80.95 116.21 20.81 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.407 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 51.0 mm -121.05 86.2 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.817 ' HB2' ' HG ' ' A' ' 750' ' ' LEU . 7.4 t30 54.01 69.06 0.76 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.13 0.967 . . . . 0.0 111.508 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.12 66.29 Favored Glycine 0 C--N 1.297 -1.635 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.49 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -140.54 168.43 19.83 Favored 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.69 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 82.7 m95 -116.26 155.51 28.23 Favored 'General case' 0 C--N 1.26 -3.31 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 798' ' ' ASP . . . . . 0.822 ' HB3' HG22 ' A' ' 791' ' ' VAL . 26.0 t70 -133.3 100.47 13.98 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 119.567 -0.254 . . . . 0.0 110.973 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 799' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 44.3 Cg_endo -73.07 145.0 82.82 Favored 'Cis proline' 0 C--O 1.24 0.59 0 C-N-CA 124.377 -1.093 . . . . 0.0 112.153 -1.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.69 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 27.0 tt0 -48.59 122.15 5.25 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.014 0.821 . . . . 0.0 111.249 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.596 HG11 HG12 ' A' ' 759' ' ' ILE . 64.4 t . . . . . 0 N--CA 1.427 -1.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.42 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 18.9 m -67.54 -80.69 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 123.326 0.391 . . . . 0.0 111.729 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 156.94 164.15 13.23 Favored Glycine 0 N--CA 1.399 -3.807 0 N-CA-C 106.845 -2.502 . . . . 0.0 106.845 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.818 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 36.5 t70 -45.68 128.91 8.85 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 124.069 0.948 . . . . 0.0 112.24 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.806 HG21 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -50.06 148.18 6.2 Favored Pre-proline 0 N--CA 1.429 -1.491 0 O-C-N 125.042 1.464 . . . . 0.0 114.294 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.412 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 36.6 Cg_endo -67.46 -164.33 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.123 2.549 . . . . 0.0 112.308 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -137.17 141.15 42.18 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 717' ' ' PHE . 25.0 tp -89.01 123.35 33.25 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.729 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -42.38 -48.53 5.12 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 126.723 2.009 . . . . 0.0 115.079 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -134.54 24.99 3.75 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.446 0.641 . . . . 0.0 110.174 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -134.02 -145.69 5.33 Favored Glycine 0 C--N 1.288 -2.11 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.272 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.447 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -154.23 172.16 18.06 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -104.23 150.37 24.47 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -81.44 -77.9 0.2 Allowed 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.674 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 67.0 tp -172.2 129.84 0.6 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.268 0.227 . . . . 0.0 110.412 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.499 ' HB2' HG13 ' A' ' 715' ' ' VAL . 48.2 t -141.2 -50.65 0.43 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.856 175.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 35.9 p 58.03 155.45 0.09 OUTLIER Pre-proline 0 CA--C 1.57 1.747 0 C-N-CA 125.392 1.477 . . . . 0.0 113.018 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.551 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 60.9 Cg_endo -66.51 174.91 5.69 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.027 1.818 . . . . 0.0 111.256 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.551 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.0 Cg_endo -79.07 -9.25 37.86 Favored 'Cis proline' 0 N--CA 1.485 1.013 0 N-CA-C 115.176 1.183 . . . . 0.0 115.176 5.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.818 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 77.8 m-85 72.59 76.17 0.15 Allowed 'General case' 0 C--N 1.316 -0.872 0 O-C-N 124.173 0.921 . . . . 0.0 110.242 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.432 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 25.0 m-85 -79.99 167.6 20.26 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.868 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.498 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 64.9 m-85 -72.77 134.81 45.12 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.042 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.61 -4.95 66.78 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.21 149.43 35.51 Favored 'General case' 0 CA--C 1.477 -1.832 0 CA-C-O 121.361 0.6 . . . . 0.0 110.853 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 12.7 m -129.58 153.38 48.11 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.806 HG21 HG21 ' A' ' 694' ' ' ILE . 24.8 t -136.48 142.35 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.656 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.49 136.67 37.58 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-O 121.532 0.682 . . . . 0.0 110.483 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.617 ' HB3' HD22 ' A' ' 697' ' ' LEU . 32.1 m-85 -135.4 118.89 16.88 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.447 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 14.2 m-80 -121.91 -163.8 1.1 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 21.6 m -116.02 141.39 48.18 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 38.8 t -64.24 -92.14 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 123.841 0.713 . . . . 0.0 111.22 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -139.09 153.6 48.05 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 74.8 m 71.62 1.51 3.9 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.491 1.119 . . . . 0.0 113.164 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.561 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.7 m-85 -132.17 143.55 50.05 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-O 121.73 0.776 . . . . 0.0 109.585 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.642 HG21 HD21 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -111.71 141.95 44.67 Favored 'General case' 0 C--N 1.253 -3.619 0 CA-C-N 113.097 -1.865 . . . . 0.0 111.869 -178.159 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.716 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 2.8 ttp -85.64 122.91 30.41 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.476 1.51 . . . . 0.0 108.977 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 50.8 mm -115.77 129.43 72.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.378 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 93.85 -85.17 1.06 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.329 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.579 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -125.36 172.41 9.63 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.716 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -135.37 18.52 3.38 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 170.203 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 34.7 p -144.92 158.91 43.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.285 0.564 . . . . 0.0 110.919 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.5 pt -123.31 162.82 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.345 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 739' ' ' THR . 24.0 m -136.15 133.75 37.53 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.204 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 733' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.4 t -85.31 101.21 12.36 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -136.9 140.08 43.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.903 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 64.38 6.39 3.04 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.94 18.43 31.99 Favored Glycine 0 CA--C 1.494 -1.279 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.044 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.18 148.62 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.439 ' CZ3' HG23 ' A' ' 715' ' ' VAL . 93.5 m95 -78.95 169.71 17.8 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.037 173.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 732' ' ' THR . 38.9 p -81.16 -166.9 1.25 Allowed 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 121.857 0.836 . . . . 0.0 112.825 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.25 -4.82 23.67 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -168.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.402 HD13 HG21 ' A' ' 731' ' ' ILE . 4.3 mm? 68.16 158.6 0.15 Allowed Pre-proline 0 N--CA 1.493 1.722 0 CA-C-O 120.998 0.428 . . . . 0.0 111.256 -175.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.579 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 44.9 Cg_endo -81.92 178.04 6.82 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.854 1.703 . . . . 0.0 111.188 170.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.544 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.6 tt0 -120.41 115.15 22.95 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.571 ' SG ' HD21 ' A' ' 697' ' ' LEU . 94.2 m -97.94 108.09 20.72 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.609 0.719 . . . . 0.0 110.71 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' A' ' 747' ' ' ILE . 26.8 t -100.93 141.95 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.596 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.525 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.561 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.39 4.11 0.58 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 125.913 1.685 . . . . 0.0 113.455 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.753 ' HA ' HD22 ' A' ' 750' ' ' LEU . 60.3 mt 74.76 -14.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 126.238 1.815 . . . . 0.0 111.028 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 746' ' ' ALA . 19.2 t70 -80.42 -30.55 37.67 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.648 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 749' ' ' LYS . . . . . 0.426 ' NZ ' ' HB3' ' A' ' 749' ' ' LYS . 0.2 OUTLIER -95.38 11.89 31.17 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.711 -1.586 . . . . 0.0 108.706 -176.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.753 HD22 ' HA ' ' A' ' 747' ' ' ILE . 0.4 OUTLIER -82.41 -168.94 2.19 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.737 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.539 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 31.7 mmmt -126.13 146.81 49.79 Favored 'General case' 0 N--CA 1.392 -3.348 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -103.72 122.39 44.95 Favored 'General case' 1 C--N 1.242 -4.068 0 CA-C-N 112.92 -1.945 . . . . 0.0 107.781 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 753' ' ' CYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 55.6 m -71.91 157.48 37.78 Favored 'General case' 0 C--N 1.253 -3.61 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.314 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -127.77 145.4 50.93 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 48.2 t -56.63 127.67 32.54 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.286 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.545 ' HB3' HG12 ' A' ' 759' ' ' ILE . 26.3 t -76.52 160.53 29.39 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.401 0.619 . . . . 0.0 110.358 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -86.92 -4.1 59.14 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.322 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -110.52 -2.71 16.35 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.966 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.555 HD12 HD11 ' A' ' 761' ' ' LEU . 28.6 pt -109.94 156.79 10.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.852 -173.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 760' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.6 mp -121.27 127.46 75.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.555 HD11 HD12 ' A' ' 759' ' ' ILE . 2.0 mm? -105.37 -178.71 3.73 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 762' ' ' GLU . . . . . 0.461 ' HB2' HD23 ' A' ' 765' ' ' LEU . 38.1 mt-10 -68.6 173.97 4.62 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.79 -17.81 64.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.964 -0.46 . . . . 0.0 111.57 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 764' ' ' HIS . . . . . 0.501 ' HB2' HD22 ' A' ' 765' ' ' LEU . 6.3 m-70 -87.26 -35.0 18.73 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 761' ' ' LEU . 2.6 mm? -90.97 -19.47 23.21 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.288 -171.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -71.04 -16.5 62.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.689 0.757 . . . . 0.0 109.25 170.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.87 16.83 22.5 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.367 1.08 . . . . 0.0 108.464 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.409 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 14.5 tppt? -111.71 111.76 22.97 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 769' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' A' ' 769' ' ' LYS . 26.8 ttpp -73.33 -42.59 62.14 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.389 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -139.53 143.4 37.41 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.105 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 753' ' ' CYS . 83.4 m-85 -113.48 135.96 53.31 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.45 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -86.52 160.73 18.88 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.687 ' HB3' HD23 ' A' ' 750' ' ' LEU . 65.7 t60 -61.84 151.27 34.87 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.382 0.134 . . . . 0.0 110.667 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 4.3 m120 78.44 14.19 1.4 Allowed 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 123.987 0.915 . . . . 0.0 112.453 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 44.3 m -91.78 113.26 25.49 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -90.65 111.4 22.71 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.497 HD12 HD12 ' A' ' 761' ' ' LEU . 10.2 pt -122.81 179.3 2.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 121.586 0.708 . . . . 0.0 109.165 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.685 ' HA ' ' HA ' ' A' ' 789' ' ' HIS . 20.7 ptt180 -133.25 120.7 21.44 Favored 'General case' 0 N--CA 1.399 -3.023 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.632 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 2.7 p90 -108.21 167.61 9.89 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 780' ' ' ARG . . . . . 0.5 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 32.9 ptt180 -146.34 156.05 43.06 Favored 'General case' 0 C--N 1.262 -3.204 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 73.7 m -100.47 134.42 43.45 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.53 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 782' ' ' ARG . . . . . 0.579 ' HB3' HD11 ' A' ' 760' ' ' ILE . 36.7 ptt180 -59.57 -48.95 79.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -85.92 6.0 82.3 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.319 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.7 mptt -110.02 -47.75 3.28 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 70.19 129.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.238 1.415 . . . . 0.0 111.771 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 111.95 144.96 9.67 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -175.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 25.9 m95 -93.93 144.23 25.63 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.632 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -100.94 -32.23 3.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.628 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 789' ' ' HIS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 11.5 m170 73.95 129.93 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 124.555 1.142 . . . . 0.0 110.091 -175.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 3.2 t -151.8 159.18 44.0 Favored 'General case' 0 C--N 1.274 -2.675 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.771 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.17 134.77 62.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.985 -176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.09 114.09 7.91 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.521 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 50.8 mm -116.94 87.92 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 124.745 1.218 . . . . 0.0 109.21 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.539 ' C ' ' HB2' ' A' ' 751' ' ' LYS . 0.5 OUTLIER 46.74 66.01 1.08 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.762 0.825 . . . . 0.0 112.353 175.473 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 69.99 27.88 72.48 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.341 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -151.03 166.44 30.7 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 98.1 m95 -110.81 160.74 16.47 Favored 'General case' 0 C--N 1.256 -3.493 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -147.68 103.3 3.68 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.05 138.22 46.1 Favored 'Cis proline' 0 C--O 1.246 0.916 0 C-N-CA 123.956 -1.268 . . . . 0.0 112.325 1.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.606 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 4.2 tp10 -59.58 126.6 28.24 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.304 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 1 N--CA 1.358 -5.054 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.584 -172.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 12.6 m -72.83 -59.4 2.73 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.908 0.385 . . . . 0.0 110.768 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 130.51 179.79 16.33 Favored Glycine 1 N--CA 1.367 -5.923 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -40.51 130.12 2.39 Favored 'General case' 0 C--N 1.278 -2.507 0 C-N-CA 126.348 1.859 . . . . 0.0 111.747 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.587 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -61.94 149.05 86.86 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.64 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.496 ' HG3' HD21 ' A' ' 741' ' ' LEU . 59.7 Cg_endo -71.98 -161.62 0.1 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.475 2.784 . . . . 0.0 111.276 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -136.31 149.74 48.57 Favored 'General case' 0 N--CA 1.408 -2.555 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' A' ' 717' ' ' PHE . 23.3 tp -93.82 123.37 37.12 Favored 'General case' 0 C--N 1.255 -3.522 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.073 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 5.0 pt-20 -34.24 -53.43 0.49 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.215 1.806 . . . . 0.0 115.545 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.451 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 82.4 m-70 -135.98 27.83 3.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -128.7 -149.96 7.07 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 119.605 -1.284 . . . . 0.0 112.096 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.434 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -146.23 175.04 10.8 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -177.121 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.12 133.55 49.71 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 14.0 mm100 -74.42 -61.76 1.76 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.054 0.454 . . . . 0.0 111.4 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.7 tt -169.65 138.29 1.86 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 103.486 -2.783 . . . . 0.0 103.486 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.52 ' HA ' HG13 ' A' ' 715' ' ' VAL . 59.2 p -115.59 -41.76 3.21 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -169.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 33.5 m 62.3 95.58 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 125.094 1.358 . . . . 0.0 113.887 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.15 172.55 13.75 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.297 1.998 . . . . 0.0 108.745 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.405 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 16.5 Cg_exo -71.16 -5.15 10.96 Favored 'Cis proline' 0 N--CA 1.506 2.226 0 CA-C-N 120.825 1.33 . . . . 0.0 115.27 4.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.456 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 56.9 m-85 78.98 69.99 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 O-C-N 124.876 1.36 . . . . 0.0 109.154 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.405 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 58.3 m-85 -77.46 170.4 16.63 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.941 -1.482 . . . . 0.0 112.589 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -73.39 129.63 38.41 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.053 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.48 -4.87 51.26 Favored Glycine 0 N--CA 1.421 -2.363 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.352 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.86 151.19 26.12 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 120.878 0.371 . . . . 0.0 110.924 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 3.8 m -131.29 156.07 46.08 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.587 HG21 HG21 ' A' ' 694' ' ' ILE . 52.7 t -137.64 129.74 40.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 47.0 mt-10 -77.35 134.46 38.47 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 123.988 0.805 . . . . 0.0 111.038 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.655 ' HB3' HD22 ' A' ' 697' ' ' LEU . 35.8 m-85 -139.94 112.94 8.16 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 125.026 1.33 . . . . 0.0 107.584 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.434 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 16.5 m-80 -121.07 -164.51 1.13 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 7.1 m -109.7 133.84 52.66 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 2.4 m -53.07 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.751 0.82 . . . . 0.0 111.137 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -169.31 158.73 8.34 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 66.0 m 69.73 13.36 8.12 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.203 0.939 . . . . 0.0 111.563 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.699 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.4 m-85 -143.74 145.14 32.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 C-N-CA 124.733 1.213 . . . . 0.0 107.752 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.495 ' HB ' HD11 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -113.74 136.41 52.88 Favored 'General case' 0 C--N 1.257 -3.44 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.988 -177.016 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.2 ttp -81.76 120.22 24.86 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.848 1.259 . . . . 0.0 109.516 -175.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 45.4 mm -113.1 121.25 64.96 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.222 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 87.49 -82.13 1.61 Allowed Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 114.856 -1.065 . . . . 0.0 114.121 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.7 m80 -114.3 173.9 6.22 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 123.797 0.839 . . . . 0.0 110.569 -173.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.482 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -146.14 15.95 1.35 Allowed 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 121.276 0.56 . . . . 0.0 109.647 172.408 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 37.5 m -152.59 162.1 41.68 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 121.554 -0.716 . . . . 0.0 110.291 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.5 pt -123.84 162.23 25.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.299 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.7 m -133.31 134.18 43.52 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 123.522 0.514 . . . . 0.0 110.841 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 5.0 t -85.24 106.42 16.65 Favored 'General case' 0 C--O 1.256 1.429 0 CA-C-O 121.694 0.759 . . . . 0.0 109.389 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.32 142.17 35.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.618 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 72.87 -53.47 0.7 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.726 1.21 . . . . 0.0 111.367 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 160.39 26.29 0.02 OUTLIER Glycine 0 C--N 1.288 -2.117 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 24.2 t -151.25 154.4 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 -173.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.432 ' HZ2' ' HB3' ' A' ' 709' ' ' TYR . 95.8 m95 -78.98 -178.85 6.31 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 18.3 p -84.69 -158.5 0.35 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.347 0.594 . . . . 0.0 112.253 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.3 pp0? -81.56 -11.45 59.15 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.496 HD21 ' HG3' ' A' ' 695' ' ' PRO . 4.4 mm? 72.17 137.69 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 30.8 Cg_endo -66.07 -179.44 1.41 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.773 2.315 . . . . 0.0 112.729 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.575 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 53.3 tt0 -124.45 137.75 54.41 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.519 ' SG ' HD21 ' A' ' 697' ' ' LEU . 58.6 m -123.92 98.75 5.94 Favored 'General case' 0 CA--C 1.466 -2.273 0 CA-C-O 121.586 0.708 . . . . 0.0 109.642 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.438 ' HB ' HD21 ' A' ' 750' ' ' LEU . 32.1 t -86.85 140.73 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.059 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.699 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.14 4.83 0.61 Allowed 'General case' 0 C--N 1.274 -2.704 0 C-N-CA 125.188 1.395 . . . . 0.0 114.112 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.85 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 32.3 mt 75.62 -17.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 125.626 1.57 . . . . 0.0 111.428 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 746' ' ' ALA . 8.4 t70 -76.64 -32.35 57.96 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 125.671 1.588 . . . . 0.0 109.124 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -103.63 12.51 34.79 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.216 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.85 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 67.5 mt -76.77 148.82 36.43 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.39 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.542 ' HD3' ' ND2' ' A' ' 794' ' ' ASN . 55.7 mtpt -90.04 -170.25 2.72 Favored 'General case' 0 C--N 1.261 -3.269 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.011 -172.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -120.26 126.8 51.5 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 113.352 -1.749 . . . . 0.0 106.477 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 35.9 m -87.77 150.59 23.48 Favored 'General case' 0 C--N 1.249 -3.763 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.061 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -116.81 139.84 50.12 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 755' ' ' SER . . . . . 0.485 ' HB3' HD11 ' A' ' 761' ' ' LEU . 14.7 p -61.54 139.58 58.23 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.237 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.665 ' HB2' HG13 ' A' ' 759' ' ' ILE . 20.3 m -78.02 149.21 34.06 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -91.95 7.95 39.76 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 112.223 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.98 -9.72 16.17 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.873 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.665 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.7 pp -109.0 152.11 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.74 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 760' ' ' ILE . . . . . 0.449 ' HB ' ' CG ' ' A' ' 780' ' ' ARG . 3.5 mp -109.18 131.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.769 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 44.9 mt -103.63 178.82 4.45 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.51 168.7 8.68 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.26 -22.29 64.69 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.752 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -79.98 -42.3 24.19 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.696 HD22 ' HE2' ' A' ' 771' ' ' PHE . 35.0 mt -83.03 -19.78 36.29 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.003 -1.908 . . . . 0.0 113.102 -167.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -70.81 -6.38 37.42 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.352 0.596 . . . . 0.0 111.121 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.48 15.38 27.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.421 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 6.2 tppt? -122.61 105.87 10.48 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -75.78 -45.6 35.35 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -125.14 131.31 53.27 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.048 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.769 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 40.2 m-85 -103.0 164.89 11.34 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.448 -175.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -104.74 142.14 35.23 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.336 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.555 ' HD2' HD12 ' A' ' 750' ' ' LEU . 32.6 p-80 -41.37 140.1 0.93 Allowed 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.825 1.25 . . . . 0.0 113.716 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 25.1 m120 70.4 23.25 4.99 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 125.171 1.389 . . . . 0.0 112.965 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 22.0 t -96.11 121.75 38.22 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -92.7 104.11 16.41 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.631 HG21 ' CE2' ' A' ' 771' ' ' PHE . 4.5 pt -114.15 -173.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.972 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 1.6 ptt180 -143.77 127.93 17.63 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.0 174.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.471 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 6.8 p90 -117.22 174.94 5.84 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 177.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 780' ' ' ARG . . . . . 0.449 ' CG ' ' HB ' ' A' ' 760' ' ' ILE . 10.6 ptm180 -153.87 170.58 20.66 Favored 'General case' 0 N--CA 1.407 -2.62 0 O-C-N 124.374 1.047 . . . . 0.0 108.447 177.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 49.7 t -100.47 161.46 13.59 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -73.74 -21.51 60.18 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.938 0.399 . . . . 0.0 109.942 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -93.03 -4.99 64.45 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.214 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 13.7 mptt -120.8 107.9 13.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 785' ' ' GLU . . . . . 0.439 ' HA ' ' NH2' ' A' ' 780' ' ' ARG . 12.2 tp10 -81.93 99.9 9.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 160.09 -165.91 34.94 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 107.665 -2.174 . . . . 0.0 107.665 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.585 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 61.4 m95 -139.72 146.62 39.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.64 1.22 . . . . 0.0 109.665 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.471 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -100.29 -34.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.456 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 789' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 12.8 m170 77.24 135.15 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.622 1.169 . . . . 0.0 110.452 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.446 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.8 t -158.57 157.58 32.27 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.091 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.5 136.84 55.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 792' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 45.8 t -71.23 107.53 4.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.631 0.729 . . . . 0.0 109.482 177.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.3 mm -113.89 83.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.165 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.42 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.588 ' HB2' HD22 ' A' ' 750' ' ' LEU . 10.8 t30 58.76 66.34 1.08 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 122.403 1.097 . . . . 0.0 111.175 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 62.03 24.31 64.81 Favored Glycine 0 C--N 1.299 -1.478 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.488 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -145.02 166.27 25.79 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.435 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.5 m95 -111.67 158.08 19.7 Favored 'General case' 0 C--N 1.255 -3.54 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -148.32 107.02 3.59 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.36 142.54 66.8 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.971 -1.262 . . . . 0.0 113.074 0.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.435 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.6 mt-10 -55.54 117.03 3.23 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.406 174.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.446 ' CG1' HG21 ' A' ' 790' ' ' THR . 7.2 m . . . . . 1 N--CA 1.376 -4.171 0 C-N-CA 124.667 1.187 . . . . 0.0 112.519 -173.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 13.7 m -93.81 -167.39 1.68 Allowed 'General case' 0 C--N 1.25 -3.735 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . -118.12 -156.23 10.22 Favored Glycine 1 N--CA 1.39 -4.386 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.19 142.36 57.7 Favored 'General case' 0 C--N 1.278 -2.507 0 O-C-N 124.717 0.892 . . . . 0.0 108.753 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.597 HG21 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -63.68 151.7 87.96 Favored Pre-proline 0 C--N 1.284 -2.25 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.928 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.488 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 55.8 Cg_endo -71.14 -162.15 0.1 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.074 2.516 . . . . 0.0 112.925 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.17 158.84 43.45 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.605 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.8 OUTLIER -98.28 134.61 41.07 Favored 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.583 177.188 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -56.24 -37.97 70.47 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -144.65 29.54 1.24 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.605 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -140.0 -138.92 3.68 Favored Glycine 0 C--N 1.305 -1.141 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.074 -176.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.405 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -159.09 179.83 8.68 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.394 0.678 . . . . 0.0 109.403 -179.022 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -114.22 144.58 42.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -71.41 -68.31 0.46 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.353 0.597 . . . . 0.0 110.861 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.9 tt -162.87 133.4 4.65 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.481 ' HB3' HG11 ' A' ' 715' ' ' VAL . 0.4 OUTLIER -137.1 114.0 10.51 Favored 'General case' 0 N--CA 1.401 -2.88 0 CA-C-O 121.747 0.784 . . . . 0.0 109.924 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -103.41 124.07 39.42 Favored Pre-proline 0 C--N 1.273 -2.749 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.447 -174.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.451 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 56.8 Cg_endo -66.45 172.49 9.03 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.495 2.13 . . . . 0.0 109.628 175.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.475 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.1 Cg_exo -75.21 -4.36 21.2 Favored 'Cis proline' 0 CA--C 1.497 -1.343 0 CA-C-N 119.801 0.965 . . . . 0.0 114.487 5.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.408 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 57.7 m-85 74.74 78.73 0.11 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 124.936 1.398 . . . . 0.0 108.488 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 22.4 m-85 -82.41 172.13 13.4 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -73.75 125.85 29.04 Favored 'General case' 0 CA--C 1.485 -1.523 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.29 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.75 -5.91 51.48 Favored Glycine 0 N--CA 1.411 -3.001 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.086 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.84 154.06 42.48 Favored 'General case' 0 C--O 1.251 1.179 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 19.8 m -140.21 143.64 36.15 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.846 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.597 HG21 HG21 ' A' ' 694' ' ' ILE . 47.0 t -131.54 137.08 56.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -85.84 135.21 33.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.966 0.889 . . . . 0.0 109.52 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -134.76 114.95 13.17 Favored 'General case' 0 C--N 1.268 -2.96 0 C-N-CA 126.395 1.878 . . . . 0.0 108.069 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.405 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 17.2 m-80 -120.84 -165.71 1.25 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 4.6 m -115.62 134.73 54.77 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.3 m -56.95 -80.5 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 O-C-N 124.166 0.916 . . . . 0.0 111.256 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 721' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 722' ' ' SER . 48.0 mt-10 -154.16 161.35 41.92 Favored 'General case' 0 CA--C 1.472 -2.047 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 58.0 m 70.63 7.24 6.14 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 124.723 1.264 . . . . 0.0 111.948 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.1 m-85 -139.72 144.56 37.56 Favored 'General case' 0 N--CA 1.4 -2.956 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.1 m -113.07 140.7 47.64 Favored 'General case' 0 C--N 1.246 -3.908 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.637 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.57 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.2 ttp -85.86 115.88 23.77 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.533 1.133 . . . . 0.0 108.853 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.0 mm -113.15 130.17 67.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.419 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 87.84 -74.65 2.17 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.914 -1.039 . . . . 0.0 114.164 173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -128.03 174.35 9.28 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -174.215 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.57 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -140.44 10.51 2.29 Favored 'General case' 0 C--O 1.201 -1.47 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.189 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 1.6 m -141.59 168.35 19.99 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.2 pt -129.32 161.09 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 739' ' ' THR . 5.8 m -135.85 139.17 43.19 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 733' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 44.0 t -94.22 116.24 28.62 Favored 'General case' 0 N--CA 1.407 -2.611 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.336 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.3 pp -144.26 147.43 19.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 C-N-CA 125.403 1.481 . . . . 0.0 108.168 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 64.18 15.04 9.07 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 86.59 17.59 59.95 Favored Glycine 0 CA--C 1.505 -0.546 0 C-N-CA 121.628 -0.32 . . . . 0.0 112.84 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.2 p -153.06 156.97 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.488 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 88.7 m95 -78.98 169.11 18.71 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 120.988 0.423 . . . . 0.0 110.16 175.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 732' ' ' THR . 21.8 p -73.48 -163.35 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.995 0.902 . . . . 0.0 112.845 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 5.1 pm0 -73.03 -12.95 61.11 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 124.772 1.229 . . . . 0.0 113.831 -170.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.4 mm? 73.28 149.96 0.13 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 123.921 0.763 . . . . 0.0 111.025 -175.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 42.6 Cg_endo -73.57 175.87 10.09 Favored 'Trans proline' 0 C--O 1.253 1.231 0 C-N-CA 121.761 1.64 . . . . 0.0 110.96 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -126.47 107.58 10.39 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 724' ' ' THR . 86.9 m -91.0 113.27 25.49 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.078 175.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.43 ' HB ' HD21 ' A' ' 750' ' ' LEU . 49.6 t -100.58 144.08 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.34 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.02 6.8 0.34 Allowed 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 125.973 1.709 . . . . 0.0 114.313 -175.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.825 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 55.4 mt 75.15 -19.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 125.663 1.585 . . . . 0.0 112.03 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.5 t70 -73.39 -34.09 65.35 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.671 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 749' ' ' LYS . . . . . 0.427 ' HB3' ' HE3' ' A' ' 749' ' ' LYS . 0.0 OUTLIER -114.11 29.93 7.65 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.859 -175.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.825 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 91.1 mt -83.32 -175.72 5.97 Favored 'General case' 0 N--CA 1.407 -2.609 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -105.92 147.09 29.17 Favored 'General case' 0 N--CA 1.384 -3.768 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 752' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 770' ' ' GLU . 22.4 mtpp -103.25 122.56 45.02 Favored 'General case' 1 C--N 1.237 -4.32 0 CA-C-N 113.041 -1.891 . . . . 0.0 108.65 -174.265 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 60.9 m -70.96 150.12 46.0 Favored 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.44 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -112.37 143.89 42.72 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.314 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 4.4 p -67.23 118.06 10.1 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.644 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.419 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 43.2 t -79.37 153.82 29.47 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -100.82 0.45 38.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.084 0.469 . . . . 0.0 111.595 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 6.4 mp -91.43 -8.49 47.69 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.049 0.928 . . . . 0.0 108.573 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.507 HG12 ' CG1' ' A' ' 801' ' ' VAL . 2.8 pp -118.45 169.73 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.649 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 760' ' ' ILE . . . . . 0.592 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.5 mp -119.44 124.88 73.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.809 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 96.2 mt -97.47 179.24 4.93 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.15 167.73 13.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.385 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -12.38 61.6 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 764' ' ' HIS . . . . . 0.563 ' CD2' ' HG ' ' A' ' 765' ' ' LEU . 4.6 p-80 -100.64 -10.99 20.38 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.531 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.653 HD22 ' CE2' ' A' ' 771' ' ' PHE . 74.7 mt -110.4 -19.44 12.96 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -69.86 -12.74 61.85 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.755 0.788 . . . . 0.0 110.274 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -101.96 11.23 38.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.734 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.445 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 14.4 tppt? -104.5 108.44 19.88 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 769' ' ' LYS . . . . . 0.499 ' HD2' ' H ' ' A' ' 769' ' ' LYS . 0.0 OUTLIER -72.45 -36.7 68.6 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.185 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 770' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 752' ' ' LYS . 43.3 mt-10 -144.41 133.4 22.69 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.898 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.809 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 71.7 m-85 -103.56 149.04 25.26 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -92.39 159.08 15.73 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.14 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.697 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 31.8 t60 -62.21 140.78 58.45 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.037 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 89.17 3.26 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.957 1.703 . . . . 0.0 109.972 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 74.9 m -83.35 114.08 21.18 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.505 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -88.25 113.47 23.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.848 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.659 HG21 ' CE2' ' A' ' 771' ' ' PHE . 4.8 pt -126.98 -173.83 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.541 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 30.4 ptt180 -143.17 127.38 17.59 Favored 'General case' 0 N--CA 1.413 -2.278 0 O-C-N 122.165 -0.334 . . . . 0.0 110.173 173.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.692 ' CD2' HG13 ' A' ' 801' ' ' VAL . 11.0 p90 -108.74 170.92 7.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 174.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 780' ' ' ARG . . . . . 0.592 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 9.3 ptt180 -146.66 155.44 42.43 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 173.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 781' ' ' CYS . . . . . . . . . . . . . 14.0 t -83.81 155.36 23.03 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -76.03 -5.74 47.81 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.624 0.726 . . . . 0.0 110.568 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -102.34 -10.13 39.7 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.074 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 784' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -122.07 125.04 45.36 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.084 -0.656 . . . . 0.0 111.697 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.65 79.9 4.8 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 122.073 0.939 . . . . 0.0 108.625 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 173.08 153.2 9.31 Favored Glycine 0 C--N 1.299 -1.494 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 40.4 m95 -101.58 164.86 11.54 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 117.085 0.443 . . . . 0.0 110.192 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 788' ' ' ILE . 3.6 mp -115.25 -34.03 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.343 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 76.18 121.35 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 124.493 1.117 . . . . 0.0 109.45 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.482 HG21 ' CG2' ' A' ' 801' ' ' VAL . 3.5 t -141.92 155.89 45.49 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.13 134.07 61.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 46.9 t -68.96 119.66 13.63 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.697 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 49.5 mm -119.54 86.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 C-N-CA 124.774 1.23 . . . . 0.0 108.694 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.435 ' H ' ' HB2' ' A' ' 773' ' ' HIS . 4.5 t30 45.69 72.17 0.24 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.567 1.147 . . . . 0.0 112.233 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 68.16 19.66 72.32 Favored Glycine 0 C--N 1.3 -1.424 0 CA-C-N 115.05 -0.977 . . . . 0.0 114.178 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -144.52 165.13 28.84 Favored 'General case' 0 C--O 1.19 -2.043 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.66 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.6 m95 -111.6 160.41 17.23 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 121.735 -0.603 . . . . 0.0 110.225 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -149.29 105.77 3.33 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.76 139.91 50.96 Favored 'Cis proline' 0 C--O 1.245 0.835 0 C-N-CA 123.842 -1.316 . . . . 0.0 110.508 -0.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.66 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.3 tt0 -56.27 125.27 21.07 Favored 'General case' 0 N--CA 1.432 -1.334 0 O-C-N 123.684 0.615 . . . . 0.0 111.153 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.692 HG13 ' CD2' ' A' ' 779' ' ' TYR . 93.9 t . . . . . 0 N--CA 1.428 -1.551 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.249 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.414 -2.266 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 40.4 m -84.59 -76.36 0.31 Allowed 'General case' 0 C--N 1.254 -3.582 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.321 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 149.09 -177.29 27.41 Favored Glycine 1 N--CA 1.358 -6.558 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -51.61 130.12 27.37 Favored 'General case' 0 C--N 1.278 -2.525 0 O-C-N 125.588 1.405 . . . . 0.0 109.946 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.63 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -60.01 150.25 70.71 Favored Pre-proline 0 N--CA 1.432 -1.352 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.915 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.552 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.0 Cg_endo -71.84 -163.51 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 122.86 2.374 . . . . 0.0 111.471 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -135.74 156.51 48.7 Favored 'General case' 0 N--CA 1.402 -2.871 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.557 HD13 ' HA3' ' A' ' 700' ' ' GLY . 1.1 mt -88.56 144.65 26.19 Favored 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.358 177.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.42 -41.09 93.24 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 744' ' ' CYS . 93.6 m-70 -146.84 32.2 0.94 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.557 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -141.72 -149.65 5.24 Favored Glycine 0 C--N 1.3 -1.434 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.775 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.417 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -148.38 -179.35 6.89 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -177.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -112.58 144.63 41.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 39.3 mm-40 -73.98 -67.71 0.58 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.33 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 68.5 tp -158.2 125.45 5.02 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.512 ' CB ' HG12 ' A' ' 694' ' ' ILE . 5.5 p -118.52 132.29 56.22 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 22.9 t -121.72 112.97 32.01 Favored Pre-proline 0 C--N 1.288 -2.098 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.999 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.33 165.62 26.27 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.143 1.896 . . . . 0.0 108.642 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.442 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 16.9 Cg_exo -67.81 -10.63 8.59 Favored 'Cis proline' 0 N--CA 1.498 1.759 0 N-CA-C 115.194 1.19 . . . . 0.0 115.194 5.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 705' ' ' SER . 61.9 m-85 74.07 87.04 0.1 Allowed 'General case' 0 C--N 1.309 -1.17 0 O-C-N 124.65 1.219 . . . . 0.0 108.044 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.53 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 50.3 m-85 -90.98 172.54 8.51 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.686 -176.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -71.45 138.51 49.1 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.255 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.77 77.78 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 713' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 2.5 t70 -77.34 165.79 23.99 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 20.2 m -151.86 142.41 22.67 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.63 HG21 HG21 ' A' ' 694' ' ' ILE . 44.8 t -133.56 134.37 56.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 39.1 mt-10 -80.51 135.67 36.15 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 123.896 0.748 . . . . 0.0 111.426 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -136.61 114.3 11.13 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 125.837 1.655 . . . . 0.0 107.471 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.417 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 14.4 m-80 -124.06 -163.0 1.11 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.609 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 10.0 m -108.16 144.23 35.86 Favored 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 720' ' ' SER . . . . . 0.599 ' O ' ' HG3' ' A' ' 721' ' ' GLU . 5.1 m -55.81 -70.43 0.11 Allowed 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.769 0.668 . . . . 0.0 109.872 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 721' ' ' GLU . . . . . 0.599 ' HG3' ' O ' ' A' ' 720' ' ' SER . 30.7 mt-10 -175.22 164.39 3.25 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 129.279 3.031 . . . . 0.0 102.822 173.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 62.6 m 68.51 12.56 8.75 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.993 0.808 . . . . 0.0 111.509 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.715 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.8 m-85 -143.74 147.96 34.96 Favored 'General case' 0 N--CA 1.407 -2.615 0 C-N-CA 124.83 1.252 . . . . 0.0 108.11 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.634 HG21 HD21 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -112.93 135.27 53.89 Favored 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.996 -177.174 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.724 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.8 ttp -85.06 113.26 21.34 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 124.93 1.292 . . . . 0.0 109.758 -177.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.545 HD12 HG23 ' A' ' 793' ' ' ILE . 45.3 mm -115.27 131.3 67.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.336 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 94.57 -91.34 1.4 Allowed Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.772 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.56 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.1 m80 -114.34 178.42 4.29 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 114.508 -0.846 . . . . 0.0 110.357 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.724 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -144.92 14.21 1.5 Allowed 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 168.2 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 33.9 m -149.18 162.41 40.05 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 714' ' ' SER . 28.8 pt -121.1 166.73 15.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 739' ' ' THR . 3.8 m -135.75 139.94 43.96 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 43.3 t -99.82 116.91 32.99 Favored 'General case' 0 N--CA 1.406 -2.634 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.47 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.2 pp -142.82 149.29 18.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-N 114.004 -1.453 . . . . 0.0 107.444 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 74.9 m80 73.74 -21.83 0.26 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.662 0.785 . . . . 0.0 112.087 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 120.24 14.27 5.53 Favored Glycine 0 CA--C 1.505 -0.542 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.3 p -148.53 150.53 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.552 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.8 m95 -77.2 169.25 18.66 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.467 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 732' ' ' THR . 24.9 p -77.23 -160.8 0.18 Allowed 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.67 0.748 . . . . 0.0 112.396 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -84.69 -12.86 53.0 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.991 -168.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.406 HD21 ' HG2' ' A' ' 695' ' ' PRO . 0.9 OUTLIER 70.81 159.32 0.16 Allowed Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 124.009 0.818 . . . . 0.0 112.237 -177.327 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.56 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 37.6 Cg_endo -75.13 178.9 6.68 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.241 1.961 . . . . 0.0 112.155 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -122.91 101.33 7.37 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.023 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 699' ' ' HIS . 73.1 m -84.59 112.4 20.4 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-O 121.094 0.474 . . . . 0.0 110.58 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.72 144.04 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.715 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.33 1.16 0.81 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 125.08 1.352 . . . . 0.0 114.254 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.751 ' HA ' HD22 ' A' ' 750' ' ' LEU . 34.5 mt 76.54 -18.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 124.991 1.317 . . . . 0.0 110.971 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.0 t70 -77.84 -23.82 48.81 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 125.884 1.673 . . . . 0.0 109.203 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -110.89 18.95 19.02 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.586 -1.643 . . . . 0.0 108.842 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.828 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 3.1 mp -85.7 -176.8 6.19 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.859 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.49 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 53.1 mtpt -140.48 164.92 28.84 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -109.02 140.39 42.61 Favored 'General case' 0 C--N 1.257 -3.423 0 C-N-CA 126.021 1.728 . . . . 0.0 108.256 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 59.8 m -88.01 165.06 15.45 Favored 'General case' 1 C--N 1.239 -4.238 0 CA-C-N 114.106 -1.407 . . . . 0.0 109.147 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 754' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 754' ' ' LYS . 17.4 ptpt -132.77 147.62 52.32 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.988 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.18 114.04 3.53 Favored 'General case' 0 C--N 1.27 -2.875 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.916 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.617 ' HB2' ' CG1' ' A' ' 759' ' ' ILE . 55.9 m -72.98 149.78 43.03 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -80.08 -9.24 59.69 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.887 0.851 . . . . 0.0 110.458 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.83 -11.92 40.63 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.402 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.617 ' CG1' ' HB2' ' A' ' 756' ' ' SER . 2.4 pp -118.06 140.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.401 -173.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 760' ' ' ILE . . . . . 0.419 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.1 mp -104.39 131.21 53.83 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.53 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 2.1 mm? -108.56 -177.79 3.41 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 120.845 0.355 . . . . 0.0 110.114 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -71.48 167.61 19.28 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -57.86 -17.54 16.98 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.054 0.941 . . . . 0.0 112.639 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -85.62 -42.1 14.63 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.62 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 66.7 mt -85.65 -15.42 42.45 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 113.452 -1.704 . . . . 0.0 112.652 -169.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -73.96 -13.81 60.94 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.472 0.653 . . . . 0.0 110.508 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -96.51 0.33 50.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.335 1.064 . . . . 0.0 108.459 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.421 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 8.7 tppt? -103.08 118.48 36.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 769' ' ' LYS . . . . . 0.405 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 9.8 ptpp? -96.76 -19.85 18.64 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 770' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 35.5 mt-10 -136.25 122.7 20.73 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.283 176.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.529 ' CE2' HD22 ' A' ' 765' ' ' LEU . 76.1 m-85 -98.96 142.56 30.31 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -87.71 148.2 24.87 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.954 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.686 ' CG ' HD23 ' A' ' 750' ' ' LEU . 47.1 p-80 -42.47 141.7 0.95 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.359 1.463 . . . . 0.0 111.259 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 63.6 t30 75.57 2.42 3.78 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.026 1.33 . . . . 0.0 111.825 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 18.2 t -82.24 118.49 23.15 Favored 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 121.292 -0.88 . . . . 0.0 108.666 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.81 106.22 17.93 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.62 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.6 pt -115.97 -170.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.584 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 7.1 ptp180 -150.82 134.99 16.86 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.525 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 8.1 p90 -119.15 173.52 6.87 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 780' ' ' ARG . . . . . 0.419 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 10.5 ptt180 -155.4 169.82 23.36 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 59.3 m -97.79 164.31 12.44 Favored 'General case' 0 C--N 1.282 -2.341 0 O-C-N 123.876 0.735 . . . . 0.0 109.093 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 782' ' ' ARG . . . . . 0.53 ' HD2' ' H ' ' A' ' 782' ' ' ARG . 0.0 OUTLIER -66.72 -36.95 83.69 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.854 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -98.35 5.18 60.64 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.404 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.0 mptt -127.65 105.15 8.28 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 785' ' ' GLU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 780' ' ' ARG . 35.9 tt0 -90.58 78.88 6.21 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.879 0.847 . . . . 0.0 109.952 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -164.1 144.58 9.56 Favored Glycine 0 CA--C 1.472 -2.636 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.584 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 38.5 m95 -101.66 131.61 47.81 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 117.405 0.602 . . . . 0.0 109.992 -174.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.525 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -87.87 -30.5 5.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.757 -174.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 789' ' ' HIS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 15.3 m170 71.53 125.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.549 1.14 . . . . 0.0 109.119 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 3.4 t -147.9 155.6 41.77 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 122.196 -0.315 . . . . 0.0 110.438 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.58 135.69 57.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 53.6 t -72.92 114.08 10.66 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.845 0.831 . . . . 0.0 110.342 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.545 HG23 HD12 ' A' ' 726' ' ' ILE . 50.9 mm -115.29 80.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 C-N-CA 124.501 1.121 . . . . 0.0 108.713 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.828 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 1.0 OUTLIER 52.08 64.64 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.464 176.072 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.61 22.53 78.31 Favored Glycine 0 C--N 1.308 -0.996 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.576 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -147.28 164.18 34.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.617 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.0 m95 -111.75 159.56 18.15 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-O 120.581 0.229 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 798' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 21.9 t70 -149.19 103.79 3.33 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 799' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 798' ' ' ASP . 47.7 Cg_endo -72.13 141.57 71.08 Favored 'Cis proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.876 -1.302 . . . . 0.0 113.602 -0.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 2.9 mm-40 -53.32 127.73 25.76 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.138 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.485 ' HB ' HG21 ' A' ' 759' ' ' ILE . 3.2 m . . . . . 1 N--CA 1.372 -4.362 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.997 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.42 -1.937 0 CA-C-O 120.971 0.415 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 39.0 m -80.62 -66.23 0.91 Allowed 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.54 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 128.37 -177.54 17.66 Favored Glycine 1 N--CA 1.367 -5.917 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.409 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 30.9 t70 -34.14 128.36 0.4 Allowed 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 127.023 2.129 . . . . 0.0 112.727 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.698 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -61.82 150.29 82.82 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.163 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.457 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 57.0 Cg_endo -72.17 -159.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.684 2.256 . . . . 0.0 111.74 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.15 -173.29 3.22 Favored 'General case' 0 N--CA 1.401 -2.884 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 717' ' ' PHE . 22.0 tp -128.6 126.0 39.36 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-O 120.872 0.368 . . . . 0.0 110.384 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -49.44 -37.9 27.47 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.4 m-70 -137.09 24.68 3.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -141.79 -146.76 4.74 Favored Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.21 -0.995 . . . . 0.0 110.846 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.476 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.01 179.21 8.25 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.704 0.288 . . . . 0.0 110.324 -177.234 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -112.49 143.41 43.68 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.2 -75.54 0.17 Allowed 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.241 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.7 tt -176.46 132.17 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.455 ' HB2' HG13 ' A' ' 715' ' ' VAL . 9.9 t -154.23 146.96 24.25 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 10.1 t -117.07 149.14 43.73 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.521 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 59.4 Cg_endo -65.97 174.54 5.64 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.61 2.207 . . . . 0.0 110.454 177.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.521 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.8 Cg_endo -79.95 -4.18 40.5 Favored 'Cis proline' 0 C--O 1.215 -0.633 0 CA-C-N 119.799 0.964 . . . . 0.0 114.541 4.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.442 ' CE1' HG23 ' A' ' 694' ' ' ILE . 77.1 m-85 68.92 79.32 0.21 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.326 0.584 . . . . 0.0 110.262 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 30.1 m-85 -83.56 170.81 13.97 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.47 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 44.0 m-85 -68.46 137.11 54.19 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.322 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.9 -5.38 68.99 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.3 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 713' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 2.9 t70 -71.14 157.59 37.9 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 20.2 m -149.22 139.36 22.17 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.698 HG21 HG21 ' A' ' 694' ' ' ILE . 41.0 t -130.48 140.93 47.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.033 -174.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 729' ' ' ARG . 1.6 mp0 -80.2 131.79 35.76 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 122.168 0.985 . . . . 0.0 112.872 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.576 ' HB3' HD22 ' A' ' 697' ' ' LEU . 32.1 m-85 -135.89 107.96 7.19 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 113.608 -1.633 . . . . 0.0 107.297 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.476 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 9.0 m-80 -115.51 -163.46 0.89 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 8.3 m -116.06 134.91 54.45 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 3.2 m -58.04 -70.87 0.12 Allowed 'General case' 0 C--N 1.288 -2.094 0 O-C-N 124.163 0.914 . . . . 0.0 111.87 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -164.33 161.37 21.72 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 74.9 m 69.84 2.75 3.99 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.995 0.81 . . . . 0.0 112.847 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.5 m-85 -137.5 148.75 46.26 Favored 'General case' 0 N--CA 1.401 -2.892 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.502 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -115.08 141.91 47.36 Favored 'General case' 0 C--N 1.259 -3.336 0 C-N-CA 124.991 1.316 . . . . 0.0 109.996 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.8 ttp -85.84 120.71 27.56 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 124.071 0.948 . . . . 0.0 109.826 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 43.2 mm -111.82 122.18 65.68 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.763 174.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 114.15 -94.86 0.71 Allowed Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.966 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 47.6 t-80 -156.97 139.1 14.55 Favored 'General case' 0 CA--C 1.472 -2.054 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.56 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -85.71 25.76 1.04 Allowed 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 15.4 m -143.87 156.24 44.39 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.776 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 714' ' ' SER . 41.2 pt -118.65 160.58 18.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.419 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 739' ' ' THR . 20.1 m -134.02 135.87 43.68 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.973 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 733' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.3 t -85.65 104.07 15.05 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.8 pp -146.65 144.18 20.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 124.034 0.934 . . . . 0.0 110.246 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 67.85 8.16 6.25 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 94.51 20.28 29.96 Favored Glycine 0 CA--C 1.5 -0.844 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.376 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.7 p -157.46 158.93 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.457 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 94.5 m95 -78.04 172.71 13.1 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 171.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 25.5 p -76.38 -169.56 1.23 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.976 0.893 . . . . 0.0 112.999 -174.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.2 pp0? -65.55 -20.64 66.41 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 -173.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 5.6 mt 70.68 138.55 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 124.547 1.154 . . . . 0.0 112.882 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 56.7 Cg_endo -67.04 167.12 20.75 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.363 2.042 . . . . 0.0 112.428 -177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.434 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 51.3 tt0 -112.47 102.42 10.53 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.493 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 89.4 m -82.55 111.19 18.31 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.614 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.461 ' HB ' HD21 ' A' ' 750' ' ' LEU . 48.2 t -99.45 145.35 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.497 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.67 4.16 0.63 Allowed 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 125.411 1.484 . . . . 0.0 113.716 -175.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.884 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 57.6 mt 76.47 -22.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 126.183 1.793 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 746' ' ' ALA . 12.1 t70 -67.41 -34.86 78.12 Favored 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 126.029 1.732 . . . . 0.0 109.841 -174.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.75 24.12 13.35 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 113.578 -1.647 . . . . 0.0 111.658 -175.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.884 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 85.9 mt -78.65 166.01 23.0 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-O 121.644 0.735 . . . . 0.0 109.899 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -91.19 -167.62 1.85 Allowed 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 126.701 2.0 . . . . 0.0 112.408 -171.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 752' ' ' LYS . . . . . 0.543 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 28.4 mmmt -123.72 134.03 53.77 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 126.357 1.863 . . . . 0.0 106.793 -176.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 753' ' ' CYS . . . . . 0.465 ' HB2' ' CZ2' ' A' ' 797' ' ' TRP . 0.0 OUTLIER -87.39 -179.47 6.39 Favored 'General case' 0 C--N 1.257 -3.454 0 C-N-CA 125.44 1.496 . . . . 0.0 109.433 -177.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -141.14 137.99 33.14 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.93 -0.481 . . . . 0.0 110.433 -176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 38.9 t -71.79 120.56 17.56 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 172.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.51 ' HB3' HG12 ' A' ' 759' ' ' ILE . 42.9 t -70.33 163.18 27.14 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -96.41 -1.09 48.27 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.95 18.26 19.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.983 0.42 . . . . 0.0 110.71 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.51 HG12 ' HB3' ' A' ' 756' ' ' SER . 23.8 pt -126.41 157.71 36.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.538 0.685 . . . . 0.0 112.07 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 760' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.2 mp -117.74 132.54 67.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.593 ' HG ' ' HZ ' ' A' ' 771' ' ' PHE . 2.7 mm? -106.94 178.17 4.64 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 762' ' ' GLU . . . . . 0.569 ' HB2' HD23 ' A' ' 765' ' ' LEU . 47.4 mt-10 -62.01 162.22 9.56 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.97 176.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.7 -11.99 56.58 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.538 0.685 . . . . 0.0 111.264 -176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.31 -0.61 26.1 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.573 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.3 mm? -122.97 -12.12 8.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 8.7 mtmp? -62.65 -27.02 68.93 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -88.1 5.71 39.86 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.707 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 19.0 ttmm -101.94 109.92 21.77 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 769' ' ' LYS . . . . . 0.522 ' HE3' ' HG3' ' A' ' 770' ' ' GLU . 34.6 ttpt -79.46 -37.29 37.24 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.251 1.024 . . . . 0.0 108.444 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 770' ' ' GLU . . . . . 0.522 ' HG3' ' HE3' ' A' ' 769' ' ' LYS . 41.4 mt-10 -127.92 114.61 17.39 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.438 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.707 ' CD2' ' HD2' ' A' ' 768' ' ' LYS . 82.3 m-85 -88.76 -178.68 5.83 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.972 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -118.68 138.54 52.55 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.59 -175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.73 ' CD2' ' HB2' ' A' ' 750' ' ' LEU . 9.8 p-80 -45.91 146.86 1.1 Allowed 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.642 1.177 . . . . 0.0 112.738 174.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 66.7 t30 72.22 10.95 5.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.27 1.028 . . . . 0.0 110.702 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 46.8 t -94.25 127.99 40.45 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.6 111.25 23.6 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.543 HD12 HD12 ' A' ' 761' ' ' LEU . 7.8 pt -118.91 176.46 3.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 121.662 0.744 . . . . 0.0 109.596 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 79.5 mtt180 -122.28 133.29 54.69 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 173.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 779' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -128.59 168.33 15.88 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -160.08 163.9 33.51 Favored 'General case' 0 N--CA 1.412 -2.372 0 O-C-N 124.521 1.138 . . . . 0.0 109.281 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 90.7 m -82.48 175.34 10.28 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 123.53 0.519 . . . . 0.0 109.797 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 782' ' ' ARG . . . . . 0.42 ' HB3' HD11 ' A' ' 760' ' ' ILE . 12.5 ptm180 -91.4 -29.19 17.21 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.936 0.398 . . . . 0.0 110.504 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -92.24 -3.11 67.71 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.791 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 2.2 mptp? -130.74 107.62 9.29 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.62 149.38 27.44 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 111.45 141.11 8.43 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -174.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 47.4 m95 -98.61 149.8 22.4 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 117.047 0.424 . . . . 0.0 110.746 -171.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 788' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.16 -31.7 3.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.06 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 73.19 118.92 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 124.843 1.257 . . . . 0.0 110.206 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.543 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.1 t -140.32 158.52 43.9 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.836 -0.54 . . . . 0.0 110.232 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.94 134.48 63.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 792' ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 54.0 t -72.19 117.27 13.62 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.533 0.682 . . . . 0.0 110.327 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.07 79.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.48 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 794' ' ' ASN . . . . . . . . . . . . . 8.9 t30 55.09 71.94 0.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.845 0.831 . . . . 0.0 112.171 171.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 795' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 75.26 3.58 70.74 Favored Glycine 0 C--N 1.292 -1.902 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.988 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 796' ' ' ARG . . . . . 0.452 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 22.9 ttt180 -136.19 174.58 10.46 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.635 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 97.5 m95 -121.12 159.48 25.71 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 798' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 9.3 t70 -148.3 106.52 3.58 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 799' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 798' ' ' ASP . 51.0 Cg_endo -71.92 142.45 73.76 Favored 'Cis proline' 0 C--O 1.244 0.814 0 C-N-CA 123.588 -1.422 . . . . 0.0 112.956 -0.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.635 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 1.9 mm-40 -50.51 126.1 14.48 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 115.096 -0.956 . . . . 0.0 113.118 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.543 ' CG1' HG21 ' A' ' 790' ' ' THR . 3.6 m . . . . . 1 N--CA 1.35 -5.462 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.589 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 690' ' ' THR . . . . . 0.63 HG21 ' HB2' ' A' ' 708' ' ' PRO . 12.4 p . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 23.7 m -72.31 -63.08 1.22 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.059 0.457 . . . . 0.0 110.169 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 131.3 -164.23 23.44 Favored Glycine 1 N--CA 1.356 -6.675 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -45.61 136.8 5.61 Favored 'General case' 0 C--N 1.26 -3.315 0 C-N-CA 126.182 1.793 . . . . 0.0 111.828 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.505 HG21 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -68.7 148.22 98.02 Favored Pre-proline 0 N--CA 1.427 -1.61 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.066 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.539 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 70.9 Cg_endo -72.76 -168.98 0.44 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 123.327 2.685 . . . . 0.0 111.838 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -135.52 143.28 45.69 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.574 HD22 ' HB3' ' A' ' 717' ' ' PHE . 24.5 tp -92.56 123.79 36.11 Favored 'General case' 0 C--N 1.254 -3.552 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.187 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.538 ' HG2' HD12 ' A' ' 697' ' ' LEU . 7.4 pt-20 -30.42 -51.74 0.15 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.319 2.248 . . . . 0.0 115.556 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 78.8 m-70 -136.15 23.39 3.26 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -134.04 -159.11 8.8 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.998 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.436 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -141.07 176.34 8.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.692 0.282 . . . . 0.0 111.382 -173.683 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -111.52 133.66 53.64 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.513 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 53.7 mm-40 -74.42 -73.26 0.24 Allowed 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 704' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 705' ' ' SER . 7.0 tt -161.3 139.63 9.58 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.474 -177.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.714 ' HB2' HG22 ' A' ' 715' ' ' VAL . 35.8 t -164.36 -175.7 4.05 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 26.7 p -152.11 140.74 13.71 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.89 167.29 23.68 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 121.798 1.666 . . . . 0.0 109.39 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.63 ' HB2' HG21 ' A' ' 690' ' ' THR . 1.3 Cg_endo -73.74 -1.83 14.62 Favored 'Cis proline' 0 C--O 1.243 0.73 0 N-CA-C 115.201 1.193 . . . . 0.0 115.201 6.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 72.5 m-85 72.55 75.58 0.15 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.39 1.056 . . . . 0.0 109.318 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.601 ' CE1' ' HG2' ' A' ' 708' ' ' PRO . 18.3 m-85 -79.49 169.95 17.3 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.158 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.533 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 54.3 m-85 -68.81 133.95 49.02 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.905 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.74 -11.23 60.98 Favored Glycine 0 N--CA 1.426 -1.973 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.463 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.29 150.82 47.78 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 15.6 m -140.01 142.77 36.24 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 121.196 0.522 . . . . 0.0 109.904 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.714 HG22 ' HB2' ' A' ' 705' ' ' SER . 20.5 t -131.88 127.09 58.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 40.0 mt-10 -71.66 138.22 48.46 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.919 0.39 . . . . 0.0 111.266 174.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.574 ' HB3' HD22 ' A' ' 697' ' ' LEU . 19.7 m-85 -138.19 123.76 19.66 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.436 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 6.7 m-80 -136.22 -165.21 1.68 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 9.4 m -115.53 130.23 56.8 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 720' ' ' SER . . . . . 0.427 ' HA ' ' CE2' ' A' ' 701' ' ' TRP . 4.0 m -47.0 -71.98 0.06 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 124.984 1.427 . . . . 0.0 112.09 -172.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -169.46 164.61 10.54 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 66.9 m 66.31 8.23 5.48 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.087 0.867 . . . . 0.0 112.288 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.66 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.5 m-85 -141.35 142.69 33.78 Favored 'General case' 0 N--CA 1.412 -2.363 0 C-N-CA 124.141 0.976 . . . . 0.0 108.771 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 0.9 OUTLIER -107.37 133.97 51.12 Favored 'General case' 0 C--N 1.251 -3.713 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.784 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.731 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.3 ttp -87.97 121.17 30.06 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.259 1.024 . . . . 0.0 109.923 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.608 HD12 HG23 ' A' ' 793' ' ' ILE . 49.9 mm -120.16 131.18 73.19 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.714 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.084 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 111.49 -81.46 0.29 Allowed Glycine 0 C--N 1.306 -1.124 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.679 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.586 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 9.9 t-80 -150.92 171.45 17.23 Favored 'General case' 0 C--O 1.202 -1.414 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.731 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -131.3 25.75 4.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.739 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 73.3 m -157.51 166.84 31.87 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.514 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 39.5 pt -129.91 161.35 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 O-C-N 124.654 1.221 . . . . 0.0 108.216 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 18.6 m -136.55 135.27 38.32 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.76 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 733' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.6 t -80.71 107.77 13.8 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.247 0.546 . . . . 0.0 110.499 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -145.89 146.72 19.05 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.229 0 C-N-CA 125.125 1.37 . . . . 0.0 110.051 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 37.7 m80 70.75 -12.93 0.51 Allowed 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 123.603 0.761 . . . . 0.0 111.685 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 105.0 19.26 10.97 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 33.2 t -143.1 159.12 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.539 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.6 m95 -86.19 179.0 7.01 Favored 'General case' 0 C--N 1.256 -3.462 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.514 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 25.1 p -76.64 -158.76 0.11 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.558 0.694 . . . . 0.0 112.053 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 4.9 pm0 -83.28 -9.38 59.14 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -165.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.2 mm? 71.82 150.59 0.13 Allowed Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 123.11 0.564 . . . . 0.0 111.11 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.586 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 10.9 Cg_exo -68.82 -161.36 0.07 OUTLIER 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.555 2.17 . . . . 0.0 112.292 173.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -142.1 137.65 31.14 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 87.3 m -130.09 107.62 9.46 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.147 0.498 . . . . 0.0 110.78 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.614 ' HB ' HD21 ' A' ' 750' ' ' LEU . 41.1 t -99.52 143.15 13.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.66 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -63.3 2.5 0.38 Allowed 'General case' 0 C--N 1.287 -2.148 0 C-N-CA 126.213 1.805 . . . . 0.0 114.79 -175.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.795 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 59.6 mt 75.48 -16.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 125.302 1.441 . . . . 0.0 111.309 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.7 t70 -72.54 -35.84 68.14 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.166 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 29.86 7.49 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.336 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.795 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 73.3 mt -86.72 -160.63 0.59 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.432 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.476 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 54.9 mtpt -145.86 168.48 20.71 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -116.77 139.83 50.13 Favored 'General case' 0 C--N 1.271 -2.823 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 753' ' ' CYS . . . . . 0.484 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 46.4 m -92.01 172.86 8.16 Favored 'General case' 0 C--N 1.249 -3.792 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.681 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -138.0 147.69 44.45 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 755' ' ' SER . . . . . 0.413 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.3 p -64.83 139.66 58.79 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.188 172.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.605 ' HB2' HG12 ' A' ' 759' ' ' ILE . 50.7 m -77.92 173.04 12.58 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -97.13 -15.52 20.9 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 121.543 -0.723 . . . . 0.0 111.608 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.27 16.47 24.23 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.774 -0.579 . . . . 0.0 110.542 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.605 HG12 ' HB2' ' A' ' 756' ' ' SER . 11.8 pt -124.27 153.94 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.701 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.57 131.91 65.27 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.575 HD11 HD12 ' A' ' 759' ' ' ILE . 1.9 mm? -108.12 178.01 4.64 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 762' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 45.8 mt-10 -65.33 156.68 31.36 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 171.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . 0.256 0.0 OUTLIER -68.51 -11.16 59.48 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 119.214 0.915 . . . . 0.0 112.802 -174.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -74.65 -31.73 62.04 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.672 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 64.3 mt -98.21 -25.37 14.9 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.708 -172.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 7.0 mtmp? -62.58 -32.17 73.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.338 0.59 . . . . 0.0 110.586 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -91.85 5.36 50.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.993 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.557 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 22.1 ttmm -87.31 -48.97 7.57 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.03 -54.41 0.57 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.038 1.335 . . . . 0.0 111.201 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 770' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 768' ' ' LYS . 47.1 mt-10 -113.69 123.75 50.65 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.582 ' CE2' HD22 ' A' ' 765' ' ' LEU . 11.4 m-85 -110.96 149.07 31.19 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -173.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.05 156.16 17.06 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -46.55 149.74 0.76 Allowed 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.57 1.148 . . . . 0.0 112.876 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 1.9 t30 67.9 12.12 8.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.379 1.472 . . . . 0.0 111.823 174.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 775' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 791' ' ' VAL . 20.1 p -77.33 110.89 12.45 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -84.92 93.7 8.6 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.672 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.6 pt -106.01 -177.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.809 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.572 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 76.8 mtt85 -132.47 135.37 45.98 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.49 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 4.7 p90 -131.37 168.63 17.25 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -159.05 164.5 35.38 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 93.8 m -83.56 161.35 21.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.93 -30.24 58.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -172.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -99.49 8.34 60.21 Favored Glycine 0 CA--C 1.499 -0.921 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 4.4 mptp? -119.62 162.53 18.81 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -131.14 162.47 29.84 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 96.92 145.03 18.45 Favored Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -172.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 54.2 m95 -110.25 139.69 45.17 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 117.339 0.57 . . . . 0.0 110.307 -174.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.49 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.0 mp -87.67 -27.41 5.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.276 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 789' ' ' HIS . . . . . 0.532 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 0.6 OUTLIER 72.45 127.43 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 124.406 1.082 . . . . 0.0 109.673 -176.215 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.492 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.0 t -149.05 151.77 35.05 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.122 176.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 775' ' ' SER . 39.3 t -113.4 132.83 61.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 C-N-CA 123.611 0.764 . . . . 0.0 110.025 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 35.8 t -70.06 113.93 7.73 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.993 0.901 . . . . 0.0 110.417 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.608 HG23 HD12 ' A' ' 726' ' ' ILE . 47.5 mm -114.64 80.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.268 -2.965 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.544 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.552 ' OD1' HD22 ' A' ' 750' ' ' LEU . 2.1 m-20 50.26 68.48 0.75 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.817 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 795' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 76.68 11.98 84.84 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.975 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -142.12 170.62 15.37 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -176.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.603 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 95.0 m95 -116.77 161.79 18.71 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 798' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 19.4 t70 -148.45 102.21 3.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 799' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 41.8 Cg_endo -71.26 142.23 72.35 Favored 'Cis proline' 0 C--O 1.244 0.777 0 C-N-CA 123.932 -1.278 . . . . 0.0 112.881 -1.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.603 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 24.7 mt-10 -51.13 121.09 5.61 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.989 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.492 ' CG1' HG21 ' A' ' 790' ' ' THR . 5.9 m . . . . . 1 N--CA 1.365 -4.709 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.196 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.422 -1.839 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 24.4 m -78.01 -54.1 6.66 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.286 0.565 . . . . 0.0 110.294 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 118.68 -171.81 14.27 Favored Glycine 1 N--CA 1.356 -6.641 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -34.48 122.54 0.51 Allowed 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 126.645 1.978 . . . . 0.0 111.884 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.636 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -62.93 147.68 93.61 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.247 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.431 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 43.0 Cg_endo -68.15 -167.02 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.777 2.318 . . . . 0.0 112.396 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -133.75 152.24 51.82 Favored 'General case' 0 N--CA 1.384 -3.773 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 717' ' ' PHE . 22.0 tp -99.74 114.19 27.17 Favored 'General case' 0 C--N 1.258 -3.371 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -43.32 -43.03 4.78 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 114.382 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -130.22 27.31 5.1 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.037 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -142.58 -150.9 5.4 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.645 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.49 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -145.05 174.54 10.96 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -177.172 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.81 147.99 28.03 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -84.65 -71.54 0.51 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.947 0.403 . . . . 0.0 110.487 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.0 tt -165.88 138.8 4.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.488 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 70.8 p -123.56 -63.95 1.19 Allowed 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 120.766 0.317 . . . . 0.0 110.854 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 32.7 t 71.41 105.96 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 125.301 1.44 . . . . 0.0 111.483 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.621 ' HB3' ' CE2' ' A' ' 709' ' ' TYR . 91.4 Cg_endo -74.43 162.88 37.37 Favored 'Trans proline' 0 CA--C 1.556 1.579 0 C-N-CA 122.407 2.072 . . . . 0.0 112.119 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 51.3 Cg_exo -65.27 171.01 34.24 Favored 'Cis proline' 0 CA--C 1.478 -2.302 0 CA-C-O 123.136 1.223 . . . . 0.0 113.599 0.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 707' ' ' PRO . 70.2 m-85 -115.14 74.83 0.9 Allowed 'General case' 1 C--N 1.23 -4.614 0 CA-C-N 112.184 -2.28 . . . . 0.0 109.871 -174.303 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -76.07 170.53 16.1 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.898 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -73.08 131.58 42.26 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.579 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.78 -8.72 63.77 Favored Glycine 0 N--CA 1.419 -2.439 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.37 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.83 154.92 38.06 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 120.783 0.325 . . . . 0.0 110.227 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 13.3 m -140.15 149.14 42.63 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 694' ' ' ILE . 44.5 t -132.61 134.02 59.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 45.0 mt-10 -89.67 141.59 28.46 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.436 0.636 . . . . 0.0 112.253 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.581 ' HB3' HD22 ' A' ' 697' ' ' LEU . 58.6 m-85 -141.16 129.85 22.83 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.875 1.67 . . . . 0.0 107.501 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.49 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 13.2 m-80 -132.63 -161.61 1.15 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 12.5 m -110.07 143.32 40.27 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 2.8 m -73.17 -84.94 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 123.373 0.421 . . . . 0.0 110.708 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -138.15 152.57 48.83 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 53.7 m 66.82 11.6 8.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.648 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.9 m-85 -137.55 148.31 45.82 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.422 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.1 m -116.65 135.11 54.06 Favored 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.54 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.8 ttp -92.81 124.26 36.67 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 123.93 0.892 . . . . 0.0 109.221 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 45.8 mm -126.13 144.0 37.74 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.593 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.441 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 100.45 -79.39 0.45 Allowed Glycine 0 N--CA 1.433 -1.505 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.456 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.483 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 3.5 t-80 -146.0 179.84 7.2 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.606 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.2 OUTLIER -136.3 22.22 3.21 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.147 177.323 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.442 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.2 p -157.2 170.1 23.25 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.087 -175.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.437 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 35.7 pt -125.42 161.57 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.69 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 738' ' ' TRP . 23.7 m -133.74 138.04 45.56 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 123.674 0.609 . . . . 0.0 110.104 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.2 103.19 15.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.49 145.21 24.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.431 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 69.42 -13.62 0.37 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 117.33 14.9 6.76 Favored Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.7 p -152.24 150.89 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.442 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 94.0 m95 -73.5 163.83 27.5 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.656 171.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 34.3 p -74.2 -161.34 0.12 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.083 0.944 . . . . 0.0 113.268 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.428 ' CD ' ' H ' ' A' ' 740' ' ' GLN . 0.4 OUTLIER -82.4 -3.06 54.92 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -165.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 68.81 155.38 0.14 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 123.665 0.603 . . . . 0.0 111.136 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 46.0 Cg_endo -74.77 177.75 8.09 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.854 1.703 . . . . 0.0 109.916 170.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -122.91 120.09 32.42 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.818 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.458 ' SG ' HD21 ' A' ' 697' ' ' LEU . 61.4 m -102.25 108.82 20.32 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.778 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.502 ' HB ' HD21 ' A' ' 750' ' ' LEU . 22.8 t -97.05 141.3 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.384 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.648 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.54 6.87 0.4 Allowed 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 125.63 1.572 . . . . 0.0 113.99 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.849 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 35.1 mt 75.82 -15.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 125.095 1.358 . . . . 0.0 111.675 177.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 746' ' ' ALA . 3.3 t70 -81.39 -31.11 33.42 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 126.109 1.763 . . . . 0.0 108.427 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 749' ' ' LYS . . . . . 0.447 ' HB2' ' CG1' ' A' ' 745' ' ' VAL . 13.6 mttm -106.64 22.86 15.19 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 113.233 -1.803 . . . . 0.0 108.221 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.849 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 73.9 mt -87.94 -169.9 2.77 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.586 174.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.603 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 58.9 mtpt -118.16 168.29 10.71 Favored 'General case' 0 N--CA 1.397 -3.091 0 CA-C-O 122.103 0.954 . . . . 0.0 111.097 -173.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 752' ' ' LYS . . . . . 0.461 ' HB2' ' HE3' ' A' ' 752' ' ' LYS . 37.0 mtmt -107.17 121.05 43.74 Favored 'General case' 0 C--N 1.253 -3.602 0 CA-C-N 112.79 -2.004 . . . . 0.0 107.141 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 753' ' ' CYS . . . . . 0.49 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 0.0 OUTLIER -77.89 158.76 29.28 Favored 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 113.824 -1.534 . . . . 0.0 107.979 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -131.75 139.93 49.1 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.14 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 3.9 m -71.26 107.81 4.43 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.497 ' HB2' HG13 ' A' ' 759' ' ' ILE . 70.1 m -58.19 143.74 43.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.821 0.343 . . . . 0.0 110.383 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -78.77 -3.3 43.7 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.336 0.589 . . . . 0.0 111.78 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.73 -15.78 15.64 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.673 -0.642 . . . . 0.0 110.689 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.7 pp -100.44 161.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.893 -174.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 760' ' ' ILE . . . . . 0.519 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.5 mp -114.2 129.87 69.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.52 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 86.5 mt -105.32 176.99 4.98 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 120.997 0.427 . . . . 0.0 110.095 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.62 168.8 7.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.988 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -71.22 -7.22 45.34 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.478 0.656 . . . . 0.0 111.42 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.65 -2.96 16.1 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.9 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.4 HD12 ' HE2' ' A' ' 771' ' ' PHE . 2.7 mm? -121.24 -10.47 8.95 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -71.28 -10.09 59.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.841 0.829 . . . . 0.0 110.15 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -88.62 -0.83 57.66 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.949 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -114.44 129.99 56.69 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 769' ' ' LYS . . . . . 0.673 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 9.6 ptpp? -107.1 -24.55 11.91 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 770' ' ' GLU . . . . . 0.673 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 46.3 mt-10 -132.65 128.44 37.07 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.673 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.52 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 83.4 m-85 -108.72 176.11 5.22 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.367 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -115.77 158.83 22.28 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.404 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -47.81 151.91 0.82 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.111 1.364 . . . . 0.0 112.622 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 15.3 m120 59.15 13.42 2.97 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 10.4 t -76.94 108.61 10.11 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -83.94 105.68 15.01 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.5 HG21 ' CE2' ' A' ' 771' ' ' PHE . 7.2 pt -119.77 -177.96 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.432 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 98.6 mtt180 -125.8 135.28 51.82 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.488 ' CE2' ' HA ' ' A' ' 801' ' ' VAL . 6.8 p90 -125.82 165.71 18.17 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 170.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 780' ' ' ARG . . . . . 0.519 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 14.5 ptt180 -145.16 163.48 34.24 Favored 'General case' 0 C--N 1.251 -3.697 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 19.9 t -109.27 162.27 14.47 Favored 'General case' 0 N--CA 1.395 -3.213 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -73.5 -39.05 65.13 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.838 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -84.08 -17.97 63.95 Favored Glycine 0 C--O 1.24 0.5 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.345 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.1 mptt -124.84 84.71 2.31 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -85.5 89.28 7.66 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 122.297 1.046 . . . . 0.0 110.836 -172.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 175.66 152.91 9.82 Favored Glycine 0 C--N 1.287 -2.19 0 N-CA-C 106.145 -2.782 . . . . 0.0 106.145 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 45.3 m95 -84.46 142.37 30.13 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 118.126 0.963 . . . . 0.0 109.797 -173.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.48 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -99.92 -31.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.041 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 74.75 116.89 0.06 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 124.836 1.254 . . . . 0.0 109.156 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 4.3 t -137.53 152.83 49.89 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.906 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 58.1 t -116.06 133.86 61.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 53.2 t -70.27 129.07 38.36 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.36 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.39 79.76 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.721 ' ND2' HD22 ' A' ' 750' ' ' LEU . 3.7 m-20 54.03 70.43 0.61 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.193 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 795' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 76.82 -4.75 51.47 Favored Glycine 0 C--N 1.301 -1.384 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.778 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -115.89 172.55 7.07 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.591 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.0 m95 -121.76 154.89 36.35 Favored 'General case' 0 C--N 1.266 -3.032 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -144.67 105.61 4.6 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.91 143.08 74.88 Favored 'Cis proline' 0 C--O 1.248 0.993 0 C-N-CA 123.8 -1.333 . . . . 0.0 112.292 -0.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 38.6 mt-10 -53.19 125.96 19.28 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.659 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.488 ' HA ' ' CE2' ' A' ' 779' ' ' TYR . 4.6 m . . . . . 1 N--CA 1.365 -4.678 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 35.6 m -72.17 -79.47 0.07 Allowed 'General case' 0 C--N 1.268 -2.954 0 C-N-CA 123.872 0.869 . . . . 0.0 111.389 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 148.03 173.19 18.76 Favored Glycine 1 N--CA 1.362 -6.255 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -38.33 130.44 1.27 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 125.926 1.69 . . . . 0.0 111.048 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.711 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -63.23 151.72 86.23 Favored Pre-proline 0 C--N 1.296 -1.741 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.449 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.518 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.1 Cg_endo -72.18 -157.84 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 122.822 2.348 . . . . 0.0 112.941 177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -133.21 146.19 51.26 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 717' ' ' PHE . 30.1 tp -90.25 126.04 35.7 Favored 'General case' 0 C--N 1.263 -3.166 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.09 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.529 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 6.8 pt-20 -32.84 -55.3 0.37 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.24 2.216 . . . . 0.0 114.527 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.529 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 92.3 m-70 -135.53 25.47 3.44 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -131.0 -150.72 6.84 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.05 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.468 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.02 179.13 8.31 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -109.69 146.28 35.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -81.32 -66.48 0.88 Allowed 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.301 0.572 . . . . 0.0 110.536 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.0 tt -161.33 139.61 9.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.455 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 58.6 p -130.73 119.48 22.41 Favored 'General case' 0 N--CA 1.395 -3.206 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 7.4 p -97.46 112.7 61.9 Favored Pre-proline 0 C--N 1.253 -3.598 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.681 -174.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.434 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 67.0 Cg_endo -72.06 172.52 14.56 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.755 2.303 . . . . 0.0 109.397 175.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.628 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 4.0 Cg_exo -74.24 -0.21 14.82 Favored 'Cis proline' 0 N--CA 1.489 1.213 0 CA-C-N 120.295 1.141 . . . . 0.0 114.544 5.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.455 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 54.2 m-85 74.53 73.1 0.11 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 124.86 1.35 . . . . 0.0 107.79 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.628 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 23.3 m-85 -78.35 172.24 13.9 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.072 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -72.25 138.44 47.47 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.927 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 89.2 -3.83 84.33 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 713' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 0.2 OUTLIER -76.1 151.22 37.1 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 17.1 m -130.32 149.9 51.8 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.929 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.711 HG21 HG21 ' A' ' 694' ' ' ILE . 31.7 t -133.92 140.25 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.862 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.43 130.98 43.46 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-O 122.063 0.935 . . . . 0.0 112.209 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.607 ' HB3' HD22 ' A' ' 697' ' ' LEU . 20.3 m-85 -131.96 122.95 26.4 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 126.305 1.842 . . . . 0.0 106.677 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.468 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 26.8 m-80 -119.47 -162.53 0.92 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 6.8 m -111.31 129.42 56.0 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 3.1 m -51.36 -76.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.783 1.233 . . . . 0.0 112.672 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -159.3 154.84 25.85 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 101.851 -3.388 . . . . 0.0 101.851 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 67.3 m 68.46 15.37 9.19 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.248 0.967 . . . . 0.0 112.852 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.705 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.0 m-85 -143.17 146.96 34.18 Favored 'General case' 0 N--CA 1.417 -2.1 0 C-N-CA 123.898 0.879 . . . . 0.0 108.981 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 2.4 t -103.24 148.37 25.89 Favored 'General case' 0 C--N 1.267 -3.0 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -177.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.6 ttp -104.59 118.06 35.64 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.475 HG12 HG23 ' A' ' 724' ' ' THR . 39.5 mm -116.12 127.75 73.62 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.545 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 108.19 -93.93 0.84 Allowed Glycine 0 CA--C 1.488 -1.652 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.841 174.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.447 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 7.2 p-80 -136.16 -175.84 4.12 Favored 'General case' 0 N--CA 1.397 -3.075 0 C-N-CA 125.618 1.567 . . . . 0.0 107.631 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.433 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -132.59 12.73 4.48 Favored 'General case' 0 C--O 1.208 -1.119 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.748 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 87.7 p -128.81 166.48 18.97 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.399 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' A' ' 741' ' ' LEU . 32.5 pt -119.07 160.14 19.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.74 174.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 739' ' ' THR . 3.7 m -134.18 134.92 42.67 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.664 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 733' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 40.3 t -94.0 119.93 33.56 Favored 'General case' 0 N--CA 1.405 -2.705 0 C-N-CA 118.821 -1.151 . . . . 0.0 110.259 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.8 140.5 25.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 113.836 -1.529 . . . . 0.0 107.676 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 66.45 7.07 4.74 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.76 8.98 61.62 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 737' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 738' ' ' TRP . 48.4 t -130.87 139.03 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -175.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.518 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.3 m95 -72.77 166.98 21.81 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.935 172.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 732' ' ' THR . 19.5 p -75.71 -163.09 0.24 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 122.084 0.945 . . . . 0.0 112.021 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.449 ' CD ' ' H ' ' A' ' 740' ' ' GLN . 0.5 OUTLIER -89.64 2.45 54.72 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.946 -171.867 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.628 ' HA ' HG22 ' A' ' 731' ' ' ILE . 2.0 mp 70.5 169.88 0.11 Allowed Pre-proline 0 C--O 1.237 0.41 0 O-C-N 124.094 0.872 . . . . 0.0 112.338 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 741' ' ' LEU . 39.2 Cg_endo -76.42 -177.06 3.44 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.416 2.077 . . . . 0.0 111.561 171.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -119.79 124.78 46.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 724' ' ' THR . 87.1 m -115.42 107.51 15.3 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 120.9 0.381 . . . . 0.0 110.207 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.541 ' HB ' HD21 ' A' ' 750' ' ' LEU . 44.0 t -96.96 145.68 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.705 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.82 1.96 1.19 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 125.039 1.336 . . . . 0.0 114.125 -174.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.789 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 15.8 mt 74.53 -19.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 125.068 1.347 . . . . 0.0 111.697 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.5 t70 -69.82 -33.72 72.71 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 126.72 2.008 . . . . 0.0 109.502 -175.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.18 31.28 6.8 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.585 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.789 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 55.1 mt -85.83 -179.28 6.79 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 121.566 0.698 . . . . 0.0 109.877 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.539 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 56.2 mtpt -116.33 -178.16 3.35 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.109 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -130.19 126.28 37.02 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 113.253 -1.794 . . . . 0.0 107.835 -175.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 753' ' ' CYS . . . . . 0.422 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 57.5 m -75.41 155.53 36.27 Favored 'General case' 0 C--N 1.264 -3.124 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.047 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -120.09 135.87 54.79 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 45.2 t -58.42 127.1 30.42 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.118 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.587 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 41.0 t -72.17 165.41 24.42 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -84.2 -19.21 34.41 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 91.6 mt -111.53 10.97 21.29 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.021 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.587 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -112.22 149.31 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-O 121.677 0.751 . . . . 0.0 112.642 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 760' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.3 mp -113.44 133.57 58.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.552 HD11 HD13 ' A' ' 759' ' ' ILE . 1.4 mm? -110.58 -177.95 3.36 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.13 152.83 19.41 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.85 -17.12 34.04 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.84 -6.3 32.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.497 0.665 . . . . 0.0 111.012 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 765' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -117.63 -4.78 11.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.677 0.751 . . . . 0.0 110.295 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 766' ' ' LYS . 17.8 mmmt -65.57 -17.35 64.51 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.336 1.055 . . . . 0.0 111.96 176.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -105.64 16.48 25.3 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.099 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.501 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 12.2 tppt? -110.21 113.07 25.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 769' ' ' LYS . . . . . 0.446 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 8.2 ptpp? -85.8 -32.03 22.0 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.472 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 770' ' ' GLU . . . . . 0.446 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 45.5 mt-10 -132.11 119.67 21.27 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.232 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.501 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 70.4 m-85 -97.58 157.34 16.08 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.804 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -93.28 148.68 21.83 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.637 ' CD2' HD12 ' A' ' 750' ' ' LEU . 15.1 p-80 -48.0 142.82 4.74 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.052 0.941 . . . . 0.0 111.669 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 22.1 m120 68.78 21.7 7.62 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 51.9 m -93.05 120.43 33.34 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -90.18 111.37 22.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 761' ' ' LEU . 7.8 pt -120.28 -179.7 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.906 0.86 . . . . 0.0 110.459 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 88.9 mtm180 -124.75 137.72 54.32 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.59 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 8.4 p90 -130.44 166.2 21.01 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 780' ' ' ARG . . . . . 0.504 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 24.3 ptt180 -154.25 157.17 38.32 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 27.6 m -87.73 166.14 14.85 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 782' ' ' ARG . . . . . 0.557 ' HB3' HD11 ' A' ' 760' ' ' ILE . 39.4 ptt85 -84.49 -27.99 27.07 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.169 -0.613 . . . . 0.0 112.089 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -91.88 -5.8 65.97 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.018 -1.087 . . . . 0.0 112.227 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 2.8 mptp? -128.36 104.85 7.95 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -86.24 115.93 24.1 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.603 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 151.57 146.96 4.45 Favored Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 31.3 m95 -94.68 143.22 26.62 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.59 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.1 mp -97.95 -27.93 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.084 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 789' ' ' HIS . . . . . 0.487 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 0.9 OUTLIER 75.95 128.88 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 124.623 1.169 . . . . 0.0 109.923 -174.77 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.507 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.7 t -151.38 157.86 42.99 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.241 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.82 135.52 59.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 792' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 50.9 t -70.76 112.15 6.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.574 0.702 . . . . 0.0 110.093 177.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.6 mm -112.89 83.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.034 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.772 ' ND2' HD22 ' A' ' 750' ' ' LEU . 3.8 m-20 53.85 56.45 7.13 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.901 172.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 795' ' ' GLY . . . . . 0.489 ' HA3' ' HE2' ' A' ' 751' ' ' LYS . . . 81.95 16.49 72.31 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.495 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -147.42 166.08 28.3 Favored 'General case' 0 C--O 1.19 -2.05 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.623 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 99.0 m95 -111.45 162.7 14.81 Favored 'General case' 0 C--N 1.256 -3.466 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -146.47 105.76 4.05 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 799' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 29.2 Cg_endo -67.21 140.61 52.68 Favored 'Cis proline' 0 C--O 1.247 0.95 0 C-N-CA 124.061 -1.225 . . . . 0.0 111.679 -1.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.623 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.7 tt0 -57.51 118.63 5.39 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-O 121.32 0.581 . . . . 0.0 110.431 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.507 ' CG1' HG21 ' A' ' 790' ' ' THR . 1.9 m . . . . . 1 N--CA 1.363 -4.816 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.91 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 690' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 708' ' ' PRO . 15.9 p . . . . . 0 N--CA 1.422 -1.838 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 67.0 m -74.23 -58.51 3.25 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 171.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 81.76 132.29 1.45 Allowed Glycine 0 N--CA 1.417 -2.612 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.137 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 21.1 t70 62.24 106.17 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.729 0.899 . . . . 0.0 111.19 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.63 HG21 HG21 ' A' ' 715' ' ' VAL . 1.7 pp -70.12 147.13 95.47 Favored Pre-proline 0 C--N 1.291 -1.952 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.828 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.474 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 58.9 Cg_endo -69.64 -162.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 123.023 2.482 . . . . 0.0 112.823 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.93 144.92 49.12 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.692 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.5 OUTLIER -85.8 132.57 34.09 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -49.26 -47.02 46.98 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.818 1.247 . . . . 0.0 113.793 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -141.63 29.58 1.74 Allowed 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.692 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -141.89 -141.01 3.86 Favored Glycine 0 C--N 1.301 -1.395 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.186 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.459 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -157.62 179.97 8.73 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -176.043 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.74 158.21 16.89 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 13.5 mm100 -86.02 -61.5 1.74 Allowed 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.341 0.591 . . . . 0.0 110.618 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.3 tt -167.0 133.24 2.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.52 ' HB2' ' CE1' ' A' ' 709' ' ' TYR . 15.8 p -126.16 137.21 53.56 Favored 'General case' 0 N--CA 1.392 -3.329 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 706' ' ' SER . . . . . 0.42 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 15.0 t -124.87 109.43 27.88 Favored Pre-proline 0 C--N 1.279 -2.469 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.248 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 706' ' ' SER . 60.7 Cg_endo -67.43 170.97 12.48 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 123.058 2.506 . . . . 0.0 110.316 177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.539 ' HB2' HG21 ' A' ' 690' ' ' THR . 15.4 Cg_exo -68.92 -7.35 8.5 Favored 'Cis proline' 0 N--CA 1.499 1.801 0 CA-C-N 119.968 1.024 . . . . 0.0 114.686 3.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 705' ' ' SER . 51.5 m-85 76.15 73.96 0.08 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.73 1.269 . . . . 0.0 108.531 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.464 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 37.0 m-85 -82.26 174.17 11.41 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.5 -176.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -72.63 125.17 26.82 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.746 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 103.52 2.18 47.06 Favored Glycine 0 N--CA 1.411 -3.014 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.313 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.09 151.0 23.61 Favored 'General case' 0 CA--C 1.5 -0.969 0 O-C-N 122.445 -0.444 . . . . 0.0 111.153 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 21.7 m -132.69 156.89 46.18 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.63 HG21 HG21 ' A' ' 694' ' ' ILE . 39.8 t -138.24 136.43 44.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 48.6 mt-10 -91.07 141.71 28.54 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 123.434 0.459 . . . . 0.0 110.249 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.623 ' HB3' HD12 ' A' ' 697' ' ' LEU . 42.8 m-85 -138.98 121.65 16.35 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 124.655 1.182 . . . . 0.0 108.693 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.459 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 41.4 m-20 -124.46 -165.76 1.42 Allowed 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 8.0 m -117.91 140.97 48.96 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.9 m -60.73 -68.1 0.34 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-O 120.83 0.348 . . . . 0.0 110.551 -175.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 721' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 722' ' ' SER . 8.3 pt-20 -172.8 160.51 4.45 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 40.4 m 71.43 7.59 6.07 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.682 1.239 . . . . 0.0 110.493 -174.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 745' ' ' VAL . 93.2 m-85 -140.03 144.73 37.05 Favored 'General case' 0 N--CA 1.382 -3.849 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.658 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.515 HG21 HD21 ' A' ' 750' ' ' LEU . 1.1 m -120.38 144.74 47.74 Favored 'General case' 0 C--N 1.264 -3.138 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.786 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.711 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.7 ttp -81.95 116.72 21.71 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 124.91 1.284 . . . . 0.0 109.564 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 46.6 mm -115.25 137.13 49.77 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.954 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.518 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 96.3 -80.05 0.75 Allowed Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.123 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.564 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 6.2 t-80 -147.09 177.48 9.13 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -173.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.711 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -133.3 22.44 4.06 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.542 176.589 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 32.4 p -156.25 162.43 40.15 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.784 -0.572 . . . . 0.0 110.42 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 741' ' ' LEU . 36.2 pt -121.67 161.09 22.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 124.217 0.948 . . . . 0.0 108.579 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 739' ' ' THR . 10.5 m -133.37 135.8 44.93 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 123.595 0.56 . . . . 0.0 110.424 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.71 104.17 16.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.7 pp -146.34 161.68 10.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.912 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 71.7 -43.62 0.57 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.406 1.082 . . . . 0.0 111.565 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 138.15 37.14 0.14 Allowed Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 125.162 1.363 . . . . 0.0 109.769 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.8 p -174.41 161.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.502 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 95.8 m95 -77.36 172.87 12.63 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.645 173.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 732' ' ' THR . 29.5 p -80.4 -159.19 0.22 Allowed 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.699 0.762 . . . . 0.0 112.259 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.478 ' CD ' ' H ' ' A' ' 740' ' ' GLN . 0.5 OUTLIER -83.9 -4.57 58.79 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -165.4 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.414 HD13 HG21 ' A' ' 731' ' ' ILE . 4.1 mm? 68.73 156.13 0.15 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 123.432 0.458 . . . . 0.0 111.504 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.564 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 59.0 Cg_endo -80.25 173.66 12.27 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.826 1.684 . . . . 0.0 111.041 172.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -116.36 114.96 25.02 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 724' ' ' THR . 59.1 m -98.08 100.29 11.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-O 122.156 0.979 . . . . 0.0 109.483 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.706 HG11 ' CD1' ' A' ' 750' ' ' LEU . 10.6 p -77.87 155.03 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.292 0 CA-C-N 113.82 -1.537 . . . . 0.0 108.737 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -79.17 1.33 24.87 Favored 'General case' 0 C--N 1.251 -3.7 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.948 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.557 ' HA ' HD22 ' A' ' 750' ' ' LEU . 18.8 mt 77.08 -24.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 126.48 1.912 . . . . 0.0 112.24 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 746' ' ' ALA . 22.9 t70 -72.23 -34.3 68.22 Favored 'General case' 0 C--N 1.264 -3.128 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.103 -175.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 749' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 749' ' ' LYS . 8.1 ptmt -102.42 27.8 6.5 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 112.687 -2.051 . . . . 0.0 111.541 -174.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.706 ' CD1' HG11 ' A' ' 745' ' ' VAL . 1.9 tp -84.31 -179.46 7.2 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -107.37 -172.82 2.15 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.586 -173.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 752' ' ' LYS . . . . . 0.543 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 25.0 mtpp -123.03 156.04 35.65 Favored 'General case' 0 C--N 1.265 -3.07 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 79.2 m -112.18 168.6 9.49 Favored 'General case' 1 C--N 1.241 -4.136 0 C-N-CA 123.354 0.662 . . . . 0.0 109.532 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -129.2 141.36 51.17 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 48.1 t -61.86 131.37 49.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.51 ' HB2' HG12 ' A' ' 759' ' ' ILE . 17.7 m -76.17 175.01 9.39 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 123.079 0.551 . . . . 0.0 111.539 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -85.73 -35.02 21.06 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -172.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.18 12.55 26.57 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.525 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.51 HG12 ' HB2' ' A' ' 756' ' ' SER . 23.2 pt -105.59 156.21 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.183 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 760' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.1 mp -122.6 129.44 75.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.659 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 81.9 mt -97.52 -173.54 2.67 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.629 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 762' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 35.0 mt-10 -68.77 162.3 26.56 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 763' ' ' GLU . . . . . 0.568 ' HA ' ' HE2' ' A' ' 766' ' ' LYS . 38.9 mm-40 -61.74 -21.81 64.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.432 0.634 . . . . 0.0 110.738 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.27 2.02 45.18 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.471 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.434 HD12 ' HE2' ' A' ' 771' ' ' PHE . 3.3 mm? -126.94 -12.44 5.88 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 763' ' ' GLU . 57.0 mtmt -68.37 -7.53 32.2 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -102.61 0.67 33.67 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 768' ' ' LYS . 8.4 tppt? -95.02 102.43 14.24 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -78.55 -31.81 47.59 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.368 0.604 . . . . 0.0 109.656 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -131.17 128.25 39.64 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.936 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.659 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 92.6 m-85 -107.15 162.62 13.71 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 772' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 752' ' ' LYS . 2.6 p30 -113.55 168.72 9.52 Favored 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 118.1 -1.44 . . . . 0.0 109.126 175.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.428 ' CD2' HG23 ' A' ' 747' ' ' ILE . 2.1 p-80 -47.42 150.09 0.98 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.984 0.914 . . . . 0.0 112.835 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 61.2 t30 70.93 3.62 4.71 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.934 1.293 . . . . 0.0 111.324 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 12.8 t -78.85 114.39 17.75 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -89.05 113.23 24.32 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.173 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 771' ' ' PHE . 8.2 pt -125.89 178.05 4.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-O 121.337 0.589 . . . . 0.0 109.688 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 31.4 ptt180 -133.45 127.84 34.18 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.521 ' CE1' HG12 ' A' ' 801' ' ' VAL . 6.6 p90 -119.38 168.04 11.33 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -144.53 161.01 40.16 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 85.2 m -90.27 143.12 27.05 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.884 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 782' ' ' ARG . . . . . 0.46 ' HB3' HD11 ' A' ' 760' ' ' ILE . 27.4 ptt180 -67.75 130.49 43.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 95.94 -10.59 68.11 Favored Glycine 0 C--N 1.294 -1.765 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.4 mptt -114.02 140.38 48.49 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -116.87 87.66 2.74 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.395 0.617 . . . . 0.0 110.066 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 172.61 158.54 17.11 Favored Glycine 0 N--CA 1.425 -2.036 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.609 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 60.4 m95 -114.32 145.39 41.84 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 117.368 0.584 . . . . 0.0 109.71 -175.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.423 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -95.84 -35.33 5.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.388 -177.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 789' ' ' HIS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 7.1 m170 70.92 114.41 0.05 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 124.31 1.044 . . . . 0.0 109.785 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 3.6 t -139.46 163.08 33.47 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.97 138.96 52.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 C-N-CA 123.388 0.675 . . . . 0.0 109.459 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.7 t -73.41 110.69 7.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.559 0.695 . . . . 0.0 110.258 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.4 mm -111.81 81.57 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.639 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.7 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.406 ' HB2' ' HG ' ' A' ' 750' ' ' LEU . 9.3 t30 53.52 68.67 0.81 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.947 0.88 . . . . 0.0 112.22 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 795' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 70.55 17.4 74.66 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.824 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -143.52 166.2 25.46 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.604 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 95.1 m95 -112.61 158.92 19.4 Favored 'General case' 0 C--N 1.252 -3.638 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -148.05 106.67 3.65 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.82 138.53 46.98 Favored 'Cis proline' 0 C--O 1.241 0.633 0 C-N-CA 123.62 -1.408 . . . . 0.0 111.541 -0.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.604 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.1 tp10 -57.36 128.27 36.17 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.669 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.521 HG12 ' CE1' ' A' ' 779' ' ' TYR . 15.8 m . . . . . 1 N--CA 1.363 -4.786 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.706 -173.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 690' ' ' THR . . . . . 0.544 ' CG2' ' HB2' ' A' ' 708' ' ' PRO . 19.6 p . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.4 m -74.82 -59.38 2.76 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 135.35 166.88 11.18 Favored Glycine 1 N--CA 1.383 -4.857 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -177.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.656 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 34.1 t70 -53.54 135.78 39.53 Favored 'General case' 0 C--N 1.281 -2.397 0 O-C-N 124.658 0.858 . . . . 0.0 111.062 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 715' ' ' VAL . 1.2 pp -52.76 150.27 9.98 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 113.15 -1.841 . . . . 0.0 115.654 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.42 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.0 Cg_endo -71.82 -162.87 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.61 2.873 . . . . 0.0 111.866 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -135.5 154.64 51.34 Favored 'General case' 0 N--CA 1.395 -3.214 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.62 HD21 ' SG ' ' A' ' 744' ' ' CYS . 21.9 tp -104.25 111.5 24.14 Favored 'General case' 0 C--N 1.252 -3.656 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.593 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -43.9 -37.11 2.68 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.806 1.642 . . . . 0.0 115.22 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -134.73 26.61 3.67 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 121.942 -0.474 . . . . 0.0 110.429 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -139.71 -147.78 5.1 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.207 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.425 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -149.61 173.3 13.8 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 122.617 0.367 . . . . 0.0 110.208 -177.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.61 139.38 40.3 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -82.27 -75.22 0.31 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.962 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 704' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 705' ' ' SER . 1.0 OUTLIER -170.66 162.38 7.83 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.217 0.532 . . . . 0.0 111.343 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.615 ' CB ' HG22 ' A' ' 715' ' ' VAL . 33.8 t 174.92 179.38 0.13 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 128.527 2.731 . . . . 0.0 105.007 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 23.4 p -148.63 140.82 14.74 Favored Pre-proline 0 C--N 1.305 -1.344 0 CA-C-N 118.619 0.645 . . . . 0.0 110.833 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.537 ' HA ' ' N ' ' A' ' 709' ' ' TYR . 50.4 Cg_endo -68.52 163.9 34.95 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.019 1.813 . . . . 0.0 109.064 175.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.544 ' HB2' ' CG2' ' A' ' 690' ' ' THR . 29.7 Cg_endo -64.68 -5.14 3.05 Favored 'Cis proline' 0 N--CA 1.502 1.973 0 N-CA-C 117.353 2.02 . . . . 0.0 117.353 4.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.656 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 74.7 m-85 66.33 66.55 0.47 Allowed 'General case' 0 C--O 1.255 1.362 0 CA-C-O 122.288 1.042 . . . . 0.0 108.566 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -67.11 169.85 7.85 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.336 -1.756 . . . . 0.0 112.111 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.485 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 58.3 m-85 -67.63 137.33 55.53 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.928 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 87.52 8.17 74.46 Favored Glycine 0 N--CA 1.41 -3.048 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.09 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.68 156.77 24.9 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 13.8 m -141.27 139.43 33.69 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 694' ' ' ILE . 20.2 t -126.78 136.65 60.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.565 ' HG3' ' HG2' ' A' ' 729' ' ' ARG . 26.5 tt0 -96.89 140.59 31.22 Favored 'General case' 0 N--CA 1.381 -3.918 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.581 ' HB3' HD22 ' A' ' 697' ' ' LEU . 50.4 m-85 -138.67 120.39 15.24 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 125.833 1.653 . . . . 0.0 107.396 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.425 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 13.5 m120 -122.28 -165.36 1.27 Allowed 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 7.1 m -112.97 135.89 53.25 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 11.9 t -57.94 -68.93 0.2 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 721' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 722' ' ' SER . 11.4 pt-20 -172.26 163.81 5.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 75.4 m 72.13 5.95 5.44 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.193 0.933 . . . . 0.0 110.872 -177.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.648 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.6 m-85 -141.52 145.53 35.28 Favored 'General case' 0 N--CA 1.401 -2.895 0 C-N-CA 125.192 1.397 . . . . 0.0 107.95 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.2 m -114.21 138.24 50.72 Favored 'General case' 0 C--N 1.251 -3.716 0 C-N-CA 125.709 1.604 . . . . 0.0 111.998 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.598 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.1 ttp -91.01 122.36 33.6 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.893 1.277 . . . . 0.0 109.486 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 39.8 mm -124.21 135.89 62.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.949 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 101.35 -74.99 0.37 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.206 173.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.537 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.1 OUTLIER -141.16 177.18 8.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -176.086 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.598 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -135.46 8.92 3.4 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.0 0.905 . . . . 0.0 109.359 170.784 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 54.4 p -145.72 163.0 36.29 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.699 -0.625 . . . . 0.0 110.235 -176.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.505 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 35.7 pt -122.76 163.4 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 739' ' ' THR . 21.2 m -139.17 137.25 35.89 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.937 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 733' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 5.7 t -86.48 99.9 11.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 734' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 739' ' ' THR . 1.7 pp -140.75 146.27 24.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.284 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 67.87 -4.78 0.93 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 112.47 13.38 11.77 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 121.581 -0.342 . . . . 0.0 112.613 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.2 p -155.09 157.22 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.429 ' CZ3' HG23 ' A' ' 715' ' ' VAL . 96.9 m95 -73.33 167.58 20.93 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 121.056 0.455 . . . . 0.0 109.816 171.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.505 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 42.8 p -77.61 -163.12 0.36 Allowed 'General case' 0 N--CA 1.426 -1.638 0 CA-C-O 122.021 0.915 . . . . 0.0 112.616 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -1.89 32.93 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -167.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 67.61 161.44 0.14 Allowed Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 122.735 0.414 . . . . 0.0 110.386 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.537 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 49.8 Cg_endo -83.64 174.35 8.79 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.443 1.429 . . . . 0.0 110.241 168.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -117.39 117.09 28.53 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.62 ' SG ' HD21 ' A' ' 697' ' ' LEU . 95.4 m -102.67 107.77 18.8 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.188 0.518 . . . . 0.0 110.154 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.437 ' HB ' HD21 ' A' ' 750' ' ' LEU . 39.6 t -96.31 145.05 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.648 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -67.89 6.89 0.61 Allowed 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 125.048 1.339 . . . . 0.0 114.438 -175.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.861 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 36.9 mt 76.34 -16.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 C-N-CA 125.561 1.544 . . . . 0.0 112.025 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 746' ' ' ALA . 14.9 t70 -81.82 -31.96 31.48 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.616 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -107.33 23.23 14.76 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.946 -1.934 . . . . 0.0 108.442 -172.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.861 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 72.5 mt -82.58 -165.21 0.98 Allowed 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.361 175.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.524 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 61.3 mtpt -124.51 152.7 43.1 Favored 'General case' 0 N--CA 1.393 -3.314 0 CA-C-O 121.834 0.826 . . . . 0.0 110.19 -173.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 752' ' ' LYS . . . . . 0.425 ' HE3' ' OE1' ' A' ' 770' ' ' GLU . 43.8 mtmt -101.87 115.56 30.8 Favored 'General case' 0 C--N 1.251 -3.674 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.034 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 753' ' ' CYS . . . . . 0.463 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 0.0 OUTLIER -75.71 166.65 23.23 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-N 112.991 -1.913 . . . . 0.0 109.143 -178.092 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -145.68 161.84 38.93 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.004 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 31.4 t -65.53 121.74 15.61 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.357 172.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.674 ' HB3' HG13 ' A' ' 759' ' ' ILE . 30.6 t -63.91 153.48 36.82 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -58.76 -26.96 64.52 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 124.24 1.016 . . . . 0.0 113.459 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.59 -13.84 14.16 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.831 -170.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.674 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -87.7 155.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.09 134.41 55.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 113.78 -1.555 . . . . 0.0 107.17 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 1.8 mm? -114.12 178.7 4.19 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 762' ' ' GLU . . . . . 0.56 ' HB2' HD23 ' A' ' 765' ' ' LEU . 34.6 mt-10 -73.15 163.12 28.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -52.93 -27.61 19.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 764' ' ' HIS . . . . . 0.487 ' HB2' HD22 ' A' ' 765' ' ' LEU . 31.2 m-70 -76.6 -35.97 57.78 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.56 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.0 mm? -91.11 -15.55 29.26 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.192 -1.822 . . . . 0.0 112.551 -168.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -77.48 -6.78 54.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.202 0.525 . . . . 0.0 110.951 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -114.46 13.18 17.59 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.465 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 13.5 tppt? -105.85 112.61 25.73 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -87.31 -29.53 21.53 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.189 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 770' ' ' GLU . . . . . 0.425 ' OE1' ' HE3' ' A' ' 752' ' ' LYS . 45.2 mt-10 -139.66 138.29 35.95 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.653 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.465 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 39.5 m-85 -117.02 177.0 4.87 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -121.48 166.2 14.5 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 792' ' ' CYS . 34.9 t60 -65.54 149.73 49.58 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 83.03 0.41 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.789 1.236 . . . . 0.0 108.668 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 54.0 m -83.41 106.57 15.27 Favored 'General case' 0 N--CA 1.41 -2.467 0 C-N-CA 119.001 -1.079 . . . . 0.0 108.885 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.41 101.94 14.4 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.402 HG12 ' CZ3' ' A' ' 797' ' ' TRP . 4.3 pt -112.87 178.36 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 121.773 0.797 . . . . 0.0 109.868 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.643 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 79.2 mtt180 -130.06 127.76 40.54 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.583 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 7.6 p90 -121.73 168.48 11.76 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -152.93 171.35 18.46 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.749 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 52.7 t -113.06 162.03 16.39 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -77.98 104.24 8.42 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 120.65 -44.21 1.41 Allowed Glycine 0 C--N 1.276 -2.765 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.037 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.749 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.7 mptt -97.89 91.04 5.15 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.75 148.28 31.55 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.245 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 100.62 154.34 27.08 Favored Glycine 0 C--N 1.294 -1.763 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -172.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.643 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 45.4 m95 -99.9 139.79 35.05 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 117.622 0.711 . . . . 0.0 110.994 -173.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.583 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -90.35 -33.01 5.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.674 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 18.6 m170 78.45 125.46 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 C-N-CA 124.784 1.234 . . . . 0.0 110.206 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.2 t -151.55 152.98 33.65 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 52.7 t -117.59 134.85 59.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 792' ' ' CYS . . . . . 0.483 ' HB3' ' HA ' ' A' ' 773' ' ' HIS . 52.4 t -67.46 132.78 48.28 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.972 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.61 83.21 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 C-N-CA 124.418 1.087 . . . . 0.0 108.074 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.815 HD22 HD22 ' A' ' 750' ' ' LEU . 3.5 m-20 45.93 72.74 0.2 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.097 0.959 . . . . 0.0 112.809 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 795' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 78.4 0.55 78.93 Favored Glycine 0 C--N 1.296 -1.666 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.012 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 796' ' ' ARG . . . . . 0.499 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 36.1 ttm180 -130.38 173.48 10.78 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.601 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 98.5 m95 -116.78 162.18 18.11 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 122.351 0.26 . . . . 0.0 111.179 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -144.68 108.08 4.73 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.17 140.05 56.5 Favored 'Cis proline' 0 C--O 1.248 0.992 0 C-N-CA 123.637 -1.401 . . . . 0.0 111.129 -1.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.601 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.9 tt0 -57.11 125.58 23.33 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.006 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 9.5 m . . . . . 1 N--CA 1.363 -4.788 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.808 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.422 -1.832 0 CA-C-O 121.721 0.772 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.7 m -76.41 -74.18 0.24 Allowed 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.161 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 143.72 179.09 20.03 Favored Glycine 1 N--CA 1.356 -6.663 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -39.66 126.52 1.92 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 126.313 1.845 . . . . 0.0 111.484 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.563 HG21 HG21 ' A' ' 715' ' ' VAL . 1.7 pp -63.16 147.78 94.07 Favored Pre-proline 0 N--CA 1.425 -1.707 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.406 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.503 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 72.9 Cg_endo -72.69 -166.22 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.818 2.345 . . . . 0.0 112.828 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -126.6 165.19 19.65 Favored 'General case' 0 N--CA 1.399 -2.977 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.602 HD22 ' HB3' ' A' ' 717' ' ' PHE . 37.6 tp -119.67 110.64 17.07 Favored 'General case' 0 C--N 1.251 -3.705 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.901 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.05 -40.24 6.5 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -173.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 79.9 m80 -128.24 20.7 6.27 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 121.473 -0.767 . . . . 0.0 110.16 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.466 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -125.29 -139.61 5.24 Favored Glycine 0 C--N 1.304 -1.2 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.93 -177.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.6 ' HE1' ' CG ' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -160.85 177.92 9.93 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -109.96 154.65 22.83 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -91.27 -74.32 0.51 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 120.933 0.397 . . . . 0.0 110.369 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 704' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 705' ' ' SER . 6.3 tt -157.22 133.56 9.77 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 177.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 709' ' ' TYR . 4.2 p -133.96 110.73 9.88 Favored 'General case' 0 N--CA 1.393 -3.297 0 CA-C-O 121.724 0.773 . . . . 0.0 110.145 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 39.8 t -90.26 111.45 47.1 Favored Pre-proline 0 C--N 1.277 -2.557 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.993 -174.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.409 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 58.3 Cg_endo -71.26 171.81 15.31 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.774 2.316 . . . . 0.0 109.363 175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.477 ' HG2' ' CE1' ' A' ' 710' ' ' TYR . 2.8 Cg_exo -70.75 -7.24 11.57 Favored 'Cis proline' 0 CA--C 1.498 -1.316 0 N-CA-C 115.505 1.31 . . . . 0.0 115.505 5.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 705' ' ' SER . 43.3 m-85 78.55 86.1 0.07 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.477 ' CE1' ' HG2' ' A' ' 708' ' ' PRO . 26.9 m-85 -91.2 174.65 7.28 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.815 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.449 ' CE2' ' HA2' ' A' ' 736' ' ' GLY . 64.1 m-85 -74.71 136.64 41.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.231 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 91.26 -4.91 81.01 Favored Glycine 0 N--CA 1.416 -2.657 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.356 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -73.59 147.79 43.52 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 6.8 m -129.02 152.53 48.53 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.563 HG21 HG21 ' A' ' 694' ' ' ILE . 41.1 t -136.29 133.01 49.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 36.7 mt-10 -95.17 140.32 30.25 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.962 0.886 . . . . 0.0 111.638 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.602 ' HB3' HD22 ' A' ' 697' ' ' LEU . 37.3 m-85 -138.76 129.96 26.95 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.6 ' CG ' ' HE1' ' A' ' 701' ' ' TRP . 9.1 p30 -128.44 -167.77 1.82 Allowed 'General case' 1 N--CA 1.377 -4.089 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 44.4 m -108.65 124.06 49.94 Favored 'General case' 0 C--N 1.247 -3.864 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 24.2 t -44.9 -80.75 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 O-C-N 125.689 1.868 . . . . 0.0 112.834 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -153.83 150.74 28.75 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.3 m 69.19 9.65 7.46 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.262 0.976 . . . . 0.0 113.611 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 719' ' ' CYS . 96.5 m-85 -134.3 145.53 49.16 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.567 HG21 HD11 ' A' ' 750' ' ' LEU . 6.4 t -75.86 -115.53 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.898 -175.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.64 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.2 ttp 165.09 107.86 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.732 2.813 . . . . 0.0 105.227 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.703 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 42.1 mm -119.03 143.96 28.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 92.48 -68.87 1.81 Allowed Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.731 173.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.544 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.5 t60 -154.58 -178.71 7.37 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -174.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.64 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -139.35 20.31 2.57 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.379 0.609 . . . . 0.0 110.012 173.278 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.606 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 59.9 p -156.08 162.3 40.29 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.879 -177.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 714' ' ' SER . 35.8 pt -120.34 157.75 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 739' ' ' THR . 6.1 m -131.26 135.6 47.48 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.0 t -95.77 111.57 23.5 Favored 'General case' 0 N--CA 1.392 -3.346 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.763 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.09 154.23 28.05 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.128 0 CA-C-N 113.649 -1.614 . . . . 0.0 107.089 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 76.76 -44.74 0.48 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.311 1.044 . . . . 0.0 110.26 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 736' ' ' GLY . . . . . 0.449 ' HA2' ' CE2' ' A' ' 711' ' ' TYR . . . 144.86 25.78 0.11 Allowed Glycine 0 C--N 1.298 -1.559 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 8.5 p -163.64 167.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.503 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 86.8 m95 -84.33 173.02 11.28 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 121.156 0.503 . . . . 0.0 111.634 177.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 732' ' ' THR . 21.3 p -86.92 -157.25 0.36 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 4.6 pm0 -69.49 -24.28 63.75 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 126.065 1.746 . . . . 0.0 113.468 -171.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.446 HD21 ' HG2' ' A' ' 695' ' ' PRO . 1.6 mt 70.08 155.27 0.15 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 124.452 1.095 . . . . 0.0 111.206 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.544 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 37.6 Cg_endo -71.61 175.28 9.75 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.792 1.661 . . . . 0.0 111.812 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.703 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 53.9 tt0 -123.11 119.2 29.59 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.567 ' SG ' HD21 ' A' ' 697' ' ' LEU . 90.7 m -105.0 104.4 14.13 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.18 0.514 . . . . 0.0 110.965 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 724' ' ' THR . 42.2 t -101.83 147.2 8.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 748' ' ' ASP . . . -65.76 3.73 0.73 Allowed 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 124.867 1.267 . . . . 0.0 113.788 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.86 ' HA ' HD22 ' A' ' 750' ' ' LEU . 61.4 mt 73.8 -17.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.821 1.648 . . . . 0.0 110.938 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 746' ' ' ALA . 7.2 t70 -72.51 -33.03 66.63 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 126.402 1.881 . . . . 0.0 109.267 -177.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -105.05 18.91 21.53 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.566 -172.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.86 HD22 ' HA ' ' A' ' 747' ' ' ILE . 0.2 OUTLIER -82.06 -172.9 4.2 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.06 179.179 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 751' ' ' LYS . 28.1 mmmt -115.04 148.7 38.55 Favored 'General case' 0 N--CA 1.381 -3.906 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.706 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -109.82 119.26 38.79 Favored 'General case' 1 C--N 1.23 -4.613 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.378 -173.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 753' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 770' ' ' GLU . 27.2 m -67.27 162.73 22.06 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.762 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 754' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 769' ' ' LYS . 16.9 ptpt -126.44 144.15 50.94 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.181 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 755' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 769' ' ' LYS . 48.0 p -68.06 114.13 6.33 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.754 171.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.585 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 45.2 t -69.76 156.9 38.31 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -84.32 -13.39 52.54 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.278 0.561 . . . . 0.0 112.385 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 5.6 mp -95.53 -4.28 45.08 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.059 -173.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.585 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.1 pp -118.96 152.24 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 CA-C-O 121.985 0.897 . . . . 0.0 112.138 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.58 127.77 64.76 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.795 0 CA-C-N 113.814 -1.539 . . . . 0.0 107.365 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.467 HD11 HD13 ' A' ' 759' ' ' ILE . 1.5 mm? -107.6 -175.18 2.72 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 762' ' ' GLU . . . . . 0.565 ' HB2' HD23 ' A' ' 765' ' ' LEU . 25.6 mt-10 -76.87 171.86 14.07 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.263 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.33 -31.34 67.47 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.282 0.633 . . . . 0.0 110.544 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.32 2.09 54.6 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.731 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.565 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.9 mm? -122.28 -24.45 5.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 53.8 mtmt -66.38 -23.78 66.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -86.77 -2.83 58.86 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.939 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.483 ' HE3' ' CD2' ' A' ' 771' ' ' PHE . 23.4 ttpt -99.4 110.22 22.74 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 769' ' ' LYS . . . . . 0.608 ' HG2' ' HG3' ' A' ' 770' ' ' GLU . 0.0 OUTLIER -93.03 -23.98 18.48 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 770' ' ' GLU . . . . . 0.608 ' HG3' ' HG2' ' A' ' 769' ' ' LYS . 37.6 mt-10 -127.77 106.41 9.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.483 ' CD2' ' HE3' ' A' ' 768' ' ' LYS . 67.5 m-85 -89.59 147.95 23.64 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.916 -174.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -89.49 144.59 25.92 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.158 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.644 ' HB3' HD23 ' A' ' 750' ' ' LEU . 49.9 t60 -57.95 146.77 31.18 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.319 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 65.5 t30 83.44 3.75 0.9 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.37 1.468 . . . . 0.0 110.232 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 67.8 m -86.41 113.6 22.5 Favored 'General case' 0 N--CA 1.398 -3.047 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.407 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -85.89 90.6 8.11 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.497 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 777' ' ' ILE . . . . . . . . . . . . . 7.4 pt -95.23 -175.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.702 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 0.2 OUTLIER -141.55 121.06 13.26 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.007 175.422 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.559 ' CD2' HG13 ' A' ' 801' ' ' VAL . 10.6 p90 -106.71 168.71 8.99 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 174.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -149.82 146.91 27.4 Favored 'General case' 0 C--N 1.257 -3.45 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.733 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 5.0 t -79.36 168.43 19.52 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -74.21 -1.38 20.25 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.113 0.482 . . . . 0.0 111.901 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -113.15 -6.6 22.2 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.733 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 3.8 mptp? -112.58 137.53 50.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -106.59 4.89 28.52 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.43 1.11 . . . . 0.0 110.805 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -113.04 157.84 14.67 Favored Glycine 0 C--N 1.268 -3.225 0 CA-C-N 113.446 -1.706 . . . . 0.0 108.943 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 46.0 m95 -100.35 141.45 33.18 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 117.231 0.516 . . . . 0.0 110.298 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.518 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -91.93 -31.31 4.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 15.4 m170 73.25 123.62 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 124.455 1.102 . . . . 0.0 110.13 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.494 HG21 ' CG2' ' A' ' 801' ' ' VAL . 2.3 t -146.33 155.36 42.57 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 24.9 t -114.21 133.26 60.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 41.6 t -70.46 117.2 11.7 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.591 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 47.8 mm -119.29 89.15 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 C-N-CA 123.861 0.865 . . . . 0.0 109.382 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.498 ' OD1' ' HG ' ' A' ' 750' ' ' LEU . 0.8 OUTLIER 43.59 62.35 1.93 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.083 0.953 . . . . 0.0 112.754 175.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.15 36.47 56.29 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.968 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -158.79 165.53 34.05 Favored 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.622 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.4 m95 -114.23 160.36 19.11 Favored 'General case' 0 C--N 1.258 -3.385 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 798' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 24.7 t70 -148.1 102.13 3.6 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 799' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 798' ' ' ASP . 48.7 Cg_endo -70.77 142.59 72.9 Favored 'Cis proline' 0 C--O 1.244 0.824 0 C-N-CA 123.886 -1.298 . . . . 0.0 112.96 0.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.622 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 45.5 mt-10 -48.55 125.34 9.66 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.287 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.559 HG13 ' CD2' ' A' ' 779' ' ' TYR . 75.5 t . . . . . 0 C--N 1.305 -1.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.24 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 54.1 m -78.62 -75.1 0.24 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.304 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 143.13 -167.9 26.26 Favored Glycine 1 N--CA 1.378 -5.226 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -48.89 130.34 18.01 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 125.462 1.505 . . . . 0.0 110.417 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.679 HG21 HG21 ' A' ' 715' ' ' VAL . 1.3 pp -58.52 150.61 55.12 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.324 -177.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.6 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 74.3 Cg_endo -72.15 -159.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 123.276 2.65 . . . . 0.0 114.147 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -125.31 158.86 33.13 Favored 'General case' 0 N--CA 1.397 -3.115 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.617 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.5 OUTLIER -107.4 129.36 54.93 Favored 'General case' 0 C--N 1.26 -3.312 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.539 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -45.87 -45.68 15.32 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -141.22 27.18 1.95 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.417 0.627 . . . . 0.0 109.536 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.617 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -134.0 -146.32 5.44 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.807 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.433 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -153.41 178.11 10.15 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 122.94 0.496 . . . . 0.0 110.257 -175.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -108.55 147.5 31.68 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -71.34 -77.78 0.09 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.146 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.6 tt 179.66 135.98 0.1 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.518 ' HB2' HG13 ' A' ' 715' ' ' VAL . 22.9 t -144.81 -168.89 3.04 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 9.7 t -152.46 139.56 12.64 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.45 169.11 10.18 Favored 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 122.963 2.442 . . . . 0.0 110.072 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 710' ' ' TYR . 2.8 Cg_exo -72.44 -9.95 16.99 Favored 'Cis proline' 0 N--CA 1.49 1.279 0 N-CA-C 115.184 1.186 . . . . 0.0 115.184 7.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.415 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 62.3 m-85 73.28 79.85 0.13 Allowed 'General case' 0 C--N 1.312 -1.064 0 O-C-N 124.575 1.172 . . . . 0.0 108.993 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 708' ' ' PRO . 21.4 m-85 -84.05 168.67 15.69 Favored 'General case' 0 CA--C 1.477 -1.84 0 CA-C-N 113.943 -1.481 . . . . 0.0 112.717 -174.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -69.66 128.3 35.97 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.07 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.57 -15.53 55.79 Favored Glycine 0 N--CA 1.414 -2.791 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.611 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.47 145.25 52.89 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 10.8 m -131.32 150.28 52.21 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.679 HG21 HG21 ' A' ' 694' ' ' ILE . 42.7 t -138.15 124.65 26.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.694 ' HG3' ' HG2' ' A' ' 729' ' ' ARG . 2.3 mp0 -65.68 134.55 53.46 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.722 0.772 . . . . 0.0 112.623 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.425 ' HB3' ' CD1' ' A' ' 697' ' ' LEU . 19.9 m-85 -137.61 114.91 10.99 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 126.374 1.87 . . . . 0.0 107.063 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.433 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 19.3 m-20 -124.15 -168.56 1.81 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -175.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 23.3 m -116.17 138.62 51.11 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 5.0 m -57.55 -78.13 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 123.973 0.796 . . . . 0.0 112.152 -174.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -157.79 159.36 36.67 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 58.4 m 65.95 9.56 6.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.598 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 94.6 m-85 -142.14 146.04 34.89 Favored 'General case' 0 N--CA 1.407 -2.586 0 C-N-CA 124.12 0.968 . . . . 0.0 108.771 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.0 OUTLIER -113.09 137.31 51.62 Favored 'General case' 0 C--N 1.256 -3.478 0 C-N-CA 125.432 1.493 . . . . 0.0 111.129 -178.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 725' ' ' MET . . . . . . . . . . . . . 9.2 tmm? -87.54 125.36 34.29 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.9 mm -124.91 133.32 69.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.009 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 121.33 -89.37 0.43 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.095 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 56.3 t-80 -157.03 145.55 19.69 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.694 ' HG2' ' HG3' ' A' ' 716' ' ' GLU . 0.0 OUTLIER -86.84 13.77 8.35 Favored 'General case' 0 C--N 1.274 -2.691 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.879 -171.552 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 716' ' ' GLU . 6.0 p -156.66 168.56 27.03 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.951 -0.468 . . . . 0.0 111.987 -176.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 714' ' ' SER . 35.1 pt -117.0 164.61 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.587 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.3 m -136.08 134.24 38.19 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.698 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 8.5 t -84.14 107.57 16.54 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.092 0.472 . . . . 0.0 110.037 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -144.95 145.64 20.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 C-N-CA 125.085 1.354 . . . . 0.0 109.896 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 66.62 -0.31 1.61 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.39 24.45 24.05 Favored Glycine 0 CA--C 1.498 -0.973 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.09 153.26 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.6 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.4 m95 -79.11 177.83 8.51 Favored 'General case' 0 C--N 1.277 -2.545 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.468 168.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.409 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 17.1 p -80.84 -169.81 2.37 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.686 0.755 . . . . 0.0 112.873 -176.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.3 pp0? -71.46 -14.98 62.31 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -171.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 2.1 mt 69.54 146.53 0.11 Allowed Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 124.394 1.059 . . . . 0.0 113.853 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 48.1 Cg_endo -69.23 169.11 19.0 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 121.968 1.778 . . . . 0.0 112.346 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -115.22 104.69 12.08 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.821 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 724' ' ' THR . 87.3 m -84.8 99.74 11.09 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.653 0.739 . . . . 0.0 110.112 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.64 ' CG1' ' HG3' ' A' ' 749' ' ' LYS . 41.7 t -92.8 142.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.537 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.598 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.32 2.29 0.62 Allowed 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 125.857 1.663 . . . . 0.0 114.624 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.773 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 49.0 mt 78.33 -14.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 126.063 1.745 . . . . 0.0 111.699 176.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 746' ' ' ALA . 24.9 t70 -83.88 -30.14 26.65 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.729 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 749' ' ' LYS . . . . . 0.64 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 7.8 ptmt -110.58 29.78 7.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.002 -1.453 . . . . 0.0 111.838 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.773 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 96.2 mt -84.33 176.1 8.94 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.827 177.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -99.81 145.31 27.87 Favored 'General case' 0 N--CA 1.388 -3.564 0 CA-C-O 122.727 1.251 . . . . 0.0 110.293 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -98.17 111.84 24.02 Favored 'General case' 1 C--N 1.236 -4.366 0 CA-C-N 111.248 -2.705 . . . . 0.0 109.21 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 42.5 m -66.99 138.54 57.32 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.867 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -107.95 136.39 47.73 Favored 'General case' 0 C--N 1.27 -2.867 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.407 -174.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 755' ' ' SER . . . . . 0.412 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 15.5 p -52.75 132.82 36.92 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.842 173.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.572 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 29.8 t -80.46 166.75 20.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -93.36 -17.28 23.72 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 74.5 mt -113.23 14.37 19.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.299 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.572 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.1 pp -115.05 149.18 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.961 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 760' ' ' ILE . . . . . 0.572 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.2 mp -107.95 129.95 61.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.862 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -177.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 1.9 mm? -108.17 178.76 4.41 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -77.96 172.21 13.84 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -66.47 -8.77 28.42 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 122.952 0.501 . . . . 0.0 112.035 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -93.13 -17.09 24.18 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.701 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 81.8 mt -117.03 -18.13 10.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -170.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -62.48 -26.17 68.39 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -101.42 8.35 42.21 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.714 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.705 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 19.2 ttmm -98.42 94.93 6.99 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 769' ' ' LYS . . . . . 0.465 ' HD2' ' H ' ' A' ' 769' ' ' LYS . 0.0 OUTLIER -71.23 -30.3 66.17 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.952 -177.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.83 123.24 20.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.558 0.694 . . . . 0.0 110.915 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.705 ' CD2' ' HD2' ' A' ' 768' ' ' LYS . 14.2 m-85 -101.51 156.51 17.43 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.709 -174.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -98.7 156.12 16.99 Favored 'General case' 0 C--N 1.281 -2.393 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.011 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.641 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 47.5 t60 -59.16 137.47 57.95 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.238 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 64.5 t30 84.93 12.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 O-C-N 125.633 1.833 . . . . 0.0 109.746 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 58.7 m -87.32 117.78 26.32 Favored 'General case' 0 N--CA 1.41 -2.473 0 C-N-CA 119.208 -0.997 . . . . 0.0 108.783 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -91.96 107.37 19.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.701 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 5.6 pt -118.9 -175.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 17.3 ptp180 -147.13 128.5 14.88 Favored 'General case' 0 N--CA 1.399 -2.979 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 173.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.532 ' CD2' HG13 ' A' ' 801' ' ' VAL . 10.3 p90 -108.36 169.54 8.57 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 780' ' ' ARG . . . . . 0.572 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 15.3 ptt180 -144.81 154.18 42.41 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 173.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.572 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 5.5 t -96.76 158.61 15.35 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -65.69 -22.94 66.67 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -103.42 -1.35 47.2 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.606 175.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.572 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 5.0 mptp? -108.56 103.09 12.14 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 122.616 -0.344 . . . . 0.0 110.879 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.84 86.43 6.92 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.512 1.148 . . . . 0.0 108.528 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 157.31 145.27 4.16 Favored Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 52.6 m95 -92.34 145.23 24.64 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.517 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -97.79 -27.56 3.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.948 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 72.53 123.61 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.842 1.257 . . . . 0.0 109.135 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.543 ' HA ' ' HD2' ' A' ' 799' ' ' PRO . 3.1 t -145.28 156.75 44.01 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.887 0.375 . . . . 0.0 111.142 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 34.7 t -118.95 135.04 60.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 C-N-CA 122.639 0.376 . . . . 0.0 110.132 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.3 t -69.97 118.79 13.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.641 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 47.2 mm -117.84 87.17 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 124.338 1.055 . . . . 0.0 108.526 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 794' ' ' ASN . . . . . . . . . . . . . 5.5 t30 42.9 67.69 0.59 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.373 1.069 . . . . 0.0 113.272 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 74.69 23.35 75.32 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 115.06 -0.973 . . . . 0.0 114.127 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -150.02 166.24 30.3 Favored 'General case' 0 C--O 1.197 -1.681 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.569 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 91.2 m95 -114.82 157.13 23.7 Favored 'General case' 0 C--N 1.264 -3.142 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -148.75 106.24 3.46 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 799' ' ' PRO . . . . . 0.543 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 38.0 Cg_endo -66.32 138.73 40.27 Favored 'Cis proline' 0 C--O 1.237 0.443 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.014 -0.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.569 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.9 tt0 -53.56 134.77 40.99 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.863 0.865 . . . . 0.0 110.888 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.532 HG13 ' CD2' ' A' ' 779' ' ' TYR . 57.9 t . . . . . 0 N--CA 1.434 -1.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.534 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.4 m -73.44 -66.57 0.68 Allowed 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.17 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 124.57 -156.0 18.48 Favored Glycine 1 N--CA 1.363 -6.213 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -36.87 123.93 0.86 Allowed 'General case' 0 C--N 1.278 -2.534 0 O-C-N 126.52 1.953 . . . . 0.0 112.239 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.688 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -69.3 146.54 96.73 Favored Pre-proline 0 N--CA 1.415 -2.198 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.271 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.462 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 72.4 Cg_endo -72.08 -165.31 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.767 2.312 . . . . 0.0 112.444 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.68 161.42 35.18 Favored 'General case' 0 N--CA 1.394 -3.265 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 717' ' ' PHE . 21.7 tp -106.07 117.97 35.41 Favored 'General case' 1 C--N 1.244 -4.017 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.186 -177.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -33.55 -44.91 0.15 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.403 2.281 . . . . 0.0 115.288 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 91.5 m-70 -137.57 25.09 2.89 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -136.76 -142.19 4.39 Favored Glycine 0 CA--C 1.497 -1.044 0 C-N-CA 120.094 -1.051 . . . . 0.0 112.252 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.436 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -158.59 174.53 14.92 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -178.196 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.37 145.78 32.46 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 57.3 mm-40 -89.03 -80.76 0.29 Allowed 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.052 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 53.5 tp -160.6 151.46 18.7 Favored 'General case' 0 C--O 1.243 0.749 0 O-C-N 122.458 -0.151 . . . . 0.0 110.683 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.634 ' CB ' HG22 ' A' ' 715' ' ' VAL . 23.5 t -166.19 -54.29 0.03 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.434 0.693 . . . . 0.0 110.38 172.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 37.4 m 70.66 142.82 0.09 OUTLIER Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.916 1.686 . . . . 0.0 113.085 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.543 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 58.1 Cg_endo -63.63 176.53 2.21 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 123.809 3.006 . . . . 0.0 113.089 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.9 Cg_exo -77.15 -7.21 30.43 Favored 'Cis proline' 0 N--CA 1.498 1.737 0 N-CA-C 114.67 0.989 . . . . 0.0 114.67 3.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 58.9 m-85 74.41 82.21 0.11 Allowed 'General case' 0 C--N 1.309 -1.167 0 O-C-N 124.515 1.134 . . . . 0.0 110.333 177.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -86.24 173.51 9.72 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.35 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -69.37 135.2 50.0 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.85 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.21 -18.69 57.02 Favored Glycine 0 N--CA 1.422 -2.278 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.207 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.22 155.15 40.28 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.228 0.537 . . . . 0.0 111.588 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 11.8 m -135.86 157.15 47.54 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.663 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.688 HG21 HG21 ' A' ' 694' ' ' ILE . 23.5 t -137.64 129.3 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 41.6 mt-10 -77.16 138.05 39.25 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 123.675 0.609 . . . . 0.0 111.733 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.586 ' HB3' HD22 ' A' ' 697' ' ' LEU . 32.7 m-85 -140.53 129.97 23.95 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 124.483 1.113 . . . . 0.0 108.698 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.451 ' O ' HD23 ' A' ' 697' ' ' LEU . 11.0 m120 -138.05 -164.81 1.68 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 10.8 m -118.99 139.74 51.18 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 6.1 m -62.49 -79.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 O-C-N 123.65 0.594 . . . . 0.0 111.613 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -148.11 161.93 40.43 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 66.6 m 71.03 -6.36 1.32 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.516 1.135 . . . . 0.0 112.859 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.547 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 93.8 m-85 -131.74 146.57 52.23 Favored 'General case' 0 N--CA 1.392 -3.361 0 CA-C-O 121.88 0.848 . . . . 0.0 108.959 -175.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.651 HG21 HD21 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -116.68 143.82 45.18 Favored 'General case' 1 C--N 1.241 -4.129 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.204 179.873 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.546 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.7 ttp -86.22 123.92 32.04 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.557 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 45.0 mm -121.44 137.45 55.06 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 113.17 -90.76 0.55 Allowed Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.562 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 23.0 t-80 -159.95 143.35 14.07 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.546 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.8 ppt_? -81.67 17.18 1.52 Allowed 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -174.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 22.0 p -161.21 153.28 19.82 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.791 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.447 HG21 HD13 ' A' ' 741' ' ' LEU . 27.3 pt -104.85 168.61 2.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.407 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 11.3 m -138.32 135.56 35.53 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.447 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 9.5 t -83.67 105.11 14.32 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.44 0.638 . . . . 0.0 109.94 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -140.31 144.62 27.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 124.695 1.198 . . . . 0.0 110.344 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 76.8 m80 69.75 -11.26 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.55 0.74 . . . . 0.0 112.673 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 113.37 10.77 14.52 Favored Glycine 0 C--O 1.242 0.617 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 737' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 738' ' ' TRP . 58.8 t -142.23 154.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.48 ' O ' HG12 ' A' ' 737' ' ' VAL . 95.5 m95 -78.76 172.53 13.6 Favored 'General case' 0 C--N 1.273 -2.727 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.211 170.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.407 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 39.9 p -74.09 -165.69 0.33 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.846 0.831 . . . . 0.0 111.211 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.5 OUTLIER -83.38 -3.03 57.14 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -166.653 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 3.9 mm? 72.79 157.25 0.16 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 124.15 0.906 . . . . 0.0 109.639 -174.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.562 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 26.2 Cg_endo -71.64 179.72 4.45 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.232 1.288 . . . . 0.0 110.825 171.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 52.0 tt0 -117.36 105.4 12.12 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 724' ' ' THR . 95.4 m -89.43 103.51 16.14 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 121.397 0.617 . . . . 0.0 110.236 177.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 747' ' ' ILE . 34.7 t -97.92 144.32 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.022 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.547 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.93 5.2 0.35 Allowed 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 125.73 1.612 . . . . 0.0 113.531 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 1.029 ' HA ' HD22 ' A' ' 750' ' ' LEU . 59.0 mt 77.15 -17.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 125.932 1.693 . . . . 0.0 111.239 176.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 746' ' ' ALA . 3.2 t70 -75.86 -31.76 59.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.517 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -103.29 21.65 15.53 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.243 -173.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 1.029 HD22 ' HA ' ' A' ' 747' ' ' ILE . 0.4 OUTLIER -85.36 -177.88 6.59 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 113.83 -1.532 . . . . 0.0 107.778 175.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.611 ' HB3' ' N ' ' A' ' 795' ' ' GLY . 39.0 tptt -98.19 161.33 13.76 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 752' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 14.5 mmmm -101.96 112.7 25.42 Favored 'General case' 1 C--N 1.233 -4.493 0 CA-C-N 112.237 -2.256 . . . . 0.0 107.452 -177.423 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 150.07 41.15 Favored 'General case' 0 C--N 1.257 -3.419 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.184 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 754' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 769' ' ' LYS . 88.4 tttt -126.94 136.77 52.73 Favored 'General case' 0 C--N 1.258 -3.391 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.69 -174.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 46.6 p -63.78 112.89 3.08 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.622 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.654 ' HB2' HG12 ' A' ' 759' ' ' ILE . 49.1 m -61.94 133.5 55.47 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 173.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.13 4.31 8.81 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.026 0.917 . . . . 0.0 111.134 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.19 -21.88 16.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.978 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 756' ' ' SER . 31.3 pt -103.27 167.97 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.401 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.837 -174.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.39 130.73 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.248 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.525 HD12 HD12 ' A' ' 777' ' ' ILE . 1.9 mm? -108.95 -177.12 3.22 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 762' ' ' GLU . . . . . 0.819 ' HB2' HD23 ' A' ' 765' ' ' LEU . 40.3 mt-10 -72.04 175.15 6.17 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.49 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 763' ' ' GLU . . . . . 0.425 ' HA ' ' HE2' ' A' ' 766' ' ' LYS . 40.9 mt-10 -77.84 4.59 11.47 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -171.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 764' ' ' HIS . . . . . 0.525 ' HB2' HD22 ' A' ' 765' ' ' LEU . 16.5 m-70 -108.13 -22.26 12.45 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 171.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.819 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.6 mm? -101.37 -13.18 18.11 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.681 -168.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 763' ' ' GLU . 50.6 mtmt -75.59 -19.92 58.93 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -85.25 -3.76 58.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.243 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.48 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 9.9 tppt? -106.12 107.5 18.53 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 769' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 754' ' ' LYS . 38.0 ttpt -85.82 -37.63 19.02 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 770' ' ' GLU . . . . . 0.424 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 47.2 mt-10 -117.48 118.02 31.05 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.511 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.48 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 66.6 m-85 -102.56 174.44 5.9 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.46 167.68 10.52 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.858 ' HB3' HD23 ' A' ' 750' ' ' LEU . 19.2 t60 -70.48 151.33 45.23 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 8.0 t30 83.36 3.17 0.95 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.998 1.436 . . . . 0.0 109.225 177.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 66.7 m -82.14 112.64 19.37 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.567 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -88.89 109.89 20.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.525 HD12 HD12 ' A' ' 761' ' ' LEU . 9.5 pt -126.15 178.19 4.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.631 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 25.6 ptt180 -131.55 128.96 40.34 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 779' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -118.03 169.16 9.89 Favored 'General case' 0 C--O 1.259 1.576 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -150.72 157.11 42.56 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 35.6 t -81.98 159.48 23.54 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -69.53 -23.3 63.57 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.762 0.315 . . . . 0.0 111.137 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -102.97 -9.03 40.79 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.813 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.3 mptt -115.89 122.89 46.69 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.915 0.358 . . . . 0.0 110.158 -177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -95.87 99.61 11.39 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.53 0.681 . . . . 0.0 109.886 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 159.78 143.22 3.6 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.631 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 34.6 m95 -98.79 144.78 27.64 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 117.402 0.601 . . . . 0.0 109.838 -174.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 788' ' ' ILE . 3.6 mp -99.17 -31.32 3.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.009 -177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 789' ' ' HIS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 12.4 m170 72.23 120.1 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 124.414 1.086 . . . . 0.0 110.152 -174.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.427 HG21 ' CG1' ' A' ' 801' ' ' VAL . 3.5 t -139.19 156.58 47.01 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.094 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 71.0 t -118.08 130.31 73.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 792' ' ' CYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 773' ' ' HIS . 49.0 t -66.55 134.63 52.76 Favored 'General case' 0 CA--C 1.479 -1.769 0 C-N-CA 118.841 -1.144 . . . . 0.0 109.299 176.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 793' ' ' ILE . . . . . 0.589 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 49.4 mm -124.68 90.3 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.404 ' H ' ' HB2' ' A' ' 773' ' ' HIS . 5.5 t30 44.22 73.5 0.15 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.001 0.92 . . . . 0.0 112.471 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 795' ' ' GLY . . . . . 0.611 ' N ' ' HB3' ' A' ' 751' ' ' LYS . . . 77.8 -11.23 21.38 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.615 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 796' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 68.4 ttt180 -117.33 178.11 4.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -175.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.598 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 99.0 m95 -122.08 162.02 21.99 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 117.761 0.255 . . . . 0.0 110.779 178.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -148.23 105.0 3.56 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.446 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -67.42 138.5 42.54 Favored 'Cis proline' 0 C--O 1.247 0.972 0 C-N-CA 123.791 -1.337 . . . . 0.0 111.344 -1.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.598 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 13.6 tt0 -55.02 119.1 4.93 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.068 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.427 ' CG1' HG21 ' A' ' 790' ' ' THR . 16.6 m . . . . . 0 N--CA 1.38 -3.945 0 C-N-CA 123.73 0.812 . . . . 0.0 112.487 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.443 -0.779 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 65.1 m -72.28 -75.97 0.12 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.026 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 141.37 -145.24 15.63 Favored Glycine 1 N--CA 1.379 -5.163 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -53.02 133.65 38.38 Favored 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 125.369 1.468 . . . . 0.0 111.814 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.685 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -76.05 148.1 81.04 Favored Pre-proline 0 N--CA 1.41 -2.474 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.885 176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.456 ' HG2' HD21 ' A' ' 741' ' ' LEU . 53.5 Cg_endo -71.04 -163.72 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.347 2.698 . . . . 0.0 112.625 176.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -148.76 169.58 20.13 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.635 HD13 ' SG ' ' A' ' 744' ' ' CYS . 17.0 mt -102.77 146.44 28.25 Favored 'General case' 0 C--N 1.27 -2.851 0 O-C-N 123.792 0.682 . . . . 0.0 111.197 175.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.62 -37.69 87.3 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.168 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 744' ' ' CYS . 96.0 m-70 -140.06 27.8 2.15 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.04 0.448 . . . . 0.0 110.688 -177.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -140.65 -146.02 4.72 Favored Glycine 0 C--N 1.297 -1.615 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.459 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -156.58 171.84 19.62 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 117.216 0.508 . . . . 0.0 111.305 -179.215 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.23 144.86 33.41 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' A' ' 703' ' ' GLN . 13.7 mt-30 -73.36 -79.75 0.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.21 0.318 . . . . 0.0 111.197 177.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 8.3 tt 172.67 130.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.63 ' CB ' HG22 ' A' ' 715' ' ' VAL . 22.7 t -131.18 -32.67 1.57 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.653 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 32.9 t 74.3 124.07 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.04 1.336 . . . . 0.0 112.41 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 37.3 Cg_endo -61.24 176.7 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.891 3.061 . . . . 0.0 111.564 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 13.3 Cg_exo -71.72 -18.86 14.12 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 N-CA-C 114.626 0.972 . . . . 0.0 114.626 4.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.451 ' HE1' ' HB3' ' A' ' 705' ' ' SER . 45.6 m-85 83.29 90.6 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.119 0 O-C-N 124.771 1.294 . . . . 0.0 110.885 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -91.93 176.03 6.66 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.205 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -72.71 136.86 45.65 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.028 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 93.02 -10.82 73.24 Favored Glycine 0 N--CA 1.417 -2.63 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.428 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.61 150.87 44.25 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 14.2 m -138.69 148.96 44.6 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.685 HG21 HG21 ' A' ' 694' ' ' ILE . 21.2 t -130.27 130.38 65.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 41.3 mt-10 -89.58 135.91 33.33 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 123.658 0.599 . . . . 0.0 111.269 -177.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.606 ' HD2' ' HG ' ' A' ' 697' ' ' LEU . 25.7 m-85 -132.23 132.34 42.99 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 124.521 1.128 . . . . 0.0 109.053 -177.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.459 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 8.0 m-80 -137.97 -162.68 1.33 Allowed 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 7.6 m -120.0 140.41 51.0 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 43.1 t -50.6 -72.44 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 O-C-N 124.216 0.948 . . . . 0.0 110.909 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.28 163.2 4.54 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 173.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 73.9 m 67.41 16.99 10.1 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 124.189 0.93 . . . . 0.0 111.271 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.712 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 87.4 m-85 -147.38 149.13 32.16 Favored 'General case' 0 N--CA 1.405 -2.703 0 C-N-CA 125.976 1.71 . . . . 0.0 107.685 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.1 m -117.5 144.93 44.57 Favored 'General case' 0 C--N 1.278 -2.522 0 O-C-N 123.805 0.69 . . . . 0.0 110.58 -176.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.5 ttp -99.1 123.32 43.31 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 123.564 0.745 . . . . 0.0 109.685 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 48.8 mm -121.14 143.68 32.64 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 114.4 -89.42 0.51 Allowed Glycine 0 C--N 1.3 -1.429 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.487 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 53.0 t60 -169.03 141.4 2.64 Favored 'General case' 0 CA--C 1.475 -1.921 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.498 ' H ' ' HD2' ' A' ' 729' ' ' ARG . 0.7 OUTLIER -82.64 20.26 1.16 Allowed 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -172.796 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 2.8 p -162.53 159.34 24.71 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.812 -0.555 . . . . 0.0 112.14 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.48 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 39.4 pt -120.09 163.56 17.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.003 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 20.9 m -136.0 137.7 41.49 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 2.4 t -85.76 108.38 18.05 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.105 0.478 . . . . 0.0 110.003 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.24 143.09 21.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 124.811 1.245 . . . . 0.0 109.624 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 68.46 -1.09 2.0 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.212 0.605 . . . . 0.0 112.599 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.21 19.33 30.88 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 737' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 738' ' ' TRP . 24.9 t -141.62 150.99 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.461 ' O ' HG12 ' A' ' 737' ' ' VAL . 96.8 m95 -80.65 170.3 16.51 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 121.712 -0.618 . . . . 0.0 109.66 168.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 40.6 p -77.14 -166.49 0.72 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.521 0.677 . . . . 0.0 112.001 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.408 ' H ' ' HB ' ' A' ' 739' ' ' THR . 0.6 OUTLIER -73.96 -15.71 61.1 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -167.241 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.456 HD21 ' HG2' ' A' ' 695' ' ' PRO . 2.3 mt 68.85 151.53 0.13 Allowed Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.487 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 56.4 Cg_endo -75.74 179.26 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.332 2.021 . . . . 0.0 111.347 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -126.08 114.61 18.63 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.635 ' SG ' HD13 ' A' ' 697' ' ' LEU . 77.7 m -93.64 114.77 27.17 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 122.073 0.939 . . . . 0.0 110.278 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 1.071 HG11 HD21 ' A' ' 750' ' ' LEU . 11.8 p -97.4 159.77 3.08 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.279 0 CA-C-N 113.071 -1.877 . . . . 0.0 108.91 -178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.712 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -80.5 -1.83 43.42 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.869 -177.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.627 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 18.2 mt 77.41 -20.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 125.526 1.53 . . . . 0.0 111.701 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 746' ' ' ALA . 32.8 t70 -84.56 -19.25 33.42 Favored 'General case' 0 C--N 1.253 -3.614 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.19 -171.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -113.03 30.14 7.42 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.142 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 1.071 HD21 HG11 ' A' ' 745' ' ' VAL . 57.0 mt -89.05 -170.26 2.83 Favored 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.355 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.46 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 58.9 mtpt -128.16 154.08 46.17 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 752' ' ' LYS . . . . . 0.463 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 93.3 mttt -100.97 145.97 27.99 Favored 'General case' 0 C--N 1.248 -3.828 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.301 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 753' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 89.3 m -89.15 160.15 17.14 Favored 'General case' 1 C--N 1.235 -4.376 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.419 179.355 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -118.7 133.19 56.03 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.77 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 42.3 t -59.17 116.21 3.71 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.716 ' HB2' HG13 ' A' ' 759' ' ' ILE . 18.4 m -79.36 135.14 36.63 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -76.14 4.36 8.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.745 0.783 . . . . 0.0 112.126 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.4 -14.63 14.82 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.279 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.716 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.3 pp -114.06 151.39 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 121.262 0.553 . . . . 0.0 111.319 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.32 134.15 52.26 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.545 HD12 HD12 ' A' ' 777' ' ' ILE . 1.9 mm? -110.24 171.83 7.22 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 762' ' ' GLU . . . . . 0.416 ' HG3' ' HB2' ' A' ' 778' ' ' ARG . 44.1 mt-10 -55.18 153.27 7.0 Favored 'General case' 0 C--O 1.208 -1.088 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.99 -2.97 14.14 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 118.245 0.475 . . . . 0.0 112.045 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -83.22 -37.5 23.51 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.671 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 96.8 mt -93.31 -16.46 24.69 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.599 -172.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -75.9 2.21 13.07 Favored 'General case' 1 N--CA 1.369 -4.49 0 CA-C-O 122.127 0.965 . . . . 0.0 110.188 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -120.1 9.34 11.13 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.175 173.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -102.89 130.05 49.8 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -95.71 -38.35 10.39 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-O 122.441 1.115 . . . . 0.0 108.119 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -129.55 129.43 44.46 Favored 'General case' 0 N--CA 1.409 -2.517 0 CA-C-N 113.283 -1.78 . . . . 0.0 109.749 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.546 ' CE2' HD22 ' A' ' 765' ' ' LEU . 73.3 m-85 -105.94 142.47 35.6 Favored 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.955 -177.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.7 155.59 18.18 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -49.23 152.01 1.29 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.065 0.946 . . . . 0.0 111.607 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 67.71 4.93 4.14 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.715 0.806 . . . . 0.0 111.376 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 8.2 t -81.23 111.76 17.93 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.85 112.69 19.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.671 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.5 pt -123.71 174.2 8.3 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.712 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 95.4 mtt180 -125.93 128.93 48.3 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 174.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.605 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 6.3 p90 -120.0 167.35 12.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -147.76 157.14 43.4 Favored 'General case' 0 C--N 1.267 -2.991 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 17.3 t -93.58 147.18 23.23 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -73.78 -12.35 60.67 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.084 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -112.93 0.68 25.73 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.894 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 1.2 mptm? -118.16 -50.71 2.46 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 72.78 140.18 0.06 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.25 1.02 . . . . 0.0 110.768 -174.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 103.17 140.75 11.01 Favored Glycine 0 CA--C 1.493 -1.316 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.55 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 29.3 m95 -89.6 143.27 26.95 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.052 0.453 . . . . 0.0 111.373 -171.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.605 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -102.95 -26.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.013 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 789' ' ' HIS . . . . . 0.417 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 0.3 OUTLIER 71.9 119.16 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.948 0 C-N-CA 124.033 0.933 . . . . 0.0 110.733 -177.022 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.1 t -143.13 157.42 44.53 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.64 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 47.5 t -119.67 135.24 60.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.57 114.18 10.41 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.668 0.747 . . . . 0.0 110.168 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.6 mm -112.66 82.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 C-N-CA 124.04 0.936 . . . . 0.0 108.494 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.739 ' ND2' HD22 ' A' ' 750' ' ' LEU . 3.4 m-20 51.32 67.74 0.9 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.76 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 795' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 78.95 3.05 87.75 Favored Glycine 0 C--N 1.299 -1.514 0 C-N-CA 120.299 -0.953 . . . . 0.0 114.334 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -134.03 167.89 19.8 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.598 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 87.3 m95 -113.92 158.79 20.64 Favored 'General case' 0 C--N 1.26 -3.298 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -149.0 107.61 3.43 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 799' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 41.0 Cg_endo -71.18 142.12 71.89 Favored 'Cis proline' 0 C--O 1.246 0.889 0 C-N-CA 123.552 -1.436 . . . . 0.0 112.687 -0.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.598 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 43.9 mt-10 -53.58 126.89 23.3 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.637 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.44 ' HA ' ' CE2' ' A' ' 779' ' ' TYR . 7.7 m . . . . . 1 N--CA 1.363 -4.825 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 45.0 m -64.69 -71.91 0.17 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.75 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 134.84 -164.5 24.71 Favored Glycine 1 N--CA 1.367 -5.952 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -43.17 119.68 1.62 Allowed 'General case' 0 C--N 1.276 -2.613 0 C-N-CA 126.173 1.789 . . . . 0.0 111.552 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.646 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -58.28 149.32 59.23 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.482 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.515 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 70.6 Cg_endo -71.01 -163.89 0.14 Allowed 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 123.001 2.467 . . . . 0.0 111.818 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.63 154.91 51.17 Favored 'General case' 0 N--CA 1.393 -3.322 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.615 HD22 ' HB3' ' A' ' 717' ' ' PHE . 18.7 tp -98.61 127.35 44.51 Favored 'General case' 0 C--N 1.25 -3.74 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.433 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.57 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 6.8 pt-20 -38.41 -61.01 0.73 Allowed 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 127.094 2.158 . . . . 0.0 114.349 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.791 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.2 m-70 -128.02 26.82 5.76 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -131.82 -155.06 7.92 Favored Glycine 0 N--CA 1.424 -2.115 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.405 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.45 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -145.48 174.28 11.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.639 0.257 . . . . 0.0 110.641 -175.222 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.83 137.17 46.31 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -86.11 -77.65 0.3 Allowed 'General case' 0 N--CA 1.427 -1.577 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.524 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 704' ' ' LEU . . . . . 0.629 HD13 ' N ' ' A' ' 705' ' ' SER . 1.9 tm? -167.72 163.1 14.25 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.629 ' N ' HD13 ' A' ' 704' ' ' LEU . 46.7 t -178.36 -62.71 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.402 1.481 . . . . 0.0 109.191 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 50.6 m 67.85 153.52 0.13 Allowed Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 125.155 1.382 . . . . 0.0 112.238 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.477 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 56.4 Cg_endo -62.95 171.94 5.45 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 123.015 2.477 . . . . 0.0 112.69 -175.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.616 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 1.9 Cg_endo -75.46 -8.18 25.04 Favored 'Cis proline' 0 N--CA 1.488 1.156 0 N-CA-C 115.235 1.206 . . . . 0.0 115.235 5.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 58.7 m-85 69.14 60.29 0.33 Allowed 'General case' 0 C--N 1.313 -0.983 0 O-C-N 124.297 0.998 . . . . 0.0 109.062 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.616 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 37.0 m-85 -68.04 173.33 4.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.429 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -72.33 136.64 46.25 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.178 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.64 -18.88 56.58 Favored Glycine 0 C--N 1.286 -2.217 0 C-N-CA 120.422 -0.894 . . . . 0.0 110.876 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 143.14 55.21 Favored 'General case' 0 CA--C 1.478 -1.79 0 CA-C-O 121.348 0.594 . . . . 0.0 110.017 178.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 16.0 m -124.58 157.27 35.83 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.054 178.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.646 HG21 HG21 ' A' ' 694' ' ' ILE . 33.1 t -137.03 133.69 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -80.85 130.72 35.2 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 123.835 0.709 . . . . 0.0 110.901 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.615 ' HB3' HD22 ' A' ' 697' ' ' LEU . 27.6 m-85 -137.09 116.93 13.12 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 125.018 1.327 . . . . 0.0 108.232 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.45 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 4.5 m-80 -127.23 -167.75 1.78 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 24.3 m -112.43 135.44 53.12 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 24.8 t -52.57 -67.63 0.24 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 124.187 0.929 . . . . 0.0 111.724 -170.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -171.32 156.88 4.77 Favored 'General case' 0 CA--C 1.476 -1.889 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 75.0 m 66.64 14.3 9.7 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 124.404 1.065 . . . . 0.0 111.242 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.548 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 85.0 m-85 -140.12 145.47 37.62 Favored 'General case' 0 N--CA 1.404 -2.755 0 C-N-CA 124.823 1.249 . . . . 0.0 108.596 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 5.5 t -97.59 151.71 19.79 Favored 'General case' 0 C--N 1.252 -3.631 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.764 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.4 ttp -108.72 118.39 36.66 Favored 'General case' 0 C--N 1.263 -3.155 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.489 HG12 HG23 ' A' ' 724' ' ' THR . 41.9 mm -121.86 135.38 62.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 118.7 -81.85 0.33 Allowed Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 121.422 -0.418 . . . . 0.0 112.323 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.465 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 29.8 t-80 -171.05 138.33 1.26 Allowed 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.764 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.3 ppt_? -84.94 19.65 2.06 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 2.7 p -156.51 159.76 38.89 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.32 0.581 . . . . 0.0 112.119 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.499 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 36.1 pt -116.89 164.71 12.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.754 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 21.5 m -139.61 136.1 34.01 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.223 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 9.1 t -83.08 107.25 15.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.316 0.579 . . . . 0.0 109.765 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -145.46 151.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 124.721 1.208 . . . . 0.0 109.839 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 80.8 m80 73.61 -51.01 0.7 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.346 1.059 . . . . 0.0 110.625 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 148.45 34.28 0.05 OUTLIER Glycine 0 C--N 1.299 -1.489 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.0 p -165.85 159.49 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.515 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.9 m95 -77.63 175.6 9.74 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 172.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 18.3 p -80.12 -171.1 2.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.047 0.927 . . . . 0.0 112.658 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.7 OUTLIER -63.55 -15.77 58.94 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -172.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.6 mm? 69.59 141.65 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.465 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 32.8 Cg_endo -67.05 177.22 3.8 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.115 1.876 . . . . 0.0 112.035 174.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -121.84 129.73 52.84 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.791 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 73.8 m -113.84 103.8 11.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.11 0.481 . . . . 0.0 110.726 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.46 ' HB ' HG22 ' A' ' 724' ' ' THR . 46.6 t -97.27 143.7 12.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.548 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -60.49 2.33 0.1 Allowed 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 126.236 1.814 . . . . 0.0 115.293 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.828 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 19.4 mt 75.75 -13.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 C-N-CA 125.625 1.57 . . . . 0.0 111.956 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 746' ' ' ALA . 17.2 t70 -87.25 -25.88 23.75 Favored 'General case' 0 C--N 1.272 -2.772 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.533 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -103.09 20.53 17.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.358 -176.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.828 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 49.5 mt -84.53 -167.13 1.67 Allowed 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.773 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.52 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 10.2 mtpm? -130.0 154.41 47.42 Favored 'General case' 0 N--CA 1.381 -3.915 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.505 -177.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 752' ' ' LYS . . . . . 0.698 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 55.2 mtpt -105.71 120.71 42.39 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 113.269 -1.787 . . . . 0.0 109.317 -175.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 56.0 m -74.34 159.05 32.91 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.403 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 754' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 754' ' ' LYS . 18.3 ptpt -132.32 151.49 51.82 Favored 'General case' 0 N--CA 1.401 -2.885 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.699 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 30.6 t -63.35 121.54 14.0 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.54 -1.663 . . . . 0.0 109.956 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.821 ' HB3' HG13 ' A' ' 759' ' ' ILE . 28.2 t -74.63 155.02 38.26 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.99 -1.4 57.27 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.09 -20.13 21.6 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.794 0.807 . . . . 0.0 109.08 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.821 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.5 pp -111.66 159.68 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.435 -177.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 19.9 mt -118.67 129.04 75.47 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.924 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.661 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.528 HD12 HD12 ' A' ' 777' ' ' ILE . 1.8 mm? -105.6 -176.94 3.22 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 762' ' ' GLU . . . . . 0.858 ' HB2' HD23 ' A' ' 765' ' ' LEU . 41.1 mt-10 -59.66 151.78 24.06 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -72.25 1.19 8.09 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -171.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 764' ' ' HIS . . . . . 0.545 ' HB2' HD22 ' A' ' 765' ' ' LEU . 8.8 m-70 -90.51 -43.47 10.21 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 168.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.858 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.3 mm? -78.5 -11.57 59.96 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.001 -168.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -67.82 -18.69 64.92 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.79 13.38 24.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.563 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -113.16 110.96 21.29 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -83.55 -34.82 25.14 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.072 -1.051 . . . . 0.0 109.372 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 770' ' ' GLU . . . . . 0.698 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 45.3 mt-10 -128.83 135.56 49.29 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.757 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 771' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -115.49 142.65 46.43 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.387 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.19 163.67 18.56 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -62.4 150.5 39.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.438 0.161 . . . . 0.0 110.758 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 65.4 t30 81.24 6.6 1.26 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.027 1.331 . . . . 0.0 110.345 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 38.9 m -80.68 105.72 12.14 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -86.42 101.87 13.53 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 761' ' ' LEU . 11.9 pt -113.25 -174.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 121.832 0.825 . . . . 0.0 109.376 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.616 ' HA ' ' HA ' ' A' ' 789' ' ' HIS . 19.9 ptt180 -139.24 134.79 33.16 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.542 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 11.0 p90 -123.44 166.33 15.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -147.4 154.85 41.37 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.507 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 0.8 OUTLIER -82.58 146.9 28.91 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-O 121.047 0.451 . . . . 0.0 111.943 178.74 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -64.26 103.78 0.67 Allowed 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 110.73 -7.9 29.83 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.476 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.507 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 0.8 OUTLIER -119.41 113.59 21.02 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -89.3 90.06 8.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.618 0.723 . . . . 0.0 110.975 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 172.02 141.78 3.51 Favored Glycine 0 CA--C 1.487 -1.674 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.607 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 44.5 m95 -101.53 145.44 29.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.992 0.396 . . . . 0.0 110.127 -174.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.542 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -100.04 -28.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.013 -178.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 789' ' ' HIS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 3.5 m-70 74.43 133.66 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.602 1.161 . . . . 0.0 108.911 -176.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.6 t -156.44 155.21 31.69 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 120.703 0.287 . . . . 0.0 111.154 178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.96 137.6 53.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.3 t -70.59 113.97 8.23 Favored 'General case' 0 C--O 1.255 1.377 0 CA-C-O 121.658 0.742 . . . . 0.0 110.359 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 47.4 mm -114.25 80.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 124.32 1.048 . . . . 0.0 109.317 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.729 ' ND2' HD22 ' A' ' 750' ' ' LEU . 4.3 m-20 52.2 65.57 1.47 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.77 175.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.87 21.2 79.52 Favored Glycine 0 C--N 1.303 -1.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.97 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -146.64 164.33 33.01 Favored 'General case' 0 C--O 1.202 -1.408 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.677 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.7 m95 -111.58 157.68 20.1 Favored 'General case' 0 C--N 1.246 -3.926 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -144.12 105.89 4.83 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 799' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 38.2 Cg_endo -70.14 139.03 53.31 Favored 'Cis proline' 0 C--O 1.248 1.006 0 C-N-CA 123.725 -1.365 . . . . 0.0 110.919 -0.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.677 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 26.5 tt0 -56.42 124.05 16.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 779' ' ' TYR . 14.0 m . . . . . 1 N--CA 1.371 -4.381 0 C-N-CA 124.391 1.077 . . . . 0.0 110.585 -175.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 59.7 m -68.02 -65.12 0.73 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 94.21 134.67 7.44 Favored Glycine 0 N--CA 1.42 -2.394 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.262 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 37.8 t70 46.28 101.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.134 1.774 . . . . 0.0 113.508 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.681 HG21 HG21 ' A' ' 715' ' ' VAL . 1.8 pp -59.34 151.33 59.72 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.289 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.438 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 37.7 Cg_endo -68.28 -157.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 123.039 2.492 . . . . 0.0 112.517 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.12 160.52 37.54 Favored 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.608 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.3 OUTLIER -99.16 133.05 43.99 Favored 'General case' 0 C--N 1.259 -3.356 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.563 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -49.06 -39.47 27.7 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 124.406 1.082 . . . . 0.0 113.689 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.402 ' HB3' ' CE1' ' A' ' 723' ' ' PHE . 90.4 m-70 -143.21 28.05 1.54 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.129 0.49 . . . . 0.0 110.264 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.608 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -141.59 -146.05 4.64 Favored Glycine 0 C--N 1.299 -1.511 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.066 -177.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.441 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -151.08 -175.56 5.2 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -176.439 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -117.5 142.83 46.7 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -74.13 -78.2 0.1 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.204 0.526 . . . . 0.0 110.785 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.3 tt -149.87 130.41 13.95 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.527 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 67.9 p -117.65 -70.83 0.77 Allowed 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -176.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 706' ' ' SER . . . . . 0.416 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 23.3 t 64.16 123.99 0.02 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 125.696 1.598 . . . . 0.0 112.559 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.543 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 41.2 Cg_endo -63.66 176.0 2.54 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.456 2.771 . . . . 0.0 111.682 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 6.0 Cg_exo -77.6 -10.28 32.26 Favored 'Cis proline' 0 CA--C 1.504 -1.002 0 N-CA-C 115.017 1.122 . . . . 0.0 115.017 5.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.527 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 56.7 m-85 72.56 78.74 0.15 Allowed 'General case' 0 C--O 1.245 0.868 0 O-C-N 124.248 0.967 . . . . 0.0 110.005 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.407 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 29.9 m-85 -85.48 171.51 11.71 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.492 0.663 . . . . 0.0 112.469 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -67.33 133.31 49.41 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.697 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.11 68.09 Favored Glycine 0 N--CA 1.418 -2.522 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.19 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.17 145.36 44.29 Favored 'General case' 0 CA--C 1.493 -1.214 0 O-C-N 122.085 -0.656 . . . . 0.0 110.706 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 14.2 m -131.07 151.04 51.85 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.681 HG21 HG21 ' A' ' 694' ' ' ILE . 34.4 t -134.99 140.1 45.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -85.64 123.44 31.05 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 124.128 0.893 . . . . 0.0 111.6 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -124.36 105.55 9.53 Favored 'General case' 0 C--N 1.273 -2.759 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.441 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 11.4 m-80 -113.37 -162.68 0.81 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 5.0 m -113.47 134.44 54.66 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -178.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 39.5 t -65.64 -64.02 0.96 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 123.689 0.618 . . . . 0.0 110.87 -172.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -164.68 156.31 15.57 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 73.9 m 69.78 1.94 3.63 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.303 1.002 . . . . 0.0 113.171 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.573 ' HB2' ' HB3' ' A' ' 719' ' ' CYS . 98.1 m-85 -134.14 147.43 50.81 Favored 'General case' 0 N--CA 1.403 -2.795 0 C-N-CA 123.75 0.82 . . . . 0.0 109.078 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.521 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -113.5 138.13 50.57 Favored 'General case' 0 C--N 1.264 -3.122 0 C-N-CA 125.546 1.539 . . . . 0.0 110.445 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.498 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.7 ttp -86.64 121.93 29.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.65 1.18 . . . . 0.0 109.348 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 726' ' ' ILE . 31.7 mm -111.87 127.4 69.08 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.973 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.132 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 99.2 -82.97 0.58 Allowed Glycine 0 CA--C 1.481 -2.051 0 CA-C-N 114.645 -1.162 . . . . 0.0 112.253 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 728' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 30.3 p-80 -147.04 178.02 8.7 Favored 'General case' 0 N--CA 1.388 -3.55 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -174.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.498 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.2 OUTLIER -128.15 6.4 5.91 Favored 'General case' 0 C--O 1.2 -1.546 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.637 -177.41 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 3.1 p -126.54 160.1 31.58 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 119.07 -1.052 . . . . 0.0 113.732 -172.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.476 HG21 HD13 ' A' ' 741' ' ' LEU . 36.6 pt -119.66 159.51 20.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.106 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 14.6 m -134.77 135.28 41.74 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.791 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 7.6 t -86.01 104.13 15.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.156 0.503 . . . . 0.0 109.953 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.7 pp -144.69 147.45 19.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 124.655 1.182 . . . . 0.0 110.037 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 64.9 4.07 2.31 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 96.81 24.87 12.41 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.14 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.04 162.22 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.438 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.3 m95 -80.29 173.08 12.96 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.518 ' HB ' ' NE2' ' A' ' 740' ' ' GLN . 23.6 p -78.8 -162.44 0.38 Allowed 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.837 0.827 . . . . 0.0 112.42 -177.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.629 ' NE2' ' H ' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -84.89 2.01 44.58 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 124.453 1.101 . . . . 0.0 113.575 -167.548 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 731' ' ' ILE . 4.1 mm? 71.21 155.87 0.16 Allowed Pre-proline 0 N--CA 1.483 1.215 0 O-C-N 123.667 0.605 . . . . 0.0 111.557 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.421 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 38.1 Cg_endo -80.24 -173.58 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.219 1.946 . . . . 0.0 111.963 173.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -123.15 104.62 9.29 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 122.359 -0.213 . . . . 0.0 110.533 -176.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 724' ' ' THR . 86.8 m -96.99 114.35 25.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.106 0.479 . . . . 0.0 110.776 172.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.681 ' HB ' HD21 ' A' ' 750' ' ' LEU . 58.8 t -108.29 146.79 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 746' ' ' ALA . . . . . 0.565 ' O ' ' HB ' ' A' ' 747' ' ' ILE . . . -64.74 2.52 0.67 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 125.726 1.611 . . . . 0.0 114.201 -175.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.784 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 37.1 mt 78.14 -24.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 125.482 1.513 . . . . 0.0 111.544 175.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 748' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 746' ' ' ALA . 28.7 t70 -81.4 -24.32 37.04 Favored 'General case' 0 C--N 1.258 -3.389 0 CA-C-N 112.893 -1.958 . . . . 0.0 109.248 -172.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 749' ' ' LYS . . . . . 0.456 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 1.7 ptmm? -115.46 23.6 12.26 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.919 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.87 HD22 HD22 ' A' ' 794' ' ' ASN . 55.1 mt -81.41 -168.88 2.03 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.442 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 751' ' ' LYS . . . . . 0.584 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 30.0 mtpp -122.63 158.43 30.02 Favored 'General case' 0 N--CA 1.396 -3.167 0 CA-C-O 121.836 0.827 . . . . 0.0 109.085 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -110.25 138.23 46.91 Favored 'General case' 0 C--N 1.245 -3.939 0 CA-C-N 113.184 -1.825 . . . . 0.0 107.943 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 753' ' ' CYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 78.2 m -85.39 178.99 7.26 Favored 'General case' 0 C--N 1.252 -3.649 0 CA-C-N 113.416 -1.72 . . . . 0.0 110.517 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -140.87 141.54 34.61 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 755' ' ' SER . . . . . 0.449 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 5.4 p -62.78 128.35 35.52 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 123.622 0.576 . . . . 0.0 110.467 173.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 756' ' ' SER . . . . . 0.601 ' HB2' ' CG1' ' A' ' 759' ' ' ILE . 9.5 m -75.35 162.99 27.91 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -89.76 -15.36 32.59 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 758' ' ' LEU . . . . . 0.414 HD22 ' NH2' ' A' ' 782' ' ' ARG . 40.2 mt -93.71 -18.43 22.12 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.66 0.743 . . . . 0.0 110.159 -174.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 759' ' ' ILE . . . . . 0.601 ' CG1' ' HB2' ' A' ' 756' ' ' SER . 2.4 pp -100.24 160.16 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.61 135.79 56.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 761' ' ' LEU . . . . . 0.468 HD11 HD13 ' A' ' 759' ' ' ILE . 1.8 mm? -110.29 -179.28 3.73 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 762' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 42.0 mt-10 -63.55 157.22 24.23 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.73 -18.43 64.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.209 0.528 . . . . 0.0 111.045 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -95.63 -0.12 52.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.922 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 765' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 765' ' ' LEU . 3.7 mm? -124.72 -11.78 7.2 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 57.1 mtmt -69.5 -21.05 63.71 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.546 0.689 . . . . 0.0 110.598 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -88.15 14.02 10.1 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.097 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 768' ' ' LYS . . . . . 0.528 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 12.0 tppt? -110.52 117.33 33.26 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.89 -43.1 20.4 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.72 117.59 23.78 Favored 'General case' 0 CA--C 1.483 -1.599 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.003 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 771' ' ' PHE . . . . . 0.528 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 88.3 m-85 -91.13 136.01 33.38 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -78.73 143.21 36.4 Favored 'General case' 0 C--N 1.276 -2.593 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.537 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 773' ' ' HIS . . . . . 0.787 ' CD2' HD12 ' A' ' 750' ' ' LEU . 47.9 p-80 -40.05 138.55 0.81 Allowed 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 124.948 1.299 . . . . 0.0 111.696 171.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 74.14 6.38 4.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.796 1.638 . . . . 0.0 113.279 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 70.5 m -75.38 116.69 16.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.01 102.16 13.56 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 777' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 761' ' ' LEU . 7.8 pt -113.93 179.56 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.676 0.751 . . . . 0.0 109.76 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 98.8 mtt180 -127.35 119.98 27.49 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 779' ' ' TYR . . . . . 0.691 ' CD2' HG13 ' A' ' 801' ' ' VAL . 13.5 p90 -105.58 164.14 12.13 Favored 'General case' 0 C--O 1.26 1.611 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 171.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -147.76 157.25 43.45 Favored 'General case' 0 C--N 1.263 -3.157 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 781' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 42.8 t -96.23 163.54 13.05 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -176.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 782' ' ' ARG . . . . . 0.414 ' NH2' HD22 ' A' ' 758' ' ' LEU . 21.3 ptt180 -82.57 -23.0 34.67 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 120.992 0.425 . . . . 0.0 110.356 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -94.15 -13.27 54.9 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.078 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 784' ' ' LYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 0.1 OUTLIER -131.19 98.46 4.57 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -88.52 87.92 7.44 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.237 1.018 . . . . 0.0 111.339 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -173.63 152.55 15.56 Favored Glycine 0 CA--C 1.479 -2.157 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 787' ' ' TRP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 26.2 m95 -93.18 134.81 34.98 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 117.571 0.685 . . . . 0.0 110.345 -172.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 788' ' ' ILE . . . . . 0.531 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.1 mp -94.61 -28.0 4.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.117 -177.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 74.62 119.54 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 124.375 1.07 . . . . 0.0 109.835 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 790' ' ' THR . . . . . 0.447 HG21 ' CG2' ' A' ' 801' ' ' VAL . 3.8 t -143.65 160.77 40.09 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.169 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.32 135.78 60.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 123.897 0.879 . . . . 0.0 109.427 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 52.8 t -72.52 103.07 3.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.05 0.928 . . . . 0.0 110.854 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.6 mm -99.28 79.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.499 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 794' ' ' ASN . . . . . 0.87 HD22 HD22 ' A' ' 750' ' ' LEU . 5.2 m-20 50.39 68.81 0.7 Allowed 'General case' 0 C--O 1.238 0.447 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.771 176.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 80.2 6.28 89.28 Favored Glycine 0 C--N 1.306 -1.092 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.043 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 796' ' ' ARG . . . . . 0.442 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 34.5 ttt180 -139.53 169.09 18.38 Favored 'General case' 0 C--O 1.198 -1.657 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 797' ' ' TRP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.6 m95 -111.43 161.09 16.47 Favored 'General case' 0 C--N 1.264 -3.112 0 O-C-N 122.293 -0.254 . . . . 0.0 110.429 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -150.33 106.23 3.14 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 799' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 34.8 Cg_endo -67.63 138.52 43.29 Favored 'Cis proline' 0 C--O 1.243 0.774 0 C-N-CA 123.651 -1.396 . . . . 0.0 111.103 -1.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 800' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 30.1 tt0 -55.16 121.59 9.14 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.058 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 801' ' ' VAL . . . . . 0.691 HG13 ' CD2' ' A' ' 779' ' ' TYR . 91.8 t . . . . . 0 C--N 1.311 -1.076 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.233 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 35.9 m -72.87 -67.83 0.53 Allowed 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.33 0.586 . . . . 0.0 109.485 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 130.11 -161.46 23.08 Favored Glycine 1 N--CA 1.367 -5.938 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -41.14 116.19 0.7 Allowed 'General case' 0 C--N 1.274 -2.696 0 C-N-CA 127.196 2.198 . . . . 0.0 112.09 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.533 HG21 HG21 ' A' ' 715' ' ' VAL . 1.7 pp -59.94 149.56 72.99 Favored Pre-proline 0 N--CA 1.435 -1.205 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.017 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.441 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 71.2 Cg_endo -74.11 -160.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.611 2.207 . . . . 0.0 110.42 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 696' ' ' GLU . . . . . 0.595 ' HA ' ' HE2' ' A' ' 717' ' ' PHE . 13.1 pt-20 -149.85 170.3 19.11 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.752 HD13 ' SG ' ' A' ' 744' ' ' CYS . 17.7 mt -97.48 128.71 44.47 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 123.914 0.759 . . . . 0.0 111.376 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -46.17 -33.88 3.9 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.078 -1.874 . . . . 0.0 112.723 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.426 ' HB3' ' CE1' ' A' ' 723' ' ' PHE . 96.4 m-70 -145.89 26.7 1.23 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -137.94 -148.36 5.36 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.472 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.461 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.6 OUTLIER -150.9 176.2 11.31 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.051 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -104.69 157.34 17.25 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -94.6 -68.75 0.78 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.092 0.472 . . . . 0.0 111.297 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 704' ' ' LEU . . . . . 0.476 ' O ' HG13 ' A' ' 715' ' ' VAL . 58.9 tp -146.14 123.39 11.56 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.487 ' HB3' ' CG1' ' A' ' 715' ' ' VAL . 2.8 p -144.86 105.0 4.06 Favored 'General case' 0 N--CA 1.396 -3.131 0 CA-C-O 122.024 0.916 . . . . 0.0 109.347 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 10.2 m -116.34 132.03 23.52 Favored Pre-proline 0 C--N 1.246 -3.914 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.621 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.457 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 57.5 Cg_endo -64.65 172.87 6.22 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.592 2.194 . . . . 0.0 110.183 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.64 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.0 Cg_exo -76.61 -7.03 28.4 Favored 'Cis proline' 0 N--CA 1.487 1.124 0 N-CA-C 114.839 1.053 . . . . 0.0 114.839 6.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.464 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 57.4 m-85 72.95 79.28 0.14 Allowed 'General case' 0 C--N 1.314 -0.975 0 O-C-N 124.242 0.964 . . . . 0.0 109.217 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.64 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 38.1 m-85 -87.0 172.52 9.94 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.235 -175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -69.32 131.7 45.26 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.994 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.65 -15.16 60.07 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 713' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 0.5 OUTLIER -65.42 145.98 55.47 Favored 'General case' 0 CA--C 1.477 -1.861 0 CA-C-O 121.42 0.628 . . . . 0.0 110.262 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 17.8 m -133.97 148.83 51.2 Favored 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.533 HG21 HG21 ' A' ' 694' ' ' ILE . 61.8 t -134.58 130.61 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.845 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.465 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 44.0 mt-10 -82.16 139.28 34.42 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 121.609 0.719 . . . . 0.0 110.813 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.595 ' HE2' ' HA ' ' A' ' 696' ' ' GLU . 28.5 m-85 -137.35 120.55 16.79 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 125.867 1.667 . . . . 0.0 107.478 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.461 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 16.1 m-80 -128.78 -163.44 1.29 Allowed 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 22.3 m -118.87 134.03 55.44 Favored 'General case' 0 C--N 1.267 -3.018 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 21.1 t -73.15 -84.5 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 O-C-N 123.923 0.764 . . . . 0.0 112.019 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -133.77 132.59 40.7 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.459 0.303 . . . . 0.0 110.632 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 4.4 t 71.9 26.29 2.97 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 124.598 1.186 . . . . 0.0 110.055 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.3 m-85 -140.72 145.98 37.17 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.551 HG21 HD11 ' A' ' 750' ' ' LEU . 6.4 t -75.23 -118.38 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.605 -174.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.517 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 7.9 ttp 162.82 104.83 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 128.898 2.879 . . . . 0.0 105.29 174.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.9 mm -119.96 139.25 47.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 102.17 -75.79 0.33 Allowed Glycine 0 N--CA 1.429 -1.797 0 O-C-N 123.559 0.537 . . . . 0.0 112.729 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.579 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 2.1 t60 -146.98 -172.97 4.12 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.517 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -141.89 22.94 2.09 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.28 170.418 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 16.4 p -157.44 162.71 38.97 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.034 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 714' ' ' SER . 32.4 pt -122.6 164.6 19.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 739' ' ' THR . 7.3 m -135.77 135.01 39.58 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.977 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 6.0 t -84.68 106.83 16.52 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.473 0.654 . . . . 0.0 110.437 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -142.97 143.58 24.98 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 125.221 1.408 . . . . 0.0 109.988 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 64.39 4.2 2.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.06 13.5 52.46 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 737' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 738' ' ' TRP . 80.7 t -140.66 154.23 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.465 ' O ' HG12 ' A' ' 737' ' ' VAL . 94.2 m95 -79.95 177.64 8.78 Favored 'General case' 0 C--N 1.273 -2.748 0 O-C-N 121.89 -0.506 . . . . 0.0 109.786 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.458 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 27.1 p -84.89 -163.95 0.91 Allowed 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.856 0.836 . . . . 0.0 112.506 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.458 ' H ' ' HB ' ' A' ' 739' ' ' THR . 5.1 pm0 -74.81 -17.05 60.68 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -168.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 1.5 mt 68.73 151.33 0.13 Allowed Pre-proline 0 N--CA 1.479 1.019 0 O-C-N 123.889 0.743 . . . . 0.0 112.231 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.579 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 42.9 Cg_endo -73.56 177.52 7.89 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.796 1.664 . . . . 0.0 111.249 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -120.17 103.09 8.97 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.234 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.752 ' SG ' HD13 ' A' ' 697' ' ' LEU . 84.1 m -79.07 110.26 14.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.971 173.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.531 ' O ' HG22 ' A' ' 724' ' ' THR . 46.6 t -104.72 147.03 11.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.96 -0.85 1.71 Allowed 'General case' 0 C--N 1.284 -2.253 0 C-N-CA 125.204 1.402 . . . . 0.0 114.089 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.714 ' HA ' HD22 ' A' ' 750' ' ' LEU . 48.6 mt 74.54 -14.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 125.589 1.555 . . . . 0.0 110.93 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 746' ' ' ALA . 1.0 OUTLIER -75.3 -27.89 59.5 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 126.149 1.78 . . . . 0.0 108.755 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -106.92 16.96 23.71 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.063 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.714 HD22 ' HA ' ' A' ' 747' ' ' ILE . 1.3 mp -83.15 -178.67 7.18 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.766 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.592 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 55.0 mtpt -125.59 150.66 47.32 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.58 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 752' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 770' ' ' GLU . 14.1 mmmm -90.14 111.22 22.29 Favored 'General case' 0 C--N 1.251 -3.689 0 CA-C-N 112.421 -2.172 . . . . 0.0 108.726 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 61.2 m -70.78 138.29 50.29 Favored 'General case' 0 C--N 1.269 -2.898 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.14 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -107.86 138.28 44.38 Favored 'General case' 0 C--N 1.271 -2.806 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.13 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 755' ' ' SER . . . . . 0.421 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.4 p -67.83 123.65 21.13 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.465 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.673 ' HB3' HG13 ' A' ' 759' ' ' ILE . 25.9 t -70.89 146.18 49.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.9 3.28 49.09 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 758' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 803' ' ' CYS . 4.1 mm? -92.46 -29.52 16.21 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.673 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -98.53 158.51 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.294 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.057 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.1 131.87 59.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.412 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 85.8 mt -105.56 179.82 4.16 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.143 0.497 . . . . 0.0 110.124 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.714 ' HB2' HD23 ' A' ' 765' ' ' LEU . 37.8 mt-10 -69.4 170.53 10.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.731 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.02 -20.09 66.32 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.16 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 764' ' ' HIS . . . . . 0.572 ' HB2' HD22 ' A' ' 765' ' ' LEU . 15.6 m-70 -90.1 -30.09 17.9 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.714 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.7 mm? -93.9 -14.18 26.33 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.371 -165.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 28.5 mtmm -71.77 -8.8 56.44 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.762 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -94.57 -1.7 52.85 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -105.28 126.34 51.98 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 769' ' ' LYS . . . . . 0.846 ' HG3' ' HG2' ' A' ' 770' ' ' GLU . 18.8 ptpt -98.49 -29.37 13.14 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.612 0.72 . . . . 0.0 109.107 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 770' ' ' GLU . . . . . 0.846 ' HG2' ' HG3' ' A' ' 769' ' ' LYS . 4.7 pt-20 -140.06 136.38 33.58 Favored 'General case' 0 N--CA 1.39 -3.456 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.462 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.484 ' HE2' HD12 ' A' ' 765' ' ' LEU . 86.3 m-85 -110.66 148.66 31.78 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.623 -175.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -90.91 166.04 13.26 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.626 ' HB3' HD23 ' A' ' 750' ' ' LEU . 26.6 t60 -62.67 157.35 21.07 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 122.328 0.251 . . . . 0.0 111.076 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 77.69 9.8 2.36 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.209 1.004 . . . . 0.0 109.654 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 47.4 t -86.36 104.5 15.93 Favored 'General case' 0 N--CA 1.385 -3.687 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -90.13 101.37 14.08 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.424 HG21 ' CE2' ' A' ' 771' ' ' PHE . 7.9 pt -112.32 -174.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 CA-C-O 121.591 0.71 . . . . 0.0 109.797 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.624 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 27.6 ptt180 -141.08 122.5 14.97 Favored 'General case' 0 N--CA 1.391 -3.424 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.555 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.488 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 9.6 p90 -113.66 172.9 6.7 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -155.47 169.26 24.68 Favored 'General case' 0 N--CA 1.411 -2.379 0 O-C-N 123.934 0.771 . . . . 0.0 109.356 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.675 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 16.4 t -102.26 162.22 13.09 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 782' ' ' ARG . . . . . 0.609 ' HG2' ' SG ' ' A' ' 803' ' ' CYS . 12.0 ptm180 -74.8 80.14 2.09 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.601 1.191 . . . . 0.0 108.293 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 147.28 -27.72 1.54 Allowed Glycine 0 N--CA 1.417 -2.596 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.269 -172.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.675 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 14.3 mptt -84.02 103.32 13.16 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -87.34 81.27 7.93 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 162.62 -170.02 38.05 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 106.261 -2.736 . . . . 0.0 106.261 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.624 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 64.7 m95 -130.76 158.51 39.93 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 118.962 1.381 . . . . 0.0 109.364 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.488 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -99.94 -41.94 9.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.132 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 0.3 OUTLIER 80.7 133.25 0.06 Allowed 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.052 1.341 . . . . 0.0 110.259 -176.043 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.419 ' HA ' ' HD2' ' A' ' 799' ' ' PRO . 4.5 t -157.17 158.98 37.27 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.107 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 45.0 t -120.91 133.24 68.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.273 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 37.9 t -68.33 115.11 7.39 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.152 0.501 . . . . 0.0 109.995 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 45.3 mm -117.3 83.09 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 C-N-CA 123.726 0.81 . . . . 0.0 109.332 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.607 ' OD1' ' HG ' ' A' ' 750' ' ' LEU . 4.7 m-20 49.78 66.01 1.25 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.811 0.845 . . . . 0.0 111.259 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 77.44 14.36 82.58 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.887 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -139.02 166.11 25.37 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.1 m95 -116.88 156.3 27.58 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 798' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 18.9 t70 -147.62 104.28 3.7 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 799' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 43.1 Cg_endo -70.51 142.76 73.04 Favored 'Cis proline' 0 C--O 1.239 0.575 0 C-N-CA 124.0 -1.25 . . . . 0.0 113.248 0.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 47.3 mt-10 -53.86 125.42 18.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.445 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 5.0 m -75.48 140.2 17.78 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.404 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.719 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -155.98 131.4 9.52 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.769 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 803' ' ' CYS . . . . . 0.609 ' SG ' ' HG2' ' A' ' 782' ' ' ARG . 42.3 t -128.65 -5.6 5.21 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.044 0.926 . . . . 0.0 109.054 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.42 -1.97 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.267 178.371 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.421 -1.892 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 51.8 m -79.06 -66.99 0.8 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 93.17 142.22 11.51 Favored Glycine 0 N--CA 1.405 -3.38 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.666 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 35.6 t70 53.69 97.32 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 125.815 1.646 . . . . 0.0 112.441 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.454 HG21 HG21 ' A' ' 715' ' ' VAL . 1.8 pp -63.68 147.3 95.94 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.399 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.449 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.9 Cg_endo -69.63 -171.61 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.729 2.286 . . . . 0.0 112.134 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -121.79 179.05 4.61 Favored 'General case' 0 N--CA 1.393 -3.297 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.587 HD22 ' HB3' ' A' ' 717' ' ' PHE . 25.0 tp -124.33 129.43 50.71 Favored 'General case' 0 C--N 1.251 -3.675 0 CA-C-O 120.915 0.388 . . . . 0.0 110.953 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -38.66 -51.34 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.479 1.912 . . . . 0.0 114.756 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.681 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.8 m-70 -141.12 26.26 2.03 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -139.16 -146.39 4.92 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.552 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.465 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -152.05 178.31 9.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -174.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -113.05 143.88 43.56 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -73.56 -62.71 1.39 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.6 tt -166.56 135.52 2.95 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.546 ' HB3' HG11 ' A' ' 715' ' ' VAL . 13.1 p -129.95 119.86 23.89 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-O 121.351 0.596 . . . . 0.0 110.074 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 706' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 13.2 p -108.47 113.17 60.42 Favored Pre-proline 0 C--N 1.276 -2.609 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.239 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.491 ' HA ' ' N ' ' A' ' 709' ' ' TYR . 57.6 Cg_endo -69.7 171.5 14.28 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.856 2.37 . . . . 0.0 110.527 176.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.84 -4.89 3.07 Favored 'Cis proline' 0 N--CA 1.496 1.676 0 N-CA-C 117.077 1.914 . . . . 0.0 117.077 2.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.521 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 35.6 m-85 68.68 65.57 0.31 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.493 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 16.7 m-85 -69.75 172.77 7.05 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.877 -1.511 . . . . 0.0 112.103 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -72.21 132.05 43.58 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.901 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.34 -6.41 65.81 Favored Glycine 0 N--CA 1.413 -2.867 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.82 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 713' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 1.4 t70 -68.79 155.89 39.35 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 19.4 m -146.81 145.08 29.78 Favored 'General case' 0 C--N 1.274 -2.697 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.546 HG11 ' HB3' ' A' ' 705' ' ' SER . 46.1 t -132.04 134.69 59.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.887 -176.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -79.85 133.85 36.29 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 123.78 0.675 . . . . 0.0 111.676 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.587 ' HB3' HD22 ' A' ' 697' ' ' LEU . 26.7 m-85 -138.28 129.88 27.88 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 125.38 1.472 . . . . 0.0 107.28 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.465 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 13.5 m120 -137.71 -161.5 1.18 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 725' ' ' MET . 11.7 m -118.71 131.77 56.15 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 18.9 t -67.02 -75.61 0.09 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 124.239 0.962 . . . . 0.0 110.721 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -149.18 152.9 36.86 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 69.3 m 72.92 2.69 4.46 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 124.285 0.991 . . . . 0.0 112.766 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.642 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.7 m-85 -138.56 144.74 40.0 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.674 HG21 HD21 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -107.09 136.43 46.95 Favored 'General case' 0 C--N 1.255 -3.505 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.265 -177.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.768 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 7.6 ttp -84.29 118.6 24.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 124.196 0.998 . . . . 0.0 109.636 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.481 HD11 HD21 ' A' ' 794' ' ' ASN . 48.3 mm -127.33 141.68 45.65 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.998 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 106.5 -66.9 0.25 Allowed Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.392 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.561 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 6.5 t-80 -165.83 -177.6 4.37 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 -175.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.768 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -143.31 25.43 1.71 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 119.027 0.831 . . . . 0.0 110.699 176.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 16.0 m -152.47 163.66 39.1 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.884 -0.51 . . . . 0.0 109.782 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 714' ' ' SER . 32.2 pt -125.3 163.45 26.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.745 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 739' ' ' THR . 17.5 m -137.03 134.1 36.2 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.252 0.345 . . . . 0.0 111.08 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 3.4 t -86.84 105.85 17.32 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -141.28 140.43 31.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.984 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 60.44 14.19 4.61 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 89.11 25.22 29.59 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.81 144.89 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.089 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.521 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 97.3 m95 -72.63 -179.34 3.01 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.5 0.667 . . . . 0.0 110.138 170.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 732' ' ' THR . 27.9 p -90.95 -152.9 0.29 Allowed 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.44 ' H ' ' HB ' ' A' ' 739' ' ' THR . 5.2 pm0 -81.52 -14.87 56.4 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -169.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.2 mm? 71.12 151.59 0.14 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 123.967 0.792 . . . . 0.0 110.824 -175.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.561 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 36.2 Cg_endo -71.13 177.64 6.29 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.028 1.819 . . . . 0.0 110.736 172.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -125.07 132.92 53.09 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.681 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 84.6 m -116.38 107.06 14.33 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-O 121.458 0.646 . . . . 0.0 109.834 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.58 142.82 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.682 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.642 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.97 1.91 1.27 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 125.247 1.419 . . . . 0.0 113.414 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.693 ' HA ' HD22 ' A' ' 750' ' ' LEU . 40.0 mt 79.35 -19.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 125.41 1.484 . . . . 0.0 111.031 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.0 t70 -72.01 -34.26 68.71 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.118 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -98.74 17.76 18.57 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.274 -1.785 . . . . 0.0 109.498 -172.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.803 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 1.7 mp -82.37 -174.06 4.93 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.539 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.627 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 1.2 mmpt? -136.43 -177.1 4.57 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -130.97 144.4 51.45 Favored 'General case' 0 C--N 1.268 -2.963 0 C-N-CA 125.297 1.439 . . . . 0.0 107.202 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 753' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 770' ' ' GLU . 69.1 m -92.78 167.08 12.1 Favored 'General case' 0 C--N 1.246 -3.899 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.24 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -125.88 136.0 52.56 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.895 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 755' ' ' SER . . . . . 0.441 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.0 p -67.18 118.44 10.6 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.582 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.577 ' HB3' HG13 ' A' ' 759' ' ' ILE . 28.3 t -66.15 143.15 57.46 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -77.85 -6.97 55.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 758' ' ' LEU . . . . . 0.545 HD13 ' HB2' ' A' ' 804' ' ' SER . 89.2 mt -105.16 -11.69 16.45 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.813 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.577 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -96.43 162.32 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.806 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 760' ' ' ILE . . . . . 0.444 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.4 mp -118.98 117.4 54.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.791 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 63.7 mt -93.51 -177.25 4.35 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 31.5 mt-10 -62.85 176.84 0.63 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.354 0.597 . . . . 0.0 110.093 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -86.02 -6.06 59.11 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 123.431 1.586 . . . . 0.0 107.406 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . 0.274 63.8 t60 -88.98 -43.04 11.43 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 110.712 -2.949 . . . . 0.0 108.194 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.691 HD22 ' HE2' ' A' ' 771' ' ' PHE . 54.8 mt -96.2 -13.43 23.49 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.861 -171.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 54.1 mtmt -65.66 -15.9 63.22 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.806 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -89.84 1.64 55.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.506 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.463 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 11.3 tppt? -103.52 109.91 21.74 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -83.02 -36.49 24.94 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 770' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 753' ' ' CYS . 3.8 pt-20 -130.29 134.02 46.9 Favored 'General case' 0 N--CA 1.403 -2.789 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.635 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.791 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 81.0 m-85 -112.09 143.19 43.53 Favored 'General case' 0 C--N 1.267 -3.012 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.009 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.89 154.78 19.61 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.634 ' CG ' HD23 ' A' ' 750' ' ' LEU . 18.5 p-80 -43.21 143.56 0.81 Allowed 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.974 1.31 . . . . 0.0 111.55 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 68.19 12.28 8.7 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.23 1.012 . . . . 0.0 113.435 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 43.4 t -77.84 110.48 12.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -86.82 101.3 13.22 Favored 'General case' 0 CA--C 1.494 -1.203 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.702 HG21 ' CE2' ' A' ' 771' ' ' PHE . 5.6 pt -114.0 -173.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.269 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 26.9 ptt180 -142.28 124.81 15.76 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.473 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 4.4 p90 -114.79 172.54 6.98 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 780' ' ' ARG . . . . . 0.444 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 27.0 ptt180 -150.19 178.57 8.86 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 48.1 t -114.94 162.94 16.27 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 782' ' ' ARG . . . . . 0.431 ' HG2' ' SG ' ' A' ' 803' ' ' CYS . 38.1 ptt180 -74.51 -21.49 59.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.286 0.565 . . . . 0.0 110.129 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -99.93 -8.79 50.56 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.072 175.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 13.3 mptt -128.14 104.53 7.81 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 122.686 -0.302 . . . . 0.0 110.735 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.31 169.92 17.39 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 97.58 -168.02 23.69 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 75.6 m95 -138.69 142.9 38.96 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 118.613 1.206 . . . . 0.0 109.714 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.473 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.5 mp -93.6 -40.51 11.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.056 -177.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.456 ' HA ' ' O ' ' A' ' 777' ' ' ILE . 0.3 OUTLIER 75.0 129.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.677 1.191 . . . . 0.0 109.633 -174.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 3.4 t -151.42 154.61 36.96 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 120.755 0.312 . . . . 0.0 110.334 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.3 t -115.99 133.42 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.395 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 54.0 t -69.38 112.48 5.95 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.788 0.804 . . . . 0.0 110.173 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 47.4 mm -112.45 81.35 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 C-N-CA 124.534 1.133 . . . . 0.0 108.84 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.803 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 0.4 OUTLIER 51.62 66.13 1.29 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.374 176.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.49 20.25 79.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.348 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -147.29 163.99 34.65 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.662 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.6 m95 -108.92 162.09 14.53 Favored 'General case' 0 C--N 1.258 -3.388 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.684 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -150.24 102.14 3.15 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.81 140.56 64.45 Favored 'Cis proline' 0 N--CA 1.48 0.705 0 C-N-CA 123.917 -1.284 . . . . 0.0 113.704 -0.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.662 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 44.6 mt-10 -50.48 123.85 9.51 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.585 175.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 3.9 m -76.67 131.64 34.46 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.264 0 CA-C-O 121.458 0.647 . . . . 0.0 111.078 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -156.59 108.17 2.45 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 803' ' ' CYS . . . . . 0.542 ' HB2' HG22 ' A' ' 759' ' ' ILE . 42.6 t -94.86 -30.73 14.04 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 804' ' ' SER . . . . . 0.545 ' HB2' HD13 ' A' ' 758' ' ' LEU . 60.7 m . . . . . 0 N--CA 1.437 -1.111 0 C-N-CA 128.87 2.868 . . . . 0.0 103.984 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.431 -1.424 0 CA-C-O 120.864 0.364 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 64.2 m -73.5 -70.89 0.35 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 94.23 135.78 7.92 Favored Glycine 0 N--CA 1.413 -2.876 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.616 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 25.3 t70 62.25 112.94 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 O-C-N 125.324 1.249 . . . . 0.0 111.829 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.662 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -80.0 147.03 64.86 Favored Pre-proline 0 C--N 1.283 -2.305 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.05 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.451 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 71.1 Cg_endo -71.64 -166.9 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 123.499 2.799 . . . . 0.0 112.994 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -129.91 164.64 23.76 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 717' ' ' PHE . 23.7 tp -109.32 132.9 53.69 Favored 'General case' 0 C--N 1.256 -3.498 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.742 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 7.0 pt-20 -43.49 -53.43 5.5 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 125.925 1.69 . . . . 0.0 113.713 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.459 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 89.9 m-70 -137.49 28.15 2.75 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.447 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -136.2 -151.63 6.14 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.541 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.438 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.21 174.55 12.68 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.411 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -108.66 142.27 39.4 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -78.3 -67.87 0.69 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 120.72 0.295 . . . . 0.0 111.524 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.3 tt -161.68 137.21 7.61 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.444 ' HA ' HG13 ' A' ' 715' ' ' VAL . 35.5 p -111.8 -49.2 3.0 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -169.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 706' ' ' SER . . . . . 0.441 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 66.0 m 58.84 100.26 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 706' ' ' SER . 40.9 Cg_endo -66.69 171.72 10.46 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.416 2.077 . . . . 0.0 109.733 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.635 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.8 Cg_endo -73.67 -2.22 14.73 Favored 'Cis proline' 0 N--CA 1.484 0.962 0 N-CA-C 116.662 1.755 . . . . 0.0 116.662 7.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 33.5 m-85 68.55 72.94 0.28 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 123.691 0.62 . . . . 0.0 109.413 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.635 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 22.5 m-85 -81.2 172.67 13.36 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.459 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -72.58 127.43 32.53 Favored 'General case' 0 CA--C 1.481 -1.691 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.143 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.1 -17.86 53.18 Favored Glycine 0 N--CA 1.406 -3.303 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.656 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.67 144.83 56.67 Favored 'General case' 0 CA--C 1.481 -1.692 0 CA-C-O 121.285 0.564 . . . . 0.0 110.089 177.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 10.2 m -128.11 153.69 46.56 Favored 'General case' 0 N--CA 1.404 -2.739 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.898 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.662 HG21 HG21 ' A' ' 694' ' ' ILE . 46.4 t -135.83 127.4 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.608 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 37.0 mt-10 -84.86 138.01 32.8 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.889 0.852 . . . . 0.0 111.702 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.658 ' HB3' HD22 ' A' ' 697' ' ' LEU . 30.1 m-85 -138.08 128.83 26.8 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 125.487 1.515 . . . . 0.0 107.028 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.438 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 21.7 m-80 -124.69 -163.12 1.14 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 22.4 m -107.39 136.55 47.0 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 23.3 t -66.14 -62.56 1.42 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 123.924 0.765 . . . . 0.0 111.416 -169.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.47 153.13 15.04 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 55.7 m 64.43 13.08 7.85 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 94.4 m-85 -141.27 146.15 36.45 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-O 122.028 0.918 . . . . 0.0 110.169 -175.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.417 ' OG1' HG12 ' A' ' 747' ' ' ILE . 1.0 OUTLIER -110.19 134.95 51.7 Favored 'General case' 0 C--N 1.253 -3.617 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.932 -179.201 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.784 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.4 ttp -82.21 121.77 27.05 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.602 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.51 128.31 74.55 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.27 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.12 -90.51 0.53 Allowed Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.154 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.657 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 22.2 t-80 -144.74 164.39 31.16 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.784 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -118.72 23.75 11.28 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.504 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.608 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 6.3 p -153.11 159.67 42.81 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.97 0.414 . . . . 0.0 111.389 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.509 HG21 HD13 ' A' ' 741' ' ' LEU . 27.8 pt -110.43 166.86 5.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.545 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 739' ' ' THR . 19.4 m -138.41 133.49 32.92 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.724 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 2.1 t -81.13 105.21 12.16 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.306 0.574 . . . . 0.0 109.708 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.97 144.75 22.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.022 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 27.9 m80 71.02 -15.49 0.4 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.982 0.913 . . . . 0.0 113.322 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 118.94 17.99 4.84 Favored Glycine 1 CA--C 1.445 -4.328 0 CA-C-O 121.364 0.424 . . . . 0.0 112.878 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -154.24 177.79 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.39 -3.456 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.519 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 89.8 m95 -90.38 -173.89 3.95 Favored 'General case' 0 C--N 1.266 -3.065 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 732' ' ' THR . 38.8 p -85.06 -155.76 0.23 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.225 0.536 . . . . 0.0 110.257 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.5 OUTLIER -93.83 3.48 55.35 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -168.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.509 HD13 HG21 ' A' ' 731' ' ' ILE . 4.0 mm? 71.6 159.93 0.16 Allowed Pre-proline 0 N--CA 1.481 1.123 0 O-C-N 123.82 0.7 . . . . 0.0 110.404 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.657 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 18.5 Cg_endo -72.94 -177.71 3.07 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 121.673 1.582 . . . . 0.0 111.356 171.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -122.1 125.94 47.29 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.435 ' SG ' HD21 ' A' ' 697' ' ' LEU . 64.7 m -116.7 94.87 4.78 Favored 'General case' 0 CA--C 1.481 -1.689 0 CA-C-O 121.659 0.742 . . . . 0.0 110.554 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.474 ' HB ' HD21 ' A' ' 750' ' ' LEU . 30.7 t -89.16 143.02 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.881 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.616 -177.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.582 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -62.51 4.31 0.16 Allowed 'General case' 0 C--N 1.283 -2.305 0 C-N-CA 125.733 1.613 . . . . 0.0 114.89 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.757 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 65.7 mt 77.37 -17.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 126.156 1.782 . . . . 0.0 111.34 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.7 t70 -79.85 -31.77 40.47 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-N 113.177 -1.829 . . . . 0.0 109.293 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -107.35 19.82 19.77 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.193 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.757 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 85.0 mt -81.46 -177.69 6.62 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 114.547 -1.206 . . . . 0.0 107.898 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.544 ' HE3' ' HA3' ' A' ' 795' ' ' GLY . 27.1 mtpp -98.63 156.4 16.83 Favored 'General case' 0 N--CA 1.386 -3.638 0 CA-C-O 121.954 0.883 . . . . 0.0 108.977 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 752' ' ' LYS . . . . . 0.637 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 43.5 mtpt -105.65 116.82 32.59 Favored 'General case' 1 C--N 1.238 -4.242 0 CA-C-N 112.524 -2.126 . . . . 0.0 108.171 -172.032 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 65.2 m -76.52 132.77 39.75 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.051 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.45 135.0 41.51 Favored 'General case' 0 C--N 1.278 -2.538 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.699 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 755' ' ' SER . . . . . 0.419 ' HB2' ' HE1' ' A' ' 771' ' ' PHE . 47.3 t -60.94 129.34 40.95 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.703 171.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.547 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 41.0 t -73.27 151.04 41.52 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -82.97 -0.38 48.42 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 98.8 mt -112.82 -8.87 13.71 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.552 HG12 HG11 ' A' ' 801' ' ' VAL . 2.2 pp -102.28 150.93 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 122.163 0.982 . . . . 0.0 113.385 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.4 mp -105.04 130.86 55.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.487 0 CA-C-N 113.595 -1.639 . . . . 0.0 107.387 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 777' ' ' ILE . 1.8 mm? -113.28 -176.6 2.93 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.46 ' HB2' HD23 ' A' ' 765' ' ' LEU . 48.1 mt-10 -65.29 165.72 11.18 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.885 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.33 -7.7 44.7 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.501 0.667 . . . . 0.0 111.795 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -4.45 17.35 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.797 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.0 mm? -117.04 -11.71 10.73 Favored 'General case' 0 C--O 1.207 -1.136 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 10.4 mtmp? -70.85 -16.49 62.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.454 0.645 . . . . 0.0 110.228 176.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -78.72 -13.53 59.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.917 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 7.9 tppt? -98.32 126.81 43.98 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 769' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 769' ' ' LYS . 15.3 ptpt -110.37 -19.65 12.89 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 770' ' ' GLU . . . . . 0.637 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 36.4 mt-10 -134.25 107.79 7.87 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.543 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.419 ' HE1' ' HB2' ' A' ' 755' ' ' SER . 79.4 m-85 -93.2 162.71 13.91 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.84 -175.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -101.86 154.78 18.61 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.566 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 28.5 t60 -60.19 144.38 50.21 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.902 0.126 . . . . 0.0 111.038 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 63.7 t30 88.12 3.1 0.31 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 125.445 1.716 . . . . 0.0 111.27 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 775' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 791' ' ' VAL . 86.8 p -73.61 105.75 5.08 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 119.803 -0.759 . . . . 0.0 108.988 177.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.03 90.2 8.27 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 789' ' ' HIS . 7.6 pt -104.55 -170.91 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.562 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.641 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 16.6 ptt180 -142.83 125.61 16.02 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.066 174.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.646 ' CD2' HG13 ' A' ' 801' ' ' VAL . 13.1 p90 -106.87 167.46 9.86 Favored 'General case' 0 C--O 1.257 1.496 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 780' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 780' ' ' ARG . 13.3 ptt180 -155.67 161.82 40.7 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 175.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.639 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 3.1 m -98.95 173.88 6.63 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -101.91 36.25 2.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.479 1.133 . . . . 0.0 109.674 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -176.72 -33.72 0.05 OUTLIER Glycine 0 CA--C 1.473 -2.564 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.639 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 0.4 OUTLIER -96.82 139.72 32.44 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 176.015 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.31 154.41 19.4 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.572 0.701 . . . . 0.0 112.891 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 91.2 154.51 30.67 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.349 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 52.0 m95 -95.85 141.04 29.77 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.471 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -95.42 -31.21 4.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.568 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.495 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 12.0 m170 72.44 118.37 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 124.062 0.945 . . . . 0.0 111.114 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.527 HG21 ' CG2' ' A' ' 801' ' ' VAL . 3.4 t -141.51 153.28 44.8 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.556 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 775' ' ' SER . 38.9 t -114.45 132.91 62.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.712 -176.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.15 115.06 8.92 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.566 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 46.5 mm -114.5 84.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.427 ' C ' ' HB2' ' A' ' 751' ' ' LYS . 6.4 t30 46.92 68.11 0.68 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.845 0.858 . . . . 0.0 111.992 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 795' ' ' GLY . . . . . 0.544 ' HA3' ' HE3' ' A' ' 751' ' ' LYS . . . 72.28 24.09 76.92 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 114.958 -1.019 . . . . 0.0 114.293 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -146.88 168.5 21.3 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.664 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 91.3 m95 -117.24 161.99 18.6 Favored 'General case' 0 C--N 1.266 -3.038 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -150.58 104.56 3.08 Favored Pre-proline 0 C--N 1.296 -1.727 0 O-C-N 123.344 0.402 . . . . 0.0 110.063 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 799' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 36.7 Cg_endo -68.57 140.98 59.77 Favored 'Cis proline' 0 C--O 1.239 0.565 0 C-N-CA 123.993 -1.253 . . . . 0.0 112.306 -1.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.664 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 52.2 mt-10 -49.33 120.71 4.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.876 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.646 HG13 ' CD2' ' A' ' 779' ' ' TYR . 67.7 t -69.6 119.2 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.104 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -141.2 141.19 34.09 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 803' ' ' CYS . . . . . 0.519 ' HB2' HG23 ' A' ' 759' ' ' ILE . 5.0 t -123.47 14.12 9.52 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.391 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.288 -2.099 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.6 179.023 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.599 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.2 m -82.25 -61.97 1.75 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.004 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 134.08 174.56 13.55 Favored Glycine 1 N--CA 1.374 -5.466 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.714 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 29.9 t70 -52.0 135.34 31.04 Favored 'General case' 0 C--N 1.276 -2.589 0 O-C-N 124.803 0.943 . . . . 0.0 111.38 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.589 HG21 HG21 ' A' ' 715' ' ' VAL . 1.3 pp -55.6 150.34 25.95 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.145 -1.389 . . . . 0.0 114.076 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.52 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 65.1 Cg_endo -72.67 -161.62 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.468 2.778 . . . . 0.0 111.321 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -135.82 151.86 50.49 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 717' ' ' PHE . 26.4 tp -92.66 123.22 35.79 Favored 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.893 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 5.4 pt-20 -34.63 -50.78 0.46 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.334 2.253 . . . . 0.0 114.417 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 83.5 m-70 -136.28 28.83 3.07 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -142.17 -156.15 6.7 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.389 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.5 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -140.25 -178.31 5.42 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.003 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -115.72 146.09 42.19 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -74.16 -68.57 0.51 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.337 0.589 . . . . 0.0 110.806 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.4 tt -159.8 138.97 10.99 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.521 ' HB3' HG11 ' A' ' 715' ' ' VAL . 4.1 p -153.44 123.54 6.96 Favored 'General case' 0 N--CA 1.395 -3.197 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 20.6 m -128.08 130.44 23.6 Favored Pre-proline 0 C--N 1.278 -2.539 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.284 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.45 168.59 14.25 Favored 'Trans proline' 0 C--O 1.248 0.976 0 C-N-CA 122.715 2.277 . . . . 0.0 109.716 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.59 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 2.6 Cg_endo -71.64 -11.71 15.77 Favored 'Cis proline' 0 N--CA 1.483 0.892 0 N-CA-C 116.097 1.537 . . . . 0.0 116.097 6.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.714 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 66.7 m-85 68.92 77.77 0.22 Allowed 'General case' 0 C--O 1.248 0.995 0 O-C-N 123.857 0.723 . . . . 0.0 109.643 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.59 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 47.5 m-85 -82.99 171.53 13.73 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.843 0.83 . . . . 0.0 113.204 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.426 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 91.1 m-85 -71.41 132.41 44.77 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.271 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.57 -15.63 55.7 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.1 147.67 46.48 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-O 121.088 0.47 . . . . 0.0 111.547 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 15.8 m -135.57 144.37 46.17 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.999 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.589 HG21 HG21 ' A' ' 694' ' ' ILE . 38.3 t -127.24 138.2 55.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.58 125.27 33.68 Favored 'General case' 0 N--CA 1.425 -1.723 0 O-C-N 124.338 1.024 . . . . 0.0 111.073 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.6 ' HB3' HD22 ' A' ' 697' ' ' LEU . 21.9 m-85 -128.21 118.12 22.76 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 125.785 1.634 . . . . 0.0 107.655 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.5 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 17.7 m-80 -120.41 -162.1 0.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 5.5 m -112.33 134.37 53.91 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 720' ' ' SER . . . . . 0.414 ' HA ' ' CE2' ' A' ' 701' ' ' TRP . 22.4 t -61.56 -58.54 7.72 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.216 0.532 . . . . 0.0 110.568 -172.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -174.18 166.2 4.14 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 68.4 m 68.33 0.63 2.58 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.239 0.962 . . . . 0.0 112.051 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' A' ' 719' ' ' CYS . 96.8 m-85 -137.22 144.83 43.01 Favored 'General case' 0 N--CA 1.395 -3.196 0 C-N-CA 124.243 1.017 . . . . 0.0 109.133 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.484 HG21 HD21 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -110.36 134.66 52.08 Favored 'General case' 0 C--N 1.254 -3.58 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.219 -177.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.497 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.0 ttp -84.62 122.81 29.58 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 124.236 1.015 . . . . 0.0 109.237 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 726' ' ' ILE . 34.5 mm -111.28 122.81 66.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.822 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.728 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 99.44 -87.62 0.77 Allowed Glycine 0 N--CA 1.42 -2.422 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.634 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.476 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 48.9 p-80 -135.8 179.13 6.53 Favored 'General case' 0 N--CA 1.393 -3.286 0 C-N-CA 124.113 0.965 . . . . 0.0 108.478 -173.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.497 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.0 ppt_? -135.7 8.99 3.34 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 32.5 m -130.82 155.1 47.27 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.49 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 714' ' ' SER . 36.5 pt -110.4 160.66 9.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.24 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 739' ' ' THR . 26.9 m -135.75 133.71 38.26 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.192 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 733' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 7.1 t -84.87 103.88 14.33 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.86 145.87 23.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.776 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 72.69 -49.93 0.7 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.63 1.172 . . . . 0.0 111.919 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 158.4 24.26 0.03 OUTLIER Glycine 0 C--N 1.29 -1.991 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.367 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.4 p -160.01 157.88 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.52 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 93.5 m95 -78.39 170.68 16.24 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 24.8 p -74.91 -163.5 0.23 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.389 1.09 . . . . 0.0 113.528 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.0 OUTLIER -68.88 -23.9 64.27 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -170.048 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.3 mm? 81.95 148.22 0.11 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 124.786 1.304 . . . . 0.0 109.22 -173.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 19.6 Cg_endo -72.85 -175.56 1.95 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.928 1.752 . . . . 0.0 112.885 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.411 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 54.0 tt0 -119.78 126.37 50.86 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 78.5 m -118.46 111.8 19.13 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.275 0.559 . . . . 0.0 109.799 177.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.47 ' CG1' ' HG3' ' A' ' 749' ' ' LYS . 41.7 t -100.91 145.14 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.548 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.99 4.25 0.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.184 1.393 . . . . 0.0 113.672 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.587 ' HA ' HD13 ' A' ' 750' ' ' LEU . 32.0 mt 80.11 -26.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 126.302 1.841 . . . . 0.0 111.801 173.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 746' ' ' ALA . 38.7 t70 -82.95 -25.31 32.45 Favored 'General case' 0 C--N 1.248 -3.841 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.375 -172.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.47 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 9.4 ptmt -112.65 34.91 4.09 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.72 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.817 ' HG ' ' HB2' ' A' ' 794' ' ' ASN . 0.8 OUTLIER -78.71 -166.36 0.87 Allowed 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.092 176.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.442 ' H ' ' HA ' ' A' ' 794' ' ' ASN . 30.6 mtpp -121.34 -178.66 3.84 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 121.542 0.687 . . . . 0.0 109.625 -174.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -114.43 132.94 56.08 Favored 'General case' 0 C--N 1.262 -3.23 0 CA-C-N 112.991 -1.913 . . . . 0.0 107.804 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 753' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 58.3 m -90.49 174.29 7.62 Favored 'General case' 0 C--N 1.244 -4.0 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.391 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 754' ' ' LYS . . . . . 0.417 ' HB2' ' HE3' ' A' ' 754' ' ' LYS . 15.7 ptmt -144.15 152.39 40.84 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.173 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 20.4 p -62.52 126.06 26.04 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.69 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.574 ' HB2' HG13 ' A' ' 759' ' ' ILE . 11.3 m -72.85 136.37 45.32 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -72.09 -4.4 28.72 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 88.6 mt -105.6 -21.0 13.29 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.032 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.596 HG12 HG11 ' A' ' 801' ' ' VAL . 2.8 pp -98.48 171.31 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.077 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.31 136.44 54.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 777' ' ' ILE . 80.4 mt -107.11 177.0 4.98 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.44 ' HB2' HD23 ' A' ' 765' ' ' LEU . 43.7 mt-10 -62.06 162.04 9.95 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.986 0.422 . . . . 0.0 110.736 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -70.18 -9.62 56.28 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.464 0.649 . . . . 0.0 111.02 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -109.86 -0.5 18.29 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.029 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.1 mm? -123.67 -14.62 7.23 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' A' ' 761' ' ' LEU . 29.3 mtmm -68.37 -19.55 64.64 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.123 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -78.95 -17.27 55.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.139 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 8.4 tppt? -85.99 107.98 18.01 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 769' ' ' LYS . . . . . 0.522 ' HG3' ' HG2' ' A' ' 770' ' ' GLU . 8.5 ptpp? -74.23 -32.65 63.07 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.688 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 770' ' ' GLU . . . . . 0.522 ' HG2' ' HG3' ' A' ' 769' ' ' LYS . 22.7 mm-40 -131.96 139.52 48.7 Favored 'General case' 0 CA--C 1.478 -1.799 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.439 ' CZ ' HD13 ' A' ' 761' ' ' LEU . 90.8 m-85 -112.45 134.0 54.22 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.724 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -86.21 155.71 20.6 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.675 ' HB2' HD23 ' A' ' 750' ' ' LEU . 18.8 p-80 -49.7 143.98 6.65 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.117 0.967 . . . . 0.0 112.052 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 19.1 m120 67.76 25.75 7.94 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 124.211 1.004 . . . . 0.0 112.781 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 69.0 m -93.86 109.12 20.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.596 ' HA ' HG12 ' A' ' 791' ' ' VAL . 2.5 m-20 -83.46 114.32 21.39 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.45 HD12 HD22 ' A' ' 761' ' ' LEU . 5.8 pt -127.38 -174.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.486 0.66 . . . . 0.0 111.006 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 98.1 mtt180 -134.29 124.52 25.99 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.535 ' CD2' HG13 ' A' ' 801' ' ' VAL . 13.2 p90 -111.98 166.77 10.93 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 171.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -152.57 160.13 43.23 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 3.4 m -95.18 163.39 13.3 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.144 0.497 . . . . 0.0 112.271 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -68.33 -27.9 66.68 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.825 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -110.23 9.09 31.13 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.961 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 1.8 mptm? -121.2 113.2 19.64 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.904 0.383 . . . . 0.0 110.469 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -90.87 87.51 6.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.571 0.7 . . . . 0.0 109.242 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 166.14 145.4 4.44 Favored Glycine 0 C--N 1.291 -1.941 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.553 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 54.4 m95 -96.1 142.86 27.79 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.533 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -96.7 -29.69 3.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.517 -176.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.467 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 1.1 m-70 76.77 128.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.565 1.146 . . . . 0.0 109.739 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.577 HG21 ' CG2' ' A' ' 801' ' ' VAL . 2.7 t -153.75 159.9 42.1 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.822 HG22 ' HB3' ' A' ' 798' ' ' ASP . 5.9 m -124.36 153.13 30.65 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.505 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 43.2 t -80.95 116.21 20.81 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.407 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 51.0 mm -121.05 86.2 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.817 ' HB2' ' HG ' ' A' ' 750' ' ' LEU . 7.4 t30 54.01 69.06 0.76 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.13 0.967 . . . . 0.0 111.508 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.12 66.29 Favored Glycine 0 C--N 1.297 -1.635 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.49 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -140.54 168.43 19.83 Favored 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.69 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 82.7 m95 -116.26 155.51 28.23 Favored 'General case' 0 C--N 1.26 -3.31 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 798' ' ' ASP . . . . . 0.822 ' HB3' HG22 ' A' ' 791' ' ' VAL . 26.0 t70 -133.3 100.47 13.98 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 119.567 -0.254 . . . . 0.0 110.973 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 799' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 44.3 Cg_endo -73.07 145.0 82.82 Favored 'Cis proline' 0 C--O 1.24 0.59 0 C-N-CA 124.377 -1.093 . . . . 0.0 112.153 -1.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.69 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 27.0 tt0 -48.59 122.15 5.25 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.014 0.821 . . . . 0.0 111.249 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.596 HG11 HG12 ' A' ' 759' ' ' ILE . 64.4 t -74.09 120.68 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.42 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -151.96 130.4 12.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 10.1 t -101.6 -25.2 13.97 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.244 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.414 -2.247 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.854 -178.458 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 18.9 m -67.54 -80.69 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 123.326 0.391 . . . . 0.0 111.729 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 156.94 164.15 13.23 Favored Glycine 0 N--CA 1.399 -3.807 0 N-CA-C 106.845 -2.502 . . . . 0.0 106.845 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.818 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 36.5 t70 -45.68 128.91 8.85 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 124.069 0.948 . . . . 0.0 112.24 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.806 HG21 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -50.06 148.18 6.2 Favored Pre-proline 0 N--CA 1.429 -1.491 0 O-C-N 125.042 1.464 . . . . 0.0 114.294 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.412 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 36.6 Cg_endo -67.46 -164.33 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.123 2.549 . . . . 0.0 112.308 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -137.17 141.15 42.18 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 717' ' ' PHE . 25.0 tp -89.01 123.35 33.25 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.729 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -42.38 -48.53 5.12 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 126.723 2.009 . . . . 0.0 115.079 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -134.54 24.99 3.75 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.446 0.641 . . . . 0.0 110.174 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -134.02 -145.69 5.33 Favored Glycine 0 C--N 1.288 -2.11 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.272 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.447 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -154.23 172.16 18.06 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -104.23 150.37 24.47 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -81.44 -77.9 0.2 Allowed 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.674 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 67.0 tp -172.2 129.84 0.6 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.268 0.227 . . . . 0.0 110.412 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.499 ' HB2' HG13 ' A' ' 715' ' ' VAL . 48.2 t -141.2 -50.65 0.43 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.856 175.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 35.9 p 58.03 155.45 0.09 OUTLIER Pre-proline 0 CA--C 1.57 1.747 0 C-N-CA 125.392 1.477 . . . . 0.0 113.018 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.551 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 60.9 Cg_endo -66.51 174.91 5.69 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.027 1.818 . . . . 0.0 111.256 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.551 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.0 Cg_endo -79.07 -9.25 37.86 Favored 'Cis proline' 0 N--CA 1.485 1.013 0 N-CA-C 115.176 1.183 . . . . 0.0 115.176 5.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.818 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 77.8 m-85 72.59 76.17 0.15 Allowed 'General case' 0 C--N 1.316 -0.872 0 O-C-N 124.173 0.921 . . . . 0.0 110.242 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.432 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 25.0 m-85 -79.99 167.6 20.26 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.868 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.498 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 64.9 m-85 -72.77 134.81 45.12 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.042 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.61 -4.95 66.78 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.21 149.43 35.51 Favored 'General case' 0 CA--C 1.477 -1.832 0 CA-C-O 121.361 0.6 . . . . 0.0 110.853 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 12.7 m -129.58 153.38 48.11 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.806 HG21 HG21 ' A' ' 694' ' ' ILE . 24.8 t -136.48 142.35 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.656 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.49 136.67 37.58 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-O 121.532 0.682 . . . . 0.0 110.483 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.617 ' HB3' HD22 ' A' ' 697' ' ' LEU . 32.1 m-85 -135.4 118.89 16.88 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.447 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 14.2 m-80 -121.91 -163.8 1.1 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 21.6 m -116.02 141.39 48.18 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 38.8 t -64.24 -92.14 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 123.841 0.713 . . . . 0.0 111.22 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -139.09 153.6 48.05 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 74.8 m 71.62 1.51 3.9 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.491 1.119 . . . . 0.0 113.164 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.561 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.7 m-85 -132.17 143.55 50.05 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-O 121.73 0.776 . . . . 0.0 109.585 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.642 HG21 HD21 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -111.71 141.95 44.67 Favored 'General case' 0 C--N 1.253 -3.619 0 CA-C-N 113.097 -1.865 . . . . 0.0 111.869 -178.159 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.716 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 2.8 ttp -85.64 122.91 30.41 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.476 1.51 . . . . 0.0 108.977 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 50.8 mm -115.77 129.43 72.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.378 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 93.85 -85.17 1.06 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.329 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.579 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -125.36 172.41 9.63 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.716 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -135.37 18.52 3.38 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 170.203 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 34.7 p -144.92 158.91 43.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.285 0.564 . . . . 0.0 110.919 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.5 pt -123.31 162.82 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.345 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 739' ' ' THR . 24.0 m -136.15 133.75 37.53 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.204 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 733' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.4 t -85.31 101.21 12.36 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -136.9 140.08 43.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.903 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 64.38 6.39 3.04 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.94 18.43 31.99 Favored Glycine 0 CA--C 1.494 -1.279 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.044 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.18 148.62 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.439 ' CZ3' HG23 ' A' ' 715' ' ' VAL . 93.5 m95 -78.95 169.71 17.8 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.037 173.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 732' ' ' THR . 38.9 p -81.16 -166.9 1.25 Allowed 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 121.857 0.836 . . . . 0.0 112.825 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.25 -4.82 23.67 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -168.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.402 HD13 HG21 ' A' ' 731' ' ' ILE . 4.3 mm? 68.16 158.6 0.15 Allowed Pre-proline 0 N--CA 1.493 1.722 0 CA-C-O 120.998 0.428 . . . . 0.0 111.256 -175.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.579 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 44.9 Cg_endo -81.92 178.04 6.82 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.854 1.703 . . . . 0.0 111.188 170.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.544 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.6 tt0 -120.41 115.15 22.95 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.571 ' SG ' HD21 ' A' ' 697' ' ' LEU . 94.2 m -97.94 108.09 20.72 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.609 0.719 . . . . 0.0 110.71 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' A' ' 747' ' ' ILE . 26.8 t -100.93 141.95 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.596 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.525 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.561 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.39 4.11 0.58 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 125.913 1.685 . . . . 0.0 113.455 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.753 ' HA ' HD22 ' A' ' 750' ' ' LEU . 60.3 mt 74.76 -14.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 126.238 1.815 . . . . 0.0 111.028 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 746' ' ' ALA . 19.2 t70 -80.42 -30.55 37.67 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.648 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.426 ' NZ ' ' HB3' ' A' ' 749' ' ' LYS . 0.2 OUTLIER -95.38 11.89 31.17 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.711 -1.586 . . . . 0.0 108.706 -176.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.753 HD22 ' HA ' ' A' ' 747' ' ' ILE . 0.4 OUTLIER -82.41 -168.94 2.19 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.737 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.539 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 31.7 mmmt -126.13 146.81 49.79 Favored 'General case' 0 N--CA 1.392 -3.348 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -103.72 122.39 44.95 Favored 'General case' 1 C--N 1.242 -4.068 0 CA-C-N 112.92 -1.945 . . . . 0.0 107.781 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 753' ' ' CYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 55.6 m -71.91 157.48 37.78 Favored 'General case' 0 C--N 1.253 -3.61 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.314 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -127.77 145.4 50.93 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 48.2 t -56.63 127.67 32.54 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.286 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.545 ' HB3' HG12 ' A' ' 759' ' ' ILE . 26.3 t -76.52 160.53 29.39 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.401 0.619 . . . . 0.0 110.358 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -86.92 -4.1 59.14 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.322 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 758' ' ' LEU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 803' ' ' CYS . 2.8 mm? -110.52 -2.71 16.35 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.966 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.687 HG22 ' SG ' ' A' ' 803' ' ' CYS . 28.6 pt -109.94 156.79 10.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.852 -173.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 760' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.6 mp -121.27 127.46 75.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.555 HD11 HD12 ' A' ' 759' ' ' ILE . 2.0 mm? -105.37 -178.71 3.73 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.461 ' HB2' HD23 ' A' ' 765' ' ' LEU . 38.1 mt-10 -68.6 173.97 4.62 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.79 -17.81 64.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.964 -0.46 . . . . 0.0 111.57 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 764' ' ' HIS . . . . . 0.501 ' HB2' HD22 ' A' ' 765' ' ' LEU . 6.3 m-70 -87.26 -35.0 18.73 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 761' ' ' LEU . 2.6 mm? -90.97 -19.47 23.21 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.288 -171.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -71.04 -16.5 62.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.689 0.757 . . . . 0.0 109.25 170.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.87 16.83 22.5 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.367 1.08 . . . . 0.0 108.464 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.409 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 14.5 tppt? -111.71 111.76 22.97 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 769' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' A' ' 769' ' ' LYS . 26.8 ttpp -73.33 -42.59 62.14 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.389 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -139.53 143.4 37.41 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.105 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 753' ' ' CYS . 83.4 m-85 -113.48 135.96 53.31 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.45 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -86.52 160.73 18.88 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.687 ' HB3' HD23 ' A' ' 750' ' ' LEU . 65.7 t60 -61.84 151.27 34.87 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.382 0.134 . . . . 0.0 110.667 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 4.3 m120 78.44 14.19 1.4 Allowed 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 123.987 0.915 . . . . 0.0 112.453 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 44.3 m -91.78 113.26 25.49 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -90.65 111.4 22.71 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.497 HD12 HD12 ' A' ' 761' ' ' LEU . 10.2 pt -122.81 179.3 2.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 121.586 0.708 . . . . 0.0 109.165 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.685 ' HA ' ' HA ' ' A' ' 789' ' ' HIS . 20.7 ptt180 -133.25 120.7 21.44 Favored 'General case' 0 N--CA 1.399 -3.023 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.632 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 2.7 p90 -108.21 167.61 9.89 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 780' ' ' ARG . . . . . 0.5 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 32.9 ptt180 -146.34 156.05 43.06 Favored 'General case' 0 C--N 1.262 -3.204 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 73.7 m -100.47 134.42 43.45 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.53 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 782' ' ' ARG . . . . . 0.579 ' HB3' HD11 ' A' ' 760' ' ' ILE . 36.7 ptt180 -59.57 -48.95 79.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -85.92 6.0 82.3 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.319 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.7 mptt -110.02 -47.75 3.28 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 70.19 129.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.238 1.415 . . . . 0.0 111.771 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 111.95 144.96 9.67 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -175.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 25.9 m95 -93.93 144.23 25.63 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.632 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -100.94 -32.23 3.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.628 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 11.5 m170 73.95 129.93 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 124.555 1.142 . . . . 0.0 110.091 -175.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 3.2 t -151.8 159.18 44.0 Favored 'General case' 0 C--N 1.274 -2.675 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.771 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.17 134.77 62.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.985 -176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.09 114.09 7.91 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.521 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 50.8 mm -116.94 87.92 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 124.745 1.218 . . . . 0.0 109.21 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.539 ' C ' ' HB2' ' A' ' 751' ' ' LYS . 0.5 OUTLIER 46.74 66.01 1.08 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.762 0.825 . . . . 0.0 112.353 175.473 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 69.99 27.88 72.48 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.341 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -151.03 166.44 30.7 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 98.1 m95 -110.81 160.74 16.47 Favored 'General case' 0 C--N 1.256 -3.493 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -147.68 103.3 3.68 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.05 138.22 46.1 Favored 'Cis proline' 0 C--O 1.246 0.916 0 C-N-CA 123.956 -1.268 . . . . 0.0 112.325 1.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.606 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 4.2 tp10 -59.58 126.6 28.24 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.304 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.02 129.28 36.1 Favored 'Isoleucine or valine' 1 N--CA 1.358 -5.054 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.584 -172.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -153.69 106.51 2.9 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 803' ' ' CYS . . . . . 0.687 ' SG ' HG22 ' A' ' 759' ' ' ILE . 85.7 m -109.02 4.05 22.76 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.119 0.485 . . . . 0.0 111.73 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 804' ' ' SER . . . . . 0.51 ' HB2' ' HG ' ' A' ' 758' ' ' LEU . 24.0 t . . . . . 0 N--CA 1.423 -1.777 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 12.6 m -72.83 -59.4 2.73 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.908 0.385 . . . . 0.0 110.768 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 130.51 179.79 16.33 Favored Glycine 1 N--CA 1.367 -5.923 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -40.51 130.12 2.39 Favored 'General case' 0 C--N 1.278 -2.507 0 C-N-CA 126.348 1.859 . . . . 0.0 111.747 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.587 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -61.94 149.05 86.86 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.64 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.496 ' HG3' HD21 ' A' ' 741' ' ' LEU . 59.7 Cg_endo -71.98 -161.62 0.1 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.475 2.784 . . . . 0.0 111.276 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -136.31 149.74 48.57 Favored 'General case' 0 N--CA 1.408 -2.555 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' A' ' 717' ' ' PHE . 23.3 tp -93.82 123.37 37.12 Favored 'General case' 0 C--N 1.255 -3.522 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.073 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 5.0 pt-20 -34.24 -53.43 0.49 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.215 1.806 . . . . 0.0 115.545 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.451 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 82.4 m-70 -135.98 27.83 3.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -128.7 -149.96 7.07 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 119.605 -1.284 . . . . 0.0 112.096 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.434 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -146.23 175.04 10.8 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -177.121 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.12 133.55 49.71 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 14.0 mm100 -74.42 -61.76 1.76 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.054 0.454 . . . . 0.0 111.4 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.7 tt -169.65 138.29 1.86 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 103.486 -2.783 . . . . 0.0 103.486 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.52 ' HA ' HG13 ' A' ' 715' ' ' VAL . 59.2 p -115.59 -41.76 3.21 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -169.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 33.5 m 62.3 95.58 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 125.094 1.358 . . . . 0.0 113.887 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.15 172.55 13.75 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.297 1.998 . . . . 0.0 108.745 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.405 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 16.5 Cg_exo -71.16 -5.15 10.96 Favored 'Cis proline' 0 N--CA 1.506 2.226 0 CA-C-N 120.825 1.33 . . . . 0.0 115.27 4.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.456 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 56.9 m-85 78.98 69.99 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 O-C-N 124.876 1.36 . . . . 0.0 109.154 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.405 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 58.3 m-85 -77.46 170.4 16.63 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.941 -1.482 . . . . 0.0 112.589 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -73.39 129.63 38.41 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.053 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.48 -4.87 51.26 Favored Glycine 0 N--CA 1.421 -2.363 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.352 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.86 151.19 26.12 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 120.878 0.371 . . . . 0.0 110.924 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 3.8 m -131.29 156.07 46.08 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.587 HG21 HG21 ' A' ' 694' ' ' ILE . 52.7 t -137.64 129.74 40.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 47.0 mt-10 -77.35 134.46 38.47 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 123.988 0.805 . . . . 0.0 111.038 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.655 ' HB3' HD22 ' A' ' 697' ' ' LEU . 35.8 m-85 -139.94 112.94 8.16 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 125.026 1.33 . . . . 0.0 107.584 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.434 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 16.5 m-80 -121.07 -164.51 1.13 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 7.1 m -109.7 133.84 52.66 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 2.4 m -53.07 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.751 0.82 . . . . 0.0 111.137 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -169.31 158.73 8.34 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 66.0 m 69.73 13.36 8.12 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.203 0.939 . . . . 0.0 111.563 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.699 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.4 m-85 -143.74 145.14 32.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 C-N-CA 124.733 1.213 . . . . 0.0 107.752 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.495 ' HB ' HD11 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -113.74 136.41 52.88 Favored 'General case' 0 C--N 1.257 -3.44 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.988 -177.016 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.2 ttp -81.76 120.22 24.86 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.848 1.259 . . . . 0.0 109.516 -175.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 45.4 mm -113.1 121.25 64.96 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.222 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 87.49 -82.13 1.61 Allowed Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 114.856 -1.065 . . . . 0.0 114.121 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.7 m80 -114.3 173.9 6.22 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 123.797 0.839 . . . . 0.0 110.569 -173.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.482 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -146.14 15.95 1.35 Allowed 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 121.276 0.56 . . . . 0.0 109.647 172.408 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 37.5 m -152.59 162.1 41.68 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 121.554 -0.716 . . . . 0.0 110.291 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.5 pt -123.84 162.23 25.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.299 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.7 m -133.31 134.18 43.52 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 123.522 0.514 . . . . 0.0 110.841 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 5.0 t -85.24 106.42 16.65 Favored 'General case' 0 C--O 1.256 1.429 0 CA-C-O 121.694 0.759 . . . . 0.0 109.389 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.32 142.17 35.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.618 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 72.87 -53.47 0.7 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.726 1.21 . . . . 0.0 111.367 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 160.39 26.29 0.02 OUTLIER Glycine 0 C--N 1.288 -2.117 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 24.2 t -151.25 154.4 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 -173.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.432 ' HZ2' ' HB3' ' A' ' 709' ' ' TYR . 95.8 m95 -78.98 -178.85 6.31 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 18.3 p -84.69 -158.5 0.35 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.347 0.594 . . . . 0.0 112.253 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.3 pp0? -81.56 -11.45 59.15 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.496 HD21 ' HG3' ' A' ' 695' ' ' PRO . 4.4 mm? 72.17 137.69 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 30.8 Cg_endo -66.07 -179.44 1.41 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.773 2.315 . . . . 0.0 112.729 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.575 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 53.3 tt0 -124.45 137.75 54.41 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.519 ' SG ' HD21 ' A' ' 697' ' ' LEU . 58.6 m -123.92 98.75 5.94 Favored 'General case' 0 CA--C 1.466 -2.273 0 CA-C-O 121.586 0.708 . . . . 0.0 109.642 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.438 ' HB ' HD21 ' A' ' 750' ' ' LEU . 32.1 t -86.85 140.73 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.059 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.699 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.14 4.83 0.61 Allowed 'General case' 0 C--N 1.274 -2.704 0 C-N-CA 125.188 1.395 . . . . 0.0 114.112 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.85 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 32.3 mt 75.62 -17.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 125.626 1.57 . . . . 0.0 111.428 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 746' ' ' ALA . 8.4 t70 -76.64 -32.35 57.96 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 125.671 1.588 . . . . 0.0 109.124 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -103.63 12.51 34.79 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.216 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.85 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 67.5 mt -76.77 148.82 36.43 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.39 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.542 ' HD3' ' ND2' ' A' ' 794' ' ' ASN . 55.7 mtpt -90.04 -170.25 2.72 Favored 'General case' 0 C--N 1.261 -3.269 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.011 -172.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -120.26 126.8 51.5 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 113.352 -1.749 . . . . 0.0 106.477 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 35.9 m -87.77 150.59 23.48 Favored 'General case' 0 C--N 1.249 -3.763 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.061 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -116.81 139.84 50.12 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 755' ' ' SER . . . . . 0.485 ' HB3' HD11 ' A' ' 761' ' ' LEU . 14.7 p -61.54 139.58 58.23 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.237 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.665 ' HB2' HG13 ' A' ' 759' ' ' ILE . 20.3 m -78.02 149.21 34.06 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -91.95 7.95 39.76 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 112.223 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 758' ' ' LEU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 803' ' ' CYS . 4.3 mm? -106.98 -9.72 16.17 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.873 174.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.665 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.7 pp -109.0 152.11 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.74 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 760' ' ' ILE . . . . . 0.449 ' HB ' ' CG ' ' A' ' 780' ' ' ARG . 3.5 mp -109.18 131.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.769 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 44.9 mt -103.63 178.82 4.45 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.51 168.7 8.68 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.26 -22.29 64.69 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.752 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -79.98 -42.3 24.19 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.696 HD22 ' HE2' ' A' ' 771' ' ' PHE . 35.0 mt -83.03 -19.78 36.29 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.003 -1.908 . . . . 0.0 113.102 -167.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -70.81 -6.38 37.42 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.352 0.596 . . . . 0.0 111.121 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.48 15.38 27.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.421 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 6.2 tppt? -122.61 105.87 10.48 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -75.78 -45.6 35.35 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -125.14 131.31 53.27 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.048 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.769 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 40.2 m-85 -103.0 164.89 11.34 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.448 -175.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -104.74 142.14 35.23 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.336 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.555 ' HD2' HD12 ' A' ' 750' ' ' LEU . 32.6 p-80 -41.37 140.1 0.93 Allowed 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.825 1.25 . . . . 0.0 113.716 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 25.1 m120 70.4 23.25 4.99 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 125.171 1.389 . . . . 0.0 112.965 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 22.0 t -96.11 121.75 38.22 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -92.7 104.11 16.41 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.631 HG21 ' CE2' ' A' ' 771' ' ' PHE . 4.5 pt -114.15 -173.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.972 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 1.6 ptt180 -143.77 127.93 17.63 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.0 174.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.471 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 6.8 p90 -117.22 174.94 5.84 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 177.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 780' ' ' ARG . . . . . 0.449 ' CG ' ' HB ' ' A' ' 760' ' ' ILE . 10.6 ptm180 -153.87 170.58 20.66 Favored 'General case' 0 N--CA 1.407 -2.62 0 O-C-N 124.374 1.047 . . . . 0.0 108.447 177.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 49.7 t -100.47 161.46 13.59 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -73.74 -21.51 60.18 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.938 0.399 . . . . 0.0 109.942 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -93.03 -4.99 64.45 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.214 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 13.7 mptt -120.8 107.9 13.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 785' ' ' GLU . . . . . 0.439 ' HA ' ' NH2' ' A' ' 780' ' ' ARG . 12.2 tp10 -81.93 99.9 9.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 160.09 -165.91 34.94 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 107.665 -2.174 . . . . 0.0 107.665 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.585 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 61.4 m95 -139.72 146.62 39.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.64 1.22 . . . . 0.0 109.665 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.471 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -100.29 -34.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.456 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 12.8 m170 77.24 135.15 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.622 1.169 . . . . 0.0 110.452 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.446 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.8 t -158.57 157.58 32.27 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.091 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.5 136.84 55.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 792' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 45.8 t -71.23 107.53 4.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.631 0.729 . . . . 0.0 109.482 177.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.3 mm -113.89 83.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.165 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.42 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.588 ' HB2' HD22 ' A' ' 750' ' ' LEU . 10.8 t30 58.76 66.34 1.08 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 122.403 1.097 . . . . 0.0 111.175 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 62.03 24.31 64.81 Favored Glycine 0 C--N 1.299 -1.478 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.488 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -145.02 166.27 25.79 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.435 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.5 m95 -111.67 158.08 19.7 Favored 'General case' 0 C--N 1.255 -3.54 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -148.32 107.02 3.59 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.36 142.54 66.8 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.971 -1.262 . . . . 0.0 113.074 0.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.435 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.6 mt-10 -55.54 117.03 3.23 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.406 174.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.446 ' CG1' HG21 ' A' ' 790' ' ' THR . 7.2 m -70.11 138.2 22.5 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.171 0 C-N-CA 124.667 1.187 . . . . 0.0 112.519 -173.254 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -153.66 138.76 17.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.566 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 803' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 758' ' ' LEU . 49.7 t -125.22 -22.92 4.28 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.975 0.893 . . . . 0.0 108.886 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.423 -1.808 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.482 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 13.7 m -93.81 -167.39 1.68 Allowed 'General case' 0 C--N 1.25 -3.735 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . -118.12 -156.23 10.22 Favored Glycine 1 N--CA 1.39 -4.386 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.19 142.36 57.7 Favored 'General case' 0 C--N 1.278 -2.507 0 O-C-N 124.717 0.892 . . . . 0.0 108.753 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.597 HG21 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -63.68 151.7 87.96 Favored Pre-proline 0 C--N 1.284 -2.25 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.928 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.488 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 55.8 Cg_endo -71.14 -162.15 0.1 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.074 2.516 . . . . 0.0 112.925 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.17 158.84 43.45 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.605 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.8 OUTLIER -98.28 134.61 41.07 Favored 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.583 177.188 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -56.24 -37.97 70.47 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -144.65 29.54 1.24 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.605 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -140.0 -138.92 3.68 Favored Glycine 0 C--N 1.305 -1.141 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.074 -176.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.405 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -159.09 179.83 8.68 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.394 0.678 . . . . 0.0 109.403 -179.022 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -114.22 144.58 42.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -71.41 -68.31 0.46 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.353 0.597 . . . . 0.0 110.861 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.9 tt -162.87 133.4 4.65 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.481 ' HB3' HG11 ' A' ' 715' ' ' VAL . 0.4 OUTLIER -137.1 114.0 10.51 Favored 'General case' 0 N--CA 1.401 -2.88 0 CA-C-O 121.747 0.784 . . . . 0.0 109.924 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -103.41 124.07 39.42 Favored Pre-proline 0 C--N 1.273 -2.749 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.447 -174.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.451 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 56.8 Cg_endo -66.45 172.49 9.03 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.495 2.13 . . . . 0.0 109.628 175.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.475 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.1 Cg_exo -75.21 -4.36 21.2 Favored 'Cis proline' 0 CA--C 1.497 -1.343 0 CA-C-N 119.801 0.965 . . . . 0.0 114.487 5.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.408 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 57.7 m-85 74.74 78.73 0.11 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 124.936 1.398 . . . . 0.0 108.488 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 22.4 m-85 -82.41 172.13 13.4 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -73.75 125.85 29.04 Favored 'General case' 0 CA--C 1.485 -1.523 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.29 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.75 -5.91 51.48 Favored Glycine 0 N--CA 1.411 -3.001 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.086 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.84 154.06 42.48 Favored 'General case' 0 C--O 1.251 1.179 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 19.8 m -140.21 143.64 36.15 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.846 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.597 HG21 HG21 ' A' ' 694' ' ' ILE . 47.0 t -131.54 137.08 56.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -85.84 135.21 33.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.966 0.889 . . . . 0.0 109.52 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -134.76 114.95 13.17 Favored 'General case' 0 C--N 1.268 -2.96 0 C-N-CA 126.395 1.878 . . . . 0.0 108.069 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.405 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 17.2 m-80 -120.84 -165.71 1.25 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 4.6 m -115.62 134.73 54.77 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.3 m -56.95 -80.5 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 O-C-N 124.166 0.916 . . . . 0.0 111.256 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 721' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 722' ' ' SER . 48.0 mt-10 -154.16 161.35 41.92 Favored 'General case' 0 CA--C 1.472 -2.047 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 58.0 m 70.63 7.24 6.14 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 124.723 1.264 . . . . 0.0 111.948 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.1 m-85 -139.72 144.56 37.56 Favored 'General case' 0 N--CA 1.4 -2.956 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.1 m -113.07 140.7 47.64 Favored 'General case' 0 C--N 1.246 -3.908 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.637 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.57 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.2 ttp -85.86 115.88 23.77 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.533 1.133 . . . . 0.0 108.853 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.0 mm -113.15 130.17 67.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.419 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 87.84 -74.65 2.17 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.914 -1.039 . . . . 0.0 114.164 173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -128.03 174.35 9.28 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -174.215 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.57 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -140.44 10.51 2.29 Favored 'General case' 0 C--O 1.201 -1.47 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 1.6 m -141.59 168.35 19.99 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.2 pt -129.32 161.09 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 739' ' ' THR . 5.8 m -135.85 139.17 43.19 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 733' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 44.0 t -94.22 116.24 28.62 Favored 'General case' 0 N--CA 1.407 -2.611 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.336 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.3 pp -144.26 147.43 19.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 C-N-CA 125.403 1.481 . . . . 0.0 108.168 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 64.18 15.04 9.07 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 86.59 17.59 59.95 Favored Glycine 0 CA--C 1.505 -0.546 0 C-N-CA 121.628 -0.32 . . . . 0.0 112.84 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.2 p -153.06 156.97 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.488 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 88.7 m95 -78.98 169.11 18.71 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 120.988 0.423 . . . . 0.0 110.16 175.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 732' ' ' THR . 21.8 p -73.48 -163.35 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.995 0.902 . . . . 0.0 112.845 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.442 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 5.1 pm0 -73.03 -12.95 61.11 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 124.772 1.229 . . . . 0.0 113.831 -170.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.4 mm? 73.28 149.96 0.13 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 123.921 0.763 . . . . 0.0 111.025 -175.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 42.6 Cg_endo -73.57 175.87 10.09 Favored 'Trans proline' 0 C--O 1.253 1.231 0 C-N-CA 121.761 1.64 . . . . 0.0 110.96 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -126.47 107.58 10.39 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 724' ' ' THR . 86.9 m -91.0 113.27 25.49 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.078 175.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.43 ' HB ' HD21 ' A' ' 750' ' ' LEU . 49.6 t -100.58 144.08 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.34 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.02 6.8 0.34 Allowed 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 125.973 1.709 . . . . 0.0 114.313 -175.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.825 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 55.4 mt 75.15 -19.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 125.663 1.585 . . . . 0.0 112.03 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.5 t70 -73.39 -34.09 65.35 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.671 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.427 ' HB3' ' HE3' ' A' ' 749' ' ' LYS . 0.0 OUTLIER -114.11 29.93 7.65 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.859 -175.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.825 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 91.1 mt -83.32 -175.72 5.97 Favored 'General case' 0 N--CA 1.407 -2.609 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -105.92 147.09 29.17 Favored 'General case' 0 N--CA 1.384 -3.768 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 752' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 770' ' ' GLU . 22.4 mtpp -103.25 122.56 45.02 Favored 'General case' 1 C--N 1.237 -4.32 0 CA-C-N 113.041 -1.891 . . . . 0.0 108.65 -174.265 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 60.9 m -70.96 150.12 46.0 Favored 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.44 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -112.37 143.89 42.72 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.314 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 4.4 p -67.23 118.06 10.1 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.644 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.419 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 43.2 t -79.37 153.82 29.47 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -100.82 0.45 38.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.084 0.469 . . . . 0.0 111.595 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 6.4 mp -91.43 -8.49 47.69 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.049 0.928 . . . . 0.0 108.573 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.507 HG12 ' CG1' ' A' ' 801' ' ' VAL . 2.8 pp -118.45 169.73 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.649 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 760' ' ' ILE . . . . . 0.592 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.5 mp -119.44 124.88 73.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.809 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 96.2 mt -97.47 179.24 4.93 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.15 167.73 13.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.385 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -12.38 61.6 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 764' ' ' HIS . . . . . 0.563 ' CD2' ' HG ' ' A' ' 765' ' ' LEU . 4.6 p-80 -100.64 -10.99 20.38 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.531 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.653 HD22 ' CE2' ' A' ' 771' ' ' PHE . 74.7 mt -110.4 -19.44 12.96 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -69.86 -12.74 61.85 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.755 0.788 . . . . 0.0 110.274 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -101.96 11.23 38.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.734 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.445 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 14.4 tppt? -104.5 108.44 19.88 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 769' ' ' LYS . . . . . 0.499 ' HD2' ' H ' ' A' ' 769' ' ' LYS . 0.0 OUTLIER -72.45 -36.7 68.6 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.185 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 770' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 752' ' ' LYS . 43.3 mt-10 -144.41 133.4 22.69 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.898 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.809 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 71.7 m-85 -103.56 149.04 25.26 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -92.39 159.08 15.73 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.14 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.697 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 31.8 t60 -62.21 140.78 58.45 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.037 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 89.17 3.26 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.957 1.703 . . . . 0.0 109.972 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 74.9 m -83.35 114.08 21.18 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.505 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -88.25 113.47 23.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.848 178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.659 HG21 ' CE2' ' A' ' 771' ' ' PHE . 4.8 pt -126.98 -173.83 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.541 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 30.4 ptt180 -143.17 127.38 17.59 Favored 'General case' 0 N--CA 1.413 -2.278 0 O-C-N 122.165 -0.334 . . . . 0.0 110.173 173.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.692 ' CD2' HG13 ' A' ' 801' ' ' VAL . 11.0 p90 -108.74 170.92 7.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 174.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 780' ' ' ARG . . . . . 0.592 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 9.3 ptt180 -146.66 155.44 42.43 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 173.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 781' ' ' CYS . . . . . . . . . . . . . 14.0 t -83.81 155.36 23.03 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -76.03 -5.74 47.81 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.624 0.726 . . . . 0.0 110.568 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -102.34 -10.13 39.7 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.074 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 784' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -122.07 125.04 45.36 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.084 -0.656 . . . . 0.0 111.697 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.65 79.9 4.8 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 122.073 0.939 . . . . 0.0 108.625 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 173.08 153.2 9.31 Favored Glycine 0 C--N 1.299 -1.494 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 40.4 m95 -101.58 164.86 11.54 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 117.085 0.443 . . . . 0.0 110.192 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 788' ' ' ILE . 3.6 mp -115.25 -34.03 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.343 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 76.18 121.35 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 124.493 1.117 . . . . 0.0 109.45 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.482 HG21 ' CG2' ' A' ' 801' ' ' VAL . 3.5 t -141.92 155.89 45.49 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.13 134.07 61.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 46.9 t -68.96 119.66 13.63 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.697 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 49.5 mm -119.54 86.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 C-N-CA 124.774 1.23 . . . . 0.0 108.694 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.435 ' H ' ' HB2' ' A' ' 773' ' ' HIS . 4.5 t30 45.69 72.17 0.24 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.567 1.147 . . . . 0.0 112.233 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 68.16 19.66 72.32 Favored Glycine 0 C--N 1.3 -1.424 0 CA-C-N 115.05 -0.977 . . . . 0.0 114.178 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -144.52 165.13 28.84 Favored 'General case' 0 C--O 1.19 -2.043 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.66 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.6 m95 -111.6 160.41 17.23 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 121.735 -0.603 . . . . 0.0 110.225 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -149.29 105.77 3.33 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.76 139.91 50.96 Favored 'Cis proline' 0 C--O 1.245 0.835 0 C-N-CA 123.842 -1.316 . . . . 0.0 110.508 -0.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.66 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.3 tt0 -56.27 125.27 21.07 Favored 'General case' 0 N--CA 1.432 -1.334 0 O-C-N 123.684 0.615 . . . . 0.0 111.153 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.692 HG13 ' CD2' ' A' ' 779' ' ' TYR . 93.9 t -65.89 108.77 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.249 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -144.62 127.1 15.96 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 803' ' ' CYS . . . . . 0.435 ' HB2' HG22 ' A' ' 759' ' ' ILE . 47.5 t -98.84 -33.48 10.87 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.439 -0.975 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.806 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.414 -2.266 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 40.4 m -84.59 -76.36 0.31 Allowed 'General case' 0 C--N 1.254 -3.582 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.321 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 149.09 -177.29 27.41 Favored Glycine 1 N--CA 1.358 -6.558 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -51.61 130.12 27.37 Favored 'General case' 0 C--N 1.278 -2.525 0 O-C-N 125.588 1.405 . . . . 0.0 109.946 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.63 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -60.01 150.25 70.71 Favored Pre-proline 0 N--CA 1.432 -1.352 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.915 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.552 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.0 Cg_endo -71.84 -163.51 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 122.86 2.374 . . . . 0.0 111.471 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -135.74 156.51 48.7 Favored 'General case' 0 N--CA 1.402 -2.871 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.557 HD13 ' HA3' ' A' ' 700' ' ' GLY . 1.1 mt -88.56 144.65 26.19 Favored 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.358 177.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.42 -41.09 93.24 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 744' ' ' CYS . 93.6 m-70 -146.84 32.2 0.94 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.557 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -141.72 -149.65 5.24 Favored Glycine 0 C--N 1.3 -1.434 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.775 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.417 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -148.38 -179.35 6.89 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -177.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -112.58 144.63 41.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 39.3 mm-40 -73.98 -67.71 0.58 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.33 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 68.5 tp -158.2 125.45 5.02 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.512 ' CB ' HG12 ' A' ' 694' ' ' ILE . 5.5 p -118.52 132.29 56.22 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 22.9 t -121.72 112.97 32.01 Favored Pre-proline 0 C--N 1.288 -2.098 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.999 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.33 165.62 26.27 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.143 1.896 . . . . 0.0 108.642 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.442 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 16.9 Cg_exo -67.81 -10.63 8.59 Favored 'Cis proline' 0 N--CA 1.498 1.759 0 N-CA-C 115.194 1.19 . . . . 0.0 115.194 5.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 705' ' ' SER . 61.9 m-85 74.07 87.04 0.1 Allowed 'General case' 0 C--N 1.309 -1.17 0 O-C-N 124.65 1.219 . . . . 0.0 108.044 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.53 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 50.3 m-85 -90.98 172.54 8.51 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.686 -176.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -71.45 138.51 49.1 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.255 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.77 77.78 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 713' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 2.5 t70 -77.34 165.79 23.99 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 20.2 m -151.86 142.41 22.67 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.63 HG21 HG21 ' A' ' 694' ' ' ILE . 44.8 t -133.56 134.37 56.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 39.1 mt-10 -80.51 135.67 36.15 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 123.896 0.748 . . . . 0.0 111.426 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -136.61 114.3 11.13 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 125.837 1.655 . . . . 0.0 107.471 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.417 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 14.4 m-80 -124.06 -163.0 1.11 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.609 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 10.0 m -108.16 144.23 35.86 Favored 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 720' ' ' SER . . . . . 0.599 ' O ' ' HG3' ' A' ' 721' ' ' GLU . 5.1 m -55.81 -70.43 0.11 Allowed 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.769 0.668 . . . . 0.0 109.872 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 721' ' ' GLU . . . . . 0.599 ' HG3' ' O ' ' A' ' 720' ' ' SER . 30.7 mt-10 -175.22 164.39 3.25 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 129.279 3.031 . . . . 0.0 102.822 173.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 62.6 m 68.51 12.56 8.75 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.993 0.808 . . . . 0.0 111.509 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.715 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.8 m-85 -143.74 147.96 34.96 Favored 'General case' 0 N--CA 1.407 -2.615 0 C-N-CA 124.83 1.252 . . . . 0.0 108.11 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.634 HG21 HD21 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -112.93 135.27 53.89 Favored 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.996 -177.174 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.724 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.8 ttp -85.06 113.26 21.34 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 124.93 1.292 . . . . 0.0 109.758 -177.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.545 HD12 HG23 ' A' ' 793' ' ' ILE . 45.3 mm -115.27 131.3 67.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.336 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 94.57 -91.34 1.4 Allowed Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.772 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.56 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.1 m80 -114.34 178.42 4.29 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 114.508 -0.846 . . . . 0.0 110.357 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.724 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -144.92 14.21 1.5 Allowed 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 168.2 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 33.9 m -149.18 162.41 40.05 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 714' ' ' SER . 28.8 pt -121.1 166.73 15.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 739' ' ' THR . 3.8 m -135.75 139.94 43.96 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 43.3 t -99.82 116.91 32.99 Favored 'General case' 0 N--CA 1.406 -2.634 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.47 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.2 pp -142.82 149.29 18.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-N 114.004 -1.453 . . . . 0.0 107.444 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 74.9 m80 73.74 -21.83 0.26 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.662 0.785 . . . . 0.0 112.087 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 120.24 14.27 5.53 Favored Glycine 0 CA--C 1.505 -0.542 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.3 p -148.53 150.53 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.552 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.8 m95 -77.2 169.25 18.66 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.467 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 732' ' ' THR . 24.9 p -77.23 -160.8 0.18 Allowed 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.67 0.748 . . . . 0.0 112.396 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -84.69 -12.86 53.0 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.991 -168.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.406 HD21 ' HG2' ' A' ' 695' ' ' PRO . 0.9 OUTLIER 70.81 159.32 0.16 Allowed Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 124.009 0.818 . . . . 0.0 112.237 -177.327 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.56 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 37.6 Cg_endo -75.13 178.9 6.68 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.241 1.961 . . . . 0.0 112.155 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -122.91 101.33 7.37 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.023 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 699' ' ' HIS . 73.1 m -84.59 112.4 20.4 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-O 121.094 0.474 . . . . 0.0 110.58 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.72 144.04 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.715 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.33 1.16 0.81 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 125.08 1.352 . . . . 0.0 114.254 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.751 ' HA ' HD22 ' A' ' 750' ' ' LEU . 34.5 mt 76.54 -18.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 124.991 1.317 . . . . 0.0 110.971 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.0 t70 -77.84 -23.82 48.81 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 125.884 1.673 . . . . 0.0 109.203 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -110.89 18.95 19.02 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.586 -1.643 . . . . 0.0 108.842 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.828 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 3.1 mp -85.7 -176.8 6.19 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.859 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.49 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 53.1 mtpt -140.48 164.92 28.84 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -109.02 140.39 42.61 Favored 'General case' 0 C--N 1.257 -3.423 0 C-N-CA 126.021 1.728 . . . . 0.0 108.256 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 59.8 m -88.01 165.06 15.45 Favored 'General case' 1 C--N 1.239 -4.238 0 CA-C-N 114.106 -1.407 . . . . 0.0 109.147 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 754' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 754' ' ' LYS . 17.4 ptpt -132.77 147.62 52.32 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.988 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.18 114.04 3.53 Favored 'General case' 0 C--N 1.27 -2.875 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.916 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.617 ' HB2' ' CG1' ' A' ' 759' ' ' ILE . 55.9 m -72.98 149.78 43.03 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -80.08 -9.24 59.69 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.887 0.851 . . . . 0.0 110.458 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.83 -11.92 40.63 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.402 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.617 ' CG1' ' HB2' ' A' ' 756' ' ' SER . 2.4 pp -118.06 140.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.401 -173.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 760' ' ' ILE . . . . . 0.419 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.1 mp -104.39 131.21 53.83 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.53 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 2.1 mm? -108.56 -177.79 3.41 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 120.845 0.355 . . . . 0.0 110.114 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -71.48 167.61 19.28 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -57.86 -17.54 16.98 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.054 0.941 . . . . 0.0 112.639 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -85.62 -42.1 14.63 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.62 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 66.7 mt -85.65 -15.42 42.45 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 113.452 -1.704 . . . . 0.0 112.652 -169.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -73.96 -13.81 60.94 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.472 0.653 . . . . 0.0 110.508 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -96.51 0.33 50.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.335 1.064 . . . . 0.0 108.459 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.421 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 8.7 tppt? -103.08 118.48 36.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 769' ' ' LYS . . . . . 0.405 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 9.8 ptpp? -96.76 -19.85 18.64 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 770' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 35.5 mt-10 -136.25 122.7 20.73 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.283 176.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.529 ' CE2' HD22 ' A' ' 765' ' ' LEU . 76.1 m-85 -98.96 142.56 30.31 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -87.71 148.2 24.87 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.954 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.686 ' CG ' HD23 ' A' ' 750' ' ' LEU . 47.1 p-80 -42.47 141.7 0.95 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.359 1.463 . . . . 0.0 111.259 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 63.6 t30 75.57 2.42 3.78 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.026 1.33 . . . . 0.0 111.825 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 18.2 t -82.24 118.49 23.15 Favored 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 121.292 -0.88 . . . . 0.0 108.666 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.81 106.22 17.93 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.62 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.6 pt -115.97 -170.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.584 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 7.1 ptp180 -150.82 134.99 16.86 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.525 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 8.1 p90 -119.15 173.52 6.87 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 780' ' ' ARG . . . . . 0.419 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 10.5 ptt180 -155.4 169.82 23.36 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 59.3 m -97.79 164.31 12.44 Favored 'General case' 0 C--N 1.282 -2.341 0 O-C-N 123.876 0.735 . . . . 0.0 109.093 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 782' ' ' ARG . . . . . 0.53 ' HD2' ' H ' ' A' ' 782' ' ' ARG . 0.0 OUTLIER -66.72 -36.95 83.69 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.854 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -98.35 5.18 60.64 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.404 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.0 mptt -127.65 105.15 8.28 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 785' ' ' GLU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 780' ' ' ARG . 35.9 tt0 -90.58 78.88 6.21 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.879 0.847 . . . . 0.0 109.952 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -164.1 144.58 9.56 Favored Glycine 0 CA--C 1.472 -2.636 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.584 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 38.5 m95 -101.66 131.61 47.81 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 117.405 0.602 . . . . 0.0 109.992 -174.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.525 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -87.87 -30.5 5.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.757 -174.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 15.3 m170 71.53 125.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.549 1.14 . . . . 0.0 109.119 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 3.4 t -147.9 155.6 41.77 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 122.196 -0.315 . . . . 0.0 110.438 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.58 135.69 57.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 53.6 t -72.92 114.08 10.66 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.845 0.831 . . . . 0.0 110.342 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.545 HG23 HD12 ' A' ' 726' ' ' ILE . 50.9 mm -115.29 80.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 C-N-CA 124.501 1.121 . . . . 0.0 108.713 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.828 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 1.0 OUTLIER 52.08 64.64 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.464 176.072 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.61 22.53 78.31 Favored Glycine 0 C--N 1.308 -0.996 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.576 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -147.28 164.18 34.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.617 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.0 m95 -111.75 159.56 18.15 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-O 120.581 0.229 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 798' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 21.9 t70 -149.19 103.79 3.33 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 799' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 798' ' ' ASP . 47.7 Cg_endo -72.13 141.57 71.08 Favored 'Cis proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.876 -1.302 . . . . 0.0 113.602 -0.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 2.9 mm-40 -53.32 127.73 25.76 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.138 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.485 ' HB ' HG21 ' A' ' 759' ' ' ILE . 3.2 m -84.17 138.75 18.64 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.362 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.997 -176.269 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -165.77 135.88 3.51 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 803' ' ' CYS . . . . . 0.453 ' SG ' HG22 ' A' ' 759' ' ' ILE . 58.1 m -142.64 34.33 1.43 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 17.8 p . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.285 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.42 -1.937 0 CA-C-O 120.971 0.415 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 39.0 m -80.62 -66.23 0.91 Allowed 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.54 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 128.37 -177.54 17.66 Favored Glycine 1 N--CA 1.367 -5.917 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.409 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 30.9 t70 -34.14 128.36 0.4 Allowed 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 127.023 2.129 . . . . 0.0 112.727 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.698 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -61.82 150.29 82.82 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.163 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.457 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 57.0 Cg_endo -72.17 -159.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.684 2.256 . . . . 0.0 111.74 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.15 -173.29 3.22 Favored 'General case' 0 N--CA 1.401 -2.884 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 717' ' ' PHE . 22.0 tp -128.6 126.0 39.36 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-O 120.872 0.368 . . . . 0.0 110.384 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -49.44 -37.9 27.47 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.4 m-70 -137.09 24.68 3.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -141.79 -146.76 4.74 Favored Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.21 -0.995 . . . . 0.0 110.846 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.476 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.01 179.21 8.25 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.704 0.288 . . . . 0.0 110.324 -177.234 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -112.49 143.41 43.68 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.2 -75.54 0.17 Allowed 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.241 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.7 tt -176.46 132.17 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.455 ' HB2' HG13 ' A' ' 715' ' ' VAL . 9.9 t -154.23 146.96 24.25 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 10.1 t -117.07 149.14 43.73 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.521 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 59.4 Cg_endo -65.97 174.54 5.64 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.61 2.207 . . . . 0.0 110.454 177.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.521 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.8 Cg_endo -79.95 -4.18 40.5 Favored 'Cis proline' 0 C--O 1.215 -0.633 0 CA-C-N 119.799 0.964 . . . . 0.0 114.541 4.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.442 ' CE1' HG23 ' A' ' 694' ' ' ILE . 77.1 m-85 68.92 79.32 0.21 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.326 0.584 . . . . 0.0 110.262 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 30.1 m-85 -83.56 170.81 13.97 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.47 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 44.0 m-85 -68.46 137.11 54.19 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.322 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.9 -5.38 68.99 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.3 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 713' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 2.9 t70 -71.14 157.59 37.9 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 20.2 m -149.22 139.36 22.17 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.698 HG21 HG21 ' A' ' 694' ' ' ILE . 41.0 t -130.48 140.93 47.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.033 -174.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 729' ' ' ARG . 1.6 mp0 -80.2 131.79 35.76 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 122.168 0.985 . . . . 0.0 112.872 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.576 ' HB3' HD22 ' A' ' 697' ' ' LEU . 32.1 m-85 -135.89 107.96 7.19 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 113.608 -1.633 . . . . 0.0 107.297 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.476 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 9.0 m-80 -115.51 -163.46 0.89 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 8.3 m -116.06 134.91 54.45 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 3.2 m -58.04 -70.87 0.12 Allowed 'General case' 0 C--N 1.288 -2.094 0 O-C-N 124.163 0.914 . . . . 0.0 111.87 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -164.33 161.37 21.72 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 74.9 m 69.84 2.75 3.99 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.995 0.81 . . . . 0.0 112.847 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.5 m-85 -137.5 148.75 46.26 Favored 'General case' 0 N--CA 1.401 -2.892 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.502 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -115.08 141.91 47.36 Favored 'General case' 0 C--N 1.259 -3.336 0 C-N-CA 124.991 1.316 . . . . 0.0 109.996 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.8 ttp -85.84 120.71 27.56 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 124.071 0.948 . . . . 0.0 109.826 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 43.2 mm -111.82 122.18 65.68 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.763 174.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 114.15 -94.86 0.71 Allowed Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.966 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 47.6 t-80 -156.97 139.1 14.55 Favored 'General case' 0 CA--C 1.472 -2.054 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.56 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -85.71 25.76 1.04 Allowed 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 15.4 m -143.87 156.24 44.39 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.776 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 714' ' ' SER . 41.2 pt -118.65 160.58 18.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.419 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 739' ' ' THR . 20.1 m -134.02 135.87 43.68 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.973 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 733' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.3 t -85.65 104.07 15.05 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.8 pp -146.65 144.18 20.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 124.034 0.934 . . . . 0.0 110.246 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 67.85 8.16 6.25 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 94.51 20.28 29.96 Favored Glycine 0 CA--C 1.5 -0.844 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.376 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.7 p -157.46 158.93 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.457 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 94.5 m95 -78.04 172.71 13.1 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 171.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 25.5 p -76.38 -169.56 1.23 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.976 0.893 . . . . 0.0 112.999 -174.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.2 pp0? -65.55 -20.64 66.41 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 -173.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 5.6 mt 70.68 138.55 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 124.547 1.154 . . . . 0.0 112.882 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 56.7 Cg_endo -67.04 167.12 20.75 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.363 2.042 . . . . 0.0 112.428 -177.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.434 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 51.3 tt0 -112.47 102.42 10.53 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.493 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 89.4 m -82.55 111.19 18.31 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.614 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.461 ' HB ' HD21 ' A' ' 750' ' ' LEU . 48.2 t -99.45 145.35 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.497 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.67 4.16 0.63 Allowed 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 125.411 1.484 . . . . 0.0 113.716 -175.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.884 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 57.6 mt 76.47 -22.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 126.183 1.793 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 746' ' ' ALA . 12.1 t70 -67.41 -34.86 78.12 Favored 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 126.029 1.732 . . . . 0.0 109.841 -174.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.75 24.12 13.35 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 113.578 -1.647 . . . . 0.0 111.658 -175.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.884 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 85.9 mt -78.65 166.01 23.0 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-O 121.644 0.735 . . . . 0.0 109.899 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 9.4 mmmm -91.19 -167.62 1.85 Allowed 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 126.701 2.0 . . . . 0.0 112.408 -171.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 752' ' ' LYS . . . . . 0.543 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 28.4 mmmt -123.72 134.03 53.77 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 126.357 1.863 . . . . 0.0 106.793 -176.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 753' ' ' CYS . . . . . 0.465 ' HB2' ' CZ2' ' A' ' 797' ' ' TRP . 0.0 OUTLIER -87.39 -179.47 6.39 Favored 'General case' 0 C--N 1.257 -3.454 0 C-N-CA 125.44 1.496 . . . . 0.0 109.433 -177.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -141.14 137.99 33.14 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.93 -0.481 . . . . 0.0 110.433 -176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 38.9 t -71.79 120.56 17.56 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 172.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.51 ' HB3' HG12 ' A' ' 759' ' ' ILE . 42.9 t -70.33 163.18 27.14 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -96.41 -1.09 48.27 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.95 18.26 19.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.983 0.42 . . . . 0.0 110.71 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.51 HG12 ' HB3' ' A' ' 756' ' ' SER . 23.8 pt -126.41 157.71 36.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.538 0.685 . . . . 0.0 112.07 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 760' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.2 mp -117.74 132.54 67.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.593 ' HG ' ' HZ ' ' A' ' 771' ' ' PHE . 2.7 mm? -106.94 178.17 4.64 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.569 ' HB2' HD23 ' A' ' 765' ' ' LEU . 47.4 mt-10 -62.01 162.22 9.56 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.97 176.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.7 -11.99 56.58 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.538 0.685 . . . . 0.0 111.264 -176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.31 -0.61 26.1 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.573 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.3 mm? -122.97 -12.12 8.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 8.7 mtmp? -62.65 -27.02 68.93 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -88.1 5.71 39.86 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.707 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 19.0 ttmm -101.94 109.92 21.77 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 769' ' ' LYS . . . . . 0.522 ' HE3' ' HG3' ' A' ' 770' ' ' GLU . 34.6 ttpt -79.46 -37.29 37.24 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.251 1.024 . . . . 0.0 108.444 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 770' ' ' GLU . . . . . 0.522 ' HG3' ' HE3' ' A' ' 769' ' ' LYS . 41.4 mt-10 -127.92 114.61 17.39 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.438 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.707 ' CD2' ' HD2' ' A' ' 768' ' ' LYS . 82.3 m-85 -88.76 -178.68 5.83 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.972 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -118.68 138.54 52.55 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.59 -175.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.73 ' CD2' ' HB2' ' A' ' 750' ' ' LEU . 9.8 p-80 -45.91 146.86 1.1 Allowed 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.642 1.177 . . . . 0.0 112.738 174.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 66.7 t30 72.22 10.95 5.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.27 1.028 . . . . 0.0 110.702 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 46.8 t -94.25 127.99 40.45 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -97.6 111.25 23.6 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.543 HD12 HD12 ' A' ' 761' ' ' LEU . 7.8 pt -118.91 176.46 3.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 121.662 0.744 . . . . 0.0 109.596 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 79.5 mtt180 -122.28 133.29 54.69 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 173.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 779' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -128.59 168.33 15.88 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -160.08 163.9 33.51 Favored 'General case' 0 N--CA 1.412 -2.372 0 O-C-N 124.521 1.138 . . . . 0.0 109.281 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 90.7 m -82.48 175.34 10.28 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 123.53 0.519 . . . . 0.0 109.797 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 782' ' ' ARG . . . . . 0.42 ' HB3' HD11 ' A' ' 760' ' ' ILE . 12.5 ptm180 -91.4 -29.19 17.21 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.936 0.398 . . . . 0.0 110.504 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -92.24 -3.11 67.71 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.791 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 2.2 mptp? -130.74 107.62 9.29 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.62 149.38 27.44 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 111.45 141.11 8.43 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -174.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 47.4 m95 -98.61 149.8 22.4 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 117.047 0.424 . . . . 0.0 110.746 -171.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 788' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.16 -31.7 3.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.06 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 73.19 118.92 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 124.843 1.257 . . . . 0.0 110.206 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.543 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.1 t -140.32 158.52 43.9 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.836 -0.54 . . . . 0.0 110.232 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.94 134.48 63.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 792' ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 54.0 t -72.19 117.27 13.62 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.533 0.682 . . . . 0.0 110.327 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.07 79.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.48 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 794' ' ' ASN . . . . . . . . . . . . . 8.9 t30 55.09 71.94 0.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.845 0.831 . . . . 0.0 112.171 171.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 795' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 75.26 3.58 70.74 Favored Glycine 0 C--N 1.292 -1.902 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.988 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 796' ' ' ARG . . . . . 0.452 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 22.9 ttt180 -136.19 174.58 10.46 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.635 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 97.5 m95 -121.12 159.48 25.71 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 798' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 9.3 t70 -148.3 106.52 3.58 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 799' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 798' ' ' ASP . 51.0 Cg_endo -71.92 142.45 73.76 Favored 'Cis proline' 0 C--O 1.244 0.814 0 C-N-CA 123.588 -1.422 . . . . 0.0 112.956 -0.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.635 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 1.9 mm-40 -50.51 126.1 14.48 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 115.096 -0.956 . . . . 0.0 113.118 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.543 ' CG1' HG21 ' A' ' 790' ' ' THR . 3.6 m -84.31 123.55 39.09 Favored 'Isoleucine or valine' 1 N--CA 1.35 -5.462 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.589 -179.069 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 802' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 801' ' ' VAL . 2.5 t-20 174.03 132.37 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 5.8 t -98.1 21.12 11.23 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.49 1.138 . . . . 0.0 109.611 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.412 -2.36 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.52 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 690' ' ' THR . . . . . 0.63 HG21 ' HB2' ' A' ' 708' ' ' PRO . 12.4 p . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 23.7 m -72.31 -63.08 1.22 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.059 0.457 . . . . 0.0 110.169 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 131.3 -164.23 23.44 Favored Glycine 1 N--CA 1.356 -6.675 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -45.61 136.8 5.61 Favored 'General case' 0 C--N 1.26 -3.315 0 C-N-CA 126.182 1.793 . . . . 0.0 111.828 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.505 HG21 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -68.7 148.22 98.02 Favored Pre-proline 0 N--CA 1.427 -1.61 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.066 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.539 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 70.9 Cg_endo -72.76 -168.98 0.44 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 123.327 2.685 . . . . 0.0 111.838 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -135.52 143.28 45.69 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.574 HD22 ' HB3' ' A' ' 717' ' ' PHE . 24.5 tp -92.56 123.79 36.11 Favored 'General case' 0 C--N 1.254 -3.552 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.187 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.538 ' HG2' HD12 ' A' ' 697' ' ' LEU . 7.4 pt-20 -30.42 -51.74 0.15 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.319 2.248 . . . . 0.0 115.556 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 78.8 m-70 -136.15 23.39 3.26 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -134.04 -159.11 8.8 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.998 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.436 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -141.07 176.34 8.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.692 0.282 . . . . 0.0 111.382 -173.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -111.52 133.66 53.64 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.513 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 53.7 mm-40 -74.42 -73.26 0.24 Allowed 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 704' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 705' ' ' SER . 7.0 tt -161.3 139.63 9.58 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.474 -177.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.714 ' HB2' HG22 ' A' ' 715' ' ' VAL . 35.8 t -164.36 -175.7 4.05 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 26.7 p -152.11 140.74 13.71 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.89 167.29 23.68 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 121.798 1.666 . . . . 0.0 109.39 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.63 ' HB2' HG21 ' A' ' 690' ' ' THR . 1.3 Cg_endo -73.74 -1.83 14.62 Favored 'Cis proline' 0 C--O 1.243 0.73 0 N-CA-C 115.201 1.193 . . . . 0.0 115.201 6.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 72.5 m-85 72.55 75.58 0.15 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.39 1.056 . . . . 0.0 109.318 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.601 ' CE1' ' HG2' ' A' ' 708' ' ' PRO . 18.3 m-85 -79.49 169.95 17.3 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.158 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.533 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 54.3 m-85 -68.81 133.95 49.02 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.905 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.74 -11.23 60.98 Favored Glycine 0 N--CA 1.426 -1.973 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.463 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.29 150.82 47.78 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 15.6 m -140.01 142.77 36.24 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 121.196 0.522 . . . . 0.0 109.904 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.714 HG22 ' HB2' ' A' ' 705' ' ' SER . 20.5 t -131.88 127.09 58.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 40.0 mt-10 -71.66 138.22 48.46 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.919 0.39 . . . . 0.0 111.266 174.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.574 ' HB3' HD22 ' A' ' 697' ' ' LEU . 19.7 m-85 -138.19 123.76 19.66 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.436 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 6.7 m-80 -136.22 -165.21 1.68 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 9.4 m -115.53 130.23 56.8 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 720' ' ' SER . . . . . 0.427 ' HA ' ' CE2' ' A' ' 701' ' ' TRP . 4.0 m -47.0 -71.98 0.06 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 124.984 1.427 . . . . 0.0 112.09 -172.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -169.46 164.61 10.54 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 66.9 m 66.31 8.23 5.48 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.087 0.867 . . . . 0.0 112.288 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.66 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.5 m-85 -141.35 142.69 33.78 Favored 'General case' 0 N--CA 1.412 -2.363 0 C-N-CA 124.141 0.976 . . . . 0.0 108.771 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 0.9 OUTLIER -107.37 133.97 51.12 Favored 'General case' 0 C--N 1.251 -3.713 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.784 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.731 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.3 ttp -87.97 121.17 30.06 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.259 1.024 . . . . 0.0 109.923 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.608 HD12 HG23 ' A' ' 793' ' ' ILE . 49.9 mm -120.16 131.18 73.19 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.714 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.084 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 111.49 -81.46 0.29 Allowed Glycine 0 C--N 1.306 -1.124 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.679 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.586 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 9.9 t-80 -150.92 171.45 17.23 Favored 'General case' 0 C--O 1.202 -1.414 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.731 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -131.3 25.75 4.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.739 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 73.3 m -157.51 166.84 31.87 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.514 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 39.5 pt -129.91 161.35 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 O-C-N 124.654 1.221 . . . . 0.0 108.216 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 18.6 m -136.55 135.27 38.32 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.76 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 733' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.6 t -80.71 107.77 13.8 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.247 0.546 . . . . 0.0 110.499 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -145.89 146.72 19.05 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.229 0 C-N-CA 125.125 1.37 . . . . 0.0 110.051 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 37.7 m80 70.75 -12.93 0.51 Allowed 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 123.603 0.761 . . . . 0.0 111.685 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 105.0 19.26 10.97 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 33.2 t -143.1 159.12 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.539 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.6 m95 -86.19 179.0 7.01 Favored 'General case' 0 C--N 1.256 -3.462 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.514 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 25.1 p -76.64 -158.76 0.11 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.558 0.694 . . . . 0.0 112.053 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 4.9 pm0 -83.28 -9.38 59.14 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -165.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.2 mm? 71.82 150.59 0.13 Allowed Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 123.11 0.564 . . . . 0.0 111.11 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.586 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 10.9 Cg_exo -68.82 -161.36 0.07 OUTLIER 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.555 2.17 . . . . 0.0 112.292 173.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -142.1 137.65 31.14 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 87.3 m -130.09 107.62 9.46 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.147 0.498 . . . . 0.0 110.78 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.614 ' HB ' HD21 ' A' ' 750' ' ' LEU . 41.1 t -99.52 143.15 13.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.66 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -63.3 2.5 0.38 Allowed 'General case' 0 C--N 1.287 -2.148 0 C-N-CA 126.213 1.805 . . . . 0.0 114.79 -175.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.795 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 59.6 mt 75.48 -16.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 125.302 1.441 . . . . 0.0 111.309 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.7 t70 -72.54 -35.84 68.14 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.166 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 29.86 7.49 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.336 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.795 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 73.3 mt -86.72 -160.63 0.59 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.432 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.476 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 54.9 mtpt -145.86 168.48 20.71 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -116.77 139.83 50.13 Favored 'General case' 0 C--N 1.271 -2.823 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 753' ' ' CYS . . . . . 0.484 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 46.4 m -92.01 172.86 8.16 Favored 'General case' 0 C--N 1.249 -3.792 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.681 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -138.0 147.69 44.45 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 755' ' ' SER . . . . . 0.413 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.3 p -64.83 139.66 58.79 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.188 172.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.605 ' HB2' HG12 ' A' ' 759' ' ' ILE . 50.7 m -77.92 173.04 12.58 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -97.13 -15.52 20.9 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 121.543 -0.723 . . . . 0.0 111.608 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.27 16.47 24.23 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.774 -0.579 . . . . 0.0 110.542 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.605 HG12 ' HB2' ' A' ' 756' ' ' SER . 11.8 pt -124.27 153.94 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.701 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.57 131.91 65.27 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.575 HD11 HD12 ' A' ' 759' ' ' ILE . 1.9 mm? -108.12 178.01 4.64 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 45.8 mt-10 -65.33 156.68 31.36 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 171.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . 0.256 0.0 OUTLIER -68.51 -11.16 59.48 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 119.214 0.915 . . . . 0.0 112.802 -174.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -74.65 -31.73 62.04 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.672 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 64.3 mt -98.21 -25.37 14.9 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.708 -172.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 7.0 mtmp? -62.58 -32.17 73.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.338 0.59 . . . . 0.0 110.586 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -91.85 5.36 50.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.993 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.557 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 22.1 ttmm -87.31 -48.97 7.57 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.03 -54.41 0.57 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.038 1.335 . . . . 0.0 111.201 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 770' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 768' ' ' LYS . 47.1 mt-10 -113.69 123.75 50.65 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.582 ' CE2' HD22 ' A' ' 765' ' ' LEU . 11.4 m-85 -110.96 149.07 31.19 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -173.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.05 156.16 17.06 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -46.55 149.74 0.76 Allowed 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.57 1.148 . . . . 0.0 112.876 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 1.9 t30 67.9 12.12 8.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.379 1.472 . . . . 0.0 111.823 174.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 775' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 791' ' ' VAL . 20.1 p -77.33 110.89 12.45 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -84.92 93.7 8.6 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.672 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.6 pt -106.01 -177.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.809 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.572 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 76.8 mtt85 -132.47 135.37 45.98 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.49 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 4.7 p90 -131.37 168.63 17.25 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -159.05 164.5 35.38 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 93.8 m -83.56 161.35 21.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.93 -30.24 58.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -172.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -99.49 8.34 60.21 Favored Glycine 0 CA--C 1.499 -0.921 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 4.4 mptp? -119.62 162.53 18.81 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -131.14 162.47 29.84 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 96.92 145.03 18.45 Favored Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -172.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 54.2 m95 -110.25 139.69 45.17 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 117.339 0.57 . . . . 0.0 110.307 -174.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.49 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.0 mp -87.67 -27.41 5.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.276 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.532 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 0.6 OUTLIER 72.45 127.43 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 124.406 1.082 . . . . 0.0 109.673 -176.215 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.492 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.0 t -149.05 151.77 35.05 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.122 176.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 775' ' ' SER . 39.3 t -113.4 132.83 61.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 C-N-CA 123.611 0.764 . . . . 0.0 110.025 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 35.8 t -70.06 113.93 7.73 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.993 0.901 . . . . 0.0 110.417 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.608 HG23 HD12 ' A' ' 726' ' ' ILE . 47.5 mm -114.64 80.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.268 -2.965 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.544 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.552 ' OD1' HD22 ' A' ' 750' ' ' LEU . 2.1 m-20 50.26 68.48 0.75 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.817 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 795' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 76.68 11.98 84.84 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.975 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -142.12 170.62 15.37 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -176.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.603 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 95.0 m95 -116.77 161.79 18.71 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 798' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 19.4 t70 -148.45 102.21 3.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 799' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 41.8 Cg_endo -71.26 142.23 72.35 Favored 'Cis proline' 0 C--O 1.244 0.777 0 C-N-CA 123.932 -1.278 . . . . 0.0 112.881 -1.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.603 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 24.7 mt-10 -51.13 121.09 5.61 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.989 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.492 ' CG1' HG21 ' A' ' 790' ' ' THR . 5.9 m -76.26 130.6 36.07 Favored 'Isoleucine or valine' 1 N--CA 1.365 -4.709 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.196 -176.249 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -156.96 122.43 4.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 84.5 m -131.12 15.99 5.11 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.422 -1.829 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.518 178.129 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.422 -1.839 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 24.4 m -78.01 -54.1 6.66 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.286 0.565 . . . . 0.0 110.294 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 118.68 -171.81 14.27 Favored Glycine 1 N--CA 1.356 -6.641 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -34.48 122.54 0.51 Allowed 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 126.645 1.978 . . . . 0.0 111.884 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.636 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -62.93 147.68 93.61 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.247 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.431 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 43.0 Cg_endo -68.15 -167.02 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.777 2.318 . . . . 0.0 112.396 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -133.75 152.24 51.82 Favored 'General case' 0 N--CA 1.384 -3.773 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 717' ' ' PHE . 22.0 tp -99.74 114.19 27.17 Favored 'General case' 0 C--N 1.258 -3.371 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -43.32 -43.03 4.78 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 114.382 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -130.22 27.31 5.1 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.037 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -142.58 -150.9 5.4 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.645 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.49 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -145.05 174.54 10.96 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -177.172 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.81 147.99 28.03 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -84.65 -71.54 0.51 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.947 0.403 . . . . 0.0 110.487 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.0 tt -165.88 138.8 4.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.488 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 70.8 p -123.56 -63.95 1.19 Allowed 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 120.766 0.317 . . . . 0.0 110.854 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 32.7 t 71.41 105.96 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 125.301 1.44 . . . . 0.0 111.483 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.621 ' HB3' ' CE2' ' A' ' 709' ' ' TYR . 91.4 Cg_endo -74.43 162.88 37.37 Favored 'Trans proline' 0 CA--C 1.556 1.579 0 C-N-CA 122.407 2.072 . . . . 0.0 112.119 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 51.3 Cg_exo -65.27 171.01 34.24 Favored 'Cis proline' 0 CA--C 1.478 -2.302 0 CA-C-O 123.136 1.223 . . . . 0.0 113.599 0.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 707' ' ' PRO . 70.2 m-85 -115.14 74.83 0.9 Allowed 'General case' 1 C--N 1.23 -4.614 0 CA-C-N 112.184 -2.28 . . . . 0.0 109.871 -174.303 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -76.07 170.53 16.1 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.898 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -73.08 131.58 42.26 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.579 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.78 -8.72 63.77 Favored Glycine 0 N--CA 1.419 -2.439 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.37 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.83 154.92 38.06 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 120.783 0.325 . . . . 0.0 110.227 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 13.3 m -140.15 149.14 42.63 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 694' ' ' ILE . 44.5 t -132.61 134.02 59.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 45.0 mt-10 -89.67 141.59 28.46 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.436 0.636 . . . . 0.0 112.253 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.581 ' HB3' HD22 ' A' ' 697' ' ' LEU . 58.6 m-85 -141.16 129.85 22.83 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.875 1.67 . . . . 0.0 107.501 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.49 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 13.2 m-80 -132.63 -161.61 1.15 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 12.5 m -110.07 143.32 40.27 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 2.8 m -73.17 -84.94 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 123.373 0.421 . . . . 0.0 110.708 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -138.15 152.57 48.83 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 53.7 m 66.82 11.6 8.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.648 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.9 m-85 -137.55 148.31 45.82 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.422 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.1 m -116.65 135.11 54.06 Favored 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.54 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.8 ttp -92.81 124.26 36.67 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 123.93 0.892 . . . . 0.0 109.221 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 45.8 mm -126.13 144.0 37.74 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.593 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.441 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 100.45 -79.39 0.45 Allowed Glycine 0 N--CA 1.433 -1.505 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.456 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.483 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 3.5 t-80 -146.0 179.84 7.2 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.606 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.2 OUTLIER -136.3 22.22 3.21 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.147 177.323 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.442 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.2 p -157.2 170.1 23.25 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.087 -175.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.437 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 35.7 pt -125.42 161.57 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.69 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 738' ' ' TRP . 23.7 m -133.74 138.04 45.56 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 123.674 0.609 . . . . 0.0 110.104 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.2 103.19 15.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.49 145.21 24.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.431 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 69.42 -13.62 0.37 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 117.33 14.9 6.76 Favored Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.7 p -152.24 150.89 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.442 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 94.0 m95 -73.5 163.83 27.5 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.656 171.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 34.3 p -74.2 -161.34 0.12 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.083 0.944 . . . . 0.0 113.268 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.428 ' CD ' ' H ' ' A' ' 740' ' ' GLN . 0.4 OUTLIER -82.4 -3.06 54.92 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -165.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 68.81 155.38 0.14 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 123.665 0.603 . . . . 0.0 111.136 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 46.0 Cg_endo -74.77 177.75 8.09 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.854 1.703 . . . . 0.0 109.916 170.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -122.91 120.09 32.42 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.818 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.458 ' SG ' HD21 ' A' ' 697' ' ' LEU . 61.4 m -102.25 108.82 20.32 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.778 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.502 ' HB ' HD21 ' A' ' 750' ' ' LEU . 22.8 t -97.05 141.3 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.384 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.648 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.54 6.87 0.4 Allowed 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 125.63 1.572 . . . . 0.0 113.99 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.849 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 35.1 mt 75.82 -15.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 125.095 1.358 . . . . 0.0 111.675 177.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 746' ' ' ALA . 3.3 t70 -81.39 -31.11 33.42 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 126.109 1.763 . . . . 0.0 108.427 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.447 ' HB2' ' CG1' ' A' ' 745' ' ' VAL . 13.6 mttm -106.64 22.86 15.19 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 113.233 -1.803 . . . . 0.0 108.221 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.849 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 73.9 mt -87.94 -169.9 2.77 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.586 174.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.603 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 58.9 mtpt -118.16 168.29 10.71 Favored 'General case' 0 N--CA 1.397 -3.091 0 CA-C-O 122.103 0.954 . . . . 0.0 111.097 -173.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 752' ' ' LYS . . . . . 0.461 ' HB2' ' HE3' ' A' ' 752' ' ' LYS . 37.0 mtmt -107.17 121.05 43.74 Favored 'General case' 0 C--N 1.253 -3.602 0 CA-C-N 112.79 -2.004 . . . . 0.0 107.141 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 753' ' ' CYS . . . . . 0.49 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 0.0 OUTLIER -77.89 158.76 29.28 Favored 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 113.824 -1.534 . . . . 0.0 107.979 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -131.75 139.93 49.1 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.14 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 3.9 m -71.26 107.81 4.43 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.497 ' HB2' HG13 ' A' ' 759' ' ' ILE . 70.1 m -58.19 143.74 43.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.821 0.343 . . . . 0.0 110.383 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -78.77 -3.3 43.7 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.336 0.589 . . . . 0.0 111.78 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 758' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 803' ' ' CYS . 3.2 mm? -103.73 -15.78 15.64 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.673 -0.642 . . . . 0.0 110.689 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.7 pp -100.44 161.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.893 -174.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 760' ' ' ILE . . . . . 0.519 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.5 mp -114.2 129.87 69.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.52 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 86.5 mt -105.32 176.99 4.98 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 120.997 0.427 . . . . 0.0 110.095 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.62 168.8 7.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.988 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -71.22 -7.22 45.34 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.478 0.656 . . . . 0.0 111.42 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.65 -2.96 16.1 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.9 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.4 HD12 ' HE2' ' A' ' 771' ' ' PHE . 2.7 mm? -121.24 -10.47 8.95 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -71.28 -10.09 59.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.841 0.829 . . . . 0.0 110.15 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -88.62 -0.83 57.66 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.949 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -114.44 129.99 56.69 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 769' ' ' LYS . . . . . 0.673 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 9.6 ptpp? -107.1 -24.55 11.91 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 770' ' ' GLU . . . . . 0.673 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 46.3 mt-10 -132.65 128.44 37.07 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.673 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.52 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 83.4 m-85 -108.72 176.11 5.22 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.367 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -115.77 158.83 22.28 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.404 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -47.81 151.91 0.82 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.111 1.364 . . . . 0.0 112.622 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 15.3 m120 59.15 13.42 2.97 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 10.4 t -76.94 108.61 10.11 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -83.94 105.68 15.01 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.5 HG21 ' CE2' ' A' ' 771' ' ' PHE . 7.2 pt -119.77 -177.96 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.432 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 98.6 mtt180 -125.8 135.28 51.82 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.488 ' CE2' ' HA ' ' A' ' 801' ' ' VAL . 6.8 p90 -125.82 165.71 18.17 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 170.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 780' ' ' ARG . . . . . 0.519 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 14.5 ptt180 -145.16 163.48 34.24 Favored 'General case' 0 C--N 1.251 -3.697 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 19.9 t -109.27 162.27 14.47 Favored 'General case' 0 N--CA 1.395 -3.213 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -73.5 -39.05 65.13 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.838 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -84.08 -17.97 63.95 Favored Glycine 0 C--O 1.24 0.5 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.345 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.1 mptt -124.84 84.71 2.31 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -85.5 89.28 7.66 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 122.297 1.046 . . . . 0.0 110.836 -172.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 175.66 152.91 9.82 Favored Glycine 0 C--N 1.287 -2.19 0 N-CA-C 106.145 -2.782 . . . . 0.0 106.145 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 45.3 m95 -84.46 142.37 30.13 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 118.126 0.963 . . . . 0.0 109.797 -173.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.48 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -99.92 -31.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.041 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 74.75 116.89 0.06 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 124.836 1.254 . . . . 0.0 109.156 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 4.3 t -137.53 152.83 49.89 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.906 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 58.1 t -116.06 133.86 61.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 53.2 t -70.27 129.07 38.36 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.36 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.39 79.76 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.721 ' ND2' HD22 ' A' ' 750' ' ' LEU . 3.7 m-20 54.03 70.43 0.61 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.193 178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 795' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 76.82 -4.75 51.47 Favored Glycine 0 C--N 1.301 -1.384 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.778 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -115.89 172.55 7.07 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.591 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.0 m95 -121.76 154.89 36.35 Favored 'General case' 0 C--N 1.266 -3.032 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -144.67 105.61 4.6 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.91 143.08 74.88 Favored 'Cis proline' 0 C--O 1.248 0.993 0 C-N-CA 123.8 -1.333 . . . . 0.0 112.292 -0.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 38.6 mt-10 -53.19 125.96 19.28 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.659 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.488 ' HA ' ' CE2' ' A' ' 779' ' ' TYR . 4.6 m -72.03 141.95 15.94 Favored 'Isoleucine or valine' 1 N--CA 1.365 -4.678 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -165.38 138.33 4.42 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.012 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 803' ' ' CYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 758' ' ' LEU . 56.8 m -137.91 -3.0 1.85 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.141 0.496 . . . . 0.0 110.849 172.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 62.9 m . . . . . 0 C--N 1.314 -0.944 0 N-CA-C 106.806 -1.554 . . . . 0.0 106.806 -179.244 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 35.6 m -72.17 -79.47 0.07 Allowed 'General case' 0 C--N 1.268 -2.954 0 C-N-CA 123.872 0.869 . . . . 0.0 111.389 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 148.03 173.19 18.76 Favored Glycine 1 N--CA 1.362 -6.255 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -38.33 130.44 1.27 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 125.926 1.69 . . . . 0.0 111.048 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.711 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -63.23 151.72 86.23 Favored Pre-proline 0 C--N 1.296 -1.741 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.449 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.518 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.1 Cg_endo -72.18 -157.84 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 122.822 2.348 . . . . 0.0 112.941 177.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -133.21 146.19 51.26 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 717' ' ' PHE . 30.1 tp -90.25 126.04 35.7 Favored 'General case' 0 C--N 1.263 -3.166 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.09 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.529 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 6.8 pt-20 -32.84 -55.3 0.37 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.24 2.216 . . . . 0.0 114.527 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.529 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 92.3 m-70 -135.53 25.47 3.44 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -131.0 -150.72 6.84 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.05 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.468 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.02 179.13 8.31 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -109.69 146.28 35.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -81.32 -66.48 0.88 Allowed 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.301 0.572 . . . . 0.0 110.536 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.0 tt -161.33 139.61 9.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.455 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 58.6 p -130.73 119.48 22.41 Favored 'General case' 0 N--CA 1.395 -3.206 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 7.4 p -97.46 112.7 61.9 Favored Pre-proline 0 C--N 1.253 -3.598 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.681 -174.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.434 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 67.0 Cg_endo -72.06 172.52 14.56 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.755 2.303 . . . . 0.0 109.397 175.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.628 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 4.0 Cg_exo -74.24 -0.21 14.82 Favored 'Cis proline' 0 N--CA 1.489 1.213 0 CA-C-N 120.295 1.141 . . . . 0.0 114.544 5.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.455 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 54.2 m-85 74.53 73.1 0.11 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 124.86 1.35 . . . . 0.0 107.79 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.628 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 23.3 m-85 -78.35 172.24 13.9 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.072 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -72.25 138.44 47.47 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.927 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 89.2 -3.83 84.33 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 713' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 0.2 OUTLIER -76.1 151.22 37.1 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 17.1 m -130.32 149.9 51.8 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.929 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.711 HG21 HG21 ' A' ' 694' ' ' ILE . 31.7 t -133.92 140.25 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.862 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.43 130.98 43.46 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-O 122.063 0.935 . . . . 0.0 112.209 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.607 ' HB3' HD22 ' A' ' 697' ' ' LEU . 20.3 m-85 -131.96 122.95 26.4 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 126.305 1.842 . . . . 0.0 106.677 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.468 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 26.8 m-80 -119.47 -162.53 0.92 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 6.8 m -111.31 129.42 56.0 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 3.1 m -51.36 -76.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.783 1.233 . . . . 0.0 112.672 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -159.3 154.84 25.85 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 101.851 -3.388 . . . . 0.0 101.851 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 67.3 m 68.46 15.37 9.19 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.248 0.967 . . . . 0.0 112.852 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.705 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.0 m-85 -143.17 146.96 34.18 Favored 'General case' 0 N--CA 1.417 -2.1 0 C-N-CA 123.898 0.879 . . . . 0.0 108.981 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 2.4 t -103.24 148.37 25.89 Favored 'General case' 0 C--N 1.267 -3.0 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -177.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.6 ttp -104.59 118.06 35.64 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.475 HG12 HG23 ' A' ' 724' ' ' THR . 39.5 mm -116.12 127.75 73.62 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.545 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 108.19 -93.93 0.84 Allowed Glycine 0 CA--C 1.488 -1.652 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.841 174.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.447 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 7.2 p-80 -136.16 -175.84 4.12 Favored 'General case' 0 N--CA 1.397 -3.075 0 C-N-CA 125.618 1.567 . . . . 0.0 107.631 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.433 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -132.59 12.73 4.48 Favored 'General case' 0 C--O 1.208 -1.119 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.748 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 87.7 p -128.81 166.48 18.97 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.399 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' A' ' 741' ' ' LEU . 32.5 pt -119.07 160.14 19.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.74 174.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 739' ' ' THR . 3.7 m -134.18 134.92 42.67 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.664 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 733' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 40.3 t -94.0 119.93 33.56 Favored 'General case' 0 N--CA 1.405 -2.705 0 C-N-CA 118.821 -1.151 . . . . 0.0 110.259 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.8 140.5 25.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 113.836 -1.529 . . . . 0.0 107.676 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 66.45 7.07 4.74 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.76 8.98 61.62 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 737' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 738' ' ' TRP . 48.4 t -130.87 139.03 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -175.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.518 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.3 m95 -72.77 166.98 21.81 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.935 172.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 732' ' ' THR . 19.5 p -75.71 -163.09 0.24 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 122.084 0.945 . . . . 0.0 112.021 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.449 ' CD ' ' H ' ' A' ' 740' ' ' GLN . 0.5 OUTLIER -89.64 2.45 54.72 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.946 -171.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.628 ' HA ' HG22 ' A' ' 731' ' ' ILE . 2.0 mp 70.5 169.88 0.11 Allowed Pre-proline 0 C--O 1.237 0.41 0 O-C-N 124.094 0.872 . . . . 0.0 112.338 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 741' ' ' LEU . 39.2 Cg_endo -76.42 -177.06 3.44 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.416 2.077 . . . . 0.0 111.561 171.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -119.79 124.78 46.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 724' ' ' THR . 87.1 m -115.42 107.51 15.3 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 120.9 0.381 . . . . 0.0 110.207 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.541 ' HB ' HD21 ' A' ' 750' ' ' LEU . 44.0 t -96.96 145.68 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.705 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.82 1.96 1.19 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 125.039 1.336 . . . . 0.0 114.125 -174.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.789 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 15.8 mt 74.53 -19.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 125.068 1.347 . . . . 0.0 111.697 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.5 t70 -69.82 -33.72 72.71 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 126.72 2.008 . . . . 0.0 109.502 -175.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.18 31.28 6.8 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.585 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.789 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 55.1 mt -85.83 -179.28 6.79 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 121.566 0.698 . . . . 0.0 109.877 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.539 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 56.2 mtpt -116.33 -178.16 3.35 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.109 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -130.19 126.28 37.02 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 113.253 -1.794 . . . . 0.0 107.835 -175.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 753' ' ' CYS . . . . . 0.422 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 57.5 m -75.41 155.53 36.27 Favored 'General case' 0 C--N 1.264 -3.124 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.047 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -120.09 135.87 54.79 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 45.2 t -58.42 127.1 30.42 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.118 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.587 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 41.0 t -72.17 165.41 24.42 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -84.2 -19.21 34.41 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 758' ' ' LEU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 803' ' ' CYS . 91.6 mt -111.53 10.97 21.29 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.021 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.587 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -112.22 149.31 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-O 121.677 0.751 . . . . 0.0 112.642 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 760' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.3 mp -113.44 133.57 58.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.552 HD11 HD13 ' A' ' 759' ' ' ILE . 1.4 mm? -110.58 -177.95 3.36 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.13 152.83 19.41 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.85 -17.12 34.04 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.84 -6.3 32.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.497 0.665 . . . . 0.0 111.012 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 765' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -117.63 -4.78 11.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.677 0.751 . . . . 0.0 110.295 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 766' ' ' LYS . 17.8 mmmt -65.57 -17.35 64.51 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.336 1.055 . . . . 0.0 111.96 176.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -105.64 16.48 25.3 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.099 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.501 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 12.2 tppt? -110.21 113.07 25.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 769' ' ' LYS . . . . . 0.446 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 8.2 ptpp? -85.8 -32.03 22.0 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.472 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 770' ' ' GLU . . . . . 0.446 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 45.5 mt-10 -132.11 119.67 21.27 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.232 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.501 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 70.4 m-85 -97.58 157.34 16.08 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.804 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -93.28 148.68 21.83 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.637 ' CD2' HD12 ' A' ' 750' ' ' LEU . 15.1 p-80 -48.0 142.82 4.74 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.052 0.941 . . . . 0.0 111.669 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 22.1 m120 68.78 21.7 7.62 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 51.9 m -93.05 120.43 33.34 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -90.18 111.37 22.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 761' ' ' LEU . 7.8 pt -120.28 -179.7 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.906 0.86 . . . . 0.0 110.459 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.451 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 88.9 mtm180 -124.75 137.72 54.32 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.59 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 8.4 p90 -130.44 166.2 21.01 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 780' ' ' ARG . . . . . 0.504 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 24.3 ptt180 -154.25 157.17 38.32 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 27.6 m -87.73 166.14 14.85 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 782' ' ' ARG . . . . . 0.557 ' HB3' HD11 ' A' ' 760' ' ' ILE . 39.4 ptt85 -84.49 -27.99 27.07 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.169 -0.613 . . . . 0.0 112.089 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -91.88 -5.8 65.97 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.018 -1.087 . . . . 0.0 112.227 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 2.8 mptp? -128.36 104.85 7.95 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -86.24 115.93 24.1 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.603 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 151.57 146.96 4.45 Favored Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 31.3 m95 -94.68 143.22 26.62 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.59 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.1 mp -97.95 -27.93 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.084 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.487 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 0.9 OUTLIER 75.95 128.88 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 124.623 1.169 . . . . 0.0 109.923 -174.77 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.507 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.7 t -151.38 157.86 42.99 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.241 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.82 135.52 59.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 792' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 50.9 t -70.76 112.15 6.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.574 0.702 . . . . 0.0 110.093 177.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.6 mm -112.89 83.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.034 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.772 ' ND2' HD22 ' A' ' 750' ' ' LEU . 3.8 m-20 53.85 56.45 7.13 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.901 172.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 795' ' ' GLY . . . . . 0.489 ' HA3' ' HE2' ' A' ' 751' ' ' LYS . . . 81.95 16.49 72.31 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.495 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -147.42 166.08 28.3 Favored 'General case' 0 C--O 1.19 -2.05 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.623 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 99.0 m95 -111.45 162.7 14.81 Favored 'General case' 0 C--N 1.256 -3.466 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -146.47 105.76 4.05 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 799' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 29.2 Cg_endo -67.21 140.61 52.68 Favored 'Cis proline' 0 C--O 1.247 0.95 0 C-N-CA 124.061 -1.225 . . . . 0.0 111.679 -1.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.623 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.7 tt0 -57.51 118.63 5.39 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-O 121.32 0.581 . . . . 0.0 110.431 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.507 ' CG1' HG21 ' A' ' 790' ' ' THR . 1.9 m -78.53 125.34 37.96 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.816 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.91 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -157.68 129.73 7.08 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 803' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 758' ' ' LEU . 8.5 t -128.9 5.45 5.43 Favored 'General case' 0 C--N 1.284 -2.239 0 C-N-CA 119.114 -1.034 . . . . 0.0 109.387 -178.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.412 -2.339 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.759 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 690' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 708' ' ' PRO . 15.9 p . . . . . 0 N--CA 1.422 -1.838 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 67.0 m -74.23 -58.51 3.25 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 171.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 81.76 132.29 1.45 Allowed Glycine 0 N--CA 1.417 -2.612 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.137 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 21.1 t70 62.24 106.17 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.729 0.899 . . . . 0.0 111.19 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.63 HG21 HG21 ' A' ' 715' ' ' VAL . 1.7 pp -70.12 147.13 95.47 Favored Pre-proline 0 C--N 1.291 -1.952 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.828 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.474 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 58.9 Cg_endo -69.64 -162.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 123.023 2.482 . . . . 0.0 112.823 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.93 144.92 49.12 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.692 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.5 OUTLIER -85.8 132.57 34.09 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -49.26 -47.02 46.98 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.818 1.247 . . . . 0.0 113.793 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -141.63 29.58 1.74 Allowed 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.692 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -141.89 -141.01 3.86 Favored Glycine 0 C--N 1.301 -1.395 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.186 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.459 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -157.62 179.97 8.73 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -176.043 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.74 158.21 16.89 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 13.5 mm100 -86.02 -61.5 1.74 Allowed 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.341 0.591 . . . . 0.0 110.618 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.3 tt -167.0 133.24 2.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.52 ' HB2' ' CE1' ' A' ' 709' ' ' TYR . 15.8 p -126.16 137.21 53.56 Favored 'General case' 0 N--CA 1.392 -3.329 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 706' ' ' SER . . . . . 0.42 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 15.0 t -124.87 109.43 27.88 Favored Pre-proline 0 C--N 1.279 -2.469 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.248 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 706' ' ' SER . 60.7 Cg_endo -67.43 170.97 12.48 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 123.058 2.506 . . . . 0.0 110.316 177.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.539 ' HB2' HG21 ' A' ' 690' ' ' THR . 15.4 Cg_exo -68.92 -7.35 8.5 Favored 'Cis proline' 0 N--CA 1.499 1.801 0 CA-C-N 119.968 1.024 . . . . 0.0 114.686 3.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 705' ' ' SER . 51.5 m-85 76.15 73.96 0.08 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.73 1.269 . . . . 0.0 108.531 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.464 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 37.0 m-85 -82.26 174.17 11.41 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.5 -176.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -72.63 125.17 26.82 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.746 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 103.52 2.18 47.06 Favored Glycine 0 N--CA 1.411 -3.014 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.313 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.09 151.0 23.61 Favored 'General case' 0 CA--C 1.5 -0.969 0 O-C-N 122.445 -0.444 . . . . 0.0 111.153 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 21.7 m -132.69 156.89 46.18 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.63 HG21 HG21 ' A' ' 694' ' ' ILE . 39.8 t -138.24 136.43 44.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 48.6 mt-10 -91.07 141.71 28.54 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 123.434 0.459 . . . . 0.0 110.249 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.623 ' HB3' HD12 ' A' ' 697' ' ' LEU . 42.8 m-85 -138.98 121.65 16.35 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 124.655 1.182 . . . . 0.0 108.693 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.459 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 41.4 m-20 -124.46 -165.76 1.42 Allowed 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 8.0 m -117.91 140.97 48.96 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.9 m -60.73 -68.1 0.34 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-O 120.83 0.348 . . . . 0.0 110.551 -175.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 721' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 722' ' ' SER . 8.3 pt-20 -172.8 160.51 4.45 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 40.4 m 71.43 7.59 6.07 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.682 1.239 . . . . 0.0 110.493 -174.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 745' ' ' VAL . 93.2 m-85 -140.03 144.73 37.05 Favored 'General case' 0 N--CA 1.382 -3.849 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.658 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.515 HG21 HD21 ' A' ' 750' ' ' LEU . 1.1 m -120.38 144.74 47.74 Favored 'General case' 0 C--N 1.264 -3.138 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.786 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.711 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.7 ttp -81.95 116.72 21.71 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 124.91 1.284 . . . . 0.0 109.564 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 46.6 mm -115.25 137.13 49.77 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.954 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.518 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 96.3 -80.05 0.75 Allowed Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.123 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.564 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 6.2 t-80 -147.09 177.48 9.13 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -173.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.711 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -133.3 22.44 4.06 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.542 176.589 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 32.4 p -156.25 162.43 40.15 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.784 -0.572 . . . . 0.0 110.42 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 741' ' ' LEU . 36.2 pt -121.67 161.09 22.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 124.217 0.948 . . . . 0.0 108.579 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 739' ' ' THR . 10.5 m -133.37 135.8 44.93 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 123.595 0.56 . . . . 0.0 110.424 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.71 104.17 16.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.7 pp -146.34 161.68 10.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.912 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 71.7 -43.62 0.57 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.406 1.082 . . . . 0.0 111.565 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 138.15 37.14 0.14 Allowed Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 125.162 1.363 . . . . 0.0 109.769 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.8 p -174.41 161.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.502 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 95.8 m95 -77.36 172.87 12.63 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.645 173.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 732' ' ' THR . 29.5 p -80.4 -159.19 0.22 Allowed 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.699 0.762 . . . . 0.0 112.259 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.478 ' CD ' ' H ' ' A' ' 740' ' ' GLN . 0.5 OUTLIER -83.9 -4.57 58.79 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -165.4 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.414 HD13 HG21 ' A' ' 731' ' ' ILE . 4.1 mm? 68.73 156.13 0.15 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 123.432 0.458 . . . . 0.0 111.504 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.564 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 59.0 Cg_endo -80.25 173.66 12.27 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.826 1.684 . . . . 0.0 111.041 172.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -116.36 114.96 25.02 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 724' ' ' THR . 59.1 m -98.08 100.29 11.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-O 122.156 0.979 . . . . 0.0 109.483 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.706 HG11 ' CD1' ' A' ' 750' ' ' LEU . 10.6 p -77.87 155.03 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.292 0 CA-C-N 113.82 -1.537 . . . . 0.0 108.737 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -79.17 1.33 24.87 Favored 'General case' 0 C--N 1.251 -3.7 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.948 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.557 ' HA ' HD22 ' A' ' 750' ' ' LEU . 18.8 mt 77.08 -24.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 126.48 1.912 . . . . 0.0 112.24 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 746' ' ' ALA . 22.9 t70 -72.23 -34.3 68.22 Favored 'General case' 0 C--N 1.264 -3.128 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.103 -175.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 749' ' ' LYS . 8.1 ptmt -102.42 27.8 6.5 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 112.687 -2.051 . . . . 0.0 111.541 -174.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.706 ' CD1' HG11 ' A' ' 745' ' ' VAL . 1.9 tp -84.31 -179.46 7.2 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -107.37 -172.82 2.15 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.586 -173.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 752' ' ' LYS . . . . . 0.543 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 25.0 mtpp -123.03 156.04 35.65 Favored 'General case' 0 C--N 1.265 -3.07 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 79.2 m -112.18 168.6 9.49 Favored 'General case' 1 C--N 1.241 -4.136 0 C-N-CA 123.354 0.662 . . . . 0.0 109.532 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -129.2 141.36 51.17 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 48.1 t -61.86 131.37 49.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.51 ' HB2' HG12 ' A' ' 759' ' ' ILE . 17.7 m -76.17 175.01 9.39 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 123.079 0.551 . . . . 0.0 111.539 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -85.73 -35.02 21.06 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -172.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.18 12.55 26.57 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.525 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.599 HG22 ' SG ' ' A' ' 803' ' ' CYS . 23.2 pt -105.59 156.21 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.183 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 760' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.1 mp -122.6 129.44 75.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.659 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 81.9 mt -97.52 -173.54 2.67 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.629 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 35.0 mt-10 -68.77 162.3 26.56 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 763' ' ' GLU . . . . . 0.568 ' HA ' ' HE2' ' A' ' 766' ' ' LYS . 38.9 mm-40 -61.74 -21.81 64.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.432 0.634 . . . . 0.0 110.738 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.27 2.02 45.18 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.471 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.434 HD12 ' HE2' ' A' ' 771' ' ' PHE . 3.3 mm? -126.94 -12.44 5.88 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 763' ' ' GLU . 57.0 mtmt -68.37 -7.53 32.2 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -102.61 0.67 33.67 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 768' ' ' LYS . 8.4 tppt? -95.02 102.43 14.24 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -78.55 -31.81 47.59 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.368 0.604 . . . . 0.0 109.656 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -131.17 128.25 39.64 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.936 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.659 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 92.6 m-85 -107.15 162.62 13.71 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 772' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 752' ' ' LYS . 2.6 p30 -113.55 168.72 9.52 Favored 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 118.1 -1.44 . . . . 0.0 109.126 175.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.428 ' CD2' HG23 ' A' ' 747' ' ' ILE . 2.1 p-80 -47.42 150.09 0.98 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.984 0.914 . . . . 0.0 112.835 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 61.2 t30 70.93 3.62 4.71 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.934 1.293 . . . . 0.0 111.324 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 12.8 t -78.85 114.39 17.75 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -89.05 113.23 24.32 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.173 178.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 771' ' ' PHE . 8.2 pt -125.89 178.05 4.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-O 121.337 0.589 . . . . 0.0 109.688 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 31.4 ptt180 -133.45 127.84 34.18 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.521 ' CE1' HG12 ' A' ' 801' ' ' VAL . 6.6 p90 -119.38 168.04 11.33 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -144.53 161.01 40.16 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 85.2 m -90.27 143.12 27.05 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.884 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 782' ' ' ARG . . . . . 0.46 ' HB3' HD11 ' A' ' 760' ' ' ILE . 27.4 ptt180 -67.75 130.49 43.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 95.94 -10.59 68.11 Favored Glycine 0 C--N 1.294 -1.765 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.4 mptt -114.02 140.38 48.49 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -116.87 87.66 2.74 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.395 0.617 . . . . 0.0 110.066 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 172.61 158.54 17.11 Favored Glycine 0 N--CA 1.425 -2.036 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.609 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 60.4 m95 -114.32 145.39 41.84 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 117.368 0.584 . . . . 0.0 109.71 -175.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.423 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -95.84 -35.33 5.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.388 -177.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 7.1 m170 70.92 114.41 0.05 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 124.31 1.044 . . . . 0.0 109.785 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 3.6 t -139.46 163.08 33.47 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.97 138.96 52.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 C-N-CA 123.388 0.675 . . . . 0.0 109.459 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.7 t -73.41 110.69 7.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.559 0.695 . . . . 0.0 110.258 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.4 mm -111.81 81.57 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.639 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.7 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.406 ' HB2' ' HG ' ' A' ' 750' ' ' LEU . 9.3 t30 53.52 68.67 0.81 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.947 0.88 . . . . 0.0 112.22 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 795' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 70.55 17.4 74.66 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.824 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -143.52 166.2 25.46 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.604 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 95.1 m95 -112.61 158.92 19.4 Favored 'General case' 0 C--N 1.252 -3.638 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -148.05 106.67 3.65 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.82 138.53 46.98 Favored 'Cis proline' 0 C--O 1.241 0.633 0 C-N-CA 123.62 -1.408 . . . . 0.0 111.541 -0.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.604 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.1 tp10 -57.36 128.27 36.17 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.669 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.521 HG12 ' CE1' ' A' ' 779' ' ' TYR . 15.8 m -72.52 136.12 26.3 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.786 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.706 -173.479 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -152.57 111.09 3.74 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.101 0.477 . . . . 0.0 110.551 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 803' ' ' CYS . . . . . 0.599 ' SG ' HG22 ' A' ' 759' ' ' ILE . 73.4 m -131.32 24.88 4.85 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 122.413 1.102 . . . . 0.0 108.598 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.417 -2.125 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.802 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 690' ' ' THR . . . . . 0.544 ' CG2' ' HB2' ' A' ' 708' ' ' PRO . 19.6 p . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.4 m -74.82 -59.38 2.76 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 135.35 166.88 11.18 Favored Glycine 1 N--CA 1.383 -4.857 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -177.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.656 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 34.1 t70 -53.54 135.78 39.53 Favored 'General case' 0 C--N 1.281 -2.397 0 O-C-N 124.658 0.858 . . . . 0.0 111.062 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 715' ' ' VAL . 1.2 pp -52.76 150.27 9.98 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 113.15 -1.841 . . . . 0.0 115.654 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.42 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.0 Cg_endo -71.82 -162.87 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.61 2.873 . . . . 0.0 111.866 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -135.5 154.64 51.34 Favored 'General case' 0 N--CA 1.395 -3.214 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.62 HD21 ' SG ' ' A' ' 744' ' ' CYS . 21.9 tp -104.25 111.5 24.14 Favored 'General case' 0 C--N 1.252 -3.656 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.593 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -43.9 -37.11 2.68 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.806 1.642 . . . . 0.0 115.22 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -134.73 26.61 3.67 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 121.942 -0.474 . . . . 0.0 110.429 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -139.71 -147.78 5.1 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.207 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.425 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -149.61 173.3 13.8 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 122.617 0.367 . . . . 0.0 110.208 -177.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.61 139.38 40.3 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -82.27 -75.22 0.31 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.962 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 704' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 705' ' ' SER . 1.0 OUTLIER -170.66 162.38 7.83 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.217 0.532 . . . . 0.0 111.343 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.615 ' CB ' HG22 ' A' ' 715' ' ' VAL . 33.8 t 174.92 179.38 0.13 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 128.527 2.731 . . . . 0.0 105.007 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 23.4 p -148.63 140.82 14.74 Favored Pre-proline 0 C--N 1.305 -1.344 0 CA-C-N 118.619 0.645 . . . . 0.0 110.833 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.537 ' HA ' ' N ' ' A' ' 709' ' ' TYR . 50.4 Cg_endo -68.52 163.9 34.95 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.019 1.813 . . . . 0.0 109.064 175.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.544 ' HB2' ' CG2' ' A' ' 690' ' ' THR . 29.7 Cg_endo -64.68 -5.14 3.05 Favored 'Cis proline' 0 N--CA 1.502 1.973 0 N-CA-C 117.353 2.02 . . . . 0.0 117.353 4.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.656 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 74.7 m-85 66.33 66.55 0.47 Allowed 'General case' 0 C--O 1.255 1.362 0 CA-C-O 122.288 1.042 . . . . 0.0 108.566 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -67.11 169.85 7.85 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.336 -1.756 . . . . 0.0 112.111 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.485 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 58.3 m-85 -67.63 137.33 55.53 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.928 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 87.52 8.17 74.46 Favored Glycine 0 N--CA 1.41 -3.048 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.09 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.68 156.77 24.9 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 13.8 m -141.27 139.43 33.69 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 694' ' ' ILE . 20.2 t -126.78 136.65 60.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.565 ' HG3' ' HG2' ' A' ' 729' ' ' ARG . 26.5 tt0 -96.89 140.59 31.22 Favored 'General case' 0 N--CA 1.381 -3.918 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.581 ' HB3' HD22 ' A' ' 697' ' ' LEU . 50.4 m-85 -138.67 120.39 15.24 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 125.833 1.653 . . . . 0.0 107.396 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.425 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 13.5 m120 -122.28 -165.36 1.27 Allowed 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 7.1 m -112.97 135.89 53.25 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 11.9 t -57.94 -68.93 0.2 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 721' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 722' ' ' SER . 11.4 pt-20 -172.26 163.81 5.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 75.4 m 72.13 5.95 5.44 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.193 0.933 . . . . 0.0 110.872 -177.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.648 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.6 m-85 -141.52 145.53 35.28 Favored 'General case' 0 N--CA 1.401 -2.895 0 C-N-CA 125.192 1.397 . . . . 0.0 107.95 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.2 m -114.21 138.24 50.72 Favored 'General case' 0 C--N 1.251 -3.716 0 C-N-CA 125.709 1.604 . . . . 0.0 111.998 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.598 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.1 ttp -91.01 122.36 33.6 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.893 1.277 . . . . 0.0 109.486 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 39.8 mm -124.21 135.89 62.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.949 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 101.35 -74.99 0.37 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.206 173.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.537 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.1 OUTLIER -141.16 177.18 8.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -176.086 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.598 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -135.46 8.92 3.4 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.0 0.905 . . . . 0.0 109.359 170.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 54.4 p -145.72 163.0 36.29 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.699 -0.625 . . . . 0.0 110.235 -176.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.505 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 35.7 pt -122.76 163.4 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 739' ' ' THR . 21.2 m -139.17 137.25 35.89 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.937 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 733' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 5.7 t -86.48 99.9 11.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 734' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 739' ' ' THR . 1.7 pp -140.75 146.27 24.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.284 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 67.87 -4.78 0.93 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 112.47 13.38 11.77 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 121.581 -0.342 . . . . 0.0 112.613 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.2 p -155.09 157.22 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.429 ' CZ3' HG23 ' A' ' 715' ' ' VAL . 96.9 m95 -73.33 167.58 20.93 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 121.056 0.455 . . . . 0.0 109.816 171.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.505 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 42.8 p -77.61 -163.12 0.36 Allowed 'General case' 0 N--CA 1.426 -1.638 0 CA-C-O 122.021 0.915 . . . . 0.0 112.616 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -1.89 32.93 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -167.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 67.61 161.44 0.14 Allowed Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 122.735 0.414 . . . . 0.0 110.386 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.537 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 49.8 Cg_endo -83.64 174.35 8.79 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.443 1.429 . . . . 0.0 110.241 168.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -117.39 117.09 28.53 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.62 ' SG ' HD21 ' A' ' 697' ' ' LEU . 95.4 m -102.67 107.77 18.8 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.188 0.518 . . . . 0.0 110.154 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.437 ' HB ' HD21 ' A' ' 750' ' ' LEU . 39.6 t -96.31 145.05 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.648 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -67.89 6.89 0.61 Allowed 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 125.048 1.339 . . . . 0.0 114.438 -175.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.861 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 36.9 mt 76.34 -16.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 C-N-CA 125.561 1.544 . . . . 0.0 112.025 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 746' ' ' ALA . 14.9 t70 -81.82 -31.96 31.48 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.616 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -107.33 23.23 14.76 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.946 -1.934 . . . . 0.0 108.442 -172.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.861 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 72.5 mt -82.58 -165.21 0.98 Allowed 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.361 175.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.524 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 61.3 mtpt -124.51 152.7 43.1 Favored 'General case' 0 N--CA 1.393 -3.314 0 CA-C-O 121.834 0.826 . . . . 0.0 110.19 -173.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 752' ' ' LYS . . . . . 0.425 ' HE3' ' OE1' ' A' ' 770' ' ' GLU . 43.8 mtmt -101.87 115.56 30.8 Favored 'General case' 0 C--N 1.251 -3.674 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.034 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 753' ' ' CYS . . . . . 0.463 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 0.0 OUTLIER -75.71 166.65 23.23 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-N 112.991 -1.913 . . . . 0.0 109.143 -178.092 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -145.68 161.84 38.93 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.004 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 31.4 t -65.53 121.74 15.61 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.357 172.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.674 ' HB3' HG13 ' A' ' 759' ' ' ILE . 30.6 t -63.91 153.48 36.82 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -58.76 -26.96 64.52 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 124.24 1.016 . . . . 0.0 113.459 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 758' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 803' ' ' CYS . 1.5 mm? -110.59 -13.84 14.16 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.831 -170.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.674 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -87.7 155.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.09 134.41 55.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 113.78 -1.555 . . . . 0.0 107.17 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 1.8 mm? -114.12 178.7 4.19 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.56 ' HB2' HD23 ' A' ' 765' ' ' LEU . 34.6 mt-10 -73.15 163.12 28.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -52.93 -27.61 19.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 764' ' ' HIS . . . . . 0.487 ' HB2' HD22 ' A' ' 765' ' ' LEU . 31.2 m-70 -76.6 -35.97 57.78 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.56 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.0 mm? -91.11 -15.55 29.26 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.192 -1.822 . . . . 0.0 112.551 -168.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -77.48 -6.78 54.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.202 0.525 . . . . 0.0 110.951 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -114.46 13.18 17.59 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.465 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 13.5 tppt? -105.85 112.61 25.73 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -87.31 -29.53 21.53 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.189 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 770' ' ' GLU . . . . . 0.425 ' OE1' ' HE3' ' A' ' 752' ' ' LYS . 45.2 mt-10 -139.66 138.29 35.95 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.653 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.465 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 39.5 m-85 -117.02 177.0 4.87 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -121.48 166.2 14.5 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 792' ' ' CYS . 34.9 t60 -65.54 149.73 49.58 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 83.03 0.41 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.789 1.236 . . . . 0.0 108.668 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 54.0 m -83.41 106.57 15.27 Favored 'General case' 0 N--CA 1.41 -2.467 0 C-N-CA 119.001 -1.079 . . . . 0.0 108.885 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.41 101.94 14.4 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.402 HG12 ' CZ3' ' A' ' 797' ' ' TRP . 4.3 pt -112.87 178.36 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 121.773 0.797 . . . . 0.0 109.868 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.643 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 79.2 mtt180 -130.06 127.76 40.54 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.583 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 7.6 p90 -121.73 168.48 11.76 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -152.93 171.35 18.46 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.749 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 52.7 t -113.06 162.03 16.39 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 782' ' ' ARG . . . . . 0.455 ' HG2' ' SG ' ' A' ' 803' ' ' CYS . 32.4 ptt180 -77.98 104.24 8.42 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 120.65 -44.21 1.41 Allowed Glycine 0 C--N 1.276 -2.765 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.037 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.749 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.7 mptt -97.89 91.04 5.15 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.75 148.28 31.55 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.245 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 100.62 154.34 27.08 Favored Glycine 0 C--N 1.294 -1.763 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -172.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.643 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 45.4 m95 -99.9 139.79 35.05 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 117.622 0.711 . . . . 0.0 110.994 -173.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.583 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -90.35 -33.01 5.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.674 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 18.6 m170 78.45 125.46 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 C-N-CA 124.784 1.234 . . . . 0.0 110.206 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.2 t -151.55 152.98 33.65 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 52.7 t -117.59 134.85 59.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 792' ' ' CYS . . . . . 0.483 ' HB3' ' HA ' ' A' ' 773' ' ' HIS . 52.4 t -67.46 132.78 48.28 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.972 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.61 83.21 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 C-N-CA 124.418 1.087 . . . . 0.0 108.074 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.815 HD22 HD22 ' A' ' 750' ' ' LEU . 3.5 m-20 45.93 72.74 0.2 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.097 0.959 . . . . 0.0 112.809 177.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 795' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 78.4 0.55 78.93 Favored Glycine 0 C--N 1.296 -1.666 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.012 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 796' ' ' ARG . . . . . 0.499 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 36.1 ttm180 -130.38 173.48 10.78 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.601 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 98.5 m95 -116.78 162.18 18.11 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 122.351 0.26 . . . . 0.0 111.179 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -144.68 108.08 4.73 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.17 140.05 56.5 Favored 'Cis proline' 0 C--O 1.248 0.992 0 C-N-CA 123.637 -1.401 . . . . 0.0 111.129 -1.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.601 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.9 tt0 -57.11 125.58 23.33 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.006 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 9.5 m -66.21 133.88 30.53 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.788 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.808 -175.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -147.99 127.03 12.82 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 803' ' ' CYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 758' ' ' LEU . 42.0 t -117.92 -18.39 9.51 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-O 121.548 0.69 . . . . 0.0 109.85 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 C--N 1.301 -1.502 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.361 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.422 -1.832 0 CA-C-O 121.721 0.772 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.7 m -76.41 -74.18 0.24 Allowed 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.161 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 143.72 179.09 20.03 Favored Glycine 1 N--CA 1.356 -6.663 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -39.66 126.52 1.92 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 126.313 1.845 . . . . 0.0 111.484 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.563 HG21 HG21 ' A' ' 715' ' ' VAL . 1.7 pp -63.16 147.78 94.07 Favored Pre-proline 0 N--CA 1.425 -1.707 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.406 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.503 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 72.9 Cg_endo -72.69 -166.22 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.818 2.345 . . . . 0.0 112.828 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -126.6 165.19 19.65 Favored 'General case' 0 N--CA 1.399 -2.977 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.602 HD22 ' HB3' ' A' ' 717' ' ' PHE . 37.6 tp -119.67 110.64 17.07 Favored 'General case' 0 C--N 1.251 -3.705 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.901 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.05 -40.24 6.5 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -173.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 79.9 m80 -128.24 20.7 6.27 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 121.473 -0.767 . . . . 0.0 110.16 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.466 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -125.29 -139.61 5.24 Favored Glycine 0 C--N 1.304 -1.2 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.93 -177.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.6 ' HE1' ' CG ' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -160.85 177.92 9.93 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -109.96 154.65 22.83 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -91.27 -74.32 0.51 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 120.933 0.397 . . . . 0.0 110.369 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 704' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 705' ' ' SER . 6.3 tt -157.22 133.56 9.77 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 177.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 709' ' ' TYR . 4.2 p -133.96 110.73 9.88 Favored 'General case' 0 N--CA 1.393 -3.297 0 CA-C-O 121.724 0.773 . . . . 0.0 110.145 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 39.8 t -90.26 111.45 47.1 Favored Pre-proline 0 C--N 1.277 -2.557 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.993 -174.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.409 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 58.3 Cg_endo -71.26 171.81 15.31 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.774 2.316 . . . . 0.0 109.363 175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.477 ' HG2' ' CE1' ' A' ' 710' ' ' TYR . 2.8 Cg_exo -70.75 -7.24 11.57 Favored 'Cis proline' 0 CA--C 1.498 -1.316 0 N-CA-C 115.505 1.31 . . . . 0.0 115.505 5.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 705' ' ' SER . 43.3 m-85 78.55 86.1 0.07 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.477 ' CE1' ' HG2' ' A' ' 708' ' ' PRO . 26.9 m-85 -91.2 174.65 7.28 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.815 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.449 ' CE2' ' HA2' ' A' ' 736' ' ' GLY . 64.1 m-85 -74.71 136.64 41.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.231 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 91.26 -4.91 81.01 Favored Glycine 0 N--CA 1.416 -2.657 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.356 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -73.59 147.79 43.52 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 6.8 m -129.02 152.53 48.53 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.563 HG21 HG21 ' A' ' 694' ' ' ILE . 41.1 t -136.29 133.01 49.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 36.7 mt-10 -95.17 140.32 30.25 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.962 0.886 . . . . 0.0 111.638 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.602 ' HB3' HD22 ' A' ' 697' ' ' LEU . 37.3 m-85 -138.76 129.96 26.95 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.6 ' CG ' ' HE1' ' A' ' 701' ' ' TRP . 9.1 p30 -128.44 -167.77 1.82 Allowed 'General case' 1 N--CA 1.377 -4.089 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 44.4 m -108.65 124.06 49.94 Favored 'General case' 0 C--N 1.247 -3.864 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 24.2 t -44.9 -80.75 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 O-C-N 125.689 1.868 . . . . 0.0 112.834 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -153.83 150.74 28.75 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.3 m 69.19 9.65 7.46 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.262 0.976 . . . . 0.0 113.611 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 719' ' ' CYS . 96.5 m-85 -134.3 145.53 49.16 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.567 HG21 HD11 ' A' ' 750' ' ' LEU . 6.4 t -75.86 -115.53 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.898 -175.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.64 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.2 ttp 165.09 107.86 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.732 2.813 . . . . 0.0 105.227 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.703 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 42.1 mm -119.03 143.96 28.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 92.48 -68.87 1.81 Allowed Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.731 173.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.544 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.5 t60 -154.58 -178.71 7.37 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -174.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.64 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -139.35 20.31 2.57 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.379 0.609 . . . . 0.0 110.012 173.278 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.606 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 59.9 p -156.08 162.3 40.29 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.879 -177.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 714' ' ' SER . 35.8 pt -120.34 157.75 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 739' ' ' THR . 6.1 m -131.26 135.6 47.48 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.0 t -95.77 111.57 23.5 Favored 'General case' 0 N--CA 1.392 -3.346 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.763 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.09 154.23 28.05 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.128 0 CA-C-N 113.649 -1.614 . . . . 0.0 107.089 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 76.76 -44.74 0.48 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.311 1.044 . . . . 0.0 110.26 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 736' ' ' GLY . . . . . 0.449 ' HA2' ' CE2' ' A' ' 711' ' ' TYR . . . 144.86 25.78 0.11 Allowed Glycine 0 C--N 1.298 -1.559 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 8.5 p -163.64 167.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.503 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 86.8 m95 -84.33 173.02 11.28 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 121.156 0.503 . . . . 0.0 111.634 177.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 732' ' ' THR . 21.3 p -86.92 -157.25 0.36 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 4.6 pm0 -69.49 -24.28 63.75 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 126.065 1.746 . . . . 0.0 113.468 -171.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.446 HD21 ' HG2' ' A' ' 695' ' ' PRO . 1.6 mt 70.08 155.27 0.15 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 124.452 1.095 . . . . 0.0 111.206 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.544 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 37.6 Cg_endo -71.61 175.28 9.75 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.792 1.661 . . . . 0.0 111.812 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.703 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 53.9 tt0 -123.11 119.2 29.59 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.567 ' SG ' HD21 ' A' ' 697' ' ' LEU . 90.7 m -105.0 104.4 14.13 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.18 0.514 . . . . 0.0 110.965 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 724' ' ' THR . 42.2 t -101.83 147.2 8.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 748' ' ' ASP . . . -65.76 3.73 0.73 Allowed 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 124.867 1.267 . . . . 0.0 113.788 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.86 ' HA ' HD22 ' A' ' 750' ' ' LEU . 61.4 mt 73.8 -17.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.821 1.648 . . . . 0.0 110.938 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 746' ' ' ALA . 7.2 t70 -72.51 -33.03 66.63 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 126.402 1.881 . . . . 0.0 109.267 -177.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -105.05 18.91 21.53 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.566 -172.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.86 HD22 ' HA ' ' A' ' 747' ' ' ILE . 0.2 OUTLIER -82.06 -172.9 4.2 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.06 179.179 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 751' ' ' LYS . 28.1 mmmt -115.04 148.7 38.55 Favored 'General case' 0 N--CA 1.381 -3.906 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.706 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -109.82 119.26 38.79 Favored 'General case' 1 C--N 1.23 -4.613 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.378 -173.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 753' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 770' ' ' GLU . 27.2 m -67.27 162.73 22.06 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.762 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 754' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 769' ' ' LYS . 16.9 ptpt -126.44 144.15 50.94 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.181 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 755' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 769' ' ' LYS . 48.0 p -68.06 114.13 6.33 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.754 171.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.585 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 45.2 t -69.76 156.9 38.31 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -84.32 -13.39 52.54 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.278 0.561 . . . . 0.0 112.385 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 5.6 mp -95.53 -4.28 45.08 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.059 -173.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.585 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.1 pp -118.96 152.24 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 CA-C-O 121.985 0.897 . . . . 0.0 112.138 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.58 127.77 64.76 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.795 0 CA-C-N 113.814 -1.539 . . . . 0.0 107.365 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.467 HD11 HD13 ' A' ' 759' ' ' ILE . 1.5 mm? -107.6 -175.18 2.72 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.565 ' HB2' HD23 ' A' ' 765' ' ' LEU . 25.6 mt-10 -76.87 171.86 14.07 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.263 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.33 -31.34 67.47 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.282 0.633 . . . . 0.0 110.544 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.32 2.09 54.6 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.731 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.565 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.9 mm? -122.28 -24.45 5.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 53.8 mtmt -66.38 -23.78 66.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -86.77 -2.83 58.86 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.939 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.483 ' HE3' ' CD2' ' A' ' 771' ' ' PHE . 23.4 ttpt -99.4 110.22 22.74 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 769' ' ' LYS . . . . . 0.608 ' HG2' ' HG3' ' A' ' 770' ' ' GLU . 0.0 OUTLIER -93.03 -23.98 18.48 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 770' ' ' GLU . . . . . 0.608 ' HG3' ' HG2' ' A' ' 769' ' ' LYS . 37.6 mt-10 -127.77 106.41 9.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.483 ' CD2' ' HE3' ' A' ' 768' ' ' LYS . 67.5 m-85 -89.59 147.95 23.64 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.916 -174.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -89.49 144.59 25.92 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.158 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.644 ' HB3' HD23 ' A' ' 750' ' ' LEU . 49.9 t60 -57.95 146.77 31.18 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.319 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 65.5 t30 83.44 3.75 0.9 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.37 1.468 . . . . 0.0 110.232 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 67.8 m -86.41 113.6 22.5 Favored 'General case' 0 N--CA 1.398 -3.047 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.407 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -85.89 90.6 8.11 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.497 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 777' ' ' ILE . . . . . . . . . . . . . 7.4 pt -95.23 -175.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.702 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 0.2 OUTLIER -141.55 121.06 13.26 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.007 175.422 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.559 ' CD2' HG13 ' A' ' 801' ' ' VAL . 10.6 p90 -106.71 168.71 8.99 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 174.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -149.82 146.91 27.4 Favored 'General case' 0 C--N 1.257 -3.45 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.733 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 5.0 t -79.36 168.43 19.52 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -74.21 -1.38 20.25 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.113 0.482 . . . . 0.0 111.901 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -113.15 -6.6 22.2 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.733 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 3.8 mptp? -112.58 137.53 50.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -106.59 4.89 28.52 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.43 1.11 . . . . 0.0 110.805 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -113.04 157.84 14.67 Favored Glycine 0 C--N 1.268 -3.225 0 CA-C-N 113.446 -1.706 . . . . 0.0 108.943 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 46.0 m95 -100.35 141.45 33.18 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 117.231 0.516 . . . . 0.0 110.298 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.518 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -91.93 -31.31 4.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 15.4 m170 73.25 123.62 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 124.455 1.102 . . . . 0.0 110.13 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.494 HG21 ' CG2' ' A' ' 801' ' ' VAL . 2.3 t -146.33 155.36 42.57 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 24.9 t -114.21 133.26 60.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 41.6 t -70.46 117.2 11.7 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.591 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 47.8 mm -119.29 89.15 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 C-N-CA 123.861 0.865 . . . . 0.0 109.382 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.498 ' OD1' ' HG ' ' A' ' 750' ' ' LEU . 0.8 OUTLIER 43.59 62.35 1.93 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.083 0.953 . . . . 0.0 112.754 175.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.15 36.47 56.29 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.968 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -158.79 165.53 34.05 Favored 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.622 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.4 m95 -114.23 160.36 19.11 Favored 'General case' 0 C--N 1.258 -3.385 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 798' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 24.7 t70 -148.1 102.13 3.6 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 799' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 798' ' ' ASP . 48.7 Cg_endo -70.77 142.59 72.9 Favored 'Cis proline' 0 C--O 1.244 0.824 0 C-N-CA 123.886 -1.298 . . . . 0.0 112.96 0.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.622 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 45.5 mt-10 -48.55 125.34 9.66 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.287 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.559 HG13 ' CD2' ' A' ' 779' ' ' TYR . 75.5 t -82.45 116.62 26.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.24 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 13.4 t30 -159.15 122.36 3.71 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.547 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 28.6 m -106.55 -18.15 14.05 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.643 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.307 -1.24 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.476 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 54.1 m -78.62 -75.1 0.24 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.304 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 143.13 -167.9 26.26 Favored Glycine 1 N--CA 1.378 -5.226 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -48.89 130.34 18.01 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 125.462 1.505 . . . . 0.0 110.417 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.679 HG21 HG21 ' A' ' 715' ' ' VAL . 1.3 pp -58.52 150.61 55.12 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.324 -177.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.6 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 74.3 Cg_endo -72.15 -159.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 123.276 2.65 . . . . 0.0 114.147 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -125.31 158.86 33.13 Favored 'General case' 0 N--CA 1.397 -3.115 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.617 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.5 OUTLIER -107.4 129.36 54.93 Favored 'General case' 0 C--N 1.26 -3.312 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.539 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -45.87 -45.68 15.32 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -141.22 27.18 1.95 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.417 0.627 . . . . 0.0 109.536 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.617 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -134.0 -146.32 5.44 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.807 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.433 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -153.41 178.11 10.15 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 122.94 0.496 . . . . 0.0 110.257 -175.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -108.55 147.5 31.68 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -71.34 -77.78 0.09 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.146 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.6 tt 179.66 135.98 0.1 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.518 ' HB2' HG13 ' A' ' 715' ' ' VAL . 22.9 t -144.81 -168.89 3.04 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 9.7 t -152.46 139.56 12.64 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.45 169.11 10.18 Favored 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 122.963 2.442 . . . . 0.0 110.072 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 710' ' ' TYR . 2.8 Cg_exo -72.44 -9.95 16.99 Favored 'Cis proline' 0 N--CA 1.49 1.279 0 N-CA-C 115.184 1.186 . . . . 0.0 115.184 7.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.415 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 62.3 m-85 73.28 79.85 0.13 Allowed 'General case' 0 C--N 1.312 -1.064 0 O-C-N 124.575 1.172 . . . . 0.0 108.993 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 708' ' ' PRO . 21.4 m-85 -84.05 168.67 15.69 Favored 'General case' 0 CA--C 1.477 -1.84 0 CA-C-N 113.943 -1.481 . . . . 0.0 112.717 -174.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -69.66 128.3 35.97 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.07 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.57 -15.53 55.79 Favored Glycine 0 N--CA 1.414 -2.791 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.611 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.47 145.25 52.89 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 10.8 m -131.32 150.28 52.21 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.679 HG21 HG21 ' A' ' 694' ' ' ILE . 42.7 t -138.15 124.65 26.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.694 ' HG3' ' HG2' ' A' ' 729' ' ' ARG . 2.3 mp0 -65.68 134.55 53.46 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.722 0.772 . . . . 0.0 112.623 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.425 ' HB3' ' CD1' ' A' ' 697' ' ' LEU . 19.9 m-85 -137.61 114.91 10.99 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 126.374 1.87 . . . . 0.0 107.063 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.433 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 19.3 m-20 -124.15 -168.56 1.81 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -175.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 23.3 m -116.17 138.62 51.11 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 5.0 m -57.55 -78.13 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 123.973 0.796 . . . . 0.0 112.152 -174.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -157.79 159.36 36.67 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 58.4 m 65.95 9.56 6.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.598 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 94.6 m-85 -142.14 146.04 34.89 Favored 'General case' 0 N--CA 1.407 -2.586 0 C-N-CA 124.12 0.968 . . . . 0.0 108.771 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.0 OUTLIER -113.09 137.31 51.62 Favored 'General case' 0 C--N 1.256 -3.478 0 C-N-CA 125.432 1.493 . . . . 0.0 111.129 -178.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 725' ' ' MET . . . . . . . . . . . . . 9.2 tmm? -87.54 125.36 34.29 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.9 mm -124.91 133.32 69.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.009 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 121.33 -89.37 0.43 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.095 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 56.3 t-80 -157.03 145.55 19.69 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.694 ' HG2' ' HG3' ' A' ' 716' ' ' GLU . 0.0 OUTLIER -86.84 13.77 8.35 Favored 'General case' 0 C--N 1.274 -2.691 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.879 -171.552 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 716' ' ' GLU . 6.0 p -156.66 168.56 27.03 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.951 -0.468 . . . . 0.0 111.987 -176.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 714' ' ' SER . 35.1 pt -117.0 164.61 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.587 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.3 m -136.08 134.24 38.19 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.698 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 8.5 t -84.14 107.57 16.54 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.092 0.472 . . . . 0.0 110.037 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -144.95 145.64 20.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 C-N-CA 125.085 1.354 . . . . 0.0 109.896 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 66.62 -0.31 1.61 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.39 24.45 24.05 Favored Glycine 0 CA--C 1.498 -0.973 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.09 153.26 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.6 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.4 m95 -79.11 177.83 8.51 Favored 'General case' 0 C--N 1.277 -2.545 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.468 168.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.409 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 17.1 p -80.84 -169.81 2.37 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.686 0.755 . . . . 0.0 112.873 -176.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.3 pp0? -71.46 -14.98 62.31 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -171.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 2.1 mt 69.54 146.53 0.11 Allowed Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 124.394 1.059 . . . . 0.0 113.853 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 48.1 Cg_endo -69.23 169.11 19.0 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 121.968 1.778 . . . . 0.0 112.346 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -115.22 104.69 12.08 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.821 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 724' ' ' THR . 87.3 m -84.8 99.74 11.09 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.653 0.739 . . . . 0.0 110.112 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.64 ' CG1' ' HG3' ' A' ' 749' ' ' LYS . 41.7 t -92.8 142.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.537 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.598 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.32 2.29 0.62 Allowed 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 125.857 1.663 . . . . 0.0 114.624 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.773 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 49.0 mt 78.33 -14.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 126.063 1.745 . . . . 0.0 111.699 176.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 746' ' ' ALA . 24.9 t70 -83.88 -30.14 26.65 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.729 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.64 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 7.8 ptmt -110.58 29.78 7.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.002 -1.453 . . . . 0.0 111.838 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.773 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 96.2 mt -84.33 176.1 8.94 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.827 177.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -99.81 145.31 27.87 Favored 'General case' 0 N--CA 1.388 -3.564 0 CA-C-O 122.727 1.251 . . . . 0.0 110.293 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -98.17 111.84 24.02 Favored 'General case' 1 C--N 1.236 -4.366 0 CA-C-N 111.248 -2.705 . . . . 0.0 109.21 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 42.5 m -66.99 138.54 57.32 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.867 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -107.95 136.39 47.73 Favored 'General case' 0 C--N 1.27 -2.867 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.407 -174.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 755' ' ' SER . . . . . 0.412 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 15.5 p -52.75 132.82 36.92 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.842 173.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.572 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 29.8 t -80.46 166.75 20.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -93.36 -17.28 23.72 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 758' ' ' LEU . . . . . 0.728 HD12 ' HA ' ' A' ' 804' ' ' SER . 74.5 mt -113.23 14.37 19.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.299 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.572 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.1 pp -115.05 149.18 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.961 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 760' ' ' ILE . . . . . 0.572 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.2 mp -107.95 129.95 61.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.862 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -177.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 1.9 mm? -108.17 178.76 4.41 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -77.96 172.21 13.84 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -66.47 -8.77 28.42 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 122.952 0.501 . . . . 0.0 112.035 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -93.13 -17.09 24.18 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.701 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 81.8 mt -117.03 -18.13 10.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -170.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -62.48 -26.17 68.39 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -101.42 8.35 42.21 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.714 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.705 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 19.2 ttmm -98.42 94.93 6.99 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 769' ' ' LYS . . . . . 0.465 ' HD2' ' H ' ' A' ' 769' ' ' LYS . 0.0 OUTLIER -71.23 -30.3 66.17 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.952 -177.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.83 123.24 20.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.558 0.694 . . . . 0.0 110.915 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.705 ' CD2' ' HD2' ' A' ' 768' ' ' LYS . 14.2 m-85 -101.51 156.51 17.43 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.709 -174.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -98.7 156.12 16.99 Favored 'General case' 0 C--N 1.281 -2.393 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.011 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.641 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 47.5 t60 -59.16 137.47 57.95 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.238 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 64.5 t30 84.93 12.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 O-C-N 125.633 1.833 . . . . 0.0 109.746 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 58.7 m -87.32 117.78 26.32 Favored 'General case' 0 N--CA 1.41 -2.473 0 C-N-CA 119.208 -0.997 . . . . 0.0 108.783 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -91.96 107.37 19.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.701 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 5.6 pt -118.9 -175.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 17.3 ptp180 -147.13 128.5 14.88 Favored 'General case' 0 N--CA 1.399 -2.979 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 173.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.532 ' CD2' HG13 ' A' ' 801' ' ' VAL . 10.3 p90 -108.36 169.54 8.57 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 780' ' ' ARG . . . . . 0.572 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 15.3 ptt180 -144.81 154.18 42.41 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 173.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.572 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 5.5 t -96.76 158.61 15.35 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -65.69 -22.94 66.67 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -103.42 -1.35 47.2 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.606 175.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.572 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 5.0 mptp? -108.56 103.09 12.14 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 122.616 -0.344 . . . . 0.0 110.879 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.84 86.43 6.92 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.512 1.148 . . . . 0.0 108.528 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 157.31 145.27 4.16 Favored Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 52.6 m95 -92.34 145.23 24.64 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.517 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -97.79 -27.56 3.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.948 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 72.53 123.61 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.842 1.257 . . . . 0.0 109.135 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.543 ' HA ' ' HD2' ' A' ' 799' ' ' PRO . 3.1 t -145.28 156.75 44.01 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.887 0.375 . . . . 0.0 111.142 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 34.7 t -118.95 135.04 60.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 C-N-CA 122.639 0.376 . . . . 0.0 110.132 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.3 t -69.97 118.79 13.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.641 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 47.2 mm -117.84 87.17 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 124.338 1.055 . . . . 0.0 108.526 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 794' ' ' ASN . . . . . . . . . . . . . 5.5 t30 42.9 67.69 0.59 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.373 1.069 . . . . 0.0 113.272 177.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 74.69 23.35 75.32 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 115.06 -0.973 . . . . 0.0 114.127 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -150.02 166.24 30.3 Favored 'General case' 0 C--O 1.197 -1.681 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.569 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 91.2 m95 -114.82 157.13 23.7 Favored 'General case' 0 C--N 1.264 -3.142 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -148.75 106.24 3.46 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 799' ' ' PRO . . . . . 0.543 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 38.0 Cg_endo -66.32 138.73 40.27 Favored 'Cis proline' 0 C--O 1.237 0.443 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.014 -0.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.569 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.9 tt0 -53.56 134.77 40.99 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.863 0.865 . . . . 0.0 110.888 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.532 HG13 ' CD2' ' A' ' 779' ' ' TYR . 57.9 t -99.8 117.12 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.534 -176.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -159.89 116.53 2.52 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 65.2 m -124.53 13.6 8.76 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 804' ' ' SER . . . . . 0.728 ' HA ' HD12 ' A' ' 758' ' ' LEU . 7.4 m . . . . . 0 N--CA 1.416 -2.145 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.501 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.4 m -73.44 -66.57 0.68 Allowed 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.17 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 124.57 -156.0 18.48 Favored Glycine 1 N--CA 1.363 -6.213 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -36.87 123.93 0.86 Allowed 'General case' 0 C--N 1.278 -2.534 0 O-C-N 126.52 1.953 . . . . 0.0 112.239 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.688 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -69.3 146.54 96.73 Favored Pre-proline 0 N--CA 1.415 -2.198 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.271 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.462 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 72.4 Cg_endo -72.08 -165.31 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.767 2.312 . . . . 0.0 112.444 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.68 161.42 35.18 Favored 'General case' 0 N--CA 1.394 -3.265 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 717' ' ' PHE . 21.7 tp -106.07 117.97 35.41 Favored 'General case' 1 C--N 1.244 -4.017 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.186 -177.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -33.55 -44.91 0.15 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.403 2.281 . . . . 0.0 115.288 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 91.5 m-70 -137.57 25.09 2.89 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -136.76 -142.19 4.39 Favored Glycine 0 CA--C 1.497 -1.044 0 C-N-CA 120.094 -1.051 . . . . 0.0 112.252 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.436 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -158.59 174.53 14.92 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -178.196 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.37 145.78 32.46 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 57.3 mm-40 -89.03 -80.76 0.29 Allowed 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.052 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 53.5 tp -160.6 151.46 18.7 Favored 'General case' 0 C--O 1.243 0.749 0 O-C-N 122.458 -0.151 . . . . 0.0 110.683 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.634 ' CB ' HG22 ' A' ' 715' ' ' VAL . 23.5 t -166.19 -54.29 0.03 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.434 0.693 . . . . 0.0 110.38 172.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 37.4 m 70.66 142.82 0.09 OUTLIER Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.916 1.686 . . . . 0.0 113.085 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.543 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 58.1 Cg_endo -63.63 176.53 2.21 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 123.809 3.006 . . . . 0.0 113.089 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.9 Cg_exo -77.15 -7.21 30.43 Favored 'Cis proline' 0 N--CA 1.498 1.737 0 N-CA-C 114.67 0.989 . . . . 0.0 114.67 3.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 58.9 m-85 74.41 82.21 0.11 Allowed 'General case' 0 C--N 1.309 -1.167 0 O-C-N 124.515 1.134 . . . . 0.0 110.333 177.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -86.24 173.51 9.72 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.35 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -69.37 135.2 50.0 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.85 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.21 -18.69 57.02 Favored Glycine 0 N--CA 1.422 -2.278 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.207 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.22 155.15 40.28 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.228 0.537 . . . . 0.0 111.588 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 11.8 m -135.86 157.15 47.54 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.663 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.688 HG21 HG21 ' A' ' 694' ' ' ILE . 23.5 t -137.64 129.3 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 41.6 mt-10 -77.16 138.05 39.25 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 123.675 0.609 . . . . 0.0 111.733 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.586 ' HB3' HD22 ' A' ' 697' ' ' LEU . 32.7 m-85 -140.53 129.97 23.95 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 124.483 1.113 . . . . 0.0 108.698 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.451 ' O ' HD23 ' A' ' 697' ' ' LEU . 11.0 m120 -138.05 -164.81 1.68 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 10.8 m -118.99 139.74 51.18 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 6.1 m -62.49 -79.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 O-C-N 123.65 0.594 . . . . 0.0 111.613 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -148.11 161.93 40.43 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 66.6 m 71.03 -6.36 1.32 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.516 1.135 . . . . 0.0 112.859 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.547 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 93.8 m-85 -131.74 146.57 52.23 Favored 'General case' 0 N--CA 1.392 -3.361 0 CA-C-O 121.88 0.848 . . . . 0.0 108.959 -175.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.651 HG21 HD21 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -116.68 143.82 45.18 Favored 'General case' 1 C--N 1.241 -4.129 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.204 179.873 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.546 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.7 ttp -86.22 123.92 32.04 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.557 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 45.0 mm -121.44 137.45 55.06 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 113.17 -90.76 0.55 Allowed Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.562 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 23.0 t-80 -159.95 143.35 14.07 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.546 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.8 ppt_? -81.67 17.18 1.52 Allowed 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -174.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 22.0 p -161.21 153.28 19.82 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.791 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.447 HG21 HD13 ' A' ' 741' ' ' LEU . 27.3 pt -104.85 168.61 2.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.407 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 11.3 m -138.32 135.56 35.53 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.447 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 9.5 t -83.67 105.11 14.32 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.44 0.638 . . . . 0.0 109.94 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -140.31 144.62 27.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 124.695 1.198 . . . . 0.0 110.344 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 76.8 m80 69.75 -11.26 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.55 0.74 . . . . 0.0 112.673 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 113.37 10.77 14.52 Favored Glycine 0 C--O 1.242 0.617 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 737' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 738' ' ' TRP . 58.8 t -142.23 154.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.48 ' O ' HG12 ' A' ' 737' ' ' VAL . 95.5 m95 -78.76 172.53 13.6 Favored 'General case' 0 C--N 1.273 -2.727 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.211 170.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.407 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 39.9 p -74.09 -165.69 0.33 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.846 0.831 . . . . 0.0 111.211 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.5 OUTLIER -83.38 -3.03 57.14 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -166.653 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 3.9 mm? 72.79 157.25 0.16 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 124.15 0.906 . . . . 0.0 109.639 -174.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.562 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 26.2 Cg_endo -71.64 179.72 4.45 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.232 1.288 . . . . 0.0 110.825 171.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 52.0 tt0 -117.36 105.4 12.12 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 724' ' ' THR . 95.4 m -89.43 103.51 16.14 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 121.397 0.617 . . . . 0.0 110.236 177.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 747' ' ' ILE . 34.7 t -97.92 144.32 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.022 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.547 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.93 5.2 0.35 Allowed 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 125.73 1.612 . . . . 0.0 113.531 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 1.029 ' HA ' HD22 ' A' ' 750' ' ' LEU . 59.0 mt 77.15 -17.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 125.932 1.693 . . . . 0.0 111.239 176.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 746' ' ' ALA . 3.2 t70 -75.86 -31.76 59.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.517 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -103.29 21.65 15.53 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.243 -173.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 1.029 HD22 ' HA ' ' A' ' 747' ' ' ILE . 0.4 OUTLIER -85.36 -177.88 6.59 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 113.83 -1.532 . . . . 0.0 107.778 175.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.611 ' HB3' ' N ' ' A' ' 795' ' ' GLY . 39.0 tptt -98.19 161.33 13.76 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 752' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 14.5 mmmm -101.96 112.7 25.42 Favored 'General case' 1 C--N 1.233 -4.493 0 CA-C-N 112.237 -2.256 . . . . 0.0 107.452 -177.423 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 150.07 41.15 Favored 'General case' 0 C--N 1.257 -3.419 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.184 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 754' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 769' ' ' LYS . 88.4 tttt -126.94 136.77 52.73 Favored 'General case' 0 C--N 1.258 -3.391 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.69 -174.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 46.6 p -63.78 112.89 3.08 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.622 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.654 ' HB2' HG12 ' A' ' 759' ' ' ILE . 49.1 m -61.94 133.5 55.47 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 173.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.13 4.31 8.81 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.026 0.917 . . . . 0.0 111.134 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.19 -21.88 16.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.978 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 756' ' ' SER . 31.3 pt -103.27 167.97 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.401 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.837 -174.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.39 130.73 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.248 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.525 HD12 HD12 ' A' ' 777' ' ' ILE . 1.9 mm? -108.95 -177.12 3.22 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.819 ' HB2' HD23 ' A' ' 765' ' ' LEU . 40.3 mt-10 -72.04 175.15 6.17 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.49 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 763' ' ' GLU . . . . . 0.425 ' HA ' ' HE2' ' A' ' 766' ' ' LYS . 40.9 mt-10 -77.84 4.59 11.47 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -171.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 764' ' ' HIS . . . . . 0.525 ' HB2' HD22 ' A' ' 765' ' ' LEU . 16.5 m-70 -108.13 -22.26 12.45 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 171.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.819 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.6 mm? -101.37 -13.18 18.11 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.681 -168.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 763' ' ' GLU . 50.6 mtmt -75.59 -19.92 58.93 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -85.25 -3.76 58.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.243 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.48 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 9.9 tppt? -106.12 107.5 18.53 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 769' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 754' ' ' LYS . 38.0 ttpt -85.82 -37.63 19.02 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 770' ' ' GLU . . . . . 0.424 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 47.2 mt-10 -117.48 118.02 31.05 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.511 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.48 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 66.6 m-85 -102.56 174.44 5.9 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.46 167.68 10.52 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.858 ' HB3' HD23 ' A' ' 750' ' ' LEU . 19.2 t60 -70.48 151.33 45.23 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 8.0 t30 83.36 3.17 0.95 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.998 1.436 . . . . 0.0 109.225 177.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 66.7 m -82.14 112.64 19.37 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.567 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -88.89 109.89 20.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.525 HD12 HD12 ' A' ' 761' ' ' LEU . 9.5 pt -126.15 178.19 4.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.631 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 25.6 ptt180 -131.55 128.96 40.34 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 779' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -118.03 169.16 9.89 Favored 'General case' 0 C--O 1.259 1.576 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -150.72 157.11 42.56 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 35.6 t -81.98 159.48 23.54 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 782' ' ' ARG . . . . . 0.4 ' HG2' ' SG ' ' A' ' 803' ' ' CYS . 35.3 ptt180 -69.53 -23.3 63.57 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.762 0.315 . . . . 0.0 111.137 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -102.97 -9.03 40.79 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.813 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.3 mptt -115.89 122.89 46.69 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.915 0.358 . . . . 0.0 110.158 -177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -95.87 99.61 11.39 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.53 0.681 . . . . 0.0 109.886 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 159.78 143.22 3.6 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.631 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 34.6 m95 -98.79 144.78 27.64 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 117.402 0.601 . . . . 0.0 109.838 -174.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 788' ' ' ILE . 3.6 mp -99.17 -31.32 3.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.009 -177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 12.4 m170 72.23 120.1 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 124.414 1.086 . . . . 0.0 110.152 -174.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.427 HG21 ' CG1' ' A' ' 801' ' ' VAL . 3.5 t -139.19 156.58 47.01 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.094 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 71.0 t -118.08 130.31 73.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 792' ' ' CYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 773' ' ' HIS . 49.0 t -66.55 134.63 52.76 Favored 'General case' 0 CA--C 1.479 -1.769 0 C-N-CA 118.841 -1.144 . . . . 0.0 109.299 176.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 793' ' ' ILE . . . . . 0.589 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 49.4 mm -124.68 90.3 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.404 ' H ' ' HB2' ' A' ' 773' ' ' HIS . 5.5 t30 44.22 73.5 0.15 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.001 0.92 . . . . 0.0 112.471 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 795' ' ' GLY . . . . . 0.611 ' N ' ' HB3' ' A' ' 751' ' ' LYS . . . 77.8 -11.23 21.38 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.615 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 796' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 68.4 ttt180 -117.33 178.11 4.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -175.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.598 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 99.0 m95 -122.08 162.02 21.99 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 117.761 0.255 . . . . 0.0 110.779 178.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -148.23 105.0 3.56 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.446 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -67.42 138.5 42.54 Favored 'Cis proline' 0 C--O 1.247 0.972 0 C-N-CA 123.791 -1.337 . . . . 0.0 111.344 -1.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.598 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 13.6 tt0 -55.02 119.1 4.93 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.068 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.427 ' CG1' HG21 ' A' ' 790' ' ' THR . 16.6 m -61.63 137.37 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.945 0 C-N-CA 123.73 0.812 . . . . 0.0 112.487 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -145.64 149.42 34.47 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 803' ' ' CYS . . . . . 0.4 ' SG ' ' HG2' ' A' ' 782' ' ' ARG . 32.7 t -142.49 27.59 1.7 Allowed 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.628 1.204 . . . . 0.0 108.644 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.156 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.443 -0.779 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 65.1 m -72.28 -75.97 0.12 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.026 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 141.37 -145.24 15.63 Favored Glycine 1 N--CA 1.379 -5.163 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -53.02 133.65 38.38 Favored 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 125.369 1.468 . . . . 0.0 111.814 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.685 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -76.05 148.1 81.04 Favored Pre-proline 0 N--CA 1.41 -2.474 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.885 176.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.456 ' HG2' HD21 ' A' ' 741' ' ' LEU . 53.5 Cg_endo -71.04 -163.72 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.347 2.698 . . . . 0.0 112.625 176.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -148.76 169.58 20.13 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.635 HD13 ' SG ' ' A' ' 744' ' ' CYS . 17.0 mt -102.77 146.44 28.25 Favored 'General case' 0 C--N 1.27 -2.851 0 O-C-N 123.792 0.682 . . . . 0.0 111.197 175.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.62 -37.69 87.3 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.168 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 744' ' ' CYS . 96.0 m-70 -140.06 27.8 2.15 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.04 0.448 . . . . 0.0 110.688 -177.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -140.65 -146.02 4.72 Favored Glycine 0 C--N 1.297 -1.615 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.459 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -156.58 171.84 19.62 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 117.216 0.508 . . . . 0.0 111.305 -179.215 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.23 144.86 33.41 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' A' ' 703' ' ' GLN . 13.7 mt-30 -73.36 -79.75 0.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.21 0.318 . . . . 0.0 111.197 177.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 8.3 tt 172.67 130.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.63 ' CB ' HG22 ' A' ' 715' ' ' VAL . 22.7 t -131.18 -32.67 1.57 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.653 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 32.9 t 74.3 124.07 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.04 1.336 . . . . 0.0 112.41 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 37.3 Cg_endo -61.24 176.7 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.891 3.061 . . . . 0.0 111.564 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 13.3 Cg_exo -71.72 -18.86 14.12 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 N-CA-C 114.626 0.972 . . . . 0.0 114.626 4.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.451 ' HE1' ' HB3' ' A' ' 705' ' ' SER . 45.6 m-85 83.29 90.6 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.119 0 O-C-N 124.771 1.294 . . . . 0.0 110.885 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -91.93 176.03 6.66 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.205 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -72.71 136.86 45.65 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.028 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 93.02 -10.82 73.24 Favored Glycine 0 N--CA 1.417 -2.63 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.428 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.61 150.87 44.25 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 14.2 m -138.69 148.96 44.6 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.685 HG21 HG21 ' A' ' 694' ' ' ILE . 21.2 t -130.27 130.38 65.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 41.3 mt-10 -89.58 135.91 33.33 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 123.658 0.599 . . . . 0.0 111.269 -177.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.606 ' HD2' ' HG ' ' A' ' 697' ' ' LEU . 25.7 m-85 -132.23 132.34 42.99 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 124.521 1.128 . . . . 0.0 109.053 -177.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.459 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 8.0 m-80 -137.97 -162.68 1.33 Allowed 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 7.6 m -120.0 140.41 51.0 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 43.1 t -50.6 -72.44 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 O-C-N 124.216 0.948 . . . . 0.0 110.909 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.28 163.2 4.54 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 173.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 73.9 m 67.41 16.99 10.1 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 124.189 0.93 . . . . 0.0 111.271 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.712 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 87.4 m-85 -147.38 149.13 32.16 Favored 'General case' 0 N--CA 1.405 -2.703 0 C-N-CA 125.976 1.71 . . . . 0.0 107.685 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.1 m -117.5 144.93 44.57 Favored 'General case' 0 C--N 1.278 -2.522 0 O-C-N 123.805 0.69 . . . . 0.0 110.58 -176.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.5 ttp -99.1 123.32 43.31 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 123.564 0.745 . . . . 0.0 109.685 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 48.8 mm -121.14 143.68 32.64 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 114.4 -89.42 0.51 Allowed Glycine 0 C--N 1.3 -1.429 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.487 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 53.0 t60 -169.03 141.4 2.64 Favored 'General case' 0 CA--C 1.475 -1.921 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.498 ' H ' ' HD2' ' A' ' 729' ' ' ARG . 0.7 OUTLIER -82.64 20.26 1.16 Allowed 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -172.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 2.8 p -162.53 159.34 24.71 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.812 -0.555 . . . . 0.0 112.14 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.48 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 39.4 pt -120.09 163.56 17.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.003 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 20.9 m -136.0 137.7 41.49 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 2.4 t -85.76 108.38 18.05 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.105 0.478 . . . . 0.0 110.003 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.24 143.09 21.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 124.811 1.245 . . . . 0.0 109.624 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 68.46 -1.09 2.0 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.212 0.605 . . . . 0.0 112.599 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.21 19.33 30.88 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 737' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 738' ' ' TRP . 24.9 t -141.62 150.99 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.461 ' O ' HG12 ' A' ' 737' ' ' VAL . 96.8 m95 -80.65 170.3 16.51 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 121.712 -0.618 . . . . 0.0 109.66 168.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 40.6 p -77.14 -166.49 0.72 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.521 0.677 . . . . 0.0 112.001 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.408 ' H ' ' HB ' ' A' ' 739' ' ' THR . 0.6 OUTLIER -73.96 -15.71 61.1 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -167.241 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.456 HD21 ' HG2' ' A' ' 695' ' ' PRO . 2.3 mt 68.85 151.53 0.13 Allowed Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.487 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 56.4 Cg_endo -75.74 179.26 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.332 2.021 . . . . 0.0 111.347 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -126.08 114.61 18.63 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.635 ' SG ' HD13 ' A' ' 697' ' ' LEU . 77.7 m -93.64 114.77 27.17 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 122.073 0.939 . . . . 0.0 110.278 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 1.071 HG11 HD21 ' A' ' 750' ' ' LEU . 11.8 p -97.4 159.77 3.08 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.279 0 CA-C-N 113.071 -1.877 . . . . 0.0 108.91 -178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.712 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -80.5 -1.83 43.42 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.869 -177.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.627 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 18.2 mt 77.41 -20.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 125.526 1.53 . . . . 0.0 111.701 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 746' ' ' ALA . 32.8 t70 -84.56 -19.25 33.42 Favored 'General case' 0 C--N 1.253 -3.614 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.19 -171.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -113.03 30.14 7.42 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.142 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 1.071 HD21 HG11 ' A' ' 745' ' ' VAL . 57.0 mt -89.05 -170.26 2.83 Favored 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.355 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.46 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 58.9 mtpt -128.16 154.08 46.17 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 752' ' ' LYS . . . . . 0.463 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 93.3 mttt -100.97 145.97 27.99 Favored 'General case' 0 C--N 1.248 -3.828 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.301 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 753' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 89.3 m -89.15 160.15 17.14 Favored 'General case' 1 C--N 1.235 -4.376 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.419 179.355 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -118.7 133.19 56.03 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.77 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 42.3 t -59.17 116.21 3.71 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.716 ' HB2' HG13 ' A' ' 759' ' ' ILE . 18.4 m -79.36 135.14 36.63 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -76.14 4.36 8.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.745 0.783 . . . . 0.0 112.126 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.4 -14.63 14.82 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.279 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.716 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.3 pp -114.06 151.39 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 121.262 0.553 . . . . 0.0 111.319 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.32 134.15 52.26 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.545 HD12 HD12 ' A' ' 777' ' ' ILE . 1.9 mm? -110.24 171.83 7.22 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.416 ' HG3' ' HB2' ' A' ' 778' ' ' ARG . 44.1 mt-10 -55.18 153.27 7.0 Favored 'General case' 0 C--O 1.208 -1.088 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.99 -2.97 14.14 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 118.245 0.475 . . . . 0.0 112.045 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -83.22 -37.5 23.51 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.671 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 96.8 mt -93.31 -16.46 24.69 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.599 -172.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -75.9 2.21 13.07 Favored 'General case' 1 N--CA 1.369 -4.49 0 CA-C-O 122.127 0.965 . . . . 0.0 110.188 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -120.1 9.34 11.13 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.175 173.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -102.89 130.05 49.8 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -95.71 -38.35 10.39 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-O 122.441 1.115 . . . . 0.0 108.119 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -129.55 129.43 44.46 Favored 'General case' 0 N--CA 1.409 -2.517 0 CA-C-N 113.283 -1.78 . . . . 0.0 109.749 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.546 ' CE2' HD22 ' A' ' 765' ' ' LEU . 73.3 m-85 -105.94 142.47 35.6 Favored 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.955 -177.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.7 155.59 18.18 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -49.23 152.01 1.29 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.065 0.946 . . . . 0.0 111.607 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 67.71 4.93 4.14 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.715 0.806 . . . . 0.0 111.376 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 8.2 t -81.23 111.76 17.93 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -81.85 112.69 19.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.671 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.5 pt -123.71 174.2 8.3 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.712 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 95.4 mtt180 -125.93 128.93 48.3 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 174.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.605 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 6.3 p90 -120.0 167.35 12.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -147.76 157.14 43.4 Favored 'General case' 0 C--N 1.267 -2.991 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 17.3 t -93.58 147.18 23.23 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -73.78 -12.35 60.67 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.084 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -112.93 0.68 25.73 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.894 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 1.2 mptm? -118.16 -50.71 2.46 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 72.78 140.18 0.06 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.25 1.02 . . . . 0.0 110.768 -174.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 103.17 140.75 11.01 Favored Glycine 0 CA--C 1.493 -1.316 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.55 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 29.3 m95 -89.6 143.27 26.95 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.052 0.453 . . . . 0.0 111.373 -171.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.605 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -102.95 -26.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.013 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.417 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 0.3 OUTLIER 71.9 119.16 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.948 0 C-N-CA 124.033 0.933 . . . . 0.0 110.733 -177.022 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.1 t -143.13 157.42 44.53 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.64 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 47.5 t -119.67 135.24 60.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.57 114.18 10.41 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.668 0.747 . . . . 0.0 110.168 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.6 mm -112.66 82.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 C-N-CA 124.04 0.936 . . . . 0.0 108.494 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.739 ' ND2' HD22 ' A' ' 750' ' ' LEU . 3.4 m-20 51.32 67.74 0.9 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.76 176.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 795' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 78.95 3.05 87.75 Favored Glycine 0 C--N 1.299 -1.514 0 C-N-CA 120.299 -0.953 . . . . 0.0 114.334 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -134.03 167.89 19.8 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.598 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 87.3 m95 -113.92 158.79 20.64 Favored 'General case' 0 C--N 1.26 -3.298 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -149.0 107.61 3.43 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 799' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 41.0 Cg_endo -71.18 142.12 71.89 Favored 'Cis proline' 0 C--O 1.246 0.889 0 C-N-CA 123.552 -1.436 . . . . 0.0 112.687 -0.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.598 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 43.9 mt-10 -53.58 126.89 23.3 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.637 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.44 ' HA ' ' CE2' ' A' ' 779' ' ' TYR . 7.7 m -70.45 141.66 16.72 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.825 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -162.44 132.01 4.44 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.937 -172.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 12.4 m -124.08 -5.84 7.85 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--N 1.308 -1.231 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 176.865 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 45.0 m -64.69 -71.91 0.17 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.75 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 134.84 -164.5 24.71 Favored Glycine 1 N--CA 1.367 -5.952 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -43.17 119.68 1.62 Allowed 'General case' 0 C--N 1.276 -2.613 0 C-N-CA 126.173 1.789 . . . . 0.0 111.552 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.646 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -58.28 149.32 59.23 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.482 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.515 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 70.6 Cg_endo -71.01 -163.89 0.14 Allowed 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 123.001 2.467 . . . . 0.0 111.818 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.63 154.91 51.17 Favored 'General case' 0 N--CA 1.393 -3.322 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.615 HD22 ' HB3' ' A' ' 717' ' ' PHE . 18.7 tp -98.61 127.35 44.51 Favored 'General case' 0 C--N 1.25 -3.74 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.433 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.57 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 6.8 pt-20 -38.41 -61.01 0.73 Allowed 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 127.094 2.158 . . . . 0.0 114.349 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.791 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.2 m-70 -128.02 26.82 5.76 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -131.82 -155.06 7.92 Favored Glycine 0 N--CA 1.424 -2.115 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.405 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.45 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -145.48 174.28 11.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.639 0.257 . . . . 0.0 110.641 -175.222 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.83 137.17 46.31 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -86.11 -77.65 0.3 Allowed 'General case' 0 N--CA 1.427 -1.577 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.524 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 704' ' ' LEU . . . . . 0.629 HD13 ' N ' ' A' ' 705' ' ' SER . 1.9 tm? -167.72 163.1 14.25 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.629 ' N ' HD13 ' A' ' 704' ' ' LEU . 46.7 t -178.36 -62.71 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.402 1.481 . . . . 0.0 109.191 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 50.6 m 67.85 153.52 0.13 Allowed Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 125.155 1.382 . . . . 0.0 112.238 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.477 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 56.4 Cg_endo -62.95 171.94 5.45 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 123.015 2.477 . . . . 0.0 112.69 -175.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.616 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 1.9 Cg_endo -75.46 -8.18 25.04 Favored 'Cis proline' 0 N--CA 1.488 1.156 0 N-CA-C 115.235 1.206 . . . . 0.0 115.235 5.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 58.7 m-85 69.14 60.29 0.33 Allowed 'General case' 0 C--N 1.313 -0.983 0 O-C-N 124.297 0.998 . . . . 0.0 109.062 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.616 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 37.0 m-85 -68.04 173.33 4.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.429 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -72.33 136.64 46.25 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.178 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.64 -18.88 56.58 Favored Glycine 0 C--N 1.286 -2.217 0 C-N-CA 120.422 -0.894 . . . . 0.0 110.876 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 143.14 55.21 Favored 'General case' 0 CA--C 1.478 -1.79 0 CA-C-O 121.348 0.594 . . . . 0.0 110.017 178.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 16.0 m -124.58 157.27 35.83 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.054 178.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.646 HG21 HG21 ' A' ' 694' ' ' ILE . 33.1 t -137.03 133.69 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -80.85 130.72 35.2 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 123.835 0.709 . . . . 0.0 110.901 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.615 ' HB3' HD22 ' A' ' 697' ' ' LEU . 27.6 m-85 -137.09 116.93 13.12 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 125.018 1.327 . . . . 0.0 108.232 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.45 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 4.5 m-80 -127.23 -167.75 1.78 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 24.3 m -112.43 135.44 53.12 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 24.8 t -52.57 -67.63 0.24 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 124.187 0.929 . . . . 0.0 111.724 -170.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -171.32 156.88 4.77 Favored 'General case' 0 CA--C 1.476 -1.889 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 75.0 m 66.64 14.3 9.7 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 124.404 1.065 . . . . 0.0 111.242 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.548 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 85.0 m-85 -140.12 145.47 37.62 Favored 'General case' 0 N--CA 1.404 -2.755 0 C-N-CA 124.823 1.249 . . . . 0.0 108.596 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 5.5 t -97.59 151.71 19.79 Favored 'General case' 0 C--N 1.252 -3.631 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.764 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.4 ttp -108.72 118.39 36.66 Favored 'General case' 0 C--N 1.263 -3.155 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.489 HG12 HG23 ' A' ' 724' ' ' THR . 41.9 mm -121.86 135.38 62.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 118.7 -81.85 0.33 Allowed Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 121.422 -0.418 . . . . 0.0 112.323 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.465 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 29.8 t-80 -171.05 138.33 1.26 Allowed 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.764 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.3 ppt_? -84.94 19.65 2.06 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 2.7 p -156.51 159.76 38.89 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.32 0.581 . . . . 0.0 112.119 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.499 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 36.1 pt -116.89 164.71 12.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.754 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 21.5 m -139.61 136.1 34.01 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.223 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 9.1 t -83.08 107.25 15.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.316 0.579 . . . . 0.0 109.765 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -145.46 151.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 124.721 1.208 . . . . 0.0 109.839 -178.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 80.8 m80 73.61 -51.01 0.7 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.346 1.059 . . . . 0.0 110.625 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 148.45 34.28 0.05 OUTLIER Glycine 0 C--N 1.299 -1.489 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.0 p -165.85 159.49 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.515 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.9 m95 -77.63 175.6 9.74 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 172.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 18.3 p -80.12 -171.1 2.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.047 0.927 . . . . 0.0 112.658 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.7 OUTLIER -63.55 -15.77 58.94 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -172.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.6 mm? 69.59 141.65 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.465 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 32.8 Cg_endo -67.05 177.22 3.8 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.115 1.876 . . . . 0.0 112.035 174.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -121.84 129.73 52.84 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.791 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 73.8 m -113.84 103.8 11.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.11 0.481 . . . . 0.0 110.726 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.46 ' HB ' HG22 ' A' ' 724' ' ' THR . 46.6 t -97.27 143.7 12.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.548 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -60.49 2.33 0.1 Allowed 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 126.236 1.814 . . . . 0.0 115.293 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.828 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 19.4 mt 75.75 -13.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 C-N-CA 125.625 1.57 . . . . 0.0 111.956 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 746' ' ' ALA . 17.2 t70 -87.25 -25.88 23.75 Favored 'General case' 0 C--N 1.272 -2.772 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.533 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -103.09 20.53 17.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.358 -176.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.828 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 49.5 mt -84.53 -167.13 1.67 Allowed 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.773 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.52 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 10.2 mtpm? -130.0 154.41 47.42 Favored 'General case' 0 N--CA 1.381 -3.915 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.505 -177.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 752' ' ' LYS . . . . . 0.698 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 55.2 mtpt -105.71 120.71 42.39 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 113.269 -1.787 . . . . 0.0 109.317 -175.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 56.0 m -74.34 159.05 32.91 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.403 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 754' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 754' ' ' LYS . 18.3 ptpt -132.32 151.49 51.82 Favored 'General case' 0 N--CA 1.401 -2.885 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.699 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 30.6 t -63.35 121.54 14.0 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.54 -1.663 . . . . 0.0 109.956 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.821 ' HB3' HG13 ' A' ' 759' ' ' ILE . 28.2 t -74.63 155.02 38.26 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.99 -1.4 57.27 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.09 -20.13 21.6 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.794 0.807 . . . . 0.0 109.08 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.821 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.5 pp -111.66 159.68 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.435 -177.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 19.9 mt -118.67 129.04 75.47 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.924 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.661 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.528 HD12 HD12 ' A' ' 777' ' ' ILE . 1.8 mm? -105.6 -176.94 3.22 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.858 ' HB2' HD23 ' A' ' 765' ' ' LEU . 41.1 mt-10 -59.66 151.78 24.06 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -72.25 1.19 8.09 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -171.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 764' ' ' HIS . . . . . 0.545 ' HB2' HD22 ' A' ' 765' ' ' LEU . 8.8 m-70 -90.51 -43.47 10.21 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 168.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.858 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.3 mm? -78.5 -11.57 59.96 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.001 -168.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -67.82 -18.69 64.92 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.79 13.38 24.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.563 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -113.16 110.96 21.29 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -83.55 -34.82 25.14 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.072 -1.051 . . . . 0.0 109.372 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 770' ' ' GLU . . . . . 0.698 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 45.3 mt-10 -128.83 135.56 49.29 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.757 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 771' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -115.49 142.65 46.43 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.387 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.19 163.67 18.56 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -62.4 150.5 39.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.438 0.161 . . . . 0.0 110.758 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 65.4 t30 81.24 6.6 1.26 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.027 1.331 . . . . 0.0 110.345 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 38.9 m -80.68 105.72 12.14 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -86.42 101.87 13.53 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 761' ' ' LEU . 11.9 pt -113.25 -174.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 121.832 0.825 . . . . 0.0 109.376 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.616 ' HA ' ' HA ' ' A' ' 789' ' ' HIS . 19.9 ptt180 -139.24 134.79 33.16 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.542 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 11.0 p90 -123.44 166.33 15.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -147.4 154.85 41.37 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.507 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 0.8 OUTLIER -82.58 146.9 28.91 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-O 121.047 0.451 . . . . 0.0 111.943 178.74 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -64.26 103.78 0.67 Allowed 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 110.73 -7.9 29.83 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.476 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.507 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 0.8 OUTLIER -119.41 113.59 21.02 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -89.3 90.06 8.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.618 0.723 . . . . 0.0 110.975 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 172.02 141.78 3.51 Favored Glycine 0 CA--C 1.487 -1.674 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.607 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 44.5 m95 -101.53 145.44 29.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.992 0.396 . . . . 0.0 110.127 -174.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.542 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -100.04 -28.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.013 -178.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 789' ' ' HIS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 3.5 m-70 74.43 133.66 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.602 1.161 . . . . 0.0 108.911 -176.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.6 t -156.44 155.21 31.69 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 120.703 0.287 . . . . 0.0 111.154 178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.96 137.6 53.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.3 t -70.59 113.97 8.23 Favored 'General case' 0 C--O 1.255 1.377 0 CA-C-O 121.658 0.742 . . . . 0.0 110.359 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 47.4 mm -114.25 80.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 124.32 1.048 . . . . 0.0 109.317 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.729 ' ND2' HD22 ' A' ' 750' ' ' LEU . 4.3 m-20 52.2 65.57 1.47 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.77 175.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.87 21.2 79.52 Favored Glycine 0 C--N 1.303 -1.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.97 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -146.64 164.33 33.01 Favored 'General case' 0 C--O 1.202 -1.408 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.677 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.7 m95 -111.58 157.68 20.1 Favored 'General case' 0 C--N 1.246 -3.926 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -144.12 105.89 4.83 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 799' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 38.2 Cg_endo -70.14 139.03 53.31 Favored 'Cis proline' 0 C--O 1.248 1.006 0 C-N-CA 123.725 -1.365 . . . . 0.0 110.919 -0.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.677 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 26.5 tt0 -56.42 124.05 16.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 779' ' ' TYR . 14.0 m -57.58 124.76 12.29 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.381 0 C-N-CA 124.391 1.077 . . . . 0.0 110.585 -175.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -129.59 116.62 19.16 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.198 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 1.1 t -121.77 3.27 10.06 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.636 175.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 53.2 m . . . . . 0 N--CA 1.422 -1.859 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 176.532 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 59.7 m -68.02 -65.12 0.73 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 94.21 134.67 7.44 Favored Glycine 0 N--CA 1.42 -2.394 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.262 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 37.8 t70 46.28 101.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.134 1.774 . . . . 0.0 113.508 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.681 HG21 HG21 ' A' ' 715' ' ' VAL . 1.8 pp -59.34 151.33 59.72 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.289 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.438 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 37.7 Cg_endo -68.28 -157.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 123.039 2.492 . . . . 0.0 112.517 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.12 160.52 37.54 Favored 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.608 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.3 OUTLIER -99.16 133.05 43.99 Favored 'General case' 0 C--N 1.259 -3.356 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.563 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -49.06 -39.47 27.7 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 124.406 1.082 . . . . 0.0 113.689 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.402 ' HB3' ' CE1' ' A' ' 723' ' ' PHE . 90.4 m-70 -143.21 28.05 1.54 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.129 0.49 . . . . 0.0 110.264 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.608 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -141.59 -146.05 4.64 Favored Glycine 0 C--N 1.299 -1.511 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.066 -177.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.441 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -151.08 -175.56 5.2 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -176.439 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -117.5 142.83 46.7 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -74.13 -78.2 0.1 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.204 0.526 . . . . 0.0 110.785 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.3 tt -149.87 130.41 13.95 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.527 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 67.9 p -117.65 -70.83 0.77 Allowed 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -176.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 706' ' ' SER . . . . . 0.416 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 23.3 t 64.16 123.99 0.02 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 125.696 1.598 . . . . 0.0 112.559 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.543 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 41.2 Cg_endo -63.66 176.0 2.54 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.456 2.771 . . . . 0.0 111.682 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 6.0 Cg_exo -77.6 -10.28 32.26 Favored 'Cis proline' 0 CA--C 1.504 -1.002 0 N-CA-C 115.017 1.122 . . . . 0.0 115.017 5.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.527 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 56.7 m-85 72.56 78.74 0.15 Allowed 'General case' 0 C--O 1.245 0.868 0 O-C-N 124.248 0.967 . . . . 0.0 110.005 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.407 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 29.9 m-85 -85.48 171.51 11.71 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.492 0.663 . . . . 0.0 112.469 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -67.33 133.31 49.41 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.697 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.11 68.09 Favored Glycine 0 N--CA 1.418 -2.522 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.19 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.17 145.36 44.29 Favored 'General case' 0 CA--C 1.493 -1.214 0 O-C-N 122.085 -0.656 . . . . 0.0 110.706 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 14.2 m -131.07 151.04 51.85 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.681 HG21 HG21 ' A' ' 694' ' ' ILE . 34.4 t -134.99 140.1 45.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -85.64 123.44 31.05 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 124.128 0.893 . . . . 0.0 111.6 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -124.36 105.55 9.53 Favored 'General case' 0 C--N 1.273 -2.759 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.441 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 11.4 m-80 -113.37 -162.68 0.81 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 5.0 m -113.47 134.44 54.66 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -178.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 39.5 t -65.64 -64.02 0.96 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 123.689 0.618 . . . . 0.0 110.87 -172.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -164.68 156.31 15.57 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 73.9 m 69.78 1.94 3.63 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.303 1.002 . . . . 0.0 113.171 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.573 ' HB2' ' HB3' ' A' ' 719' ' ' CYS . 98.1 m-85 -134.14 147.43 50.81 Favored 'General case' 0 N--CA 1.403 -2.795 0 C-N-CA 123.75 0.82 . . . . 0.0 109.078 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.521 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -113.5 138.13 50.57 Favored 'General case' 0 C--N 1.264 -3.122 0 C-N-CA 125.546 1.539 . . . . 0.0 110.445 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.498 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.7 ttp -86.64 121.93 29.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.65 1.18 . . . . 0.0 109.348 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 726' ' ' ILE . 31.7 mm -111.87 127.4 69.08 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.973 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.132 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 99.2 -82.97 0.58 Allowed Glycine 0 CA--C 1.481 -2.051 0 CA-C-N 114.645 -1.162 . . . . 0.0 112.253 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 728' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 30.3 p-80 -147.04 178.02 8.7 Favored 'General case' 0 N--CA 1.388 -3.55 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -174.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.498 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.2 OUTLIER -128.15 6.4 5.91 Favored 'General case' 0 C--O 1.2 -1.546 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.637 -177.41 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 3.1 p -126.54 160.1 31.58 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 119.07 -1.052 . . . . 0.0 113.732 -172.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.476 HG21 HD13 ' A' ' 741' ' ' LEU . 36.6 pt -119.66 159.51 20.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.106 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 14.6 m -134.77 135.28 41.74 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.791 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 7.6 t -86.01 104.13 15.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.156 0.503 . . . . 0.0 109.953 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.7 pp -144.69 147.45 19.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 124.655 1.182 . . . . 0.0 110.037 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 64.9 4.07 2.31 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 96.81 24.87 12.41 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.14 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.04 162.22 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.438 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.3 m95 -80.29 173.08 12.96 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.518 ' HB ' ' NE2' ' A' ' 740' ' ' GLN . 23.6 p -78.8 -162.44 0.38 Allowed 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.837 0.827 . . . . 0.0 112.42 -177.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.629 ' NE2' ' H ' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -84.89 2.01 44.58 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 124.453 1.101 . . . . 0.0 113.575 -167.548 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 731' ' ' ILE . 4.1 mm? 71.21 155.87 0.16 Allowed Pre-proline 0 N--CA 1.483 1.215 0 O-C-N 123.667 0.605 . . . . 0.0 111.557 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.421 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 38.1 Cg_endo -80.24 -173.58 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.219 1.946 . . . . 0.0 111.963 173.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -123.15 104.62 9.29 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 122.359 -0.213 . . . . 0.0 110.533 -176.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 724' ' ' THR . 86.8 m -96.99 114.35 25.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.106 0.479 . . . . 0.0 110.776 172.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.681 ' HB ' HD21 ' A' ' 750' ' ' LEU . 58.8 t -108.29 146.79 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 746' ' ' ALA . . . . . 0.565 ' O ' ' HB ' ' A' ' 747' ' ' ILE . . . -64.74 2.52 0.67 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 125.726 1.611 . . . . 0.0 114.201 -175.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.784 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 37.1 mt 78.14 -24.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 125.482 1.513 . . . . 0.0 111.544 175.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 748' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 746' ' ' ALA . 28.7 t70 -81.4 -24.32 37.04 Favored 'General case' 0 C--N 1.258 -3.389 0 CA-C-N 112.893 -1.958 . . . . 0.0 109.248 -172.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 749' ' ' LYS . . . . . 0.456 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 1.7 ptmm? -115.46 23.6 12.26 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.919 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.87 HD22 HD22 ' A' ' 794' ' ' ASN . 55.1 mt -81.41 -168.88 2.03 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.442 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 751' ' ' LYS . . . . . 0.584 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 30.0 mtpp -122.63 158.43 30.02 Favored 'General case' 0 N--CA 1.396 -3.167 0 CA-C-O 121.836 0.827 . . . . 0.0 109.085 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -110.25 138.23 46.91 Favored 'General case' 0 C--N 1.245 -3.939 0 CA-C-N 113.184 -1.825 . . . . 0.0 107.943 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 753' ' ' CYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 78.2 m -85.39 178.99 7.26 Favored 'General case' 0 C--N 1.252 -3.649 0 CA-C-N 113.416 -1.72 . . . . 0.0 110.517 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -140.87 141.54 34.61 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 755' ' ' SER . . . . . 0.449 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 5.4 p -62.78 128.35 35.52 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 123.622 0.576 . . . . 0.0 110.467 173.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 756' ' ' SER . . . . . 0.601 ' HB2' ' CG1' ' A' ' 759' ' ' ILE . 9.5 m -75.35 162.99 27.91 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -89.76 -15.36 32.59 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 758' ' ' LEU . . . . . 0.414 HD22 ' NH2' ' A' ' 782' ' ' ARG . 40.2 mt -93.71 -18.43 22.12 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.66 0.743 . . . . 0.0 110.159 -174.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 759' ' ' ILE . . . . . 0.601 ' CG1' ' HB2' ' A' ' 756' ' ' SER . 2.4 pp -100.24 160.16 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.61 135.79 56.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 761' ' ' LEU . . . . . 0.468 HD11 HD13 ' A' ' 759' ' ' ILE . 1.8 mm? -110.29 -179.28 3.73 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 762' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 42.0 mt-10 -63.55 157.22 24.23 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.73 -18.43 64.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.209 0.528 . . . . 0.0 111.045 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -95.63 -0.12 52.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.922 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 765' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 765' ' ' LEU . 3.7 mm? -124.72 -11.78 7.2 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 57.1 mtmt -69.5 -21.05 63.71 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.546 0.689 . . . . 0.0 110.598 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -88.15 14.02 10.1 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.097 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 768' ' ' LYS . . . . . 0.528 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 12.0 tppt? -110.52 117.33 33.26 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.89 -43.1 20.4 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.72 117.59 23.78 Favored 'General case' 0 CA--C 1.483 -1.599 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.003 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 771' ' ' PHE . . . . . 0.528 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 88.3 m-85 -91.13 136.01 33.38 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -78.73 143.21 36.4 Favored 'General case' 0 C--N 1.276 -2.593 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.537 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 773' ' ' HIS . . . . . 0.787 ' CD2' HD12 ' A' ' 750' ' ' LEU . 47.9 p-80 -40.05 138.55 0.81 Allowed 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 124.948 1.299 . . . . 0.0 111.696 171.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 74.14 6.38 4.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.796 1.638 . . . . 0.0 113.279 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 70.5 m -75.38 116.69 16.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.01 102.16 13.56 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 777' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 761' ' ' LEU . 7.8 pt -113.93 179.56 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.676 0.751 . . . . 0.0 109.76 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 98.8 mtt180 -127.35 119.98 27.49 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 779' ' ' TYR . . . . . 0.691 ' CD2' HG13 ' A' ' 801' ' ' VAL . 13.5 p90 -105.58 164.14 12.13 Favored 'General case' 0 C--O 1.26 1.611 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 171.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -147.76 157.25 43.45 Favored 'General case' 0 C--N 1.263 -3.157 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 781' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 42.8 t -96.23 163.54 13.05 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -176.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 782' ' ' ARG . . . . . 0.414 ' NH2' HD22 ' A' ' 758' ' ' LEU . 21.3 ptt180 -82.57 -23.0 34.67 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 120.992 0.425 . . . . 0.0 110.356 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -94.15 -13.27 54.9 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.078 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 784' ' ' LYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 0.1 OUTLIER -131.19 98.46 4.57 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -88.52 87.92 7.44 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.237 1.018 . . . . 0.0 111.339 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -173.63 152.55 15.56 Favored Glycine 0 CA--C 1.479 -2.157 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 787' ' ' TRP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 26.2 m95 -93.18 134.81 34.98 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 117.571 0.685 . . . . 0.0 110.345 -172.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 788' ' ' ILE . . . . . 0.531 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.1 mp -94.61 -28.0 4.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.117 -177.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 74.62 119.54 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 124.375 1.07 . . . . 0.0 109.835 -179.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 790' ' ' THR . . . . . 0.447 HG21 ' CG2' ' A' ' 801' ' ' VAL . 3.8 t -143.65 160.77 40.09 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.169 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.32 135.78 60.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 123.897 0.879 . . . . 0.0 109.427 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 52.8 t -72.52 103.07 3.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.05 0.928 . . . . 0.0 110.854 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.6 mm -99.28 79.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.499 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 794' ' ' ASN . . . . . 0.87 HD22 HD22 ' A' ' 750' ' ' LEU . 5.2 m-20 50.39 68.81 0.7 Allowed 'General case' 0 C--O 1.238 0.447 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.771 176.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 80.2 6.28 89.28 Favored Glycine 0 C--N 1.306 -1.092 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.043 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 796' ' ' ARG . . . . . 0.442 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 34.5 ttt180 -139.53 169.09 18.38 Favored 'General case' 0 C--O 1.198 -1.657 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 797' ' ' TRP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.6 m95 -111.43 161.09 16.47 Favored 'General case' 0 C--N 1.264 -3.112 0 O-C-N 122.293 -0.254 . . . . 0.0 110.429 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -150.33 106.23 3.14 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 799' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 34.8 Cg_endo -67.63 138.52 43.29 Favored 'Cis proline' 0 C--O 1.243 0.774 0 C-N-CA 123.651 -1.396 . . . . 0.0 111.103 -1.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 800' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 30.1 tt0 -55.16 121.59 9.14 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.058 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 801' ' ' VAL . . . . . 0.691 HG13 ' CD2' ' A' ' 779' ' ' TYR . 91.8 t -63.07 123.21 15.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.233 -174.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 51.7 t30 -141.03 138.51 33.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 803' ' ' CYS . . . . . 0.463 ' HB2' HG23 ' A' ' 759' ' ' ILE . 21.7 t -131.38 23.89 4.8 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.594 1.188 . . . . 0.0 108.929 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 C--N 1.293 -1.885 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.018 176.293 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 35.9 m -72.87 -67.83 0.53 Allowed 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.33 0.586 . . . . 0.0 109.485 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 130.11 -161.46 23.08 Favored Glycine 1 N--CA 1.367 -5.938 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -41.14 116.19 0.7 Allowed 'General case' 0 C--N 1.274 -2.696 0 C-N-CA 127.196 2.198 . . . . 0.0 112.09 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.533 HG21 HG21 ' A' ' 715' ' ' VAL . 1.7 pp -59.94 149.56 72.99 Favored Pre-proline 0 N--CA 1.435 -1.205 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.017 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.441 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 71.2 Cg_endo -74.11 -160.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.611 2.207 . . . . 0.0 110.42 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . 0.595 ' HA ' ' HE2' ' A' ' 717' ' ' PHE . 13.1 pt-20 -149.85 170.3 19.11 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.752 HD13 ' SG ' ' A' ' 744' ' ' CYS . 17.7 mt -97.48 128.71 44.47 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 123.914 0.759 . . . . 0.0 111.376 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -46.17 -33.88 3.9 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.078 -1.874 . . . . 0.0 112.723 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.426 ' HB3' ' CE1' ' A' ' 723' ' ' PHE . 96.4 m-70 -145.89 26.7 1.23 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -137.94 -148.36 5.36 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.472 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.461 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.6 OUTLIER -150.9 176.2 11.31 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -104.69 157.34 17.25 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -94.6 -68.75 0.78 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.092 0.472 . . . . 0.0 111.297 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . 0.476 ' O ' HG13 ' A' ' 715' ' ' VAL . 58.9 tp -146.14 123.39 11.56 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.487 ' HB3' ' CG1' ' A' ' 715' ' ' VAL . 2.8 p -144.86 105.0 4.06 Favored 'General case' 0 N--CA 1.396 -3.131 0 CA-C-O 122.024 0.916 . . . . 0.0 109.347 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 10.2 m -116.34 132.03 23.52 Favored Pre-proline 0 C--N 1.246 -3.914 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.621 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.457 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 57.5 Cg_endo -64.65 172.87 6.22 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.592 2.194 . . . . 0.0 110.183 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.64 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.0 Cg_exo -76.61 -7.03 28.4 Favored 'Cis proline' 0 N--CA 1.487 1.124 0 N-CA-C 114.839 1.053 . . . . 0.0 114.839 6.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.464 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 57.4 m-85 72.95 79.28 0.14 Allowed 'General case' 0 C--N 1.314 -0.975 0 O-C-N 124.242 0.964 . . . . 0.0 109.217 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.64 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 38.1 m-85 -87.0 172.52 9.94 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.235 -175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -69.32 131.7 45.26 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.994 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.65 -15.16 60.07 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 0.5 OUTLIER -65.42 145.98 55.47 Favored 'General case' 0 CA--C 1.477 -1.861 0 CA-C-O 121.42 0.628 . . . . 0.0 110.262 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 17.8 m -133.97 148.83 51.2 Favored 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.533 HG21 HG21 ' A' ' 694' ' ' ILE . 61.8 t -134.58 130.61 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.845 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.465 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 44.0 mt-10 -82.16 139.28 34.42 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 121.609 0.719 . . . . 0.0 110.813 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.595 ' HE2' ' HA ' ' A' ' 696' ' ' GLU . 28.5 m-85 -137.35 120.55 16.79 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 125.867 1.667 . . . . 0.0 107.478 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.461 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 16.1 m-80 -128.78 -163.44 1.29 Allowed 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 22.3 m -118.87 134.03 55.44 Favored 'General case' 0 C--N 1.267 -3.018 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 21.1 t -73.15 -84.5 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 O-C-N 123.923 0.764 . . . . 0.0 112.019 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -133.77 132.59 40.7 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.459 0.303 . . . . 0.0 110.632 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 4.4 t 71.9 26.29 2.97 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 124.598 1.186 . . . . 0.0 110.055 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.3 m-85 -140.72 145.98 37.17 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.551 HG21 HD11 ' A' ' 750' ' ' LEU . 6.4 t -75.23 -118.38 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.605 -174.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.517 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 7.9 ttp 162.82 104.83 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 128.898 2.879 . . . . 0.0 105.29 174.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.4 HD11 ' ND2' ' A' ' 794' ' ' ASN . 43.9 mm -119.96 139.25 47.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 102.17 -75.79 0.33 Allowed Glycine 0 N--CA 1.429 -1.797 0 O-C-N 123.559 0.537 . . . . 0.0 112.729 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.579 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 2.1 t60 -146.98 -172.97 4.12 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.517 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -141.89 22.94 2.09 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.28 170.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 16.4 p -157.44 162.71 38.97 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.034 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 714' ' ' SER . 32.4 pt -122.6 164.6 19.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 739' ' ' THR . 7.3 m -135.77 135.01 39.58 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.977 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 6.0 t -84.68 106.83 16.52 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.473 0.654 . . . . 0.0 110.437 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -142.97 143.58 24.98 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 125.221 1.408 . . . . 0.0 109.988 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 64.39 4.2 2.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.06 13.5 52.46 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 738' ' ' TRP . 80.7 t -140.66 154.23 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.465 ' O ' HG12 ' A' ' 737' ' ' VAL . 94.2 m95 -79.95 177.64 8.78 Favored 'General case' 0 C--N 1.273 -2.748 0 O-C-N 121.89 -0.506 . . . . 0.0 109.786 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.458 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 27.1 p -84.89 -163.95 0.91 Allowed 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.856 0.836 . . . . 0.0 112.506 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.548 ' NE2' ' H ' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -74.81 -17.05 60.68 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -168.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 1.5 mt 68.73 151.33 0.13 Allowed Pre-proline 0 N--CA 1.479 1.019 0 O-C-N 123.889 0.743 . . . . 0.0 112.231 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.579 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 42.9 Cg_endo -73.56 177.52 7.89 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.796 1.664 . . . . 0.0 111.249 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -120.17 103.09 8.97 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.234 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.752 ' SG ' HD13 ' A' ' 697' ' ' LEU . 84.1 m -79.07 110.26 14.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.971 173.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.531 ' O ' HG22 ' A' ' 724' ' ' THR . 46.6 t -104.72 147.03 11.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.96 -0.85 1.71 Allowed 'General case' 0 C--N 1.284 -2.253 0 C-N-CA 125.204 1.402 . . . . 0.0 114.089 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.714 ' HA ' HD22 ' A' ' 750' ' ' LEU . 48.6 mt 74.54 -14.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 125.589 1.555 . . . . 0.0 110.93 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 746' ' ' ALA . 1.0 OUTLIER -75.3 -27.89 59.5 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 126.149 1.78 . . . . 0.0 108.755 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -106.92 16.96 23.71 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.063 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.754 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 1.3 mp -83.15 -178.67 7.18 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.766 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.592 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 55.0 mtpt -125.59 150.66 47.32 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.58 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 770' ' ' GLU . 14.1 mmmm -90.14 111.22 22.29 Favored 'General case' 0 C--N 1.251 -3.689 0 CA-C-N 112.421 -2.172 . . . . 0.0 108.726 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 61.2 m -70.78 138.29 50.29 Favored 'General case' 0 C--N 1.269 -2.898 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.14 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -107.86 138.28 44.38 Favored 'General case' 0 C--N 1.271 -2.806 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.13 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . 0.421 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.4 p -67.83 123.65 21.13 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.465 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.673 ' HB3' HG13 ' A' ' 759' ' ' ILE . 25.9 t -70.89 146.18 49.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.9 3.28 49.09 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -92.46 -29.52 16.21 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.673 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -98.53 158.51 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.294 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.057 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.1 131.87 59.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.412 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 85.8 mt -105.56 179.82 4.16 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.143 0.497 . . . . 0.0 110.124 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . 0.714 ' HB2' HD23 ' A' ' 765' ' ' LEU . 37.8 mt-10 -69.4 170.53 10.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.731 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.02 -20.09 66.32 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.16 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . 0.572 ' HB2' HD22 ' A' ' 765' ' ' LEU . 15.6 m-70 -90.1 -30.09 17.9 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.714 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.7 mm? -93.9 -14.18 26.33 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.371 -165.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 28.5 mtmm -71.77 -8.8 56.44 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.762 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -94.57 -1.7 52.85 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -105.28 126.34 51.98 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . 0.846 ' HG3' ' HG2' ' A' ' 770' ' ' GLU . 18.8 ptpt -98.49 -29.37 13.14 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.612 0.72 . . . . 0.0 109.107 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . 0.846 ' HG2' ' HG3' ' A' ' 769' ' ' LYS . 4.7 pt-20 -140.06 136.38 33.58 Favored 'General case' 0 N--CA 1.39 -3.456 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.462 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.484 ' HE2' HD12 ' A' ' 765' ' ' LEU . 86.3 m-85 -110.66 148.66 31.78 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.623 -175.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -90.91 166.04 13.26 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.626 ' HB3' HD23 ' A' ' 750' ' ' LEU . 26.6 t60 -62.67 157.35 21.07 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 122.328 0.251 . . . . 0.0 111.076 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 77.69 9.8 2.36 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.209 1.004 . . . . 0.0 109.654 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 47.4 t -86.36 104.5 15.93 Favored 'General case' 0 N--CA 1.385 -3.687 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.468 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -90.13 101.37 14.08 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 177.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.424 HG21 ' CE2' ' A' ' 771' ' ' PHE . 7.9 pt -112.32 -174.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 CA-C-O 121.591 0.71 . . . . 0.0 109.797 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.624 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 27.6 ptt180 -141.08 122.5 14.97 Favored 'General case' 0 N--CA 1.391 -3.424 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.555 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.488 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 9.6 p90 -113.66 172.9 6.7 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -155.47 169.26 24.68 Favored 'General case' 0 N--CA 1.411 -2.379 0 O-C-N 123.934 0.771 . . . . 0.0 109.356 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.675 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 16.4 t -102.26 162.22 13.09 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -74.8 80.14 2.09 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.601 1.191 . . . . 0.0 108.293 175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 147.28 -27.72 1.54 Allowed Glycine 0 N--CA 1.417 -2.596 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.269 -172.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.675 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 14.3 mptt -84.02 103.32 13.16 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -87.34 81.27 7.93 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 162.62 -170.02 38.05 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 106.261 -2.736 . . . . 0.0 106.261 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.624 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 64.7 m95 -130.76 158.51 39.93 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 118.962 1.381 . . . . 0.0 109.364 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.488 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -99.94 -41.94 9.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.132 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 11.3 m170 80.7 133.25 0.06 Allowed 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.052 1.341 . . . . 0.0 110.259 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.419 ' HA ' ' HD2' ' A' ' 799' ' ' PRO . 4.5 t -157.17 158.98 37.27 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.107 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 45.0 t -120.91 133.24 68.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.273 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 37.9 t -68.33 115.11 7.39 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.152 0.501 . . . . 0.0 109.995 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 45.3 mm -117.3 83.09 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 C-N-CA 123.726 0.81 . . . . 0.0 109.332 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.754 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 0.6 OUTLIER 49.78 66.01 1.25 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.811 0.845 . . . . 0.0 111.259 176.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 77.44 14.36 82.58 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.887 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -139.02 166.11 25.37 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.1 m95 -116.88 156.3 27.58 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 18.9 t70 -147.62 104.28 3.7 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 43.1 Cg_endo -70.51 142.76 73.04 Favored 'Cis proline' 0 C--O 1.239 0.575 0 C-N-CA 124.0 -1.25 . . . . 0.0 113.248 0.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 47.3 mt-10 -53.86 125.42 18.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.445 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 1 N--CA 1.371 -4.404 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.719 -175.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.421 -1.892 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 51.8 m -79.06 -66.99 0.8 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 93.17 142.22 11.51 Favored Glycine 0 N--CA 1.405 -3.38 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.666 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 35.6 t70 53.69 97.32 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 125.815 1.646 . . . . 0.0 112.441 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.454 HG21 HG21 ' A' ' 715' ' ' VAL . 1.8 pp -63.68 147.3 95.94 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.399 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.449 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.9 Cg_endo -69.63 -171.61 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.729 2.286 . . . . 0.0 112.134 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -121.79 179.05 4.61 Favored 'General case' 0 N--CA 1.393 -3.297 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.587 HD22 ' HB3' ' A' ' 717' ' ' PHE . 25.0 tp -124.33 129.43 50.71 Favored 'General case' 0 C--N 1.251 -3.675 0 CA-C-O 120.915 0.388 . . . . 0.0 110.953 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -38.66 -51.34 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.479 1.912 . . . . 0.0 114.756 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.681 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.8 m-70 -141.12 26.26 2.03 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -139.16 -146.39 4.92 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.552 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.465 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -152.05 178.31 9.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -174.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -113.05 143.88 43.56 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -73.56 -62.71 1.39 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.6 tt -166.56 135.52 2.95 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.546 ' HB3' HG11 ' A' ' 715' ' ' VAL . 13.1 p -129.95 119.86 23.89 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-O 121.351 0.596 . . . . 0.0 110.074 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 13.2 p -108.47 113.17 60.42 Favored Pre-proline 0 C--N 1.276 -2.609 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.239 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.491 ' HA ' ' N ' ' A' ' 709' ' ' TYR . 57.6 Cg_endo -69.7 171.5 14.28 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.856 2.37 . . . . 0.0 110.527 176.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.84 -4.89 3.07 Favored 'Cis proline' 0 N--CA 1.496 1.676 0 N-CA-C 117.077 1.914 . . . . 0.0 117.077 2.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.521 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 35.6 m-85 68.68 65.57 0.31 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.493 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 16.7 m-85 -69.75 172.77 7.05 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.877 -1.511 . . . . 0.0 112.103 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -72.21 132.05 43.58 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.901 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.34 -6.41 65.81 Favored Glycine 0 N--CA 1.413 -2.867 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.82 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 1.4 t70 -68.79 155.89 39.35 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 19.4 m -146.81 145.08 29.78 Favored 'General case' 0 C--N 1.274 -2.697 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.546 HG11 ' HB3' ' A' ' 705' ' ' SER . 46.1 t -132.04 134.69 59.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.887 -176.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -79.85 133.85 36.29 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 123.78 0.675 . . . . 0.0 111.676 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.587 ' HB3' HD22 ' A' ' 697' ' ' LEU . 26.7 m-85 -138.28 129.88 27.88 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 125.38 1.472 . . . . 0.0 107.28 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.465 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 15.6 m-80 -137.71 -161.5 1.18 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 725' ' ' MET . 11.7 m -118.71 131.77 56.15 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 18.9 t -67.02 -75.61 0.09 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 124.239 0.962 . . . . 0.0 110.721 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -149.18 152.9 36.86 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 69.3 m 72.92 2.69 4.46 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 124.285 0.991 . . . . 0.0 112.766 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.642 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.7 m-85 -138.56 144.74 40.0 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.674 HG21 HD21 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -107.09 136.43 46.95 Favored 'General case' 0 C--N 1.255 -3.505 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.265 -177.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.768 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 7.6 ttp -84.29 118.6 24.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 124.196 0.998 . . . . 0.0 109.636 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.481 HD11 HD21 ' A' ' 794' ' ' ASN . 48.3 mm -127.33 141.68 45.65 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.998 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 106.5 -66.9 0.25 Allowed Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.392 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.561 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 20.7 t60 -165.83 -177.6 4.37 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 -175.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.768 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -143.31 25.43 1.71 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 119.027 0.831 . . . . 0.0 110.699 176.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 16.0 m -152.47 163.66 39.1 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.884 -0.51 . . . . 0.0 109.782 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 714' ' ' SER . 32.2 pt -125.3 163.45 26.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.745 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 739' ' ' THR . 17.5 m -137.03 134.1 36.2 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.252 0.345 . . . . 0.0 111.08 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 3.4 t -86.84 105.85 17.32 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -141.28 140.43 31.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.984 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 60.44 14.19 4.61 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 89.11 25.22 29.59 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.81 144.89 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.089 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.521 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 97.3 m95 -72.63 -179.34 3.01 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.5 0.667 . . . . 0.0 110.138 170.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 732' ' ' THR . 27.9 p -90.95 -152.9 0.29 Allowed 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.507 ' NE2' ' H ' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -81.52 -14.87 56.4 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -169.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.2 mm? 71.12 151.59 0.14 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 123.967 0.792 . . . . 0.0 110.824 -175.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.561 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 36.2 Cg_endo -71.13 177.64 6.29 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.028 1.819 . . . . 0.0 110.736 172.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -125.07 132.92 53.09 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.681 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 84.6 m -116.38 107.06 14.33 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-O 121.458 0.646 . . . . 0.0 109.834 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.58 142.82 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.682 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.642 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.97 1.91 1.27 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 125.247 1.419 . . . . 0.0 113.414 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.693 ' HA ' HD22 ' A' ' 750' ' ' LEU . 40.0 mt 79.35 -19.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 125.41 1.484 . . . . 0.0 111.031 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.0 t70 -72.01 -34.26 68.71 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.118 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -98.74 17.76 18.57 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.274 -1.785 . . . . 0.0 109.498 -172.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.803 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 1.7 mp -82.37 -174.06 4.93 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.539 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.627 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 1.2 mmpt? -136.43 -177.1 4.57 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -130.97 144.4 51.45 Favored 'General case' 0 C--N 1.268 -2.963 0 C-N-CA 125.297 1.439 . . . . 0.0 107.202 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 770' ' ' GLU . 69.1 m -92.78 167.08 12.1 Favored 'General case' 0 C--N 1.246 -3.899 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.24 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -125.88 136.0 52.56 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.895 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . 0.441 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.0 p -67.18 118.44 10.6 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.582 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.577 ' HB3' HG13 ' A' ' 759' ' ' ILE . 28.3 t -66.15 143.15 57.46 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -77.85 -6.97 55.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 89.2 mt -105.16 -11.69 16.45 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.813 -177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.577 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -96.43 162.32 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.806 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . 0.444 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.4 mp -118.98 117.4 54.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.791 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 63.7 mt -93.51 -177.25 4.35 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 31.5 mt-10 -62.85 176.84 0.63 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.354 0.597 . . . . 0.0 110.093 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -86.02 -6.06 59.11 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 123.431 1.586 . . . . 0.0 107.406 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . 0.274 63.8 t60 -88.98 -43.04 11.43 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 110.712 -2.949 . . . . 0.0 108.194 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.691 HD22 ' HE2' ' A' ' 771' ' ' PHE . 54.8 mt -96.2 -13.43 23.49 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.861 -171.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 54.1 mtmt -65.66 -15.9 63.22 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.806 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -89.84 1.64 55.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.506 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.463 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 11.3 tppt? -103.52 109.91 21.74 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -83.02 -36.49 24.94 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 753' ' ' CYS . 3.8 pt-20 -130.29 134.02 46.9 Favored 'General case' 0 N--CA 1.403 -2.789 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.635 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.791 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 81.0 m-85 -112.09 143.19 43.53 Favored 'General case' 0 C--N 1.267 -3.012 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.009 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.89 154.78 19.61 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.634 ' CG ' HD23 ' A' ' 750' ' ' LEU . 18.5 p-80 -43.21 143.56 0.81 Allowed 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.974 1.31 . . . . 0.0 111.55 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 14.0 m120 68.19 12.28 8.7 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.23 1.012 . . . . 0.0 113.435 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 43.4 t -77.84 110.48 12.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.445 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.8 OUTLIER -86.82 101.3 13.22 Favored 'General case' 0 CA--C 1.494 -1.203 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.702 HG21 ' CE2' ' A' ' 771' ' ' PHE . 5.6 pt -114.0 -173.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.269 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 26.9 ptt180 -142.28 124.81 15.76 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.473 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 4.4 p90 -114.79 172.54 6.98 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . 0.444 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 27.0 ptt180 -150.19 178.57 8.86 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 48.1 t -114.94 162.94 16.27 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -74.51 -21.49 59.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.286 0.565 . . . . 0.0 110.129 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -99.93 -8.79 50.56 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.072 175.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 13.3 mptt -128.14 104.53 7.81 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 122.686 -0.302 . . . . 0.0 110.735 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.31 169.92 17.39 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 97.58 -168.02 23.69 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 75.6 m95 -138.69 142.9 38.96 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 118.613 1.206 . . . . 0.0 109.714 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.473 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.5 mp -93.6 -40.51 11.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.056 -177.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.471 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 15.3 m170 75.0 129.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.677 1.191 . . . . 0.0 109.633 -174.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 3.4 t -151.42 154.61 36.96 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 120.755 0.312 . . . . 0.0 110.334 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.3 t -115.99 133.42 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.395 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 54.0 t -69.38 112.48 5.95 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.788 0.804 . . . . 0.0 110.173 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 47.4 mm -112.45 81.35 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 C-N-CA 124.534 1.133 . . . . 0.0 108.84 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.803 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 0.4 OUTLIER 51.62 66.13 1.29 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.374 176.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.49 20.25 79.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.348 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -147.29 163.99 34.65 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.662 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.6 m95 -108.92 162.09 14.53 Favored 'General case' 0 C--N 1.258 -3.388 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.684 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -150.24 102.14 3.15 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.81 140.56 64.45 Favored 'Cis proline' 0 N--CA 1.48 0.705 0 C-N-CA 123.917 -1.284 . . . . 0.0 113.704 -0.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.662 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 44.6 mt-10 -50.48 123.85 9.51 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.585 175.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 1 N--CA 1.374 -4.264 0 CA-C-O 121.458 0.647 . . . . 0.0 111.078 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.431 -1.424 0 CA-C-O 120.864 0.364 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 64.2 m -73.5 -70.89 0.35 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 94.23 135.78 7.92 Favored Glycine 0 N--CA 1.413 -2.876 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.616 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 25.3 t70 62.25 112.94 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 O-C-N 125.324 1.249 . . . . 0.0 111.829 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.662 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -80.0 147.03 64.86 Favored Pre-proline 0 C--N 1.283 -2.305 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.05 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.451 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 71.1 Cg_endo -71.64 -166.9 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 123.499 2.799 . . . . 0.0 112.994 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -129.91 164.64 23.76 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 717' ' ' PHE . 23.7 tp -109.32 132.9 53.69 Favored 'General case' 0 C--N 1.256 -3.498 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.742 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 7.0 pt-20 -43.49 -53.43 5.5 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 125.925 1.69 . . . . 0.0 113.713 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.459 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 89.9 m-70 -137.49 28.15 2.75 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.447 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -136.2 -151.63 6.14 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.541 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.438 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.21 174.55 12.68 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -108.66 142.27 39.4 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -78.3 -67.87 0.69 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 120.72 0.295 . . . . 0.0 111.524 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.3 tt -161.68 137.21 7.61 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.444 ' HA ' HG13 ' A' ' 715' ' ' VAL . 35.5 p -111.8 -49.2 3.0 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -169.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . 0.441 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 66.0 m 58.84 100.26 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 706' ' ' SER . 40.9 Cg_endo -66.69 171.72 10.46 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.416 2.077 . . . . 0.0 109.733 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.635 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.8 Cg_endo -73.67 -2.22 14.73 Favored 'Cis proline' 0 N--CA 1.484 0.962 0 N-CA-C 116.662 1.755 . . . . 0.0 116.662 7.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 33.5 m-85 68.55 72.94 0.28 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 123.691 0.62 . . . . 0.0 109.413 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.635 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 22.5 m-85 -81.2 172.67 13.36 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.459 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -72.58 127.43 32.53 Favored 'General case' 0 CA--C 1.481 -1.691 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.143 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.1 -17.86 53.18 Favored Glycine 0 N--CA 1.406 -3.303 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.656 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.67 144.83 56.67 Favored 'General case' 0 CA--C 1.481 -1.692 0 CA-C-O 121.285 0.564 . . . . 0.0 110.089 177.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 10.2 m -128.11 153.69 46.56 Favored 'General case' 0 N--CA 1.404 -2.739 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.898 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.662 HG21 HG21 ' A' ' 694' ' ' ILE . 46.4 t -135.83 127.4 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.608 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 37.0 mt-10 -84.86 138.01 32.8 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.889 0.852 . . . . 0.0 111.702 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.658 ' HB3' HD22 ' A' ' 697' ' ' LEU . 30.1 m-85 -138.08 128.83 26.8 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 125.487 1.515 . . . . 0.0 107.028 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.438 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 21.7 m-80 -124.69 -163.12 1.14 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 22.4 m -107.39 136.55 47.0 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 23.3 t -66.14 -62.56 1.42 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 123.924 0.765 . . . . 0.0 111.416 -169.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.47 153.13 15.04 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 55.7 m 64.43 13.08 7.85 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 94.4 m-85 -141.27 146.15 36.45 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-O 122.028 0.918 . . . . 0.0 110.169 -175.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.417 ' OG1' HG12 ' A' ' 747' ' ' ILE . 1.0 OUTLIER -110.19 134.95 51.7 Favored 'General case' 0 C--N 1.253 -3.617 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.932 -179.201 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.784 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.4 ttp -82.21 121.77 27.05 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.602 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.51 128.31 74.55 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.27 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.12 -90.51 0.53 Allowed Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.154 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.657 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 15.6 t60 -144.74 164.39 31.16 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.784 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -118.72 23.75 11.28 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.504 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.608 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 6.3 p -153.11 159.67 42.81 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.97 0.414 . . . . 0.0 111.389 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.509 HG21 HD13 ' A' ' 741' ' ' LEU . 27.8 pt -110.43 166.86 5.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.545 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 739' ' ' THR . 19.4 m -138.41 133.49 32.92 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.724 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 2.1 t -81.13 105.21 12.16 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.306 0.574 . . . . 0.0 109.708 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.97 144.75 22.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.022 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 71.02 -15.49 0.4 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.982 0.913 . . . . 0.0 113.322 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 118.94 17.99 4.84 Favored Glycine 1 CA--C 1.445 -4.328 0 CA-C-O 121.364 0.424 . . . . 0.0 112.878 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -154.24 177.79 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.39 -3.456 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.519 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 89.8 m95 -90.38 -173.89 3.95 Favored 'General case' 0 C--N 1.266 -3.065 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 732' ' ' THR . 38.8 p -85.06 -155.76 0.23 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.225 0.536 . . . . 0.0 110.257 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.5 OUTLIER -93.83 3.48 55.35 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -168.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.509 HD13 HG21 ' A' ' 731' ' ' ILE . 4.0 mm? 71.6 159.93 0.16 Allowed Pre-proline 0 N--CA 1.481 1.123 0 O-C-N 123.82 0.7 . . . . 0.0 110.404 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.657 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 18.5 Cg_endo -72.94 -177.71 3.07 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 121.673 1.582 . . . . 0.0 111.356 171.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -122.1 125.94 47.29 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.435 ' SG ' HD21 ' A' ' 697' ' ' LEU . 64.7 m -116.7 94.87 4.78 Favored 'General case' 0 CA--C 1.481 -1.689 0 CA-C-O 121.659 0.742 . . . . 0.0 110.554 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.474 ' HB ' HD21 ' A' ' 750' ' ' LEU . 30.7 t -89.16 143.02 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.881 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.616 -177.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.582 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -62.51 4.31 0.16 Allowed 'General case' 0 C--N 1.283 -2.305 0 C-N-CA 125.733 1.613 . . . . 0.0 114.89 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.757 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 65.7 mt 77.37 -17.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 126.156 1.782 . . . . 0.0 111.34 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.7 t70 -79.85 -31.77 40.47 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-N 113.177 -1.829 . . . . 0.0 109.293 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -107.35 19.82 19.77 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.193 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.757 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 85.0 mt -81.46 -177.69 6.62 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 114.547 -1.206 . . . . 0.0 107.898 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.544 ' HE3' ' HA3' ' A' ' 795' ' ' GLY . 27.1 mtpp -98.63 156.4 16.83 Favored 'General case' 0 N--CA 1.386 -3.638 0 CA-C-O 121.954 0.883 . . . . 0.0 108.977 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . 0.637 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 43.5 mtpt -105.65 116.82 32.59 Favored 'General case' 1 C--N 1.238 -4.242 0 CA-C-N 112.524 -2.126 . . . . 0.0 108.171 -172.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 65.2 m -76.52 132.77 39.75 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.051 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.45 135.0 41.51 Favored 'General case' 0 C--N 1.278 -2.538 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.699 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . 0.419 ' HB2' ' HE1' ' A' ' 771' ' ' PHE . 47.3 t -60.94 129.34 40.95 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.703 171.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.547 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 41.0 t -73.27 151.04 41.52 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -82.97 -0.38 48.42 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 98.8 mt -112.82 -8.87 13.71 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.552 HG12 HG11 ' A' ' 801' ' ' VAL . 2.2 pp -102.28 150.93 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 122.163 0.982 . . . . 0.0 113.385 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.4 mp -105.04 130.86 55.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.487 0 CA-C-N 113.595 -1.639 . . . . 0.0 107.387 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 777' ' ' ILE . 1.8 mm? -113.28 -176.6 2.93 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . 0.46 ' HB2' HD23 ' A' ' 765' ' ' LEU . 48.1 mt-10 -65.29 165.72 11.18 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.885 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.33 -7.7 44.7 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.501 0.667 . . . . 0.0 111.795 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -4.45 17.35 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.797 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.0 mm? -117.04 -11.71 10.73 Favored 'General case' 0 C--O 1.207 -1.136 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 10.4 mtmp? -70.85 -16.49 62.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.454 0.645 . . . . 0.0 110.228 176.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -78.72 -13.53 59.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.917 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 7.9 tppt? -98.32 126.81 43.98 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 769' ' ' LYS . 15.3 ptpt -110.37 -19.65 12.89 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . 0.637 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 36.4 mt-10 -134.25 107.79 7.87 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.543 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.419 ' HE1' ' HB2' ' A' ' 755' ' ' SER . 79.4 m-85 -93.2 162.71 13.91 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.84 -175.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -101.86 154.78 18.61 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.566 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 28.5 t60 -60.19 144.38 50.21 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.902 0.126 . . . . 0.0 111.038 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 63.7 t30 88.12 3.1 0.31 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 125.445 1.716 . . . . 0.0 111.27 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 791' ' ' VAL . 86.8 p -73.61 105.75 5.08 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 119.803 -0.759 . . . . 0.0 108.988 177.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.469 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -87.03 90.2 8.27 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 789' ' ' HIS . 7.6 pt -104.55 -170.91 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.562 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.641 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 16.6 ptt180 -142.83 125.61 16.02 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.066 174.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.646 ' CD2' HG13 ' A' ' 801' ' ' VAL . 13.1 p90 -106.87 167.46 9.86 Favored 'General case' 0 C--O 1.257 1.496 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 780' ' ' ARG . 13.3 ptt180 -155.67 161.82 40.7 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 175.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.639 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 3.1 m -98.95 173.88 6.63 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -101.91 36.25 2.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.479 1.133 . . . . 0.0 109.674 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -176.72 -33.72 0.05 OUTLIER Glycine 0 CA--C 1.473 -2.564 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.639 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 0.4 OUTLIER -96.82 139.72 32.44 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 176.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.31 154.41 19.4 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.572 0.701 . . . . 0.0 112.891 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 91.2 154.51 30.67 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.349 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 52.0 m95 -95.85 141.04 29.77 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.471 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -95.42 -31.21 4.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.568 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.495 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 12.0 m170 72.44 118.37 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 124.062 0.945 . . . . 0.0 111.114 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.527 HG21 ' CG2' ' A' ' 801' ' ' VAL . 3.4 t -141.51 153.28 44.8 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.556 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 775' ' ' SER . 38.9 t -114.45 132.91 62.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.712 -176.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.15 115.06 8.92 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.566 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 46.5 mm -114.5 84.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.455 HD22 HD22 ' A' ' 750' ' ' LEU . 7.7 t-20 46.92 68.11 0.68 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.845 0.858 . . . . 0.0 111.992 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . 0.544 ' HA3' ' HE3' ' A' ' 751' ' ' LYS . . . 72.28 24.09 76.92 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 114.958 -1.019 . . . . 0.0 114.293 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -146.88 168.5 21.3 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.664 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 91.3 m95 -117.24 161.99 18.6 Favored 'General case' 0 C--N 1.266 -3.038 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -150.58 104.56 3.08 Favored Pre-proline 0 C--N 1.296 -1.727 0 O-C-N 123.344 0.402 . . . . 0.0 110.063 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 36.7 Cg_endo -68.57 140.98 59.77 Favored 'Cis proline' 0 C--O 1.239 0.565 0 C-N-CA 123.993 -1.253 . . . . 0.0 112.306 -1.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.664 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 52.2 mt-10 -49.33 120.71 4.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.876 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.646 HG13 ' CD2' ' A' ' 779' ' ' TYR . 67.7 t . . . . . 0 N--CA 1.439 -1.004 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.104 -177.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.599 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.2 m -82.25 -61.97 1.75 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.004 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 134.08 174.56 13.55 Favored Glycine 1 N--CA 1.374 -5.466 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.714 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 29.9 t70 -52.0 135.34 31.04 Favored 'General case' 0 C--N 1.276 -2.589 0 O-C-N 124.803 0.943 . . . . 0.0 111.38 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.589 HG21 HG21 ' A' ' 715' ' ' VAL . 1.3 pp -55.6 150.34 25.95 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.145 -1.389 . . . . 0.0 114.076 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.52 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 65.1 Cg_endo -72.67 -161.62 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.468 2.778 . . . . 0.0 111.321 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -135.82 151.86 50.49 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 717' ' ' PHE . 26.4 tp -92.66 123.22 35.79 Favored 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.893 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 5.4 pt-20 -34.63 -50.78 0.46 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.334 2.253 . . . . 0.0 114.417 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 83.5 m-70 -136.28 28.83 3.07 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -142.17 -156.15 6.7 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.389 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.5 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -140.25 -178.31 5.42 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -115.72 146.09 42.19 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -74.16 -68.57 0.51 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.337 0.589 . . . . 0.0 110.806 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.4 tt -159.8 138.97 10.99 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.521 ' HB3' HG11 ' A' ' 715' ' ' VAL . 4.1 p -153.44 123.54 6.96 Favored 'General case' 0 N--CA 1.395 -3.197 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 20.6 m -128.08 130.44 23.6 Favored Pre-proline 0 C--N 1.278 -2.539 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.284 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.45 168.59 14.25 Favored 'Trans proline' 0 C--O 1.248 0.976 0 C-N-CA 122.715 2.277 . . . . 0.0 109.716 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.59 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 2.6 Cg_endo -71.64 -11.71 15.77 Favored 'Cis proline' 0 N--CA 1.483 0.892 0 N-CA-C 116.097 1.537 . . . . 0.0 116.097 6.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.714 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 66.7 m-85 68.92 77.77 0.22 Allowed 'General case' 0 C--O 1.248 0.995 0 O-C-N 123.857 0.723 . . . . 0.0 109.643 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.59 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 47.5 m-85 -82.99 171.53 13.73 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.843 0.83 . . . . 0.0 113.204 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.426 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 91.1 m-85 -71.41 132.41 44.77 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.271 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.57 -15.63 55.7 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.1 147.67 46.48 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-O 121.088 0.47 . . . . 0.0 111.547 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 15.8 m -135.57 144.37 46.17 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.999 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.589 HG21 HG21 ' A' ' 694' ' ' ILE . 38.3 t -127.24 138.2 55.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.58 125.27 33.68 Favored 'General case' 0 N--CA 1.425 -1.723 0 O-C-N 124.338 1.024 . . . . 0.0 111.073 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.6 ' HB3' HD22 ' A' ' 697' ' ' LEU . 21.9 m-85 -128.21 118.12 22.76 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 125.785 1.634 . . . . 0.0 107.655 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.5 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 17.7 m-80 -120.41 -162.1 0.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 5.5 m -112.33 134.37 53.91 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . 0.414 ' HA ' ' CE2' ' A' ' 701' ' ' TRP . 22.4 t -61.56 -58.54 7.72 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.216 0.532 . . . . 0.0 110.568 -172.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -174.18 166.2 4.14 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 68.4 m 68.33 0.63 2.58 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.239 0.962 . . . . 0.0 112.051 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' A' ' 719' ' ' CYS . 96.8 m-85 -137.22 144.83 43.01 Favored 'General case' 0 N--CA 1.395 -3.196 0 C-N-CA 124.243 1.017 . . . . 0.0 109.133 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.484 HG21 HD21 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -110.36 134.66 52.08 Favored 'General case' 0 C--N 1.254 -3.58 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.219 -177.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.497 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.0 ttp -84.62 122.81 29.58 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 124.236 1.015 . . . . 0.0 109.237 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 726' ' ' ILE . 34.5 mm -111.28 122.81 66.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.822 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.728 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 99.44 -87.62 0.77 Allowed Glycine 0 N--CA 1.42 -2.422 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.634 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.476 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 48.9 p-80 -135.8 179.13 6.53 Favored 'General case' 0 N--CA 1.393 -3.286 0 C-N-CA 124.113 0.965 . . . . 0.0 108.478 -173.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.497 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.0 ppt_? -135.7 8.99 3.34 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 32.5 m -130.82 155.1 47.27 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.49 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 714' ' ' SER . 36.5 pt -110.4 160.66 9.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.24 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 739' ' ' THR . 26.9 m -135.75 133.71 38.26 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.192 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 7.1 t -84.87 103.88 14.33 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.86 145.87 23.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.776 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 72.69 -49.93 0.7 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.63 1.172 . . . . 0.0 111.919 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 158.4 24.26 0.03 OUTLIER Glycine 0 C--N 1.29 -1.991 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.367 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.4 p -160.01 157.88 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.52 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 93.5 m95 -78.39 170.68 16.24 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 24.8 p -74.91 -163.5 0.23 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.389 1.09 . . . . 0.0 113.528 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.0 OUTLIER -68.88 -23.9 64.27 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -170.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.3 mm? 81.95 148.22 0.11 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 124.786 1.304 . . . . 0.0 109.22 -173.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 19.6 Cg_endo -72.85 -175.56 1.95 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.928 1.752 . . . . 0.0 112.885 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.411 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.6 tt0 -119.78 126.37 50.86 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 78.5 m -118.46 111.8 19.13 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.275 0.559 . . . . 0.0 109.799 177.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.47 ' CG1' ' HG3' ' A' ' 749' ' ' LYS . 41.7 t -100.91 145.14 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.548 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.99 4.25 0.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.184 1.393 . . . . 0.0 113.672 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.587 ' HA ' HD13 ' A' ' 750' ' ' LEU . 32.0 mt 80.11 -26.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 126.302 1.841 . . . . 0.0 111.801 173.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 746' ' ' ALA . 38.7 t70 -82.95 -25.31 32.45 Favored 'General case' 0 C--N 1.248 -3.841 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.375 -172.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . 0.47 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 9.4 ptmt -112.65 34.91 4.09 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.72 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.817 ' HG ' ' HB2' ' A' ' 794' ' ' ASN . 0.8 OUTLIER -78.71 -166.36 0.87 Allowed 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.092 176.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.442 ' H ' ' HA ' ' A' ' 794' ' ' ASN . 30.6 mtpp -121.34 -178.66 3.84 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 121.542 0.687 . . . . 0.0 109.625 -174.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -114.43 132.94 56.08 Favored 'General case' 0 C--N 1.262 -3.23 0 CA-C-N 112.991 -1.913 . . . . 0.0 107.804 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 58.3 m -90.49 174.29 7.62 Favored 'General case' 0 C--N 1.244 -4.0 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.391 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . 0.417 ' HB2' ' HE3' ' A' ' 754' ' ' LYS . 15.7 ptmt -144.15 152.39 40.84 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.173 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 20.4 p -62.52 126.06 26.04 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.69 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.574 ' HB2' HG13 ' A' ' 759' ' ' ILE . 11.3 m -72.85 136.37 45.32 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -72.09 -4.4 28.72 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 88.6 mt -105.6 -21.0 13.29 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.032 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.596 HG12 HG11 ' A' ' 801' ' ' VAL . 2.8 pp -98.48 171.31 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.077 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.31 136.44 54.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 777' ' ' ILE . 80.4 mt -107.11 177.0 4.98 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . 0.44 ' HB2' HD23 ' A' ' 765' ' ' LEU . 43.7 mt-10 -62.06 162.04 9.95 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.986 0.422 . . . . 0.0 110.736 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -70.18 -9.62 56.28 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.464 0.649 . . . . 0.0 111.02 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -109.86 -0.5 18.29 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.029 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.1 mm? -123.67 -14.62 7.23 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' A' ' 761' ' ' LEU . 29.3 mtmm -68.37 -19.55 64.64 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.123 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -78.95 -17.27 55.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.139 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 8.4 tppt? -85.99 107.98 18.01 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . 0.522 ' HG3' ' HG2' ' A' ' 770' ' ' GLU . 8.5 ptpp? -74.23 -32.65 63.07 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.688 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . 0.522 ' HG2' ' HG3' ' A' ' 769' ' ' LYS . 22.7 mm-40 -131.96 139.52 48.7 Favored 'General case' 0 CA--C 1.478 -1.799 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.439 ' CZ ' HD13 ' A' ' 761' ' ' LEU . 90.8 m-85 -112.45 134.0 54.22 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.724 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -86.21 155.71 20.6 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.675 ' HB2' HD23 ' A' ' 750' ' ' LEU . 18.8 p-80 -49.7 143.98 6.65 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.117 0.967 . . . . 0.0 112.052 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 19.1 m120 67.76 25.75 7.94 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 124.211 1.004 . . . . 0.0 112.781 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 69.0 m -93.86 109.12 20.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.596 ' HA ' HG12 ' A' ' 791' ' ' VAL . 0.7 OUTLIER -83.46 114.32 21.39 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.45 HD12 HD22 ' A' ' 761' ' ' LEU . 5.8 pt -127.38 -174.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.486 0.66 . . . . 0.0 111.006 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 98.1 mtt180 -134.29 124.52 25.99 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.535 ' CD2' HG13 ' A' ' 801' ' ' VAL . 13.2 p90 -111.98 166.77 10.93 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 171.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -152.57 160.13 43.23 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 3.4 m -95.18 163.39 13.3 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.144 0.497 . . . . 0.0 112.271 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -68.33 -27.9 66.68 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.825 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -110.23 9.09 31.13 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.961 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 1.8 mptm? -121.2 113.2 19.64 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.904 0.383 . . . . 0.0 110.469 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -90.87 87.51 6.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.571 0.7 . . . . 0.0 109.242 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 166.14 145.4 4.44 Favored Glycine 0 C--N 1.291 -1.941 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.553 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 54.4 m95 -96.1 142.86 27.79 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.533 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -96.7 -29.69 3.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.517 -176.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.467 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 21.5 m170 76.77 128.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.565 1.146 . . . . 0.0 109.739 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.577 HG21 ' CG2' ' A' ' 801' ' ' VAL . 2.7 t -153.75 159.9 42.1 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.822 HG22 ' HB3' ' A' ' 798' ' ' ASP . 5.9 m -124.36 153.13 30.65 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.505 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 43.2 t -80.95 116.21 20.81 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.407 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 51.0 mm -121.05 86.2 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.817 ' HB2' ' HG ' ' A' ' 750' ' ' LEU . 23.7 t-20 54.01 69.06 0.76 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.13 0.967 . . . . 0.0 111.508 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.12 66.29 Favored Glycine 0 C--N 1.297 -1.635 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.49 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -140.54 168.43 19.83 Favored 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.69 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 82.7 m95 -116.26 155.51 28.23 Favored 'General case' 0 C--N 1.26 -3.31 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . 0.822 ' HB3' HG22 ' A' ' 791' ' ' VAL . 26.0 t70 -133.3 100.47 13.98 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 119.567 -0.254 . . . . 0.0 110.973 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 44.3 Cg_endo -73.07 145.0 82.82 Favored 'Cis proline' 0 C--O 1.24 0.59 0 C-N-CA 124.377 -1.093 . . . . 0.0 112.153 -1.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.69 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 27.0 tt0 -48.59 122.15 5.25 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.014 0.821 . . . . 0.0 111.249 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.596 HG11 HG12 ' A' ' 759' ' ' ILE . 64.4 t . . . . . 0 N--CA 1.427 -1.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.42 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 18.9 m -67.54 -80.69 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 123.326 0.391 . . . . 0.0 111.729 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 156.94 164.15 13.23 Favored Glycine 0 N--CA 1.399 -3.807 0 N-CA-C 106.845 -2.502 . . . . 0.0 106.845 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.818 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 36.5 t70 -45.68 128.91 8.85 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 124.069 0.948 . . . . 0.0 112.24 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.806 HG21 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -50.06 148.18 6.2 Favored Pre-proline 0 N--CA 1.429 -1.491 0 O-C-N 125.042 1.464 . . . . 0.0 114.294 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.412 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 36.6 Cg_endo -67.46 -164.33 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.123 2.549 . . . . 0.0 112.308 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -137.17 141.15 42.18 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 717' ' ' PHE . 25.0 tp -89.01 123.35 33.25 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.729 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -42.38 -48.53 5.12 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 126.723 2.009 . . . . 0.0 115.079 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -134.54 24.99 3.75 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.446 0.641 . . . . 0.0 110.174 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -134.02 -145.69 5.33 Favored Glycine 0 C--N 1.288 -2.11 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.272 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.447 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -154.23 172.16 18.06 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -104.23 150.37 24.47 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -81.44 -77.9 0.2 Allowed 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.674 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 67.0 tp -172.2 129.84 0.6 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.268 0.227 . . . . 0.0 110.412 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.499 ' HB2' HG13 ' A' ' 715' ' ' VAL . 48.2 t -141.2 -50.65 0.43 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.856 175.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 35.9 p 58.03 155.45 0.09 OUTLIER Pre-proline 0 CA--C 1.57 1.747 0 C-N-CA 125.392 1.477 . . . . 0.0 113.018 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.551 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 60.9 Cg_endo -66.51 174.91 5.69 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.027 1.818 . . . . 0.0 111.256 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.551 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.0 Cg_endo -79.07 -9.25 37.86 Favored 'Cis proline' 0 N--CA 1.485 1.013 0 N-CA-C 115.176 1.183 . . . . 0.0 115.176 5.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.818 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 77.8 m-85 72.59 76.17 0.15 Allowed 'General case' 0 C--N 1.316 -0.872 0 O-C-N 124.173 0.921 . . . . 0.0 110.242 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.432 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 25.0 m-85 -79.99 167.6 20.26 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.868 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.498 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 64.9 m-85 -72.77 134.81 45.12 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.042 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.61 -4.95 66.78 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.21 149.43 35.51 Favored 'General case' 0 CA--C 1.477 -1.832 0 CA-C-O 121.361 0.6 . . . . 0.0 110.853 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 12.7 m -129.58 153.38 48.11 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.806 HG21 HG21 ' A' ' 694' ' ' ILE . 24.8 t -136.48 142.35 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.656 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.49 136.67 37.58 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-O 121.532 0.682 . . . . 0.0 110.483 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.617 ' HB3' HD22 ' A' ' 697' ' ' LEU . 32.1 m-85 -135.4 118.89 16.88 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.447 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 14.2 m-80 -121.91 -163.8 1.1 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 21.6 m -116.02 141.39 48.18 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 38.8 t -64.24 -92.14 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 123.841 0.713 . . . . 0.0 111.22 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -139.09 153.6 48.05 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 74.8 m 71.62 1.51 3.9 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.491 1.119 . . . . 0.0 113.164 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.561 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.7 m-85 -132.17 143.55 50.05 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-O 121.73 0.776 . . . . 0.0 109.585 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.642 HG21 HD21 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -111.71 141.95 44.67 Favored 'General case' 0 C--N 1.253 -3.619 0 CA-C-N 113.097 -1.865 . . . . 0.0 111.869 -178.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.716 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 2.8 ttp -85.64 122.91 30.41 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.476 1.51 . . . . 0.0 108.977 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 50.8 mm -115.77 129.43 72.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.378 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 93.85 -85.17 1.06 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.329 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.579 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -125.36 172.41 9.63 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.716 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -135.37 18.52 3.38 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 170.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 34.7 p -144.92 158.91 43.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.285 0.564 . . . . 0.0 110.919 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.5 pt -123.31 162.82 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.345 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 739' ' ' THR . 24.0 m -136.15 133.75 37.53 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.204 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.4 t -85.31 101.21 12.36 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -136.9 140.08 43.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.903 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 64.38 6.39 3.04 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.94 18.43 31.99 Favored Glycine 0 CA--C 1.494 -1.279 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.044 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.18 148.62 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.439 ' CZ3' HG23 ' A' ' 715' ' ' VAL . 93.5 m95 -78.95 169.71 17.8 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.037 173.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 732' ' ' THR . 38.9 p -81.16 -166.9 1.25 Allowed 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 121.857 0.836 . . . . 0.0 112.825 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.25 -4.82 23.67 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -168.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.402 HD13 HG21 ' A' ' 731' ' ' ILE . 4.3 mm? 68.16 158.6 0.15 Allowed Pre-proline 0 N--CA 1.493 1.722 0 CA-C-O 120.998 0.428 . . . . 0.0 111.256 -175.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.579 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 44.9 Cg_endo -81.92 178.04 6.82 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.854 1.703 . . . . 0.0 111.188 170.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.544 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.6 tt0 -120.41 115.15 22.95 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.571 ' SG ' HD21 ' A' ' 697' ' ' LEU . 94.2 m -97.94 108.09 20.72 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.609 0.719 . . . . 0.0 110.71 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' A' ' 747' ' ' ILE . 26.8 t -100.93 141.95 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.596 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.525 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.561 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.39 4.11 0.58 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 125.913 1.685 . . . . 0.0 113.455 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.753 ' HA ' HD22 ' A' ' 750' ' ' LEU . 60.3 mt 74.76 -14.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 126.238 1.815 . . . . 0.0 111.028 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 746' ' ' ALA . 19.2 t70 -80.42 -30.55 37.67 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.648 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . 0.426 ' NZ ' ' HB3' ' A' ' 749' ' ' LYS . 0.2 OUTLIER -95.38 11.89 31.17 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.711 -1.586 . . . . 0.0 108.706 -176.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 1.113 ' HG ' HD22 ' A' ' 794' ' ' ASN . 0.4 OUTLIER -82.41 -168.94 2.19 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.737 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.539 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 31.7 mmmt -126.13 146.81 49.79 Favored 'General case' 0 N--CA 1.392 -3.348 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -103.72 122.39 44.95 Favored 'General case' 1 C--N 1.242 -4.068 0 CA-C-N 112.92 -1.945 . . . . 0.0 107.781 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 55.6 m -71.91 157.48 37.78 Favored 'General case' 0 C--N 1.253 -3.61 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.314 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -127.77 145.4 50.93 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 48.2 t -56.63 127.67 32.54 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.286 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.545 ' HB3' HG12 ' A' ' 759' ' ' ILE . 26.3 t -76.52 160.53 29.39 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.401 0.619 . . . . 0.0 110.358 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -86.92 -4.1 59.14 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.322 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -110.52 -2.71 16.35 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.966 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.555 HD12 HD11 ' A' ' 761' ' ' LEU . 28.6 pt -109.94 156.79 10.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.852 -173.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.6 mp -121.27 127.46 75.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.555 HD11 HD12 ' A' ' 759' ' ' ILE . 2.0 mm? -105.37 -178.71 3.73 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . 0.461 ' HB2' HD23 ' A' ' 765' ' ' LEU . 38.1 mt-10 -68.6 173.97 4.62 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.79 -17.81 64.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.964 -0.46 . . . . 0.0 111.57 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . 0.501 ' HB2' HD22 ' A' ' 765' ' ' LEU . 6.3 m-70 -87.26 -35.0 18.73 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 761' ' ' LEU . 2.6 mm? -90.97 -19.47 23.21 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.288 -171.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -71.04 -16.5 62.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.689 0.757 . . . . 0.0 109.25 170.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.87 16.83 22.5 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.367 1.08 . . . . 0.0 108.464 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.409 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 14.5 tppt? -111.71 111.76 22.97 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' A' ' 769' ' ' LYS . 26.8 ttpp -73.33 -42.59 62.14 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.389 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -139.53 143.4 37.41 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.105 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 753' ' ' CYS . 83.4 m-85 -113.48 135.96 53.31 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.45 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -86.52 160.73 18.88 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.687 ' HB3' HD23 ' A' ' 750' ' ' LEU . 65.7 t60 -61.84 151.27 34.87 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.382 0.134 . . . . 0.0 110.667 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 4.3 m120 78.44 14.19 1.4 Allowed 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 123.987 0.915 . . . . 0.0 112.453 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 44.3 m -91.78 113.26 25.49 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -90.65 111.4 22.71 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.497 HD12 HD12 ' A' ' 761' ' ' LEU . 10.2 pt -122.81 179.3 2.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 121.586 0.708 . . . . 0.0 109.165 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.685 ' HA ' ' HA ' ' A' ' 789' ' ' HIS . 20.7 ptt180 -133.25 120.7 21.44 Favored 'General case' 0 N--CA 1.399 -3.023 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.632 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 2.7 p90 -108.21 167.61 9.89 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . 0.5 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 32.9 ptt180 -146.34 156.05 43.06 Favored 'General case' 0 C--N 1.262 -3.204 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 73.7 m -100.47 134.42 43.45 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.53 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . 0.579 ' HB3' HD11 ' A' ' 760' ' ' ILE . 36.7 ptt180 -59.57 -48.95 79.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -85.92 6.0 82.3 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.319 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.7 mptt -110.02 -47.75 3.28 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 70.19 129.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.238 1.415 . . . . 0.0 111.771 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 111.95 144.96 9.67 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -175.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 25.9 m95 -93.93 144.23 25.63 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.632 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -100.94 -32.23 3.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.628 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 11.5 m170 73.95 129.93 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 124.555 1.142 . . . . 0.0 110.091 -175.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 3.2 t -151.8 159.18 44.0 Favored 'General case' 0 C--N 1.274 -2.675 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.771 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.17 134.77 62.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.985 -176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.09 114.09 7.91 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.521 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 50.8 mm -116.94 87.92 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 124.745 1.218 . . . . 0.0 109.21 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 1.113 HD22 ' HG ' ' A' ' 750' ' ' LEU . 0.6 OUTLIER 46.74 66.01 1.08 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.762 0.825 . . . . 0.0 112.353 175.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 69.99 27.88 72.48 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.341 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -151.03 166.44 30.7 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 98.1 m95 -110.81 160.74 16.47 Favored 'General case' 0 C--N 1.256 -3.493 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -147.68 103.3 3.68 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.05 138.22 46.1 Favored 'Cis proline' 0 C--O 1.246 0.916 0 C-N-CA 123.956 -1.268 . . . . 0.0 112.325 1.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.606 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 4.2 tp10 -59.58 126.6 28.24 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.304 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 1 N--CA 1.358 -5.054 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.584 -172.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 12.6 m -72.83 -59.4 2.73 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.908 0.385 . . . . 0.0 110.768 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 130.51 179.79 16.33 Favored Glycine 1 N--CA 1.367 -5.923 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -40.51 130.12 2.39 Favored 'General case' 0 C--N 1.278 -2.507 0 C-N-CA 126.348 1.859 . . . . 0.0 111.747 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.587 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -61.94 149.05 86.86 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.64 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.496 ' HG3' HD21 ' A' ' 741' ' ' LEU . 59.7 Cg_endo -71.98 -161.62 0.1 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.475 2.784 . . . . 0.0 111.276 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -136.31 149.74 48.57 Favored 'General case' 0 N--CA 1.408 -2.555 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' A' ' 717' ' ' PHE . 23.3 tp -93.82 123.37 37.12 Favored 'General case' 0 C--N 1.255 -3.522 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.073 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 5.0 pt-20 -34.24 -53.43 0.49 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.215 1.806 . . . . 0.0 115.545 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.451 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 82.4 m-70 -135.98 27.83 3.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -128.7 -149.96 7.07 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 119.605 -1.284 . . . . 0.0 112.096 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.434 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -146.23 175.04 10.8 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -177.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.12 133.55 49.71 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 14.0 mm100 -74.42 -61.76 1.76 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.054 0.454 . . . . 0.0 111.4 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.7 tt -169.65 138.29 1.86 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 103.486 -2.783 . . . . 0.0 103.486 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.52 ' HA ' HG13 ' A' ' 715' ' ' VAL . 59.2 p -115.59 -41.76 3.21 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -169.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 33.5 m 62.3 95.58 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 125.094 1.358 . . . . 0.0 113.887 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.15 172.55 13.75 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.297 1.998 . . . . 0.0 108.745 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.405 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 16.5 Cg_exo -71.16 -5.15 10.96 Favored 'Cis proline' 0 N--CA 1.506 2.226 0 CA-C-N 120.825 1.33 . . . . 0.0 115.27 4.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.456 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 56.9 m-85 78.98 69.99 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 O-C-N 124.876 1.36 . . . . 0.0 109.154 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.405 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 58.3 m-85 -77.46 170.4 16.63 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.941 -1.482 . . . . 0.0 112.589 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -73.39 129.63 38.41 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.053 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.48 -4.87 51.26 Favored Glycine 0 N--CA 1.421 -2.363 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.352 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.86 151.19 26.12 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 120.878 0.371 . . . . 0.0 110.924 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 3.8 m -131.29 156.07 46.08 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.587 HG21 HG21 ' A' ' 694' ' ' ILE . 52.7 t -137.64 129.74 40.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 47.0 mt-10 -77.35 134.46 38.47 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 123.988 0.805 . . . . 0.0 111.038 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.655 ' HB3' HD22 ' A' ' 697' ' ' LEU . 35.8 m-85 -139.94 112.94 8.16 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 125.026 1.33 . . . . 0.0 107.584 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.434 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 16.5 m-80 -121.07 -164.51 1.13 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 7.1 m -109.7 133.84 52.66 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 2.4 m -53.07 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.751 0.82 . . . . 0.0 111.137 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -169.31 158.73 8.34 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 66.0 m 69.73 13.36 8.12 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.203 0.939 . . . . 0.0 111.563 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.699 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.4 m-85 -143.74 145.14 32.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 C-N-CA 124.733 1.213 . . . . 0.0 107.752 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.495 ' HB ' HD11 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -113.74 136.41 52.88 Favored 'General case' 0 C--N 1.257 -3.44 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.988 -177.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.2 ttp -81.76 120.22 24.86 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.848 1.259 . . . . 0.0 109.516 -175.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 45.4 mm -113.1 121.25 64.96 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.222 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 87.49 -82.13 1.61 Allowed Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 114.856 -1.065 . . . . 0.0 114.121 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.7 m80 -114.3 173.9 6.22 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 123.797 0.839 . . . . 0.0 110.569 -173.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.482 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -146.14 15.95 1.35 Allowed 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 121.276 0.56 . . . . 0.0 109.647 172.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 37.5 m -152.59 162.1 41.68 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 121.554 -0.716 . . . . 0.0 110.291 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.5 pt -123.84 162.23 25.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.299 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.7 m -133.31 134.18 43.52 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 123.522 0.514 . . . . 0.0 110.841 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 5.0 t -85.24 106.42 16.65 Favored 'General case' 0 C--O 1.256 1.429 0 CA-C-O 121.694 0.759 . . . . 0.0 109.389 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.32 142.17 35.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.618 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 72.87 -53.47 0.7 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.726 1.21 . . . . 0.0 111.367 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 160.39 26.29 0.02 OUTLIER Glycine 0 C--N 1.288 -2.117 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 24.2 t -151.25 154.4 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 -173.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.432 ' HZ2' ' HB3' ' A' ' 709' ' ' TYR . 95.8 m95 -78.98 -178.85 6.31 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 18.3 p -84.69 -158.5 0.35 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.347 0.594 . . . . 0.0 112.253 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.3 pp0? -81.56 -11.45 59.15 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.496 HD21 ' HG3' ' A' ' 695' ' ' PRO . 4.4 mm? 72.17 137.69 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 30.8 Cg_endo -66.07 -179.44 1.41 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.773 2.315 . . . . 0.0 112.729 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.575 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 53.3 tt0 -124.45 137.75 54.41 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.519 ' SG ' HD21 ' A' ' 697' ' ' LEU . 58.6 m -123.92 98.75 5.94 Favored 'General case' 0 CA--C 1.466 -2.273 0 CA-C-O 121.586 0.708 . . . . 0.0 109.642 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.438 ' HB ' HD21 ' A' ' 750' ' ' LEU . 32.1 t -86.85 140.73 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.059 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.699 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.14 4.83 0.61 Allowed 'General case' 0 C--N 1.274 -2.704 0 C-N-CA 125.188 1.395 . . . . 0.0 114.112 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.85 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 32.3 mt 75.62 -17.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 125.626 1.57 . . . . 0.0 111.428 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 746' ' ' ALA . 8.4 t70 -76.64 -32.35 57.96 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 125.671 1.588 . . . . 0.0 109.124 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -103.63 12.51 34.79 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.216 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.85 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 67.5 mt -76.77 148.82 36.43 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.39 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -90.04 -170.25 2.72 Favored 'General case' 0 C--N 1.261 -3.269 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.011 -172.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -120.26 126.8 51.5 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 113.352 -1.749 . . . . 0.0 106.477 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 35.9 m -87.77 150.59 23.48 Favored 'General case' 0 C--N 1.249 -3.763 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.061 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -116.81 139.84 50.12 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . 0.485 ' HB3' HD11 ' A' ' 761' ' ' LEU . 14.7 p -61.54 139.58 58.23 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.237 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.665 ' HB2' HG13 ' A' ' 759' ' ' ILE . 20.3 m -78.02 149.21 34.06 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -91.95 7.95 39.76 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 112.223 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -106.98 -9.72 16.17 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.873 174.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.665 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.7 pp -109.0 152.11 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.74 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . 0.449 ' HB ' ' CG ' ' A' ' 780' ' ' ARG . 3.5 mp -109.18 131.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.769 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 44.9 mt -103.63 178.82 4.45 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.51 168.7 8.68 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.26 -22.29 64.69 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.752 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -79.98 -42.3 24.19 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.696 HD22 ' HE2' ' A' ' 771' ' ' PHE . 35.0 mt -83.03 -19.78 36.29 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.003 -1.908 . . . . 0.0 113.102 -167.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -70.81 -6.38 37.42 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.352 0.596 . . . . 0.0 111.121 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.48 15.38 27.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.421 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 6.2 tppt? -122.61 105.87 10.48 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -75.78 -45.6 35.35 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -125.14 131.31 53.27 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.048 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.769 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 40.2 m-85 -103.0 164.89 11.34 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.448 -175.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -104.74 142.14 35.23 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.336 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.555 ' HD2' HD12 ' A' ' 750' ' ' LEU . 32.6 p-80 -41.37 140.1 0.93 Allowed 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.825 1.25 . . . . 0.0 113.716 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 25.1 m120 70.4 23.25 4.99 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 125.171 1.389 . . . . 0.0 112.965 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 22.0 t -96.11 121.75 38.22 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.473 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -92.7 104.11 16.41 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.631 HG21 ' CE2' ' A' ' 771' ' ' PHE . 4.5 pt -114.15 -173.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.972 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 1.6 ptt180 -143.77 127.93 17.63 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.0 174.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.471 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 6.8 p90 -117.22 174.94 5.84 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 177.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . 0.449 ' CG ' ' HB ' ' A' ' 760' ' ' ILE . 10.6 ptm180 -153.87 170.58 20.66 Favored 'General case' 0 N--CA 1.407 -2.62 0 O-C-N 124.374 1.047 . . . . 0.0 108.447 177.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 49.7 t -100.47 161.46 13.59 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -73.74 -21.51 60.18 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.938 0.399 . . . . 0.0 109.942 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -93.03 -4.99 64.45 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.214 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 13.7 mptt -120.8 107.9 13.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . 0.439 ' HA ' ' NH2' ' A' ' 780' ' ' ARG . 12.2 tp10 -81.93 99.9 9.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 160.09 -165.91 34.94 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 107.665 -2.174 . . . . 0.0 107.665 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.585 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 61.4 m95 -139.72 146.62 39.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.64 1.22 . . . . 0.0 109.665 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.471 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -100.29 -34.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.456 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 12.8 m170 77.24 135.15 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.622 1.169 . . . . 0.0 110.452 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.446 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.8 t -158.57 157.58 32.27 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.091 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.5 136.84 55.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 45.8 t -71.23 107.53 4.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.631 0.729 . . . . 0.0 109.482 177.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.3 mm -113.89 83.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.165 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.42 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.652 HD22 ' HA ' ' A' ' 750' ' ' LEU . 25.3 t-20 58.76 66.34 1.08 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 122.403 1.097 . . . . 0.0 111.175 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 62.03 24.31 64.81 Favored Glycine 0 C--N 1.299 -1.478 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.488 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -145.02 166.27 25.79 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.435 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.5 m95 -111.67 158.08 19.7 Favored 'General case' 0 C--N 1.255 -3.54 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -148.32 107.02 3.59 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.36 142.54 66.8 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.971 -1.262 . . . . 0.0 113.074 0.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.435 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.6 mt-10 -55.54 117.03 3.23 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.406 174.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.446 ' CG1' HG21 ' A' ' 790' ' ' THR . 7.2 m . . . . . 1 N--CA 1.376 -4.171 0 C-N-CA 124.667 1.187 . . . . 0.0 112.519 -173.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 13.7 m -93.81 -167.39 1.68 Allowed 'General case' 0 C--N 1.25 -3.735 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . -118.12 -156.23 10.22 Favored Glycine 1 N--CA 1.39 -4.386 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.19 142.36 57.7 Favored 'General case' 0 C--N 1.278 -2.507 0 O-C-N 124.717 0.892 . . . . 0.0 108.753 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.597 HG21 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -63.68 151.7 87.96 Favored Pre-proline 0 C--N 1.284 -2.25 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.928 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.488 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 55.8 Cg_endo -71.14 -162.15 0.1 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.074 2.516 . . . . 0.0 112.925 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.17 158.84 43.45 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.605 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.8 OUTLIER -98.28 134.61 41.07 Favored 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.583 177.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -56.24 -37.97 70.47 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -144.65 29.54 1.24 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.605 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -140.0 -138.92 3.68 Favored Glycine 0 C--N 1.305 -1.141 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.074 -176.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.405 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -159.09 179.83 8.68 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.394 0.678 . . . . 0.0 109.403 -179.022 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -114.22 144.58 42.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -71.41 -68.31 0.46 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.353 0.597 . . . . 0.0 110.861 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.9 tt -162.87 133.4 4.65 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.481 ' HB3' HG11 ' A' ' 715' ' ' VAL . 0.4 OUTLIER -137.1 114.0 10.51 Favored 'General case' 0 N--CA 1.401 -2.88 0 CA-C-O 121.747 0.784 . . . . 0.0 109.924 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -103.41 124.07 39.42 Favored Pre-proline 0 C--N 1.273 -2.749 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.447 -174.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.451 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 56.8 Cg_endo -66.45 172.49 9.03 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.495 2.13 . . . . 0.0 109.628 175.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.475 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.1 Cg_exo -75.21 -4.36 21.2 Favored 'Cis proline' 0 CA--C 1.497 -1.343 0 CA-C-N 119.801 0.965 . . . . 0.0 114.487 5.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.408 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 57.7 m-85 74.74 78.73 0.11 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 124.936 1.398 . . . . 0.0 108.488 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 22.4 m-85 -82.41 172.13 13.4 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -73.75 125.85 29.04 Favored 'General case' 0 CA--C 1.485 -1.523 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.29 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.75 -5.91 51.48 Favored Glycine 0 N--CA 1.411 -3.001 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.086 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.84 154.06 42.48 Favored 'General case' 0 C--O 1.251 1.179 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 19.8 m -140.21 143.64 36.15 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.846 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.597 HG21 HG21 ' A' ' 694' ' ' ILE . 47.0 t -131.54 137.08 56.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -85.84 135.21 33.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.966 0.889 . . . . 0.0 109.52 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -134.76 114.95 13.17 Favored 'General case' 0 C--N 1.268 -2.96 0 C-N-CA 126.395 1.878 . . . . 0.0 108.069 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.405 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 17.2 m-80 -120.84 -165.71 1.25 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 4.6 m -115.62 134.73 54.77 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.3 m -56.95 -80.5 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 O-C-N 124.166 0.916 . . . . 0.0 111.256 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 722' ' ' SER . 48.0 mt-10 -154.16 161.35 41.92 Favored 'General case' 0 CA--C 1.472 -2.047 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 58.0 m 70.63 7.24 6.14 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 124.723 1.264 . . . . 0.0 111.948 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.1 m-85 -139.72 144.56 37.56 Favored 'General case' 0 N--CA 1.4 -2.956 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.1 m -113.07 140.7 47.64 Favored 'General case' 0 C--N 1.246 -3.908 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.637 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.57 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.2 ttp -85.86 115.88 23.77 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.533 1.133 . . . . 0.0 108.853 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.0 mm -113.15 130.17 67.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.419 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 87.84 -74.65 2.17 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.914 -1.039 . . . . 0.0 114.164 173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -128.03 174.35 9.28 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -174.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.57 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -140.44 10.51 2.29 Favored 'General case' 0 C--O 1.201 -1.47 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 1.6 m -141.59 168.35 19.99 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.2 pt -129.32 161.09 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 739' ' ' THR . 5.8 m -135.85 139.17 43.19 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 44.0 t -94.22 116.24 28.62 Favored 'General case' 0 N--CA 1.407 -2.611 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.336 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.3 pp -144.26 147.43 19.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 C-N-CA 125.403 1.481 . . . . 0.0 108.168 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 64.18 15.04 9.07 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 86.59 17.59 59.95 Favored Glycine 0 CA--C 1.505 -0.546 0 C-N-CA 121.628 -0.32 . . . . 0.0 112.84 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.2 p -153.06 156.97 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.488 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 88.7 m95 -78.98 169.11 18.71 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 120.988 0.423 . . . . 0.0 110.16 175.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 732' ' ' THR . 21.8 p -73.48 -163.35 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.995 0.902 . . . . 0.0 112.845 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.548 ' NE2' ' H ' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -73.03 -12.95 61.11 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 124.772 1.229 . . . . 0.0 113.831 -170.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.4 mm? 73.28 149.96 0.13 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 123.921 0.763 . . . . 0.0 111.025 -175.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 42.6 Cg_endo -73.57 175.87 10.09 Favored 'Trans proline' 0 C--O 1.253 1.231 0 C-N-CA 121.761 1.64 . . . . 0.0 110.96 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -126.47 107.58 10.39 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 724' ' ' THR . 86.9 m -91.0 113.27 25.49 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.078 175.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.43 ' HB ' HD21 ' A' ' 750' ' ' LEU . 49.6 t -100.58 144.08 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.34 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.02 6.8 0.34 Allowed 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 125.973 1.709 . . . . 0.0 114.313 -175.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.825 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 55.4 mt 75.15 -19.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 125.663 1.585 . . . . 0.0 112.03 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.5 t70 -73.39 -34.09 65.35 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.671 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . 0.427 ' HB3' ' HE3' ' A' ' 749' ' ' LYS . 0.0 OUTLIER -114.11 29.93 7.65 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.859 -175.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.825 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 91.1 mt -83.32 -175.72 5.97 Favored 'General case' 0 N--CA 1.407 -2.609 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -105.92 147.09 29.17 Favored 'General case' 0 N--CA 1.384 -3.768 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 770' ' ' GLU . 22.4 mtpp -103.25 122.56 45.02 Favored 'General case' 1 C--N 1.237 -4.32 0 CA-C-N 113.041 -1.891 . . . . 0.0 108.65 -174.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 60.9 m -70.96 150.12 46.0 Favored 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.44 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -112.37 143.89 42.72 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.314 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 4.4 p -67.23 118.06 10.1 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.644 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.419 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 43.2 t -79.37 153.82 29.47 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -100.82 0.45 38.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.084 0.469 . . . . 0.0 111.595 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 6.4 mp -91.43 -8.49 47.69 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.049 0.928 . . . . 0.0 108.573 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.507 HG12 ' CG1' ' A' ' 801' ' ' VAL . 2.8 pp -118.45 169.73 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.649 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . 0.592 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.5 mp -119.44 124.88 73.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.809 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 96.2 mt -97.47 179.24 4.93 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.15 167.73 13.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.385 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -12.38 61.6 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . 0.563 ' CD2' ' HG ' ' A' ' 765' ' ' LEU . 4.6 p-80 -100.64 -10.99 20.38 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.531 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.653 HD22 ' CE2' ' A' ' 771' ' ' PHE . 74.7 mt -110.4 -19.44 12.96 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -69.86 -12.74 61.85 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.755 0.788 . . . . 0.0 110.274 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -101.96 11.23 38.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.734 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.445 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 14.4 tppt? -104.5 108.44 19.88 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . 0.499 ' HD2' ' H ' ' A' ' 769' ' ' LYS . 0.0 OUTLIER -72.45 -36.7 68.6 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.185 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 752' ' ' LYS . 43.3 mt-10 -144.41 133.4 22.69 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.898 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.809 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 71.7 m-85 -103.56 149.04 25.26 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -92.39 159.08 15.73 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.14 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.697 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 31.8 t60 -62.21 140.78 58.45 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.037 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 89.17 3.26 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.957 1.703 . . . . 0.0 109.972 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 74.9 m -83.35 114.08 21.18 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.505 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.465 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -88.25 113.47 23.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.848 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.659 HG21 ' CE2' ' A' ' 771' ' ' PHE . 4.8 pt -126.98 -173.83 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.541 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 30.4 ptt180 -143.17 127.38 17.59 Favored 'General case' 0 N--CA 1.413 -2.278 0 O-C-N 122.165 -0.334 . . . . 0.0 110.173 173.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.692 ' CD2' HG13 ' A' ' 801' ' ' VAL . 11.0 p90 -108.74 170.92 7.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 174.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . 0.592 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 9.3 ptt180 -146.66 155.44 42.43 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 173.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . . . . . . . . . 14.0 t -83.81 155.36 23.03 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -76.03 -5.74 47.81 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.624 0.726 . . . . 0.0 110.568 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -102.34 -10.13 39.7 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.074 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -122.07 125.04 45.36 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.084 -0.656 . . . . 0.0 111.697 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.65 79.9 4.8 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 122.073 0.939 . . . . 0.0 108.625 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 173.08 153.2 9.31 Favored Glycine 0 C--N 1.299 -1.494 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 40.4 m95 -101.58 164.86 11.54 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 117.085 0.443 . . . . 0.0 110.192 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 788' ' ' ILE . 3.6 mp -115.25 -34.03 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.343 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.46 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 31.6 m170 76.18 121.35 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 124.493 1.117 . . . . 0.0 109.45 -173.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.482 HG21 ' CG2' ' A' ' 801' ' ' VAL . 3.5 t -141.92 155.89 45.49 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.13 134.07 61.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 46.9 t -68.96 119.66 13.63 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.697 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 49.5 mm -119.54 86.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 C-N-CA 124.774 1.23 . . . . 0.0 108.694 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.44 HD22 HD22 ' A' ' 750' ' ' LEU . 6.0 t-20 45.69 72.17 0.24 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.567 1.147 . . . . 0.0 112.233 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 68.16 19.66 72.32 Favored Glycine 0 C--N 1.3 -1.424 0 CA-C-N 115.05 -0.977 . . . . 0.0 114.178 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -144.52 165.13 28.84 Favored 'General case' 0 C--O 1.19 -2.043 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.66 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.6 m95 -111.6 160.41 17.23 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 121.735 -0.603 . . . . 0.0 110.225 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -149.29 105.77 3.33 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.76 139.91 50.96 Favored 'Cis proline' 0 C--O 1.245 0.835 0 C-N-CA 123.842 -1.316 . . . . 0.0 110.508 -0.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.66 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.3 tt0 -56.27 125.27 21.07 Favored 'General case' 0 N--CA 1.432 -1.334 0 O-C-N 123.684 0.615 . . . . 0.0 111.153 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.692 HG13 ' CD2' ' A' ' 779' ' ' TYR . 93.9 t . . . . . 0 N--CA 1.428 -1.551 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.249 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.414 -2.266 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 40.4 m -84.59 -76.36 0.31 Allowed 'General case' 0 C--N 1.254 -3.582 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.321 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 149.09 -177.29 27.41 Favored Glycine 1 N--CA 1.358 -6.558 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -51.61 130.12 27.37 Favored 'General case' 0 C--N 1.278 -2.525 0 O-C-N 125.588 1.405 . . . . 0.0 109.946 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.63 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -60.01 150.25 70.71 Favored Pre-proline 0 N--CA 1.432 -1.352 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.915 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.552 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.0 Cg_endo -71.84 -163.51 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 122.86 2.374 . . . . 0.0 111.471 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -135.74 156.51 48.7 Favored 'General case' 0 N--CA 1.402 -2.871 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.557 HD13 ' HA3' ' A' ' 700' ' ' GLY . 1.1 mt -88.56 144.65 26.19 Favored 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.358 177.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.42 -41.09 93.24 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 744' ' ' CYS . 93.6 m-70 -146.84 32.2 0.94 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.557 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -141.72 -149.65 5.24 Favored Glycine 0 C--N 1.3 -1.434 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.775 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.417 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -148.38 -179.35 6.89 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -177.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -112.58 144.63 41.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 39.3 mm-40 -73.98 -67.71 0.58 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.33 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 68.5 tp -158.2 125.45 5.02 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.512 ' CB ' HG12 ' A' ' 694' ' ' ILE . 5.5 p -118.52 132.29 56.22 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 22.9 t -121.72 112.97 32.01 Favored Pre-proline 0 C--N 1.288 -2.098 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.999 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.33 165.62 26.27 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.143 1.896 . . . . 0.0 108.642 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.442 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 16.9 Cg_exo -67.81 -10.63 8.59 Favored 'Cis proline' 0 N--CA 1.498 1.759 0 N-CA-C 115.194 1.19 . . . . 0.0 115.194 5.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 705' ' ' SER . 61.9 m-85 74.07 87.04 0.1 Allowed 'General case' 0 C--N 1.309 -1.17 0 O-C-N 124.65 1.219 . . . . 0.0 108.044 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.53 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 50.3 m-85 -90.98 172.54 8.51 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.686 -176.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -71.45 138.51 49.1 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.255 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.77 77.78 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 2.5 t70 -77.34 165.79 23.99 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 20.2 m -151.86 142.41 22.67 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.63 HG21 HG21 ' A' ' 694' ' ' ILE . 44.8 t -133.56 134.37 56.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 39.1 mt-10 -80.51 135.67 36.15 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 123.896 0.748 . . . . 0.0 111.426 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -136.61 114.3 11.13 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 125.837 1.655 . . . . 0.0 107.471 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.417 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 14.4 m-80 -124.06 -163.0 1.11 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.609 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 10.0 m -108.16 144.23 35.86 Favored 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . 0.599 ' O ' ' HG3' ' A' ' 721' ' ' GLU . 5.1 m -55.81 -70.43 0.11 Allowed 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.769 0.668 . . . . 0.0 109.872 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . 0.599 ' HG3' ' O ' ' A' ' 720' ' ' SER . 30.7 mt-10 -175.22 164.39 3.25 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 129.279 3.031 . . . . 0.0 102.822 173.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 62.6 m 68.51 12.56 8.75 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.993 0.808 . . . . 0.0 111.509 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.715 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.8 m-85 -143.74 147.96 34.96 Favored 'General case' 0 N--CA 1.407 -2.615 0 C-N-CA 124.83 1.252 . . . . 0.0 108.11 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.634 HG21 HD21 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -112.93 135.27 53.89 Favored 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.996 -177.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.724 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.8 ttp -85.06 113.26 21.34 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 124.93 1.292 . . . . 0.0 109.758 -177.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.545 HD12 HG23 ' A' ' 793' ' ' ILE . 45.3 mm -115.27 131.3 67.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.336 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 94.57 -91.34 1.4 Allowed Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.772 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.56 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.1 m80 -114.34 178.42 4.29 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 114.508 -0.846 . . . . 0.0 110.357 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.724 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -144.92 14.21 1.5 Allowed 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 168.2 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 33.9 m -149.18 162.41 40.05 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 714' ' ' SER . 28.8 pt -121.1 166.73 15.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 739' ' ' THR . 3.8 m -135.75 139.94 43.96 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 43.3 t -99.82 116.91 32.99 Favored 'General case' 0 N--CA 1.406 -2.634 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.47 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.2 pp -142.82 149.29 18.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-N 114.004 -1.453 . . . . 0.0 107.444 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 73.74 -21.83 0.26 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.662 0.785 . . . . 0.0 112.087 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 120.24 14.27 5.53 Favored Glycine 0 CA--C 1.505 -0.542 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.3 p -148.53 150.53 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.552 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.8 m95 -77.2 169.25 18.66 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.467 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 732' ' ' THR . 24.9 p -77.23 -160.8 0.18 Allowed 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.67 0.748 . . . . 0.0 112.396 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.501 ' NE2' ' H ' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -84.69 -12.86 53.0 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.991 -168.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.406 HD21 ' HG2' ' A' ' 695' ' ' PRO . 0.9 OUTLIER 70.81 159.32 0.16 Allowed Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 124.009 0.818 . . . . 0.0 112.237 -177.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.56 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 37.6 Cg_endo -75.13 178.9 6.68 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.241 1.961 . . . . 0.0 112.155 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -122.91 101.33 7.37 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.023 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 699' ' ' HIS . 73.1 m -84.59 112.4 20.4 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-O 121.094 0.474 . . . . 0.0 110.58 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.72 144.04 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.715 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.33 1.16 0.81 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 125.08 1.352 . . . . 0.0 114.254 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.751 ' HA ' HD22 ' A' ' 750' ' ' LEU . 34.5 mt 76.54 -18.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 124.991 1.317 . . . . 0.0 110.971 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.0 t70 -77.84 -23.82 48.81 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 125.884 1.673 . . . . 0.0 109.203 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -110.89 18.95 19.02 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.586 -1.643 . . . . 0.0 108.842 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.828 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 3.1 mp -85.7 -176.8 6.19 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.859 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.49 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 53.1 mtpt -140.48 164.92 28.84 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -109.02 140.39 42.61 Favored 'General case' 0 C--N 1.257 -3.423 0 C-N-CA 126.021 1.728 . . . . 0.0 108.256 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 59.8 m -88.01 165.06 15.45 Favored 'General case' 1 C--N 1.239 -4.238 0 CA-C-N 114.106 -1.407 . . . . 0.0 109.147 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 754' ' ' LYS . 17.4 ptpt -132.77 147.62 52.32 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.988 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.18 114.04 3.53 Favored 'General case' 0 C--N 1.27 -2.875 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.916 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.617 ' HB2' ' CG1' ' A' ' 759' ' ' ILE . 55.9 m -72.98 149.78 43.03 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -80.08 -9.24 59.69 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.887 0.851 . . . . 0.0 110.458 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.83 -11.92 40.63 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.402 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.617 ' CG1' ' HB2' ' A' ' 756' ' ' SER . 2.4 pp -118.06 140.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.401 -173.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . 0.419 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.1 mp -104.39 131.21 53.83 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.53 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 2.1 mm? -108.56 -177.79 3.41 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 120.845 0.355 . . . . 0.0 110.114 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -71.48 167.61 19.28 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -57.86 -17.54 16.98 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.054 0.941 . . . . 0.0 112.639 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -85.62 -42.1 14.63 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.62 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 66.7 mt -85.65 -15.42 42.45 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 113.452 -1.704 . . . . 0.0 112.652 -169.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -73.96 -13.81 60.94 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.472 0.653 . . . . 0.0 110.508 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -96.51 0.33 50.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.335 1.064 . . . . 0.0 108.459 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.421 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 8.7 tppt? -103.08 118.48 36.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . 0.405 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 9.8 ptpp? -96.76 -19.85 18.64 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 35.5 mt-10 -136.25 122.7 20.73 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.283 176.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.529 ' CE2' HD22 ' A' ' 765' ' ' LEU . 76.1 m-85 -98.96 142.56 30.31 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -87.71 148.2 24.87 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.954 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.686 ' CG ' HD23 ' A' ' 750' ' ' LEU . 47.1 p-80 -42.47 141.7 0.95 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.359 1.463 . . . . 0.0 111.259 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 63.6 t30 75.57 2.42 3.78 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.026 1.33 . . . . 0.0 111.825 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 18.2 t -82.24 118.49 23.15 Favored 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 121.292 -0.88 . . . . 0.0 108.666 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.474 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -87.81 106.22 17.93 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.159 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.62 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.6 pt -115.97 -170.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.584 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 7.1 ptp180 -150.82 134.99 16.86 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.525 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 8.1 p90 -119.15 173.52 6.87 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . 0.419 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 10.5 ptt180 -155.4 169.82 23.36 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 59.3 m -97.79 164.31 12.44 Favored 'General case' 0 C--N 1.282 -2.341 0 O-C-N 123.876 0.735 . . . . 0.0 109.093 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . 0.53 ' HD2' ' H ' ' A' ' 782' ' ' ARG . 0.0 OUTLIER -66.72 -36.95 83.69 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.854 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -98.35 5.18 60.64 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.404 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.0 mptt -127.65 105.15 8.28 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 780' ' ' ARG . 35.9 tt0 -90.58 78.88 6.21 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.879 0.847 . . . . 0.0 109.952 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -164.1 144.58 9.56 Favored Glycine 0 CA--C 1.472 -2.636 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.584 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 38.5 m95 -101.66 131.61 47.81 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 117.405 0.602 . . . . 0.0 109.992 -174.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.525 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -87.87 -30.5 5.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.757 -174.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 15.3 m170 71.53 125.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.549 1.14 . . . . 0.0 109.119 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 3.4 t -147.9 155.6 41.77 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 122.196 -0.315 . . . . 0.0 110.438 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.58 135.69 57.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 53.6 t -72.92 114.08 10.66 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.845 0.831 . . . . 0.0 110.342 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.545 HG23 HD12 ' A' ' 726' ' ' ILE . 50.9 mm -115.29 80.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 C-N-CA 124.501 1.121 . . . . 0.0 108.713 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.828 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 1.0 OUTLIER 52.08 64.64 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.464 176.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.61 22.53 78.31 Favored Glycine 0 C--N 1.308 -0.996 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.576 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -147.28 164.18 34.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.617 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.0 m95 -111.75 159.56 18.15 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-O 120.581 0.229 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 21.9 t70 -149.19 103.79 3.33 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 798' ' ' ASP . 47.7 Cg_endo -72.13 141.57 71.08 Favored 'Cis proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.876 -1.302 . . . . 0.0 113.602 -0.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 2.9 mm-40 -53.32 127.73 25.76 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.138 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.485 ' HB ' HG21 ' A' ' 759' ' ' ILE . 3.2 m . . . . . 1 N--CA 1.372 -4.362 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.997 -176.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.42 -1.937 0 CA-C-O 120.971 0.415 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 39.0 m -80.62 -66.23 0.91 Allowed 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.54 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 128.37 -177.54 17.66 Favored Glycine 1 N--CA 1.367 -5.917 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.409 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 30.9 t70 -34.14 128.36 0.4 Allowed 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 127.023 2.129 . . . . 0.0 112.727 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.698 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -61.82 150.29 82.82 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.163 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.457 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 57.0 Cg_endo -72.17 -159.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.684 2.256 . . . . 0.0 111.74 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.15 -173.29 3.22 Favored 'General case' 0 N--CA 1.401 -2.884 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 717' ' ' PHE . 22.0 tp -128.6 126.0 39.36 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-O 120.872 0.368 . . . . 0.0 110.384 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -49.44 -37.9 27.47 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.4 m-70 -137.09 24.68 3.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -141.79 -146.76 4.74 Favored Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.21 -0.995 . . . . 0.0 110.846 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.476 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.01 179.21 8.25 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.704 0.288 . . . . 0.0 110.324 -177.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -112.49 143.41 43.68 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.2 -75.54 0.17 Allowed 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.241 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.7 tt -176.46 132.17 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.455 ' HB2' HG13 ' A' ' 715' ' ' VAL . 9.9 t -154.23 146.96 24.25 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 10.1 t -117.07 149.14 43.73 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.521 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 59.4 Cg_endo -65.97 174.54 5.64 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.61 2.207 . . . . 0.0 110.454 177.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.521 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.8 Cg_endo -79.95 -4.18 40.5 Favored 'Cis proline' 0 C--O 1.215 -0.633 0 CA-C-N 119.799 0.964 . . . . 0.0 114.541 4.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.442 ' CE1' HG23 ' A' ' 694' ' ' ILE . 77.1 m-85 68.92 79.32 0.21 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.326 0.584 . . . . 0.0 110.262 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 30.1 m-85 -83.56 170.81 13.97 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.47 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 44.0 m-85 -68.46 137.11 54.19 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.322 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.9 -5.38 68.99 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.3 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 2.9 t70 -71.14 157.59 37.9 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 20.2 m -149.22 139.36 22.17 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.698 HG21 HG21 ' A' ' 694' ' ' ILE . 41.0 t -130.48 140.93 47.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.033 -174.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 729' ' ' ARG . 1.6 mp0 -80.2 131.79 35.76 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 122.168 0.985 . . . . 0.0 112.872 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.576 ' HB3' HD22 ' A' ' 697' ' ' LEU . 32.1 m-85 -135.89 107.96 7.19 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 113.608 -1.633 . . . . 0.0 107.297 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.476 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 9.0 m-80 -115.51 -163.46 0.89 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 8.3 m -116.06 134.91 54.45 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 3.2 m -58.04 -70.87 0.12 Allowed 'General case' 0 C--N 1.288 -2.094 0 O-C-N 124.163 0.914 . . . . 0.0 111.87 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -164.33 161.37 21.72 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 74.9 m 69.84 2.75 3.99 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.995 0.81 . . . . 0.0 112.847 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.5 m-85 -137.5 148.75 46.26 Favored 'General case' 0 N--CA 1.401 -2.892 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.502 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -115.08 141.91 47.36 Favored 'General case' 0 C--N 1.259 -3.336 0 C-N-CA 124.991 1.316 . . . . 0.0 109.996 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.8 ttp -85.84 120.71 27.56 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 124.071 0.948 . . . . 0.0 109.826 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 43.2 mm -111.82 122.18 65.68 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.763 174.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 114.15 -94.86 0.71 Allowed Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.966 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 53.0 t60 -156.97 139.1 14.55 Favored 'General case' 0 CA--C 1.472 -2.054 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.56 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -85.71 25.76 1.04 Allowed 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 15.4 m -143.87 156.24 44.39 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.776 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 714' ' ' SER . 41.2 pt -118.65 160.58 18.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.419 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 739' ' ' THR . 20.1 m -134.02 135.87 43.68 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.973 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.3 t -85.65 104.07 15.05 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.8 pp -146.65 144.18 20.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 124.034 0.934 . . . . 0.0 110.246 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 67.85 8.16 6.25 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 94.51 20.28 29.96 Favored Glycine 0 CA--C 1.5 -0.844 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.376 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.7 p -157.46 158.93 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.457 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 94.5 m95 -78.04 172.71 13.1 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 171.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 25.5 p -76.38 -169.56 1.23 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.976 0.893 . . . . 0.0 112.999 -174.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.2 pp0? -65.55 -20.64 66.41 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 -173.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 5.6 mt 70.68 138.55 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 124.547 1.154 . . . . 0.0 112.882 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 56.7 Cg_endo -67.04 167.12 20.75 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.363 2.042 . . . . 0.0 112.428 -177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.434 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.2 tt0 -112.47 102.42 10.53 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.493 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 89.4 m -82.55 111.19 18.31 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.614 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.461 ' HB ' HD21 ' A' ' 750' ' ' LEU . 48.2 t -99.45 145.35 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.497 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.67 4.16 0.63 Allowed 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 125.411 1.484 . . . . 0.0 113.716 -175.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.884 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 57.6 mt 76.47 -22.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 126.183 1.793 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 746' ' ' ALA . 12.1 t70 -67.41 -34.86 78.12 Favored 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 126.029 1.732 . . . . 0.0 109.841 -174.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.75 24.12 13.35 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 113.578 -1.647 . . . . 0.0 111.658 -175.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.884 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 85.9 mt -78.65 166.01 23.0 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-O 121.644 0.735 . . . . 0.0 109.899 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.418 ' H ' ' ND2' ' A' ' 794' ' ' ASN . 9.4 mmmm -91.19 -167.62 1.85 Allowed 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 126.701 2.0 . . . . 0.0 112.408 -171.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . 0.543 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 28.4 mmmt -123.72 134.03 53.77 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 126.357 1.863 . . . . 0.0 106.793 -176.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . 0.465 ' HB2' ' CZ2' ' A' ' 797' ' ' TRP . 0.0 OUTLIER -87.39 -179.47 6.39 Favored 'General case' 0 C--N 1.257 -3.454 0 C-N-CA 125.44 1.496 . . . . 0.0 109.433 -177.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -141.14 137.99 33.14 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.93 -0.481 . . . . 0.0 110.433 -176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 38.9 t -71.79 120.56 17.56 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 172.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.51 ' HB3' HG12 ' A' ' 759' ' ' ILE . 42.9 t -70.33 163.18 27.14 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -96.41 -1.09 48.27 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.95 18.26 19.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.983 0.42 . . . . 0.0 110.71 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.51 HG12 ' HB3' ' A' ' 756' ' ' SER . 23.8 pt -126.41 157.71 36.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.538 0.685 . . . . 0.0 112.07 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.2 mp -117.74 132.54 67.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.593 ' HG ' ' HZ ' ' A' ' 771' ' ' PHE . 2.7 mm? -106.94 178.17 4.64 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . 0.569 ' HB2' HD23 ' A' ' 765' ' ' LEU . 47.4 mt-10 -62.01 162.22 9.56 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.97 176.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.7 -11.99 56.58 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.538 0.685 . . . . 0.0 111.264 -176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.31 -0.61 26.1 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.573 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.3 mm? -122.97 -12.12 8.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 8.7 mtmp? -62.65 -27.02 68.93 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -88.1 5.71 39.86 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.707 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 19.0 ttmm -101.94 109.92 21.77 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . 0.522 ' HE3' ' HG3' ' A' ' 770' ' ' GLU . 34.6 ttpt -79.46 -37.29 37.24 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.251 1.024 . . . . 0.0 108.444 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . 0.522 ' HG3' ' HE3' ' A' ' 769' ' ' LYS . 41.4 mt-10 -127.92 114.61 17.39 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.438 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.707 ' CD2' ' HD2' ' A' ' 768' ' ' LYS . 82.3 m-85 -88.76 -178.68 5.83 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.972 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -118.68 138.54 52.55 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.59 -175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.73 ' CD2' ' HB2' ' A' ' 750' ' ' LEU . 9.8 p-80 -45.91 146.86 1.1 Allowed 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.642 1.177 . . . . 0.0 112.738 174.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 72.22 10.95 5.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.27 1.028 . . . . 0.0 110.702 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 46.8 t -94.25 127.99 40.45 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.492 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.6 OUTLIER -97.6 111.25 23.6 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.543 HD12 HD12 ' A' ' 761' ' ' LEU . 7.8 pt -118.91 176.46 3.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 121.662 0.744 . . . . 0.0 109.596 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 79.5 mtt180 -122.28 133.29 54.69 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 173.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -128.59 168.33 15.88 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -160.08 163.9 33.51 Favored 'General case' 0 N--CA 1.412 -2.372 0 O-C-N 124.521 1.138 . . . . 0.0 109.281 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 90.7 m -82.48 175.34 10.28 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 123.53 0.519 . . . . 0.0 109.797 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . 0.42 ' HB3' HD11 ' A' ' 760' ' ' ILE . 12.5 ptm180 -91.4 -29.19 17.21 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.936 0.398 . . . . 0.0 110.504 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -92.24 -3.11 67.71 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.791 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 2.2 mptp? -130.74 107.62 9.29 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.62 149.38 27.44 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 111.45 141.11 8.43 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -174.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 47.4 m95 -98.61 149.8 22.4 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 117.047 0.424 . . . . 0.0 110.746 -171.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.16 -31.7 3.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.06 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 36.7 m170 73.19 118.92 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 124.843 1.257 . . . . 0.0 110.206 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.543 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.1 t -140.32 158.52 43.9 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.836 -0.54 . . . . 0.0 110.232 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.94 134.48 63.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 54.0 t -72.19 117.27 13.62 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.533 0.682 . . . . 0.0 110.327 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.07 79.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.48 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' ' 750' ' ' LEU . 24.8 t-20 55.09 71.94 0.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.845 0.831 . . . . 0.0 112.171 171.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 75.26 3.58 70.74 Favored Glycine 0 C--N 1.292 -1.902 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.988 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . 0.452 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 22.9 ttt180 -136.19 174.58 10.46 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.635 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 97.5 m95 -121.12 159.48 25.71 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 9.3 t70 -148.3 106.52 3.58 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 798' ' ' ASP . 51.0 Cg_endo -71.92 142.45 73.76 Favored 'Cis proline' 0 C--O 1.244 0.814 0 C-N-CA 123.588 -1.422 . . . . 0.0 112.956 -0.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.635 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 1.9 mm-40 -50.51 126.1 14.48 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 115.096 -0.956 . . . . 0.0 113.118 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.543 ' CG1' HG21 ' A' ' 790' ' ' THR . 3.6 m . . . . . 1 N--CA 1.35 -5.462 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.589 -179.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . 0.63 HG21 ' HB2' ' A' ' 708' ' ' PRO . 12.4 p . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 23.7 m -72.31 -63.08 1.22 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.059 0.457 . . . . 0.0 110.169 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 131.3 -164.23 23.44 Favored Glycine 1 N--CA 1.356 -6.675 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -45.61 136.8 5.61 Favored 'General case' 0 C--N 1.26 -3.315 0 C-N-CA 126.182 1.793 . . . . 0.0 111.828 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.505 HG21 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -68.7 148.22 98.02 Favored Pre-proline 0 N--CA 1.427 -1.61 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.066 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.539 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 70.9 Cg_endo -72.76 -168.98 0.44 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 123.327 2.685 . . . . 0.0 111.838 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -135.52 143.28 45.69 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.574 HD22 ' HB3' ' A' ' 717' ' ' PHE . 24.5 tp -92.56 123.79 36.11 Favored 'General case' 0 C--N 1.254 -3.552 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.187 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.538 ' HG2' HD12 ' A' ' 697' ' ' LEU . 7.4 pt-20 -30.42 -51.74 0.15 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.319 2.248 . . . . 0.0 115.556 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 78.8 m-70 -136.15 23.39 3.26 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -134.04 -159.11 8.8 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.998 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.436 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -141.07 176.34 8.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.692 0.282 . . . . 0.0 111.382 -173.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -111.52 133.66 53.64 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.513 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 53.7 mm-40 -74.42 -73.26 0.24 Allowed 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 705' ' ' SER . 7.0 tt -161.3 139.63 9.58 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.474 -177.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.714 ' HB2' HG22 ' A' ' 715' ' ' VAL . 35.8 t -164.36 -175.7 4.05 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 26.7 p -152.11 140.74 13.71 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.89 167.29 23.68 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 121.798 1.666 . . . . 0.0 109.39 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.63 ' HB2' HG21 ' A' ' 690' ' ' THR . 1.3 Cg_endo -73.74 -1.83 14.62 Favored 'Cis proline' 0 C--O 1.243 0.73 0 N-CA-C 115.201 1.193 . . . . 0.0 115.201 6.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 72.5 m-85 72.55 75.58 0.15 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.39 1.056 . . . . 0.0 109.318 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.601 ' CE1' ' HG2' ' A' ' 708' ' ' PRO . 18.3 m-85 -79.49 169.95 17.3 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.158 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.533 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 54.3 m-85 -68.81 133.95 49.02 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.905 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.74 -11.23 60.98 Favored Glycine 0 N--CA 1.426 -1.973 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.463 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.29 150.82 47.78 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 15.6 m -140.01 142.77 36.24 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 121.196 0.522 . . . . 0.0 109.904 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.714 HG22 ' HB2' ' A' ' 705' ' ' SER . 20.5 t -131.88 127.09 58.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 40.0 mt-10 -71.66 138.22 48.46 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.919 0.39 . . . . 0.0 111.266 174.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.574 ' HB3' HD22 ' A' ' 697' ' ' LEU . 19.7 m-85 -138.19 123.76 19.66 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.436 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 6.7 m-80 -136.22 -165.21 1.68 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 9.4 m -115.53 130.23 56.8 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . 0.427 ' HA ' ' CE2' ' A' ' 701' ' ' TRP . 4.0 m -47.0 -71.98 0.06 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 124.984 1.427 . . . . 0.0 112.09 -172.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -169.46 164.61 10.54 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 66.9 m 66.31 8.23 5.48 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.087 0.867 . . . . 0.0 112.288 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.66 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.5 m-85 -141.35 142.69 33.78 Favored 'General case' 0 N--CA 1.412 -2.363 0 C-N-CA 124.141 0.976 . . . . 0.0 108.771 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 0.9 OUTLIER -107.37 133.97 51.12 Favored 'General case' 0 C--N 1.251 -3.713 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.784 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.731 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.3 ttp -87.97 121.17 30.06 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.259 1.024 . . . . 0.0 109.923 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.608 HD12 HG23 ' A' ' 793' ' ' ILE . 49.9 mm -120.16 131.18 73.19 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.714 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.084 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 111.49 -81.46 0.29 Allowed Glycine 0 C--N 1.306 -1.124 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.679 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.586 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 5.9 t60 -150.92 171.45 17.23 Favored 'General case' 0 C--O 1.202 -1.414 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.731 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -131.3 25.75 4.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 73.3 m -157.51 166.84 31.87 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.514 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 39.5 pt -129.91 161.35 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 O-C-N 124.654 1.221 . . . . 0.0 108.216 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 18.6 m -136.55 135.27 38.32 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.76 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.6 t -80.71 107.77 13.8 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.247 0.546 . . . . 0.0 110.499 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . 0.451 ' HB ' ' HD2' ' A' ' 735' ' ' HIS . 1.4 pp -145.89 146.72 19.05 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.229 0 C-N-CA 125.125 1.37 . . . . 0.0 110.051 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . 0.451 ' HD2' ' HB ' ' A' ' 734' ' ' ILE . 19.1 m-70 70.75 -12.93 0.51 Allowed 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 123.603 0.761 . . . . 0.0 111.685 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 105.0 19.26 10.97 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 33.2 t -143.1 159.12 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.539 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.6 m95 -86.19 179.0 7.01 Favored 'General case' 0 C--N 1.256 -3.462 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.514 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 25.1 p -76.64 -158.76 0.11 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.558 0.694 . . . . 0.0 112.053 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.584 ' NE2' ' H ' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -83.28 -9.38 59.14 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -165.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.2 mm? 71.82 150.59 0.13 Allowed Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 123.11 0.564 . . . . 0.0 111.11 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.586 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 10.9 Cg_exo -68.82 -161.36 0.07 OUTLIER 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.555 2.17 . . . . 0.0 112.292 173.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -142.1 137.65 31.14 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 87.3 m -130.09 107.62 9.46 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.147 0.498 . . . . 0.0 110.78 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.614 ' HB ' HD21 ' A' ' 750' ' ' LEU . 41.1 t -99.52 143.15 13.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.66 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -63.3 2.5 0.38 Allowed 'General case' 0 C--N 1.287 -2.148 0 C-N-CA 126.213 1.805 . . . . 0.0 114.79 -175.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.795 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 59.6 mt 75.48 -16.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 125.302 1.441 . . . . 0.0 111.309 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.7 t70 -72.54 -35.84 68.14 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.166 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 29.86 7.49 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.336 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.795 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 73.3 mt -86.72 -160.63 0.59 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.432 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.476 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 54.9 mtpt -145.86 168.48 20.71 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -116.77 139.83 50.13 Favored 'General case' 0 C--N 1.271 -2.823 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . 0.484 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 46.4 m -92.01 172.86 8.16 Favored 'General case' 0 C--N 1.249 -3.792 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.681 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -138.0 147.69 44.45 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . 0.413 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.3 p -64.83 139.66 58.79 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.188 172.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.605 ' HB2' HG12 ' A' ' 759' ' ' ILE . 50.7 m -77.92 173.04 12.58 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -97.13 -15.52 20.9 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 121.543 -0.723 . . . . 0.0 111.608 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.27 16.47 24.23 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.774 -0.579 . . . . 0.0 110.542 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.605 HG12 ' HB2' ' A' ' 756' ' ' SER . 11.8 pt -124.27 153.94 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.701 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.57 131.91 65.27 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.575 HD11 HD12 ' A' ' 759' ' ' ILE . 1.9 mm? -108.12 178.01 4.64 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 45.8 mt-10 -65.33 156.68 31.36 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 171.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . 0.256 0.0 OUTLIER -68.51 -11.16 59.48 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 119.214 0.915 . . . . 0.0 112.802 -174.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -74.65 -31.73 62.04 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.672 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 64.3 mt -98.21 -25.37 14.9 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.708 -172.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 7.0 mtmp? -62.58 -32.17 73.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.338 0.59 . . . . 0.0 110.586 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -91.85 5.36 50.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.993 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.557 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 22.1 ttmm -87.31 -48.97 7.57 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.03 -54.41 0.57 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.038 1.335 . . . . 0.0 111.201 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 768' ' ' LYS . 47.1 mt-10 -113.69 123.75 50.65 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.582 ' CE2' HD22 ' A' ' 765' ' ' LEU . 11.4 m-85 -110.96 149.07 31.19 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -173.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.05 156.16 17.06 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -46.55 149.74 0.76 Allowed 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.57 1.148 . . . . 0.0 112.876 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 1.9 t30 67.9 12.12 8.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.379 1.472 . . . . 0.0 111.823 174.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 791' ' ' VAL . 20.1 p -77.33 110.89 12.45 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.465 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -84.92 93.7 8.6 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.672 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.6 pt -106.01 -177.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.809 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.572 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 76.8 mtt85 -132.47 135.37 45.98 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.49 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 4.7 p90 -131.37 168.63 17.25 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -159.05 164.5 35.38 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 93.8 m -83.56 161.35 21.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.93 -30.24 58.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -172.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -99.49 8.34 60.21 Favored Glycine 0 CA--C 1.499 -0.921 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 4.4 mptp? -119.62 162.53 18.81 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -131.14 162.47 29.84 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 96.92 145.03 18.45 Favored Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -172.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 54.2 m95 -110.25 139.69 45.17 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 117.339 0.57 . . . . 0.0 110.307 -174.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.49 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.0 mp -87.67 -27.41 5.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.276 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.532 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 24.4 m170 72.45 127.43 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 124.406 1.082 . . . . 0.0 109.673 -176.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.492 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.0 t -149.05 151.77 35.05 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.122 176.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 775' ' ' SER . 39.3 t -113.4 132.83 61.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 C-N-CA 123.611 0.764 . . . . 0.0 110.025 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 35.8 t -70.06 113.93 7.73 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.993 0.901 . . . . 0.0 110.417 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.608 HG23 HD12 ' A' ' 726' ' ' ILE . 47.5 mm -114.64 80.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.268 -2.965 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.544 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.693 ' ND2' HD22 ' A' ' 750' ' ' LEU . 1.1 m120 50.26 68.48 0.75 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.817 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 76.68 11.98 84.84 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.975 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -142.12 170.62 15.37 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -176.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.603 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 95.0 m95 -116.77 161.79 18.71 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 19.4 t70 -148.45 102.21 3.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 41.8 Cg_endo -71.26 142.23 72.35 Favored 'Cis proline' 0 C--O 1.244 0.777 0 C-N-CA 123.932 -1.278 . . . . 0.0 112.881 -1.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.603 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 24.7 mt-10 -51.13 121.09 5.61 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.989 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.492 ' CG1' HG21 ' A' ' 790' ' ' THR . 5.9 m . . . . . 1 N--CA 1.365 -4.709 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.196 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.422 -1.839 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 24.4 m -78.01 -54.1 6.66 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.286 0.565 . . . . 0.0 110.294 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 118.68 -171.81 14.27 Favored Glycine 1 N--CA 1.356 -6.641 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -34.48 122.54 0.51 Allowed 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 126.645 1.978 . . . . 0.0 111.884 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.636 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -62.93 147.68 93.61 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.247 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.431 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 43.0 Cg_endo -68.15 -167.02 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.777 2.318 . . . . 0.0 112.396 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -133.75 152.24 51.82 Favored 'General case' 0 N--CA 1.384 -3.773 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 717' ' ' PHE . 22.0 tp -99.74 114.19 27.17 Favored 'General case' 0 C--N 1.258 -3.371 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -43.32 -43.03 4.78 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 114.382 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -130.22 27.31 5.1 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.037 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -142.58 -150.9 5.4 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.645 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.49 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -145.05 174.54 10.96 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -177.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.81 147.99 28.03 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -84.65 -71.54 0.51 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.947 0.403 . . . . 0.0 110.487 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.0 tt -165.88 138.8 4.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.488 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 70.8 p -123.56 -63.95 1.19 Allowed 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 120.766 0.317 . . . . 0.0 110.854 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 32.7 t 71.41 105.96 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 125.301 1.44 . . . . 0.0 111.483 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.621 ' HB3' ' CE2' ' A' ' 709' ' ' TYR . 91.4 Cg_endo -74.43 162.88 37.37 Favored 'Trans proline' 0 CA--C 1.556 1.579 0 C-N-CA 122.407 2.072 . . . . 0.0 112.119 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 51.3 Cg_exo -65.27 171.01 34.24 Favored 'Cis proline' 0 CA--C 1.478 -2.302 0 CA-C-O 123.136 1.223 . . . . 0.0 113.599 0.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 707' ' ' PRO . 70.2 m-85 -115.14 74.83 0.9 Allowed 'General case' 1 C--N 1.23 -4.614 0 CA-C-N 112.184 -2.28 . . . . 0.0 109.871 -174.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -76.07 170.53 16.1 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.898 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -73.08 131.58 42.26 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.579 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.78 -8.72 63.77 Favored Glycine 0 N--CA 1.419 -2.439 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.37 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.83 154.92 38.06 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 120.783 0.325 . . . . 0.0 110.227 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 13.3 m -140.15 149.14 42.63 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 694' ' ' ILE . 44.5 t -132.61 134.02 59.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 45.0 mt-10 -89.67 141.59 28.46 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.436 0.636 . . . . 0.0 112.253 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.581 ' HB3' HD22 ' A' ' 697' ' ' LEU . 58.6 m-85 -141.16 129.85 22.83 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.875 1.67 . . . . 0.0 107.501 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.49 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 13.2 m-80 -132.63 -161.61 1.15 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 12.5 m -110.07 143.32 40.27 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 2.8 m -73.17 -84.94 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 123.373 0.421 . . . . 0.0 110.708 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -138.15 152.57 48.83 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 53.7 m 66.82 11.6 8.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.648 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.9 m-85 -137.55 148.31 45.82 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.422 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.1 m -116.65 135.11 54.06 Favored 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.54 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.8 ttp -92.81 124.26 36.67 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 123.93 0.892 . . . . 0.0 109.221 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 45.8 mm -126.13 144.0 37.74 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.593 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.441 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 100.45 -79.39 0.45 Allowed Glycine 0 N--CA 1.433 -1.505 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.456 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.483 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 2.8 t60 -146.0 179.84 7.2 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.606 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.2 OUTLIER -136.3 22.22 3.21 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.147 177.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.442 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.2 p -157.2 170.1 23.25 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.087 -175.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.437 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 35.7 pt -125.42 161.57 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.69 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 738' ' ' TRP . 23.7 m -133.74 138.04 45.56 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 123.674 0.609 . . . . 0.0 110.104 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.2 103.19 15.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.49 145.21 24.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.431 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 69.42 -13.62 0.37 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 117.33 14.9 6.76 Favored Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.7 p -152.24 150.89 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.442 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 94.0 m95 -73.5 163.83 27.5 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.656 171.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 34.3 p -74.2 -161.34 0.12 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.083 0.944 . . . . 0.0 113.268 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.428 ' CD ' ' H ' ' A' ' 740' ' ' GLN . 0.4 OUTLIER -82.4 -3.06 54.92 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -165.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 68.81 155.38 0.14 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 123.665 0.603 . . . . 0.0 111.136 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 46.0 Cg_endo -74.77 177.75 8.09 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.854 1.703 . . . . 0.0 109.916 170.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -122.91 120.09 32.42 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.818 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.458 ' SG ' HD21 ' A' ' 697' ' ' LEU . 61.4 m -102.25 108.82 20.32 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.778 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.502 ' HB ' HD21 ' A' ' 750' ' ' LEU . 22.8 t -97.05 141.3 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.384 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.648 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.54 6.87 0.4 Allowed 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 125.63 1.572 . . . . 0.0 113.99 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.849 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 35.1 mt 75.82 -15.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 125.095 1.358 . . . . 0.0 111.675 177.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 746' ' ' ALA . 3.3 t70 -81.39 -31.11 33.42 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 126.109 1.763 . . . . 0.0 108.427 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . 0.447 ' HB2' ' CG1' ' A' ' 745' ' ' VAL . 13.6 mttm -106.64 22.86 15.19 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 113.233 -1.803 . . . . 0.0 108.221 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.849 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 73.9 mt -87.94 -169.9 2.77 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.586 174.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.603 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 58.9 mtpt -118.16 168.29 10.71 Favored 'General case' 0 N--CA 1.397 -3.091 0 CA-C-O 122.103 0.954 . . . . 0.0 111.097 -173.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . 0.461 ' HB2' ' HE3' ' A' ' 752' ' ' LYS . 37.0 mtmt -107.17 121.05 43.74 Favored 'General case' 0 C--N 1.253 -3.602 0 CA-C-N 112.79 -2.004 . . . . 0.0 107.141 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . 0.49 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 0.0 OUTLIER -77.89 158.76 29.28 Favored 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 113.824 -1.534 . . . . 0.0 107.979 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -131.75 139.93 49.1 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.14 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 3.9 m -71.26 107.81 4.43 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.497 ' HB2' HG13 ' A' ' 759' ' ' ILE . 70.1 m -58.19 143.74 43.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.821 0.343 . . . . 0.0 110.383 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -78.77 -3.3 43.7 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.336 0.589 . . . . 0.0 111.78 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -103.73 -15.78 15.64 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.673 -0.642 . . . . 0.0 110.689 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.7 pp -100.44 161.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.893 -174.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . 0.519 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.5 mp -114.2 129.87 69.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.52 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 86.5 mt -105.32 176.99 4.98 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 120.997 0.427 . . . . 0.0 110.095 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.62 168.8 7.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.988 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -71.22 -7.22 45.34 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.478 0.656 . . . . 0.0 111.42 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.65 -2.96 16.1 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.9 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.4 HD12 ' HE2' ' A' ' 771' ' ' PHE . 2.7 mm? -121.24 -10.47 8.95 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -71.28 -10.09 59.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.841 0.829 . . . . 0.0 110.15 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -88.62 -0.83 57.66 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.949 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -114.44 129.99 56.69 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . 0.673 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 9.6 ptpp? -107.1 -24.55 11.91 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . 0.673 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 46.3 mt-10 -132.65 128.44 37.07 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.673 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.52 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 83.4 m-85 -108.72 176.11 5.22 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.367 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -115.77 158.83 22.28 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.404 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -47.81 151.91 0.82 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.111 1.364 . . . . 0.0 112.622 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 15.3 m120 59.15 13.42 2.97 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 10.4 t -76.94 108.61 10.11 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.431 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.8 OUTLIER -83.94 105.68 15.01 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.5 HG21 ' CE2' ' A' ' 771' ' ' PHE . 7.2 pt -119.77 -177.96 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.508 ' HG2' ' CD2' ' A' ' 789' ' ' HIS . 98.6 mtt180 -125.8 135.28 51.82 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.488 ' CE2' ' HA ' ' A' ' 801' ' ' VAL . 6.8 p90 -125.82 165.71 18.17 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 170.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . 0.519 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 14.5 ptt180 -145.16 163.48 34.24 Favored 'General case' 0 C--N 1.251 -3.697 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 19.9 t -109.27 162.27 14.47 Favored 'General case' 0 N--CA 1.395 -3.213 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -73.5 -39.05 65.13 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.838 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -84.08 -17.97 63.95 Favored Glycine 0 C--O 1.24 0.5 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.345 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.1 mptt -124.84 84.71 2.31 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -85.5 89.28 7.66 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 122.297 1.046 . . . . 0.0 110.836 -172.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 175.66 152.91 9.82 Favored Glycine 0 C--N 1.287 -2.19 0 N-CA-C 106.145 -2.782 . . . . 0.0 106.145 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 45.3 m95 -84.46 142.37 30.13 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 118.126 0.963 . . . . 0.0 109.797 -173.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.48 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -99.92 -31.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.041 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.508 ' CD2' ' HG2' ' A' ' 778' ' ' ARG . 28.1 m170 74.75 116.89 0.06 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 124.836 1.254 . . . . 0.0 109.156 -174.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 4.3 t -137.53 152.83 49.89 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.906 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 58.1 t -116.06 133.86 61.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 53.2 t -70.27 129.07 38.36 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.36 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.39 79.76 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.603 ' C ' ' HB2' ' A' ' 751' ' ' LYS . 0.7 OUTLIER 54.03 70.43 0.61 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.193 178.398 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 76.82 -4.75 51.47 Favored Glycine 0 C--N 1.301 -1.384 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.778 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -115.89 172.55 7.07 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.591 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.0 m95 -121.76 154.89 36.35 Favored 'General case' 0 C--N 1.266 -3.032 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -144.67 105.61 4.6 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.91 143.08 74.88 Favored 'Cis proline' 0 C--O 1.248 0.993 0 C-N-CA 123.8 -1.333 . . . . 0.0 112.292 -0.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 38.6 mt-10 -53.19 125.96 19.28 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.659 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.488 ' HA ' ' CE2' ' A' ' 779' ' ' TYR . 4.6 m . . . . . 1 N--CA 1.365 -4.678 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 35.6 m -72.17 -79.47 0.07 Allowed 'General case' 0 C--N 1.268 -2.954 0 C-N-CA 123.872 0.869 . . . . 0.0 111.389 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 148.03 173.19 18.76 Favored Glycine 1 N--CA 1.362 -6.255 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -38.33 130.44 1.27 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 125.926 1.69 . . . . 0.0 111.048 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.711 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -63.23 151.72 86.23 Favored Pre-proline 0 C--N 1.296 -1.741 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.449 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.518 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.1 Cg_endo -72.18 -157.84 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 122.822 2.348 . . . . 0.0 112.941 177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -133.21 146.19 51.26 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 717' ' ' PHE . 30.1 tp -90.25 126.04 35.7 Favored 'General case' 0 C--N 1.263 -3.166 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.09 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.529 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 6.8 pt-20 -32.84 -55.3 0.37 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.24 2.216 . . . . 0.0 114.527 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.529 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 92.3 m-70 -135.53 25.47 3.44 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -131.0 -150.72 6.84 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.05 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.468 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.02 179.13 8.31 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -109.69 146.28 35.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -81.32 -66.48 0.88 Allowed 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.301 0.572 . . . . 0.0 110.536 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.0 tt -161.33 139.61 9.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.455 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 58.6 p -130.73 119.48 22.41 Favored 'General case' 0 N--CA 1.395 -3.206 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 7.4 p -97.46 112.7 61.9 Favored Pre-proline 0 C--N 1.253 -3.598 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.681 -174.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.434 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 67.0 Cg_endo -72.06 172.52 14.56 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.755 2.303 . . . . 0.0 109.397 175.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.628 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 4.0 Cg_exo -74.24 -0.21 14.82 Favored 'Cis proline' 0 N--CA 1.489 1.213 0 CA-C-N 120.295 1.141 . . . . 0.0 114.544 5.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.455 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 54.2 m-85 74.53 73.1 0.11 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 124.86 1.35 . . . . 0.0 107.79 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.628 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 23.3 m-85 -78.35 172.24 13.9 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.072 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -72.25 138.44 47.47 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.927 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 89.2 -3.83 84.33 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 0.2 OUTLIER -76.1 151.22 37.1 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 17.1 m -130.32 149.9 51.8 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.929 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.711 HG21 HG21 ' A' ' 694' ' ' ILE . 31.7 t -133.92 140.25 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.862 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.43 130.98 43.46 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-O 122.063 0.935 . . . . 0.0 112.209 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.607 ' HB3' HD22 ' A' ' 697' ' ' LEU . 20.3 m-85 -131.96 122.95 26.4 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 126.305 1.842 . . . . 0.0 106.677 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.468 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 26.8 m-80 -119.47 -162.53 0.92 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 6.8 m -111.31 129.42 56.0 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 3.1 m -51.36 -76.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.783 1.233 . . . . 0.0 112.672 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -159.3 154.84 25.85 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 101.851 -3.388 . . . . 0.0 101.851 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 67.3 m 68.46 15.37 9.19 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.248 0.967 . . . . 0.0 112.852 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.705 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.0 m-85 -143.17 146.96 34.18 Favored 'General case' 0 N--CA 1.417 -2.1 0 C-N-CA 123.898 0.879 . . . . 0.0 108.981 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 2.4 t -103.24 148.37 25.89 Favored 'General case' 0 C--N 1.267 -3.0 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -177.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.6 ttp -104.59 118.06 35.64 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.475 HG12 HG23 ' A' ' 724' ' ' THR . 39.5 mm -116.12 127.75 73.62 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.545 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 108.19 -93.93 0.84 Allowed Glycine 0 CA--C 1.488 -1.652 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.841 174.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.447 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 7.2 p-80 -136.16 -175.84 4.12 Favored 'General case' 0 N--CA 1.397 -3.075 0 C-N-CA 125.618 1.567 . . . . 0.0 107.631 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.433 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -132.59 12.73 4.48 Favored 'General case' 0 C--O 1.208 -1.119 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.748 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 87.7 p -128.81 166.48 18.97 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.399 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' A' ' 741' ' ' LEU . 32.5 pt -119.07 160.14 19.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.74 174.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 739' ' ' THR . 3.7 m -134.18 134.92 42.67 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.664 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 40.3 t -94.0 119.93 33.56 Favored 'General case' 0 N--CA 1.405 -2.705 0 C-N-CA 118.821 -1.151 . . . . 0.0 110.259 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.8 140.5 25.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 113.836 -1.529 . . . . 0.0 107.676 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 66.45 7.07 4.74 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.76 8.98 61.62 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 738' ' ' TRP . 48.4 t -130.87 139.03 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -175.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.518 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.3 m95 -72.77 166.98 21.81 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.935 172.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 732' ' ' THR . 19.5 p -75.71 -163.09 0.24 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 122.084 0.945 . . . . 0.0 112.021 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.449 ' CD ' ' H ' ' A' ' 740' ' ' GLN . 0.5 OUTLIER -89.64 2.45 54.72 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.946 -171.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.628 ' HA ' HG22 ' A' ' 731' ' ' ILE . 2.0 mp 70.5 169.88 0.11 Allowed Pre-proline 0 C--O 1.237 0.41 0 O-C-N 124.094 0.872 . . . . 0.0 112.338 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 741' ' ' LEU . 39.2 Cg_endo -76.42 -177.06 3.44 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.416 2.077 . . . . 0.0 111.561 171.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -119.79 124.78 46.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 724' ' ' THR . 87.1 m -115.42 107.51 15.3 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 120.9 0.381 . . . . 0.0 110.207 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.541 ' HB ' HD21 ' A' ' 750' ' ' LEU . 44.0 t -96.96 145.68 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.705 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.82 1.96 1.19 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 125.039 1.336 . . . . 0.0 114.125 -174.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.789 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 15.8 mt 74.53 -19.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 125.068 1.347 . . . . 0.0 111.697 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.5 t70 -69.82 -33.72 72.71 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 126.72 2.008 . . . . 0.0 109.502 -175.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.18 31.28 6.8 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.585 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.789 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 55.1 mt -85.83 -179.28 6.79 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 121.566 0.698 . . . . 0.0 109.877 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.539 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 56.2 mtpt -116.33 -178.16 3.35 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.109 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -130.19 126.28 37.02 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 113.253 -1.794 . . . . 0.0 107.835 -175.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . 0.422 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 57.5 m -75.41 155.53 36.27 Favored 'General case' 0 C--N 1.264 -3.124 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.047 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -120.09 135.87 54.79 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 45.2 t -58.42 127.1 30.42 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.118 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.587 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 41.0 t -72.17 165.41 24.42 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -84.2 -19.21 34.41 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 91.6 mt -111.53 10.97 21.29 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.021 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.587 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -112.22 149.31 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-O 121.677 0.751 . . . . 0.0 112.642 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.3 mp -113.44 133.57 58.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.552 HD11 HD13 ' A' ' 759' ' ' ILE . 1.4 mm? -110.58 -177.95 3.36 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.13 152.83 19.41 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.85 -17.12 34.04 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.84 -6.3 32.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.497 0.665 . . . . 0.0 111.012 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -117.63 -4.78 11.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.677 0.751 . . . . 0.0 110.295 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 766' ' ' LYS . 17.8 mmmt -65.57 -17.35 64.51 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.336 1.055 . . . . 0.0 111.96 176.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -105.64 16.48 25.3 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.099 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.501 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 12.2 tppt? -110.21 113.07 25.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . 0.446 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 8.2 ptpp? -85.8 -32.03 22.0 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.472 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . 0.446 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 45.5 mt-10 -132.11 119.67 21.27 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.232 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.501 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 70.4 m-85 -97.58 157.34 16.08 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.804 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -93.28 148.68 21.83 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.637 ' CD2' HD12 ' A' ' 750' ' ' LEU . 15.1 p-80 -48.0 142.82 4.74 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.052 0.941 . . . . 0.0 111.669 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 22.1 m120 68.78 21.7 7.62 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 51.9 m -93.05 120.43 33.34 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.516 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -90.18 111.37 22.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.195 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 761' ' ' LEU . 7.8 pt -120.28 -179.7 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.906 0.86 . . . . 0.0 110.459 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.468 ' HG2' ' CD2' ' A' ' 789' ' ' HIS . 88.9 mtm180 -124.75 137.72 54.32 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.59 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 8.4 p90 -130.44 166.2 21.01 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . 0.504 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 24.3 ptt180 -154.25 157.17 38.32 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 27.6 m -87.73 166.14 14.85 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . 0.557 ' HB3' HD11 ' A' ' 760' ' ' ILE . 39.4 ptt85 -84.49 -27.99 27.07 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.169 -0.613 . . . . 0.0 112.089 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -91.88 -5.8 65.97 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.018 -1.087 . . . . 0.0 112.227 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 2.8 mptp? -128.36 104.85 7.95 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -86.24 115.93 24.1 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.603 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 151.57 146.96 4.45 Favored Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 31.3 m95 -94.68 143.22 26.62 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.59 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.1 mp -97.95 -27.93 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.084 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.487 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 28.8 m170 75.95 128.88 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 124.623 1.169 . . . . 0.0 109.923 -174.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.507 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.7 t -151.38 157.86 42.99 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.241 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.82 135.52 59.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 50.9 t -70.76 112.15 6.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.574 0.702 . . . . 0.0 110.093 177.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.6 mm -112.89 83.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.034 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.618 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 53.85 56.45 7.13 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.901 172.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . 0.489 ' HA3' ' HE2' ' A' ' 751' ' ' LYS . . . 81.95 16.49 72.31 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.495 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -147.42 166.08 28.3 Favored 'General case' 0 C--O 1.19 -2.05 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.623 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 99.0 m95 -111.45 162.7 14.81 Favored 'General case' 0 C--N 1.256 -3.466 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -146.47 105.76 4.05 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 29.2 Cg_endo -67.21 140.61 52.68 Favored 'Cis proline' 0 C--O 1.247 0.95 0 C-N-CA 124.061 -1.225 . . . . 0.0 111.679 -1.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.623 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.7 tt0 -57.51 118.63 5.39 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-O 121.32 0.581 . . . . 0.0 110.431 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.507 ' CG1' HG21 ' A' ' 790' ' ' THR . 1.9 m . . . . . 1 N--CA 1.363 -4.816 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.91 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 708' ' ' PRO . 15.9 p . . . . . 0 N--CA 1.422 -1.838 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 67.0 m -74.23 -58.51 3.25 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 171.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 81.76 132.29 1.45 Allowed Glycine 0 N--CA 1.417 -2.612 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.137 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 21.1 t70 62.24 106.17 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.729 0.899 . . . . 0.0 111.19 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.63 HG21 HG21 ' A' ' 715' ' ' VAL . 1.7 pp -70.12 147.13 95.47 Favored Pre-proline 0 C--N 1.291 -1.952 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.828 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.474 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 58.9 Cg_endo -69.64 -162.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 123.023 2.482 . . . . 0.0 112.823 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.93 144.92 49.12 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.692 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.5 OUTLIER -85.8 132.57 34.09 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -49.26 -47.02 46.98 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.818 1.247 . . . . 0.0 113.793 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -141.63 29.58 1.74 Allowed 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.692 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -141.89 -141.01 3.86 Favored Glycine 0 C--N 1.301 -1.395 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.186 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.459 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -157.62 179.97 8.73 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -176.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.74 158.21 16.89 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 13.5 mm100 -86.02 -61.5 1.74 Allowed 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.341 0.591 . . . . 0.0 110.618 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.3 tt -167.0 133.24 2.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.52 ' HB2' ' CE1' ' A' ' 709' ' ' TYR . 15.8 p -126.16 137.21 53.56 Favored 'General case' 0 N--CA 1.392 -3.329 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . 0.42 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 15.0 t -124.87 109.43 27.88 Favored Pre-proline 0 C--N 1.279 -2.469 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.248 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 706' ' ' SER . 60.7 Cg_endo -67.43 170.97 12.48 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 123.058 2.506 . . . . 0.0 110.316 177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.539 ' HB2' HG21 ' A' ' 690' ' ' THR . 15.4 Cg_exo -68.92 -7.35 8.5 Favored 'Cis proline' 0 N--CA 1.499 1.801 0 CA-C-N 119.968 1.024 . . . . 0.0 114.686 3.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 705' ' ' SER . 51.5 m-85 76.15 73.96 0.08 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.73 1.269 . . . . 0.0 108.531 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.464 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 37.0 m-85 -82.26 174.17 11.41 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.5 -176.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -72.63 125.17 26.82 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.746 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 103.52 2.18 47.06 Favored Glycine 0 N--CA 1.411 -3.014 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.313 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.09 151.0 23.61 Favored 'General case' 0 CA--C 1.5 -0.969 0 O-C-N 122.445 -0.444 . . . . 0.0 111.153 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 21.7 m -132.69 156.89 46.18 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.63 HG21 HG21 ' A' ' 694' ' ' ILE . 39.8 t -138.24 136.43 44.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 48.6 mt-10 -91.07 141.71 28.54 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 123.434 0.459 . . . . 0.0 110.249 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.623 ' HB3' HD12 ' A' ' 697' ' ' LEU . 42.8 m-85 -138.98 121.65 16.35 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 124.655 1.182 . . . . 0.0 108.693 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.459 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 41.4 m-20 -124.46 -165.76 1.42 Allowed 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 8.0 m -117.91 140.97 48.96 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.9 m -60.73 -68.1 0.34 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-O 120.83 0.348 . . . . 0.0 110.551 -175.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 722' ' ' SER . 8.3 pt-20 -172.8 160.51 4.45 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 40.4 m 71.43 7.59 6.07 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.682 1.239 . . . . 0.0 110.493 -174.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 745' ' ' VAL . 93.2 m-85 -140.03 144.73 37.05 Favored 'General case' 0 N--CA 1.382 -3.849 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.658 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.515 HG21 HD21 ' A' ' 750' ' ' LEU . 1.1 m -120.38 144.74 47.74 Favored 'General case' 0 C--N 1.264 -3.138 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.786 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.711 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.7 ttp -81.95 116.72 21.71 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 124.91 1.284 . . . . 0.0 109.564 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 46.6 mm -115.25 137.13 49.77 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.954 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.518 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 96.3 -80.05 0.75 Allowed Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.123 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.564 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 4.2 t60 -147.09 177.48 9.13 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -173.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.711 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -133.3 22.44 4.06 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.542 176.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 32.4 p -156.25 162.43 40.15 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.784 -0.572 . . . . 0.0 110.42 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 741' ' ' LEU . 36.2 pt -121.67 161.09 22.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 124.217 0.948 . . . . 0.0 108.579 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 739' ' ' THR . 10.5 m -133.37 135.8 44.93 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 123.595 0.56 . . . . 0.0 110.424 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.71 104.17 16.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.7 pp -146.34 161.68 10.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.912 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 71.7 -43.62 0.57 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.406 1.082 . . . . 0.0 111.565 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 138.15 37.14 0.14 Allowed Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 125.162 1.363 . . . . 0.0 109.769 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.8 p -174.41 161.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.502 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 95.8 m95 -77.36 172.87 12.63 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.645 173.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 732' ' ' THR . 29.5 p -80.4 -159.19 0.22 Allowed 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.699 0.762 . . . . 0.0 112.259 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.478 ' CD ' ' H ' ' A' ' 740' ' ' GLN . 0.5 OUTLIER -83.9 -4.57 58.79 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -165.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.414 HD13 HG21 ' A' ' 731' ' ' ILE . 4.1 mm? 68.73 156.13 0.15 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 123.432 0.458 . . . . 0.0 111.504 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.564 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 59.0 Cg_endo -80.25 173.66 12.27 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.826 1.684 . . . . 0.0 111.041 172.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -116.36 114.96 25.02 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 724' ' ' THR . 59.1 m -98.08 100.29 11.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-O 122.156 0.979 . . . . 0.0 109.483 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.706 HG11 ' CD1' ' A' ' 750' ' ' LEU . 10.6 p -77.87 155.03 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.292 0 CA-C-N 113.82 -1.537 . . . . 0.0 108.737 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -79.17 1.33 24.87 Favored 'General case' 0 C--N 1.251 -3.7 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.948 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.557 ' HA ' HD22 ' A' ' 750' ' ' LEU . 18.8 mt 77.08 -24.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 126.48 1.912 . . . . 0.0 112.24 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 746' ' ' ALA . 22.9 t70 -72.23 -34.3 68.22 Favored 'General case' 0 C--N 1.264 -3.128 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.103 -175.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 749' ' ' LYS . 8.1 ptmt -102.42 27.8 6.5 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 112.687 -2.051 . . . . 0.0 111.541 -174.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.706 ' CD1' HG11 ' A' ' 745' ' ' VAL . 1.9 tp -84.31 -179.46 7.2 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -107.37 -172.82 2.15 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.586 -173.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . 0.543 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 25.0 mtpp -123.03 156.04 35.65 Favored 'General case' 0 C--N 1.265 -3.07 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 79.2 m -112.18 168.6 9.49 Favored 'General case' 1 C--N 1.241 -4.136 0 C-N-CA 123.354 0.662 . . . . 0.0 109.532 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -129.2 141.36 51.17 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 48.1 t -61.86 131.37 49.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.51 ' HB2' HG12 ' A' ' 759' ' ' ILE . 17.7 m -76.17 175.01 9.39 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 123.079 0.551 . . . . 0.0 111.539 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -85.73 -35.02 21.06 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -172.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.18 12.55 26.57 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.525 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.51 HG12 ' HB2' ' A' ' 756' ' ' SER . 23.2 pt -105.59 156.21 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.183 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.1 mp -122.6 129.44 75.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.659 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 81.9 mt -97.52 -173.54 2.67 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.629 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 35.0 mt-10 -68.77 162.3 26.56 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . 0.568 ' HA ' ' HE2' ' A' ' 766' ' ' LYS . 38.9 mm-40 -61.74 -21.81 64.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.432 0.634 . . . . 0.0 110.738 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.27 2.02 45.18 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.471 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.434 HD12 ' HE2' ' A' ' 771' ' ' PHE . 3.3 mm? -126.94 -12.44 5.88 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 763' ' ' GLU . 57.0 mtmt -68.37 -7.53 32.2 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -102.61 0.67 33.67 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 768' ' ' LYS . 8.4 tppt? -95.02 102.43 14.24 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -78.55 -31.81 47.59 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.368 0.604 . . . . 0.0 109.656 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -131.17 128.25 39.64 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.936 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.659 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 92.6 m-85 -107.15 162.62 13.71 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 752' ' ' LYS . 2.6 p30 -113.55 168.72 9.52 Favored 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 118.1 -1.44 . . . . 0.0 109.126 175.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.428 ' CD2' HG23 ' A' ' 747' ' ' ILE . 2.1 p-80 -47.42 150.09 0.98 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.984 0.914 . . . . 0.0 112.835 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 70.93 3.62 4.71 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.934 1.293 . . . . 0.0 111.324 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 12.8 t -78.85 114.39 17.75 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.461 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.8 OUTLIER -89.05 113.23 24.32 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.173 178.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 771' ' ' PHE . 8.2 pt -125.89 178.05 4.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-O 121.337 0.589 . . . . 0.0 109.688 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 31.4 ptt180 -133.45 127.84 34.18 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.521 ' CE1' HG12 ' A' ' 801' ' ' VAL . 6.6 p90 -119.38 168.04 11.33 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -144.53 161.01 40.16 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 85.2 m -90.27 143.12 27.05 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.884 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . 0.46 ' HB3' HD11 ' A' ' 760' ' ' ILE . 27.4 ptt180 -67.75 130.49 43.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 95.94 -10.59 68.11 Favored Glycine 0 C--N 1.294 -1.765 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.4 mptt -114.02 140.38 48.49 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -116.87 87.66 2.74 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.395 0.617 . . . . 0.0 110.066 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 172.61 158.54 17.11 Favored Glycine 0 N--CA 1.425 -2.036 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.609 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 60.4 m95 -114.32 145.39 41.84 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 117.368 0.584 . . . . 0.0 109.71 -175.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.423 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -95.84 -35.33 5.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.388 -177.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 7.1 m170 70.92 114.41 0.05 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 124.31 1.044 . . . . 0.0 109.785 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 3.6 t -139.46 163.08 33.47 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.97 138.96 52.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 C-N-CA 123.388 0.675 . . . . 0.0 109.459 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.7 t -73.41 110.69 7.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.559 0.695 . . . . 0.0 110.258 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.4 mm -111.81 81.57 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.639 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.7 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.491 HD22 HD12 ' A' ' 750' ' ' LEU . 26.5 t-20 53.52 68.67 0.81 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.947 0.88 . . . . 0.0 112.22 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 70.55 17.4 74.66 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.824 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -143.52 166.2 25.46 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.604 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 95.1 m95 -112.61 158.92 19.4 Favored 'General case' 0 C--N 1.252 -3.638 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -148.05 106.67 3.65 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.82 138.53 46.98 Favored 'Cis proline' 0 C--O 1.241 0.633 0 C-N-CA 123.62 -1.408 . . . . 0.0 111.541 -0.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.604 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.1 tp10 -57.36 128.27 36.17 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.669 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.521 HG12 ' CE1' ' A' ' 779' ' ' TYR . 15.8 m . . . . . 1 N--CA 1.363 -4.786 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.706 -173.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . 0.544 ' CG2' ' HB2' ' A' ' 708' ' ' PRO . 19.6 p . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.4 m -74.82 -59.38 2.76 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 135.35 166.88 11.18 Favored Glycine 1 N--CA 1.383 -4.857 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -177.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.656 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 34.1 t70 -53.54 135.78 39.53 Favored 'General case' 0 C--N 1.281 -2.397 0 O-C-N 124.658 0.858 . . . . 0.0 111.062 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 715' ' ' VAL . 1.2 pp -52.76 150.27 9.98 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 113.15 -1.841 . . . . 0.0 115.654 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.42 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.0 Cg_endo -71.82 -162.87 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.61 2.873 . . . . 0.0 111.866 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -135.5 154.64 51.34 Favored 'General case' 0 N--CA 1.395 -3.214 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.62 HD21 ' SG ' ' A' ' 744' ' ' CYS . 21.9 tp -104.25 111.5 24.14 Favored 'General case' 0 C--N 1.252 -3.656 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.593 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -43.9 -37.11 2.68 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.806 1.642 . . . . 0.0 115.22 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -134.73 26.61 3.67 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 121.942 -0.474 . . . . 0.0 110.429 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -139.71 -147.78 5.1 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.207 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.425 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -149.61 173.3 13.8 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 122.617 0.367 . . . . 0.0 110.208 -177.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.61 139.38 40.3 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -82.27 -75.22 0.31 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.962 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 705' ' ' SER . 1.0 OUTLIER -170.66 162.38 7.83 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.217 0.532 . . . . 0.0 111.343 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.615 ' CB ' HG22 ' A' ' 715' ' ' VAL . 33.8 t 174.92 179.38 0.13 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 128.527 2.731 . . . . 0.0 105.007 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 23.4 p -148.63 140.82 14.74 Favored Pre-proline 0 C--N 1.305 -1.344 0 CA-C-N 118.619 0.645 . . . . 0.0 110.833 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.537 ' HA ' ' N ' ' A' ' 709' ' ' TYR . 50.4 Cg_endo -68.52 163.9 34.95 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.019 1.813 . . . . 0.0 109.064 175.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.544 ' HB2' ' CG2' ' A' ' 690' ' ' THR . 29.7 Cg_endo -64.68 -5.14 3.05 Favored 'Cis proline' 0 N--CA 1.502 1.973 0 N-CA-C 117.353 2.02 . . . . 0.0 117.353 4.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.656 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 74.7 m-85 66.33 66.55 0.47 Allowed 'General case' 0 C--O 1.255 1.362 0 CA-C-O 122.288 1.042 . . . . 0.0 108.566 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -67.11 169.85 7.85 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.336 -1.756 . . . . 0.0 112.111 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.485 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 58.3 m-85 -67.63 137.33 55.53 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.928 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 87.52 8.17 74.46 Favored Glycine 0 N--CA 1.41 -3.048 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.09 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.68 156.77 24.9 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 13.8 m -141.27 139.43 33.69 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 694' ' ' ILE . 20.2 t -126.78 136.65 60.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.565 ' HG3' ' HG2' ' A' ' 729' ' ' ARG . 26.5 tt0 -96.89 140.59 31.22 Favored 'General case' 0 N--CA 1.381 -3.918 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.581 ' HB3' HD22 ' A' ' 697' ' ' LEU . 50.4 m-85 -138.67 120.39 15.24 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 125.833 1.653 . . . . 0.0 107.396 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.425 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 13.5 m-80 -122.28 -165.36 1.27 Allowed 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 7.1 m -112.97 135.89 53.25 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 11.9 t -57.94 -68.93 0.2 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 722' ' ' SER . 11.4 pt-20 -172.26 163.81 5.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 75.4 m 72.13 5.95 5.44 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.193 0.933 . . . . 0.0 110.872 -177.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.648 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.6 m-85 -141.52 145.53 35.28 Favored 'General case' 0 N--CA 1.401 -2.895 0 C-N-CA 125.192 1.397 . . . . 0.0 107.95 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.2 m -114.21 138.24 50.72 Favored 'General case' 0 C--N 1.251 -3.716 0 C-N-CA 125.709 1.604 . . . . 0.0 111.998 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.598 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.1 ttp -91.01 122.36 33.6 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.893 1.277 . . . . 0.0 109.486 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 39.8 mm -124.21 135.89 62.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.949 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 101.35 -74.99 0.37 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.206 173.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.537 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.1 OUTLIER -141.16 177.18 8.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -176.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.598 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -135.46 8.92 3.4 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.0 0.905 . . . . 0.0 109.359 170.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 54.4 p -145.72 163.0 36.29 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.699 -0.625 . . . . 0.0 110.235 -176.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.505 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 35.7 pt -122.76 163.4 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 739' ' ' THR . 21.2 m -139.17 137.25 35.89 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.937 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 5.7 t -86.48 99.9 11.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 739' ' ' THR . 1.7 pp -140.75 146.27 24.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.284 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 67.87 -4.78 0.93 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 112.47 13.38 11.77 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 121.581 -0.342 . . . . 0.0 112.613 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.2 p -155.09 157.22 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.429 ' CZ3' HG23 ' A' ' 715' ' ' VAL . 96.9 m95 -73.33 167.58 20.93 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 121.056 0.455 . . . . 0.0 109.816 171.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.505 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 42.8 p -77.61 -163.12 0.36 Allowed 'General case' 0 N--CA 1.426 -1.638 0 CA-C-O 122.021 0.915 . . . . 0.0 112.616 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -1.89 32.93 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -167.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 67.61 161.44 0.14 Allowed Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 122.735 0.414 . . . . 0.0 110.386 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.537 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 49.8 Cg_endo -83.64 174.35 8.79 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.443 1.429 . . . . 0.0 110.241 168.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -117.39 117.09 28.53 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.62 ' SG ' HD21 ' A' ' 697' ' ' LEU . 95.4 m -102.67 107.77 18.8 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.188 0.518 . . . . 0.0 110.154 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.437 ' HB ' HD21 ' A' ' 750' ' ' LEU . 39.6 t -96.31 145.05 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.648 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -67.89 6.89 0.61 Allowed 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 125.048 1.339 . . . . 0.0 114.438 -175.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.861 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 36.9 mt 76.34 -16.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 C-N-CA 125.561 1.544 . . . . 0.0 112.025 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 746' ' ' ALA . 14.9 t70 -81.82 -31.96 31.48 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.616 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -107.33 23.23 14.76 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.946 -1.934 . . . . 0.0 108.442 -172.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.861 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 72.5 mt -82.58 -165.21 0.98 Allowed 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.361 175.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.524 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 61.3 mtpt -124.51 152.7 43.1 Favored 'General case' 0 N--CA 1.393 -3.314 0 CA-C-O 121.834 0.826 . . . . 0.0 110.19 -173.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . 0.425 ' HE3' ' OE1' ' A' ' 770' ' ' GLU . 43.8 mtmt -101.87 115.56 30.8 Favored 'General case' 0 C--N 1.251 -3.674 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.034 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . 0.463 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 0.0 OUTLIER -75.71 166.65 23.23 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-N 112.991 -1.913 . . . . 0.0 109.143 -178.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -145.68 161.84 38.93 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.004 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 31.4 t -65.53 121.74 15.61 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.357 172.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.674 ' HB3' HG13 ' A' ' 759' ' ' ILE . 30.6 t -63.91 153.48 36.82 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -58.76 -26.96 64.52 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 124.24 1.016 . . . . 0.0 113.459 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.59 -13.84 14.16 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.831 -170.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.674 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -87.7 155.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.09 134.41 55.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 113.78 -1.555 . . . . 0.0 107.17 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 1.8 mm? -114.12 178.7 4.19 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . 0.56 ' HB2' HD23 ' A' ' 765' ' ' LEU . 34.6 mt-10 -73.15 163.12 28.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -52.93 -27.61 19.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . 0.487 ' HB2' HD22 ' A' ' 765' ' ' LEU . 31.2 m-70 -76.6 -35.97 57.78 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.56 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.0 mm? -91.11 -15.55 29.26 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.192 -1.822 . . . . 0.0 112.551 -168.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -77.48 -6.78 54.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.202 0.525 . . . . 0.0 110.951 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -114.46 13.18 17.59 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.465 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 13.5 tppt? -105.85 112.61 25.73 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -87.31 -29.53 21.53 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.189 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . 0.425 ' OE1' ' HE3' ' A' ' 752' ' ' LYS . 45.2 mt-10 -139.66 138.29 35.95 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.653 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.465 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 39.5 m-85 -117.02 177.0 4.87 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -121.48 166.2 14.5 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 792' ' ' CYS . 34.9 t60 -65.54 149.73 49.58 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 83.03 0.41 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.789 1.236 . . . . 0.0 108.668 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 54.0 m -83.41 106.57 15.27 Favored 'General case' 0 N--CA 1.41 -2.467 0 C-N-CA 119.001 -1.079 . . . . 0.0 108.885 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.454 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -88.41 101.94 14.4 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.402 HG12 ' CZ3' ' A' ' 797' ' ' TRP . 4.3 pt -112.87 178.36 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 121.773 0.797 . . . . 0.0 109.868 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.643 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 79.2 mtt180 -130.06 127.76 40.54 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.583 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 7.6 p90 -121.73 168.48 11.76 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -152.93 171.35 18.46 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.749 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 52.7 t -113.06 162.03 16.39 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -77.98 104.24 8.42 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 120.65 -44.21 1.41 Allowed Glycine 0 C--N 1.276 -2.765 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.037 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.749 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.7 mptt -97.89 91.04 5.15 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.75 148.28 31.55 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.245 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 100.62 154.34 27.08 Favored Glycine 0 C--N 1.294 -1.763 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -172.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.643 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 45.4 m95 -99.9 139.79 35.05 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 117.622 0.711 . . . . 0.0 110.994 -173.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.583 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -90.35 -33.01 5.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.674 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 18.6 m170 78.45 125.46 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 C-N-CA 124.784 1.234 . . . . 0.0 110.206 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.2 t -151.55 152.98 33.65 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 52.7 t -117.59 134.85 59.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . 0.483 ' HB3' ' HA ' ' A' ' 773' ' ' HIS . 52.4 t -67.46 132.78 48.28 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.972 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.61 83.21 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 C-N-CA 124.418 1.087 . . . . 0.0 108.074 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.567 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.8 OUTLIER 45.93 72.74 0.2 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.097 0.959 . . . . 0.0 112.809 177.468 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 78.4 0.55 78.93 Favored Glycine 0 C--N 1.296 -1.666 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.012 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . 0.499 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 36.1 ttm180 -130.38 173.48 10.78 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.601 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 98.5 m95 -116.78 162.18 18.11 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 122.351 0.26 . . . . 0.0 111.179 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -144.68 108.08 4.73 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.17 140.05 56.5 Favored 'Cis proline' 0 C--O 1.248 0.992 0 C-N-CA 123.637 -1.401 . . . . 0.0 111.129 -1.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.601 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.9 tt0 -57.11 125.58 23.33 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.006 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 9.5 m . . . . . 1 N--CA 1.363 -4.788 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.808 -175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.422 -1.832 0 CA-C-O 121.721 0.772 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.7 m -76.41 -74.18 0.24 Allowed 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.161 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 143.72 179.09 20.03 Favored Glycine 1 N--CA 1.356 -6.663 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -39.66 126.52 1.92 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 126.313 1.845 . . . . 0.0 111.484 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.563 HG21 HG21 ' A' ' 715' ' ' VAL . 1.7 pp -63.16 147.78 94.07 Favored Pre-proline 0 N--CA 1.425 -1.707 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.406 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.503 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 72.9 Cg_endo -72.69 -166.22 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.818 2.345 . . . . 0.0 112.828 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -126.6 165.19 19.65 Favored 'General case' 0 N--CA 1.399 -2.977 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.602 HD22 ' HB3' ' A' ' 717' ' ' PHE . 37.6 tp -119.67 110.64 17.07 Favored 'General case' 0 C--N 1.251 -3.705 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.901 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.05 -40.24 6.5 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -173.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 88.2 m-70 -128.24 20.7 6.27 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 121.473 -0.767 . . . . 0.0 110.16 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.466 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -125.29 -139.61 5.24 Favored Glycine 0 C--N 1.304 -1.2 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.93 -177.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.6 ' HE1' ' CG ' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -160.85 177.92 9.93 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -109.96 154.65 22.83 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -91.27 -74.32 0.51 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 120.933 0.397 . . . . 0.0 110.369 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 705' ' ' SER . 6.3 tt -157.22 133.56 9.77 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 177.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 709' ' ' TYR . 4.2 p -133.96 110.73 9.88 Favored 'General case' 0 N--CA 1.393 -3.297 0 CA-C-O 121.724 0.773 . . . . 0.0 110.145 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 39.8 t -90.26 111.45 47.1 Favored Pre-proline 0 C--N 1.277 -2.557 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.993 -174.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.409 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 58.3 Cg_endo -71.26 171.81 15.31 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.774 2.316 . . . . 0.0 109.363 175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.477 ' HG2' ' CE1' ' A' ' 710' ' ' TYR . 2.8 Cg_exo -70.75 -7.24 11.57 Favored 'Cis proline' 0 CA--C 1.498 -1.316 0 N-CA-C 115.505 1.31 . . . . 0.0 115.505 5.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 705' ' ' SER . 43.3 m-85 78.55 86.1 0.07 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.477 ' CE1' ' HG2' ' A' ' 708' ' ' PRO . 26.9 m-85 -91.2 174.65 7.28 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.815 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.449 ' CE2' ' HA2' ' A' ' 736' ' ' GLY . 64.1 m-85 -74.71 136.64 41.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.231 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 91.26 -4.91 81.01 Favored Glycine 0 N--CA 1.416 -2.657 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.356 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -73.59 147.79 43.52 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 6.8 m -129.02 152.53 48.53 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.563 HG21 HG21 ' A' ' 694' ' ' ILE . 41.1 t -136.29 133.01 49.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 36.7 mt-10 -95.17 140.32 30.25 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.962 0.886 . . . . 0.0 111.638 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.602 ' HB3' HD22 ' A' ' 697' ' ' LEU . 37.3 m-85 -138.76 129.96 26.95 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.6 ' CG ' ' HE1' ' A' ' 701' ' ' TRP . 9.1 p30 -128.44 -167.77 1.82 Allowed 'General case' 1 N--CA 1.377 -4.089 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 44.4 m -108.65 124.06 49.94 Favored 'General case' 0 C--N 1.247 -3.864 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 24.2 t -44.9 -80.75 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 O-C-N 125.689 1.868 . . . . 0.0 112.834 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -153.83 150.74 28.75 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.3 m 69.19 9.65 7.46 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.262 0.976 . . . . 0.0 113.611 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 719' ' ' CYS . 96.5 m-85 -134.3 145.53 49.16 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.567 HG21 HD11 ' A' ' 750' ' ' LEU . 6.4 t -75.86 -115.53 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.898 -175.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.64 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.2 ttp 165.09 107.86 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.732 2.813 . . . . 0.0 105.227 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.703 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 42.1 mm -119.03 143.96 28.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 92.48 -68.87 1.81 Allowed Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.731 173.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.544 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.5 t60 -154.58 -178.71 7.37 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -174.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.64 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -139.35 20.31 2.57 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.379 0.609 . . . . 0.0 110.012 173.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.606 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 59.9 p -156.08 162.3 40.29 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.879 -177.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 714' ' ' SER . 35.8 pt -120.34 157.75 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 739' ' ' THR . 6.1 m -131.26 135.6 47.48 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.0 t -95.77 111.57 23.5 Favored 'General case' 0 N--CA 1.392 -3.346 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.763 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.09 154.23 28.05 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.128 0 CA-C-N 113.649 -1.614 . . . . 0.0 107.089 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 76.76 -44.74 0.48 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.311 1.044 . . . . 0.0 110.26 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . 0.449 ' HA2' ' CE2' ' A' ' 711' ' ' TYR . . . 144.86 25.78 0.11 Allowed Glycine 0 C--N 1.298 -1.559 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 8.5 p -163.64 167.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.503 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 86.8 m95 -84.33 173.02 11.28 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 121.156 0.503 . . . . 0.0 111.634 177.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 732' ' ' THR . 21.3 p -86.92 -157.25 0.36 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.496 ' NE2' ' HB ' ' A' ' 739' ' ' THR . 0.0 OUTLIER -69.49 -24.28 63.75 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 126.065 1.746 . . . . 0.0 113.468 -171.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.446 HD21 ' HG2' ' A' ' 695' ' ' PRO . 1.6 mt 70.08 155.27 0.15 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 124.452 1.095 . . . . 0.0 111.206 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.544 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 37.6 Cg_endo -71.61 175.28 9.75 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.792 1.661 . . . . 0.0 111.812 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.703 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.4 tt0 -123.11 119.2 29.59 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.567 ' SG ' HD21 ' A' ' 697' ' ' LEU . 90.7 m -105.0 104.4 14.13 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.18 0.514 . . . . 0.0 110.965 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 724' ' ' THR . 42.2 t -101.83 147.2 8.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 748' ' ' ASP . . . -65.76 3.73 0.73 Allowed 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 124.867 1.267 . . . . 0.0 113.788 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.86 ' HA ' HD22 ' A' ' 750' ' ' LEU . 61.4 mt 73.8 -17.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.821 1.648 . . . . 0.0 110.938 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 746' ' ' ALA . 7.2 t70 -72.51 -33.03 66.63 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 126.402 1.881 . . . . 0.0 109.267 -177.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -105.05 18.91 21.53 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.566 -172.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 1.022 ' HG ' HD22 ' A' ' 794' ' ' ASN . 0.2 OUTLIER -82.06 -172.9 4.2 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.06 179.179 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 751' ' ' LYS . 28.1 mmmt -115.04 148.7 38.55 Favored 'General case' 0 N--CA 1.381 -3.906 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.706 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -109.82 119.26 38.79 Favored 'General case' 1 C--N 1.23 -4.613 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.378 -173.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 770' ' ' GLU . 27.2 m -67.27 162.73 22.06 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.762 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 769' ' ' LYS . 16.9 ptpt -126.44 144.15 50.94 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.181 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 769' ' ' LYS . 48.0 p -68.06 114.13 6.33 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.754 171.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.585 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 45.2 t -69.76 156.9 38.31 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -84.32 -13.39 52.54 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.278 0.561 . . . . 0.0 112.385 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 5.6 mp -95.53 -4.28 45.08 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.059 -173.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.585 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.1 pp -118.96 152.24 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 CA-C-O 121.985 0.897 . . . . 0.0 112.138 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.58 127.77 64.76 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.795 0 CA-C-N 113.814 -1.539 . . . . 0.0 107.365 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.467 HD11 HD13 ' A' ' 759' ' ' ILE . 1.5 mm? -107.6 -175.18 2.72 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . 0.565 ' HB2' HD23 ' A' ' 765' ' ' LEU . 25.6 mt-10 -76.87 171.86 14.07 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.263 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.33 -31.34 67.47 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.282 0.633 . . . . 0.0 110.544 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.32 2.09 54.6 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.731 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.565 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.9 mm? -122.28 -24.45 5.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 53.8 mtmt -66.38 -23.78 66.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -86.77 -2.83 58.86 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.939 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.483 ' HE3' ' CD2' ' A' ' 771' ' ' PHE . 23.4 ttpt -99.4 110.22 22.74 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . 0.608 ' HG2' ' HG3' ' A' ' 770' ' ' GLU . 0.0 OUTLIER -93.03 -23.98 18.48 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . 0.608 ' HG3' ' HG2' ' A' ' 769' ' ' LYS . 37.6 mt-10 -127.77 106.41 9.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.483 ' CD2' ' HE3' ' A' ' 768' ' ' LYS . 67.5 m-85 -89.59 147.95 23.64 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.916 -174.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -89.49 144.59 25.92 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.158 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.644 ' HB3' HD23 ' A' ' 750' ' ' LEU . 49.9 t60 -57.95 146.77 31.18 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.319 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 83.44 3.75 0.9 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.37 1.468 . . . . 0.0 110.232 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 67.8 m -86.41 113.6 22.5 Favored 'General case' 0 N--CA 1.398 -3.047 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.407 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.459 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -85.89 90.6 8.11 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.497 179.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . . . . . . . . . 7.4 pt -95.23 -175.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.702 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 0.2 OUTLIER -141.55 121.06 13.26 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.007 175.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.559 ' CD2' HG13 ' A' ' 801' ' ' VAL . 10.6 p90 -106.71 168.71 8.99 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 174.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -149.82 146.91 27.4 Favored 'General case' 0 C--N 1.257 -3.45 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.733 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 5.0 t -79.36 168.43 19.52 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -74.21 -1.38 20.25 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.113 0.482 . . . . 0.0 111.901 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -113.15 -6.6 22.2 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.733 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 3.8 mptp? -112.58 137.53 50.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -106.59 4.89 28.52 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.43 1.11 . . . . 0.0 110.805 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -113.04 157.84 14.67 Favored Glycine 0 C--N 1.268 -3.225 0 CA-C-N 113.446 -1.706 . . . . 0.0 108.943 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 46.0 m95 -100.35 141.45 33.18 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 117.231 0.516 . . . . 0.0 110.298 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.518 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -91.93 -31.31 4.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 15.4 m170 73.25 123.62 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 124.455 1.102 . . . . 0.0 110.13 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.494 HG21 ' CG2' ' A' ' 801' ' ' VAL . 2.3 t -146.33 155.36 42.57 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 24.9 t -114.21 133.26 60.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 41.6 t -70.46 117.2 11.7 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.591 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 47.8 mm -119.29 89.15 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 C-N-CA 123.861 0.865 . . . . 0.0 109.382 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 1.022 HD22 ' HG ' ' A' ' 750' ' ' LEU . 0.9 OUTLIER 43.59 62.35 1.93 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.083 0.953 . . . . 0.0 112.754 175.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.15 36.47 56.29 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.968 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -158.79 165.53 34.05 Favored 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.622 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.4 m95 -114.23 160.36 19.11 Favored 'General case' 0 C--N 1.258 -3.385 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 24.7 t70 -148.1 102.13 3.6 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 798' ' ' ASP . 48.7 Cg_endo -70.77 142.59 72.9 Favored 'Cis proline' 0 C--O 1.244 0.824 0 C-N-CA 123.886 -1.298 . . . . 0.0 112.96 0.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.622 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 45.5 mt-10 -48.55 125.34 9.66 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.287 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.559 HG13 ' CD2' ' A' ' 779' ' ' TYR . 75.5 t . . . . . 0 C--N 1.305 -1.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.24 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 54.1 m -78.62 -75.1 0.24 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.304 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 143.13 -167.9 26.26 Favored Glycine 1 N--CA 1.378 -5.226 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -48.89 130.34 18.01 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 125.462 1.505 . . . . 0.0 110.417 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.679 HG21 HG21 ' A' ' 715' ' ' VAL . 1.3 pp -58.52 150.61 55.12 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.324 -177.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.6 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 74.3 Cg_endo -72.15 -159.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 123.276 2.65 . . . . 0.0 114.147 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -125.31 158.86 33.13 Favored 'General case' 0 N--CA 1.397 -3.115 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.617 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.5 OUTLIER -107.4 129.36 54.93 Favored 'General case' 0 C--N 1.26 -3.312 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -45.87 -45.68 15.32 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -141.22 27.18 1.95 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.417 0.627 . . . . 0.0 109.536 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.617 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -134.0 -146.32 5.44 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.807 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.433 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -153.41 178.11 10.15 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 122.94 0.496 . . . . 0.0 110.257 -175.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -108.55 147.5 31.68 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -71.34 -77.78 0.09 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.146 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.6 tt 179.66 135.98 0.1 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.518 ' HB2' HG13 ' A' ' 715' ' ' VAL . 22.9 t -144.81 -168.89 3.04 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 9.7 t -152.46 139.56 12.64 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.45 169.11 10.18 Favored 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 122.963 2.442 . . . . 0.0 110.072 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 710' ' ' TYR . 2.8 Cg_exo -72.44 -9.95 16.99 Favored 'Cis proline' 0 N--CA 1.49 1.279 0 N-CA-C 115.184 1.186 . . . . 0.0 115.184 7.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.415 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 62.3 m-85 73.28 79.85 0.13 Allowed 'General case' 0 C--N 1.312 -1.064 0 O-C-N 124.575 1.172 . . . . 0.0 108.993 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 708' ' ' PRO . 21.4 m-85 -84.05 168.67 15.69 Favored 'General case' 0 CA--C 1.477 -1.84 0 CA-C-N 113.943 -1.481 . . . . 0.0 112.717 -174.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -69.66 128.3 35.97 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.07 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.57 -15.53 55.79 Favored Glycine 0 N--CA 1.414 -2.791 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.611 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.47 145.25 52.89 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 10.8 m -131.32 150.28 52.21 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.679 HG21 HG21 ' A' ' 694' ' ' ILE . 42.7 t -138.15 124.65 26.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.694 ' HG3' ' HG2' ' A' ' 729' ' ' ARG . 2.3 mp0 -65.68 134.55 53.46 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.722 0.772 . . . . 0.0 112.623 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.425 ' HB3' ' CD1' ' A' ' 697' ' ' LEU . 19.9 m-85 -137.61 114.91 10.99 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 126.374 1.87 . . . . 0.0 107.063 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.433 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 19.3 m-20 -124.15 -168.56 1.81 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -175.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 23.3 m -116.17 138.62 51.11 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 5.0 m -57.55 -78.13 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 123.973 0.796 . . . . 0.0 112.152 -174.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -157.79 159.36 36.67 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 58.4 m 65.95 9.56 6.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.598 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 94.6 m-85 -142.14 146.04 34.89 Favored 'General case' 0 N--CA 1.407 -2.586 0 C-N-CA 124.12 0.968 . . . . 0.0 108.771 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.0 OUTLIER -113.09 137.31 51.62 Favored 'General case' 0 C--N 1.256 -3.478 0 C-N-CA 125.432 1.493 . . . . 0.0 111.129 -178.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . . . . . . . . . 9.2 tmm? -87.54 125.36 34.29 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.9 mm -124.91 133.32 69.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.009 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 121.33 -89.37 0.43 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.095 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 28.0 t60 -157.03 145.55 19.69 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.694 ' HG2' ' HG3' ' A' ' 716' ' ' GLU . 0.0 OUTLIER -86.84 13.77 8.35 Favored 'General case' 0 C--N 1.274 -2.691 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.879 -171.552 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 716' ' ' GLU . 6.0 p -156.66 168.56 27.03 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.951 -0.468 . . . . 0.0 111.987 -176.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 714' ' ' SER . 35.1 pt -117.0 164.61 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.587 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.3 m -136.08 134.24 38.19 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.698 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 8.5 t -84.14 107.57 16.54 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.092 0.472 . . . . 0.0 110.037 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -144.95 145.64 20.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 C-N-CA 125.085 1.354 . . . . 0.0 109.896 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 66.62 -0.31 1.61 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.39 24.45 24.05 Favored Glycine 0 CA--C 1.498 -0.973 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.09 153.26 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.6 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.4 m95 -79.11 177.83 8.51 Favored 'General case' 0 C--N 1.277 -2.545 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.468 168.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.409 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 17.1 p -80.84 -169.81 2.37 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.686 0.755 . . . . 0.0 112.873 -176.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.3 pp0? -71.46 -14.98 62.31 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -171.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 2.1 mt 69.54 146.53 0.11 Allowed Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 124.394 1.059 . . . . 0.0 113.853 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 48.1 Cg_endo -69.23 169.11 19.0 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 121.968 1.778 . . . . 0.0 112.346 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -115.22 104.69 12.08 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.821 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 724' ' ' THR . 87.3 m -84.8 99.74 11.09 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.653 0.739 . . . . 0.0 110.112 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.64 ' CG1' ' HG3' ' A' ' 749' ' ' LYS . 41.7 t -92.8 142.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.537 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.598 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.32 2.29 0.62 Allowed 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 125.857 1.663 . . . . 0.0 114.624 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.773 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 49.0 mt 78.33 -14.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 126.063 1.745 . . . . 0.0 111.699 176.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 746' ' ' ALA . 24.9 t70 -83.88 -30.14 26.65 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.729 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . 0.64 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 7.8 ptmt -110.58 29.78 7.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.002 -1.453 . . . . 0.0 111.838 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.773 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 96.2 mt -84.33 176.1 8.94 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.827 177.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -99.81 145.31 27.87 Favored 'General case' 0 N--CA 1.388 -3.564 0 CA-C-O 122.727 1.251 . . . . 0.0 110.293 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -98.17 111.84 24.02 Favored 'General case' 1 C--N 1.236 -4.366 0 CA-C-N 111.248 -2.705 . . . . 0.0 109.21 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 42.5 m -66.99 138.54 57.32 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.867 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -107.95 136.39 47.73 Favored 'General case' 0 C--N 1.27 -2.867 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.407 -174.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . 0.412 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 15.5 p -52.75 132.82 36.92 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.842 173.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.572 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 29.8 t -80.46 166.75 20.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -93.36 -17.28 23.72 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 74.5 mt -113.23 14.37 19.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.299 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.572 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.1 pp -115.05 149.18 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.961 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . 0.572 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.2 mp -107.95 129.95 61.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.862 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -177.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 1.9 mm? -108.17 178.76 4.41 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -77.96 172.21 13.84 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -66.47 -8.77 28.42 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 122.952 0.501 . . . . 0.0 112.035 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -93.13 -17.09 24.18 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.701 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 81.8 mt -117.03 -18.13 10.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -170.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -62.48 -26.17 68.39 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -101.42 8.35 42.21 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.714 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.705 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 19.2 ttmm -98.42 94.93 6.99 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . 0.465 ' HD2' ' H ' ' A' ' 769' ' ' LYS . 0.0 OUTLIER -71.23 -30.3 66.17 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.952 -177.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.83 123.24 20.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.558 0.694 . . . . 0.0 110.915 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.705 ' CD2' ' HD2' ' A' ' 768' ' ' LYS . 14.2 m-85 -101.51 156.51 17.43 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.709 -174.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -98.7 156.12 16.99 Favored 'General case' 0 C--N 1.281 -2.393 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.011 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.641 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 47.5 t60 -59.16 137.47 57.95 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.238 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 84.93 12.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 O-C-N 125.633 1.833 . . . . 0.0 109.746 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 58.7 m -87.32 117.78 26.32 Favored 'General case' 0 N--CA 1.41 -2.473 0 C-N-CA 119.208 -0.997 . . . . 0.0 108.783 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.502 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -91.96 107.37 19.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.701 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 5.6 pt -118.9 -175.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 17.3 ptp180 -147.13 128.5 14.88 Favored 'General case' 0 N--CA 1.399 -2.979 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 173.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.532 ' CD2' HG13 ' A' ' 801' ' ' VAL . 10.3 p90 -108.36 169.54 8.57 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . 0.572 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 15.3 ptt180 -144.81 154.18 42.41 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 173.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.572 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 5.5 t -96.76 158.61 15.35 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -65.69 -22.94 66.67 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -103.42 -1.35 47.2 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.606 175.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.572 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 5.0 mptp? -108.56 103.09 12.14 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 122.616 -0.344 . . . . 0.0 110.879 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.84 86.43 6.92 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.512 1.148 . . . . 0.0 108.528 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 157.31 145.27 4.16 Favored Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 52.6 m95 -92.34 145.23 24.64 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.517 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -97.79 -27.56 3.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.948 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 15.1 m170 72.53 123.61 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.842 1.257 . . . . 0.0 109.135 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.543 ' HA ' ' HD2' ' A' ' 799' ' ' PRO . 3.1 t -145.28 156.75 44.01 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.887 0.375 . . . . 0.0 111.142 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 34.7 t -118.95 135.04 60.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 C-N-CA 122.639 0.376 . . . . 0.0 110.132 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.3 t -69.97 118.79 13.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.641 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 47.2 mm -117.84 87.17 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 124.338 1.055 . . . . 0.0 108.526 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.471 HD22 HD22 ' A' ' 750' ' ' LEU . 6.8 t-20 42.9 67.69 0.59 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.373 1.069 . . . . 0.0 113.272 177.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 74.69 23.35 75.32 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 115.06 -0.973 . . . . 0.0 114.127 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -150.02 166.24 30.3 Favored 'General case' 0 C--O 1.197 -1.681 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.569 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 91.2 m95 -114.82 157.13 23.7 Favored 'General case' 0 C--N 1.264 -3.142 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -148.75 106.24 3.46 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . 0.543 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 38.0 Cg_endo -66.32 138.73 40.27 Favored 'Cis proline' 0 C--O 1.237 0.443 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.014 -0.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.569 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.9 tt0 -53.56 134.77 40.99 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.863 0.865 . . . . 0.0 110.888 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.532 HG13 ' CD2' ' A' ' 779' ' ' TYR . 57.9 t . . . . . 0 N--CA 1.434 -1.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.534 -176.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.4 m -73.44 -66.57 0.68 Allowed 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.17 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 124.57 -156.0 18.48 Favored Glycine 1 N--CA 1.363 -6.213 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -36.87 123.93 0.86 Allowed 'General case' 0 C--N 1.278 -2.534 0 O-C-N 126.52 1.953 . . . . 0.0 112.239 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.688 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -69.3 146.54 96.73 Favored Pre-proline 0 N--CA 1.415 -2.198 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.271 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.462 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 72.4 Cg_endo -72.08 -165.31 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.767 2.312 . . . . 0.0 112.444 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.68 161.42 35.18 Favored 'General case' 0 N--CA 1.394 -3.265 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 717' ' ' PHE . 21.7 tp -106.07 117.97 35.41 Favored 'General case' 1 C--N 1.244 -4.017 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.186 -177.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -33.55 -44.91 0.15 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.403 2.281 . . . . 0.0 115.288 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 91.5 m-70 -137.57 25.09 2.89 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -136.76 -142.19 4.39 Favored Glycine 0 CA--C 1.497 -1.044 0 C-N-CA 120.094 -1.051 . . . . 0.0 112.252 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.436 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -158.59 174.53 14.92 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -178.196 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.37 145.78 32.46 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 57.3 mm-40 -89.03 -80.76 0.29 Allowed 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.052 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 53.5 tp -160.6 151.46 18.7 Favored 'General case' 0 C--O 1.243 0.749 0 O-C-N 122.458 -0.151 . . . . 0.0 110.683 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.634 ' CB ' HG22 ' A' ' 715' ' ' VAL . 23.5 t -166.19 -54.29 0.03 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.434 0.693 . . . . 0.0 110.38 172.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 37.4 m 70.66 142.82 0.09 OUTLIER Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.916 1.686 . . . . 0.0 113.085 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.543 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 58.1 Cg_endo -63.63 176.53 2.21 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 123.809 3.006 . . . . 0.0 113.089 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.9 Cg_exo -77.15 -7.21 30.43 Favored 'Cis proline' 0 N--CA 1.498 1.737 0 N-CA-C 114.67 0.989 . . . . 0.0 114.67 3.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 58.9 m-85 74.41 82.21 0.11 Allowed 'General case' 0 C--N 1.309 -1.167 0 O-C-N 124.515 1.134 . . . . 0.0 110.333 177.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -86.24 173.51 9.72 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.35 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -69.37 135.2 50.0 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.85 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.21 -18.69 57.02 Favored Glycine 0 N--CA 1.422 -2.278 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.207 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.22 155.15 40.28 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.228 0.537 . . . . 0.0 111.588 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 11.8 m -135.86 157.15 47.54 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.663 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.688 HG21 HG21 ' A' ' 694' ' ' ILE . 23.5 t -137.64 129.3 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 41.6 mt-10 -77.16 138.05 39.25 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 123.675 0.609 . . . . 0.0 111.733 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.586 ' HB3' HD22 ' A' ' 697' ' ' LEU . 32.7 m-85 -140.53 129.97 23.95 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 124.483 1.113 . . . . 0.0 108.698 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.451 ' O ' HD23 ' A' ' 697' ' ' LEU . 10.9 m-80 -138.05 -164.81 1.68 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 10.8 m -118.99 139.74 51.18 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 6.1 m -62.49 -79.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 O-C-N 123.65 0.594 . . . . 0.0 111.613 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -148.11 161.93 40.43 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 66.6 m 71.03 -6.36 1.32 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.516 1.135 . . . . 0.0 112.859 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.547 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 93.8 m-85 -131.74 146.57 52.23 Favored 'General case' 0 N--CA 1.392 -3.361 0 CA-C-O 121.88 0.848 . . . . 0.0 108.959 -175.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.651 HG21 HD21 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -116.68 143.82 45.18 Favored 'General case' 1 C--N 1.241 -4.129 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.204 179.873 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.546 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.7 ttp -86.22 123.92 32.04 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.557 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 45.0 mm -121.44 137.45 55.06 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 113.17 -90.76 0.55 Allowed Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.562 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 27.6 t60 -159.95 143.35 14.07 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.546 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.8 ppt_? -81.67 17.18 1.52 Allowed 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -174.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 22.0 p -161.21 153.28 19.82 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.791 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.447 HG21 HD13 ' A' ' 741' ' ' LEU . 27.3 pt -104.85 168.61 2.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.407 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 11.3 m -138.32 135.56 35.53 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.447 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 9.5 t -83.67 105.11 14.32 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.44 0.638 . . . . 0.0 109.94 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -140.31 144.62 27.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 124.695 1.198 . . . . 0.0 110.344 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 69.75 -11.26 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.55 0.74 . . . . 0.0 112.673 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 113.37 10.77 14.52 Favored Glycine 0 C--O 1.242 0.617 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 738' ' ' TRP . 58.8 t -142.23 154.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.48 ' O ' HG12 ' A' ' 737' ' ' VAL . 95.5 m95 -78.76 172.53 13.6 Favored 'General case' 0 C--N 1.273 -2.727 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.211 170.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.407 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 39.9 p -74.09 -165.69 0.33 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.846 0.831 . . . . 0.0 111.211 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.5 OUTLIER -83.38 -3.03 57.14 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -166.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 3.9 mm? 72.79 157.25 0.16 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 124.15 0.906 . . . . 0.0 109.639 -174.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.562 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 26.2 Cg_endo -71.64 179.72 4.45 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.232 1.288 . . . . 0.0 110.825 171.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 52.0 tt0 -117.36 105.4 12.12 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 724' ' ' THR . 95.4 m -89.43 103.51 16.14 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 121.397 0.617 . . . . 0.0 110.236 177.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 747' ' ' ILE . 34.7 t -97.92 144.32 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.022 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.547 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.93 5.2 0.35 Allowed 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 125.73 1.612 . . . . 0.0 113.531 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 1.029 ' HA ' HD22 ' A' ' 750' ' ' LEU . 59.0 mt 77.15 -17.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 125.932 1.693 . . . . 0.0 111.239 176.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 746' ' ' ALA . 3.2 t70 -75.86 -31.76 59.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.517 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -103.29 21.65 15.53 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.243 -173.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 1.029 HD22 ' HA ' ' A' ' 747' ' ' ILE . 0.4 OUTLIER -85.36 -177.88 6.59 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 113.83 -1.532 . . . . 0.0 107.778 175.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.611 ' HB3' ' N ' ' A' ' 795' ' ' GLY . 39.0 tptt -98.19 161.33 13.76 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 14.5 mmmm -101.96 112.7 25.42 Favored 'General case' 1 C--N 1.233 -4.493 0 CA-C-N 112.237 -2.256 . . . . 0.0 107.452 -177.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 150.07 41.15 Favored 'General case' 0 C--N 1.257 -3.419 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.184 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 769' ' ' LYS . 88.4 tttt -126.94 136.77 52.73 Favored 'General case' 0 C--N 1.258 -3.391 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.69 -174.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 46.6 p -63.78 112.89 3.08 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.622 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.654 ' HB2' HG12 ' A' ' 759' ' ' ILE . 49.1 m -61.94 133.5 55.47 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 173.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.13 4.31 8.81 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.026 0.917 . . . . 0.0 111.134 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.19 -21.88 16.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.978 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 756' ' ' SER . 31.3 pt -103.27 167.97 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.401 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.837 -174.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.39 130.73 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.248 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.525 HD12 HD12 ' A' ' 777' ' ' ILE . 1.9 mm? -108.95 -177.12 3.22 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . 0.819 ' HB2' HD23 ' A' ' 765' ' ' LEU . 40.3 mt-10 -72.04 175.15 6.17 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.49 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . 0.425 ' HA ' ' HE2' ' A' ' 766' ' ' LYS . 40.9 mt-10 -77.84 4.59 11.47 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -171.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . 0.525 ' HB2' HD22 ' A' ' 765' ' ' LEU . 16.5 m-70 -108.13 -22.26 12.45 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 171.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.819 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.6 mm? -101.37 -13.18 18.11 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.681 -168.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 763' ' ' GLU . 50.6 mtmt -75.59 -19.92 58.93 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -85.25 -3.76 58.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.243 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.48 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 9.9 tppt? -106.12 107.5 18.53 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 754' ' ' LYS . 38.0 ttpt -85.82 -37.63 19.02 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . 0.424 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 47.2 mt-10 -117.48 118.02 31.05 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.511 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.48 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 66.6 m-85 -102.56 174.44 5.9 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.46 167.68 10.52 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.858 ' HB3' HD23 ' A' ' 750' ' ' LEU . 19.2 t60 -70.48 151.33 45.23 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 8.0 t30 83.36 3.17 0.95 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.998 1.436 . . . . 0.0 109.225 177.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 66.7 m -82.14 112.64 19.37 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.567 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -88.89 109.89 20.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.525 HD12 HD12 ' A' ' 761' ' ' LEU . 9.5 pt -126.15 178.19 4.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.631 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 25.6 ptt180 -131.55 128.96 40.34 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -118.03 169.16 9.89 Favored 'General case' 0 C--O 1.259 1.576 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -150.72 157.11 42.56 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 35.6 t -81.98 159.48 23.54 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -69.53 -23.3 63.57 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.762 0.315 . . . . 0.0 111.137 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -102.97 -9.03 40.79 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.813 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.3 mptt -115.89 122.89 46.69 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.915 0.358 . . . . 0.0 110.158 -177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -95.87 99.61 11.39 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.53 0.681 . . . . 0.0 109.886 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 159.78 143.22 3.6 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.631 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 34.6 m95 -98.79 144.78 27.64 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 117.402 0.601 . . . . 0.0 109.838 -174.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 788' ' ' ILE . 3.6 mp -99.17 -31.32 3.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.009 -177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 12.4 m170 72.23 120.1 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 124.414 1.086 . . . . 0.0 110.152 -174.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.427 HG21 ' CG1' ' A' ' 801' ' ' VAL . 3.5 t -139.19 156.58 47.01 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.094 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 71.0 t -118.08 130.31 73.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 773' ' ' HIS . 49.0 t -66.55 134.63 52.76 Favored 'General case' 0 CA--C 1.479 -1.769 0 C-N-CA 118.841 -1.144 . . . . 0.0 109.299 176.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . 0.589 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 49.4 mm -124.68 90.3 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.924 HD22 ' HG ' ' A' ' 750' ' ' LEU . 18.7 t-20 44.22 73.5 0.15 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.001 0.92 . . . . 0.0 112.471 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . 0.611 ' N ' ' HB3' ' A' ' 751' ' ' LYS . . . 77.8 -11.23 21.38 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.615 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 68.4 ttt180 -117.33 178.11 4.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -175.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.598 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 99.0 m95 -122.08 162.02 21.99 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 117.761 0.255 . . . . 0.0 110.779 178.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -148.23 105.0 3.56 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.446 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -67.42 138.5 42.54 Favored 'Cis proline' 0 C--O 1.247 0.972 0 C-N-CA 123.791 -1.337 . . . . 0.0 111.344 -1.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.598 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 13.6 tt0 -55.02 119.1 4.93 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.068 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.427 ' CG1' HG21 ' A' ' 790' ' ' THR . 16.6 m . . . . . 0 N--CA 1.38 -3.945 0 C-N-CA 123.73 0.812 . . . . 0.0 112.487 -173.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.443 -0.779 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 65.1 m -72.28 -75.97 0.12 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.026 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 141.37 -145.24 15.63 Favored Glycine 1 N--CA 1.379 -5.163 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -53.02 133.65 38.38 Favored 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 125.369 1.468 . . . . 0.0 111.814 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.685 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -76.05 148.1 81.04 Favored Pre-proline 0 N--CA 1.41 -2.474 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.885 176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.456 ' HG2' HD21 ' A' ' 741' ' ' LEU . 53.5 Cg_endo -71.04 -163.72 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.347 2.698 . . . . 0.0 112.625 176.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -148.76 169.58 20.13 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.635 HD13 ' SG ' ' A' ' 744' ' ' CYS . 17.0 mt -102.77 146.44 28.25 Favored 'General case' 0 C--N 1.27 -2.851 0 O-C-N 123.792 0.682 . . . . 0.0 111.197 175.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.62 -37.69 87.3 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.168 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 744' ' ' CYS . 96.0 m-70 -140.06 27.8 2.15 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.04 0.448 . . . . 0.0 110.688 -177.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -140.65 -146.02 4.72 Favored Glycine 0 C--N 1.297 -1.615 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.459 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -156.58 171.84 19.62 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 117.216 0.508 . . . . 0.0 111.305 -179.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.23 144.86 33.41 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' A' ' 703' ' ' GLN . 13.7 mt-30 -73.36 -79.75 0.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.21 0.318 . . . . 0.0 111.197 177.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 8.3 tt 172.67 130.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.63 ' CB ' HG22 ' A' ' 715' ' ' VAL . 22.7 t -131.18 -32.67 1.57 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.653 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 32.9 t 74.3 124.07 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.04 1.336 . . . . 0.0 112.41 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 37.3 Cg_endo -61.24 176.7 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.891 3.061 . . . . 0.0 111.564 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 13.3 Cg_exo -71.72 -18.86 14.12 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 N-CA-C 114.626 0.972 . . . . 0.0 114.626 4.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.451 ' HE1' ' HB3' ' A' ' 705' ' ' SER . 45.6 m-85 83.29 90.6 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.119 0 O-C-N 124.771 1.294 . . . . 0.0 110.885 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -91.93 176.03 6.66 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.205 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -72.71 136.86 45.65 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.028 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 93.02 -10.82 73.24 Favored Glycine 0 N--CA 1.417 -2.63 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.428 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.61 150.87 44.25 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 14.2 m -138.69 148.96 44.6 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.685 HG21 HG21 ' A' ' 694' ' ' ILE . 21.2 t -130.27 130.38 65.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 41.3 mt-10 -89.58 135.91 33.33 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 123.658 0.599 . . . . 0.0 111.269 -177.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.606 ' HD2' ' HG ' ' A' ' 697' ' ' LEU . 25.7 m-85 -132.23 132.34 42.99 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 124.521 1.128 . . . . 0.0 109.053 -177.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.459 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 8.0 m-80 -137.97 -162.68 1.33 Allowed 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 7.6 m -120.0 140.41 51.0 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 43.1 t -50.6 -72.44 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 O-C-N 124.216 0.948 . . . . 0.0 110.909 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.28 163.2 4.54 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 173.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 73.9 m 67.41 16.99 10.1 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 124.189 0.93 . . . . 0.0 111.271 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.712 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 87.4 m-85 -147.38 149.13 32.16 Favored 'General case' 0 N--CA 1.405 -2.703 0 C-N-CA 125.976 1.71 . . . . 0.0 107.685 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.1 m -117.5 144.93 44.57 Favored 'General case' 0 C--N 1.278 -2.522 0 O-C-N 123.805 0.69 . . . . 0.0 110.58 -176.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.5 ttp -99.1 123.32 43.31 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 123.564 0.745 . . . . 0.0 109.685 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.45 HD11 ' ND2' ' A' ' 794' ' ' ASN . 48.8 mm -121.14 143.68 32.64 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 114.4 -89.42 0.51 Allowed Glycine 0 C--N 1.3 -1.429 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.487 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 53.0 t60 -169.03 141.4 2.64 Favored 'General case' 0 CA--C 1.475 -1.921 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.498 ' H ' ' HD2' ' A' ' 729' ' ' ARG . 0.7 OUTLIER -82.64 20.26 1.16 Allowed 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -172.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 2.8 p -162.53 159.34 24.71 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.812 -0.555 . . . . 0.0 112.14 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.48 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 39.4 pt -120.09 163.56 17.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.003 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 20.9 m -136.0 137.7 41.49 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 2.4 t -85.76 108.38 18.05 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.105 0.478 . . . . 0.0 110.003 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.24 143.09 21.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 124.811 1.245 . . . . 0.0 109.624 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 68.46 -1.09 2.0 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.212 0.605 . . . . 0.0 112.599 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.21 19.33 30.88 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 738' ' ' TRP . 24.9 t -141.62 150.99 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.461 ' O ' HG12 ' A' ' 737' ' ' VAL . 96.8 m95 -80.65 170.3 16.51 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 121.712 -0.618 . . . . 0.0 109.66 168.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 40.6 p -77.14 -166.49 0.72 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.521 0.677 . . . . 0.0 112.001 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.408 ' H ' ' HB ' ' A' ' 739' ' ' THR . 0.6 OUTLIER -73.96 -15.71 61.1 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -167.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.456 HD21 ' HG2' ' A' ' 695' ' ' PRO . 2.3 mt 68.85 151.53 0.13 Allowed Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.487 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 56.4 Cg_endo -75.74 179.26 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.332 2.021 . . . . 0.0 111.347 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -126.08 114.61 18.63 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.635 ' SG ' HD13 ' A' ' 697' ' ' LEU . 77.7 m -93.64 114.77 27.17 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 122.073 0.939 . . . . 0.0 110.278 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 1.071 HG11 HD21 ' A' ' 750' ' ' LEU . 11.8 p -97.4 159.77 3.08 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.279 0 CA-C-N 113.071 -1.877 . . . . 0.0 108.91 -178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.712 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -80.5 -1.83 43.42 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.869 -177.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.627 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 18.2 mt 77.41 -20.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 125.526 1.53 . . . . 0.0 111.701 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 746' ' ' ALA . 32.8 t70 -84.56 -19.25 33.42 Favored 'General case' 0 C--N 1.253 -3.614 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.19 -171.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -113.03 30.14 7.42 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.142 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 1.071 HD21 HG11 ' A' ' 745' ' ' VAL . 57.0 mt -89.05 -170.26 2.83 Favored 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.355 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.46 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 58.9 mtpt -128.16 154.08 46.17 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . 0.463 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 93.3 mttt -100.97 145.97 27.99 Favored 'General case' 0 C--N 1.248 -3.828 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.301 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 89.3 m -89.15 160.15 17.14 Favored 'General case' 1 C--N 1.235 -4.376 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.419 179.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -118.7 133.19 56.03 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.77 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 42.3 t -59.17 116.21 3.71 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.716 ' HB2' HG13 ' A' ' 759' ' ' ILE . 18.4 m -79.36 135.14 36.63 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -76.14 4.36 8.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.745 0.783 . . . . 0.0 112.126 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.4 -14.63 14.82 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.279 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.716 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.3 pp -114.06 151.39 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 121.262 0.553 . . . . 0.0 111.319 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.32 134.15 52.26 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.545 HD12 HD12 ' A' ' 777' ' ' ILE . 1.9 mm? -110.24 171.83 7.22 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . 0.416 ' HG3' ' HB2' ' A' ' 778' ' ' ARG . 44.1 mt-10 -55.18 153.27 7.0 Favored 'General case' 0 C--O 1.208 -1.088 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.99 -2.97 14.14 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 118.245 0.475 . . . . 0.0 112.045 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -83.22 -37.5 23.51 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.671 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 96.8 mt -93.31 -16.46 24.69 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.599 -172.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -75.9 2.21 13.07 Favored 'General case' 1 N--CA 1.369 -4.49 0 CA-C-O 122.127 0.965 . . . . 0.0 110.188 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -120.1 9.34 11.13 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.175 173.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -102.89 130.05 49.8 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -95.71 -38.35 10.39 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-O 122.441 1.115 . . . . 0.0 108.119 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -129.55 129.43 44.46 Favored 'General case' 0 N--CA 1.409 -2.517 0 CA-C-N 113.283 -1.78 . . . . 0.0 109.749 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.546 ' CE2' HD22 ' A' ' 765' ' ' LEU . 73.3 m-85 -105.94 142.47 35.6 Favored 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.955 -177.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.7 155.59 18.18 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -49.23 152.01 1.29 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.065 0.946 . . . . 0.0 111.607 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 67.71 4.93 4.14 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.715 0.806 . . . . 0.0 111.376 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 8.2 t -81.23 111.76 17.93 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.444 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.8 OUTLIER -81.85 112.69 19.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.671 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.5 pt -123.71 174.2 8.3 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.712 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 95.4 mtt180 -125.93 128.93 48.3 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 174.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.605 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 6.3 p90 -120.0 167.35 12.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -147.76 157.14 43.4 Favored 'General case' 0 C--N 1.267 -2.991 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 17.3 t -93.58 147.18 23.23 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -73.78 -12.35 60.67 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.084 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -112.93 0.68 25.73 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.894 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 1.2 mptm? -118.16 -50.71 2.46 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 72.78 140.18 0.06 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.25 1.02 . . . . 0.0 110.768 -174.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 103.17 140.75 11.01 Favored Glycine 0 CA--C 1.493 -1.316 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.55 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 29.3 m95 -89.6 143.27 26.95 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.052 0.453 . . . . 0.0 111.373 -171.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.605 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -102.95 -26.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.013 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.417 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 17.6 m170 71.9 119.16 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.948 0 C-N-CA 124.033 0.933 . . . . 0.0 110.733 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.1 t -143.13 157.42 44.53 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.64 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 47.5 t -119.67 135.24 60.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.57 114.18 10.41 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.668 0.747 . . . . 0.0 110.168 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.6 mm -112.66 82.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 C-N-CA 124.04 0.936 . . . . 0.0 108.494 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.593 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 51.32 67.74 0.9 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.76 176.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 78.95 3.05 87.75 Favored Glycine 0 C--N 1.299 -1.514 0 C-N-CA 120.299 -0.953 . . . . 0.0 114.334 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -134.03 167.89 19.8 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.598 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 87.3 m95 -113.92 158.79 20.64 Favored 'General case' 0 C--N 1.26 -3.298 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -149.0 107.61 3.43 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 41.0 Cg_endo -71.18 142.12 71.89 Favored 'Cis proline' 0 C--O 1.246 0.889 0 C-N-CA 123.552 -1.436 . . . . 0.0 112.687 -0.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.598 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 43.9 mt-10 -53.58 126.89 23.3 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.637 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.44 ' HA ' ' CE2' ' A' ' 779' ' ' TYR . 7.7 m . . . . . 1 N--CA 1.363 -4.825 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 45.0 m -64.69 -71.91 0.17 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.75 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 134.84 -164.5 24.71 Favored Glycine 1 N--CA 1.367 -5.952 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -43.17 119.68 1.62 Allowed 'General case' 0 C--N 1.276 -2.613 0 C-N-CA 126.173 1.789 . . . . 0.0 111.552 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.646 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -58.28 149.32 59.23 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.482 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.515 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 70.6 Cg_endo -71.01 -163.89 0.14 Allowed 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 123.001 2.467 . . . . 0.0 111.818 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.63 154.91 51.17 Favored 'General case' 0 N--CA 1.393 -3.322 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.615 HD22 ' HB3' ' A' ' 717' ' ' PHE . 18.7 tp -98.61 127.35 44.51 Favored 'General case' 0 C--N 1.25 -3.74 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.433 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.57 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 6.8 pt-20 -38.41 -61.01 0.73 Allowed 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 127.094 2.158 . . . . 0.0 114.349 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.791 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.2 m-70 -128.02 26.82 5.76 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -131.82 -155.06 7.92 Favored Glycine 0 N--CA 1.424 -2.115 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.405 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.45 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -145.48 174.28 11.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.639 0.257 . . . . 0.0 110.641 -175.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.83 137.17 46.31 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -86.11 -77.65 0.3 Allowed 'General case' 0 N--CA 1.427 -1.577 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.524 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . 0.629 HD13 ' N ' ' A' ' 705' ' ' SER . 1.9 tm? -167.72 163.1 14.25 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.629 ' N ' HD13 ' A' ' 704' ' ' LEU . 46.7 t -178.36 -62.71 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.402 1.481 . . . . 0.0 109.191 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 50.6 m 67.85 153.52 0.13 Allowed Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 125.155 1.382 . . . . 0.0 112.238 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.477 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 56.4 Cg_endo -62.95 171.94 5.45 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 123.015 2.477 . . . . 0.0 112.69 -175.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.616 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 1.9 Cg_endo -75.46 -8.18 25.04 Favored 'Cis proline' 0 N--CA 1.488 1.156 0 N-CA-C 115.235 1.206 . . . . 0.0 115.235 5.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 58.7 m-85 69.14 60.29 0.33 Allowed 'General case' 0 C--N 1.313 -0.983 0 O-C-N 124.297 0.998 . . . . 0.0 109.062 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.616 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 37.0 m-85 -68.04 173.33 4.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.429 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -72.33 136.64 46.25 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.178 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.64 -18.88 56.58 Favored Glycine 0 C--N 1.286 -2.217 0 C-N-CA 120.422 -0.894 . . . . 0.0 110.876 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 143.14 55.21 Favored 'General case' 0 CA--C 1.478 -1.79 0 CA-C-O 121.348 0.594 . . . . 0.0 110.017 178.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 16.0 m -124.58 157.27 35.83 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.054 178.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.646 HG21 HG21 ' A' ' 694' ' ' ILE . 33.1 t -137.03 133.69 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -80.85 130.72 35.2 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 123.835 0.709 . . . . 0.0 110.901 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.615 ' HB3' HD22 ' A' ' 697' ' ' LEU . 27.6 m-85 -137.09 116.93 13.12 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 125.018 1.327 . . . . 0.0 108.232 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.45 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 4.5 m-80 -127.23 -167.75 1.78 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 24.3 m -112.43 135.44 53.12 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 24.8 t -52.57 -67.63 0.24 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 124.187 0.929 . . . . 0.0 111.724 -170.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -171.32 156.88 4.77 Favored 'General case' 0 CA--C 1.476 -1.889 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 75.0 m 66.64 14.3 9.7 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 124.404 1.065 . . . . 0.0 111.242 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.548 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 85.0 m-85 -140.12 145.47 37.62 Favored 'General case' 0 N--CA 1.404 -2.755 0 C-N-CA 124.823 1.249 . . . . 0.0 108.596 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 5.5 t -97.59 151.71 19.79 Favored 'General case' 0 C--N 1.252 -3.631 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.764 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.4 ttp -108.72 118.39 36.66 Favored 'General case' 0 C--N 1.263 -3.155 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.489 HG12 HG23 ' A' ' 724' ' ' THR . 41.9 mm -121.86 135.38 62.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 118.7 -81.85 0.33 Allowed Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 121.422 -0.418 . . . . 0.0 112.323 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.465 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 43.3 t60 -171.05 138.33 1.26 Allowed 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.764 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.3 ppt_? -84.94 19.65 2.06 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 2.7 p -156.51 159.76 38.89 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.32 0.581 . . . . 0.0 112.119 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.499 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 36.1 pt -116.89 164.71 12.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.754 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 21.5 m -139.61 136.1 34.01 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.223 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 9.1 t -83.08 107.25 15.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.316 0.579 . . . . 0.0 109.765 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . 0.51 HD13 ' HD2' ' A' ' 735' ' ' HIS . 1.5 pp -145.46 151.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 124.721 1.208 . . . . 0.0 109.839 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . 0.51 ' HD2' HD13 ' A' ' 734' ' ' ILE . 82.6 m-70 73.61 -51.01 0.7 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.346 1.059 . . . . 0.0 110.625 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 148.45 34.28 0.05 OUTLIER Glycine 0 C--N 1.299 -1.489 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.0 p -165.85 159.49 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.515 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.9 m95 -77.63 175.6 9.74 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 172.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 18.3 p -80.12 -171.1 2.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.047 0.927 . . . . 0.0 112.658 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.7 OUTLIER -63.55 -15.77 58.94 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -172.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.6 mm? 69.59 141.65 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.465 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 32.8 Cg_endo -67.05 177.22 3.8 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.115 1.876 . . . . 0.0 112.035 174.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -121.84 129.73 52.84 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.791 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 73.8 m -113.84 103.8 11.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.11 0.481 . . . . 0.0 110.726 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.46 ' HB ' HG22 ' A' ' 724' ' ' THR . 46.6 t -97.27 143.7 12.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.548 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -60.49 2.33 0.1 Allowed 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 126.236 1.814 . . . . 0.0 115.293 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.828 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 19.4 mt 75.75 -13.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 C-N-CA 125.625 1.57 . . . . 0.0 111.956 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 746' ' ' ALA . 17.2 t70 -87.25 -25.88 23.75 Favored 'General case' 0 C--N 1.272 -2.772 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.533 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -103.09 20.53 17.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.358 -176.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.828 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 49.5 mt -84.53 -167.13 1.67 Allowed 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.773 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.52 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 10.2 mtpm? -130.0 154.41 47.42 Favored 'General case' 0 N--CA 1.381 -3.915 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.505 -177.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . 0.698 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 55.2 mtpt -105.71 120.71 42.39 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 113.269 -1.787 . . . . 0.0 109.317 -175.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 56.0 m -74.34 159.05 32.91 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.403 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 754' ' ' LYS . 18.3 ptpt -132.32 151.49 51.82 Favored 'General case' 0 N--CA 1.401 -2.885 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.699 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 30.6 t -63.35 121.54 14.0 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.54 -1.663 . . . . 0.0 109.956 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.821 ' HB3' HG13 ' A' ' 759' ' ' ILE . 28.2 t -74.63 155.02 38.26 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.99 -1.4 57.27 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.09 -20.13 21.6 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.794 0.807 . . . . 0.0 109.08 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.821 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.5 pp -111.66 159.68 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.435 -177.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 19.9 mt -118.67 129.04 75.47 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.924 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.661 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.528 HD12 HD12 ' A' ' 777' ' ' ILE . 1.8 mm? -105.6 -176.94 3.22 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . 0.858 ' HB2' HD23 ' A' ' 765' ' ' LEU . 41.1 mt-10 -59.66 151.78 24.06 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -72.25 1.19 8.09 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -171.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . 0.545 ' HB2' HD22 ' A' ' 765' ' ' LEU . 8.8 m-70 -90.51 -43.47 10.21 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 168.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.858 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.3 mm? -78.5 -11.57 59.96 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.001 -168.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -67.82 -18.69 64.92 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.79 13.38 24.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.563 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -113.16 110.96 21.29 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -83.55 -34.82 25.14 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.072 -1.051 . . . . 0.0 109.372 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . 0.698 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 45.3 mt-10 -128.83 135.56 49.29 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.757 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -115.49 142.65 46.43 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.387 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.19 163.67 18.56 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -62.4 150.5 39.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.438 0.161 . . . . 0.0 110.758 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 81.24 6.6 1.26 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.027 1.331 . . . . 0.0 110.345 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 38.9 m -80.68 105.72 12.14 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.427 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.8 OUTLIER -86.42 101.87 13.53 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 761' ' ' LEU . 11.9 pt -113.25 -174.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 121.832 0.825 . . . . 0.0 109.376 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.616 ' HA ' ' HA ' ' A' ' 789' ' ' HIS . 19.9 ptt180 -139.24 134.79 33.16 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.542 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 11.0 p90 -123.44 166.33 15.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -147.4 154.85 41.37 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.507 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 0.8 OUTLIER -82.58 146.9 28.91 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-O 121.047 0.451 . . . . 0.0 111.943 178.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -64.26 103.78 0.67 Allowed 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 110.73 -7.9 29.83 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.476 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.507 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 0.8 OUTLIER -119.41 113.59 21.02 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -89.3 90.06 8.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.618 0.723 . . . . 0.0 110.975 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 172.02 141.78 3.51 Favored Glycine 0 CA--C 1.487 -1.674 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.607 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 44.5 m95 -101.53 145.44 29.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.992 0.396 . . . . 0.0 110.127 -174.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.542 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -100.04 -28.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.013 -178.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 25.6 m170 74.43 133.66 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.602 1.161 . . . . 0.0 108.911 -176.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.6 t -156.44 155.21 31.69 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 120.703 0.287 . . . . 0.0 111.154 178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.96 137.6 53.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.3 t -70.59 113.97 8.23 Favored 'General case' 0 C--O 1.255 1.377 0 CA-C-O 121.658 0.742 . . . . 0.0 110.359 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 47.4 mm -114.25 80.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 124.32 1.048 . . . . 0.0 109.317 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.567 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 52.2 65.57 1.47 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.77 175.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.87 21.2 79.52 Favored Glycine 0 C--N 1.303 -1.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.97 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -146.64 164.33 33.01 Favored 'General case' 0 C--O 1.202 -1.408 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.677 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.7 m95 -111.58 157.68 20.1 Favored 'General case' 0 C--N 1.246 -3.926 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -144.12 105.89 4.83 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 38.2 Cg_endo -70.14 139.03 53.31 Favored 'Cis proline' 0 C--O 1.248 1.006 0 C-N-CA 123.725 -1.365 . . . . 0.0 110.919 -0.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.677 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 26.5 tt0 -56.42 124.05 16.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 779' ' ' TYR . 14.0 m . . . . . 1 N--CA 1.371 -4.381 0 C-N-CA 124.391 1.077 . . . . 0.0 110.585 -175.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 59.7 m -68.02 -65.12 0.73 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 94.21 134.67 7.44 Favored Glycine 0 N--CA 1.42 -2.394 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.262 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 37.8 t70 46.28 101.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.134 1.774 . . . . 0.0 113.508 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.681 HG21 HG21 ' A' ' 715' ' ' VAL . 1.8 pp -59.34 151.33 59.72 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.289 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.438 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 37.7 Cg_endo -68.28 -157.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 123.039 2.492 . . . . 0.0 112.517 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.12 160.52 37.54 Favored 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.608 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.3 OUTLIER -99.16 133.05 43.99 Favored 'General case' 0 C--N 1.259 -3.356 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -49.06 -39.47 27.7 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 124.406 1.082 . . . . 0.0 113.689 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.402 ' HB3' ' CE1' ' A' ' 723' ' ' PHE . 90.4 m-70 -143.21 28.05 1.54 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.129 0.49 . . . . 0.0 110.264 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.608 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -141.59 -146.05 4.64 Favored Glycine 0 C--N 1.299 -1.511 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.066 -177.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.441 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -151.08 -175.56 5.2 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -176.439 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -117.5 142.83 46.7 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -74.13 -78.2 0.1 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.204 0.526 . . . . 0.0 110.785 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.3 tt -149.87 130.41 13.95 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.527 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 67.9 p -117.65 -70.83 0.77 Allowed 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -176.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . 0.416 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 23.3 t 64.16 123.99 0.02 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 125.696 1.598 . . . . 0.0 112.559 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.543 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 41.2 Cg_endo -63.66 176.0 2.54 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.456 2.771 . . . . 0.0 111.682 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 6.0 Cg_exo -77.6 -10.28 32.26 Favored 'Cis proline' 0 CA--C 1.504 -1.002 0 N-CA-C 115.017 1.122 . . . . 0.0 115.017 5.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.527 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 56.7 m-85 72.56 78.74 0.15 Allowed 'General case' 0 C--O 1.245 0.868 0 O-C-N 124.248 0.967 . . . . 0.0 110.005 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.407 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 29.9 m-85 -85.48 171.51 11.71 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.492 0.663 . . . . 0.0 112.469 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -67.33 133.31 49.41 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.697 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.11 68.09 Favored Glycine 0 N--CA 1.418 -2.522 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.19 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.17 145.36 44.29 Favored 'General case' 0 CA--C 1.493 -1.214 0 O-C-N 122.085 -0.656 . . . . 0.0 110.706 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 14.2 m -131.07 151.04 51.85 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.681 HG21 HG21 ' A' ' 694' ' ' ILE . 34.4 t -134.99 140.1 45.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -85.64 123.44 31.05 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 124.128 0.893 . . . . 0.0 111.6 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -124.36 105.55 9.53 Favored 'General case' 0 C--N 1.273 -2.759 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.441 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 11.4 m-80 -113.37 -162.68 0.81 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 5.0 m -113.47 134.44 54.66 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -178.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 39.5 t -65.64 -64.02 0.96 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 123.689 0.618 . . . . 0.0 110.87 -172.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -164.68 156.31 15.57 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 73.9 m 69.78 1.94 3.63 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.303 1.002 . . . . 0.0 113.171 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.573 ' HB2' ' HB3' ' A' ' 719' ' ' CYS . 98.1 m-85 -134.14 147.43 50.81 Favored 'General case' 0 N--CA 1.403 -2.795 0 C-N-CA 123.75 0.82 . . . . 0.0 109.078 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.521 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -113.5 138.13 50.57 Favored 'General case' 0 C--N 1.264 -3.122 0 C-N-CA 125.546 1.539 . . . . 0.0 110.445 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.498 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.7 ttp -86.64 121.93 29.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.65 1.18 . . . . 0.0 109.348 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 726' ' ' ILE . 31.7 mm -111.87 127.4 69.08 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.973 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.132 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 99.2 -82.97 0.58 Allowed Glycine 0 CA--C 1.481 -2.051 0 CA-C-N 114.645 -1.162 . . . . 0.0 112.253 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 30.3 p-80 -147.04 178.02 8.7 Favored 'General case' 0 N--CA 1.388 -3.55 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -174.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.498 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.2 OUTLIER -128.15 6.4 5.91 Favored 'General case' 0 C--O 1.2 -1.546 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.637 -177.41 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 3.1 p -126.54 160.1 31.58 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 119.07 -1.052 . . . . 0.0 113.732 -172.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.476 HG21 HD13 ' A' ' 741' ' ' LEU . 36.6 pt -119.66 159.51 20.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.106 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 14.6 m -134.77 135.28 41.74 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.791 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 7.6 t -86.01 104.13 15.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.156 0.503 . . . . 0.0 109.953 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.7 pp -144.69 147.45 19.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 124.655 1.182 . . . . 0.0 110.037 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 64.9 4.07 2.31 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 96.81 24.87 12.41 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.14 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.04 162.22 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.438 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.3 m95 -80.29 173.08 12.96 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.518 ' HB ' ' NE2' ' A' ' 740' ' ' GLN . 23.6 p -78.8 -162.44 0.38 Allowed 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.837 0.827 . . . . 0.0 112.42 -177.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.629 ' NE2' ' H ' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -84.89 2.01 44.58 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 124.453 1.101 . . . . 0.0 113.575 -167.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 731' ' ' ILE . 4.1 mm? 71.21 155.87 0.16 Allowed Pre-proline 0 N--CA 1.483 1.215 0 O-C-N 123.667 0.605 . . . . 0.0 111.557 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.421 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 38.1 Cg_endo -80.24 -173.58 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.219 1.946 . . . . 0.0 111.963 173.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -123.15 104.62 9.29 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 122.359 -0.213 . . . . 0.0 110.533 -176.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 724' ' ' THR . 86.8 m -96.99 114.35 25.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.106 0.479 . . . . 0.0 110.776 172.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.681 ' HB ' HD21 ' A' ' 750' ' ' LEU . 58.8 t -108.29 146.79 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . 0.565 ' O ' ' HB ' ' A' ' 747' ' ' ILE . . . -64.74 2.52 0.67 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 125.726 1.611 . . . . 0.0 114.201 -175.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.784 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 37.1 mt 78.14 -24.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 125.482 1.513 . . . . 0.0 111.544 175.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 748' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 746' ' ' ALA . 28.7 t70 -81.4 -24.32 37.04 Favored 'General case' 0 C--N 1.258 -3.389 0 CA-C-N 112.893 -1.958 . . . . 0.0 109.248 -172.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 749' ' ' LYS . . . . . 0.456 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 1.7 ptmm? -115.46 23.6 12.26 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.919 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.787 HD12 ' CD2' ' A' ' 773' ' ' HIS . 55.1 mt -81.41 -168.88 2.03 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.442 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 751' ' ' LYS . . . . . 0.584 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 30.0 mtpp -122.63 158.43 30.02 Favored 'General case' 0 N--CA 1.396 -3.167 0 CA-C-O 121.836 0.827 . . . . 0.0 109.085 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -110.25 138.23 46.91 Favored 'General case' 0 C--N 1.245 -3.939 0 CA-C-N 113.184 -1.825 . . . . 0.0 107.943 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 753' ' ' CYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 78.2 m -85.39 178.99 7.26 Favored 'General case' 0 C--N 1.252 -3.649 0 CA-C-N 113.416 -1.72 . . . . 0.0 110.517 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -140.87 141.54 34.61 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 755' ' ' SER . . . . . 0.449 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 5.4 p -62.78 128.35 35.52 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 123.622 0.576 . . . . 0.0 110.467 173.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 756' ' ' SER . . . . . 0.601 ' HB2' ' CG1' ' A' ' 759' ' ' ILE . 9.5 m -75.35 162.99 27.91 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -89.76 -15.36 32.59 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 758' ' ' LEU . . . . . 0.414 HD22 ' NH2' ' A' ' 782' ' ' ARG . 40.2 mt -93.71 -18.43 22.12 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.66 0.743 . . . . 0.0 110.159 -174.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 759' ' ' ILE . . . . . 0.601 ' CG1' ' HB2' ' A' ' 756' ' ' SER . 2.4 pp -100.24 160.16 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.61 135.79 56.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 761' ' ' LEU . . . . . 0.468 HD11 HD13 ' A' ' 759' ' ' ILE . 1.8 mm? -110.29 -179.28 3.73 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 762' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 42.0 mt-10 -63.55 157.22 24.23 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.73 -18.43 64.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.209 0.528 . . . . 0.0 111.045 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -95.63 -0.12 52.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.922 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 765' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 765' ' ' LEU . 3.7 mm? -124.72 -11.78 7.2 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 57.1 mtmt -69.5 -21.05 63.71 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.546 0.689 . . . . 0.0 110.598 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -88.15 14.02 10.1 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.097 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 768' ' ' LYS . . . . . 0.528 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 12.0 tppt? -110.52 117.33 33.26 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.89 -43.1 20.4 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.72 117.59 23.78 Favored 'General case' 0 CA--C 1.483 -1.599 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.003 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 771' ' ' PHE . . . . . 0.528 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 88.3 m-85 -91.13 136.01 33.38 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -78.73 143.21 36.4 Favored 'General case' 0 C--N 1.276 -2.593 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.537 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 773' ' ' HIS . . . . . 0.787 ' CD2' HD12 ' A' ' 750' ' ' LEU . 47.9 p-80 -40.05 138.55 0.81 Allowed 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 124.948 1.299 . . . . 0.0 111.696 171.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 74.14 6.38 4.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.796 1.638 . . . . 0.0 113.279 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 70.5 m -75.38 116.69 16.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.458 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -86.01 102.16 13.56 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 777' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 761' ' ' LEU . 7.8 pt -113.93 179.56 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.676 0.751 . . . . 0.0 109.76 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 98.8 mtt180 -127.35 119.98 27.49 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 779' ' ' TYR . . . . . 0.691 ' CD2' HG13 ' A' ' 801' ' ' VAL . 13.5 p90 -105.58 164.14 12.13 Favored 'General case' 0 C--O 1.26 1.611 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 171.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -147.76 157.25 43.45 Favored 'General case' 0 C--N 1.263 -3.157 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 781' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 42.8 t -96.23 163.54 13.05 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -176.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 782' ' ' ARG . . . . . 0.414 ' NH2' HD22 ' A' ' 758' ' ' LEU . 21.3 ptt180 -82.57 -23.0 34.67 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 120.992 0.425 . . . . 0.0 110.356 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -94.15 -13.27 54.9 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.078 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 784' ' ' LYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 0.1 OUTLIER -131.19 98.46 4.57 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -88.52 87.92 7.44 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.237 1.018 . . . . 0.0 111.339 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -173.63 152.55 15.56 Favored Glycine 0 CA--C 1.479 -2.157 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 787' ' ' TRP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 26.2 m95 -93.18 134.81 34.98 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 117.571 0.685 . . . . 0.0 110.345 -172.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 788' ' ' ILE . . . . . 0.531 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.1 mp -94.61 -28.0 4.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.117 -177.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 18.7 m170 74.62 119.54 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 124.375 1.07 . . . . 0.0 109.835 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 790' ' ' THR . . . . . 0.447 HG21 ' CG2' ' A' ' 801' ' ' VAL . 3.8 t -143.65 160.77 40.09 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.169 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.32 135.78 60.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 123.897 0.879 . . . . 0.0 109.427 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 52.8 t -72.52 103.07 3.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.05 0.928 . . . . 0.0 110.854 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.6 mm -99.28 79.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.499 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 794' ' ' ASN . . . . . 0.629 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 50.39 68.81 0.7 Allowed 'General case' 0 C--O 1.238 0.447 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.771 176.145 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 80.2 6.28 89.28 Favored Glycine 0 C--N 1.306 -1.092 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.043 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 796' ' ' ARG . . . . . 0.442 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 34.5 ttt180 -139.53 169.09 18.38 Favored 'General case' 0 C--O 1.198 -1.657 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 797' ' ' TRP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.6 m95 -111.43 161.09 16.47 Favored 'General case' 0 C--N 1.264 -3.112 0 O-C-N 122.293 -0.254 . . . . 0.0 110.429 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -150.33 106.23 3.14 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 799' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 34.8 Cg_endo -67.63 138.52 43.29 Favored 'Cis proline' 0 C--O 1.243 0.774 0 C-N-CA 123.651 -1.396 . . . . 0.0 111.103 -1.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 800' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 30.1 tt0 -55.16 121.59 9.14 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.058 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 801' ' ' VAL . . . . . 0.691 HG13 ' CD2' ' A' ' 779' ' ' TYR . 91.8 t . . . . . 0 C--N 1.311 -1.076 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.233 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 40.6 p . . . . . 0 N--CA 1.422 -1.844 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 35.9 m -72.87 -67.83 0.53 Allowed 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.33 0.586 . . . . 0.0 109.485 173.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 130.11 -161.46 23.08 Favored Glycine 1 N--CA 1.367 -5.938 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -41.14 116.19 0.7 Allowed 'General case' 0 C--N 1.274 -2.696 0 C-N-CA 127.196 2.198 . . . . 0.0 112.09 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.533 HG21 HG21 ' A' ' 715' ' ' VAL . 1.7 pp -59.94 149.56 72.99 Favored Pre-proline 0 N--CA 1.435 -1.205 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.017 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.441 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 71.2 Cg_endo -74.11 -160.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.611 2.207 . . . . 0.0 110.42 175.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . 0.595 ' HA ' ' HE2' ' A' ' 717' ' ' PHE . 13.1 pt-20 -149.85 170.3 19.11 Favored 'General case' 0 N--CA 1.396 -3.131 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.752 HD13 ' SG ' ' A' ' 744' ' ' CYS . 17.7 mt -97.48 128.71 44.47 Favored 'General case' 0 C--N 1.261 -3.282 0 O-C-N 123.914 0.759 . . . . 0.0 111.376 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -46.17 -33.88 3.9 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.078 -1.874 . . . . 0.0 112.723 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.426 ' HB3' ' CE1' ' A' ' 723' ' ' PHE . 96.4 m-70 -145.89 26.7 1.23 Allowed 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -137.94 -148.36 5.36 Favored Glycine 0 C--N 1.302 -1.33 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.472 -177.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.461 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.6 OUTLIER -150.9 176.2 11.31 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -178.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -104.69 157.34 17.25 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 177.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -94.6 -68.75 0.78 Allowed 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.092 0.472 . . . . 0.0 111.297 175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . 0.476 ' O ' HG13 ' A' ' 715' ' ' VAL . 58.9 tp -146.14 123.39 11.56 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.487 ' HB3' ' CG1' ' A' ' 715' ' ' VAL . 2.8 p -144.86 105.0 4.06 Favored 'General case' 0 N--CA 1.396 -3.131 0 CA-C-O 122.024 0.916 . . . . 0.0 109.347 179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 10.2 m -116.34 132.03 23.52 Favored Pre-proline 0 C--N 1.246 -3.914 0 CA-C-N 114.277 -1.329 . . . . 0.0 108.621 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.457 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 57.5 Cg_endo -64.65 172.87 6.22 Favored 'Trans proline' 0 C--O 1.245 0.859 0 C-N-CA 122.592 2.194 . . . . 0.0 110.183 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.64 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.0 Cg_exo -76.61 -7.03 28.4 Favored 'Cis proline' 0 N--CA 1.487 1.124 0 N-CA-C 114.839 1.053 . . . . 0.0 114.839 6.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.464 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 57.4 m-85 72.95 79.28 0.14 Allowed 'General case' 0 C--N 1.314 -0.975 0 O-C-N 124.242 0.964 . . . . 0.0 109.217 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.64 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 38.1 m-85 -87.0 172.52 9.94 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.235 -175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -69.32 131.7 45.26 Favored 'General case' 0 CA--C 1.49 -1.328 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.994 176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.65 -15.16 60.07 Favored Glycine 0 N--CA 1.419 -2.443 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 0.5 OUTLIER -65.42 145.98 55.47 Favored 'General case' 0 CA--C 1.477 -1.861 0 CA-C-O 121.42 0.628 . . . . 0.0 110.262 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 17.8 m -133.97 148.83 51.2 Favored 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.533 HG21 HG21 ' A' ' 694' ' ' ILE . 61.8 t -134.58 130.61 53.52 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.845 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.465 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 44.0 mt-10 -82.16 139.28 34.42 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 121.609 0.719 . . . . 0.0 110.813 177.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.595 ' HE2' ' HA ' ' A' ' 696' ' ' GLU . 28.5 m-85 -137.35 120.55 16.79 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 125.867 1.667 . . . . 0.0 107.478 -179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.461 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 16.1 m-80 -128.78 -163.44 1.29 Allowed 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 22.3 m -118.87 134.03 55.44 Favored 'General case' 0 C--N 1.267 -3.018 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 21.1 t -73.15 -84.5 0.04 OUTLIER 'General case' 0 C--N 1.29 -2.004 0 O-C-N 123.923 0.764 . . . . 0.0 112.019 -170.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -133.77 132.59 40.7 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 122.459 0.303 . . . . 0.0 110.632 -176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 4.4 t 71.9 26.29 2.97 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 124.598 1.186 . . . . 0.0 110.055 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.581 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.3 m-85 -140.72 145.98 37.17 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.551 HG21 HD11 ' A' ' 750' ' ' LEU . 6.4 t -75.23 -118.38 0.01 OUTLIER 'General case' 0 C--N 1.274 -2.697 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.605 -174.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.517 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 7.9 ttp 162.82 104.83 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 128.898 2.879 . . . . 0.0 105.29 174.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.4 HD11 ' ND2' ' A' ' 794' ' ' ASN . 43.9 mm -119.96 139.25 47.88 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 110.04 -0.355 . . . . 0.0 110.04 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 102.17 -75.79 0.33 Allowed Glycine 0 N--CA 1.429 -1.797 0 O-C-N 123.559 0.537 . . . . 0.0 112.729 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.579 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 2.1 t60 -146.98 -172.97 4.12 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -173.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.517 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -141.89 22.94 2.09 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.28 170.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.465 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 16.4 p -157.44 162.71 38.97 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.034 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 714' ' ' SER . 32.4 pt -122.6 164.6 19.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 739' ' ' THR . 7.3 m -135.77 135.01 39.58 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.977 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 6.0 t -84.68 106.83 16.52 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.473 0.654 . . . . 0.0 110.437 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -142.97 143.58 24.98 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 C-N-CA 125.221 1.408 . . . . 0.0 109.988 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 70.2 m-70 64.39 4.2 2.12 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.06 13.5 52.46 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . 0.465 HG12 ' O ' ' A' ' 738' ' ' TRP . 80.7 t -140.66 154.23 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 -177.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.465 ' O ' HG12 ' A' ' 737' ' ' VAL . 94.2 m95 -79.95 177.64 8.78 Favored 'General case' 0 C--N 1.273 -2.748 0 O-C-N 121.89 -0.506 . . . . 0.0 109.786 172.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.458 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 27.1 p -84.89 -163.95 0.91 Allowed 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.856 0.836 . . . . 0.0 112.506 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.548 ' NE2' ' H ' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -74.81 -17.05 60.68 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -168.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 1.5 mt 68.73 151.33 0.13 Allowed Pre-proline 0 N--CA 1.479 1.019 0 O-C-N 123.889 0.743 . . . . 0.0 112.231 -177.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.579 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 42.9 Cg_endo -73.56 177.52 7.89 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 121.796 1.664 . . . . 0.0 111.249 175.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -120.17 103.09 8.97 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.234 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.752 ' SG ' HD13 ' A' ' 697' ' ' LEU . 84.1 m -79.07 110.26 14.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.971 173.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.531 ' O ' HG22 ' A' ' 724' ' ' THR . 46.6 t -104.72 147.03 11.21 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.581 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.96 -0.85 1.71 Allowed 'General case' 0 C--N 1.284 -2.253 0 C-N-CA 125.204 1.402 . . . . 0.0 114.089 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.714 ' HA ' HD22 ' A' ' 750' ' ' LEU . 48.6 mt 74.54 -14.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 125.589 1.555 . . . . 0.0 110.93 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 746' ' ' ALA . 1.0 OUTLIER -75.3 -27.89 59.5 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 126.149 1.78 . . . . 0.0 108.755 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 11.7 mttm -106.92 16.96 23.71 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.428 -1.715 . . . . 0.0 109.063 -172.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.754 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 1.3 mp -83.15 -178.67 7.18 Favored 'General case' 0 N--CA 1.408 -2.558 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.766 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.592 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 55.0 mtpt -125.59 150.66 47.32 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.58 -175.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 770' ' ' GLU . 14.1 mmmm -90.14 111.22 22.29 Favored 'General case' 0 C--N 1.251 -3.689 0 CA-C-N 112.421 -2.172 . . . . 0.0 108.726 -178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 61.2 m -70.78 138.29 50.29 Favored 'General case' 0 C--N 1.269 -2.898 0 CA-C-N 114.603 -1.181 . . . . 0.0 108.14 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -107.86 138.28 44.38 Favored 'General case' 0 C--N 1.271 -2.806 0 C-N-CA 118.985 -1.086 . . . . 0.0 110.13 -177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . 0.421 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.4 p -67.83 123.65 21.13 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.465 173.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.673 ' HB3' HG13 ' A' ' 759' ' ' ILE . 25.9 t -70.89 146.18 49.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 176.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.9 3.28 49.09 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 803' ' ' CYS . 4.1 mm? -92.46 -29.52 16.21 Favored 'General case' 0 CA--C 1.49 -1.364 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.673 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -98.53 158.51 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.294 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.057 -176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -110.1 131.87 59.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.412 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 85.8 mt -105.56 179.82 4.16 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.143 0.497 . . . . 0.0 110.124 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.714 ' HB2' HD23 ' A' ' 765' ' ' LEU . 37.8 mt-10 -69.4 170.53 10.26 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.731 177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.02 -20.09 66.32 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.43 -0.804 . . . . 0.0 112.16 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . 0.572 ' HB2' HD22 ' A' ' 765' ' ' LEU . 15.6 m-70 -90.1 -30.09 17.9 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.714 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.7 mm? -93.9 -14.18 26.33 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.371 -165.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 28.5 mtmm -71.77 -8.8 56.44 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.762 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -94.57 -1.7 52.85 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? -105.28 126.34 51.98 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . 0.846 ' HG3' ' HG2' ' A' ' 770' ' ' GLU . 18.8 ptpt -98.49 -29.37 13.14 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.612 0.72 . . . . 0.0 109.107 178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . 0.846 ' HG2' ' HG3' ' A' ' 769' ' ' LYS . 4.7 pt-20 -140.06 136.38 33.58 Favored 'General case' 0 N--CA 1.39 -3.456 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.462 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.484 ' HE2' HD12 ' A' ' 765' ' ' LEU . 86.3 m-85 -110.66 148.66 31.78 Favored 'General case' 0 C--N 1.259 -3.355 0 CA-C-N 114.148 -1.387 . . . . 0.0 110.623 -175.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -90.91 166.04 13.26 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.626 ' HB3' HD23 ' A' ' 750' ' ' LEU . 26.6 t60 -62.67 157.35 21.07 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 122.328 0.251 . . . . 0.0 111.076 -179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 77.69 9.8 2.36 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.209 1.004 . . . . 0.0 109.654 176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 47.4 t -86.36 104.5 15.93 Favored 'General case' 0 N--CA 1.385 -3.687 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.468 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -90.13 101.37 14.08 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 177.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.424 HG21 ' CE2' ' A' ' 771' ' ' PHE . 7.9 pt -112.32 -174.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.589 0 CA-C-O 121.591 0.71 . . . . 0.0 109.797 -176.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.624 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 27.6 ptt180 -141.08 122.5 14.97 Favored 'General case' 0 N--CA 1.391 -3.424 0 CA-C-N 115.045 -0.98 . . . . 0.0 108.555 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.488 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 9.6 p90 -113.66 172.9 6.7 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -155.47 169.26 24.68 Favored 'General case' 0 N--CA 1.411 -2.379 0 O-C-N 123.934 0.771 . . . . 0.0 109.356 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.675 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 16.4 t -102.26 162.22 13.09 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . 0.609 ' HG2' ' SG ' ' A' ' 803' ' ' CYS . 12.0 ptm180 -74.8 80.14 2.09 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 122.601 1.191 . . . . 0.0 108.293 175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 147.28 -27.72 1.54 Allowed Glycine 0 N--CA 1.417 -2.596 0 C-N-CA 119.777 -1.202 . . . . 0.0 110.269 -172.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.675 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 14.3 mptt -84.02 103.32 13.16 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 173.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -87.34 81.27 7.93 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 162.62 -170.02 38.05 Favored Glycine 0 N--CA 1.419 -2.495 0 N-CA-C 106.261 -2.736 . . . . 0.0 106.261 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.624 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 64.7 m95 -130.76 158.51 39.93 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 118.962 1.381 . . . . 0.0 109.364 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.488 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -99.94 -41.94 9.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.512 -0.475 . . . . 0.0 111.132 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 11.3 m170 80.7 133.25 0.06 Allowed 'General case' 0 N--CA 1.502 2.137 0 C-N-CA 125.052 1.341 . . . . 0.0 110.259 -176.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.419 ' HA ' ' HD2' ' A' ' 799' ' ' PRO . 4.5 t -157.17 158.98 37.27 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.107 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 45.0 t -120.91 133.24 68.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.273 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 37.9 t -68.33 115.11 7.39 Favored 'General case' 0 C--O 1.245 0.85 0 CA-C-O 121.152 0.501 . . . . 0.0 109.995 176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 45.3 mm -117.3 83.09 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 C-N-CA 123.726 0.81 . . . . 0.0 109.332 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.754 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 0.6 OUTLIER 49.78 66.01 1.25 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.811 0.845 . . . . 0.0 111.259 176.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 77.44 14.36 82.58 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.887 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -139.02 166.11 25.37 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.539 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.1 m95 -116.88 156.3 27.58 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 18.9 t70 -147.62 104.28 3.7 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 43.1 Cg_endo -70.51 142.76 73.04 Favored 'Cis proline' 0 C--O 1.239 0.575 0 C-N-CA 124.0 -1.25 . . . . 0.0 113.248 0.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.539 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 47.3 mt-10 -53.86 125.42 18.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.445 175.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 5.0 m -75.48 140.2 17.78 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.404 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.719 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -155.98 131.4 9.52 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.769 175.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . 0.609 ' SG ' ' HG2' ' A' ' 782' ' ' ARG . 42.3 t -128.65 -5.6 5.21 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.044 0.926 . . . . 0.0 109.054 175.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.42 -1.97 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.267 178.371 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.421 -1.892 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 51.8 m -79.06 -66.99 0.8 Allowed 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 170.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 93.17 142.22 11.51 Favored Glycine 0 N--CA 1.405 -3.38 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.666 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 35.6 t70 53.69 97.32 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 125.815 1.646 . . . . 0.0 112.441 177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.454 HG21 HG21 ' A' ' 715' ' ' VAL . 1.8 pp -63.68 147.3 95.94 Favored Pre-proline 0 C--N 1.298 -1.663 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.399 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.449 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.9 Cg_endo -69.63 -171.61 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.729 2.286 . . . . 0.0 112.134 178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -121.79 179.05 4.61 Favored 'General case' 0 N--CA 1.393 -3.297 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.587 HD22 ' HB3' ' A' ' 717' ' ' PHE . 25.0 tp -124.33 129.43 50.71 Favored 'General case' 0 C--N 1.251 -3.675 0 CA-C-O 120.915 0.388 . . . . 0.0 110.953 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -38.66 -51.34 1.66 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 126.479 1.912 . . . . 0.0 114.756 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.681 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.8 m-70 -141.12 26.26 2.03 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -139.16 -146.39 4.92 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.552 -176.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.465 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -152.05 178.31 9.58 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -174.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -113.05 143.88 43.56 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -73.56 -62.71 1.39 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.003 0.43 . . . . 0.0 110.685 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.6 tt -166.56 135.52 2.95 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.546 ' HB3' HG11 ' A' ' 715' ' ' VAL . 13.1 p -129.95 119.86 23.89 Favored 'General case' 0 N--CA 1.412 -2.362 0 CA-C-O 121.351 0.596 . . . . 0.0 110.074 -177.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . 0.406 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 13.2 p -108.47 113.17 60.42 Favored Pre-proline 0 C--N 1.276 -2.609 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.239 -174.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.491 ' HA ' ' N ' ' A' ' 709' ' ' TYR . 57.6 Cg_endo -69.7 171.5 14.28 Favored 'Trans proline' 0 C--O 1.245 0.838 0 C-N-CA 122.856 2.37 . . . . 0.0 110.527 176.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -64.84 -4.89 3.07 Favored 'Cis proline' 0 N--CA 1.496 1.676 0 N-CA-C 117.077 1.914 . . . . 0.0 117.077 2.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.521 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 35.6 m-85 68.68 65.57 0.31 Allowed 'General case' 0 C--O 1.253 1.241 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.493 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 16.7 m-85 -69.75 172.77 7.05 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.877 -1.511 . . . . 0.0 112.103 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 39.4 m-85 -72.21 132.05 43.58 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.901 175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.34 -6.41 65.81 Favored Glycine 0 N--CA 1.413 -2.867 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.82 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 1.4 t70 -68.79 155.89 39.35 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 19.4 m -146.81 145.08 29.78 Favored 'General case' 0 C--N 1.274 -2.697 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.546 HG11 ' HB3' ' A' ' 705' ' ' SER . 46.1 t -132.04 134.69 59.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 116.158 -0.473 . . . . 0.0 109.887 -176.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -79.85 133.85 36.29 Favored 'General case' 0 C--N 1.314 -0.958 0 O-C-N 123.78 0.675 . . . . 0.0 111.676 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.587 ' HB3' HD22 ' A' ' 697' ' ' LEU . 26.7 m-85 -138.28 129.88 27.88 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 125.38 1.472 . . . . 0.0 107.28 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.465 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 15.6 m-80 -137.71 -161.5 1.18 Allowed 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 725' ' ' MET . 11.7 m -118.71 131.77 56.15 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 18.9 t -67.02 -75.61 0.09 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 124.239 0.962 . . . . 0.0 110.721 -170.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -149.18 152.9 36.86 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.622 -1.621 . . . . 0.0 106.622 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 69.3 m 72.92 2.69 4.46 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 124.285 0.991 . . . . 0.0 112.766 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.642 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.7 m-85 -138.56 144.74 40.0 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.674 HG21 HD21 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -107.09 136.43 46.95 Favored 'General case' 0 C--N 1.255 -3.505 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.265 -177.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.768 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 7.6 ttp -84.29 118.6 24.3 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 124.196 0.998 . . . . 0.0 109.636 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.481 HD11 HD21 ' A' ' 794' ' ' ASN . 48.3 mm -127.33 141.68 45.65 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.998 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 106.5 -66.9 0.25 Allowed Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.974 -0.557 . . . . 0.0 113.392 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.561 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 20.7 t60 -165.83 -177.6 4.37 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 -175.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.768 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -143.31 25.43 1.71 Allowed 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 119.027 0.831 . . . . 0.0 110.699 176.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 16.0 m -152.47 163.66 39.1 Favored 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.884 -0.51 . . . . 0.0 109.782 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 714' ' ' SER . 32.2 pt -125.3 163.45 26.16 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.745 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.491 ' O ' HG23 ' A' ' 739' ' ' THR . 17.5 m -137.03 134.1 36.2 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.252 0.345 . . . . 0.0 111.08 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 3.4 t -86.84 105.85 17.32 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -141.28 140.43 31.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.984 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 60.44 14.19 4.61 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 89.11 25.22 29.59 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.81 144.89 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.089 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.521 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 97.3 m95 -72.63 -179.34 3.01 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-O 121.5 0.667 . . . . 0.0 110.138 170.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.491 HG23 ' O ' ' A' ' 732' ' ' THR . 27.9 p -90.95 -152.9 0.29 Allowed 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -175.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.507 ' NE2' ' H ' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -81.52 -14.87 56.4 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -169.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.2 mm? 71.12 151.59 0.14 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 123.967 0.792 . . . . 0.0 110.824 -175.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.561 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 36.2 Cg_endo -71.13 177.64 6.29 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.028 1.819 . . . . 0.0 110.736 172.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -125.07 132.92 53.09 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.681 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 84.6 m -116.38 107.06 14.33 Favored 'General case' 0 CA--C 1.473 -1.997 0 CA-C-O 121.458 0.646 . . . . 0.0 109.834 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.58 142.82 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.682 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.642 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.97 1.91 1.27 Allowed 'General case' 0 C--N 1.289 -2.023 0 C-N-CA 125.247 1.419 . . . . 0.0 113.414 -176.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.693 ' HA ' HD22 ' A' ' 750' ' ' LEU . 40.0 mt 79.35 -19.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 C-N-CA 125.41 1.484 . . . . 0.0 111.031 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.42 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.0 t70 -72.01 -34.26 68.71 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.118 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -98.74 17.76 18.57 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 113.274 -1.785 . . . . 0.0 109.498 -172.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.803 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 1.7 mp -82.37 -174.06 4.93 Favored 'General case' 0 N--CA 1.4 -2.962 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.539 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.627 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 1.2 mmpt? -136.43 -177.1 4.57 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -130.97 144.4 51.45 Favored 'General case' 0 C--N 1.268 -2.963 0 C-N-CA 125.297 1.439 . . . . 0.0 107.202 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 770' ' ' GLU . 69.1 m -92.78 167.08 12.1 Favored 'General case' 0 C--N 1.246 -3.899 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.24 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -125.88 136.0 52.56 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.895 -177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . 0.441 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.0 p -67.18 118.44 10.6 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.582 173.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.577 ' HB3' HG13 ' A' ' 759' ' ' ILE . 28.3 t -66.15 143.15 57.46 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -77.85 -6.97 55.97 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . 0.545 HD13 ' HB2' ' A' ' 804' ' ' SER . 89.2 mt -105.16 -11.69 16.45 Favored 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.813 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.577 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -96.43 162.32 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.806 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . 0.444 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.4 mp -118.98 117.4 54.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.791 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 63.7 mt -93.51 -177.25 4.35 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 31.5 mt-10 -62.85 176.84 0.63 Allowed 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.354 0.597 . . . . 0.0 110.093 174.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -86.02 -6.06 59.11 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 123.431 1.586 . . . . 0.0 107.406 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . 0.274 63.8 t60 -88.98 -43.04 11.43 Favored 'General case' 0 N--CA 1.402 -2.861 0 CA-C-N 110.712 -2.949 . . . . 0.0 108.194 178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.691 HD22 ' HE2' ' A' ' 771' ' ' PHE . 54.8 mt -96.2 -13.43 23.49 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.05 -1.432 . . . . 0.0 113.861 -171.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 54.1 mtmt -65.66 -15.9 63.22 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.476 -0.489 . . . . 0.0 111.806 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -89.84 1.64 55.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.506 174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.463 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 11.3 tppt? -103.52 109.91 21.74 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -177.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -83.02 -36.49 24.94 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 177.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 753' ' ' CYS . 3.8 pt-20 -130.29 134.02 46.9 Favored 'General case' 0 N--CA 1.403 -2.789 0 CA-C-N 114.086 -1.415 . . . . 0.0 110.635 -178.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.791 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 81.0 m-85 -112.09 143.19 43.53 Favored 'General case' 0 C--N 1.267 -3.012 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.009 -178.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -89.89 154.78 19.61 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.634 ' CG ' HD23 ' A' ' 750' ' ' LEU . 18.5 p-80 -43.21 143.56 0.81 Allowed 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.974 1.31 . . . . 0.0 111.55 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 14.0 m120 68.19 12.28 8.7 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 124.23 1.012 . . . . 0.0 113.435 177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 43.4 t -77.84 110.48 12.76 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.445 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.8 OUTLIER -86.82 101.3 13.22 Favored 'General case' 0 CA--C 1.494 -1.203 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.702 HG21 ' CE2' ' A' ' 771' ' ' PHE . 5.6 pt -114.0 -173.71 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.269 -177.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.568 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 26.9 ptt180 -142.28 124.81 15.76 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.473 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 4.4 p90 -114.79 172.54 6.98 Favored 'General case' 0 C--N 1.286 -2.153 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . 0.444 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 27.0 ptt180 -150.19 178.57 8.86 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.593 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 48.1 t -114.94 162.94 16.27 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . 0.431 ' HG2' ' SG ' ' A' ' 803' ' ' CYS . 38.1 ptt180 -74.51 -21.49 59.53 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.286 0.565 . . . . 0.0 110.129 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -99.93 -8.79 50.56 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.072 175.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 13.3 mptt -128.14 104.53 7.81 Favored 'General case' 0 CA--C 1.5 -0.949 0 O-C-N 122.686 -0.302 . . . . 0.0 110.735 -178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -79.31 169.92 17.39 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 97.58 -168.02 23.69 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 107.538 -2.225 . . . . 0.0 107.538 -173.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 75.6 m95 -138.69 142.9 38.96 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 118.613 1.206 . . . . 0.0 109.714 177.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.473 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.5 mp -93.6 -40.51 11.81 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.056 -177.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.471 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 15.3 m170 75.0 129.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.677 1.191 . . . . 0.0 109.633 -174.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 3.4 t -151.42 154.61 36.96 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 120.755 0.312 . . . . 0.0 110.334 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.3 t -115.99 133.42 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.395 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 54.0 t -69.38 112.48 5.95 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.788 0.804 . . . . 0.0 110.173 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 47.4 mm -112.45 81.35 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.636 0 C-N-CA 124.534 1.133 . . . . 0.0 108.84 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.803 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 0.4 OUTLIER 51.62 66.13 1.29 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.374 176.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.49 20.25 79.82 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 119.937 -1.125 . . . . 0.0 113.348 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -147.29 163.99 34.65 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.662 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.6 m95 -108.92 162.09 14.53 Favored 'General case' 0 C--N 1.258 -3.388 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.684 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -150.24 102.14 3.15 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.81 140.56 64.45 Favored 'Cis proline' 0 N--CA 1.48 0.705 0 C-N-CA 123.917 -1.284 . . . . 0.0 113.704 -0.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.662 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 44.6 mt-10 -50.48 123.85 9.51 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.585 175.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 3.9 m -76.67 131.64 34.46 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.264 0 CA-C-O 121.458 0.647 . . . . 0.0 111.078 -178.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -156.59 108.17 2.45 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . 0.542 ' HB2' HG22 ' A' ' 759' ' ' ILE . 42.6 t -94.86 -30.73 14.04 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . 0.545 ' HB2' HD13 ' A' ' 758' ' ' LEU . 60.7 m . . . . . 0 N--CA 1.437 -1.111 0 C-N-CA 128.87 2.868 . . . . 0.0 103.984 -176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.431 -1.424 0 CA-C-O 120.864 0.364 . . . . 0.0 110.209 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 64.2 m -73.5 -70.89 0.35 Allowed 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 94.23 135.78 7.92 Favored Glycine 0 N--CA 1.413 -2.876 0 C-N-CA 119.894 -1.146 . . . . 0.0 111.616 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 25.3 t70 62.25 112.94 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 O-C-N 125.324 1.249 . . . . 0.0 111.829 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.662 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -80.0 147.03 64.86 Favored Pre-proline 0 C--N 1.283 -2.305 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.05 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.451 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 71.1 Cg_endo -71.64 -166.9 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 123.499 2.799 . . . . 0.0 112.994 178.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -129.91 164.64 23.76 Favored 'General case' 0 N--CA 1.402 -2.857 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.658 HD22 ' HB3' ' A' ' 717' ' ' PHE . 23.7 tp -109.32 132.9 53.69 Favored 'General case' 0 C--N 1.256 -3.498 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.742 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 7.0 pt-20 -43.49 -53.43 5.5 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 125.925 1.69 . . . . 0.0 113.713 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.459 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 89.9 m-70 -137.49 28.15 2.75 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.447 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -136.2 -151.63 6.14 Favored Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.541 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.438 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.21 174.55 12.68 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -176.411 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -108.66 142.27 39.4 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 17.4 mm100 -78.3 -67.87 0.69 Allowed 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 120.72 0.295 . . . . 0.0 111.524 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.3 tt -161.68 137.21 7.61 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.444 ' HA ' HG13 ' A' ' 715' ' ' VAL . 35.5 p -111.8 -49.2 3.0 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 -169.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . 0.441 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 66.0 m 58.84 100.26 0.04 OUTLIER Pre-proline 0 CA--C 1.559 1.323 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 706' ' ' SER . 40.9 Cg_endo -66.69 171.72 10.46 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 122.416 2.077 . . . . 0.0 109.733 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.635 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.8 Cg_endo -73.67 -2.22 14.73 Favored 'Cis proline' 0 N--CA 1.484 0.962 0 N-CA-C 116.662 1.755 . . . . 0.0 116.662 7.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 33.5 m-85 68.55 72.94 0.28 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 123.691 0.62 . . . . 0.0 109.413 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.635 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 22.5 m-85 -81.2 172.67 13.36 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.459 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -72.58 127.43 32.53 Favored 'General case' 0 CA--C 1.481 -1.691 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.143 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.1 -17.86 53.18 Favored Glycine 0 N--CA 1.406 -3.303 0 CA-C-N 114.937 -1.028 . . . . 0.0 110.656 -175.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.67 144.83 56.67 Favored 'General case' 0 CA--C 1.481 -1.692 0 CA-C-O 121.285 0.564 . . . . 0.0 110.089 177.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 10.2 m -128.11 153.69 46.56 Favored 'General case' 0 N--CA 1.404 -2.739 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.898 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.662 HG21 HG21 ' A' ' 694' ' ' ILE . 46.4 t -135.83 127.4 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.608 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 37.0 mt-10 -84.86 138.01 32.8 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 121.889 0.852 . . . . 0.0 111.702 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.658 ' HB3' HD22 ' A' ' 697' ' ' LEU . 30.1 m-85 -138.08 128.83 26.8 Favored 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 125.487 1.515 . . . . 0.0 107.028 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.438 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 21.7 m-80 -124.69 -163.12 1.14 Allowed 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 22.4 m -107.39 136.55 47.0 Favored 'General case' 0 C--N 1.277 -2.584 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 23.3 t -66.14 -62.56 1.42 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 123.924 0.765 . . . . 0.0 111.416 -169.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -163.47 153.13 15.04 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 55.7 m 64.43 13.08 7.85 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 94.4 m-85 -141.27 146.15 36.45 Favored 'General case' 0 N--CA 1.413 -2.285 0 CA-C-O 122.028 0.918 . . . . 0.0 110.169 -175.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.417 ' OG1' HG12 ' A' ' 747' ' ' ILE . 1.0 OUTLIER -110.19 134.95 51.7 Favored 'General case' 0 C--N 1.253 -3.617 0 CA-C-N 113.695 -1.593 . . . . 0.0 111.932 -179.201 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.784 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.4 ttp -82.21 121.77 27.05 Favored 'General case' 0 N--CA 1.423 -1.775 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.602 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 46.0 mm -123.51 128.31 74.55 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 115.157 -0.928 . . . . 0.0 109.27 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.12 -90.51 0.53 Allowed Glycine 0 N--CA 1.427 -1.904 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.154 175.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.657 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 15.6 t60 -144.74 164.39 31.16 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.784 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -118.72 23.75 11.28 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.504 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.608 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 6.3 p -153.11 159.67 42.81 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 120.97 0.414 . . . . 0.0 111.389 -179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.509 HG21 HD13 ' A' ' 741' ' ' LEU . 27.8 pt -110.43 166.86 5.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.545 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 739' ' ' THR . 19.4 m -138.41 133.49 32.92 Favored 'General case' 0 C--N 1.29 -2.0 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.724 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 2.1 t -81.13 105.21 12.16 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.306 0.574 . . . . 0.0 109.708 176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -143.97 144.75 22.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-N 114.647 -1.16 . . . . 0.0 110.022 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 71.02 -15.49 0.4 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.982 0.913 . . . . 0.0 113.322 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 118.94 17.99 4.84 Favored Glycine 1 CA--C 1.445 -4.328 0 CA-C-O 121.364 0.424 . . . . 0.0 112.878 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -154.24 177.79 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.39 -3.456 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.519 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 89.8 m95 -90.38 -173.89 3.95 Favored 'General case' 0 C--N 1.266 -3.065 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 175.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 732' ' ' THR . 38.8 p -85.06 -155.76 0.23 Allowed 'General case' 0 N--CA 1.427 -1.594 0 CA-C-O 121.225 0.536 . . . . 0.0 110.257 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.5 OUTLIER -93.83 3.48 55.35 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -168.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.509 HD13 HG21 ' A' ' 731' ' ' ILE . 4.0 mm? 71.6 159.93 0.16 Allowed Pre-proline 0 N--CA 1.481 1.123 0 O-C-N 123.82 0.7 . . . . 0.0 110.404 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.657 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 18.5 Cg_endo -72.94 -177.71 3.07 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 121.673 1.582 . . . . 0.0 111.356 171.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -122.1 125.94 47.29 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.435 ' SG ' HD21 ' A' ' 697' ' ' LEU . 64.7 m -116.7 94.87 4.78 Favored 'General case' 0 CA--C 1.481 -1.689 0 CA-C-O 121.659 0.742 . . . . 0.0 110.554 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.474 ' HB ' HD21 ' A' ' 750' ' ' LEU . 30.7 t -89.16 143.02 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.881 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.616 -177.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.582 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -62.51 4.31 0.16 Allowed 'General case' 0 C--N 1.283 -2.305 0 C-N-CA 125.733 1.613 . . . . 0.0 114.89 -176.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.757 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 65.7 mt 77.37 -17.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 126.156 1.782 . . . . 0.0 111.34 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.7 t70 -79.85 -31.77 40.47 Favored 'General case' 0 C--N 1.274 -2.708 0 CA-C-N 113.177 -1.829 . . . . 0.0 109.293 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -107.35 19.82 19.77 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.193 -173.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.757 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 85.0 mt -81.46 -177.69 6.62 Favored 'General case' 0 N--CA 1.405 -2.691 0 CA-C-N 114.547 -1.206 . . . . 0.0 107.898 176.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.544 ' HE3' ' HA3' ' A' ' 795' ' ' GLY . 27.1 mtpp -98.63 156.4 16.83 Favored 'General case' 0 N--CA 1.386 -3.638 0 CA-C-O 121.954 0.883 . . . . 0.0 108.977 -177.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . 0.637 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 43.5 mtpt -105.65 116.82 32.59 Favored 'General case' 1 C--N 1.238 -4.242 0 CA-C-N 112.524 -2.126 . . . . 0.0 108.171 -172.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 65.2 m -76.52 132.77 39.75 Favored 'General case' 0 C--N 1.26 -3.313 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.051 177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -99.45 135.0 41.51 Favored 'General case' 0 C--N 1.278 -2.538 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.699 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . 0.419 ' HB2' ' HE1' ' A' ' 771' ' ' PHE . 47.3 t -60.94 129.34 40.95 Favored 'General case' 0 N--CA 1.434 -1.236 0 CA-C-N 114.959 -1.019 . . . . 0.0 108.703 171.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.547 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 41.0 t -73.27 151.04 41.52 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -82.97 -0.38 48.42 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -173.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 98.8 mt -112.82 -8.87 13.71 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.552 HG12 HG11 ' A' ' 801' ' ' VAL . 2.2 pp -102.28 150.93 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.527 0 CA-C-O 122.163 0.982 . . . . 0.0 113.385 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.4 mp -105.04 130.86 55.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.487 0 CA-C-N 113.595 -1.639 . . . . 0.0 107.387 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.412 HD12 HD12 ' A' ' 777' ' ' ILE . 1.8 mm? -113.28 -176.6 2.93 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.46 ' HB2' HD23 ' A' ' 765' ' ' LEU . 48.1 mt-10 -65.29 165.72 11.18 Favored 'General case' 0 C--N 1.31 -1.15 0 C-N-CA 120.845 -0.342 . . . . 0.0 110.885 177.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -70.33 -7.7 44.7 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 121.501 0.667 . . . . 0.0 111.795 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.41 -4.45 17.35 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.797 176.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.0 mm? -117.04 -11.71 10.73 Favored 'General case' 0 C--O 1.207 -1.136 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 10.4 mtmp? -70.85 -16.49 62.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.454 0.645 . . . . 0.0 110.228 176.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -78.72 -13.53 59.77 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.917 176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.433 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 7.9 tppt? -98.32 126.81 43.98 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 -177.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 769' ' ' LYS . 15.3 ptpt -110.37 -19.65 12.89 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 175.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . 0.637 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 36.4 mt-10 -134.25 107.79 7.87 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.543 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.419 ' HE1' ' HB2' ' A' ' 755' ' ' SER . 79.4 m-85 -93.2 162.71 13.91 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.84 -175.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -101.86 154.78 18.61 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.566 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 28.5 t60 -60.19 144.38 50.21 Favored 'General case' 0 C--N 1.315 -0.906 0 O-C-N 122.902 0.126 . . . . 0.0 111.038 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 63.7 t30 88.12 3.1 0.31 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 125.445 1.716 . . . . 0.0 111.27 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 791' ' ' VAL . 86.8 p -73.61 105.75 5.08 Favored 'General case' 0 N--CA 1.418 -2.073 0 C-N-CA 119.803 -0.759 . . . . 0.0 108.988 177.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.469 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -87.03 90.2 8.27 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 177.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 789' ' ' HIS . 7.6 pt -104.55 -170.91 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.562 -176.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.641 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 16.6 ptt180 -142.83 125.61 16.02 Favored 'General case' 0 N--CA 1.408 -2.526 0 CA-C-N 115.492 -0.777 . . . . 0.0 111.066 174.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.646 ' CD2' HG13 ' A' ' 801' ' ' VAL . 13.1 p90 -106.87 167.46 9.86 Favored 'General case' 0 C--O 1.257 1.496 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 780' ' ' ARG . 13.3 ptt180 -155.67 161.82 40.7 Favored 'General case' 0 C--N 1.275 -2.669 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 175.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.639 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 3.1 m -98.95 173.88 6.63 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -101.91 36.25 2.14 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 122.479 1.133 . . . . 0.0 109.674 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -176.72 -33.72 0.05 OUTLIER Glycine 0 CA--C 1.473 -2.564 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -175.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.639 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 0.4 OUTLIER -96.82 139.72 32.44 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 176.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.31 154.41 19.4 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-O 121.572 0.701 . . . . 0.0 112.891 -174.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 91.2 154.51 30.67 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.349 177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.641 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 52.0 m95 -95.85 141.04 29.77 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.471 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -95.42 -31.21 4.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 120.538 -0.465 . . . . 0.0 111.568 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.495 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 12.0 m170 72.44 118.37 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.479 0 C-N-CA 124.062 0.945 . . . . 0.0 111.114 -176.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.527 HG21 ' CG2' ' A' ' 801' ' ' VAL . 3.4 t -141.51 153.28 44.8 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.556 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 775' ' ' SER . 38.9 t -114.45 132.91 62.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.712 -176.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 37.3 t -70.15 115.06 8.92 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.566 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 46.5 mm -114.5 84.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.468 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.455 HD22 HD22 ' A' ' 750' ' ' LEU . 7.7 t-20 46.92 68.11 0.68 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.845 0.858 . . . . 0.0 111.992 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . 0.544 ' HA3' ' HE3' ' A' ' 751' ' ' LYS . . . 72.28 24.09 76.92 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 114.958 -1.019 . . . . 0.0 114.293 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 31.4 ttt180 -146.88 168.5 21.3 Favored 'General case' 0 C--O 1.204 -1.318 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.664 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 91.3 m95 -117.24 161.99 18.6 Favored 'General case' 0 C--N 1.266 -3.038 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -150.58 104.56 3.08 Favored Pre-proline 0 C--N 1.296 -1.727 0 O-C-N 123.344 0.402 . . . . 0.0 110.063 176.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . 0.425 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 36.7 Cg_endo -68.57 140.98 59.77 Favored 'Cis proline' 0 C--O 1.239 0.565 0 C-N-CA 123.993 -1.253 . . . . 0.0 112.306 -1.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.664 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 52.2 mt-10 -49.33 120.71 4.27 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.876 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.646 HG13 ' CD2' ' A' ' 779' ' ' TYR . 67.7 t -69.6 119.2 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.104 -177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . 0.595 HD21 ' HB2' ' A' ' 804' ' ' SER . 7.6 t30 -141.2 141.19 34.09 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . 0.519 ' HB2' HG23 ' A' ' 759' ' ' ILE . 5.0 t -123.47 14.12 9.52 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.391 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . 0.595 ' HB2' HD21 ' A' ' 802' ' ' ASN . 13.9 m . . . . . 0 C--N 1.288 -2.099 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.6 179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.599 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.2 m -82.25 -61.97 1.75 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.004 173.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 134.08 174.56 13.55 Favored Glycine 1 N--CA 1.374 -5.466 0 N-CA-C 107.359 -2.296 . . . . 0.0 107.359 -176.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.714 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 29.9 t70 -52.0 135.34 31.04 Favored 'General case' 0 C--N 1.276 -2.589 0 O-C-N 124.803 0.943 . . . . 0.0 111.38 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.589 HG21 HG21 ' A' ' 715' ' ' VAL . 1.3 pp -55.6 150.34 25.95 Favored Pre-proline 0 C--N 1.297 -1.71 0 CA-C-N 114.145 -1.389 . . . . 0.0 114.076 -174.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.52 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 65.1 Cg_endo -72.67 -161.62 0.11 Allowed 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 123.468 2.778 . . . . 0.0 111.321 175.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -135.82 151.86 50.49 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 717' ' ' PHE . 26.4 tp -92.66 123.22 35.79 Favored 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.893 -177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.517 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 5.4 pt-20 -34.63 -50.78 0.46 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.334 2.253 . . . . 0.0 114.417 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 83.5 m-70 -136.28 28.83 3.07 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -142.17 -156.15 6.7 Favored Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.389 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.5 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -140.25 -178.31 5.42 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -115.72 146.09 42.19 Favored 'General case' 0 C--N 1.291 -1.969 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -74.16 -68.57 0.51 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.337 0.589 . . . . 0.0 110.806 177.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.4 tt -159.8 138.97 10.99 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.521 ' HB3' HG11 ' A' ' 715' ' ' VAL . 4.1 p -153.44 123.54 6.96 Favored 'General case' 0 N--CA 1.395 -3.197 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 -175.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 20.6 m -128.08 130.44 23.6 Favored Pre-proline 0 C--N 1.278 -2.539 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.284 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.45 168.59 14.25 Favored 'Trans proline' 0 C--O 1.248 0.976 0 C-N-CA 122.715 2.277 . . . . 0.0 109.716 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.59 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 2.6 Cg_endo -71.64 -11.71 15.77 Favored 'Cis proline' 0 N--CA 1.483 0.892 0 N-CA-C 116.097 1.537 . . . . 0.0 116.097 6.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.714 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 66.7 m-85 68.92 77.77 0.22 Allowed 'General case' 0 C--O 1.248 0.995 0 O-C-N 123.857 0.723 . . . . 0.0 109.643 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.59 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 47.5 m-85 -82.99 171.53 13.73 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.843 0.83 . . . . 0.0 113.204 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.426 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 91.1 m-85 -71.41 132.41 44.77 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 114.399 -1.273 . . . . 0.0 110.271 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.57 -15.63 55.7 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 -177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.1 147.67 46.48 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-O 121.088 0.47 . . . . 0.0 111.547 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 15.8 m -135.57 144.37 46.17 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.999 178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.589 HG21 HG21 ' A' ' 694' ' ' ILE . 38.3 t -127.24 138.2 55.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -176.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.58 125.27 33.68 Favored 'General case' 0 N--CA 1.425 -1.723 0 O-C-N 124.338 1.024 . . . . 0.0 111.073 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.6 ' HB3' HD22 ' A' ' 697' ' ' LEU . 21.9 m-85 -128.21 118.12 22.76 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 125.785 1.634 . . . . 0.0 107.655 177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.5 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 17.7 m-80 -120.41 -162.1 0.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.598 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 5.5 m -112.33 134.37 53.91 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . 0.414 ' HA ' ' CE2' ' A' ' 701' ' ' TRP . 22.4 t -61.56 -58.54 7.72 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.216 0.532 . . . . 0.0 110.568 -172.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -174.18 166.2 4.14 Favored 'General case' 0 CA--C 1.479 -1.756 0 N-CA-C 104.327 -2.472 . . . . 0.0 104.327 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 68.4 m 68.33 0.63 2.58 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.239 0.962 . . . . 0.0 112.051 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.598 ' HB2' ' HB3' ' A' ' 719' ' ' CYS . 96.8 m-85 -137.22 144.83 43.01 Favored 'General case' 0 N--CA 1.395 -3.196 0 C-N-CA 124.243 1.017 . . . . 0.0 109.133 -177.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.484 HG21 HD21 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -110.36 134.66 52.08 Favored 'General case' 0 C--N 1.254 -3.58 0 CA-C-N 113.523 -1.671 . . . . 0.0 110.219 -177.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.497 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.0 ttp -84.62 122.81 29.58 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 124.236 1.015 . . . . 0.0 109.237 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.411 ' HA ' HD13 ' A' ' 726' ' ' ILE . 34.5 mm -111.28 122.81 66.41 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.822 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.728 177.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 99.44 -87.62 0.77 Allowed Glycine 0 N--CA 1.42 -2.422 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.634 173.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.476 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 48.9 p-80 -135.8 179.13 6.53 Favored 'General case' 0 N--CA 1.393 -3.286 0 C-N-CA 124.113 0.965 . . . . 0.0 108.478 -173.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.497 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.0 ppt_? -135.7 8.99 3.34 Favored 'General case' 0 C--O 1.201 -1.457 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 32.5 m -130.82 155.1 47.27 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.848 -1.141 . . . . 0.0 112.49 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 714' ' ' SER . 36.5 pt -110.4 160.66 9.38 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.24 176.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 739' ' ' THR . 26.9 m -135.75 133.71 38.26 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.139 -0.625 . . . . 0.0 111.192 -178.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . 0.426 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 7.1 t -84.87 103.88 14.33 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.86 145.87 23.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.776 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 72.69 -49.93 0.7 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.63 1.172 . . . . 0.0 111.919 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 158.4 24.26 0.03 OUTLIER Glycine 0 C--N 1.29 -1.991 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.367 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.4 p -160.01 157.88 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.056 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.52 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 93.5 m95 -78.39 170.68 16.24 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 172.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 24.8 p -74.91 -163.5 0.23 Allowed 'General case' 0 C--N 1.292 -1.902 0 CA-C-O 122.389 1.09 . . . . 0.0 113.528 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.0 OUTLIER -68.88 -23.9 64.27 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 114.988 1.477 . . . . 0.0 114.988 -170.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.3 mm? 81.95 148.22 0.11 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 124.786 1.304 . . . . 0.0 109.22 -173.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 19.6 Cg_endo -72.85 -175.56 1.95 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.928 1.752 . . . . 0.0 112.885 176.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.411 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.6 tt0 -119.78 126.37 50.86 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.532 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 78.5 m -118.46 111.8 19.13 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-O 121.275 0.559 . . . . 0.0 109.799 177.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.47 ' CG1' ' HG3' ' A' ' 749' ' ' LYS . 41.7 t -100.91 145.14 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.99 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.548 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.99 4.25 0.69 Allowed 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 125.184 1.393 . . . . 0.0 113.672 -177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.587 ' HA ' HD13 ' A' ' 750' ' ' LEU . 32.0 mt 80.11 -26.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 126.302 1.841 . . . . 0.0 111.801 173.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 746' ' ' ALA . 38.7 t70 -82.95 -25.31 32.45 Favored 'General case' 0 C--N 1.248 -3.841 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.375 -172.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.47 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 9.4 ptmt -112.65 34.91 4.09 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 113.749 -1.569 . . . . 0.0 110.72 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.817 ' HG ' ' HB2' ' A' ' 794' ' ' ASN . 0.8 OUTLIER -78.71 -166.36 0.87 Allowed 'General case' 0 N--CA 1.409 -2.491 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.092 176.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.442 ' H ' ' HA ' ' A' ' 794' ' ' ASN . 30.6 mtpp -121.34 -178.66 3.84 Favored 'General case' 0 C--N 1.277 -2.568 0 CA-C-O 121.542 0.687 . . . . 0.0 109.625 -174.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -114.43 132.94 56.08 Favored 'General case' 0 C--N 1.262 -3.23 0 CA-C-N 112.991 -1.913 . . . . 0.0 107.804 -178.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 58.3 m -90.49 174.29 7.62 Favored 'General case' 0 C--N 1.244 -4.0 0 CA-C-N 113.886 -1.506 . . . . 0.0 108.391 176.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . 0.417 ' HB2' ' HE3' ' A' ' 754' ' ' LYS . 15.7 ptmt -144.15 152.39 40.84 Favored 'General case' 0 C--N 1.284 -2.247 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.173 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 20.4 p -62.52 126.06 26.04 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.69 175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.574 ' HB2' HG13 ' A' ' 759' ' ' ILE . 11.3 m -72.85 136.37 45.32 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 175.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -72.09 -4.4 28.72 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.295 1.221 . . . . 0.0 114.295 -173.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 88.6 mt -105.6 -21.0 13.29 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.032 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.596 HG12 HG11 ' A' ' 801' ' ' VAL . 2.8 pp -98.48 171.31 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.077 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.31 136.44 54.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.45 HD22 HD12 ' A' ' 777' ' ' ILE . 80.4 mt -107.11 177.0 4.98 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.44 ' HB2' HD23 ' A' ' 765' ' ' LEU . 43.7 mt-10 -62.06 162.04 9.95 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.986 0.422 . . . . 0.0 110.736 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -70.18 -9.62 56.28 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-O 121.464 0.649 . . . . 0.0 111.02 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -109.86 -0.5 18.29 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.029 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.44 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.1 mm? -123.67 -14.62 7.23 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' A' ' 761' ' ' LEU . 29.3 mtmm -68.37 -19.55 64.64 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.123 177.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -78.95 -17.27 55.76 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.139 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 8.4 tppt? -85.99 107.98 18.01 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 -178.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . 0.522 ' HG3' ' HG2' ' A' ' 770' ' ' GLU . 8.5 ptpp? -74.23 -32.65 63.07 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.688 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . 0.522 ' HG2' ' HG3' ' A' ' 769' ' ' LYS . 22.7 mm-40 -131.96 139.52 48.7 Favored 'General case' 0 CA--C 1.478 -1.799 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.439 ' CZ ' HD13 ' A' ' 761' ' ' LEU . 90.8 m-85 -112.45 134.0 54.22 Favored 'General case' 0 C--N 1.256 -3.47 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.724 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -86.21 155.71 20.6 Favored 'General case' 0 C--N 1.275 -2.649 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.675 ' HB2' HD23 ' A' ' 750' ' ' LEU . 18.8 p-80 -49.7 143.98 6.65 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 124.117 0.967 . . . . 0.0 112.052 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 19.1 m120 67.76 25.75 7.94 Favored 'General case' 0 CA--C 1.506 -0.742 0 C-N-CA 124.211 1.004 . . . . 0.0 112.781 177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 69.0 m -93.86 109.12 20.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.596 ' HA ' HG12 ' A' ' 791' ' ' VAL . 0.7 OUTLIER -83.46 114.32 21.39 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -178.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.45 HD12 HD22 ' A' ' 761' ' ' LEU . 5.8 pt -127.38 -174.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-O 121.486 0.66 . . . . 0.0 111.006 -176.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.553 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 98.1 mtt180 -134.29 124.52 25.99 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.535 ' CD2' HG13 ' A' ' 801' ' ' VAL . 13.2 p90 -111.98 166.77 10.93 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 171.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 36.8 ptt180 -152.57 160.13 43.23 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 3.4 m -95.18 163.39 13.3 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.144 0.497 . . . . 0.0 112.271 178.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -68.33 -27.9 66.68 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.825 -177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -110.23 9.09 31.13 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 121.11 -0.567 . . . . 0.0 111.961 176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.545 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 1.8 mptm? -121.2 113.2 19.64 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.904 0.383 . . . . 0.0 110.469 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -90.87 87.51 6.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.571 0.7 . . . . 0.0 109.242 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 166.14 145.4 4.44 Favored Glycine 0 C--N 1.291 -1.941 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.553 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 54.4 m95 -96.1 142.86 27.79 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.533 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -96.7 -29.69 3.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.517 -176.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.467 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 21.5 m170 76.77 128.38 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 124.565 1.146 . . . . 0.0 109.739 -177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.577 HG21 ' CG2' ' A' ' 801' ' ' VAL . 2.7 t -153.75 159.9 42.1 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.822 HG22 ' HB3' ' A' ' 798' ' ' ASP . 5.9 m -124.36 153.13 30.65 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.505 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 43.2 t -80.95 116.21 20.81 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.901 0.381 . . . . 0.0 110.407 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 51.0 mm -121.05 86.2 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.817 ' HB2' ' HG ' ' A' ' 750' ' ' LEU . 23.7 t-20 54.01 69.06 0.76 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.13 0.967 . . . . 0.0 111.508 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.12 66.29 Favored Glycine 0 C--N 1.297 -1.635 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.49 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -140.54 168.43 19.83 Favored 'General case' 0 C--O 1.199 -1.565 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 -177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.69 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 82.7 m95 -116.26 155.51 28.23 Favored 'General case' 0 C--N 1.26 -3.31 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . 0.822 ' HB3' HG22 ' A' ' 791' ' ' VAL . 26.0 t70 -133.3 100.47 13.98 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 119.567 -0.254 . . . . 0.0 110.973 177.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 44.3 Cg_endo -73.07 145.0 82.82 Favored 'Cis proline' 0 C--O 1.24 0.59 0 C-N-CA 124.377 -1.093 . . . . 0.0 112.153 -1.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.69 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 27.0 tt0 -48.59 122.15 5.25 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.014 0.821 . . . . 0.0 111.249 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.596 HG11 HG12 ' A' ' 759' ' ' ILE . 64.4 t -74.09 120.68 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.42 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -151.96 130.4 12.15 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 10.1 t -101.6 -25.2 13.97 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.244 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.414 -2.247 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.854 -178.458 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 18.9 m -67.54 -80.69 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.449 0 O-C-N 123.326 0.391 . . . . 0.0 111.729 175.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 156.94 164.15 13.23 Favored Glycine 0 N--CA 1.399 -3.807 0 N-CA-C 106.845 -2.502 . . . . 0.0 106.845 -176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.818 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 36.5 t70 -45.68 128.91 8.85 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 124.069 0.948 . . . . 0.0 112.24 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.806 HG21 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -50.06 148.18 6.2 Favored Pre-proline 0 N--CA 1.429 -1.491 0 O-C-N 125.042 1.464 . . . . 0.0 114.294 -175.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.412 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 36.6 Cg_endo -67.46 -164.33 0.09 OUTLIER 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.123 2.549 . . . . 0.0 112.308 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -137.17 141.15 42.18 Favored 'General case' 0 N--CA 1.409 -2.509 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 717' ' ' PHE . 25.0 tp -89.01 123.35 33.25 Favored 'General case' 0 C--N 1.27 -2.857 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.729 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -42.38 -48.53 5.12 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 126.723 2.009 . . . . 0.0 115.079 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -134.54 24.99 3.75 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.446 0.641 . . . . 0.0 110.174 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -134.02 -145.69 5.33 Favored Glycine 0 C--N 1.288 -2.11 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.272 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.447 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -154.23 172.16 18.06 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -104.23 150.37 24.47 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -81.44 -77.9 0.2 Allowed 'General case' 0 C--N 1.287 -2.134 0 C-N-CA 120.988 -0.285 . . . . 0.0 110.674 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 67.0 tp -172.2 129.84 0.6 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 122.268 0.227 . . . . 0.0 110.412 -178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.499 ' HB2' HG13 ' A' ' 715' ' ' VAL . 48.2 t -141.2 -50.65 0.43 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.856 175.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 35.9 p 58.03 155.45 0.09 OUTLIER Pre-proline 0 CA--C 1.57 1.747 0 C-N-CA 125.392 1.477 . . . . 0.0 113.018 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.551 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 60.9 Cg_endo -66.51 174.91 5.69 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 122.027 1.818 . . . . 0.0 111.256 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.551 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.0 Cg_endo -79.07 -9.25 37.86 Favored 'Cis proline' 0 N--CA 1.485 1.013 0 N-CA-C 115.176 1.183 . . . . 0.0 115.176 5.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.818 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 77.8 m-85 72.59 76.17 0.15 Allowed 'General case' 0 C--N 1.316 -0.872 0 O-C-N 124.173 0.921 . . . . 0.0 110.242 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.432 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 25.0 m-85 -79.99 167.6 20.26 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.868 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.498 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 64.9 m-85 -72.77 134.81 45.12 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.042 178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.61 -4.95 66.78 Favored Glycine 0 N--CA 1.42 -2.369 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.21 149.43 35.51 Favored 'General case' 0 CA--C 1.477 -1.832 0 CA-C-O 121.361 0.6 . . . . 0.0 110.853 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 12.7 m -129.58 153.38 48.11 Favored 'General case' 0 C--N 1.279 -2.491 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.806 HG21 HG21 ' A' ' 694' ' ' ILE . 24.8 t -136.48 142.35 38.58 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.656 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -178.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -97.49 136.67 37.58 Favored 'General case' 0 N--CA 1.41 -2.429 0 CA-C-O 121.532 0.682 . . . . 0.0 110.483 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.617 ' HB3' HD22 ' A' ' 697' ' ' LEU . 32.1 m-85 -135.4 118.89 16.88 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.447 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 14.2 m-80 -121.91 -163.8 1.1 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 21.6 m -116.02 141.39 48.18 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 38.8 t -64.24 -92.14 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.498 0 O-C-N 123.841 0.713 . . . . 0.0 111.22 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -139.09 153.6 48.05 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 74.8 m 71.62 1.51 3.9 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 124.491 1.119 . . . . 0.0 113.164 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.561 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.7 m-85 -132.17 143.55 50.05 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-O 121.73 0.776 . . . . 0.0 109.585 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.642 HG21 HD21 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -111.71 141.95 44.67 Favored 'General case' 0 C--N 1.253 -3.619 0 CA-C-N 113.097 -1.865 . . . . 0.0 111.869 -178.159 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.716 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 2.8 ttp -85.64 122.91 30.41 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.476 1.51 . . . . 0.0 108.977 178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.544 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 50.8 mm -115.77 129.43 72.12 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.575 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.378 175.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 93.85 -85.17 1.06 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.5 -0.773 . . . . 0.0 113.329 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.579 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -125.36 172.41 9.63 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -174.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.716 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -135.37 18.52 3.38 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 170.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 34.7 p -144.92 158.91 43.64 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 121.285 0.564 . . . . 0.0 110.919 -177.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.5 pt -123.31 162.82 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 CA-C-N 114.459 -1.246 . . . . 0.0 108.345 177.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 739' ' ' THR . 24.0 m -136.15 133.75 37.53 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.204 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.4 t -85.31 101.21 12.36 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -136.9 140.08 43.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.636 -1.165 . . . . 0.0 109.903 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 64.38 6.39 3.04 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.94 18.43 31.99 Favored Glycine 0 CA--C 1.494 -1.279 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.044 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 9.7 p -148.18 148.62 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.009 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.439 ' CZ3' HG23 ' A' ' 715' ' ' VAL . 93.5 m95 -78.95 169.71 17.8 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.037 173.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 732' ' ' THR . 38.9 p -81.16 -166.9 1.25 Allowed 'General case' 0 N--CA 1.422 -1.854 0 CA-C-O 121.857 0.836 . . . . 0.0 112.825 -177.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -70.25 -4.82 23.67 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -168.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.402 HD13 HG21 ' A' ' 731' ' ' ILE . 4.3 mm? 68.16 158.6 0.15 Allowed Pre-proline 0 N--CA 1.493 1.722 0 CA-C-O 120.998 0.428 . . . . 0.0 111.256 -175.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.579 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 44.9 Cg_endo -81.92 178.04 6.82 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 121.854 1.703 . . . . 0.0 111.188 170.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.544 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.6 tt0 -120.41 115.15 22.95 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.571 ' SG ' HD21 ' A' ' 697' ' ' LEU . 94.2 m -97.94 108.09 20.72 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.609 0.719 . . . . 0.0 110.71 176.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.416 ' C ' ' H ' ' A' ' 747' ' ' ILE . 26.8 t -100.93 141.95 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.596 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.525 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.561 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.39 4.11 0.58 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 125.913 1.685 . . . . 0.0 113.455 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.753 ' HA ' HD22 ' A' ' 750' ' ' LEU . 60.3 mt 74.76 -14.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 126.238 1.815 . . . . 0.0 111.028 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.463 ' H ' ' C ' ' A' ' 746' ' ' ALA . 19.2 t70 -80.42 -30.55 37.67 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 114.166 -1.379 . . . . 0.0 108.648 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.426 ' NZ ' ' HB3' ' A' ' 749' ' ' LYS . 0.2 OUTLIER -95.38 11.89 31.17 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.711 -1.586 . . . . 0.0 108.706 -176.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 1.113 ' HG ' HD22 ' A' ' 794' ' ' ASN . 0.4 OUTLIER -82.41 -168.94 2.19 Favored 'General case' 0 N--CA 1.409 -2.513 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.737 179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.539 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 31.7 mmmt -126.13 146.81 49.79 Favored 'General case' 0 N--CA 1.392 -3.348 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -103.72 122.39 44.95 Favored 'General case' 1 C--N 1.242 -4.068 0 CA-C-N 112.92 -1.945 . . . . 0.0 107.781 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . 0.511 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 55.6 m -71.91 157.48 37.78 Favored 'General case' 0 C--N 1.253 -3.61 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.314 177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -127.77 145.4 50.93 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 176.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 48.2 t -56.63 127.67 32.54 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.286 174.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.545 ' HB3' HG12 ' A' ' 759' ' ' ILE . 26.3 t -76.52 160.53 29.39 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.401 0.619 . . . . 0.0 110.358 178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -86.92 -4.1 59.14 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.322 -176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 803' ' ' CYS . 2.8 mm? -110.52 -2.71 16.35 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.966 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.687 HG22 ' SG ' ' A' ' 803' ' ' CYS . 28.6 pt -109.94 156.79 10.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.852 -173.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . 0.579 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.6 mp -121.27 127.46 75.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.555 HD11 HD12 ' A' ' 759' ' ' ILE . 2.0 mm? -105.37 -178.71 3.73 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.461 ' HB2' HD23 ' A' ' 765' ' ' LEU . 38.1 mt-10 -68.6 173.97 4.62 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 175.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.79 -17.81 64.65 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.964 -0.46 . . . . 0.0 111.57 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . 0.501 ' HB2' HD22 ' A' ' 765' ' ' LEU . 6.3 m-70 -87.26 -35.0 18.73 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 -178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.513 ' HB2' ' HB3' ' A' ' 761' ' ' LEU . 2.6 mm? -90.97 -19.47 23.21 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-N 114.173 -1.376 . . . . 0.0 112.288 -171.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm -71.04 -16.5 62.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.689 0.757 . . . . 0.0 109.25 170.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -99.87 16.83 22.5 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-O 122.367 1.08 . . . . 0.0 108.464 176.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.409 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 14.5 tppt? -111.71 111.76 22.97 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . 0.403 ' HB3' ' HE3' ' A' ' 769' ' ' LYS . 26.8 ttpp -73.33 -42.59 62.14 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.389 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -139.53 143.4 37.41 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.105 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 753' ' ' CYS . 83.4 m-85 -113.48 135.96 53.31 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.45 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -86.52 160.73 18.88 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.687 ' HB3' HD23 ' A' ' 750' ' ' LEU . 65.7 t60 -61.84 151.27 34.87 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.382 0.134 . . . . 0.0 110.667 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 4.3 m120 78.44 14.19 1.4 Allowed 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 123.987 0.915 . . . . 0.0 112.453 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 44.3 m -91.78 113.26 25.49 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -90.65 111.4 22.71 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.497 HD12 HD12 ' A' ' 761' ' ' LEU . 10.2 pt -122.81 179.3 2.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 CA-C-O 121.586 0.708 . . . . 0.0 109.165 -178.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.685 ' HA ' ' HA ' ' A' ' 789' ' ' HIS . 20.7 ptt180 -133.25 120.7 21.44 Favored 'General case' 0 N--CA 1.399 -3.023 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 172.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.632 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 2.7 p90 -108.21 167.61 9.89 Favored 'General case' 0 N--CA 1.407 -2.6 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 175.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . 0.5 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 32.9 ptt180 -146.34 156.05 43.06 Favored 'General case' 0 C--N 1.262 -3.204 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 73.7 m -100.47 134.42 43.45 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.53 177.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . 0.579 ' HB3' HD11 ' A' ' 760' ' ' ILE . 36.7 ptt180 -59.57 -48.95 79.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -176.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -85.92 6.0 82.3 Favored Glycine 0 C--O 1.217 -0.967 0 C-N-CA 120.309 -0.948 . . . . 0.0 113.319 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.7 mptt -110.02 -47.75 3.28 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 70.19 129.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 125.238 1.415 . . . . 0.0 111.771 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 111.95 144.96 9.67 Favored Glycine 0 N--CA 1.431 -1.643 0 N-CA-C 110.184 -1.166 . . . . 0.0 110.184 -175.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 25.9 m95 -93.93 144.23 25.63 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -176.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.632 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -100.94 -32.23 3.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.628 -178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 11.5 m170 73.95 129.93 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 124.555 1.142 . . . . 0.0 110.091 -175.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.522 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 3.2 t -151.8 159.18 44.0 Favored 'General case' 0 C--N 1.274 -2.675 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.771 -177.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 48.2 t -120.17 134.77 62.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.985 -176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.09 114.09 7.91 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.521 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 50.8 mm -116.94 87.92 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.048 0 C-N-CA 124.745 1.218 . . . . 0.0 109.21 -178.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 1.113 HD22 ' HG ' ' A' ' 750' ' ' LEU . 0.6 OUTLIER 46.74 66.01 1.08 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.762 0.825 . . . . 0.0 112.353 175.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 69.99 27.88 72.48 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.341 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -151.03 166.44 30.7 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 98.1 m95 -110.81 160.74 16.47 Favored 'General case' 0 C--N 1.256 -3.493 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -147.68 103.3 3.68 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.05 138.22 46.1 Favored 'Cis proline' 0 C--O 1.246 0.916 0 C-N-CA 123.956 -1.268 . . . . 0.0 112.325 1.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.606 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 4.2 tp10 -59.58 126.6 28.24 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.304 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 16.4 m -73.02 129.28 36.1 Favored 'Isoleucine or valine' 1 N--CA 1.358 -5.054 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.584 -172.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -153.69 106.51 2.9 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . 0.687 ' SG ' HG22 ' A' ' 759' ' ' ILE . 85.7 m -109.02 4.05 22.76 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.119 0.485 . . . . 0.0 111.73 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . 0.51 ' HB2' ' HG ' ' A' ' 758' ' ' LEU . 24.0 t . . . . . 0 N--CA 1.423 -1.777 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.434 -1.258 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 12.6 m -72.83 -59.4 2.73 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.908 0.385 . . . . 0.0 110.768 176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 130.51 179.79 16.33 Favored Glycine 1 N--CA 1.367 -5.923 0 N-CA-C 108.154 -1.978 . . . . 0.0 108.154 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -40.51 130.12 2.39 Favored 'General case' 0 C--N 1.278 -2.507 0 C-N-CA 126.348 1.859 . . . . 0.0 111.747 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.587 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -61.94 149.05 86.86 Favored Pre-proline 0 N--CA 1.432 -1.345 0 CA-C-N 114.596 -1.184 . . . . 0.0 112.64 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.496 ' HG3' HD21 ' A' ' 741' ' ' LEU . 59.7 Cg_endo -71.98 -161.62 0.1 Allowed 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.475 2.784 . . . . 0.0 111.276 176.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -136.31 149.74 48.57 Favored 'General case' 0 N--CA 1.408 -2.555 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.655 HD22 ' HB3' ' A' ' 717' ' ' PHE . 23.3 tp -93.82 123.37 37.12 Favored 'General case' 0 C--N 1.255 -3.522 0 CA-C-N 114.706 -1.134 . . . . 0.0 110.073 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 5.0 pt-20 -34.24 -53.43 0.49 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.215 1.806 . . . . 0.0 115.545 -176.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.451 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 82.4 m-70 -135.98 27.83 3.22 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -128.7 -149.96 7.07 Favored Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 119.605 -1.284 . . . . 0.0 112.096 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.434 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -146.23 175.04 10.8 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -177.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.12 133.55 49.71 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 14.0 mm100 -74.42 -61.76 1.76 Allowed 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.054 0.454 . . . . 0.0 111.4 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.7 tt -169.65 138.29 1.86 Allowed 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 103.486 -2.783 . . . . 0.0 103.486 176.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.52 ' HA ' HG13 ' A' ' 715' ' ' VAL . 59.2 p -115.59 -41.76 3.21 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -169.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 33.5 m 62.3 95.58 0.05 OUTLIER Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 125.094 1.358 . . . . 0.0 113.887 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.15 172.55 13.75 Favored 'Trans proline' 0 C--O 1.25 1.1 0 C-N-CA 122.297 1.998 . . . . 0.0 108.745 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.405 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 16.5 Cg_exo -71.16 -5.15 10.96 Favored 'Cis proline' 0 N--CA 1.506 2.226 0 CA-C-N 120.825 1.33 . . . . 0.0 115.27 4.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.456 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 56.9 m-85 78.98 69.99 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.655 0 O-C-N 124.876 1.36 . . . . 0.0 109.154 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.405 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 58.3 m-85 -77.46 170.4 16.63 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.941 -1.482 . . . . 0.0 112.589 -179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -73.39 129.63 38.41 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.053 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.48 -4.87 51.26 Favored Glycine 0 N--CA 1.421 -2.363 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.352 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -82.86 151.19 26.12 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 120.878 0.371 . . . . 0.0 110.924 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 3.8 m -131.29 156.07 46.08 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.587 HG21 HG21 ' A' ' 694' ' ' ILE . 52.7 t -137.64 129.74 40.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 47.0 mt-10 -77.35 134.46 38.47 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 123.988 0.805 . . . . 0.0 111.038 176.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.655 ' HB3' HD22 ' A' ' 697' ' ' LEU . 35.8 m-85 -139.94 112.94 8.16 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 125.026 1.33 . . . . 0.0 107.584 177.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.434 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 16.5 m-80 -121.07 -164.51 1.13 Allowed 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.514 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 7.1 m -109.7 133.84 52.66 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 2.4 m -53.07 -73.23 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.751 0.82 . . . . 0.0 111.137 -174.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -169.31 158.73 8.34 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 66.0 m 69.73 13.36 8.12 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.203 0.939 . . . . 0.0 111.563 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.699 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.4 m-85 -143.74 145.14 32.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 C-N-CA 124.733 1.213 . . . . 0.0 107.752 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.495 ' HB ' HD11 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -113.74 136.41 52.88 Favored 'General case' 0 C--N 1.257 -3.44 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.988 -177.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.482 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.2 ttp -81.76 120.22 24.86 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 124.848 1.259 . . . . 0.0 109.516 -175.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.575 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 45.4 mm -113.1 121.25 64.96 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.647 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.222 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 87.49 -82.13 1.61 Allowed Glycine 0 N--CA 1.439 -1.147 0 CA-C-N 114.856 -1.065 . . . . 0.0 114.121 174.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.428 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.7 m80 -114.3 173.9 6.22 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 123.797 0.839 . . . . 0.0 110.569 -173.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.482 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -146.14 15.95 1.35 Allowed 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 121.276 0.56 . . . . 0.0 109.647 172.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 37.5 m -152.59 162.1 41.68 Favored 'General case' 0 C--N 1.311 -1.084 0 O-C-N 121.554 -0.716 . . . . 0.0 110.291 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.5 pt -123.84 162.23 25.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.299 178.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 8.7 m -133.31 134.18 43.52 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 123.522 0.514 . . . . 0.0 110.841 -178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 5.0 t -85.24 106.42 16.65 Favored 'General case' 0 C--O 1.256 1.429 0 CA-C-O 121.694 0.759 . . . . 0.0 109.389 175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.32 142.17 35.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.618 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 72.87 -53.47 0.7 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.726 1.21 . . . . 0.0 111.367 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 160.39 26.29 0.02 OUTLIER Glycine 0 C--N 1.288 -2.117 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 24.2 t -151.25 154.4 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 -173.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.432 ' HZ2' ' HB3' ' A' ' 709' ' ' TYR . 95.8 m95 -78.98 -178.85 6.31 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 169.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 18.3 p -84.69 -158.5 0.35 Allowed 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.347 0.594 . . . . 0.0 112.253 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.3 pp0? -81.56 -11.45 59.15 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -168.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.496 HD21 ' HG3' ' A' ' 695' ' ' PRO . 4.4 mm? 72.17 137.69 0.05 OUTLIER Pre-proline 0 N--CA 1.478 0.97 0 N-CA-C 113.126 0.788 . . . . 0.0 113.126 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.428 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 30.8 Cg_endo -66.07 -179.44 1.41 Allowed 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.773 2.315 . . . . 0.0 112.729 177.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.575 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 53.3 tt0 -124.45 137.75 54.41 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.519 ' SG ' HD21 ' A' ' 697' ' ' LEU . 58.6 m -123.92 98.75 5.94 Favored 'General case' 0 CA--C 1.466 -2.273 0 CA-C-O 121.586 0.708 . . . . 0.0 109.642 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.438 ' HB ' HD21 ' A' ' 750' ' ' LEU . 32.1 t -86.85 140.73 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.059 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.699 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.14 4.83 0.61 Allowed 'General case' 0 C--N 1.274 -2.704 0 C-N-CA 125.188 1.395 . . . . 0.0 114.112 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.85 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 32.3 mt 75.62 -17.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 C-N-CA 125.626 1.57 . . . . 0.0 111.428 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 746' ' ' ALA . 8.4 t70 -76.64 -32.35 57.96 Favored 'General case' 0 C--N 1.277 -2.58 0 C-N-CA 125.671 1.588 . . . . 0.0 109.124 -177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 11.8 mttm -103.63 12.51 34.79 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.827 -1.533 . . . . 0.0 109.216 -173.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.85 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 67.5 mt -76.77 148.82 36.43 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.39 178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -90.04 -170.25 2.72 Favored 'General case' 0 C--N 1.261 -3.269 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.011 -172.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt -120.26 126.8 51.5 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 113.352 -1.749 . . . . 0.0 106.477 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 35.9 m -87.77 150.59 23.48 Favored 'General case' 0 C--N 1.249 -3.763 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.061 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -116.81 139.84 50.12 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . 0.485 ' HB3' HD11 ' A' ' 761' ' ' LEU . 14.7 p -61.54 139.58 58.23 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.237 175.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.665 ' HB2' HG13 ' A' ' 759' ' ' ILE . 20.3 m -78.02 149.21 34.06 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 173.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -91.95 7.95 39.76 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 112.223 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 803' ' ' CYS . 4.3 mm? -106.98 -9.72 16.17 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.873 174.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.665 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.7 pp -109.0 152.11 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.74 -177.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . 0.449 ' HB ' ' CG ' ' A' ' 780' ' ' ARG . 3.5 mp -109.18 131.88 58.77 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.769 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 44.9 mt -103.63 178.82 4.45 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.51 168.7 8.68 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -61.26 -22.29 64.69 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.752 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -79.98 -42.3 24.19 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.696 HD22 ' HE2' ' A' ' 771' ' ' PHE . 35.0 mt -83.03 -19.78 36.29 Favored 'General case' 0 N--CA 1.423 -1.785 0 CA-C-N 113.003 -1.908 . . . . 0.0 113.102 -167.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -70.81 -6.38 37.42 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 121.352 0.596 . . . . 0.0 111.121 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -105.48 15.38 27.2 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.421 ' HE2' ' HB2' ' A' ' 768' ' ' LYS . 6.2 tppt? -122.61 105.87 10.48 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -75.78 -45.6 35.35 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -125.14 131.31 53.27 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.048 -178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.769 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 40.2 m-85 -103.0 164.89 11.34 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.448 -175.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -104.74 142.14 35.23 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.336 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.555 ' HD2' HD12 ' A' ' 750' ' ' LEU . 32.6 p-80 -41.37 140.1 0.93 Allowed 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 124.825 1.25 . . . . 0.0 113.716 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 25.1 m120 70.4 23.25 4.99 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 125.171 1.389 . . . . 0.0 112.965 176.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 22.0 t -96.11 121.75 38.22 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.473 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -92.7 104.11 16.41 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.631 HG21 ' CE2' ' A' ' 771' ' ' PHE . 4.5 pt -114.15 -173.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.12 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.972 -176.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 1.6 ptt180 -143.77 127.93 17.63 Favored 'General case' 0 N--CA 1.411 -2.411 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.0 174.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.471 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 6.8 p90 -117.22 174.94 5.84 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 177.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . 0.449 ' CG ' ' HB ' ' A' ' 760' ' ' ILE . 10.6 ptm180 -153.87 170.58 20.66 Favored 'General case' 0 N--CA 1.407 -2.62 0 O-C-N 124.374 1.047 . . . . 0.0 108.447 177.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.446 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 49.7 t -100.47 161.46 13.59 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -73.74 -21.51 60.18 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.938 0.399 . . . . 0.0 109.942 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -93.03 -4.99 64.45 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.214 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.446 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 13.7 mptt -120.8 107.9 13.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 112.33 0.492 . . . . 0.0 112.33 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . 0.439 ' HA ' ' NH2' ' A' ' 780' ' ' ARG . 12.2 tp10 -81.93 99.9 9.34 Favored 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 160.09 -165.91 34.94 Favored Glycine 0 CA--C 1.475 -2.424 0 N-CA-C 107.665 -2.174 . . . . 0.0 107.665 -177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.585 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 61.4 m95 -139.72 146.62 39.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 118.64 1.22 . . . . 0.0 109.665 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.471 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -100.29 -34.32 4.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.456 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 12.8 m170 77.24 135.15 0.06 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 124.622 1.169 . . . . 0.0 110.452 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.446 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.8 t -158.57 157.58 32.27 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.091 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 43.4 t -119.5 136.84 55.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 45.8 t -71.23 107.53 4.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.631 0.729 . . . . 0.0 109.482 177.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.3 mm -113.89 83.62 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.165 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.42 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.652 HD22 ' HA ' ' A' ' 750' ' ' LEU . 25.3 t-20 58.76 66.34 1.08 Allowed 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 122.403 1.097 . . . . 0.0 111.175 173.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 62.03 24.31 64.81 Favored Glycine 0 C--N 1.299 -1.478 0 CA-C-N 114.585 -1.189 . . . . 0.0 113.488 -178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -145.02 166.27 25.79 Favored 'General case' 0 C--O 1.202 -1.415 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.435 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.5 m95 -111.67 158.08 19.7 Favored 'General case' 0 C--N 1.255 -3.54 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -148.32 107.02 3.59 Favored Pre-proline 0 C--N 1.292 -1.929 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.36 142.54 66.8 Favored 'Cis proline' 0 C--O 1.243 0.758 0 C-N-CA 123.971 -1.262 . . . . 0.0 113.074 0.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.435 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.6 mt-10 -55.54 117.03 3.23 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.406 174.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.446 ' CG1' HG21 ' A' ' 790' ' ' THR . 7.2 m -70.11 138.2 22.5 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.171 0 C-N-CA 124.667 1.187 . . . . 0.0 112.519 -173.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -153.66 138.76 17.35 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.566 177.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 758' ' ' LEU . 49.7 t -125.22 -22.92 4.28 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 121.975 0.893 . . . . 0.0 108.886 175.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.423 -1.808 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 179.482 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 32.8 p . . . . . 0 N--CA 1.418 -2.068 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 13.7 m -93.81 -167.39 1.68 Allowed 'General case' 0 C--N 1.25 -3.735 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . -118.12 -156.23 10.22 Favored Glycine 1 N--CA 1.39 -4.386 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 178.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -62.19 142.36 57.7 Favored 'General case' 0 C--N 1.278 -2.507 0 O-C-N 124.717 0.892 . . . . 0.0 108.753 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.597 HG21 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -63.68 151.7 87.96 Favored Pre-proline 0 C--N 1.284 -2.25 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.928 -178.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.488 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 55.8 Cg_endo -71.14 -162.15 0.1 Allowed 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.074 2.516 . . . . 0.0 112.925 177.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.17 158.84 43.45 Favored 'General case' 0 N--CA 1.402 -2.866 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.605 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.8 OUTLIER -98.28 134.61 41.07 Favored 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.583 177.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -56.24 -37.97 70.47 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 113.469 0.915 . . . . 0.0 113.469 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -144.65 29.54 1.24 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.605 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -140.0 -138.92 3.68 Favored Glycine 0 C--N 1.305 -1.141 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.074 -176.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.405 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -159.09 179.83 8.68 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.394 0.678 . . . . 0.0 109.403 -179.022 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -114.22 144.58 42.98 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 176.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -71.41 -68.31 0.46 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.353 0.597 . . . . 0.0 110.861 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.9 tt -162.87 133.4 4.65 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.481 ' HB3' HG11 ' A' ' 715' ' ' VAL . 0.4 OUTLIER -137.1 114.0 10.51 Favored 'General case' 0 N--CA 1.401 -2.88 0 CA-C-O 121.747 0.784 . . . . 0.0 109.924 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -103.41 124.07 39.42 Favored Pre-proline 0 C--N 1.273 -2.749 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.447 -174.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.451 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 56.8 Cg_endo -66.45 172.49 9.03 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.495 2.13 . . . . 0.0 109.628 175.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.475 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 6.1 Cg_exo -75.21 -4.36 21.2 Favored 'Cis proline' 0 CA--C 1.497 -1.343 0 CA-C-N 119.801 0.965 . . . . 0.0 114.487 5.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.408 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 57.7 m-85 74.74 78.73 0.11 Allowed 'General case' 0 C--N 1.311 -1.068 0 O-C-N 124.936 1.398 . . . . 0.0 108.488 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.475 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 22.4 m-85 -82.41 172.13 13.4 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -73.75 125.85 29.04 Favored 'General case' 0 CA--C 1.485 -1.523 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.29 177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.75 -5.91 51.48 Favored Glycine 0 N--CA 1.411 -3.001 0 CA-C-N 115.283 -0.872 . . . . 0.0 111.086 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -69.84 154.06 42.48 Favored 'General case' 0 C--O 1.251 1.179 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 19.8 m -140.21 143.64 36.15 Favored 'General case' 0 C--N 1.271 -2.815 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.846 178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.597 HG21 HG21 ' A' ' 694' ' ' ILE . 47.0 t -131.54 137.08 56.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -85.84 135.21 33.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.966 0.889 . . . . 0.0 109.52 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -134.76 114.95 13.17 Favored 'General case' 0 C--N 1.268 -2.96 0 C-N-CA 126.395 1.878 . . . . 0.0 108.069 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.405 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 17.2 m-80 -120.84 -165.71 1.25 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 4.6 m -115.62 134.73 54.77 Favored 'General case' 0 C--N 1.276 -2.618 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -178.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.3 m -56.95 -80.5 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 O-C-N 124.166 0.916 . . . . 0.0 111.256 -175.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 722' ' ' SER . 48.0 mt-10 -154.16 161.35 41.92 Favored 'General case' 0 CA--C 1.472 -2.047 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 58.0 m 70.63 7.24 6.14 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 124.723 1.264 . . . . 0.0 111.948 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.1 m-85 -139.72 144.56 37.56 Favored 'General case' 0 N--CA 1.4 -2.956 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.481 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.1 m -113.07 140.7 47.64 Favored 'General case' 0 C--N 1.246 -3.908 0 CA-C-N 113.745 -1.571 . . . . 0.0 111.637 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.57 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.2 ttp -85.86 115.88 23.77 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 124.533 1.133 . . . . 0.0 108.853 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.0 mm -113.15 130.17 67.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.394 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.419 177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 87.84 -74.65 2.17 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 114.914 -1.039 . . . . 0.0 114.164 173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -128.03 174.35 9.28 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -174.215 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.57 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -140.44 10.51 2.29 Favored 'General case' 0 C--O 1.201 -1.47 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 170.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 1.6 m -141.59 168.35 19.99 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 714' ' ' SER . 34.2 pt -129.32 161.09 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 176.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.512 ' O ' HG23 ' A' ' 739' ' ' THR . 5.8 m -135.85 139.17 43.19 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 177.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 44.0 t -94.22 116.24 28.62 Favored 'General case' 0 N--CA 1.407 -2.611 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.336 175.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.3 pp -144.26 147.43 19.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 C-N-CA 125.403 1.481 . . . . 0.0 108.168 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 64.18 15.04 9.07 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 86.59 17.59 59.95 Favored Glycine 0 CA--C 1.505 -0.546 0 C-N-CA 121.628 -0.32 . . . . 0.0 112.84 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.2 p -153.06 156.97 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.824 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.488 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 88.7 m95 -78.98 169.11 18.71 Favored 'General case' 0 C--N 1.271 -2.829 0 CA-C-O 120.988 0.423 . . . . 0.0 110.16 175.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.512 HG23 ' O ' ' A' ' 732' ' ' THR . 21.8 p -73.48 -163.35 0.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.995 0.902 . . . . 0.0 112.845 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.548 ' NE2' ' H ' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -73.03 -12.95 61.11 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 124.772 1.229 . . . . 0.0 113.831 -170.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.4 mm? 73.28 149.96 0.13 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 123.921 0.763 . . . . 0.0 111.025 -175.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.411 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 42.6 Cg_endo -73.57 175.87 10.09 Favored 'Trans proline' 0 C--O 1.253 1.231 0 C-N-CA 121.761 1.64 . . . . 0.0 110.96 173.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -126.47 107.58 10.39 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 724' ' ' THR . 86.9 m -91.0 113.27 25.49 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.078 175.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.43 ' HB ' HD21 ' A' ' 750' ' ' LEU . 49.6 t -100.58 144.08 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.34 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.02 6.8 0.34 Allowed 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 125.973 1.709 . . . . 0.0 114.313 -175.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.825 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 55.4 mt 75.15 -19.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 125.663 1.585 . . . . 0.0 112.03 177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.5 t70 -73.39 -34.09 65.35 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.671 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.427 ' HB3' ' HE3' ' A' ' 749' ' ' LYS . 0.0 OUTLIER -114.11 29.93 7.65 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.859 -175.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.825 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 91.1 mt -83.32 -175.72 5.97 Favored 'General case' 0 N--CA 1.407 -2.609 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 173.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -105.92 147.09 29.17 Favored 'General case' 0 N--CA 1.384 -3.768 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 770' ' ' GLU . 22.4 mtpp -103.25 122.56 45.02 Favored 'General case' 1 C--N 1.237 -4.32 0 CA-C-N 113.041 -1.891 . . . . 0.0 108.65 -174.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 60.9 m -70.96 150.12 46.0 Favored 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.44 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -112.37 143.89 42.72 Favored 'General case' 0 N--CA 1.419 -2.016 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.314 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 4.4 p -67.23 118.06 10.1 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.644 171.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.419 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 43.2 t -79.37 153.82 29.47 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 176.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -100.82 0.45 38.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.084 0.469 . . . . 0.0 111.595 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 6.4 mp -91.43 -8.49 47.69 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.049 0.928 . . . . 0.0 108.573 178.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.507 HG12 ' CG1' ' A' ' 801' ' ' VAL . 2.8 pp -118.45 169.73 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.561 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.649 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . 0.592 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.5 mp -119.44 124.88 73.77 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.232 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.809 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 96.2 mt -97.47 179.24 4.93 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -68.15 167.73 13.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.385 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -12.38 61.6 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -174.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . 0.563 ' CD2' ' HG ' ' A' ' 765' ' ' LEU . 4.6 p-80 -100.64 -10.99 20.38 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.531 175.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.653 HD22 ' CE2' ' A' ' 771' ' ' PHE . 74.7 mt -110.4 -19.44 12.96 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -174.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -69.86 -12.74 61.85 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.755 0.788 . . . . 0.0 110.274 174.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -101.96 11.23 38.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.734 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.445 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 14.4 tppt? -104.5 108.44 19.88 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . 0.499 ' HD2' ' H ' ' A' ' 769' ' ' LYS . 0.0 OUTLIER -72.45 -36.7 68.6 Favored 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.185 -179.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 752' ' ' LYS . 43.3 mt-10 -144.41 133.4 22.69 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.898 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.809 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 71.7 m-85 -103.56 149.04 25.26 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -92.39 159.08 15.73 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.14 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.697 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 31.8 t60 -62.21 140.78 58.45 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.037 178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 89.17 3.26 0.21 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.957 1.703 . . . . 0.0 109.972 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 74.9 m -83.35 114.08 21.18 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.505 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.465 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -88.25 113.47 23.9 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.848 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.659 HG21 ' CE2' ' A' ' 771' ' ' PHE . 4.8 pt -126.98 -173.83 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -178.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.541 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 30.4 ptt180 -143.17 127.38 17.59 Favored 'General case' 0 N--CA 1.413 -2.278 0 O-C-N 122.165 -0.334 . . . . 0.0 110.173 173.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.692 ' CD2' HG13 ' A' ' 801' ' ' VAL . 11.0 p90 -108.74 170.92 7.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 174.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . 0.592 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 9.3 ptt180 -146.66 155.44 42.43 Favored 'General case' 0 C--N 1.269 -2.919 0 N-CA-C 106.213 -1.773 . . . . 0.0 106.213 173.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . . . . . . . . . 14.0 t -83.81 155.36 23.03 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -76.03 -5.74 47.81 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.624 0.726 . . . . 0.0 110.568 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -102.34 -10.13 39.7 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.074 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -122.07 125.04 45.36 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 122.084 -0.656 . . . . 0.0 111.697 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -92.65 79.9 4.8 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-O 122.073 0.939 . . . . 0.0 108.625 174.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 173.08 153.2 9.31 Favored Glycine 0 C--N 1.299 -1.494 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.541 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 40.4 m95 -101.58 164.86 11.54 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 117.085 0.443 . . . . 0.0 110.192 -173.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 788' ' ' ILE . 3.6 mp -115.25 -34.03 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.343 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.46 ' CD2' ' HB3' ' A' ' 778' ' ' ARG . 31.6 m170 76.18 121.35 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 124.493 1.117 . . . . 0.0 109.45 -173.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.482 HG21 ' CG2' ' A' ' 801' ' ' VAL . 3.5 t -141.92 155.89 45.49 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.13 134.07 61.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 46.9 t -68.96 119.66 13.63 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.697 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 49.5 mm -119.54 86.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 C-N-CA 124.774 1.23 . . . . 0.0 108.694 -179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.44 HD22 HD22 ' A' ' 750' ' ' LEU . 6.0 t-20 45.69 72.17 0.24 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.567 1.147 . . . . 0.0 112.233 177.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 68.16 19.66 72.32 Favored Glycine 0 C--N 1.3 -1.424 0 CA-C-N 115.05 -0.977 . . . . 0.0 114.178 -178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -144.52 165.13 28.84 Favored 'General case' 0 C--O 1.19 -2.043 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.66 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.6 m95 -111.6 160.41 17.23 Favored 'General case' 0 C--N 1.26 -3.287 0 O-C-N 121.735 -0.603 . . . . 0.0 110.225 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -149.29 105.77 3.33 Favored Pre-proline 0 C--N 1.314 -0.973 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -67.76 139.91 50.96 Favored 'Cis proline' 0 C--O 1.245 0.835 0 C-N-CA 123.842 -1.316 . . . . 0.0 110.508 -0.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.66 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.3 tt0 -56.27 125.27 21.07 Favored 'General case' 0 N--CA 1.432 -1.334 0 O-C-N 123.684 0.615 . . . . 0.0 111.153 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.692 HG13 ' CD2' ' A' ' 779' ' ' TYR . 93.9 t -65.89 108.77 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.249 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -144.62 127.1 15.96 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . 0.435 ' HB2' HG22 ' A' ' 759' ' ' ILE . 47.5 t -98.84 -33.48 10.87 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.439 -0.975 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 -177.806 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 34.0 p . . . . . 0 N--CA 1.414 -2.266 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 40.4 m -84.59 -76.36 0.31 Allowed 'General case' 0 C--N 1.254 -3.582 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.321 -178.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 149.09 -177.29 27.41 Favored Glycine 1 N--CA 1.358 -6.558 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -51.61 130.12 27.37 Favored 'General case' 0 C--N 1.278 -2.525 0 O-C-N 125.588 1.405 . . . . 0.0 109.946 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.63 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -60.01 150.25 70.71 Favored Pre-proline 0 N--CA 1.432 -1.352 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.915 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.552 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.0 Cg_endo -71.84 -163.51 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.954 0 C-N-CA 122.86 2.374 . . . . 0.0 111.471 177.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -135.74 156.51 48.7 Favored 'General case' 0 N--CA 1.402 -2.871 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.557 HD13 ' HA3' ' A' ' 700' ' ' GLY . 1.1 mt -88.56 144.65 26.19 Favored 'General case' 0 C--N 1.258 -3.37 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.358 177.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -60.42 -41.09 93.24 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 744' ' ' CYS . 93.6 m-70 -146.84 32.2 0.94 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -175.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.557 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -141.72 -149.65 5.24 Favored Glycine 0 C--N 1.3 -1.434 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.775 -176.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.417 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -148.38 -179.35 6.89 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -177.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -112.58 144.63 41.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 39.3 mm-40 -73.98 -67.71 0.58 Allowed 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.804 0.335 . . . . 0.0 110.33 176.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 68.5 tp -158.2 125.45 5.02 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.512 ' CB ' HG12 ' A' ' 694' ' ' ILE . 5.5 p -118.52 132.29 56.22 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 22.9 t -121.72 112.97 32.01 Favored Pre-proline 0 C--N 1.288 -2.098 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.999 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.33 165.62 26.27 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.143 1.896 . . . . 0.0 108.642 174.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.442 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 16.9 Cg_exo -67.81 -10.63 8.59 Favored 'Cis proline' 0 N--CA 1.498 1.759 0 N-CA-C 115.194 1.19 . . . . 0.0 115.194 5.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 705' ' ' SER . 61.9 m-85 74.07 87.04 0.1 Allowed 'General case' 0 C--N 1.309 -1.17 0 O-C-N 124.65 1.219 . . . . 0.0 108.044 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.53 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 50.3 m-85 -90.98 172.54 8.51 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.821 -1.082 . . . . 0.0 112.686 -176.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -71.45 138.51 49.1 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.255 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 88.07 4.77 77.78 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -178.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 2.5 t70 -77.34 165.79 23.99 Favored 'General case' 0 C--O 1.245 0.856 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 20.2 m -151.86 142.41 22.67 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.63 HG21 HG21 ' A' ' 694' ' ' ILE . 44.8 t -133.56 134.37 56.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 39.1 mt-10 -80.51 135.67 36.15 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 123.896 0.748 . . . . 0.0 111.426 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -136.61 114.3 11.13 Favored 'General case' 0 C--N 1.291 -1.961 0 C-N-CA 125.837 1.655 . . . . 0.0 107.471 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.417 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 14.4 m-80 -124.06 -163.0 1.11 Allowed 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.609 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 10.0 m -108.16 144.23 35.86 Favored 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . 0.599 ' O ' ' HG3' ' A' ' 721' ' ' GLU . 5.1 m -55.81 -70.43 0.11 Allowed 'General case' 0 C--N 1.313 -0.992 0 O-C-N 123.769 0.668 . . . . 0.0 109.872 -175.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . 0.599 ' HG3' ' O ' ' A' ' 720' ' ' SER . 30.7 mt-10 -175.22 164.39 3.25 Favored 'General case' 0 CA--C 1.485 -1.532 0 C-N-CA 129.279 3.031 . . . . 0.0 102.822 173.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 62.6 m 68.51 12.56 8.75 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.993 0.808 . . . . 0.0 111.509 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.715 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.8 m-85 -143.74 147.96 34.96 Favored 'General case' 0 N--CA 1.407 -2.615 0 C-N-CA 124.83 1.252 . . . . 0.0 108.11 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.634 HG21 HD21 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -112.93 135.27 53.89 Favored 'General case' 0 C--N 1.255 -3.528 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.996 -177.174 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.724 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.8 ttp -85.06 113.26 21.34 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 124.93 1.292 . . . . 0.0 109.758 -177.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.545 HD12 HG23 ' A' ' 793' ' ' ILE . 45.3 mm -115.27 131.3 67.96 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.336 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 94.57 -91.34 1.4 Allowed Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.772 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.56 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.1 m80 -114.34 178.42 4.29 Favored 'General case' 0 C--N 1.274 -2.706 0 CA-C-N 114.508 -0.846 . . . . 0.0 110.357 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.724 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -144.92 14.21 1.5 Allowed 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 168.2 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 33.9 m -149.18 162.41 40.05 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 714' ' ' SER . 28.8 pt -121.1 166.73 15.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 739' ' ' THR . 3.8 m -135.75 139.94 43.96 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 43.3 t -99.82 116.91 32.99 Favored 'General case' 0 N--CA 1.406 -2.634 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.47 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.2 pp -142.82 149.29 18.9 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-N 114.004 -1.453 . . . . 0.0 107.444 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 73.74 -21.83 0.26 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 123.662 0.785 . . . . 0.0 112.087 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 120.24 14.27 5.53 Favored Glycine 0 CA--C 1.505 -0.542 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.3 p -148.53 150.53 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.552 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.8 m95 -77.2 169.25 18.66 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.467 175.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 732' ' ' THR . 24.9 p -77.23 -160.8 0.18 Allowed 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.67 0.748 . . . . 0.0 112.396 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.501 ' NE2' ' H ' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -84.69 -12.86 53.0 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.991 -168.419 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.406 HD21 ' HG2' ' A' ' 695' ' ' PRO . 0.9 OUTLIER 70.81 159.32 0.16 Allowed Pre-proline 0 N--CA 1.47 0.55 0 O-C-N 124.009 0.818 . . . . 0.0 112.237 -177.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.56 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 37.6 Cg_endo -75.13 178.9 6.68 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.241 1.961 . . . . 0.0 112.155 175.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -122.91 101.33 7.37 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.023 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 699' ' ' HIS . 73.1 m -84.59 112.4 20.4 Favored 'General case' 0 CA--C 1.485 -1.536 0 CA-C-O 121.094 0.474 . . . . 0.0 110.58 175.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 22.5 t -99.72 144.04 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.715 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.33 1.16 0.81 Allowed 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 125.08 1.352 . . . . 0.0 114.254 -176.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.751 ' HA ' HD22 ' A' ' 750' ' ' LEU . 34.5 mt 76.54 -18.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 C-N-CA 124.991 1.317 . . . . 0.0 110.971 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.0 t70 -77.84 -23.82 48.81 Favored 'General case' 0 C--N 1.293 -1.851 0 C-N-CA 125.884 1.673 . . . . 0.0 109.203 -177.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -110.89 18.95 19.02 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 113.586 -1.643 . . . . 0.0 108.842 -173.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.828 ' HG ' ' ND2' ' A' ' 794' ' ' ASN . 3.1 mp -85.7 -176.8 6.19 Favored 'General case' 0 N--CA 1.416 -2.138 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.859 177.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.49 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 53.1 mtpt -140.48 164.92 28.84 Favored 'General case' 0 C--N 1.273 -2.746 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -177.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -109.02 140.39 42.61 Favored 'General case' 0 C--N 1.257 -3.423 0 C-N-CA 126.021 1.728 . . . . 0.0 108.256 -178.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 59.8 m -88.01 165.06 15.45 Favored 'General case' 1 C--N 1.239 -4.238 0 CA-C-N 114.106 -1.407 . . . . 0.0 109.147 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . 0.412 ' HE2' ' HB3' ' A' ' 754' ' ' LYS . 17.4 ptpt -132.77 147.62 52.32 Favored 'General case' 0 N--CA 1.413 -2.323 0 C-N-CA 120.119 -0.632 . . . . 0.0 109.988 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.18 114.04 3.53 Favored 'General case' 0 C--N 1.27 -2.875 0 CA-C-N 114.033 -1.439 . . . . 0.0 109.916 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.617 ' HB2' ' CG1' ' A' ' 759' ' ' ILE . 55.9 m -72.98 149.78 43.03 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -80.08 -9.24 59.69 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.887 0.851 . . . . 0.0 110.458 -176.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 90.9 mt -89.83 -11.92 40.63 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.402 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.617 ' CG1' ' HB2' ' A' ' 756' ' ' SER . 2.4 pp -118.06 140.03 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.401 -173.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . 0.419 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.1 mp -104.39 131.21 53.83 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.014 -1.448 . . . . 0.0 107.53 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.618 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 2.1 mm? -108.56 -177.79 3.41 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 120.845 0.355 . . . . 0.0 110.114 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -71.48 167.61 19.28 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -57.86 -17.54 16.98 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.054 0.941 . . . . 0.0 112.639 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -85.62 -42.1 14.63 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.62 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 66.7 mt -85.65 -15.42 42.45 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 113.452 -1.704 . . . . 0.0 112.652 -169.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -73.96 -13.81 60.94 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.472 0.653 . . . . 0.0 110.508 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -96.51 0.33 50.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.335 1.064 . . . . 0.0 108.459 176.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.421 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 8.7 tppt? -103.08 118.48 36.9 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . 0.405 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 9.8 ptpp? -96.76 -19.85 18.64 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . 0.405 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 35.5 mt-10 -136.25 122.7 20.73 Favored 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.283 176.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.529 ' CE2' HD22 ' A' ' 765' ' ' LEU . 76.1 m-85 -98.96 142.56 30.31 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -87.71 148.2 24.87 Favored 'General case' 0 C--N 1.286 -2.193 0 C-N-CA 120.29 -0.564 . . . . 0.0 109.954 -177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.686 ' CG ' HD23 ' A' ' 750' ' ' LEU . 47.1 p-80 -42.47 141.7 0.95 Allowed 'General case' 0 CA--C 1.558 1.265 0 C-N-CA 125.359 1.463 . . . . 0.0 111.259 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 63.6 t30 75.57 2.42 3.78 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 125.026 1.33 . . . . 0.0 111.825 177.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 18.2 t -82.24 118.49 23.15 Favored 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 121.292 -0.88 . . . . 0.0 108.666 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.474 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -87.81 106.22 17.93 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 178.159 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.62 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.6 pt -115.97 -170.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.584 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 7.1 ptp180 -150.82 134.99 16.86 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 175.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.525 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 8.1 p90 -119.15 173.52 6.87 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . 0.419 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 10.5 ptt180 -155.4 169.82 23.36 Favored 'General case' 0 N--CA 1.408 -2.535 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 59.3 m -97.79 164.31 12.44 Favored 'General case' 0 C--N 1.282 -2.341 0 O-C-N 123.876 0.735 . . . . 0.0 109.093 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . 0.53 ' HD2' ' H ' ' A' ' 782' ' ' ARG . 0.0 OUTLIER -66.72 -36.95 83.69 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.854 178.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -98.35 5.18 60.64 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.404 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.0 mptt -127.65 105.15 8.28 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . 0.417 ' HA ' ' HD2' ' A' ' 780' ' ' ARG . 35.9 tt0 -90.58 78.88 6.21 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.879 0.847 . . . . 0.0 109.952 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -164.1 144.58 9.56 Favored Glycine 0 CA--C 1.472 -2.636 0 N-CA-C 107.208 -2.357 . . . . 0.0 107.208 177.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.584 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 38.5 m95 -101.66 131.61 47.81 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 117.405 0.602 . . . . 0.0 109.992 -174.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.525 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -87.87 -30.5 5.6 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.757 -174.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 15.3 m170 71.53 125.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 124.549 1.14 . . . . 0.0 109.119 -176.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.408 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 3.4 t -147.9 155.6 41.77 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 122.196 -0.315 . . . . 0.0 110.438 -178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.4 t -117.58 135.69 57.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -176.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 53.6 t -72.92 114.08 10.66 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.845 0.831 . . . . 0.0 110.342 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.545 HG23 HD12 ' A' ' 726' ' ' ILE . 50.9 mm -115.29 80.6 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 C-N-CA 124.501 1.121 . . . . 0.0 108.713 -177.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.828 ' ND2' ' HG ' ' A' ' 750' ' ' LEU . 1.0 OUTLIER 52.08 64.64 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.464 176.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.61 22.53 78.31 Favored Glycine 0 C--N 1.308 -0.996 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.576 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -147.28 164.18 34.05 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.617 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 89.0 m95 -111.75 159.56 18.15 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-O 120.581 0.229 . . . . 0.0 110.534 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 21.9 t70 -149.19 103.79 3.33 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 798' ' ' ASP . 47.7 Cg_endo -72.13 141.57 71.08 Favored 'Cis proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.876 -1.302 . . . . 0.0 113.602 -0.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.617 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 2.9 mm-40 -53.32 127.73 25.76 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.138 174.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.485 ' HB ' HG21 ' A' ' 759' ' ' ILE . 3.2 m -84.17 138.75 18.64 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.362 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.997 -176.269 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -165.77 135.88 3.51 Favored 'General case' 0 CA--C 1.493 -1.218 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . 0.453 ' SG ' HG22 ' A' ' 759' ' ' ILE . 58.1 m -142.64 34.33 1.43 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -176.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 17.8 p . . . . . 0 N--CA 1.422 -1.869 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 174.285 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.42 -1.937 0 CA-C-O 120.971 0.415 . . . . 0.0 110.022 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 39.0 m -80.62 -66.23 0.91 Allowed 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.54 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 128.37 -177.54 17.66 Favored Glycine 1 N--CA 1.367 -5.917 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.409 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 30.9 t70 -34.14 128.36 0.4 Allowed 'General case' 0 C--N 1.279 -2.499 0 C-N-CA 127.023 2.129 . . . . 0.0 112.727 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.698 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -61.82 150.29 82.82 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.163 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.457 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 57.0 Cg_endo -72.17 -159.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.684 2.256 . . . . 0.0 111.74 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.15 -173.29 3.22 Favored 'General case' 0 N--CA 1.401 -2.884 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 175.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 717' ' ' PHE . 22.0 tp -128.6 126.0 39.36 Favored 'General case' 0 C--N 1.269 -2.921 0 CA-C-O 120.872 0.368 . . . . 0.0 110.384 -177.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -49.44 -37.9 27.47 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.4 m-70 -137.09 24.68 3.01 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -141.79 -146.76 4.74 Favored Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.21 -0.995 . . . . 0.0 110.846 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.476 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.01 179.21 8.25 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.704 0.288 . . . . 0.0 110.324 -177.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -112.49 143.41 43.68 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -75.2 -75.54 0.17 Allowed 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.241 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.7 tt -176.46 132.17 0.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.455 ' HB2' HG13 ' A' ' 715' ' ' VAL . 9.9 t -154.23 146.96 24.25 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 10.1 t -117.07 149.14 43.73 Favored Pre-proline 0 C--N 1.279 -2.461 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -175.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.521 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 59.4 Cg_endo -65.97 174.54 5.64 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.61 2.207 . . . . 0.0 110.454 177.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.521 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.8 Cg_endo -79.95 -4.18 40.5 Favored 'Cis proline' 0 C--O 1.215 -0.633 0 CA-C-N 119.799 0.964 . . . . 0.0 114.541 4.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.442 ' CE1' HG23 ' A' ' 694' ' ' ILE . 77.1 m-85 68.92 79.32 0.21 Allowed 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 121.326 0.584 . . . . 0.0 110.262 177.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 30.1 m-85 -83.56 170.81 13.97 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.47 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 44.0 m-85 -68.46 137.11 54.19 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.322 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.9 -5.38 68.99 Favored Glycine 0 N--CA 1.427 -1.928 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.3 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 2.9 t70 -71.14 157.59 37.9 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 20.2 m -149.22 139.36 22.17 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.698 HG21 HG21 ' A' ' 694' ' ' ILE . 41.0 t -130.48 140.93 47.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.033 -174.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 729' ' ' ARG . 1.6 mp0 -80.2 131.79 35.76 Favored 'General case' 0 C--O 1.249 1.074 0 CA-C-O 122.168 0.985 . . . . 0.0 112.872 176.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.576 ' HB3' HD22 ' A' ' 697' ' ' LEU . 32.1 m-85 -135.89 107.96 7.19 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 113.608 -1.633 . . . . 0.0 107.297 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.476 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 9.0 m-80 -115.51 -163.46 0.89 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 8.3 m -116.06 134.91 54.45 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 3.2 m -58.04 -70.87 0.12 Allowed 'General case' 0 C--N 1.288 -2.094 0 O-C-N 124.163 0.914 . . . . 0.0 111.87 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -164.33 161.37 21.72 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 74.9 m 69.84 2.75 3.99 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.995 0.81 . . . . 0.0 112.847 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.609 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.5 m-85 -137.5 148.75 46.26 Favored 'General case' 0 N--CA 1.401 -2.892 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.502 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -115.08 141.91 47.36 Favored 'General case' 0 C--N 1.259 -3.336 0 C-N-CA 124.991 1.316 . . . . 0.0 109.996 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.8 ttp -85.84 120.71 27.56 Favored 'General case' 0 CA--C 1.494 -1.177 0 C-N-CA 124.071 0.948 . . . . 0.0 109.826 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 43.2 mm -111.82 122.18 65.68 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.819 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.763 174.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 114.15 -94.86 0.71 Allowed Glycine 0 N--CA 1.423 -2.226 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.966 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 53.0 t60 -156.97 139.1 14.55 Favored 'General case' 0 CA--C 1.472 -2.054 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.56 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -85.71 25.76 1.04 Allowed 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -174.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 15.4 m -143.87 156.24 44.39 Favored 'General case' 0 C--N 1.289 -2.039 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.776 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 714' ' ' SER . 41.2 pt -118.65 160.58 18.33 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.062 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.419 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.474 ' O ' HG23 ' A' ' 739' ' ' THR . 20.1 m -134.02 135.87 43.68 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.973 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . 0.47 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.3 t -85.65 104.07 15.05 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.8 pp -146.65 144.18 20.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 C-N-CA 124.034 0.934 . . . . 0.0 110.246 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 67.85 8.16 6.25 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 94.51 20.28 29.96 Favored Glycine 0 CA--C 1.5 -0.844 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.376 178.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.7 p -157.46 158.93 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.457 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 94.5 m95 -78.04 172.71 13.1 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 171.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 25.5 p -76.38 -169.56 1.23 Allowed 'General case' 0 N--CA 1.426 -1.644 0 CA-C-O 121.976 0.893 . . . . 0.0 112.999 -174.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.2 pp0? -65.55 -20.64 66.41 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 -173.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 5.6 mt 70.68 138.55 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 124.547 1.154 . . . . 0.0 112.882 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.501 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 56.7 Cg_endo -67.04 167.12 20.75 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.363 2.042 . . . . 0.0 112.428 -177.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.434 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.2 tt0 -112.47 102.42 10.53 Favored 'General case' 0 C--N 1.27 -2.883 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.493 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 89.4 m -82.55 111.19 18.31 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.614 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.461 ' HB ' HD21 ' A' ' 750' ' ' LEU . 48.2 t -99.45 145.35 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.497 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.67 4.16 0.63 Allowed 'General case' 0 C--N 1.291 -1.976 0 C-N-CA 125.411 1.484 . . . . 0.0 113.716 -175.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.884 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 57.6 mt 76.47 -22.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 C-N-CA 126.183 1.793 . . . . 0.0 110.757 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 746' ' ' ALA . 12.1 t70 -67.41 -34.86 78.12 Favored 'General case' 0 C--N 1.265 -3.092 0 C-N-CA 126.029 1.732 . . . . 0.0 109.841 -174.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.75 24.12 13.35 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 113.578 -1.647 . . . . 0.0 111.658 -175.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.884 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 85.9 mt -78.65 166.01 23.0 Favored 'General case' 0 N--CA 1.401 -2.882 0 CA-C-O 121.644 0.735 . . . . 0.0 109.899 176.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.418 ' H ' ' ND2' ' A' ' 794' ' ' ASN . 9.4 mmmm -91.19 -167.62 1.85 Allowed 'General case' 0 C--N 1.283 -2.292 0 C-N-CA 126.701 2.0 . . . . 0.0 112.408 -171.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . 0.543 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 28.4 mmmt -123.72 134.03 53.77 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 126.357 1.863 . . . . 0.0 106.793 -176.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . 0.465 ' HB2' ' CZ2' ' A' ' 797' ' ' TRP . 0.0 OUTLIER -87.39 -179.47 6.39 Favored 'General case' 0 C--N 1.257 -3.454 0 C-N-CA 125.44 1.496 . . . . 0.0 109.433 -177.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -141.14 137.99 33.14 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.93 -0.481 . . . . 0.0 110.433 -176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 38.9 t -71.79 120.56 17.56 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 172.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.51 ' HB3' HG12 ' A' ' 759' ' ' ILE . 42.9 t -70.33 163.18 27.14 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 173.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 22.0 p-10 -96.41 -1.09 48.27 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -110.95 18.26 19.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.983 0.42 . . . . 0.0 110.71 178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.51 HG12 ' HB3' ' A' ' 756' ' ' SER . 23.8 pt -126.41 157.71 36.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-O 121.538 0.685 . . . . 0.0 112.07 -176.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . 0.42 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.2 mp -117.74 132.54 67.27 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 174.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.593 ' HG ' ' HZ ' ' A' ' 771' ' ' PHE . 2.7 mm? -106.94 178.17 4.64 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.569 ' HB2' HD23 ' A' ' 765' ' ' LEU . 47.4 mt-10 -62.01 162.22 9.56 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.97 176.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -66.7 -11.99 56.58 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.538 0.685 . . . . 0.0 111.264 -176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.31 -0.61 26.1 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.573 177.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.569 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.3 mm? -122.97 -12.12 8.02 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 8.7 mtmp? -62.65 -27.02 68.93 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -88.1 5.71 39.86 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.707 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 19.0 ttmm -101.94 109.92 21.77 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . 0.522 ' HE3' ' HG3' ' A' ' 770' ' ' GLU . 34.6 ttpt -79.46 -37.29 37.24 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 122.251 1.024 . . . . 0.0 108.444 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . 0.522 ' HG3' ' HE3' ' A' ' 769' ' ' LYS . 41.4 mt-10 -127.92 114.61 17.39 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.161 -1.381 . . . . 0.0 108.438 -177.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.707 ' CD2' ' HD2' ' A' ' 768' ' ' LYS . 82.3 m-85 -88.76 -178.68 5.83 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.972 -175.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -118.68 138.54 52.55 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.59 -175.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.73 ' CD2' ' HB2' ' A' ' 750' ' ' LEU . 9.8 p-80 -45.91 146.86 1.1 Allowed 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 124.642 1.177 . . . . 0.0 112.738 174.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 72.22 10.95 5.95 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.27 1.028 . . . . 0.0 110.702 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 46.8 t -94.25 127.99 40.45 Favored 'General case' 0 N--CA 1.41 -2.447 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.492 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.6 OUTLIER -97.6 111.25 23.6 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.543 HD12 HD12 ' A' ' 761' ' ' LEU . 7.8 pt -118.91 176.46 3.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 121.662 0.744 . . . . 0.0 109.596 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 79.5 mtt180 -122.28 133.29 54.69 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 173.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -128.59 168.33 15.88 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 29.8 ptt180 -160.08 163.9 33.51 Favored 'General case' 0 N--CA 1.412 -2.372 0 O-C-N 124.521 1.138 . . . . 0.0 109.281 177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 90.7 m -82.48 175.34 10.28 Favored 'General case' 0 C--N 1.293 -1.871 0 O-C-N 123.53 0.519 . . . . 0.0 109.797 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . 0.42 ' HB3' HD11 ' A' ' 760' ' ' ILE . 12.5 ptm180 -91.4 -29.19 17.21 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 120.936 0.398 . . . . 0.0 110.504 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -92.24 -3.11 67.71 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.791 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 2.2 mptp? -130.74 107.62 9.29 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -82.62 149.38 27.44 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 111.45 141.11 8.43 Favored Glycine 0 C--N 1.294 -1.798 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -174.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 47.4 m95 -98.61 149.8 22.4 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 117.047 0.424 . . . . 0.0 110.746 -171.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.16 -31.7 3.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.06 -179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 36.7 m170 73.19 118.92 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 124.843 1.257 . . . . 0.0 110.206 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.543 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.1 t -140.32 158.52 43.9 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.836 -0.54 . . . . 0.0 110.232 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 47.2 t -119.94 134.48 63.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . 0.542 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 54.0 t -72.19 117.27 13.62 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-O 121.533 0.682 . . . . 0.0 110.327 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.07 79.51 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.48 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' ' 750' ' ' LEU . 24.8 t-20 55.09 71.94 0.51 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.845 0.831 . . . . 0.0 112.171 171.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 75.26 3.58 70.74 Favored Glycine 0 C--N 1.292 -1.902 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.988 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . 0.452 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 22.9 ttt180 -136.19 174.58 10.46 Favored 'General case' 0 N--CA 1.429 -1.503 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 -177.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.635 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 97.5 m95 -121.12 159.48 25.71 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 177.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 9.3 t70 -148.3 106.52 3.58 Favored Pre-proline 0 C--N 1.3 -1.573 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 798' ' ' ASP . 51.0 Cg_endo -71.92 142.45 73.76 Favored 'Cis proline' 0 C--O 1.244 0.814 0 C-N-CA 123.588 -1.422 . . . . 0.0 112.956 -0.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.635 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 1.9 mm-40 -50.51 126.1 14.48 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 115.096 -0.956 . . . . 0.0 113.118 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.543 ' CG1' HG21 ' A' ' 790' ' ' THR . 3.6 m -84.31 123.55 39.09 Favored 'Isoleucine or valine' 1 N--CA 1.35 -5.462 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.589 -179.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 801' ' ' VAL . 2.5 t-20 174.03 132.37 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 174.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 5.8 t -98.1 21.12 11.23 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 122.49 1.138 . . . . 0.0 109.611 -176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 16.7 m . . . . . 0 N--CA 1.412 -2.36 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 175.52 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . 0.63 HG21 ' HB2' ' A' ' 708' ' ' PRO . 12.4 p . . . . . 0 N--CA 1.42 -1.969 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 23.7 m -72.31 -63.08 1.22 Allowed 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.059 0.457 . . . . 0.0 110.169 175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 131.3 -164.23 23.44 Favored Glycine 1 N--CA 1.356 -6.675 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -45.61 136.8 5.61 Favored 'General case' 0 C--N 1.26 -3.315 0 C-N-CA 126.182 1.793 . . . . 0.0 111.828 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.505 HG21 HG21 ' A' ' 715' ' ' VAL . 1.4 pp -68.7 148.22 98.02 Favored Pre-proline 0 N--CA 1.427 -1.61 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.066 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.539 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 70.9 Cg_endo -72.76 -168.98 0.44 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 123.327 2.685 . . . . 0.0 111.838 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -135.52 143.28 45.69 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.574 HD22 ' HB3' ' A' ' 717' ' ' PHE . 24.5 tp -92.56 123.79 36.11 Favored 'General case' 0 C--N 1.254 -3.552 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.187 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.538 ' HG2' HD12 ' A' ' 697' ' ' LEU . 7.4 pt-20 -30.42 -51.74 0.15 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.319 2.248 . . . . 0.0 115.556 -178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 78.8 m-70 -136.15 23.39 3.26 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -134.04 -159.11 8.8 Favored Glycine 0 N--CA 1.434 -1.434 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.998 -175.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.436 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -141.07 176.34 8.9 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 120.692 0.282 . . . . 0.0 111.382 -173.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -111.52 133.66 53.64 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.513 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 53.7 mm-40 -74.42 -73.26 0.24 Allowed 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 705' ' ' SER . 7.0 tt -161.3 139.63 9.58 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.474 -177.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.714 ' HB2' HG22 ' A' ' 715' ' ' VAL . 35.8 t -164.36 -175.7 4.05 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.908 -1.886 . . . . 0.0 105.908 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 26.7 p -152.11 140.74 13.71 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -68.89 167.29 23.68 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 121.798 1.666 . . . . 0.0 109.39 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.63 ' HB2' HG21 ' A' ' 690' ' ' THR . 1.3 Cg_endo -73.74 -1.83 14.62 Favored 'Cis proline' 0 C--O 1.243 0.73 0 N-CA-C 115.201 1.193 . . . . 0.0 115.201 6.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 72.5 m-85 72.55 75.58 0.15 Allowed 'General case' 0 C--N 1.315 -0.906 0 O-C-N 124.39 1.056 . . . . 0.0 109.318 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.601 ' CE1' ' HG2' ' A' ' 708' ' ' PRO . 18.3 m-85 -79.49 169.95 17.3 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.655 -1.157 . . . . 0.0 112.158 -178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.533 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 54.3 m-85 -68.81 133.95 49.02 Favored 'General case' 0 CA--C 1.496 -1.112 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.905 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.74 -11.23 60.98 Favored Glycine 0 N--CA 1.426 -1.973 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.463 -178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -68.29 150.82 47.78 Favored 'General case' 0 C--O 1.253 1.288 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 15.6 m -140.01 142.77 36.24 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-O 121.196 0.522 . . . . 0.0 109.904 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.714 HG22 ' HB2' ' A' ' 705' ' ' SER . 20.5 t -131.88 127.09 58.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -176.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.513 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 40.0 mt-10 -71.66 138.22 48.46 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.919 0.39 . . . . 0.0 111.266 174.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.574 ' HB3' HD22 ' A' ' 697' ' ' LEU . 19.7 m-85 -138.19 123.76 19.66 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.436 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 6.7 m-80 -136.22 -165.21 1.68 Allowed 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 -177.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 9.4 m -115.53 130.23 56.8 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . 0.427 ' HA ' ' CE2' ' A' ' 701' ' ' TRP . 4.0 m -47.0 -71.98 0.06 Allowed 'General case' 0 C--N 1.3 -1.559 0 O-C-N 124.984 1.427 . . . . 0.0 112.09 -172.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -169.46 164.61 10.54 Favored 'General case' 0 N--CA 1.418 -2.058 0 N-CA-C 102.848 -3.019 . . . . 0.0 102.848 175.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 66.9 m 66.31 8.23 5.48 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.087 0.867 . . . . 0.0 112.288 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.66 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 98.5 m-85 -141.35 142.69 33.78 Favored 'General case' 0 N--CA 1.412 -2.363 0 C-N-CA 124.141 0.976 . . . . 0.0 108.771 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 0.9 OUTLIER -107.37 133.97 51.12 Favored 'General case' 0 C--N 1.251 -3.713 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.784 -177.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.731 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.3 ttp -87.97 121.17 30.06 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.259 1.024 . . . . 0.0 109.923 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.608 HD12 HG23 ' A' ' 793' ' ' ILE . 49.9 mm -120.16 131.18 73.19 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.714 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.084 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 111.49 -81.46 0.29 Allowed Glycine 0 C--N 1.306 -1.124 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.679 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.586 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 5.9 t60 -150.92 171.45 17.23 Favored 'General case' 0 C--O 1.202 -1.414 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.731 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -131.3 25.75 4.84 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 179.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 73.3 m -157.51 166.84 31.87 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.514 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 39.5 pt -129.91 161.35 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 O-C-N 124.654 1.221 . . . . 0.0 108.216 178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 18.6 m -136.55 135.27 38.32 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.76 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . 0.533 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 2.6 t -80.71 107.77 13.8 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.247 0.546 . . . . 0.0 110.499 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . 0.451 ' HB ' ' HD2' ' A' ' 735' ' ' HIS . 1.4 pp -145.89 146.72 19.05 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.229 0 C-N-CA 125.125 1.37 . . . . 0.0 110.051 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . 0.451 ' HD2' ' HB ' ' A' ' 734' ' ' ILE . 19.1 m-70 70.75 -12.93 0.51 Allowed 'General case' 0 N--CA 1.503 2.219 0 C-N-CA 123.603 0.761 . . . . 0.0 111.685 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 105.0 19.26 10.97 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 33.2 t -143.1 159.12 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 N-CA-C 105.02 -2.215 . . . . 0.0 105.02 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.539 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.6 m95 -86.19 179.0 7.01 Favored 'General case' 0 C--N 1.256 -3.462 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 170.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.514 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 25.1 p -76.64 -158.76 0.11 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.558 0.694 . . . . 0.0 112.053 -179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.584 ' NE2' ' H ' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -83.28 -9.38 59.14 Favored 'General case' 0 C--N 1.273 -2.755 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -165.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.2 mm? 71.82 150.59 0.13 Allowed Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 123.11 0.564 . . . . 0.0 111.11 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.586 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 10.9 Cg_exo -68.82 -161.36 0.07 OUTLIER 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 122.555 2.17 . . . . 0.0 112.292 173.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -142.1 137.65 31.14 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 87.3 m -130.09 107.62 9.46 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.147 0.498 . . . . 0.0 110.78 -178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.614 ' HB ' HD21 ' A' ' 750' ' ' LEU . 41.1 t -99.52 143.15 13.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.66 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -63.3 2.5 0.38 Allowed 'General case' 0 C--N 1.287 -2.148 0 C-N-CA 126.213 1.805 . . . . 0.0 114.79 -175.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.795 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 59.6 mt 75.48 -16.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 C-N-CA 125.302 1.441 . . . . 0.0 111.309 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 746' ' ' ALA . 6.7 t70 -72.54 -35.84 68.14 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 113.785 -1.552 . . . . 0.0 109.166 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 29.86 7.49 Favored 'General case' 0 C--N 1.288 -2.072 0 CA-C-N 113.686 -1.597 . . . . 0.0 111.336 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.795 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 73.3 mt -86.72 -160.63 0.59 Allowed 'General case' 0 N--CA 1.424 -1.752 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.432 175.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.476 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 54.9 mtpt -145.86 168.48 20.71 Favored 'General case' 0 N--CA 1.408 -2.554 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 15.4 mtpp -116.77 139.83 50.13 Favored 'General case' 0 C--N 1.271 -2.823 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 -177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . 0.484 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 46.4 m -92.01 172.86 8.16 Favored 'General case' 0 C--N 1.249 -3.792 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.681 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -138.0 147.69 44.45 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 175.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . 0.413 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 9.3 p -64.83 139.66 58.79 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.188 172.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.605 ' HB2' HG12 ' A' ' 759' ' ' ILE . 50.7 m -77.92 173.04 12.58 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -97.13 -15.52 20.9 Favored 'General case' 0 C--N 1.313 -1.011 0 O-C-N 121.543 -0.723 . . . . 0.0 111.608 -175.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.27 16.47 24.23 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.774 -0.579 . . . . 0.0 110.542 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.605 HG12 ' HB2' ' A' ' 756' ' ' SER . 11.8 pt -124.27 153.94 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.835 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.701 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 2.8 mp -114.57 131.91 65.27 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.575 HD11 HD12 ' A' ' 759' ' ' ILE . 1.9 mm? -108.12 178.01 4.64 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 45.8 mt-10 -65.33 156.68 31.36 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 171.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . 0.256 0.0 OUTLIER -68.51 -11.16 59.48 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 119.214 0.915 . . . . 0.0 112.802 -174.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -74.65 -31.73 62.04 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.672 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 64.3 mt -98.21 -25.37 14.9 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.433 -1.712 . . . . 0.0 112.708 -172.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 7.0 mtmp? -62.58 -32.17 73.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.338 0.59 . . . . 0.0 110.586 -178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -91.85 5.36 50.26 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.993 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.557 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 22.1 ttmm -87.31 -48.97 7.57 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.03 -54.41 0.57 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.038 1.335 . . . . 0.0 111.201 178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 768' ' ' LYS . 47.1 mt-10 -113.69 123.75 50.65 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.582 ' CE2' HD22 ' A' ' 765' ' ' LEU . 11.4 m-85 -110.96 149.07 31.19 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -173.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -93.05 156.16 17.06 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -46.55 149.74 0.76 Allowed 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.57 1.148 . . . . 0.0 112.876 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 1.9 t30 67.9 12.12 8.67 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.379 1.472 . . . . 0.0 111.823 174.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 791' ' ' VAL . 20.1 p -77.33 110.89 12.45 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 178.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.465 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -84.92 93.7 8.6 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.672 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.6 pt -106.01 -177.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.809 -177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.572 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 76.8 mtt85 -132.47 135.37 45.98 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 177.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.49 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 4.7 p90 -131.37 168.63 17.25 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 174.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -159.05 164.5 35.38 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 93.8 m -83.56 161.35 21.22 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.93 -30.24 58.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -172.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -99.49 8.34 60.21 Favored Glycine 0 CA--C 1.499 -0.921 0 N-CA-C 110.364 -1.094 . . . . 0.0 110.364 178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 4.4 mptp? -119.62 162.53 18.81 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -131.14 162.47 29.84 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 96.92 145.03 18.45 Favored Glycine 0 C--N 1.301 -1.386 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -172.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 54.2 m95 -110.25 139.69 45.17 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 117.339 0.57 . . . . 0.0 110.307 -174.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.49 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.0 mp -87.67 -27.41 5.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.276 -175.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.532 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 24.4 m170 72.45 127.43 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 C-N-CA 124.406 1.082 . . . . 0.0 109.673 -176.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.492 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.0 t -149.05 151.77 35.05 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.122 176.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 775' ' ' SER . 39.3 t -113.4 132.83 61.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 C-N-CA 123.611 0.764 . . . . 0.0 110.025 -176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 35.8 t -70.06 113.93 7.73 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-O 121.993 0.901 . . . . 0.0 110.417 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.608 HG23 HD12 ' A' ' 726' ' ' ILE . 47.5 mm -114.64 80.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.268 -2.965 0 CA-C-N 114.793 -1.094 . . . . 0.0 108.544 -178.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.693 ' ND2' HD22 ' A' ' 750' ' ' LEU . 1.1 m120 50.26 68.48 0.75 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.597 -1.183 . . . . 0.0 111.817 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 76.68 11.98 84.84 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 120.757 -0.735 . . . . 0.0 113.975 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -142.12 170.62 15.37 Favored 'General case' 0 C--O 1.204 -1.325 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -176.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.603 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 95.0 m95 -116.77 161.79 18.71 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 19.4 t70 -148.45 102.21 3.51 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . 0.532 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 41.8 Cg_endo -71.26 142.23 72.35 Favored 'Cis proline' 0 C--O 1.244 0.777 0 C-N-CA 123.932 -1.278 . . . . 0.0 112.881 -1.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.603 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 24.7 mt-10 -51.13 121.09 5.61 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.989 174.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.492 ' CG1' HG21 ' A' ' 790' ' ' THR . 5.9 m -76.26 130.6 36.07 Favored 'Isoleucine or valine' 1 N--CA 1.365 -4.709 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.196 -176.249 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -156.96 122.43 4.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 84.5 m -131.12 15.99 5.11 Favored 'General case' 0 C--N 1.279 -2.464 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.422 -1.829 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.518 178.129 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.422 -1.839 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 24.4 m -78.01 -54.1 6.66 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.286 0.565 . . . . 0.0 110.294 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 118.68 -171.81 14.27 Favored Glycine 1 N--CA 1.356 -6.641 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -34.48 122.54 0.51 Allowed 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 126.645 1.978 . . . . 0.0 111.884 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.636 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -62.93 147.68 93.61 Favored Pre-proline 0 N--CA 1.426 -1.627 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.247 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.431 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 43.0 Cg_endo -68.15 -167.02 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.777 2.318 . . . . 0.0 112.396 177.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -133.75 152.24 51.82 Favored 'General case' 0 N--CA 1.384 -3.773 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.581 HD22 ' HB3' ' A' ' 717' ' ' PHE . 22.0 tp -99.74 114.19 27.17 Favored 'General case' 0 C--N 1.258 -3.371 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 177.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -43.32 -43.03 4.78 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 114.382 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -130.22 27.31 5.1 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.037 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -142.58 -150.9 5.4 Favored Glycine 0 C--N 1.31 -0.896 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.645 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.49 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -145.05 174.54 10.96 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 -177.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.81 147.99 28.03 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -84.65 -71.54 0.51 Allowed 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.947 0.403 . . . . 0.0 110.487 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.0 tt -165.88 138.8 4.17 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.488 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 70.8 p -123.56 -63.95 1.19 Allowed 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 120.766 0.317 . . . . 0.0 110.854 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 32.7 t 71.41 105.96 0.03 OUTLIER Pre-proline 0 C--N 1.316 -0.857 0 C-N-CA 125.301 1.44 . . . . 0.0 111.483 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.621 ' HB3' ' CE2' ' A' ' 709' ' ' TYR . 91.4 Cg_endo -74.43 162.88 37.37 Favored 'Trans proline' 0 CA--C 1.556 1.579 0 C-N-CA 122.407 2.072 . . . . 0.0 112.119 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 51.3 Cg_exo -65.27 171.01 34.24 Favored 'Cis proline' 0 CA--C 1.478 -2.302 0 CA-C-O 123.136 1.223 . . . . 0.0 113.599 0.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.621 ' CE2' ' HB3' ' A' ' 707' ' ' PRO . 70.2 m-85 -115.14 74.83 0.9 Allowed 'General case' 1 C--N 1.23 -4.614 0 CA-C-N 112.184 -2.28 . . . . 0.0 109.871 -174.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -76.07 170.53 16.1 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.695 -1.139 . . . . 0.0 113.898 -175.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -73.08 131.58 42.26 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.035 -1.439 . . . . 0.0 110.579 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.78 -8.72 63.77 Favored Glycine 0 N--CA 1.419 -2.439 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.37 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.83 154.92 38.06 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 120.783 0.325 . . . . 0.0 110.227 178.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 13.3 m -140.15 149.14 42.63 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 694' ' ' ILE . 44.5 t -132.61 134.02 59.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.442 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 45.0 mt-10 -89.67 141.59 28.46 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.436 0.636 . . . . 0.0 112.253 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.581 ' HB3' HD22 ' A' ' 697' ' ' LEU . 58.6 m-85 -141.16 129.85 22.83 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.875 1.67 . . . . 0.0 107.501 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.49 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 13.2 m-80 -132.63 -161.61 1.15 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.54 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 12.5 m -110.07 143.32 40.27 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 2.8 m -73.17 -84.94 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 123.373 0.421 . . . . 0.0 110.708 -175.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 52.0 mm-40 -138.15 152.57 48.83 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 53.7 m 66.82 11.6 8.37 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.648 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.9 m-85 -137.55 148.31 45.82 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.422 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.1 m -116.65 135.11 54.06 Favored 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.54 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.8 ttp -92.81 124.26 36.67 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 123.93 0.892 . . . . 0.0 109.221 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 45.8 mm -126.13 144.0 37.74 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.593 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.441 178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 100.45 -79.39 0.45 Allowed Glycine 0 N--CA 1.433 -1.505 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.456 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.483 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 2.8 t60 -146.0 179.84 7.2 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.214 -2.143 . . . . 0.0 105.214 -175.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.606 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.2 OUTLIER -136.3 22.22 3.21 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.147 177.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.442 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.2 p -157.2 170.1 23.25 Favored 'General case' 0 C--N 1.285 -2.235 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.087 -175.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.437 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 35.7 pt -125.42 161.57 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.918 0 CA-C-N 114.381 -1.281 . . . . 0.0 108.69 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 738' ' ' TRP . 23.7 m -133.74 138.04 45.56 Favored 'General case' 0 C--N 1.294 -1.843 0 O-C-N 123.674 0.609 . . . . 0.0 110.104 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 8.9 t -90.2 103.19 15.89 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.49 145.21 24.93 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.431 -178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 69.42 -13.62 0.37 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 117.33 14.9 6.76 Favored Glycine 0 N--CA 1.433 -1.515 0 N-CA-C 111.643 -0.583 . . . . 0.0 111.643 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.7 p -152.24 150.89 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.442 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 94.0 m95 -73.5 163.83 27.5 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 120.377 -0.529 . . . . 0.0 109.656 171.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 34.3 p -74.2 -161.34 0.12 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.083 0.944 . . . . 0.0 113.268 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.428 ' CD ' ' H ' ' A' ' 740' ' ' GLN . 0.4 OUTLIER -82.4 -3.06 54.92 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -165.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 68.81 155.38 0.14 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 123.665 0.603 . . . . 0.0 111.136 -176.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 46.0 Cg_endo -74.77 177.75 8.09 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.854 1.703 . . . . 0.0 109.916 170.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -122.91 120.09 32.42 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.818 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.458 ' SG ' HD21 ' A' ' 697' ' ' LEU . 61.4 m -102.25 108.82 20.32 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.778 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.502 ' HB ' HD21 ' A' ' 750' ' ' LEU . 22.8 t -97.05 141.3 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.384 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.648 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -66.54 6.87 0.4 Allowed 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 125.63 1.572 . . . . 0.0 113.99 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.849 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 35.1 mt 75.82 -15.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 C-N-CA 125.095 1.358 . . . . 0.0 111.675 177.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 746' ' ' ALA . 3.3 t70 -81.39 -31.11 33.42 Favored 'General case' 0 C--N 1.284 -2.242 0 C-N-CA 126.109 1.763 . . . . 0.0 108.427 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.447 ' HB2' ' CG1' ' A' ' 745' ' ' VAL . 13.6 mttm -106.64 22.86 15.19 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 113.233 -1.803 . . . . 0.0 108.221 -173.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.849 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 73.9 mt -87.94 -169.9 2.77 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.586 174.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.603 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 58.9 mtpt -118.16 168.29 10.71 Favored 'General case' 0 N--CA 1.397 -3.091 0 CA-C-O 122.103 0.954 . . . . 0.0 111.097 -173.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . 0.461 ' HB2' ' HE3' ' A' ' 752' ' ' LYS . 37.0 mtmt -107.17 121.05 43.74 Favored 'General case' 0 C--N 1.253 -3.602 0 CA-C-N 112.79 -2.004 . . . . 0.0 107.141 -178.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . 0.49 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 0.0 OUTLIER -77.89 158.76 29.28 Favored 'General case' 0 C--N 1.249 -3.765 0 CA-C-N 113.824 -1.534 . . . . 0.0 107.979 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -131.75 139.93 49.1 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.14 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 3.9 m -71.26 107.81 4.43 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.497 ' HB2' HG13 ' A' ' 759' ' ' ILE . 70.1 m -58.19 143.74 43.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.821 0.343 . . . . 0.0 110.383 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -78.77 -3.3 43.7 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.336 0.589 . . . . 0.0 111.78 -171.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 803' ' ' CYS . 3.2 mm? -103.73 -15.78 15.64 Favored 'General case' 0 C--N 1.31 -1.121 0 O-C-N 121.673 -0.642 . . . . 0.0 110.689 -178.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.497 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.7 pp -100.44 161.03 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.893 -174.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . 0.519 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.5 mp -114.2 129.87 69.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.52 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 86.5 mt -105.32 176.99 4.98 Favored 'General case' 0 C--O 1.249 1.027 0 CA-C-O 120.997 0.427 . . . . 0.0 110.095 178.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -65.62 168.8 7.03 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.988 177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -71.22 -7.22 45.34 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.478 0.656 . . . . 0.0 111.42 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.65 -2.96 16.1 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.9 178.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.4 HD12 ' HE2' ' A' ' 771' ' ' PHE . 2.7 mm? -121.24 -10.47 8.95 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -71.28 -10.09 59.18 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.841 0.829 . . . . 0.0 110.15 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -88.62 -0.83 57.66 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.587 -1.188 . . . . 0.0 108.949 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -114.44 129.99 56.69 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . 0.673 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 9.6 ptpp? -107.1 -24.55 11.91 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . 0.673 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 46.3 mt-10 -132.65 128.44 37.07 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.673 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.52 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 83.4 m-85 -108.72 176.11 5.22 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.367 -177.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -115.77 158.83 22.28 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.404 174.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -47.81 151.91 0.82 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.111 1.364 . . . . 0.0 112.622 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 15.3 m120 59.15 13.42 2.97 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 115.049 1.499 . . . . 0.0 115.049 172.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 10.4 t -76.94 108.61 10.11 Favored 'General case' 0 N--CA 1.414 -2.239 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.431 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.8 OUTLIER -83.94 105.68 15.01 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.5 HG21 ' CE2' ' A' ' 771' ' ' PHE . 7.2 pt -119.77 -177.96 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.508 ' HG2' ' CD2' ' A' ' 789' ' ' HIS . 98.6 mtt180 -125.8 135.28 51.82 Favored 'General case' 0 N--CA 1.404 -2.734 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.488 ' CE2' ' HA ' ' A' ' 801' ' ' VAL . 6.8 p90 -125.82 165.71 18.17 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 170.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . 0.519 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 14.5 ptt180 -145.16 163.48 34.24 Favored 'General case' 0 C--N 1.251 -3.697 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 176.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.625 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 19.9 t -109.27 162.27 14.47 Favored 'General case' 0 N--CA 1.395 -3.213 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -73.5 -39.05 65.13 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.838 175.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -84.08 -17.97 63.95 Favored Glycine 0 C--O 1.24 0.5 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.345 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.625 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.1 mptt -124.84 84.71 2.31 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -85.5 89.28 7.66 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 122.297 1.046 . . . . 0.0 110.836 -172.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 175.66 152.91 9.82 Favored Glycine 0 C--N 1.287 -2.19 0 N-CA-C 106.145 -2.782 . . . . 0.0 106.145 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.432 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 45.3 m95 -84.46 142.37 30.13 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 118.126 0.963 . . . . 0.0 109.797 -173.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.48 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -99.92 -31.68 3.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.041 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.508 ' CD2' ' HG2' ' A' ' 778' ' ' ARG . 28.1 m170 74.75 116.89 0.06 Allowed 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 124.836 1.254 . . . . 0.0 109.156 -174.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 4.3 t -137.53 152.83 49.89 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 120.356 -0.537 . . . . 0.0 110.906 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 58.1 t -116.06 133.86 61.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -178.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 53.2 t -70.27 129.07 38.36 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.36 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.0 mm -121.39 79.76 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.603 ' C ' ' HB2' ' A' ' 751' ' ' LYS . 0.7 OUTLIER 54.03 70.43 0.61 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.193 178.398 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 76.82 -4.75 51.47 Favored Glycine 0 C--N 1.301 -1.384 0 C-N-CA 120.561 -0.828 . . . . 0.0 113.778 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -115.89 172.55 7.07 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -177.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.591 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.0 m95 -121.76 154.89 36.35 Favored 'General case' 0 C--N 1.266 -3.032 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -144.67 105.61 4.6 Favored Pre-proline 0 C--N 1.291 -1.952 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.91 143.08 74.88 Favored 'Cis proline' 0 C--O 1.248 0.993 0 C-N-CA 123.8 -1.333 . . . . 0.0 112.292 -0.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 38.6 mt-10 -53.19 125.96 19.28 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.659 175.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.488 ' HA ' ' CE2' ' A' ' 779' ' ' TYR . 4.6 m -72.03 141.95 15.94 Favored 'Isoleucine or valine' 1 N--CA 1.365 -4.678 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -165.38 138.33 4.42 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.012 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 758' ' ' LEU . 56.8 m -137.91 -3.0 1.85 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.141 0.496 . . . . 0.0 110.849 172.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 62.9 m . . . . . 0 C--N 1.314 -0.944 0 N-CA-C 106.806 -1.554 . . . . 0.0 106.806 -179.244 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.424 -1.739 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 35.6 m -72.17 -79.47 0.07 Allowed 'General case' 0 C--N 1.268 -2.954 0 C-N-CA 123.872 0.869 . . . . 0.0 111.389 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 148.03 173.19 18.76 Favored Glycine 1 N--CA 1.362 -6.255 0 N-CA-C 108.903 -1.679 . . . . 0.0 108.903 -179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -38.33 130.44 1.27 Allowed 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 125.926 1.69 . . . . 0.0 111.048 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.711 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -63.23 151.72 86.23 Favored Pre-proline 0 C--N 1.296 -1.741 0 CA-C-N 115.252 -0.885 . . . . 0.0 112.449 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.518 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.1 Cg_endo -72.18 -157.84 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.291 0 C-N-CA 122.822 2.348 . . . . 0.0 112.941 177.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -133.21 146.19 51.26 Favored 'General case' 0 N--CA 1.402 -2.834 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.607 HD22 ' HB3' ' A' ' 717' ' ' PHE . 30.1 tp -90.25 126.04 35.7 Favored 'General case' 0 C--N 1.263 -3.166 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.09 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.529 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 6.8 pt-20 -32.84 -55.3 0.37 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.24 2.216 . . . . 0.0 114.527 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.529 ' H ' ' HG3' ' A' ' 698' ' ' GLU . 92.3 m-70 -135.53 25.47 3.44 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -131.0 -150.72 6.84 Favored Glycine 0 N--CA 1.431 -1.643 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.05 -176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.468 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -150.02 179.13 8.31 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -177.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -109.69 146.28 35.13 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 20.7 mm100 -81.32 -66.48 0.88 Allowed 'General case' 0 N--CA 1.428 -1.547 0 CA-C-O 121.301 0.572 . . . . 0.0 110.536 178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.0 tt -161.33 139.61 9.53 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 104.238 -2.504 . . . . 0.0 104.238 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.455 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 58.6 p -130.73 119.48 22.41 Favored 'General case' 0 N--CA 1.395 -3.206 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 7.4 p -97.46 112.7 61.9 Favored Pre-proline 0 C--N 1.253 -3.598 0 CA-C-N 114.594 -1.185 . . . . 0.0 112.681 -174.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.434 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 67.0 Cg_endo -72.06 172.52 14.56 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.755 2.303 . . . . 0.0 109.397 175.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.628 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 4.0 Cg_exo -74.24 -0.21 14.82 Favored 'Cis proline' 0 N--CA 1.489 1.213 0 CA-C-N 120.295 1.141 . . . . 0.0 114.544 5.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.455 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 54.2 m-85 74.53 73.1 0.11 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 124.86 1.35 . . . . 0.0 107.79 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.628 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 23.3 m-85 -78.35 172.24 13.9 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.436 -1.256 . . . . 0.0 112.072 179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -72.25 138.44 47.47 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.927 177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 89.2 -3.83 84.33 Favored Glycine 0 N--CA 1.427 -1.913 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 710' ' ' TYR . 0.2 OUTLIER -76.1 151.22 37.1 Favored 'General case' 0 CA--C 1.488 -1.407 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 17.1 m -130.32 149.9 51.8 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.929 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.711 HG21 HG21 ' A' ' 694' ' ' ILE . 31.7 t -133.92 140.25 46.77 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.862 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -96.43 130.98 43.46 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-O 122.063 0.935 . . . . 0.0 112.209 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.607 ' HB3' HD22 ' A' ' 697' ' ' LEU . 20.3 m-85 -131.96 122.95 26.4 Favored 'General case' 0 C--N 1.294 -1.842 0 C-N-CA 126.305 1.842 . . . . 0.0 106.677 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.468 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 26.8 m-80 -119.47 -162.53 0.92 Allowed 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 6.8 m -111.31 129.42 56.0 Favored 'General case' 0 C--N 1.274 -2.705 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 3.1 m -51.36 -76.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 124.783 1.233 . . . . 0.0 112.672 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -159.3 154.84 25.85 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 101.851 -3.388 . . . . 0.0 101.851 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 67.3 m 68.46 15.37 9.19 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.248 0.967 . . . . 0.0 112.852 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.705 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 97.0 m-85 -143.17 146.96 34.18 Favored 'General case' 0 N--CA 1.417 -2.1 0 C-N-CA 123.898 0.879 . . . . 0.0 108.981 -178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 2.4 t -103.24 148.37 25.89 Favored 'General case' 0 C--N 1.267 -3.0 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -177.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.6 ttp -104.59 118.06 35.64 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.475 HG12 HG23 ' A' ' 724' ' ' THR . 39.5 mm -116.12 127.75 73.62 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.545 178.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 108.19 -93.93 0.84 Allowed Glycine 0 CA--C 1.488 -1.652 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.841 174.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.447 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 7.2 p-80 -136.16 -175.84 4.12 Favored 'General case' 0 N--CA 1.397 -3.075 0 C-N-CA 125.618 1.567 . . . . 0.0 107.631 -176.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.433 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -132.59 12.73 4.48 Favored 'General case' 0 C--O 1.208 -1.119 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.748 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 87.7 p -128.81 166.48 18.97 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 119.245 -0.982 . . . . 0.0 112.399 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' A' ' 741' ' ' LEU . 32.5 pt -119.07 160.14 19.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.44 -1.255 . . . . 0.0 107.74 174.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 739' ' ' THR . 3.7 m -134.18 134.92 42.67 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.664 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 40.3 t -94.0 119.93 33.56 Favored 'General case' 0 N--CA 1.405 -2.705 0 C-N-CA 118.821 -1.151 . . . . 0.0 110.259 175.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.8 140.5 25.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 113.836 -1.529 . . . . 0.0 107.676 -178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 66.45 7.07 4.74 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.76 8.98 61.62 Favored Glycine 0 CA--C 1.485 -1.8 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 738' ' ' TRP . 48.4 t -130.87 139.03 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -175.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.518 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.3 m95 -72.77 166.98 21.81 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.935 172.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 732' ' ' THR . 19.5 p -75.71 -163.09 0.24 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 122.084 0.945 . . . . 0.0 112.021 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.449 ' CD ' ' H ' ' A' ' 740' ' ' GLN . 0.5 OUTLIER -89.64 2.45 54.72 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.946 -171.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.628 ' HA ' HG22 ' A' ' 731' ' ' ILE . 2.0 mp 70.5 169.88 0.11 Allowed Pre-proline 0 C--O 1.237 0.41 0 O-C-N 124.094 0.872 . . . . 0.0 112.338 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.621 ' HD2' ' HB3' ' A' ' 741' ' ' LEU . 39.2 Cg_endo -76.42 -177.06 3.44 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.416 2.077 . . . . 0.0 111.561 171.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -119.79 124.78 46.97 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.573 ' HA ' ' O ' ' A' ' 724' ' ' THR . 87.1 m -115.42 107.51 15.3 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 120.9 0.381 . . . . 0.0 110.207 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.541 ' HB ' HD21 ' A' ' 750' ' ' LEU . 44.0 t -96.96 145.68 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.705 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -65.82 1.96 1.19 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 125.039 1.336 . . . . 0.0 114.125 -174.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.789 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 15.8 mt 74.53 -19.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 125.068 1.347 . . . . 0.0 111.697 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 746' ' ' ALA . 4.5 t70 -69.82 -33.72 72.71 Favored 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 126.72 2.008 . . . . 0.0 109.502 -175.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.18 31.28 6.8 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.585 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.789 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 55.1 mt -85.83 -179.28 6.79 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-O 121.566 0.698 . . . . 0.0 109.877 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.539 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 56.2 mtpt -116.33 -178.16 3.35 Favored 'General case' 0 C--N 1.268 -2.947 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.109 -176.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -130.19 126.28 37.02 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 113.253 -1.794 . . . . 0.0 107.835 -175.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . 0.422 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 57.5 m -75.41 155.53 36.27 Favored 'General case' 0 C--N 1.264 -3.124 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.047 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -120.09 135.87 54.79 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 45.2 t -58.42 127.1 30.42 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.118 173.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.587 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 41.0 t -72.17 165.41 24.42 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -84.2 -19.21 34.41 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 -172.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 803' ' ' CYS . 91.6 mt -111.53 10.97 21.29 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.122 -0.631 . . . . 0.0 112.021 -175.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.587 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -112.22 149.31 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.628 0 CA-C-O 121.677 0.751 . . . . 0.0 112.642 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.3 mp -113.44 133.57 58.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.462 0 N-CA-C 105.971 -1.863 . . . . 0.0 105.971 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.552 HD11 HD13 ' A' ' 759' ' ' ILE . 1.4 mm? -110.58 -177.95 3.36 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -59.13 152.83 19.41 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 174.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.85 -17.12 34.04 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -176.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -97.84 -6.3 32.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.497 0.665 . . . . 0.0 111.012 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -117.63 -4.78 11.19 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.677 0.751 . . . . 0.0 110.295 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 766' ' ' LYS . 17.8 mmmt -65.57 -17.35 64.51 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.336 1.055 . . . . 0.0 111.96 176.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -105.64 16.48 25.3 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.099 -178.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.501 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 12.2 tppt? -110.21 113.07 25.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . 0.446 ' HG3' ' HG3' ' A' ' 770' ' ' GLU . 8.2 ptpp? -85.8 -32.03 22.0 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.509 -0.877 . . . . 0.0 109.472 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . 0.446 ' HG3' ' HG3' ' A' ' 769' ' ' LYS . 45.5 mt-10 -132.11 119.67 21.27 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.232 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.501 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 70.4 m-85 -97.58 157.34 16.08 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.804 -175.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -93.28 148.68 21.83 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.637 ' CD2' HD12 ' A' ' 750' ' ' LEU . 15.1 p-80 -48.0 142.82 4.74 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.052 0.941 . . . . 0.0 111.669 177.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 22.1 m120 68.78 21.7 7.62 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 51.9 m -93.05 120.43 33.34 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 173.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.516 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -90.18 111.37 22.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.195 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.522 HD12 HD12 ' A' ' 761' ' ' LEU . 7.8 pt -120.28 -179.7 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 CA-C-O 121.906 0.86 . . . . 0.0 110.459 -177.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.468 ' HG2' ' CD2' ' A' ' 789' ' ' HIS . 88.9 mtm180 -124.75 137.72 54.32 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 174.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.59 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 8.4 p90 -130.44 166.2 21.01 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 174.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . 0.504 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 24.3 ptt180 -154.25 157.17 38.32 Favored 'General case' 0 C--N 1.279 -2.475 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 27.6 m -87.73 166.14 14.85 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . 0.557 ' HB3' HD11 ' A' ' 760' ' ' ILE . 39.4 ptt85 -84.49 -27.99 27.07 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.169 -0.613 . . . . 0.0 112.089 -179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -91.88 -5.8 65.97 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.018 -1.087 . . . . 0.0 112.227 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 2.8 mptp? -128.36 104.85 7.95 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -86.24 115.93 24.1 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.203 -0.999 . . . . 0.0 111.603 -178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 151.57 146.96 4.45 Favored Glycine 0 CA--C 1.486 -1.736 0 N-CA-C 108.747 -1.741 . . . . 0.0 108.747 178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 31.3 m95 -94.68 143.22 26.62 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -174.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.59 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.1 mp -97.95 -27.93 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.084 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.487 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 28.8 m170 75.95 128.88 0.04 OUTLIER 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 124.623 1.169 . . . . 0.0 109.923 -174.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.507 HG21 ' CG1' ' A' ' 801' ' ' VAL . 4.7 t -151.38 157.86 42.99 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.051 -0.66 . . . . 0.0 111.241 175.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.82 135.52 59.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . 0.401 ' SG ' ' HA ' ' A' ' 773' ' ' HIS . 50.9 t -70.76 112.15 6.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.574 0.702 . . . . 0.0 110.093 177.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.6 mm -112.89 83.94 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.102 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.034 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.618 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 53.85 56.45 7.13 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.901 172.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . 0.489 ' HA3' ' HE2' ' A' ' 751' ' ' LYS . . . 81.95 16.49 72.31 Favored Glycine 0 C--N 1.307 -1.075 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.495 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -147.42 166.08 28.3 Favored 'General case' 0 C--O 1.19 -2.05 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.623 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 99.0 m95 -111.45 162.7 14.81 Favored 'General case' 0 C--N 1.256 -3.466 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -146.47 105.76 4.05 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 175.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 29.2 Cg_endo -67.21 140.61 52.68 Favored 'Cis proline' 0 C--O 1.247 0.95 0 C-N-CA 124.061 -1.225 . . . . 0.0 111.679 -1.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.623 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.7 tt0 -57.51 118.63 5.39 Favored 'General case' 0 C--O 1.251 1.135 0 CA-C-O 121.32 0.581 . . . . 0.0 110.431 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.507 ' CG1' HG21 ' A' ' 790' ' ' THR . 1.9 m -78.53 125.34 37.96 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.816 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.91 -179.194 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -157.68 129.73 7.08 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 758' ' ' LEU . 8.5 t -128.9 5.45 5.43 Favored 'General case' 0 C--N 1.284 -2.239 0 C-N-CA 119.114 -1.034 . . . . 0.0 109.387 -178.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.412 -2.339 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.759 178.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . 0.539 HG21 ' HB2' ' A' ' 708' ' ' PRO . 15.9 p . . . . . 0 N--CA 1.422 -1.838 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 67.0 m -74.23 -58.51 3.25 Favored 'General case' 0 C--N 1.285 -2.236 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 171.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 81.76 132.29 1.45 Allowed Glycine 0 N--CA 1.417 -2.612 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.137 176.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 21.1 t70 62.24 106.17 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.729 0.899 . . . . 0.0 111.19 -178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.63 HG21 HG21 ' A' ' 715' ' ' VAL . 1.7 pp -70.12 147.13 95.47 Favored Pre-proline 0 C--N 1.291 -1.952 0 C-N-CA 119.497 -0.881 . . . . 0.0 110.828 176.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.474 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 58.9 Cg_endo -69.64 -162.0 0.08 OUTLIER 'Trans proline' 0 C--N 1.317 -1.085 0 C-N-CA 123.023 2.482 . . . . 0.0 112.823 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -133.93 144.92 49.12 Favored 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.692 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.5 OUTLIER -85.8 132.57 34.09 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 175.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -49.26 -47.02 46.98 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 124.818 1.247 . . . . 0.0 113.793 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -141.63 29.58 1.74 Allowed 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.692 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -141.89 -141.01 3.86 Favored Glycine 0 C--N 1.301 -1.395 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.186 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.459 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -157.62 179.97 8.73 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -176.043 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.74 158.21 16.89 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.435 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 13.5 mm100 -86.02 -61.5 1.74 Allowed 'General case' 0 C--N 1.289 -2.052 0 CA-C-O 121.341 0.591 . . . . 0.0 110.618 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.3 tt -167.0 133.24 2.26 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.52 ' HB2' ' CE1' ' A' ' 709' ' ' TYR . 15.8 p -126.16 137.21 53.56 Favored 'General case' 0 N--CA 1.392 -3.329 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . 0.42 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 15.0 t -124.87 109.43 27.88 Favored Pre-proline 0 C--N 1.279 -2.469 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.248 -177.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 706' ' ' SER . 60.7 Cg_endo -67.43 170.97 12.48 Favored 'Trans proline' 0 C--N 1.355 0.893 0 C-N-CA 123.058 2.506 . . . . 0.0 110.316 177.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.539 ' HB2' HG21 ' A' ' 690' ' ' THR . 15.4 Cg_exo -68.92 -7.35 8.5 Favored 'Cis proline' 0 N--CA 1.499 1.801 0 CA-C-N 119.968 1.024 . . . . 0.0 114.686 3.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.52 ' CE1' ' HB2' ' A' ' 705' ' ' SER . 51.5 m-85 76.15 73.96 0.08 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 124.73 1.269 . . . . 0.0 108.531 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.464 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 37.0 m-85 -82.26 174.17 11.41 Favored 'General case' 0 CA--C 1.485 -1.524 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.5 -176.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -72.63 125.17 26.82 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.746 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 103.52 2.18 47.06 Favored Glycine 0 N--CA 1.411 -3.014 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.313 -177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -87.09 151.0 23.61 Favored 'General case' 0 CA--C 1.5 -0.969 0 O-C-N 122.445 -0.444 . . . . 0.0 111.153 175.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 21.7 m -132.69 156.89 46.18 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.63 HG21 HG21 ' A' ' 694' ' ' ILE . 39.8 t -138.24 136.43 44.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 48.6 mt-10 -91.07 141.71 28.54 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 123.434 0.459 . . . . 0.0 110.249 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.623 ' HB3' HD12 ' A' ' 697' ' ' LEU . 42.8 m-85 -138.98 121.65 16.35 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 124.655 1.182 . . . . 0.0 108.693 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.459 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 41.4 m-20 -124.46 -165.76 1.42 Allowed 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 8.0 m -117.91 140.97 48.96 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -178.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.9 m -60.73 -68.1 0.34 Allowed 'General case' 0 C--O 1.247 0.931 0 CA-C-O 120.83 0.348 . . . . 0.0 110.551 -175.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 722' ' ' SER . 8.3 pt-20 -172.8 160.51 4.45 Favored 'General case' 0 CA--C 1.487 -1.469 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 40.4 m 71.43 7.59 6.07 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.682 1.239 . . . . 0.0 110.493 -174.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.619 ' HA ' ' O ' ' A' ' 745' ' ' VAL . 93.2 m-85 -140.03 144.73 37.05 Favored 'General case' 0 N--CA 1.382 -3.849 0 CA-C-N 114.246 -1.343 . . . . 0.0 108.658 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.515 HG21 HD21 ' A' ' 750' ' ' LEU . 1.1 m -120.38 144.74 47.74 Favored 'General case' 0 C--N 1.264 -3.138 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.786 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.711 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.7 ttp -81.95 116.72 21.71 Favored 'General case' 0 N--CA 1.434 -1.267 0 C-N-CA 124.91 1.284 . . . . 0.0 109.564 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 46.6 mm -115.25 137.13 49.77 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.954 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.518 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 96.3 -80.05 0.75 Allowed Glycine 0 N--CA 1.435 -1.392 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.123 174.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.564 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 4.2 t60 -147.09 177.48 9.13 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 -173.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.711 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -133.3 22.44 4.06 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.542 176.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 32.4 p -156.25 162.43 40.15 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.784 -0.572 . . . . 0.0 110.42 -177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 741' ' ' LEU . 36.2 pt -121.67 161.09 22.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 124.217 0.948 . . . . 0.0 108.579 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.404 ' O ' HG23 ' A' ' 739' ' ' THR . 10.5 m -133.37 135.8 44.93 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 123.595 0.56 . . . . 0.0 110.424 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 17.9 t -90.71 104.17 16.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.7 pp -146.34 161.68 10.25 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.912 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 71.7 -43.62 0.57 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 124.406 1.082 . . . . 0.0 111.565 175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 138.15 37.14 0.14 Allowed Glycine 0 N--CA 1.431 -1.655 0 C-N-CA 125.162 1.363 . . . . 0.0 109.769 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 14.8 p -174.41 161.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.502 ' CZ2' ' HB3' ' A' ' 709' ' ' TYR . 95.8 m95 -77.36 172.87 12.63 Favored 'General case' 0 C--N 1.286 -2.179 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.645 173.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 732' ' ' THR . 29.5 p -80.4 -159.19 0.22 Allowed 'General case' 0 N--CA 1.424 -1.773 0 CA-C-O 121.699 0.762 . . . . 0.0 112.259 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.478 ' CD ' ' H ' ' A' ' 740' ' ' GLN . 0.5 OUTLIER -83.9 -4.57 58.79 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -165.4 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.414 HD13 HG21 ' A' ' 731' ' ' ILE . 4.1 mm? 68.73 156.13 0.15 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 123.432 0.458 . . . . 0.0 111.504 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.564 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 59.0 Cg_endo -80.25 173.66 12.27 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.826 1.684 . . . . 0.0 111.041 172.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -116.36 114.96 25.02 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 724' ' ' THR . 59.1 m -98.08 100.29 11.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-O 122.156 0.979 . . . . 0.0 109.483 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.706 HG11 ' CD1' ' A' ' 750' ' ' LEU . 10.6 p -77.87 155.03 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.292 0 CA-C-N 113.82 -1.537 . . . . 0.0 108.737 -178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -79.17 1.33 24.87 Favored 'General case' 0 C--N 1.251 -3.7 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.948 179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.557 ' HA ' HD22 ' A' ' 750' ' ' LEU . 18.8 mt 77.08 -24.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 126.48 1.912 . . . . 0.0 112.24 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.438 ' H ' ' C ' ' A' ' 746' ' ' ALA . 22.9 t70 -72.23 -34.3 68.22 Favored 'General case' 0 C--N 1.264 -3.128 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.103 -175.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 749' ' ' LYS . 8.1 ptmt -102.42 27.8 6.5 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 112.687 -2.051 . . . . 0.0 111.541 -174.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.706 ' CD1' HG11 ' A' ' 745' ' ' VAL . 1.9 tp -84.31 -179.46 7.2 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.363 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -107.37 -172.82 2.15 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.586 -173.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . 0.543 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 25.0 mtpp -123.03 156.04 35.65 Favored 'General case' 0 C--N 1.265 -3.07 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 -176.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 79.2 m -112.18 168.6 9.49 Favored 'General case' 1 C--N 1.241 -4.136 0 C-N-CA 123.354 0.662 . . . . 0.0 109.532 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -129.2 141.36 51.17 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 48.1 t -61.86 131.37 49.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 173.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.51 ' HB2' HG12 ' A' ' 759' ' ' ILE . 17.7 m -76.17 175.01 9.39 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 123.079 0.551 . . . . 0.0 111.539 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -85.73 -35.02 21.06 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -172.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 85.3 mt -108.18 12.55 26.57 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.905 -0.718 . . . . 0.0 111.525 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.599 HG22 ' SG ' ' A' ' 803' ' ' CYS . 23.2 pt -105.59 156.21 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.183 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . 0.46 HD11 ' HB3' ' A' ' 782' ' ' ARG . 3.1 mp -122.6 129.44 75.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 176.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.659 HD13 ' HZ ' ' A' ' 771' ' ' PHE . 81.9 mt -97.52 -173.54 2.67 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.629 178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 35.0 mt-10 -68.77 162.3 26.56 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . 0.568 ' HA ' ' HE2' ' A' ' 766' ' ' LYS . 38.9 mm-40 -61.74 -21.81 64.85 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.432 0.634 . . . . 0.0 110.738 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -99.27 2.02 45.18 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.471 -178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.434 HD12 ' HE2' ' A' ' 771' ' ' PHE . 3.3 mm? -126.94 -12.44 5.88 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 763' ' ' GLU . 57.0 mtmt -68.37 -7.53 32.2 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.843 0.683 . . . . 0.0 112.843 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -102.61 0.67 33.67 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 768' ' ' LYS . 8.4 tppt? -95.02 102.43 14.24 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -78.55 -31.81 47.59 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.368 0.604 . . . . 0.0 109.656 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -131.17 128.25 39.64 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.936 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.659 ' HZ ' HD13 ' A' ' 761' ' ' LEU . 92.6 m-85 -107.15 162.62 13.71 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 752' ' ' LYS . 2.6 p30 -113.55 168.72 9.52 Favored 'General case' 0 C--N 1.279 -2.487 0 C-N-CA 118.1 -1.44 . . . . 0.0 109.126 175.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.428 ' CD2' HG23 ' A' ' 747' ' ' ILE . 2.1 p-80 -47.42 150.09 0.98 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.984 0.914 . . . . 0.0 112.835 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 70.93 3.62 4.71 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 124.934 1.293 . . . . 0.0 111.324 175.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 12.8 t -78.85 114.39 17.75 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.461 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.8 OUTLIER -89.05 113.23 24.32 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.173 178.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.454 HG21 ' CE2' ' A' ' 771' ' ' PHE . 8.2 pt -125.89 178.05 4.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 CA-C-O 121.337 0.589 . . . . 0.0 109.688 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.609 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 31.4 ptt180 -133.45 127.84 34.18 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 172.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.521 ' CE1' HG12 ' A' ' 801' ' ' VAL . 6.6 p90 -119.38 168.04 11.33 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 177.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -144.53 161.01 40.16 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 784' ' ' LYS . 85.2 m -90.27 143.12 27.05 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.884 177.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . 0.46 ' HB3' HD11 ' A' ' 760' ' ' ILE . 27.4 ptt180 -67.75 130.49 43.17 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 95.94 -10.59 68.11 Favored Glycine 0 C--N 1.294 -1.765 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 781' ' ' CYS . 13.4 mptt -114.02 140.38 48.49 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -116.87 87.66 2.74 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.395 0.617 . . . . 0.0 110.066 -179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 172.61 158.54 17.11 Favored Glycine 0 N--CA 1.425 -2.036 0 N-CA-C 108.771 -1.731 . . . . 0.0 108.771 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.609 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 60.4 m95 -114.32 145.39 41.84 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 117.368 0.584 . . . . 0.0 109.71 -175.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.423 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -95.84 -35.33 5.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.388 -177.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 7.1 m170 70.92 114.41 0.05 Allowed 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 124.31 1.044 . . . . 0.0 109.785 -178.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . . . . . . . . . 3.6 t -139.46 163.08 33.47 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.798 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 39.6 t -124.97 138.96 52.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 C-N-CA 123.388 0.675 . . . . 0.0 109.459 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.7 t -73.41 110.69 7.89 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.559 0.695 . . . . 0.0 110.258 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.4 mm -111.81 81.57 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.639 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.7 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.491 HD22 HD12 ' A' ' 750' ' ' LEU . 26.5 t-20 53.52 68.67 0.81 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.947 0.88 . . . . 0.0 112.22 175.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 70.55 17.4 74.66 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 115.37 -0.832 . . . . 0.0 113.824 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -143.52 166.2 25.46 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.604 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 95.1 m95 -112.61 158.92 19.4 Favored 'General case' 0 C--N 1.252 -3.638 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -148.05 106.67 3.65 Favored Pre-proline 0 C--N 1.299 -1.625 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 177.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.82 138.53 46.98 Favored 'Cis proline' 0 C--O 1.241 0.633 0 C-N-CA 123.62 -1.408 . . . . 0.0 111.541 -0.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.604 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 22.1 tp10 -57.36 128.27 36.17 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.669 179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.521 HG12 ' CE1' ' A' ' 779' ' ' TYR . 15.8 m -72.52 136.12 26.3 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.786 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.706 -173.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -152.57 111.09 3.74 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.101 0.477 . . . . 0.0 110.551 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . 0.599 ' SG ' HG22 ' A' ' 759' ' ' ILE . 73.4 m -131.32 24.88 4.85 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 122.413 1.102 . . . . 0.0 108.598 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.417 -2.125 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.802 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . 0.544 ' CG2' ' HB2' ' A' ' 708' ' ' PRO . 19.6 p . . . . . 0 N--CA 1.433 -1.296 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.4 m -74.82 -59.38 2.76 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 135.35 166.88 11.18 Favored Glycine 1 N--CA 1.383 -4.857 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -177.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.656 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 34.1 t70 -53.54 135.78 39.53 Favored 'General case' 0 C--N 1.281 -2.397 0 O-C-N 124.658 0.858 . . . . 0.0 111.062 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 715' ' ' VAL . 1.2 pp -52.76 150.27 9.98 Favored Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 113.15 -1.841 . . . . 0.0 115.654 -172.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.42 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.0 Cg_endo -71.82 -162.87 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.61 2.873 . . . . 0.0 111.866 175.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -135.5 154.64 51.34 Favored 'General case' 0 N--CA 1.395 -3.214 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.62 HD21 ' SG ' ' A' ' 744' ' ' CYS . 21.9 tp -104.25 111.5 24.14 Favored 'General case' 0 C--N 1.252 -3.656 0 CA-C-N 114.67 -1.15 . . . . 0.0 108.593 176.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -43.9 -37.11 2.68 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.806 1.642 . . . . 0.0 115.22 -175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -134.73 26.61 3.67 Favored 'General case' 0 CA--C 1.501 -0.938 0 O-C-N 121.942 -0.474 . . . . 0.0 110.429 -178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -139.71 -147.78 5.1 Favored Glycine 0 C--N 1.299 -1.482 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.207 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.425 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -149.61 173.3 13.8 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 122.617 0.367 . . . . 0.0 110.208 -177.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -105.61 139.38 40.3 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -82.27 -75.22 0.31 Allowed 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.962 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . 0.553 HD13 ' N ' ' A' ' 705' ' ' SER . 1.0 OUTLIER -170.66 162.38 7.83 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.217 0.532 . . . . 0.0 111.343 177.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.615 ' CB ' HG22 ' A' ' 715' ' ' VAL . 33.8 t 174.92 179.38 0.13 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 128.527 2.731 . . . . 0.0 105.007 177.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 23.4 p -148.63 140.82 14.74 Favored Pre-proline 0 C--N 1.305 -1.344 0 CA-C-N 118.619 0.645 . . . . 0.0 110.833 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.537 ' HA ' ' N ' ' A' ' 709' ' ' TYR . 50.4 Cg_endo -68.52 163.9 34.95 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.019 1.813 . . . . 0.0 109.064 175.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.544 ' HB2' ' CG2' ' A' ' 690' ' ' THR . 29.7 Cg_endo -64.68 -5.14 3.05 Favored 'Cis proline' 0 N--CA 1.502 1.973 0 N-CA-C 117.353 2.02 . . . . 0.0 117.353 4.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.656 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 74.7 m-85 66.33 66.55 0.47 Allowed 'General case' 0 C--O 1.255 1.362 0 CA-C-O 122.288 1.042 . . . . 0.0 108.566 -176.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -67.11 169.85 7.85 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 113.336 -1.756 . . . . 0.0 112.111 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.485 ' HA ' ' SG ' ' A' ' 733' ' ' CYS . 58.3 m-85 -67.63 137.33 55.53 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.928 176.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 87.52 8.17 74.46 Favored Glycine 0 N--CA 1.41 -3.048 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.09 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -81.68 156.77 24.9 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 13.8 m -141.27 139.43 33.69 Favored 'General case' 0 C--N 1.279 -2.496 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 694' ' ' ILE . 20.2 t -126.78 136.65 60.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.565 ' HG3' ' HG2' ' A' ' 729' ' ' ARG . 26.5 tt0 -96.89 140.59 31.22 Favored 'General case' 0 N--CA 1.381 -3.918 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.581 ' HB3' HD22 ' A' ' 697' ' ' LEU . 50.4 m-85 -138.67 120.39 15.24 Favored 'General case' 0 C--N 1.283 -2.312 0 C-N-CA 125.833 1.653 . . . . 0.0 107.396 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.425 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 13.5 m-80 -122.28 -165.36 1.27 Allowed 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 7.1 m -112.97 135.89 53.25 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 103.849 -2.648 . . . . 0.0 103.849 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 11.9 t -57.94 -68.93 0.2 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 722' ' ' SER . 11.4 pt-20 -172.26 163.81 5.82 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 175.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 721' ' ' GLU . 75.4 m 72.13 5.95 5.44 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 124.193 0.933 . . . . 0.0 110.872 -177.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.648 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 96.6 m-85 -141.52 145.53 35.28 Favored 'General case' 0 N--CA 1.401 -2.895 0 C-N-CA 125.192 1.397 . . . . 0.0 107.95 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.2 m -114.21 138.24 50.72 Favored 'General case' 0 C--N 1.251 -3.716 0 C-N-CA 125.709 1.604 . . . . 0.0 111.998 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.598 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.1 ttp -91.01 122.36 33.6 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 124.893 1.277 . . . . 0.0 109.486 -177.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 39.8 mm -124.21 135.89 62.2 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.949 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 101.35 -74.99 0.37 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.636 -0.711 . . . . 0.0 113.206 173.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.537 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 0.1 OUTLIER -141.16 177.18 8.25 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -176.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.598 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.0 OUTLIER -135.46 8.92 3.4 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.0 0.905 . . . . 0.0 109.359 170.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 54.4 p -145.72 163.0 36.29 Favored 'General case' 0 C--N 1.287 -2.144 0 O-C-N 121.699 -0.625 . . . . 0.0 110.235 -176.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.505 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 35.7 pt -122.76 163.4 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.196 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.446 ' O ' HG23 ' A' ' 739' ' ' THR . 21.2 m -139.17 137.25 35.89 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.937 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 5.7 t -86.48 99.9 11.99 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 739' ' ' THR . 1.7 pp -140.75 146.27 24.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.284 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 67.87 -4.78 0.93 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 112.47 13.38 11.77 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 121.581 -0.342 . . . . 0.0 112.613 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.2 p -155.09 157.22 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.429 ' CZ3' HG23 ' A' ' 715' ' ' VAL . 96.9 m95 -73.33 167.58 20.93 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 121.056 0.455 . . . . 0.0 109.816 171.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.505 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 42.8 p -77.61 -163.12 0.36 Allowed 'General case' 0 N--CA 1.426 -1.638 0 CA-C-O 122.021 0.915 . . . . 0.0 112.616 -177.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -77.55 -1.89 32.93 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -167.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . . . . . . . . . 4.4 mm? 67.61 161.44 0.14 Allowed Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 122.735 0.414 . . . . 0.0 110.386 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.537 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 49.8 Cg_endo -83.64 174.35 8.79 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.443 1.429 . . . . 0.0 110.241 168.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -117.39 117.09 28.53 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.62 ' SG ' HD21 ' A' ' 697' ' ' LEU . 95.4 m -102.67 107.77 18.8 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.188 0.518 . . . . 0.0 110.154 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.437 ' HB ' HD21 ' A' ' 750' ' ' LEU . 39.6 t -96.31 145.05 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.549 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.648 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -67.89 6.89 0.61 Allowed 'General case' 0 C--N 1.281 -2.394 0 C-N-CA 125.048 1.339 . . . . 0.0 114.438 -175.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.861 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 36.9 mt 76.34 -16.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 C-N-CA 125.561 1.544 . . . . 0.0 112.025 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 746' ' ' ALA . 14.9 t70 -81.82 -31.96 31.48 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.616 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -107.33 23.23 14.76 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 112.946 -1.934 . . . . 0.0 108.442 -172.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.861 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 72.5 mt -82.58 -165.21 0.98 Allowed 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.087 -1.415 . . . . 0.0 108.361 175.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.524 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 61.3 mtpt -124.51 152.7 43.1 Favored 'General case' 0 N--CA 1.393 -3.314 0 CA-C-O 121.834 0.826 . . . . 0.0 110.19 -173.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . 0.425 ' HE3' ' OE1' ' A' ' 770' ' ' GLU . 43.8 mtmt -101.87 115.56 30.8 Favored 'General case' 0 C--N 1.251 -3.674 0 CA-C-N 112.717 -2.038 . . . . 0.0 109.034 -176.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . 0.463 ' HA ' ' HA2' ' A' ' 795' ' ' GLY . 0.0 OUTLIER -75.71 166.65 23.23 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-N 112.991 -1.913 . . . . 0.0 109.143 -178.092 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -145.68 161.84 38.93 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.004 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 31.4 t -65.53 121.74 15.61 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 114.624 -1.171 . . . . 0.0 109.357 172.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.674 ' HB3' HG13 ' A' ' 759' ' ' ILE . 30.6 t -63.91 153.48 36.82 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 173.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -58.76 -26.96 64.52 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 124.24 1.016 . . . . 0.0 113.459 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 803' ' ' CYS . 1.5 mm? -110.59 -13.84 14.16 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 118.824 -1.15 . . . . 0.0 112.831 -170.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.674 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.7 pp -87.7 155.25 3.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -174.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.09 134.41 55.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 113.78 -1.555 . . . . 0.0 107.17 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 1.8 mm? -114.12 178.7 4.19 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.56 ' HB2' HD23 ' A' ' 765' ' ' LEU . 34.6 mt-10 -73.15 163.12 28.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 176.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -52.93 -27.61 19.63 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . 0.487 ' HB2' HD22 ' A' ' 765' ' ' LEU . 31.2 m-70 -76.6 -35.97 57.78 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 -179.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.56 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.0 mm? -91.11 -15.55 29.26 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 113.192 -1.822 . . . . 0.0 112.551 -168.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -77.48 -6.78 54.75 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.202 0.525 . . . . 0.0 110.951 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -114.46 13.18 17.59 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.465 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 13.5 tppt? -105.85 112.61 25.73 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -87.31 -29.53 21.53 Favored 'General case' 0 C--N 1.29 -1.994 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.189 -178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . 0.425 ' OE1' ' HE3' ' A' ' 752' ' ' LYS . 45.2 mt-10 -139.66 138.29 35.95 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.653 -178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.465 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 39.5 m-85 -117.02 177.0 4.87 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -175.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -121.48 166.2 14.5 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 792' ' ' CYS . 34.9 t60 -65.54 149.73 49.58 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 172.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 83.03 0.41 1.16 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.789 1.236 . . . . 0.0 108.668 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 54.0 m -83.41 106.57 15.27 Favored 'General case' 0 N--CA 1.41 -2.467 0 C-N-CA 119.001 -1.079 . . . . 0.0 108.885 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.454 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -88.41 101.94 14.4 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.402 HG12 ' CZ3' ' A' ' 797' ' ' TRP . 4.3 pt -112.87 178.36 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-O 121.773 0.797 . . . . 0.0 109.868 -177.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.643 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 79.2 mtt180 -130.06 127.76 40.54 Favored 'General case' 0 N--CA 1.41 -2.434 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.583 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 7.6 p90 -121.73 168.48 11.76 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -152.93 171.35 18.46 Favored 'General case' 0 C--N 1.274 -2.677 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.749 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 52.7 t -113.06 162.03 16.39 Favored 'General case' 0 C--N 1.277 -2.568 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 -178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . 0.455 ' HG2' ' SG ' ' A' ' 803' ' ' CYS . 32.4 ptt180 -77.98 104.24 8.42 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 120.65 -44.21 1.41 Allowed Glycine 0 C--N 1.276 -2.765 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.037 -174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.749 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.7 mptt -97.89 91.04 5.15 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -79.75 148.28 31.55 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.245 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 100.62 154.34 27.08 Favored Glycine 0 C--N 1.294 -1.763 0 N-CA-C 107.962 -2.055 . . . . 0.0 107.962 -172.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.643 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 45.4 m95 -99.9 139.79 35.05 Favored 'General case' 0 C--N 1.285 -2.238 0 CA-C-N 117.622 0.711 . . . . 0.0 110.994 -173.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.583 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.8 mp -90.35 -33.01 5.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.674 -175.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 18.6 m170 78.45 125.46 0.04 OUTLIER 'General case' 0 N--CA 1.515 2.786 0 C-N-CA 124.784 1.234 . . . . 0.0 110.206 -177.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.458 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.2 t -151.55 152.98 33.65 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.839 0.352 . . . . 0.0 110.808 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 52.7 t -117.59 134.85 59.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . 0.483 ' HB3' ' HA ' ' A' ' 773' ' ' HIS . 52.4 t -67.46 132.78 48.28 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.972 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 48.8 mm -120.61 83.21 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 C-N-CA 124.418 1.087 . . . . 0.0 108.074 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.567 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.8 OUTLIER 45.93 72.74 0.2 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.097 0.959 . . . . 0.0 112.809 177.468 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 753' ' ' CYS . . . 78.4 0.55 78.93 Favored Glycine 0 C--N 1.296 -1.666 0 C-N-CA 120.234 -0.984 . . . . 0.0 114.012 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . 0.499 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 36.1 ttm180 -130.38 173.48 10.78 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.601 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 98.5 m95 -116.78 162.18 18.11 Favored 'General case' 0 C--N 1.273 -2.757 0 C-N-CA 122.351 0.26 . . . . 0.0 111.179 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -144.68 108.08 4.73 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 175.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.17 140.05 56.5 Favored 'Cis proline' 0 C--O 1.248 0.992 0 C-N-CA 123.637 -1.401 . . . . 0.0 111.129 -1.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.601 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.9 tt0 -57.11 125.58 23.33 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.006 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . . . . . . . . . 9.5 m -66.21 133.88 30.53 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.788 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.808 -175.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -147.99 127.03 12.82 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 758' ' ' LEU . 42.0 t -117.92 -18.39 9.51 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-O 121.548 0.69 . . . . 0.0 109.85 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 C--N 1.301 -1.502 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.361 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.422 -1.832 0 CA-C-O 121.721 0.772 . . . . 0.0 110.077 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 20.7 m -76.41 -74.18 0.24 Allowed 'General case' 0 C--N 1.276 -2.629 0 CA-C-N 113.895 -1.502 . . . . 0.0 111.161 -178.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 143.72 179.09 20.03 Favored Glycine 1 N--CA 1.356 -6.663 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -39.66 126.52 1.92 Allowed 'General case' 0 C--N 1.285 -2.203 0 C-N-CA 126.313 1.845 . . . . 0.0 111.484 175.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.563 HG21 HG21 ' A' ' 715' ' ' VAL . 1.7 pp -63.16 147.78 94.07 Favored Pre-proline 0 N--CA 1.425 -1.707 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.406 179.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.503 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 72.9 Cg_endo -72.69 -166.22 0.27 Allowed 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.818 2.345 . . . . 0.0 112.828 178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -126.6 165.19 19.65 Favored 'General case' 0 N--CA 1.399 -2.977 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 -177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.602 HD22 ' HB3' ' A' ' 717' ' ' PHE . 37.6 tp -119.67 110.64 17.07 Favored 'General case' 0 C--N 1.251 -3.705 0 CA-C-N 115.309 -0.859 . . . . 0.0 108.901 176.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -45.05 -40.24 6.5 Favored 'General case' 0 C--O 1.216 -0.677 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -173.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 88.2 m-70 -128.24 20.7 6.27 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 121.473 -0.767 . . . . 0.0 110.16 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.466 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -125.29 -139.61 5.24 Favored Glycine 0 C--N 1.304 -1.2 0 C-N-CA 120.205 -0.998 . . . . 0.0 111.93 -177.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.6 ' HE1' ' CG ' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -160.85 177.92 9.93 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 -179.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -109.96 154.65 22.83 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 26.2 mm-40 -91.27 -74.32 0.51 Allowed 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 120.933 0.397 . . . . 0.0 110.369 176.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 705' ' ' SER . 6.3 tt -157.22 133.56 9.77 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 177.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 709' ' ' TYR . 4.2 p -133.96 110.73 9.88 Favored 'General case' 0 N--CA 1.393 -3.297 0 CA-C-O 121.724 0.773 . . . . 0.0 110.145 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 39.8 t -90.26 111.45 47.1 Favored Pre-proline 0 C--N 1.277 -2.557 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.993 -174.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.409 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 58.3 Cg_endo -71.26 171.81 15.31 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.774 2.316 . . . . 0.0 109.363 175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.477 ' HG2' ' CE1' ' A' ' 710' ' ' TYR . 2.8 Cg_exo -70.75 -7.24 11.57 Favored 'Cis proline' 0 CA--C 1.498 -1.316 0 N-CA-C 115.505 1.31 . . . . 0.0 115.505 5.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 705' ' ' SER . 43.3 m-85 78.55 86.1 0.07 Allowed 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.477 ' CE1' ' HG2' ' A' ' 708' ' ' PRO . 26.9 m-85 -91.2 174.65 7.28 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.815 -179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.449 ' CE2' ' HA2' ' A' ' 736' ' ' GLY . 64.1 m-85 -74.71 136.64 41.8 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.231 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 91.26 -4.91 81.01 Favored Glycine 0 N--CA 1.416 -2.657 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.356 -178.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -73.59 147.79 43.52 Favored 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 6.8 m -129.02 152.53 48.53 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.563 HG21 HG21 ' A' ' 694' ' ' ILE . 41.1 t -136.29 133.01 49.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 36.7 mt-10 -95.17 140.32 30.25 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.962 0.886 . . . . 0.0 111.638 -178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.602 ' HB3' HD22 ' A' ' 697' ' ' LEU . 37.3 m-85 -138.76 129.96 26.95 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -178.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.6 ' CG ' ' HE1' ' A' ' 701' ' ' TRP . 9.1 p30 -128.44 -167.77 1.82 Allowed 'General case' 1 N--CA 1.377 -4.089 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 176.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 44.4 m -108.65 124.06 49.94 Favored 'General case' 0 C--N 1.247 -3.864 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -175.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 24.2 t -44.9 -80.75 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 O-C-N 125.689 1.868 . . . . 0.0 112.834 -169.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -153.83 150.74 28.75 Favored 'General case' 0 CA--C 1.485 -1.536 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.3 m 69.19 9.65 7.46 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 124.262 0.976 . . . . 0.0 113.611 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.484 ' HB2' ' HB3' ' A' ' 719' ' ' CYS . 96.5 m-85 -134.3 145.53 49.16 Favored 'General case' 0 N--CA 1.409 -2.5 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.567 HG21 HD11 ' A' ' 750' ' ' LEU . 6.4 t -75.86 -115.53 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.898 -175.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.64 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.2 ttp 165.09 107.86 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.732 2.813 . . . . 0.0 105.227 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.703 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 42.1 mm -119.03 143.96 28.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.005 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 92.48 -68.87 1.81 Allowed Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 116.088 -0.505 . . . . 0.0 113.731 173.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.544 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 1.5 t60 -154.58 -178.71 7.37 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 -174.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.64 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.1 OUTLIER -139.35 20.31 2.57 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.379 0.609 . . . . 0.0 110.012 173.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.606 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 59.9 p -156.08 162.3 40.29 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.879 -177.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 714' ' ' SER . 35.8 pt -120.34 157.75 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.639 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 739' ' ' THR . 6.1 m -131.26 135.6 47.48 Favored 'General case' 0 C--N 1.275 -2.636 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.0 t -95.77 111.57 23.5 Favored 'General case' 0 N--CA 1.392 -3.346 0 C-N-CA 118.955 -1.098 . . . . 0.0 109.763 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -138.09 154.23 28.05 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.128 0 CA-C-N 113.649 -1.614 . . . . 0.0 107.089 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 76.76 -44.74 0.48 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.311 1.044 . . . . 0.0 110.26 177.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . 0.449 ' HA2' ' CE2' ' A' ' 711' ' ' TYR . . . 144.86 25.78 0.11 Allowed Glycine 0 C--N 1.298 -1.559 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 8.5 p -163.64 167.69 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -175.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.503 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 86.8 m95 -84.33 173.02 11.28 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-O 121.156 0.503 . . . . 0.0 111.634 177.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 732' ' ' THR . 21.3 p -86.92 -157.25 0.36 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -175.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.496 ' NE2' ' HB ' ' A' ' 739' ' ' THR . 0.0 OUTLIER -69.49 -24.28 63.75 Favored 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 126.065 1.746 . . . . 0.0 113.468 -171.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.446 HD21 ' HG2' ' A' ' 695' ' ' PRO . 1.6 mt 70.08 155.27 0.15 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 124.452 1.095 . . . . 0.0 111.206 -172.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.544 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 37.6 Cg_endo -71.61 175.28 9.75 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.792 1.661 . . . . 0.0 111.812 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.703 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 8.4 tt0 -123.11 119.2 29.59 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.567 ' SG ' HD21 ' A' ' 697' ' ' LEU . 90.7 m -105.0 104.4 14.13 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 121.18 0.514 . . . . 0.0 110.965 -177.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 724' ' ' THR . 42.2 t -101.83 147.2 8.89 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 748' ' ' ASP . . . -65.76 3.73 0.73 Allowed 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 124.867 1.267 . . . . 0.0 113.788 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.86 ' HA ' HD22 ' A' ' 750' ' ' LEU . 61.4 mt 73.8 -17.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 125.821 1.648 . . . . 0.0 110.938 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.51 ' H ' ' C ' ' A' ' 746' ' ' ALA . 7.2 t70 -72.51 -33.03 66.63 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 126.402 1.881 . . . . 0.0 109.267 -177.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -105.05 18.91 21.53 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.592 -1.64 . . . . 0.0 109.566 -172.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 1.022 ' HG ' HD22 ' A' ' 794' ' ' ASN . 0.2 OUTLIER -82.06 -172.9 4.2 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.06 179.179 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 751' ' ' LYS . 28.1 mmmt -115.04 148.7 38.55 Favored 'General case' 0 N--CA 1.381 -3.906 0 CA-C-N 114.17 -1.377 . . . . 0.0 107.706 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -109.82 119.26 38.79 Favored 'General case' 1 C--N 1.23 -4.613 0 CA-C-N 112.947 -1.933 . . . . 0.0 109.378 -173.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 770' ' ' GLU . 27.2 m -67.27 162.73 22.06 Favored 'General case' 0 C--N 1.278 -2.535 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.762 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 769' ' ' LYS . 16.9 ptpt -126.44 144.15 50.94 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.181 -176.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 769' ' ' LYS . 48.0 p -68.06 114.13 6.33 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.754 171.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.585 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 45.2 t -69.76 156.9 38.31 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 173.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -84.32 -13.39 52.54 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.278 0.561 . . . . 0.0 112.385 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 5.6 mp -95.53 -4.28 45.08 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.059 -173.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.585 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.1 pp -118.96 152.24 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.545 0 CA-C-O 121.985 0.897 . . . . 0.0 112.138 -178.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.58 127.77 64.76 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.795 0 CA-C-N 113.814 -1.539 . . . . 0.0 107.365 -178.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.467 HD11 HD13 ' A' ' 759' ' ' ILE . 1.5 mm? -107.6 -175.18 2.72 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.565 ' HB2' HD23 ' A' ' 765' ' ' LEU . 25.6 mt-10 -76.87 171.86 14.07 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.263 177.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.33 -31.34 67.47 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.282 0.633 . . . . 0.0 110.544 179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -95.32 2.09 54.6 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 114.779 -1.101 . . . . 0.0 111.731 -175.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.565 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.9 mm? -122.28 -24.45 5.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 53.8 mtmt -66.38 -23.78 66.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -86.77 -2.83 58.86 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 119.917 -0.713 . . . . 0.0 109.939 178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.483 ' HE3' ' CD2' ' A' ' 771' ' ' PHE . 23.4 ttpt -99.4 110.22 22.74 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . 0.608 ' HG2' ' HG3' ' A' ' 770' ' ' GLU . 0.0 OUTLIER -93.03 -23.98 18.48 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . 0.608 ' HG3' ' HG2' ' A' ' 769' ' ' LYS . 37.6 mt-10 -127.77 106.41 9.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.483 ' CD2' ' HE3' ' A' ' 768' ' ' LYS . 67.5 m-85 -89.59 147.95 23.64 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.916 -174.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -89.49 144.59 25.92 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.158 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.644 ' HB3' HD23 ' A' ' 750' ' ' LEU . 49.9 t60 -57.95 146.77 31.18 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.319 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 83.44 3.75 0.9 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.37 1.468 . . . . 0.0 110.232 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 67.8 m -86.41 113.6 22.5 Favored 'General case' 0 N--CA 1.398 -3.047 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.407 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.459 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -85.89 90.6 8.11 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.674 -1.148 . . . . 0.0 108.497 179.633 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . . . . . . . . . 7.4 pt -95.23 -175.5 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.702 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 0.2 OUTLIER -141.55 121.06 13.26 Favored 'General case' 0 N--CA 1.396 -3.142 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.007 175.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.559 ' CD2' HG13 ' A' ' 801' ' ' VAL . 10.6 p90 -106.71 168.71 8.99 Favored 'General case' 0 N--CA 1.417 -2.099 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 174.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 34.9 ptt180 -149.82 146.91 27.4 Favored 'General case' 0 C--N 1.257 -3.45 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 172.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.733 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 5.0 t -79.36 168.43 19.52 Favored 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -177.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 31.5 ptt180 -74.21 -1.38 20.25 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 121.113 0.482 . . . . 0.0 111.901 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -113.15 -6.6 22.2 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 111.53 -0.628 . . . . 0.0 111.53 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.733 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 3.8 mptp? -112.58 137.53 50.69 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -106.59 4.89 28.52 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 122.43 1.11 . . . . 0.0 110.805 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -113.04 157.84 14.67 Favored Glycine 0 C--N 1.268 -3.225 0 CA-C-N 113.446 -1.706 . . . . 0.0 108.943 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 46.0 m95 -100.35 141.45 33.18 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 117.231 0.516 . . . . 0.0 110.298 -173.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.518 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -91.93 -31.31 4.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 -177.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 15.4 m170 73.25 123.62 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 124.455 1.102 . . . . 0.0 110.13 -177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.494 HG21 ' CG2' ' A' ' 801' ' ' VAL . 2.3 t -146.33 155.36 42.57 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 24.9 t -114.21 133.26 60.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -176.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 41.6 t -70.46 117.2 11.7 Favored 'General case' 0 CA--C 1.502 -0.87 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.591 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 47.8 mm -119.29 89.15 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 C-N-CA 123.861 0.865 . . . . 0.0 109.382 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 1.022 HD22 ' HG ' ' A' ' 750' ' ' LEU . 0.9 OUTLIER 43.59 62.35 1.93 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.083 0.953 . . . . 0.0 112.754 175.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.15 36.47 56.29 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.968 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -158.79 165.53 34.05 Favored 'General case' 0 C--O 1.203 -1.384 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.622 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.4 m95 -114.23 160.36 19.11 Favored 'General case' 0 C--N 1.258 -3.385 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 799' ' ' PRO . 24.7 t70 -148.1 102.13 3.6 Favored Pre-proline 0 C--N 1.297 -1.68 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 798' ' ' ASP . 48.7 Cg_endo -70.77 142.59 72.9 Favored 'Cis proline' 0 C--O 1.244 0.824 0 C-N-CA 123.886 -1.298 . . . . 0.0 112.96 0.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.622 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 45.5 mt-10 -48.55 125.34 9.66 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.287 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.559 HG13 ' CD2' ' A' ' 779' ' ' TYR . 75.5 t -82.45 116.62 26.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.24 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -159.15 122.36 3.71 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.547 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 28.6 m -106.55 -18.15 14.05 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.643 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.307 -1.24 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.476 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 29.1 p . . . . . 0 N--CA 1.425 -1.694 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 54.1 m -78.62 -75.1 0.24 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.304 174.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 143.13 -167.9 26.26 Favored Glycine 1 N--CA 1.378 -5.226 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -48.89 130.34 18.01 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 125.462 1.505 . . . . 0.0 110.417 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.679 HG21 HG21 ' A' ' 715' ' ' VAL . 1.3 pp -58.52 150.61 55.12 Favored Pre-proline 0 C--N 1.302 -1.484 0 CA-C-N 115.3 -0.864 . . . . 0.0 113.324 -177.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.6 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 74.3 Cg_endo -72.15 -159.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.549 1.234 0 C-N-CA 123.276 2.65 . . . . 0.0 114.147 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -125.31 158.86 33.13 Favored 'General case' 0 N--CA 1.397 -3.115 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.617 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.5 OUTLIER -107.4 129.36 54.93 Favored 'General case' 0 C--N 1.26 -3.312 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 176.539 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -45.87 -45.68 15.32 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -141.22 27.18 1.95 Allowed 'General case' 0 CA--C 1.502 -0.886 0 CA-C-O 121.417 0.627 . . . . 0.0 109.536 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.617 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -134.0 -146.32 5.44 Favored Glycine 0 N--CA 1.431 -1.687 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.807 -177.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.433 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -153.41 178.11 10.15 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 122.94 0.496 . . . . 0.0 110.257 -175.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -108.55 147.5 31.68 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 22.9 mm-40 -71.34 -77.78 0.09 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.146 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 7.6 tt 179.66 135.98 0.1 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.518 ' HB2' HG13 ' A' ' 715' ' ' VAL . 22.9 t -144.81 -168.89 3.04 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 173.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 9.7 t -152.46 139.56 12.64 Favored Pre-proline 0 N--CA 1.426 -1.644 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.45 169.11 10.18 Favored 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 122.963 2.442 . . . . 0.0 110.072 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 710' ' ' TYR . 2.8 Cg_exo -72.44 -9.95 16.99 Favored 'Cis proline' 0 N--CA 1.49 1.279 0 N-CA-C 115.184 1.186 . . . . 0.0 115.184 7.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.415 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 62.3 m-85 73.28 79.85 0.13 Allowed 'General case' 0 C--N 1.312 -1.064 0 O-C-N 124.575 1.172 . . . . 0.0 108.993 -177.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 708' ' ' PRO . 21.4 m-85 -84.05 168.67 15.69 Favored 'General case' 0 CA--C 1.477 -1.84 0 CA-C-N 113.943 -1.481 . . . . 0.0 112.717 -174.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -69.66 128.3 35.97 Favored 'General case' 0 CA--C 1.486 -1.496 0 CA-C-N 114.348 -1.296 . . . . 0.0 109.07 174.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 102.57 -15.53 55.79 Favored Glycine 0 N--CA 1.414 -2.791 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.611 -177.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.47 145.25 52.89 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 10.8 m -131.32 150.28 52.21 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.679 HG21 HG21 ' A' ' 694' ' ' ILE . 42.7 t -138.15 124.65 26.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -176.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.694 ' HG3' ' HG2' ' A' ' 729' ' ' ARG . 2.3 mp0 -65.68 134.55 53.46 Favored 'General case' 0 C--O 1.249 1.047 0 CA-C-O 121.722 0.772 . . . . 0.0 112.623 175.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.425 ' HB3' ' CD1' ' A' ' 697' ' ' LEU . 19.9 m-85 -137.61 114.91 10.99 Favored 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 126.374 1.87 . . . . 0.0 107.063 178.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.433 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 19.3 m-20 -124.15 -168.56 1.81 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -175.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 23.3 m -116.17 138.62 51.11 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 5.0 m -57.55 -78.13 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 O-C-N 123.973 0.796 . . . . 0.0 112.152 -174.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -157.79 159.36 36.67 Favored 'General case' 0 CA--C 1.487 -1.473 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 58.4 m 65.95 9.56 6.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.598 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 94.6 m-85 -142.14 146.04 34.89 Favored 'General case' 0 N--CA 1.407 -2.586 0 C-N-CA 124.12 0.968 . . . . 0.0 108.771 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.0 OUTLIER -113.09 137.31 51.62 Favored 'General case' 0 C--N 1.256 -3.478 0 C-N-CA 125.432 1.493 . . . . 0.0 111.129 -178.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . . . . . . . . . 9.2 tmm? -87.54 125.36 34.29 Favored 'General case' 0 CA--C 1.48 -1.716 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.9 mm -124.91 133.32 69.76 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.009 175.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 121.33 -89.37 0.43 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.095 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 28.0 t60 -157.03 145.55 19.69 Favored 'General case' 0 CA--C 1.472 -2.024 0 N-CA-C 104.245 -2.502 . . . . 0.0 104.245 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.694 ' HG2' ' HG3' ' A' ' 716' ' ' GLU . 0.0 OUTLIER -86.84 13.77 8.35 Favored 'General case' 0 C--N 1.274 -2.691 0 C-N-CA 119.419 -0.912 . . . . 0.0 112.879 -171.552 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.464 ' HB3' ' HA ' ' A' ' 716' ' ' GLU . 6.0 p -156.66 168.56 27.03 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.951 -0.468 . . . . 0.0 111.987 -176.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 714' ' ' SER . 35.1 pt -117.0 164.61 13.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.587 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 9.3 m -136.08 134.24 38.19 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.698 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 8.5 t -84.14 107.57 16.54 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.092 0.472 . . . . 0.0 110.037 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -144.95 145.64 20.73 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.132 0 C-N-CA 125.085 1.354 . . . . 0.0 109.896 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 66.62 -0.31 1.61 Allowed 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.39 24.45 24.05 Favored Glycine 0 CA--C 1.498 -0.973 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.09 153.26 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.404 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.6 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.4 m95 -79.11 177.83 8.51 Favored 'General case' 0 C--N 1.277 -2.545 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.468 168.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.409 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 17.1 p -80.84 -169.81 2.37 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.686 0.755 . . . . 0.0 112.873 -176.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 1.3 pp0? -71.46 -14.98 62.31 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -171.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 2.1 mt 69.54 146.53 0.11 Allowed Pre-proline 0 CA--C 1.545 0.767 0 O-C-N 124.394 1.059 . . . . 0.0 113.853 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 48.1 Cg_endo -69.23 169.11 19.0 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 121.968 1.778 . . . . 0.0 112.346 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -115.22 104.69 12.08 Favored 'General case' 0 C--N 1.276 -2.624 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.821 -176.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 724' ' ' THR . 87.3 m -84.8 99.74 11.09 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.653 0.739 . . . . 0.0 110.112 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.64 ' CG1' ' HG3' ' A' ' 749' ' ' LYS . 41.7 t -92.8 142.19 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.761 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.537 -179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.598 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.32 2.29 0.62 Allowed 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 125.857 1.663 . . . . 0.0 114.624 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.773 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 49.0 mt 78.33 -14.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 126.063 1.745 . . . . 0.0 111.699 176.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 746' ' ' ALA . 24.9 t70 -83.88 -30.14 26.65 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.729 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.64 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 7.8 ptmt -110.58 29.78 7.4 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.002 -1.453 . . . . 0.0 111.838 -177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.773 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 96.2 mt -84.33 176.1 8.94 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.827 177.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -99.81 145.31 27.87 Favored 'General case' 0 N--CA 1.388 -3.564 0 CA-C-O 122.727 1.251 . . . . 0.0 110.293 -176.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -98.17 111.84 24.02 Favored 'General case' 1 C--N 1.236 -4.366 0 CA-C-N 111.248 -2.705 . . . . 0.0 109.21 -176.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 42.5 m -66.99 138.54 57.32 Favored 'General case' 0 C--N 1.273 -2.728 0 CA-C-N 114.365 -1.289 . . . . 0.0 109.867 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -107.95 136.39 47.73 Favored 'General case' 0 C--N 1.27 -2.867 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.407 -174.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . 0.412 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 15.5 p -52.75 132.82 36.92 Favored 'General case' 0 CA--C 1.554 1.12 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.842 173.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.572 ' HB3' ' CG1' ' A' ' 759' ' ' ILE . 29.8 t -80.46 166.75 20.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -93.36 -17.28 23.72 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -171.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . 0.728 HD12 ' HA ' ' A' ' 804' ' ' SER . 74.5 mt -113.23 14.37 19.35 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.025 -0.67 . . . . 0.0 112.299 -177.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.572 ' CG1' ' HB3' ' A' ' 756' ' ' SER . 2.1 pp -115.05 149.18 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.0 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.961 175.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . 0.572 ' HB ' ' HG2' ' A' ' 780' ' ' ARG . 3.2 mp -107.95 129.95 61.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.862 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -177.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 765' ' ' LEU . 1.9 mm? -108.17 178.76 4.41 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -77.96 172.21 13.84 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -66.47 -8.77 28.42 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 122.952 0.501 . . . . 0.0 112.035 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -93.13 -17.09 24.18 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.701 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 81.8 mt -117.03 -18.13 10.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -170.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -62.48 -26.17 68.39 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -175.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -101.42 8.35 42.21 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.714 175.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.705 ' HD2' ' CD2' ' A' ' 771' ' ' PHE . 19.2 ttmm -98.42 94.93 6.99 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . 0.465 ' HD2' ' H ' ' A' ' 769' ' ' LYS . 0.0 OUTLIER -71.23 -30.3 66.17 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.952 -177.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -136.83 123.24 20.75 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.558 0.694 . . . . 0.0 110.915 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.705 ' CD2' ' HD2' ' A' ' 768' ' ' LYS . 14.2 m-85 -101.51 156.51 17.43 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.316 -1.311 . . . . 0.0 107.709 -174.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -98.7 156.12 16.99 Favored 'General case' 0 C--N 1.281 -2.393 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.011 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.641 ' HD1' ' HA ' ' A' ' 793' ' ' ILE . 47.5 t60 -59.16 137.47 57.95 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.238 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 84.93 12.63 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 O-C-N 125.633 1.833 . . . . 0.0 109.746 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 58.7 m -87.32 117.78 26.32 Favored 'General case' 0 N--CA 1.41 -2.473 0 C-N-CA 119.208 -0.997 . . . . 0.0 108.783 175.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.502 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -91.96 107.37 19.16 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 -178.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.701 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 5.6 pt -118.9 -175.14 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 -177.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.433 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 17.3 ptp180 -147.13 128.5 14.88 Favored 'General case' 0 N--CA 1.399 -2.979 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 173.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.532 ' CD2' HG13 ' A' ' 801' ' ' VAL . 10.3 p90 -108.36 169.54 8.57 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 177.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . 0.572 ' HG2' ' HB ' ' A' ' 760' ' ' ILE . 15.3 ptt180 -144.81 154.18 42.41 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 173.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.572 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 5.5 t -96.76 158.61 15.35 Favored 'General case' 0 C--N 1.268 -2.974 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 -176.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -65.69 -22.94 66.67 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -103.42 -1.35 47.2 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.606 175.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.572 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 5.0 mptp? -108.56 103.09 12.14 Favored 'General case' 0 C--N 1.316 -0.879 0 O-C-N 122.616 -0.344 . . . . 0.0 110.879 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.84 86.43 6.92 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 122.512 1.148 . . . . 0.0 108.528 175.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 157.31 145.27 4.16 Favored Glycine 0 C--N 1.287 -2.153 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -177.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 52.6 m95 -92.34 145.23 24.64 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -176.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.517 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -97.79 -27.56 3.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.948 -175.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 15.1 m170 72.53 123.61 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 124.842 1.257 . . . . 0.0 109.135 -178.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.543 ' HA ' ' HD2' ' A' ' 799' ' ' PRO . 3.1 t -145.28 156.75 44.01 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.887 0.375 . . . . 0.0 111.142 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 34.7 t -118.95 135.04 60.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 C-N-CA 122.639 0.376 . . . . 0.0 110.132 -178.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.3 t -69.97 118.79 13.26 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.641 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 47.2 mm -117.84 87.17 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 C-N-CA 124.338 1.055 . . . . 0.0 108.526 179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.471 HD22 HD22 ' A' ' 750' ' ' LEU . 6.8 t-20 42.9 67.69 0.59 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.373 1.069 . . . . 0.0 113.272 177.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 74.69 23.35 75.32 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 115.06 -0.973 . . . . 0.0 114.127 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -150.02 166.24 30.3 Favored 'General case' 0 C--O 1.197 -1.681 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.569 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 91.2 m95 -114.82 157.13 23.7 Favored 'General case' 0 C--N 1.264 -3.142 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -148.75 106.24 3.46 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . 0.543 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 38.0 Cg_endo -66.32 138.73 40.27 Favored 'Cis proline' 0 C--O 1.237 0.443 0 C-N-CA 124.11 -1.204 . . . . 0.0 112.014 -0.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.569 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 40.9 tt0 -53.56 134.77 40.99 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.863 0.865 . . . . 0.0 110.888 -178.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.532 HG13 ' CD2' ' A' ' 779' ' ' TYR . 57.9 t -99.8 117.12 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.534 -176.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -159.89 116.53 2.52 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 177.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 65.2 m -124.53 13.6 8.76 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . 0.728 ' HA ' HD12 ' A' ' 758' ' ' LEU . 7.4 m . . . . . 0 N--CA 1.416 -2.145 0 CA-C-N 114.423 -1.262 . . . . 0.0 108.501 -176.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 32.5 p . . . . . 0 N--CA 1.425 -1.676 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.4 m -73.44 -66.57 0.68 Allowed 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 119.196 -1.002 . . . . 0.0 109.17 173.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 124.57 -156.0 18.48 Favored Glycine 1 N--CA 1.363 -6.213 0 N-CA-C 107.953 -2.059 . . . . 0.0 107.953 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -36.87 123.93 0.86 Allowed 'General case' 0 C--N 1.278 -2.534 0 O-C-N 126.52 1.953 . . . . 0.0 112.239 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.688 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -69.3 146.54 96.73 Favored Pre-proline 0 N--CA 1.415 -2.198 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.271 177.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.462 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 72.4 Cg_endo -72.08 -165.31 0.21 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.767 2.312 . . . . 0.0 112.444 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.68 161.42 35.18 Favored 'General case' 0 N--CA 1.394 -3.265 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 717' ' ' PHE . 21.7 tp -106.07 117.97 35.41 Favored 'General case' 1 C--N 1.244 -4.017 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.186 -177.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -33.55 -44.91 0.15 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 127.403 2.281 . . . . 0.0 115.288 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 91.5 m-70 -137.57 25.09 2.89 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -136.76 -142.19 4.39 Favored Glycine 0 CA--C 1.497 -1.044 0 C-N-CA 120.094 -1.051 . . . . 0.0 112.252 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.436 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -158.59 174.53 14.92 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -178.196 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.37 145.78 32.46 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 716' ' ' GLU . 57.3 mm-40 -89.03 -80.76 0.29 Allowed 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 116.255 -0.429 . . . . 0.0 112.052 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 53.5 tp -160.6 151.46 18.7 Favored 'General case' 0 C--O 1.243 0.749 0 O-C-N 122.458 -0.151 . . . . 0.0 110.683 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.634 ' CB ' HG22 ' A' ' 715' ' ' VAL . 23.5 t -166.19 -54.29 0.03 OUTLIER 'General case' 0 C--O 1.237 0.402 0 C-N-CA 123.434 0.693 . . . . 0.0 110.38 172.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 37.4 m 70.66 142.82 0.09 OUTLIER Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.916 1.686 . . . . 0.0 113.085 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.543 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 58.1 Cg_endo -63.63 176.53 2.21 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 123.809 3.006 . . . . 0.0 113.089 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 2.9 Cg_exo -77.15 -7.21 30.43 Favored 'Cis proline' 0 N--CA 1.498 1.737 0 N-CA-C 114.67 0.989 . . . . 0.0 114.67 3.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 738' ' ' TRP . 58.9 m-85 74.41 82.21 0.11 Allowed 'General case' 0 C--N 1.309 -1.167 0 O-C-N 124.515 1.134 . . . . 0.0 110.333 177.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -86.24 173.51 9.72 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.35 -178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -69.37 135.2 50.0 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.85 177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.21 -18.69 57.02 Favored Glycine 0 N--CA 1.422 -2.278 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.207 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -68.22 155.15 40.28 Favored 'General case' 0 CA--C 1.488 -1.405 0 CA-C-O 121.228 0.537 . . . . 0.0 111.588 -179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 11.8 m -135.86 157.15 47.54 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.663 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.688 HG21 HG21 ' A' ' 694' ' ' ILE . 23.5 t -137.64 129.3 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.244 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 703' ' ' GLN . 41.6 mt-10 -77.16 138.05 39.25 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 123.675 0.609 . . . . 0.0 111.733 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.586 ' HB3' HD22 ' A' ' 697' ' ' LEU . 32.7 m-85 -140.53 129.97 23.95 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 124.483 1.113 . . . . 0.0 108.698 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.451 ' O ' HD23 ' A' ' 697' ' ' LEU . 10.9 m-80 -138.05 -164.81 1.68 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.493 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 10.8 m -118.99 139.74 51.18 Favored 'General case' 0 C--N 1.275 -2.661 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 -178.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 6.1 m -62.49 -79.51 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 O-C-N 123.65 0.594 . . . . 0.0 111.613 -176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -148.11 161.93 40.43 Favored 'General case' 0 CA--C 1.482 -1.637 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 66.6 m 71.03 -6.36 1.32 Allowed 'General case' 0 N--CA 1.473 0.724 0 O-C-N 124.516 1.135 . . . . 0.0 112.859 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.547 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 93.8 m-85 -131.74 146.57 52.23 Favored 'General case' 0 N--CA 1.392 -3.361 0 CA-C-O 121.88 0.848 . . . . 0.0 108.959 -175.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.651 HG21 HD21 ' A' ' 750' ' ' LEU . 0.9 OUTLIER -116.68 143.82 45.18 Favored 'General case' 1 C--N 1.241 -4.129 0 CA-C-N 113.721 -1.581 . . . . 0.0 112.204 179.873 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.546 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 4.7 ttp -86.22 123.92 32.04 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.557 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' A' ' 743' ' ' GLN . 45.0 mm -121.44 137.45 55.06 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 113.17 -90.76 0.55 Allowed Glycine 0 N--CA 1.429 -1.819 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.562 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 27.6 t60 -159.95 143.35 14.07 Favored 'General case' 0 CA--C 1.482 -1.651 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.546 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.8 ppt_? -81.67 17.18 1.52 Allowed 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 114.568 1.322 . . . . 0.0 114.568 -174.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 22.0 p -161.21 153.28 19.82 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.791 -177.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.447 HG21 HD13 ' A' ' 741' ' ' LEU . 27.3 pt -104.85 168.61 2.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.407 -179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 11.3 m -138.32 135.56 35.53 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.447 178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 9.5 t -83.67 105.11 14.32 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.44 0.638 . . . . 0.0 109.94 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.4 pp -140.31 144.62 27.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 C-N-CA 124.695 1.198 . . . . 0.0 110.344 -177.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 69.75 -11.26 0.54 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.55 0.74 . . . . 0.0 112.673 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 113.37 10.77 14.52 Favored Glycine 0 C--O 1.242 0.617 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 738' ' ' TRP . 58.8 t -142.23 154.34 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.48 ' O ' HG12 ' A' ' 737' ' ' VAL . 95.5 m95 -78.76 172.53 13.6 Favored 'General case' 0 C--N 1.273 -2.727 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.211 170.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.407 ' HB ' ' H ' ' A' ' 740' ' ' GLN . 39.9 p -74.09 -165.69 0.33 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 121.846 0.831 . . . . 0.0 111.211 178.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.472 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.5 OUTLIER -83.38 -3.03 57.14 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -166.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 3.9 mm? 72.79 157.25 0.16 Allowed Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 124.15 0.906 . . . . 0.0 109.639 -174.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.562 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 26.2 Cg_endo -71.64 179.72 4.45 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 121.232 1.288 . . . . 0.0 110.825 171.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 726' ' ' ILE . 52.0 tt0 -117.36 105.4 12.12 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 724' ' ' THR . 95.4 m -89.43 103.51 16.14 Favored 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 121.397 0.617 . . . . 0.0 110.236 177.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.418 ' C ' ' H ' ' A' ' 747' ' ' ILE . 34.7 t -97.92 144.32 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.022 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.547 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -64.93 5.2 0.35 Allowed 'General case' 0 C--N 1.293 -1.862 0 C-N-CA 125.73 1.612 . . . . 0.0 113.531 -177.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 1.029 ' HA ' HD22 ' A' ' 750' ' ' LEU . 59.0 mt 77.15 -17.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 C-N-CA 125.932 1.693 . . . . 0.0 111.239 176.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 746' ' ' ALA . 3.2 t70 -75.86 -31.76 59.43 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.517 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -103.29 21.65 15.53 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.243 -173.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 1.029 HD22 ' HA ' ' A' ' 747' ' ' ILE . 0.4 OUTLIER -85.36 -177.88 6.59 Favored 'General case' 0 N--CA 1.406 -2.642 0 CA-C-N 113.83 -1.532 . . . . 0.0 107.778 175.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.611 ' HB3' ' N ' ' A' ' 795' ' ' GLY . 39.0 tptt -98.19 161.33 13.76 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 14.5 mmmm -101.96 112.7 25.42 Favored 'General case' 1 C--N 1.233 -4.493 0 CA-C-N 112.237 -2.256 . . . . 0.0 107.452 -177.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.87 150.07 41.15 Favored 'General case' 0 C--N 1.257 -3.419 0 CA-C-N 114.03 -1.441 . . . . 0.0 107.184 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 769' ' ' LYS . 88.4 tttt -126.94 136.77 52.73 Favored 'General case' 0 C--N 1.258 -3.391 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.69 -174.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 46.6 p -63.78 112.89 3.08 Favored 'General case' 0 N--CA 1.421 -1.877 0 CA-C-N 115.189 -0.914 . . . . 0.0 108.622 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.654 ' HB2' HG12 ' A' ' 759' ' ' ILE . 49.1 m -61.94 133.5 55.47 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 173.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -76.13 4.31 8.81 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 122.026 0.917 . . . . 0.0 111.134 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -98.19 -21.88 16.47 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.978 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.654 HG12 ' HB2' ' A' ' 756' ' ' SER . 31.3 pt -103.27 167.97 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.401 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.837 -174.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.2 mp -121.39 130.73 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.248 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.525 HD12 HD12 ' A' ' 777' ' ' ILE . 1.9 mm? -108.95 -177.12 3.22 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.819 ' HB2' HD23 ' A' ' 765' ' ' LEU . 40.3 mt-10 -72.04 175.15 6.17 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.49 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . 0.425 ' HA ' ' HE2' ' A' ' 766' ' ' LYS . 40.9 mt-10 -77.84 4.59 11.47 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -171.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . 0.525 ' HB2' HD22 ' A' ' 765' ' ' LEU . 16.5 m-70 -108.13 -22.26 12.45 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 171.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.819 HD23 ' HB2' ' A' ' 762' ' ' GLU . 2.6 mm? -101.37 -13.18 18.11 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.681 -168.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 763' ' ' GLU . 50.6 mtmt -75.59 -19.92 58.93 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 174.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -85.25 -3.76 58.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.243 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.48 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 9.9 tppt? -106.12 107.5 18.53 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 754' ' ' LYS . 38.0 ttpt -85.82 -37.63 19.02 Favored 'General case' 0 C--N 1.289 -2.039 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . 0.424 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 47.2 mt-10 -117.48 118.02 31.05 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.511 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.48 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 66.6 m-85 -102.56 174.44 5.9 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -114.46 167.68 10.52 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.858 ' HB3' HD23 ' A' ' 750' ' ' LEU . 19.2 t60 -70.48 151.33 45.23 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 8.0 t30 83.36 3.17 0.95 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 124.998 1.436 . . . . 0.0 109.225 177.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 66.7 m -82.14 112.64 19.37 Favored 'General case' 0 N--CA 1.406 -2.626 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.567 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -88.89 109.89 20.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.525 HD12 HD12 ' A' ' 761' ' ' LEU . 9.5 pt -126.15 178.19 4.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.631 ' HB2' ' HB3' ' A' ' 787' ' ' TRP . 25.6 ptt180 -131.55 128.96 40.34 Favored 'General case' 0 N--CA 1.41 -2.455 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 172.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -118.03 169.16 9.89 Favored 'General case' 0 C--O 1.259 1.576 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -150.72 157.11 42.56 Favored 'General case' 0 N--CA 1.401 -2.91 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.544 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 35.6 t -81.98 159.48 23.54 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . 0.4 ' HG2' ' SG ' ' A' ' 803' ' ' CYS . 35.3 ptt180 -69.53 -23.3 63.57 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.762 0.315 . . . . 0.0 111.137 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -102.97 -9.03 40.79 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.813 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 12.3 mptt -115.89 122.89 46.69 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.915 0.358 . . . . 0.0 110.158 -177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -95.87 99.61 11.39 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.53 0.681 . . . . 0.0 109.886 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 159.78 143.22 3.6 Favored Glycine 0 C--N 1.294 -1.776 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.631 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 34.6 m95 -98.79 144.78 27.64 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 117.402 0.601 . . . . 0.0 109.838 -174.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.415 HD12 ' N ' ' A' ' 788' ' ' ILE . 3.6 mp -99.17 -31.32 3.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.009 -177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 12.4 m170 72.23 120.1 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 C-N-CA 124.414 1.086 . . . . 0.0 110.152 -174.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.427 HG21 ' CG1' ' A' ' 801' ' ' VAL . 3.5 t -139.19 156.58 47.01 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.094 -179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 71.0 t -118.08 130.31 73.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . 0.419 ' HB3' ' HA ' ' A' ' 773' ' ' HIS . 49.0 t -66.55 134.63 52.76 Favored 'General case' 0 CA--C 1.479 -1.769 0 C-N-CA 118.841 -1.144 . . . . 0.0 109.299 176.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . 0.589 ' HA ' ' HD1' ' A' ' 773' ' ' HIS . 49.4 mm -124.68 90.3 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.544 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.924 HD22 ' HG ' ' A' ' 750' ' ' LEU . 18.7 t-20 44.22 73.5 0.15 Allowed 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.001 0.92 . . . . 0.0 112.471 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . 0.611 ' N ' ' HB3' ' A' ' 751' ' ' LYS . . . 77.8 -11.23 21.38 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.386 -0.825 . . . . 0.0 114.615 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . 0.409 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 68.4 ttt180 -117.33 178.11 4.49 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 -175.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.598 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 99.0 m95 -122.08 162.02 21.99 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 117.761 0.255 . . . . 0.0 110.779 178.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -148.23 105.0 3.56 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.446 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -67.42 138.5 42.54 Favored 'Cis proline' 0 C--O 1.247 0.972 0 C-N-CA 123.791 -1.337 . . . . 0.0 111.344 -1.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.598 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 13.6 tt0 -55.02 119.1 4.93 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.068 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.427 ' CG1' HG21 ' A' ' 790' ' ' THR . 16.6 m -61.63 137.37 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.945 0 C-N-CA 123.73 0.812 . . . . 0.0 112.487 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -145.64 149.42 34.47 Favored 'General case' 0 N--CA 1.419 -2.02 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . 0.4 ' SG ' ' HG2' ' A' ' 782' ' ' ARG . 32.7 t -142.49 27.59 1.7 Allowed 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.628 1.204 . . . . 0.0 108.644 178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 176.156 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.443 -0.779 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 65.1 m -72.28 -75.97 0.12 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.026 175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 141.37 -145.24 15.63 Favored Glycine 1 N--CA 1.379 -5.163 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -53.02 133.65 38.38 Favored 'General case' 0 C--N 1.278 -2.517 0 C-N-CA 125.369 1.468 . . . . 0.0 111.814 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.685 HG21 HG21 ' A' ' 715' ' ' VAL . 1.6 pp -76.05 148.1 81.04 Favored Pre-proline 0 N--CA 1.41 -2.474 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.885 176.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.456 ' HG2' HD21 ' A' ' 741' ' ' LEU . 53.5 Cg_endo -71.04 -163.72 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 123.347 2.698 . . . . 0.0 112.625 176.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -148.76 169.58 20.13 Favored 'General case' 0 N--CA 1.408 -2.559 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.635 HD13 ' SG ' ' A' ' 744' ' ' CYS . 17.0 mt -102.77 146.44 28.25 Favored 'General case' 0 C--N 1.27 -2.851 0 O-C-N 123.792 0.682 . . . . 0.0 111.197 175.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -65.62 -37.69 87.3 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.168 176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 744' ' ' CYS . 96.0 m-70 -140.06 27.8 2.15 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 121.04 0.448 . . . . 0.0 110.688 -177.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -140.65 -146.02 4.72 Favored Glycine 0 C--N 1.297 -1.615 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.459 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -156.58 171.84 19.62 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 117.216 0.508 . . . . 0.0 111.305 -179.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.23 144.86 33.41 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' A' ' 703' ' ' GLN . 13.7 mt-30 -73.36 -79.75 0.08 Allowed 'General case' 0 C--N 1.295 -1.777 0 O-C-N 123.21 0.318 . . . . 0.0 111.197 177.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 8.3 tt 172.67 130.27 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 178.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.63 ' CB ' HG22 ' A' ' 715' ' ' VAL . 22.7 t -131.18 -32.67 1.57 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.653 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 32.9 t 74.3 124.07 0.03 OUTLIER Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 125.04 1.336 . . . . 0.0 112.41 177.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 37.3 Cg_endo -61.24 176.7 0.98 Allowed 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 123.891 3.061 . . . . 0.0 111.564 177.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.524 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 13.3 Cg_exo -71.72 -18.86 14.12 Favored 'Cis proline' 0 N--CA 1.495 1.573 0 N-CA-C 114.626 0.972 . . . . 0.0 114.626 4.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.451 ' HE1' ' HB3' ' A' ' 705' ' ' SER . 45.6 m-85 83.29 90.6 0.03 OUTLIER 'General case' 0 CA--C 1.496 -1.119 0 O-C-N 124.771 1.294 . . . . 0.0 110.885 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -91.93 176.03 6.66 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.205 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -72.71 136.86 45.65 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.028 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 93.02 -10.82 73.24 Favored Glycine 0 N--CA 1.417 -2.63 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.428 -176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -71.61 150.87 44.25 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 175.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 14.2 m -138.69 148.96 44.6 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -177.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.685 HG21 HG21 ' A' ' 694' ' ' ILE . 21.2 t -130.27 130.38 65.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.527 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 41.3 mt-10 -89.58 135.91 33.33 Favored 'General case' 0 C--N 1.292 -1.923 0 O-C-N 123.658 0.599 . . . . 0.0 111.269 -177.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.606 ' HD2' ' HG ' ' A' ' 697' ' ' LEU . 25.7 m-85 -132.23 132.34 42.99 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 124.521 1.128 . . . . 0.0 109.053 -177.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.459 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 8.0 m-80 -137.97 -162.68 1.33 Allowed 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 7.6 m -120.0 140.41 51.0 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 104.873 -2.269 . . . . 0.0 104.873 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 43.1 t -50.6 -72.44 0.05 OUTLIER 'General case' 0 C--N 1.309 -1.164 0 O-C-N 124.216 0.948 . . . . 0.0 110.909 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -173.28 163.2 4.54 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 105.064 -2.199 . . . . 0.0 105.064 173.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 73.9 m 67.41 16.99 10.1 Favored 'General case' 0 C--O 1.241 0.639 0 O-C-N 124.189 0.93 . . . . 0.0 111.271 -177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.712 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 87.4 m-85 -147.38 149.13 32.16 Favored 'General case' 0 N--CA 1.405 -2.703 0 C-N-CA 125.976 1.71 . . . . 0.0 107.685 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 1.1 m -117.5 144.93 44.57 Favored 'General case' 0 C--N 1.278 -2.522 0 O-C-N 123.805 0.69 . . . . 0.0 110.58 -176.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 6.5 ttp -99.1 123.32 43.31 Favored 'General case' 0 N--CA 1.428 -1.541 0 C-N-CA 123.564 0.745 . . . . 0.0 109.685 -177.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.45 HD11 ' ND2' ' A' ' 794' ' ' ASN . 48.8 mm -121.14 143.68 32.64 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 114.4 -89.42 0.51 Allowed Glycine 0 C--N 1.3 -1.429 0 N-CA-C 111.478 -0.649 . . . . 0.0 111.478 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.487 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 53.0 t60 -169.03 141.4 2.64 Favored 'General case' 0 CA--C 1.475 -1.921 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.498 ' H ' ' HD2' ' A' ' 729' ' ' ARG . 0.7 OUTLIER -82.64 20.26 1.16 Allowed 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 -172.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.527 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 2.8 p -162.53 159.34 24.71 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.812 -0.555 . . . . 0.0 112.14 -178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.48 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 39.4 pt -120.09 163.56 17.42 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 114.937 -1.028 . . . . 0.0 109.003 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 20.9 m -136.0 137.7 41.49 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.888 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 2.4 t -85.76 108.38 18.05 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.105 0.478 . . . . 0.0 110.003 176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.24 143.09 21.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 124.811 1.245 . . . . 0.0 109.624 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 68.46 -1.09 2.0 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 123.212 0.605 . . . . 0.0 112.599 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 95.21 19.33 30.88 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 738' ' ' TRP . 24.9 t -141.62 150.99 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -176.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.461 ' O ' HG12 ' A' ' 737' ' ' VAL . 96.8 m95 -80.65 170.3 16.51 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 121.712 -0.618 . . . . 0.0 109.66 168.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 40.6 p -77.14 -166.49 0.72 Allowed 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.521 0.677 . . . . 0.0 112.001 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.408 ' H ' ' HB ' ' A' ' 739' ' ' THR . 0.6 OUTLIER -73.96 -15.71 61.1 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -167.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.456 HD21 ' HG2' ' A' ' 695' ' ' PRO . 2.3 mt 68.85 151.53 0.13 Allowed Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.487 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 56.4 Cg_endo -75.74 179.26 6.42 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.332 2.021 . . . . 0.0 111.347 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -126.08 114.61 18.63 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.635 ' SG ' HD13 ' A' ' 697' ' ' LEU . 77.7 m -93.64 114.77 27.17 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 122.073 0.939 . . . . 0.0 110.278 174.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 1.071 HG11 HD21 ' A' ' 750' ' ' LEU . 11.8 p -97.4 159.77 3.08 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.279 0 CA-C-N 113.071 -1.877 . . . . 0.0 108.91 -178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.712 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -80.5 -1.83 43.42 Favored 'General case' 0 C--N 1.262 -3.205 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.869 -177.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.627 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 18.2 mt 77.41 -20.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 125.526 1.53 . . . . 0.0 111.701 177.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.462 ' H ' ' C ' ' A' ' 746' ' ' ALA . 32.8 t70 -84.56 -19.25 33.42 Favored 'General case' 0 C--N 1.253 -3.614 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.19 -171.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -113.03 30.14 7.42 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.142 176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 1.071 HD21 HG11 ' A' ' 745' ' ' VAL . 57.0 mt -89.05 -170.26 2.83 Favored 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.355 177.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.46 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 58.9 mtpt -128.16 154.08 46.17 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -176.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . 0.463 ' O ' ' HA2' ' A' ' 795' ' ' GLY . 93.3 mttt -100.97 145.97 27.99 Favored 'General case' 0 C--N 1.248 -3.828 0 CA-C-N 113.853 -1.521 . . . . 0.0 109.301 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 89.3 m -89.15 160.15 17.14 Favored 'General case' 1 C--N 1.235 -4.376 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.419 179.355 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -118.7 133.19 56.03 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.77 -178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 42.3 t -59.17 116.21 3.71 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 170.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.716 ' HB2' HG13 ' A' ' 759' ' ' ILE . 18.4 m -79.36 135.14 36.63 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -76.14 4.36 8.72 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.745 0.783 . . . . 0.0 112.126 -173.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.4 -14.63 14.82 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.279 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.716 HG13 ' HB2' ' A' ' 756' ' ' SER . 2.3 pp -114.06 151.39 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-O 121.262 0.553 . . . . 0.0 111.319 -178.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.3 mp -109.32 134.15 52.26 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.438 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.545 HD12 HD12 ' A' ' 777' ' ' ILE . 1.9 mm? -110.24 171.83 7.22 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.416 ' HG3' ' HB2' ' A' ' 778' ' ' ARG . 44.1 mt-10 -55.18 153.27 7.0 Favored 'General case' 0 C--O 1.208 -1.088 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -69.99 -2.97 14.14 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 118.245 0.475 . . . . 0.0 112.045 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -83.22 -37.5 23.51 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 173.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.671 ' CD1' ' HB ' ' A' ' 777' ' ' ILE . 96.8 mt -93.31 -16.46 24.69 Favored 'General case' 0 CA--C 1.493 -1.244 0 CA-C-N 113.321 -1.763 . . . . 0.0 111.599 -172.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -75.9 2.21 13.07 Favored 'General case' 1 N--CA 1.369 -4.49 0 CA-C-O 122.127 0.965 . . . . 0.0 110.188 -179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -120.1 9.34 11.13 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.175 173.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -102.89 130.05 49.8 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -95.71 -38.35 10.39 Favored 'General case' 0 C--N 1.275 -2.637 0 CA-C-O 122.441 1.115 . . . . 0.0 108.119 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -129.55 129.43 44.46 Favored 'General case' 0 N--CA 1.409 -2.517 0 CA-C-N 113.283 -1.78 . . . . 0.0 109.749 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.546 ' CE2' HD22 ' A' ' 765' ' ' LEU . 73.3 m-85 -105.94 142.47 35.6 Favored 'General case' 0 C--N 1.253 -3.603 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.955 -177.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -91.7 155.59 18.18 Favored 'General case' 0 C--N 1.273 -2.734 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -49.23 152.01 1.29 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.065 0.946 . . . . 0.0 111.607 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 67.71 4.93 4.14 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.715 0.806 . . . . 0.0 111.376 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 8.2 t -81.23 111.76 17.93 Favored 'General case' 0 N--CA 1.401 -2.919 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -177.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.444 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.8 OUTLIER -81.85 112.69 19.21 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.671 ' HB ' ' CD1' ' A' ' 765' ' ' LEU . 4.5 pt -123.71 174.2 8.3 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.398 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.712 -176.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.55 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 95.4 mtt180 -125.93 128.93 48.3 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 174.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.605 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 6.3 p90 -120.0 167.35 12.25 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 174.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -147.76 157.14 43.4 Favored 'General case' 0 C--N 1.267 -2.991 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 176.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.564 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 17.3 t -93.58 147.18 23.23 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -73.78 -12.35 60.67 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.084 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -112.93 0.68 25.73 Favored Glycine 0 N--CA 1.431 -1.668 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.894 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.564 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 1.2 mptm? -118.16 -50.71 2.46 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.315 0.858 . . . . 0.0 113.315 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 72.78 140.18 0.06 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.25 1.02 . . . . 0.0 110.768 -174.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 103.17 140.75 11.01 Favored Glycine 0 CA--C 1.493 -1.316 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -174.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.55 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 29.3 m95 -89.6 143.27 26.95 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-O 121.052 0.453 . . . . 0.0 111.373 -171.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.605 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.9 mp -102.95 -26.43 3.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.013 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.417 ' O ' ' HD2' ' A' ' 799' ' ' PRO . 17.6 m170 71.9 119.16 0.04 OUTLIER 'General case' 0 N--CA 1.518 2.948 0 C-N-CA 124.033 0.933 . . . . 0.0 110.733 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.1 t -143.13 157.42 44.53 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.944 -0.303 . . . . 0.0 110.64 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 47.5 t -119.67 135.24 60.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -177.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 51.0 t -72.57 114.18 10.41 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-O 121.668 0.747 . . . . 0.0 110.168 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 46.6 mm -112.66 82.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.421 0 C-N-CA 124.04 0.936 . . . . 0.0 108.494 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.593 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 51.32 67.74 0.9 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.76 176.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 752' ' ' LYS . . . 78.95 3.05 87.75 Favored Glycine 0 C--N 1.299 -1.514 0 C-N-CA 120.299 -0.953 . . . . 0.0 114.334 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -134.03 167.89 19.8 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -176.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.598 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 87.3 m95 -113.92 158.79 20.64 Favored 'General case' 0 C--N 1.26 -3.298 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -178.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -149.0 107.61 3.43 Favored Pre-proline 0 C--N 1.296 -1.725 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 41.0 Cg_endo -71.18 142.12 71.89 Favored 'Cis proline' 0 C--O 1.246 0.889 0 C-N-CA 123.552 -1.436 . . . . 0.0 112.687 -0.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.598 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 43.9 mt-10 -53.58 126.89 23.3 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.637 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.44 ' HA ' ' CE2' ' A' ' 779' ' ' TYR . 7.7 m -70.45 141.66 16.72 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.825 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 -179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -162.44 132.01 4.44 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.937 -172.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 12.4 m -124.08 -5.84 7.85 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.098 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--N 1.308 -1.231 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 176.865 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.437 -1.113 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 45.0 m -64.69 -71.91 0.17 Allowed 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.75 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 134.84 -164.5 24.71 Favored Glycine 1 N--CA 1.367 -5.952 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -43.17 119.68 1.62 Allowed 'General case' 0 C--N 1.276 -2.613 0 C-N-CA 126.173 1.789 . . . . 0.0 111.552 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.646 HG21 HG21 ' A' ' 715' ' ' VAL . 1.5 pp -58.28 149.32 59.23 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.482 -178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.515 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 70.6 Cg_endo -71.01 -163.89 0.14 Allowed 'Trans proline' 0 C--O 1.249 1.037 0 C-N-CA 123.001 2.467 . . . . 0.0 111.818 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.63 154.91 51.17 Favored 'General case' 0 N--CA 1.393 -3.322 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.615 HD22 ' HB3' ' A' ' 717' ' ' PHE . 18.7 tp -98.61 127.35 44.51 Favored 'General case' 0 C--N 1.25 -3.74 0 CA-C-N 114.526 -1.215 . . . . 0.0 110.433 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.57 ' HG3' ' H ' ' A' ' 699' ' ' HIS . 6.8 pt-20 -38.41 -61.01 0.73 Allowed 'General case' 0 C--N 1.312 -1.065 0 C-N-CA 127.094 2.158 . . . . 0.0 114.349 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.791 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 85.2 m-70 -128.02 26.82 5.76 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . . . . . . . . . . . -131.82 -155.06 7.92 Favored Glycine 0 N--CA 1.424 -2.115 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.405 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.45 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -145.48 174.28 11.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 120.639 0.257 . . . . 0.0 110.641 -175.222 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -107.83 137.17 46.31 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -86.11 -77.65 0.3 Allowed 'General case' 0 N--CA 1.427 -1.577 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.524 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . 0.629 HD13 ' N ' ' A' ' 705' ' ' SER . 1.9 tm? -167.72 163.1 14.25 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.629 ' N ' HD13 ' A' ' 704' ' ' LEU . 46.7 t -178.36 -62.71 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 125.402 1.481 . . . . 0.0 109.191 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 50.6 m 67.85 153.52 0.13 Allowed Pre-proline 0 CA--C 1.568 1.646 0 C-N-CA 125.155 1.382 . . . . 0.0 112.238 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.477 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 56.4 Cg_endo -62.95 171.94 5.45 Favored 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 123.015 2.477 . . . . 0.0 112.69 -175.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.616 ' HG2' ' CE2' ' A' ' 710' ' ' TYR . 1.9 Cg_endo -75.46 -8.18 25.04 Favored 'Cis proline' 0 N--CA 1.488 1.156 0 N-CA-C 115.235 1.206 . . . . 0.0 115.235 5.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.416 ' HB3' ' HZ2' ' A' ' 738' ' ' TRP . 58.7 m-85 69.14 60.29 0.33 Allowed 'General case' 0 C--N 1.313 -0.983 0 O-C-N 124.297 0.998 . . . . 0.0 109.062 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.616 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 37.0 m-85 -68.04 173.33 4.68 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.485 -1.234 . . . . 0.0 112.429 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -72.33 136.64 46.25 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.178 175.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 97.64 -18.88 56.58 Favored Glycine 0 C--N 1.286 -2.217 0 C-N-CA 120.422 -0.894 . . . . 0.0 110.876 -177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.39 143.14 55.21 Favored 'General case' 0 CA--C 1.478 -1.79 0 CA-C-O 121.348 0.594 . . . . 0.0 110.017 178.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 16.0 m -124.58 157.27 35.83 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 114.722 -1.126 . . . . 0.0 108.054 178.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.646 HG21 HG21 ' A' ' 694' ' ' ILE . 33.1 t -137.03 133.69 47.71 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.475 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -178.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -80.85 130.72 35.2 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 123.835 0.709 . . . . 0.0 110.901 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.615 ' HB3' HD22 ' A' ' 697' ' ' LEU . 27.6 m-85 -137.09 116.93 13.12 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 125.018 1.327 . . . . 0.0 108.232 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.45 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 4.5 m-80 -127.23 -167.75 1.78 Allowed 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 24.3 m -112.43 135.44 53.12 Favored 'General case' 0 C--N 1.272 -2.785 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 24.8 t -52.57 -67.63 0.24 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 124.187 0.929 . . . . 0.0 111.724 -170.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -171.32 156.88 4.77 Favored 'General case' 0 CA--C 1.476 -1.889 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 75.0 m 66.64 14.3 9.7 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 124.404 1.065 . . . . 0.0 111.242 178.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.548 ' CD1' ' HA ' ' A' ' 746' ' ' ALA . 85.0 m-85 -140.12 145.47 37.62 Favored 'General case' 0 N--CA 1.404 -2.755 0 C-N-CA 124.823 1.249 . . . . 0.0 108.596 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 5.5 t -97.59 151.71 19.79 Favored 'General case' 0 C--N 1.252 -3.631 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 -177.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.764 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 5.4 ttp -108.72 118.39 36.66 Favored 'General case' 0 C--N 1.263 -3.155 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.489 HG12 HG23 ' A' ' 724' ' ' THR . 41.9 mm -121.86 135.38 62.17 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.437 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 176.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 118.7 -81.85 0.33 Allowed Glycine 0 N--CA 1.429 -1.801 0 C-N-CA 121.422 -0.418 . . . . 0.0 112.323 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.465 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 43.3 t60 -171.05 138.33 1.26 Allowed 'General case' 0 CA--C 1.482 -1.659 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.764 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 3.3 ppt_? -84.94 19.65 2.06 Favored 'General case' 0 C--N 1.271 -2.842 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -173.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 2.7 p -156.51 159.76 38.89 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.32 0.581 . . . . 0.0 112.119 -177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.499 ' HA ' ' OG1' ' A' ' 739' ' ' THR . 36.1 pt -116.89 164.71 12.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.754 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 21.5 m -139.61 136.1 34.01 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.138 -0.625 . . . . 0.0 111.223 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 9.1 t -83.08 107.25 15.52 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.316 0.579 . . . . 0.0 109.765 176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . 0.51 HD13 ' HD2' ' A' ' 735' ' ' HIS . 1.5 pp -145.46 151.42 14.99 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.1 0 C-N-CA 124.721 1.208 . . . . 0.0 109.839 -178.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . 0.51 ' HD2' HD13 ' A' ' 734' ' ' ILE . 82.6 m-70 73.61 -51.01 0.7 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.346 1.059 . . . . 0.0 110.625 -179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 148.45 34.28 0.05 OUTLIER Glycine 0 C--N 1.299 -1.489 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.0 p -165.85 159.49 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.515 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.9 m95 -77.63 175.6 9.74 Favored 'General case' 0 C--N 1.283 -2.311 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 172.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 731' ' ' ILE . 18.3 p -80.12 -171.1 2.79 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.047 0.927 . . . . 0.0 112.658 -176.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 741' ' ' LEU . 0.7 OUTLIER -63.55 -15.77 58.94 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 -172.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 740' ' ' GLN . 4.6 mm? 69.59 141.65 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.69 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.465 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 32.8 Cg_endo -67.05 177.22 3.8 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.115 1.876 . . . . 0.0 112.035 174.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -121.84 129.73 52.84 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.791 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 73.8 m -113.84 103.8 11.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.11 0.481 . . . . 0.0 110.726 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.46 ' HB ' HG22 ' A' ' 724' ' ' THR . 46.6 t -97.27 143.7 12.07 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.548 ' HA ' ' CD1' ' A' ' 723' ' ' PHE . . . -60.49 2.33 0.1 Allowed 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 126.236 1.814 . . . . 0.0 115.293 -176.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.828 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 19.4 mt 75.75 -13.6 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 C-N-CA 125.625 1.57 . . . . 0.0 111.956 177.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 746' ' ' ALA . 17.2 t70 -87.25 -25.88 23.75 Favored 'General case' 0 C--N 1.272 -2.772 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.533 -178.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -103.09 20.53 17.45 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.358 -176.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.828 ' HG ' ' HA ' ' A' ' 747' ' ' ILE . 49.5 mt -84.53 -167.13 1.67 Allowed 'General case' 0 N--CA 1.417 -2.081 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.773 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.52 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 10.2 mtpm? -130.0 154.41 47.42 Favored 'General case' 0 N--CA 1.381 -3.915 0 CA-C-N 114.966 -1.015 . . . . 0.0 108.505 -177.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . 0.698 ' HE2' ' HB3' ' A' ' 770' ' ' GLU . 55.2 mtpt -105.71 120.71 42.39 Favored 'General case' 0 C--N 1.251 -3.691 0 CA-C-N 113.269 -1.787 . . . . 0.0 109.317 -175.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . . . . . . . . . 56.0 m -74.34 159.05 32.91 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.403 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 754' ' ' LYS . 18.3 ptpt -132.32 151.49 51.82 Favored 'General case' 0 N--CA 1.401 -2.885 0 C-N-CA 118.987 -1.085 . . . . 0.0 111.699 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 30.6 t -63.35 121.54 14.0 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 113.54 -1.663 . . . . 0.0 109.956 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.821 ' HB3' HG13 ' A' ' 759' ' ' ILE . 28.2 t -74.63 155.02 38.26 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 172.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.99 -1.4 57.27 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.09 -20.13 21.6 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.794 0.807 . . . . 0.0 109.08 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.821 HG13 ' HB3' ' A' ' 756' ' ' SER . 2.5 pp -111.66 159.68 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.435 -177.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 19.9 mt -118.67 129.04 75.47 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.924 0 CA-C-N 113.718 -1.583 . . . . 0.0 107.661 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.528 HD12 HD12 ' A' ' 777' ' ' ILE . 1.8 mm? -105.6 -176.94 3.22 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.858 ' HB2' HD23 ' A' ' 765' ' ' LEU . 41.1 mt-10 -59.66 151.78 24.06 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 174.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -72.25 1.19 8.09 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -171.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . 0.545 ' HB2' HD22 ' A' ' 765' ' ' LEU . 8.8 m-70 -90.51 -43.47 10.21 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 105.121 -2.177 . . . . 0.0 105.121 168.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.858 HD23 ' HB2' ' A' ' 762' ' ' GLU . 3.3 mm? -78.5 -11.57 59.96 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.001 -168.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -67.82 -18.69 64.92 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 174.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 40.0 m-80 -94.79 13.38 24.77 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.563 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -113.16 110.96 21.29 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -83.55 -34.82 25.14 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.072 -1.051 . . . . 0.0 109.372 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . 0.698 ' HB3' ' HE2' ' A' ' 752' ' ' LYS . 45.3 mt-10 -128.83 135.56 49.29 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.757 -177.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -115.49 142.65 46.43 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.387 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -85.19 163.67 18.56 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 176.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . . . . . . . . . 12.4 t60 -62.4 150.5 39.58 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.438 0.161 . . . . 0.0 110.758 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 81.24 6.6 1.26 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.027 1.331 . . . . 0.0 110.345 177.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 38.9 m -80.68 105.72 12.14 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.427 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.8 OUTLIER -86.42 101.87 13.53 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 761' ' ' LEU . 11.9 pt -113.25 -174.91 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 CA-C-O 121.832 0.825 . . . . 0.0 109.376 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.616 ' HA ' ' HA ' ' A' ' 789' ' ' HIS . 19.9 ptt180 -139.24 134.79 33.16 Favored 'General case' 0 N--CA 1.413 -2.311 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 172.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.542 ' CE1' ' HB ' ' A' ' 788' ' ' ILE . 11.0 p90 -123.44 166.33 15.56 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -147.4 154.85 41.37 Favored 'General case' 0 C--N 1.277 -2.583 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.507 ' HB3' ' HD3' ' A' ' 784' ' ' LYS . 0.8 OUTLIER -82.58 146.9 28.91 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-O 121.047 0.451 . . . . 0.0 111.943 178.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -64.26 103.78 0.67 Allowed 'General case' 0 N--CA 1.407 -2.579 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . 110.73 -7.9 29.83 Favored Glycine 0 N--CA 1.439 -1.124 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.476 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.507 ' HD3' ' HB3' ' A' ' 781' ' ' CYS . 0.8 OUTLIER -119.41 113.59 21.02 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -178.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -89.3 90.06 8.17 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.618 0.723 . . . . 0.0 110.975 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . 172.02 141.78 3.51 Favored Glycine 0 CA--C 1.487 -1.674 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.607 ' HB3' ' HB2' ' A' ' 778' ' ' ARG . 44.5 m95 -101.53 145.44 29.01 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 116.992 0.396 . . . . 0.0 110.127 -174.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.542 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 3.7 mp -100.04 -28.58 3.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.013 -178.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 778' ' ' ARG . 25.6 m170 74.43 133.66 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 124.602 1.161 . . . . 0.0 108.911 -176.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 797' ' ' TRP . 4.6 t -156.44 155.21 31.69 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 120.703 0.287 . . . . 0.0 111.154 178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.96 137.6 53.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 40.3 t -70.59 113.97 8.23 Favored 'General case' 0 C--O 1.255 1.377 0 CA-C-O 121.658 0.742 . . . . 0.0 110.359 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 47.4 mm -114.25 80.4 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 C-N-CA 124.32 1.048 . . . . 0.0 109.317 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.567 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 52.2 65.57 1.47 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.77 175.506 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 73.87 21.2 79.52 Favored Glycine 0 C--N 1.303 -1.276 0 C-N-CA 120.887 -0.673 . . . . 0.0 113.97 -179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -146.64 164.33 33.01 Favored 'General case' 0 C--O 1.202 -1.408 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.677 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 90.7 m95 -111.58 157.68 20.1 Favored 'General case' 0 C--N 1.246 -3.926 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -144.12 105.89 4.83 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 789' ' ' HIS . 38.2 Cg_endo -70.14 139.03 53.31 Favored 'Cis proline' 0 C--O 1.248 1.006 0 C-N-CA 123.725 -1.365 . . . . 0.0 110.919 -0.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.677 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 26.5 tt0 -56.42 124.05 16.79 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 779' ' ' TYR . 14.0 m -57.58 124.76 12.29 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.381 0 C-N-CA 124.391 1.077 . . . . 0.0 110.585 -175.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -129.59 116.62 19.16 Favored 'General case' 0 C--N 1.279 -2.479 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.198 -176.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . . . . . . . . . 1.1 t -121.77 3.27 10.06 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.636 175.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 53.2 m . . . . . 0 N--CA 1.422 -1.859 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 176.532 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.4 p . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 59.7 m -68.02 -65.12 0.73 Allowed 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 94.21 134.67 7.44 Favored Glycine 0 N--CA 1.42 -2.394 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.262 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . . . . . . . . . 37.8 t70 46.28 101.27 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.134 1.774 . . . . 0.0 113.508 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.681 HG21 HG21 ' A' ' 715' ' ' VAL . 1.8 pp -59.34 151.33 59.72 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.289 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.438 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 37.7 Cg_endo -68.28 -157.44 0.04 OUTLIER 'Trans proline' 0 CA--C 1.55 1.324 0 C-N-CA 123.039 2.492 . . . . 0.0 112.517 176.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -134.12 160.52 37.54 Favored 'General case' 0 N--CA 1.4 -2.941 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.608 HD13 ' HA3' ' A' ' 700' ' ' GLY . 0.3 OUTLIER -99.16 133.05 43.99 Favored 'General case' 0 C--N 1.259 -3.356 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 177.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -49.06 -39.47 27.7 Favored 'General case' 0 C--N 1.31 -1.125 0 C-N-CA 124.406 1.082 . . . . 0.0 113.689 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.402 ' HB3' ' CE1' ' A' ' 723' ' ' PHE . 90.4 m-70 -143.21 28.05 1.54 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.129 0.49 . . . . 0.0 110.264 -177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.608 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -141.59 -146.05 4.64 Favored Glycine 0 C--N 1.299 -1.511 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.066 -177.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.441 ' HE1' ' HB2' ' A' ' 718' ' ' ASN . 0.5 OUTLIER -151.08 -175.56 5.2 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -176.439 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -117.5 142.83 46.7 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 34.2 mm-40 -74.13 -78.2 0.1 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.204 0.526 . . . . 0.0 110.785 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 6.3 tt -149.87 130.41 13.95 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.527 ' HB2' ' HE1' ' A' ' 709' ' ' TYR . 67.9 p -117.65 -70.83 0.77 Allowed 'General case' 0 N--CA 1.398 -3.033 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -176.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . 0.416 ' HA ' ' HD2' ' A' ' 707' ' ' PRO . 23.3 t 64.16 123.99 0.02 OUTLIER Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 125.696 1.598 . . . . 0.0 112.559 178.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.543 ' HB2' ' HA ' ' A' ' 708' ' ' PRO . 41.2 Cg_endo -63.66 176.0 2.54 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.456 2.771 . . . . 0.0 111.682 177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.543 ' HA ' ' HB2' ' A' ' 707' ' ' PRO . 6.0 Cg_exo -77.6 -10.28 32.26 Favored 'Cis proline' 0 CA--C 1.504 -1.002 0 N-CA-C 115.017 1.122 . . . . 0.0 115.017 5.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.527 ' HE1' ' HB2' ' A' ' 705' ' ' SER . 56.7 m-85 72.56 78.74 0.15 Allowed 'General case' 0 C--O 1.245 0.868 0 O-C-N 124.248 0.967 . . . . 0.0 110.005 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.407 ' CE2' ' HG2' ' A' ' 708' ' ' PRO . 29.9 m-85 -85.48 171.51 11.71 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.492 0.663 . . . . 0.0 112.469 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -67.33 133.31 49.41 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.697 176.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.91 -11.11 68.09 Favored Glycine 0 N--CA 1.418 -2.522 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.19 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.17 145.36 44.29 Favored 'General case' 0 CA--C 1.493 -1.214 0 O-C-N 122.085 -0.656 . . . . 0.0 110.706 177.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 14.2 m -131.07 151.04 51.85 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.681 HG21 HG21 ' A' ' 694' ' ' ILE . 34.4 t -134.99 140.1 45.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 -177.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -85.64 123.44 31.05 Favored 'General case' 0 N--CA 1.431 -1.382 0 O-C-N 124.128 0.893 . . . . 0.0 111.6 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -124.36 105.55 9.53 Favored 'General case' 0 C--N 1.273 -2.759 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.441 ' HB2' ' HE1' ' A' ' 701' ' ' TRP . 11.4 m-80 -113.37 -162.68 0.81 Allowed 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -178.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 723' ' ' PHE . 5.0 m -113.47 134.44 54.66 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -178.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 39.5 t -65.64 -64.02 0.96 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 123.689 0.618 . . . . 0.0 110.87 -172.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -164.68 156.31 15.57 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 73.9 m 69.78 1.94 3.63 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.303 1.002 . . . . 0.0 113.171 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.573 ' HB2' ' HB3' ' A' ' 719' ' ' CYS . 98.1 m-85 -134.14 147.43 50.81 Favored 'General case' 0 N--CA 1.403 -2.795 0 C-N-CA 123.75 0.82 . . . . 0.0 109.078 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.521 ' HB ' HD11 ' A' ' 750' ' ' LEU . 1.0 OUTLIER -113.5 138.13 50.57 Favored 'General case' 0 C--N 1.264 -3.122 0 C-N-CA 125.546 1.539 . . . . 0.0 110.445 -178.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.498 ' SD ' ' HB3' ' A' ' 729' ' ' ARG . 3.7 ttp -86.64 121.93 29.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.65 1.18 . . . . 0.0 109.348 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.45 HD13 ' HA ' ' A' ' 726' ' ' ILE . 31.7 mm -111.87 127.4 69.08 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.973 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.132 176.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 99.2 -82.97 0.58 Allowed Glycine 0 CA--C 1.481 -2.051 0 CA-C-N 114.645 -1.162 . . . . 0.0 112.253 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 742' ' ' PRO . 30.3 p-80 -147.04 178.02 8.7 Favored 'General case' 0 N--CA 1.388 -3.55 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -174.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.498 ' HB3' ' SD ' ' A' ' 725' ' ' MET . 0.2 OUTLIER -128.15 6.4 5.91 Favored 'General case' 0 C--O 1.2 -1.546 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.637 -177.41 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 3.1 p -126.54 160.1 31.58 Favored 'General case' 0 C--N 1.282 -2.369 0 C-N-CA 119.07 -1.052 . . . . 0.0 113.732 -172.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.476 HG21 HD13 ' A' ' 741' ' ' LEU . 36.6 pt -119.66 159.51 20.6 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.106 176.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 14.6 m -134.77 135.28 41.74 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.484 -0.486 . . . . 0.0 110.791 -178.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 7.6 t -86.01 104.13 15.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.156 0.503 . . . . 0.0 109.953 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 1.7 pp -144.69 147.45 19.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 124.655 1.182 . . . . 0.0 110.037 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 38.6 m-70 64.9 4.07 2.31 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 96.81 24.87 12.41 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.14 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.6 p -161.04 162.22 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.438 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 95.3 m95 -80.29 173.08 12.96 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.518 ' HB ' ' NE2' ' A' ' 740' ' ' GLN . 23.6 p -78.8 -162.44 0.38 Allowed 'General case' 0 N--CA 1.42 -1.958 0 CA-C-O 121.837 0.827 . . . . 0.0 112.42 -177.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.629 ' NE2' ' H ' ' A' ' 740' ' ' GLN . 0.0 OUTLIER -84.89 2.01 44.58 Favored 'General case' 0 C--N 1.281 -2.408 0 C-N-CA 124.453 1.101 . . . . 0.0 113.575 -167.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 731' ' ' ILE . 4.1 mm? 71.21 155.87 0.16 Allowed Pre-proline 0 N--CA 1.483 1.215 0 O-C-N 123.667 0.605 . . . . 0.0 111.557 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.421 ' HB3' ' O ' ' A' ' 728' ' ' HIS . 38.1 Cg_endo -80.24 -173.58 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.219 1.946 . . . . 0.0 111.963 173.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -123.15 104.62 9.29 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 122.359 -0.213 . . . . 0.0 110.533 -176.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 724' ' ' THR . 86.8 m -96.99 114.35 25.95 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.106 0.479 . . . . 0.0 110.776 172.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.681 ' HB ' HD21 ' A' ' 750' ' ' LEU . 58.8 t -108.29 146.79 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . 0.565 ' O ' ' HB ' ' A' ' 747' ' ' ILE . . . -64.74 2.52 0.67 Allowed 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 125.726 1.611 . . . . 0.0 114.201 -175.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.784 ' HA ' ' HG ' ' A' ' 750' ' ' LEU . 37.1 mt 78.14 -24.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 125.482 1.513 . . . . 0.0 111.544 175.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 748' ' ' ASP . . . . . 0.489 ' H ' ' C ' ' A' ' 746' ' ' ALA . 28.7 t70 -81.4 -24.32 37.04 Favored 'General case' 0 C--N 1.258 -3.389 0 CA-C-N 112.893 -1.958 . . . . 0.0 109.248 -172.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 749' ' ' LYS . . . . . 0.456 ' HG3' ' CG1' ' A' ' 745' ' ' VAL . 1.7 ptmm? -115.46 23.6 12.26 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 113.624 -1.625 . . . . 0.0 110.919 -179.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.787 HD12 ' CD2' ' A' ' 773' ' ' HIS . 55.1 mt -81.41 -168.88 2.03 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.442 175.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 751' ' ' LYS . . . . . 0.584 ' HB2' ' C ' ' A' ' 794' ' ' ASN . 30.0 mtpp -122.63 158.43 30.02 Favored 'General case' 0 N--CA 1.396 -3.167 0 CA-C-O 121.836 0.827 . . . . 0.0 109.085 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 752' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -110.25 138.23 46.91 Favored 'General case' 0 C--N 1.245 -3.939 0 CA-C-N 113.184 -1.825 . . . . 0.0 107.943 -179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 753' ' ' CYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 771' ' ' PHE . 78.2 m -85.39 178.99 7.26 Favored 'General case' 0 C--N 1.252 -3.649 0 CA-C-N 113.416 -1.72 . . . . 0.0 110.517 179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 754' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -140.87 141.54 34.61 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . 0.449 ' HB3' ' HE1' ' A' ' 771' ' ' PHE . 5.4 p -62.78 128.35 35.52 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 123.622 0.576 . . . . 0.0 110.467 173.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 756' ' ' SER . . . . . 0.601 ' HB2' ' CG1' ' A' ' 759' ' ' ILE . 9.5 m -75.35 162.99 27.91 Favored 'General case' 0 N--CA 1.422 -1.842 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 757' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -89.76 -15.36 32.59 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 758' ' ' LEU . . . . . 0.414 HD22 ' NH2' ' A' ' 782' ' ' ARG . 40.2 mt -93.71 -18.43 22.12 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.66 0.743 . . . . 0.0 110.159 -174.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 759' ' ' ILE . . . . . 0.601 ' CG1' ' HB2' ' A' ' 756' ' ' SER . 2.4 pp -100.24 160.16 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.792 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -174.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 760' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.61 135.79 56.86 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.27 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 761' ' ' LEU . . . . . 0.468 HD11 HD13 ' A' ' 759' ' ' ILE . 1.8 mm? -110.29 -179.28 3.73 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 762' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 766' ' ' LYS . 42.0 mt-10 -63.55 157.22 24.23 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 176.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 763' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -67.73 -18.43 64.89 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.209 0.528 . . . . 0.0 111.045 -175.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 764' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -95.63 -0.12 52.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.922 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 765' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 765' ' ' LEU . 3.7 mm? -124.72 -11.78 7.2 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 762' ' ' GLU . 57.1 mtmt -69.5 -21.05 63.71 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.546 0.689 . . . . 0.0 110.598 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 767' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -88.15 14.02 10.1 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.097 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 768' ' ' LYS . . . . . 0.528 ' HG2' ' CD2' ' A' ' 771' ' ' PHE . 12.0 tppt? -110.52 117.33 33.26 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 769' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -80.89 -43.1 20.4 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 770' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -125.72 117.59 23.78 Favored 'General case' 0 CA--C 1.483 -1.599 0 CA-C-N 114.087 -1.415 . . . . 0.0 110.003 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 771' ' ' PHE . . . . . 0.528 ' CD2' ' HG2' ' A' ' 768' ' ' LYS . 88.3 m-85 -91.13 136.01 33.38 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 772' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -78.73 143.21 36.4 Favored 'General case' 0 C--N 1.276 -2.593 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.537 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 773' ' ' HIS . . . . . 0.787 ' CD2' HD12 ' A' ' 750' ' ' LEU . 47.9 p-80 -40.05 138.55 0.81 Allowed 'General case' 0 C--N 1.29 -2.021 0 C-N-CA 124.948 1.299 . . . . 0.0 111.696 171.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 774' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 74.14 6.38 4.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.796 1.638 . . . . 0.0 113.279 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 775' ' ' SER . . . . . . . . . . . . . 70.5 m -75.38 116.69 16.37 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 174.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.458 HD22 ' N ' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -86.01 102.16 13.56 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 777' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 761' ' ' LEU . 7.8 pt -113.93 179.56 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.676 0.751 . . . . 0.0 109.76 -177.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' A' ' 787' ' ' TRP . 98.8 mtt180 -127.35 119.98 27.49 Favored 'General case' 0 N--CA 1.411 -2.384 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 779' ' ' TYR . . . . . 0.691 ' CD2' HG13 ' A' ' 801' ' ' VAL . 13.5 p90 -105.58 164.14 12.13 Favored 'General case' 0 C--O 1.26 1.611 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 171.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 780' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -147.76 157.25 43.45 Favored 'General case' 0 C--N 1.263 -3.157 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 781' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 784' ' ' LYS . 42.8 t -96.23 163.54 13.05 Favored 'General case' 0 C--N 1.274 -2.69 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -176.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 782' ' ' ARG . . . . . 0.414 ' NH2' HD22 ' A' ' 758' ' ' LEU . 21.3 ptt180 -82.57 -23.0 34.67 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 120.992 0.425 . . . . 0.0 110.356 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 783' ' ' GLY . . . . . . . . . . . . . . . -94.15 -13.27 54.9 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.078 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 784' ' ' LYS . . . . . 0.52 ' HB2' ' HB3' ' A' ' 781' ' ' CYS . 0.1 OUTLIER -131.19 98.46 4.57 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 785' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -88.52 87.92 7.44 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 122.237 1.018 . . . . 0.0 111.339 -175.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 786' ' ' GLY . . . . . . . . . . . . . . . -173.63 152.55 15.56 Favored Glycine 0 CA--C 1.479 -2.157 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 787' ' ' TRP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 778' ' ' ARG . 26.2 m95 -93.18 134.81 34.98 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-N 117.571 0.685 . . . . 0.0 110.345 -172.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 788' ' ' ILE . . . . . 0.531 ' HB ' ' CE1' ' A' ' 779' ' ' TYR . 4.1 mp -94.61 -28.0 4.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.117 -177.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 789' ' ' HIS . . . . . . . . . . . . . 18.7 m170 74.62 119.54 0.05 OUTLIER 'General case' 0 N--CA 1.511 2.591 0 C-N-CA 124.375 1.07 . . . . 0.0 109.835 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 790' ' ' THR . . . . . 0.447 HG21 ' CG2' ' A' ' 801' ' ' VAL . 3.8 t -143.65 160.77 40.09 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.169 179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . . . . . . . . . 61.8 t -121.32 135.78 60.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 C-N-CA 123.897 0.879 . . . . 0.0 109.427 -177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 792' ' ' CYS . . . . . . . . . . . . . 52.8 t -72.52 103.07 3.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 122.05 0.928 . . . . 0.0 110.854 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 793' ' ' ILE . . . . . . . . . . . . . 50.6 mm -99.28 79.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.256 -3.499 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 794' ' ' ASN . . . . . 0.629 ' OD1' HD22 ' A' ' 750' ' ' LEU . 0.7 OUTLIER 50.39 68.81 0.7 Allowed 'General case' 0 C--O 1.238 0.447 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.771 176.145 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 795' ' ' GLY . . . . . . . . . . . . . . . 80.2 6.28 89.28 Favored Glycine 0 C--N 1.306 -1.092 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.043 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 796' ' ' ARG . . . . . 0.442 ' HG2' ' H ' ' A' ' 797' ' ' TRP . 34.5 ttt180 -139.53 169.09 18.38 Favored 'General case' 0 C--O 1.198 -1.657 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 797' ' ' TRP . . . . . 0.594 ' HB2' ' HA ' ' A' ' 800' ' ' GLU . 94.6 m95 -111.43 161.09 16.47 Favored 'General case' 0 C--N 1.264 -3.112 0 O-C-N 122.293 -0.254 . . . . 0.0 110.429 -179.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 798' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -150.33 106.23 3.14 Favored Pre-proline 0 C--N 1.315 -0.919 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 799' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 790' ' ' THR . 34.8 Cg_endo -67.63 138.52 43.29 Favored 'Cis proline' 0 C--O 1.243 0.774 0 C-N-CA 123.651 -1.396 . . . . 0.0 111.103 -1.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 800' ' ' GLU . . . . . 0.594 ' HA ' ' HB2' ' A' ' 797' ' ' TRP . 30.1 tt0 -55.16 121.59 9.14 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.058 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 801' ' ' VAL . . . . . 0.691 HG13 ' CD2' ' A' ' 779' ' ' TYR . 91.8 t -63.07 123.21 15.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.233 -174.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 802' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -141.03 138.51 33.7 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 803' ' ' CYS . . . . . 0.463 ' HB2' HG23 ' A' ' 759' ' ' ILE . 21.7 t -131.38 23.89 4.8 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 122.594 1.188 . . . . 0.0 108.929 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 804' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 C--N 1.293 -1.885 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.018 176.293 . . . . . . . . 0 0 . 1 stop_ save_